X.CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	NW_001_C	NW_001_F	NW_001_M	Allele	Consequence	IMPACT	SYMBOL	Gene	Feature_type	Feature	BIOTYPE	EXON	INTRON	HGVSc	HGVSp	cDNA_position	CDS_position	Protein_position	Amino_acids	Codons	Existing_variation	DISTANCE	STRAND	FLAGS	VARIANT_CLASS	SYMBOL_SOURCE	HGNC_ID	CANONICAL	REFSEQ_MATCH	REFSEQ_OFFSET	GIVEN_REF	USED_REF	BAM_EDIT	SOURCE	SIFT	PolyPhen	HGVS_OFFSET	AF	gnomADe_AF	gnomADe_AFR_AF	gnomADe_AMR_AF	gnomADe_ASJ_AF	gnomADe_EAS_AF	gnomADe_FIN_AF	gnomADe_MID_AF	gnomADe_NFE_AF	gnomADe_REMAINING_AF	gnomADe_SAS_AF	gnomADg_AF	gnomADg_AFR_AF	gnomADg_AMI_AF	gnomADg_AMR_AF	gnomADg_ASJ_AF	gnomADg_EAS_AF	gnomADg_FIN_AF	gnomADg_MID_AF	gnomADg_NFE_AF	gnomADg_REMAINING_AF	gnomADg_SAS_AF	MAX_AF	MAX_AF_POPS	CLIN_SIG	SOMATIC	PHENO	ada_score	rf_score	REVEL	BayesDel_addAF_pred	BayesDel_addAF_rankscore	BayesDel_addAF_score	BayesDel_noAF_pred	BayesDel_noAF_rankscore	BayesDel_noAF_score	REVEL_rankscore	REVEL_score	SpliceAI_pred_DP_AG	SpliceAI_pred_DP_AL	SpliceAI_pred_DP_DG	SpliceAI_pred_DP_DL	SpliceAI_pred_DS_AG	SpliceAI_pred_DS_AL	SpliceAI_pred_DS_DG	SpliceAI_pred_DS_DL	SpliceAI_pred_SYMBOL	am_class	am_genome	am_pathogenicity	am_protein_variant	am_transcript_id	am_uniprot_id	ClinVar	ClinVar_ID	ClinVar_CLNSIG	ClinVar_CLNDN	ClinVar_CLNHGVS	ClinVar_CLNSIGINCL	ClinVar_CLNVC	ClinVar_GENEINFO	ClinVar_CLNDISDB	ClinVar_CLNSIGCONF	ClinVar_CLNREVSTAT	ClinVar_CLNDNINCL	Genes	Disease	Inheritance	MIM	Disorder_Group	Project	acmg_score	acmg_classification	acmg_criteria	rsID	variant_info	Gender	Genotype	Zygosity
chr10	8054743	.	T	TAA	50	PASS	"FS=2.128;MQ=250;MQRankSum=3.423;QD=2.27;ReadPosRankSum=-0.454;SOR=1.765;FractionInformativeReads=0.909;R2_5P_bias=-11.088;DP=22;AF=0.5;AN=2;AC=1;CSQ=AA|5_prime_UTR_variant|MODIFIER|GATA3|2625|Transcript|NM_001002295.2|protein_coding|1/6||NM_001002295.2:c.-503_-502dup||56-57|||||rs60098638||1||insertion|EntrezGene||YES|||||||||16||0|||||||0|||0.3404|0.2526|0.5119|0.3594|0.3904|0.4331|0.2812|0.3682|0.3745|0.3511|0.4468|0.5119|gnomADg_AMI|uncertain_significance||1|||||||||||||||||||||||||||301100||Uncertain_significance|Hypoparathyroidism&_deafness&_renal_disease_syndrome&not_provided|NC_000010.11:g.8054758_8054759dup||Duplication|GATA3:2625|MONDO:MONDO:0007797&MedGen:C1840333&OMIM:146255&Orphanet:2237&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:6,14:0.7:20:3,6:3,8:44:57,0,43:50,0.00015532,45.895:0,7,10:3,3,4,10:2,4,8,6	AA	5_prime_UTR_variant	MODIFIER	GATA3	2625	Transcript	NM_001002295.2	protein_coding	06-Jan		c.-503_-502dup		56-57					rs60098638	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			16	NA	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.3404	0.2526	0.5119	0.3594	0.3904	0.4331	0.2812	0.3682	0.3745	0.3511	0.4468	0.5119	gnomADg_AMI	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				301100	NA	Uncertain_significance	Hypoparathyroidism&_deafness&_renal_disease_syndrome&not_provided	NC_000010.11:g.8054758_8054759dup		Duplication	GATA3:2625	MONDO:MONDO:0007797&MedGen:C1840333&OMIM:146255&Orphanet:2237&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		GATA3	Hypoparathyroidism, deafness, renal disease syndrome	AD	146255	Complex genetic syndromes	NBScreening	-8	Benign	BA1	rs60098638	chr10_8054743_T_TAA	Female	./.	Other
chr10	8074278	.	G	GA	153.49	PASS	"FS=4.993;MQ=250;MQRankSum=5.017;QD=1.43;ReadPosRankSum=-2.368;SOR=1.609;FractionInformativeReads=1;R2_5P_bias=25.044;DP=103;AF=1;AN=6;AC=4;CSQ=A|3_prime_UTR_variant|MODIFIER|GATA3|2625|Transcript|NM_001002295.2|protein_coding|6/6||NM_001002295.2:c.*265dup||2163-2164|||||rs3839918||1||insertion|EntrezGene||YES|||||||||10||0.5994|0.5196|0.6349|0.6406|0.7495|0.5934|0.6034|0.5826|0.602|0.6001|0.7439|0.6481|0.8703|0.8139|0.8267|0.944|0.783|0.8082|0.752|0.7632|0.8348|0.944|gnomADg_EAS|uncertain_significance&benign&likely_benign||1||||||||||||36|-16|-24|36|0.00|0.00|0.00|0.00|GATA3|||||||301133||Conflicting_classifications_of_pathogenicity|not_provided&Hypoparathyroidism&_deafness&_renal_disease_syndrome|NC_000010.11:g.8074288dup||Duplication|GATA3:2625|MedGen:CN517202&MONDO:MONDO:0007797&MedGen:C1840333&OMIM:146255&Orphanet:2237|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,19:0.543:35:3,8:13,11:48:64,0,49:50,6.8339e-05,52.434:0,14,17:8,8,13,6:9,7,10,9	0/1:11,18:0.621:29:8,11:3,7:47:64,0,46:50,9.4744e-05,49.267:0,14,17:9,2,10,8:6,5,7,11	1/1:0,36:1:36:0,17:0,19:103:170,106,0:153.49,103.49,0:0,14,17:0,0,25,11:0,0,14,22	A	3_prime_UTR_variant	MODIFIER	GATA3	2625	Transcript	NM_001002295.2	protein_coding	06-Jun		c.*265dup		2163-2164					rs3839918	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			10	NA	0.5994	0.5196	0.6349	0.6406	0.7495	0.5934	0.6034	0.5826	0.602	0.6001	0.7439	0.6481	0.8703	0.8139	0.8267	0.944	0.783	0.8082	0.752	0.7632	0.8348	0.944	gnomADg_EAS	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		36	-16	-24	36	0	0	0	0	GATA3			NA				301133	NA	Conflicting_classifications_of_pathogenicity	not_provided&Hypoparathyroidism&_deafness&_renal_disease_syndrome	NC_000010.11:g.8074288dup		Duplication	GATA3:2625	MedGen:CN517202&MONDO:MONDO:0007797&MedGen:C1840333&OMIM:146255&Orphanet:2237	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		GATA3	Hypoparathyroidism, deafness, renal disease syndrome	AD	146255	Complex genetic syndromes	NBScreening	-9	Benign	BP6,BA1	rs3839918	chr10_8074278_G_GA	Female	0/1	Heterozygous
chr10	14907857	.	C	CT	50	PASS	"FS=6.825;MQ=224.64;MQRankSum=1.232;QD=1.92;ReadPosRankSum=1.287;SOR=0.086;FractionInformativeReads=0.962;R2_5P_bias=1.446;DP=59;AF=0.5;AN=4;AC=2;CSQ=T|3_prime_UTR_variant|MODIFIER|DCLRE1C|64421|Transcript|NM_001033855.3|protein_coding|14/14||NM_001033855.3:c.*550dup||2715-2716|||||rs60410513||-1||insertion|EntrezGene||YES|||||||||||0|0|0||0|0||0|0||0.06933|0.1317|0.1504|0.06188|0.08349|0.2482|0.004587|0.02222|0.0279|0.06166|0.1154|0.2482|gnomADg_EAS|uncertain_significance&benign||1|||||||||||||||||||||||||||299296||Uncertain_significance|Histiocytic_medullary_reticulosis&not_provided|NC_000010.11:g.14907878dup||Duplication|DCLRE1C:64421|MONDO:MONDO:0011338&MedGen:C2700553&OMIM:603554&Orphanet:39041&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,14:0.56:25:9,8:2,6:48:54,0,49:50,7.3776e-05,51.557:0,4,7:2,9,7,7:4,7,11,3	0/1:16,15:0.484:31:8,11:8,4:48:54,0,50:49.894,6.6269e-05,53:0,4,7:3,13,5,10:9,7,7,8	T	3_prime_UTR_variant	MODIFIER	DCLRE1C	64421	Transcript	NM_001033855.3	protein_coding	14/14		c.*550dup		2715-2716					rs60410513	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0	0	0	NA	0	0	NA	0	0	NA	0.06933	0.1317	0.1504	0.06188	0.08349	0.2482	0.004587	0.02222	0.0279	0.06166	0.1154	0.2482	gnomADg_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				299296	NA	Uncertain_significance	Histiocytic_medullary_reticulosis&not_provided	NC_000010.11:g.14907878dup		Duplication	DCLRE1C:64421	MONDO:MONDO:0011338&MedGen:C2700553&OMIM:603554&Orphanet:39041&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		DCLRE1C	Severe combined immunodeficiency due to DCLRE1C deficiency	AR	602450	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-8	Benign	BA1	rs60410513	chr10_14907857_C_CT	Female	./.	Other
chr10	14907857	.	C	CT	50	PASS	"FS=6.825;MQ=224.64;MQRankSum=1.232;QD=1.92;ReadPosRankSum=1.287;SOR=0.086;FractionInformativeReads=0.962;R2_5P_bias=1.446;DP=59;AF=0.5;AN=4;AC=2;CSQ=T|3_prime_UTR_variant|MODIFIER|DCLRE1C|64421|Transcript|NM_001033855.3|protein_coding|14/14||NM_001033855.3:c.*550dup||2715-2716|||||rs60410513||-1||insertion|EntrezGene||YES|||||||||||0|0|0||0|0||0|0||0.06933|0.1317|0.1504|0.06188|0.08349|0.2482|0.004587|0.02222|0.0279|0.06166|0.1154|0.2482|gnomADg_EAS|uncertain_significance&benign||1|||||||||||||||||||||||||||299296||Uncertain_significance|Histiocytic_medullary_reticulosis&not_provided|NC_000010.11:g.14907878dup||Duplication|DCLRE1C:64421|MONDO:MONDO:0011338&MedGen:C2700553&OMIM:603554&Orphanet:39041&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,14:0.56:25:9,8:2,6:48:54,0,49:50,7.3776e-05,51.557:0,4,7:2,9,7,7:4,7,11,3	0/1:16,15:0.484:31:8,11:8,4:48:54,0,50:49.894,6.6269e-05,53:0,4,7:3,13,5,10:9,7,7,8	T	3_prime_UTR_variant	MODIFIER	DCLRE1C	64421	Transcript	NM_001033855.3	protein_coding	14/14		c.*550dup		2715-2716					rs60410513	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0	0	0	NA	0	0	NA	0	0	NA	0.06933	0.1317	0.1504	0.06188	0.08349	0.2482	0.004587	0.02222	0.0279	0.06166	0.1154	0.2482	gnomADg_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				299296	NA	Uncertain_significance	Histiocytic_medullary_reticulosis&not_provided	NC_000010.11:g.14907878dup		Duplication	DCLRE1C:64421	MONDO:MONDO:0011338&MedGen:C2700553&OMIM:603554&Orphanet:39041&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		DCLRE1C	Histiocytic medullary reticulosis	AR	603554	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-8	Benign	BA1	rs60410513	chr10_14907857_C_CT	Female	./.	Other
chr10	23193706	.	T	C	181.52	PASS	"FS=0;MQ=249.91;QD=4.03;SOR=1.038;FractionInformativeReads=1;MQRankSum=4.796;ReadPosRankSum=3.927;R2_5P_bias=-13.914;DP=118;AF=0.5;AN=6;AC=4;CSQ=C|missense_variant&splice_region_variant|MODERATE|PTF1A|256297|Transcript|NM_178161.3|protein_coding|2/2||NM_178161.3:c.787T>C|NP_835455.1:p.Ser263Pro|1006|787|263|S/P|Tcc/Ccc|rs7918487&COSV64734830||1||SNV|EntrezGene||YES|||T|T|||deleterious(0.04)|unknown(0)||0.6244|0.4938|0.5601|0.6724|0.5597|0.8378|0.4417|0.6054|0.4672|0.5268|0.5353|0.524|0.5578|0.4215|0.5843|0.5542|0.8799|0.4411|0.6327|0.4725|0.5375|0.5558|0.8799|gnomADg_EAS|uncertain_significance&benign&likely_benign|0&1|1&1||||T|0.01736|-0.418964|T|0.51698|-0.230769|0.67782|0.357|43|-28|-44|-2|0.04|0.00|0.00|0.00|PTF1A|likely_benign|hg38|0.1613|S263P|ENST00000376504.4|Q7RTS3|130055||Conflicting_classifications_of_pathogenicity|not_provided&Permanent_neonatal_diabetes_mellitus-pancreatic_and_cerebellar_agenesis_syndrome&Pancreatic_beta_cell_agenesis_with_neonatal_diabetes_mellitus&Permanent_neonatal_diabetes_mellitus&not_specified&Pancreatic_agenesis_2|NC_000010.11:g.23193706T>C||single_nucleotide_variant|PTF1A:256297|MedGen:C3661900&MONDO:MONDO:0012192&MedGen:C1836780&OMIM:609069&Orphanet:65288&MONDO:MONDO:0010813&MedGen:C1838655&OMIM:600089&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN169374&MONDO:MONDO:0014406&MedGen:C4014737&OMIM:615935&Orphanet:2805|Uncertain_significance(1)&Benign(7)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,45:1:45:0,26:0,19:132:219,135,0:181.52,131.52,0:0,34.77,37.77:0,0,19,26:0,0,20,25	0/1:15,17:0.531:32:7,11:8,6:48:85,0,50:50,6.6527e-05,52.724:0,34.77,37.77:6,9,11,6:6,9,15,2	0/1:20,21:0.512:41:10,14:10,7:48:85,0,50:50,6.5233e-05,52.968:0,34.77,37.77:8,12,9,12:8,12,8,13	C	missense_variant&splice_region_variant	MODERATE	PTF1A	256297	Transcript	NM_178161.3	protein_coding	02-Feb		c.787T>C	p.Ser263Pro	1006	787	263	S/P	Tcc/Ccc	rs7918487&COSV64734830	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	deleterious(0.04)	unknown(0)	NA	0.6244	0.4938	0.5601	0.6724	0.5597	0.8378	0.4417	0.6054	0.4672	0.5268	0.5353	0.524	0.5578	0.4215	0.5843	0.5542	0.8799	0.4411	0.6327	0.4725	0.5375	0.5558	0.8799	gnomADg_EAS	uncertain_significance&benign&likely_benign	0&1	1&1	NA	NA	NA	T	0.01736	-0.418964	T	0.51698	-0.230769	0.67782	0.357	43	-28	-44	-2	0.04	0	0	0	PTF1A	likely_benign	hg38	0.1613	S263P	ENST00000376504.4	Q7RTS3	130055	NA	Conflicting_classifications_of_pathogenicity	not_provided&Permanent_neonatal_diabetes_mellitus-pancreatic_and_cerebellar_agenesis_syndrome&Pancreatic_beta_cell_agenesis_with_neonatal_diabetes_mellitus&Permanent_neonatal_diabetes_mellitus&not_specified&Pancreatic_agenesis_2	NC_000010.11:g.23193706T>C		single_nucleotide_variant	PTF1A:256297	MedGen:C3661900&MONDO:MONDO:0012192&MedGen:C1836780&OMIM:609069&Orphanet:65288&MONDO:MONDO:0010813&MedGen:C1838655&OMIM:600089&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN169374&MONDO:MONDO:0014406&MedGen:C4014737&OMIM:615935&Orphanet:2805	Uncertain_significance(1)&Benign(7)	criteria_provided&_conflicting_classifications		PTF1A	Pancreatic agenesis 2	AR	615935	Gastrointestinal disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs7918487	chr10_23193706_T_C	Female	01-Jan	Homozygous
chr10	26212351	.	AT	A	49.9	PASS	"FS=0;MQ=249.31;MQRankSum=3.293;QD=2.08;ReadPosRankSum=-0.4;SOR=1.022;FractionInformativeReads=0.958;R2_5P_bias=4.445;DP=59;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|MYO3A|53904|Transcript|NM_017433.5|protein_coding|35/35||NM_017433.5:c.*399del||5444|||||rs558895234||1||deletion|EntrezGene||YES|||T|T|||||10||0.2767|0.6121|0.2875|0.2434|0.4049|0.1917|0.3223|0.251|0.2936|0.2871|0.334|0.681|0.2439|0.2707|0.1702|0.3245|0.1459|0.2937|0.1788|0.3177|0.2446|0.681|gnomADg_AFR|uncertain_significance||1||||||||||||-1|39|-21|-18|0.00|0.00|0.00|0.00|MYO3A|||||||299687||Uncertain_significance|Hearing_loss&_autosomal_recessive&not_provided|NC_000010.11:g.26212362del||Deletion|MYO3A:53904|MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,11:0.478:23:7,5:5,6:48:62,0,50:49.903,6.6269e-05,53:0,12,15:9,3,9,2:8,4,5,6	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:20,13:0.394:33:11,8:9,5:46:59,0,50:46.736,0.0001139,53:0,12,15:12,8,6,7:9,11,5,8	-	3_prime_UTR_variant	MODIFIER	MYO3A	53904	Transcript	NM_017433.5	protein_coding	35/35		c.*399del		5444					rs558895234	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			10	NA	0.2767	0.6121	0.2875	0.2434	0.4049	0.1917	0.3223	0.251	0.2936	0.2871	0.334	0.681	0.2439	0.2707	0.1702	0.3245	0.1459	0.2937	0.1788	0.3177	0.2446	0.681	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-1	39	-21	-18	0	0	0	0	MYO3A			NA				299687	NA	Uncertain_significance	Hearing_loss&_autosomal_recessive&not_provided	NC_000010.11:g.26212362del		Deletion	MYO3A:53904	MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		MYO3A	Autosomal recessive nonsyndromic hearing loss 30	AR	607101	Hearing disorders	NBScreening	-8	Benign	BA1	rs558895234	chr10_26212351_AT_A	Female	0/1	Heterozygous
chr10	26212351	.	AT	A	49.9	PASS	"FS=0;MQ=249.31;MQRankSum=3.293;QD=2.08;ReadPosRankSum=-0.4;SOR=1.022;FractionInformativeReads=0.958;R2_5P_bias=4.445;DP=59;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|MYO3A|53904|Transcript|NM_017433.5|protein_coding|35/35||NM_017433.5:c.*399del||5444|||||rs558895234||1||deletion|EntrezGene||YES|||T|T|||||10||0.2767|0.6121|0.2875|0.2434|0.4049|0.1917|0.3223|0.251|0.2936|0.2871|0.334|0.681|0.2439|0.2707|0.1702|0.3245|0.1459|0.2937|0.1788|0.3177|0.2446|0.681|gnomADg_AFR|uncertain_significance||1||||||||||||-1|39|-21|-18|0.00|0.00|0.00|0.00|MYO3A|||||||299687||Uncertain_significance|Hearing_loss&_autosomal_recessive&not_provided|NC_000010.11:g.26212362del||Deletion|MYO3A:53904|MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,11:0.478:23:7,5:5,6:48:62,0,50:49.903,6.6269e-05,53:0,12,15:9,3,9,2:8,4,5,6	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:20,13:0.394:33:11,8:9,5:46:59,0,50:46.736,0.0001139,53:0,12,15:12,8,6,7:9,11,5,8	-	3_prime_UTR_variant	MODIFIER	MYO3A	53904	Transcript	NM_017433.5	protein_coding	35/35		c.*399del		5444					rs558895234	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			10	NA	0.2767	0.6121	0.2875	0.2434	0.4049	0.1917	0.3223	0.251	0.2936	0.2871	0.334	0.681	0.2439	0.2707	0.1702	0.3245	0.1459	0.2937	0.1788	0.3177	0.2446	0.681	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-1	39	-21	-18	0	0	0	0	MYO3A			NA				299687	NA	Uncertain_significance	Hearing_loss&_autosomal_recessive&not_provided	NC_000010.11:g.26212362del		Deletion	MYO3A:53904	MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		MYO3A	Sensorineural hearing loss	AR	267300	Hearing disorders	NBScreening	-8	Benign	BA1	rs558895234	chr10_26212351_AT_A	Female	0/1	Heterozygous
chr10	74120011	.	T	TAA	222.14	PASS	"FS=0;MQ=149;QD=5.06;SOR=2.925;FractionInformativeReads=0.923;MQRankSum=-1.733;ReadPosRankSum=-0.657;R2_5P_bias=0;DP=83;AF=0.5;AN=6;AC=3;CSQ=AA|3_prime_UTR_variant|MODIFIER|VCL|7414|Transcript|NM_014000.3|protein_coding|22/22||NM_014000.3:c.*1861_*1862dup||5339-5340|||||rs3037361||1||insertion|EntrezGene||YES|||||||||20||0|||||0|||||0.5177|0.3697|0.5375|0.5324|0.7186|0.2906|0.4907|0.6198|0.6053|0.5758|0.4274|0.7186|gnomADg_ASJ|uncertain_significance||1|||||||||||||||||||||||||||300824||Uncertain_significance|not_provided&Dilated_Cardiomyopathy&_Dominant|NC_000010.11:g.74120030_74120031dup||Duplication|VCL:7414|MedGen:C3661900&MedGen:CN239310||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:0,5:0.208:24:0,2:0,3:14:141,270,52:131.63,265.4,50.166:0,5,8.01:0,0,20,4:0,0,11,13	0/1:0,11:0.458:24:0,5:0,6:49:230,177,53:222.14,173.14,52.025:0,4,7:0,0,14,10:0,0,11,13	0/1:1,17:0.586:29:1,8:0,9:48:192,139,51:184.48,135.23,50.246:0,4,7:1,0,21,7:1,0,14,14	AA	3_prime_UTR_variant	MODIFIER	VCL	7414	Transcript	NM_014000.3	protein_coding	22/22		c.*1861_*1862dup		5339-5340					rs3037361	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			20	NA	0	NA	NA	NA	NA	0	NA	NA	NA	NA	0.5177	0.3697	0.5375	0.5324	0.7186	0.2906	0.4907	0.6198	0.6053	0.5758	0.4274	0.7186	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				300824	NA	Uncertain_significance	not_provided&Dilated_Cardiomyopathy&_Dominant	NC_000010.11:g.74120030_74120031dup		Duplication	VCL:7414	MedGen:C3661900&MedGen:CN239310		criteria_provided&_multiple_submitters&_no_conflicts		VCL	Dilated cardiomyopathy 1W	AD	611407	Cardiac and vascular disorders	NBScreening	-8	Benign	BA1	rs3037361	chr10_74120011_T_TAA	Female	0/1	Heterozygous
chr10	74120011	.	T	TAA	222.14	PASS	"FS=0;MQ=149;QD=5.06;SOR=2.925;FractionInformativeReads=0.923;MQRankSum=-1.733;ReadPosRankSum=-0.657;R2_5P_bias=0;DP=83;AF=0.5;AN=6;AC=3;CSQ=AA|3_prime_UTR_variant|MODIFIER|VCL|7414|Transcript|NM_014000.3|protein_coding|22/22||NM_014000.3:c.*1861_*1862dup||5339-5340|||||rs3037361||1||insertion|EntrezGene||YES|||||||||20||0|||||0|||||0.5177|0.3697|0.5375|0.5324|0.7186|0.2906|0.4907|0.6198|0.6053|0.5758|0.4274|0.7186|gnomADg_ASJ|uncertain_significance||1|||||||||||||||||||||||||||300824||Uncertain_significance|not_provided&Dilated_Cardiomyopathy&_Dominant|NC_000010.11:g.74120030_74120031dup||Duplication|VCL:7414|MedGen:C3661900&MedGen:CN239310||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:0,5:0.208:24:0,2:0,3:14:141,270,52:131.63,265.4,50.166:0,5,8.01:0,0,20,4:0,0,11,13	0/1:0,11:0.458:24:0,5:0,6:49:230,177,53:222.14,173.14,52.025:0,4,7:0,0,14,10:0,0,11,13	0/1:1,17:0.586:29:1,8:0,9:48:192,139,51:184.48,135.23,50.246:0,4,7:1,0,21,7:1,0,14,14	AA	3_prime_UTR_variant	MODIFIER	VCL	7414	Transcript	NM_014000.3	protein_coding	22/22		c.*1861_*1862dup		5339-5340					rs3037361	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			20	NA	0	NA	NA	NA	NA	0	NA	NA	NA	NA	0.5177	0.3697	0.5375	0.5324	0.7186	0.2906	0.4907	0.6198	0.6053	0.5758	0.4274	0.7186	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				300824	NA	Uncertain_significance	not_provided&Dilated_Cardiomyopathy&_Dominant	NC_000010.11:g.74120030_74120031dup		Duplication	VCL:7414	MedGen:C3661900&MedGen:CN239310		criteria_provided&_multiple_submitters&_no_conflicts		VCL	Hypertrophic cardiomyopathy 15	AD	613255	Cardiac and vascular disorders	NBScreening	-8	Benign	BA1	rs3037361	chr10_74120011_T_TAA	Female	0/1	Heterozygous
chr10	86924465	.	A	G	18.79	PASS	"FS=7.04;MQ=49.01;MQRankSum=-3.555;QD=0.67;ReadPosRankSum=-1.857;SOR=1.485;FractionInformativeReads=1;R2_5P_bias=-21.636;DP=28;AF=0.5;AN=2;AC=1;CSQ=G|3_prime_UTR_variant|MODIFIER|BMPR1A|657|Transcript|NM_004329.3|protein_coding|13/13||NM_004329.3:c.*746A>G||2913|||||rs61856965&COSV64404816||1||SNV|EntrezGene||YES|||A|A|||||||0.001335|0.000565|0.001002|0.001414|0.0008259|0.04511|0|0.001214|0.001607|0.001712|0.001481|0.0008585|0|0.004208|0|0.001854|0.003539|0|0.0009518|0.001175|0.003528|0.04511|gnomADe_FIN|uncertain_significance|0&1|1&1||||||||||||-15|7|18|-3|0.00|0.00|0.00|0.00|BMPR1A|||||||301363||Uncertain_significance|Generalized_juvenile_polyposis/juvenile_polyposis_coli|NC_000010.11:g.86924465A>G||single_nucleotide_variant|BMPR1A:657|MONDO:MONDO:0008276&MedGen:C1868081&Orphanet:329971||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:21,7:0.25:28:15,3:6,4:19:54,0,43:18.787,0.057917,46.058:0,34.77,37.77:8,13,5,2:6,15,3,4	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	G	3_prime_UTR_variant	MODIFIER	BMPR1A	657	Transcript	NM_004329.3	protein_coding	13/13		c.*746A>G		2913					rs61856965&COSV64404816	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.001335	0.000565	0.001002	0.001414	0.0008259	0.04511	0	0.001214	0.001607	0.001712	0.001481	0.0008585	0	0.004208	0	0.001854	0.003539	0	0.0009518	0.001175	0.003528	0.04511	gnomADe_FIN	uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-15	7	18	-3	0	0	0	0	BMPR1A			NA				301363	NA	Uncertain_significance	Generalized_juvenile_polyposis/juvenile_polyposis_coli	NC_000010.11:g.86924465A>G		single_nucleotide_variant	BMPR1A:657	MONDO:MONDO:0008276&MedGen:C1868081&Orphanet:329971		criteria_provided&_single_submitter		BMPR1A	Juvenile polyposis syndrome	AD	174900	Tumor predisposition syndromes	NBScreening	-4	Likely_benign	BP4_Strong	rs61856965	chr10_86924465_A_G	Female	0/1	Heterozygous
chr10	87966902	.	GTT	G	134.53	PASS	"FS=0;MQ=240.77;QD=6.2;SOR=1.493;FractionInformativeReads=0.9;DP=58;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|PTEN|5728|Transcript|NM_000314.8|protein_coding|9/9||NM_000314.8:c.*1458_*1459del||3488-3489|||||rs5786797||1||deletion|EntrezGene||YES|||TT|TT|||||27||0.1844|0.1803|0.1826|0.1807|0.2003|0.002551|0.2188|0.1855|0.1793|0.216|0.2955|0.3073|0.38|0.2542|0.3086|0.2374|0.1198|0.32|0.3003|0.2944|0.3398|0.38|gnomADg_AMI|uncertain_significance||1||||||||||||-35|39|-2|9|0.00|0.00|0.00|0.00|PTEN|||||||301452||Uncertain_significance|not_provided&PTEN_hamartoma_tumor_syndrome|NC_000010.11:g.87966930_87966931del||Deletion|PTEN:5728|MedGen:C3661900&MONDO:MONDO:0017623&MeSH:D006223&MedGen:C1959582&Orphanet:306498||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,12:0.667:18:0,7:0,5:44:132,78,46:123.98,73.985,44.822:0,4,7:0,0,6,12:0,0,11,7	0/1:0,8:0.533:15:0,3:0,5:50:143,89,54:134.53,84.535,53:0,4,7:0,0,5,10:0,0,11,4	0/1:0,8:0.571:14:0,6:0,2:50:131,77,53:122.78,72.784,52.423:0,4,7:0,0,7,7:0,0,9,5	-	3_prime_UTR_variant	MODIFIER	PTEN	5728	Transcript	NM_000314.8	protein_coding	09-Sep		c.*1458_*1459del		3488-3489					rs5786797	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TT	TT	NA	NA			27	NA	0.1844	0.1803	0.1826	0.1807	0.2003	0.002551	0.2188	0.1855	0.1793	0.216	0.2955	0.3073	0.38	0.2542	0.3086	0.2374	0.1198	0.32	0.3003	0.2944	0.3398	0.38	gnomADg_AMI	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-35	39	-2	9	0	0	0	0	PTEN			NA				301452	NA	Uncertain_significance	not_provided&PTEN_hamartoma_tumor_syndrome	NC_000010.11:g.87966930_87966931del		Deletion	PTEN:5728	MedGen:C3661900&MONDO:MONDO:0017623&MeSH:D006223&MedGen:C1959582&Orphanet:306498		criteria_provided&_multiple_submitters&_no_conflicts		PTEN	Cowden syndrome 1	AD	158350	Tumor predisposition syndromes	NBScreening	-4	Likely_benign	BS2	rs5786797	chr10_87966902_GTT_G	Female	1/0	Heterozygous
chr10	87966902	.	GTT	G	134.53	PASS	"FS=0;MQ=240.77;QD=6.2;SOR=1.493;FractionInformativeReads=0.9;DP=58;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|PTEN|5728|Transcript|NM_000314.8|protein_coding|9/9||NM_000314.8:c.*1458_*1459del||3488-3489|||||rs5786797||1||deletion|EntrezGene||YES|||TT|TT|||||27||0.1844|0.1803|0.1826|0.1807|0.2003|0.002551|0.2188|0.1855|0.1793|0.216|0.2955|0.3073|0.38|0.2542|0.3086|0.2374|0.1198|0.32|0.3003|0.2944|0.3398|0.38|gnomADg_AMI|uncertain_significance||1||||||||||||-35|39|-2|9|0.00|0.00|0.00|0.00|PTEN|||||||301452||Uncertain_significance|not_provided&PTEN_hamartoma_tumor_syndrome|NC_000010.11:g.87966930_87966931del||Deletion|PTEN:5728|MedGen:C3661900&MONDO:MONDO:0017623&MeSH:D006223&MedGen:C1959582&Orphanet:306498||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,12:0.667:18:0,7:0,5:44:132,78,46:123.98,73.985,44.822:0,4,7:0,0,6,12:0,0,11,7	0/1:0,8:0.533:15:0,3:0,5:50:143,89,54:134.53,84.535,53:0,4,7:0,0,5,10:0,0,11,4	0/1:0,8:0.571:14:0,6:0,2:50:131,77,53:122.78,72.784,52.423:0,4,7:0,0,7,7:0,0,9,5	-	3_prime_UTR_variant	MODIFIER	PTEN	5728	Transcript	NM_000314.8	protein_coding	09-Sep		c.*1458_*1459del		3488-3489					rs5786797	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TT	TT	NA	NA			27	NA	0.1844	0.1803	0.1826	0.1807	0.2003	0.002551	0.2188	0.1855	0.1793	0.216	0.2955	0.3073	0.38	0.2542	0.3086	0.2374	0.1198	0.32	0.3003	0.2944	0.3398	0.38	gnomADg_AMI	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-35	39	-2	9	0	0	0	0	PTEN			NA				301452	NA	Uncertain_significance	not_provided&PTEN_hamartoma_tumor_syndrome	NC_000010.11:g.87966930_87966931del		Deletion	PTEN:5728	MedGen:C3661900&MONDO:MONDO:0017623&MeSH:D006223&MedGen:C1959582&Orphanet:306498		criteria_provided&_multiple_submitters&_no_conflicts		PTEN	Cowden disease	AD	616858	Tumor predisposition syndromes	NBScreening	-4	Likely_benign	BS2	rs5786797	chr10_87966902_GTT_G	Female	1/0	Heterozygous
chr10	97612009	.	A	AT	50	PASS	"FS=0;MQ=247.34;MQRankSum=2.989;QD=1.6;ReadPosRankSum=0.022;SOR=0.648;FractionInformativeReads=1;R2_5P_bias=-3.229;DP=69;AF=0.5;AN=6;AC=3;CSQ=T|3_prime_UTR_variant|MODIFIER|HOGA1|112817|Transcript|NM_138413.4|protein_coding|7/7||NM_138413.4:c.*354dup||1649-1650|||||rs5787248||1||insertion|EntrezGene||YES|||||||||4||0.1373|0.2277|0.1689|0.06921|0.1065|0.1239|0.1372|0.1439|0.1361|0.113|0.3626|0.4841|0.2767|0.3269|0.2041|0.2937|0.2967|0.3514|0.3361|0.3365|0.26|0.4841|gnomADg_AFR|uncertain_significance||1||||||||||||32|-10|-10|21|0.00|0.00|0.00|0.00|HOGA1|||||||301811||Uncertain_significance|Primary_hyperoxaluria&not_provided|NC_000010.11:g.97612013dup||Duplication|HOGA1:112817|MONDO:MONDO:0002474&MedGen:C0020501&OMIM:PS259900&Orphanet:416&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	0|1:18,11:0.379:29:10,6:8,5:45:76,0,47:46.304,0.00014522,50:0,30,33.01:10,8,6,5:6,12,7,4:97612009	0|1:13,13:0.5:26:6,7:7,6:47:80,0,47:50,8.6978e-05,50:0,30,33.01:7,6,6,7:8,5,8,5:97612009	0|1:7,6:0.462:13:3,4:4,2:47:80,0,47:50,8.8272e-05,49.855:0,30,33.01:6,1,4,2:2,5,2,4:97612009	T	3_prime_UTR_variant	MODIFIER	HOGA1	112817	Transcript	NM_138413.4	protein_coding	07-Jul		c.*354dup		1649-1650					rs5787248	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			4	NA	0.1373	0.2277	0.1689	0.06921	0.1065	0.1239	0.1372	0.1439	0.1361	0.113	0.3626	0.4841	0.2767	0.3269	0.2041	0.2937	0.2967	0.3514	0.3361	0.3365	0.26	0.4841	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		32	-10	-10	21	0	0	0	0	HOGA1			NA				301811	NA	Uncertain_significance	Primary_hyperoxaluria&not_provided	NC_000010.11:g.97612013dup		Duplication	HOGA1:112817	MONDO:MONDO:0002474&MedGen:C0020501&OMIM:PS259900&Orphanet:416&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		HOGA1	Primary hyperoxaluria type 3	AR	613616	Renal disorders	NBScreening	-8	Benign	BA1	rs5787248	chr10_97612009_A_AT	Female	0|1	Heterozygous
chr10	123053169	.	AT	A	166.62	PASS	"FS=0;MQ=250;QD=4.06;SOR=1.445;FractionInformativeReads=0.976;DP=108;AF=1;AN=6;AC=6;CSQ=-|intron_variant|MODIFIER|ACADSB|36|Transcript|NM_001609.4|protein_coding||10/10|NM_001609.4:c.1228+21del|||||||rs11307362||1||deletion|EntrezGene||YES|||T|T|||||11|0.8413|0.7759|0.7806|0.8253|0.8229|0.7285|0.829|0.8488|0.7651|0.7838|0.8403|0.8799|0.8803|0.7561|0.8926|0.931|0.8443|0.9259|0.9555|0.8677|0.8681|0.9355|0.9555|gnomADg_MID|uncertain_significance&benign&likely_benign||1||||||||||||43|-34|-13|-10|0.00|0.00|0.00|0.01|ACADSB|||||||299089||Conflicting_classifications_of_pathogenicity|Deficiency_of_2-methylbutyryl-CoA_dehydrogenase|NC_000010.11:g.123053181del||Deletion|ACADSB:36|Human_Phenotype_Ontology:HP:0020147&MONDO:MONDO:0012392&MedGen:C1864912&OMIM:610006&Orphanet:79157|Uncertain_significance(1)&Benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,40:1:40:0,21:0,19:117:180,120,0:166.62,116.62,0:0,10,13:0,0,26,14:0,0,19,21	1/1:0,29:1:29:0,17:0,12:84:148,87,0:133.75,83.751,0:0,11,14:0,0,23,6:0,0,15,14	1/1:0,36:1:36:0,20:0,16:105:168,108,0:154.64,104.64,0:0,10,13:0,0,22,14:0,0,22,14	-	intron_variant	MODIFIER	ACADSB	36	Transcript	NM_001609.4	protein_coding		10-Oct	c.1228+21del							rs11307362	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			11	0.8413	0.7759	0.7806	0.8253	0.8229	0.7285	0.829	0.8488	0.7651	0.7838	0.8403	0.8799	0.8803	0.7561	0.8926	0.931	0.8443	0.9259	0.9555	0.8677	0.8681	0.9355	0.9555	gnomADg_MID	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		43	-34	-13	-10	0	0	0	0.01	ACADSB			NA				299089	NA	Conflicting_classifications_of_pathogenicity	Deficiency_of_2-methylbutyryl-CoA_dehydrogenase	NC_000010.11:g.123053181del		Deletion	ACADSB:36	Human_Phenotype_Ontology:HP:0020147&MONDO:MONDO:0012392&MedGen:C1864912&OMIM:610006&Orphanet:79157	Uncertain_significance(1)&Benign(3)	criteria_provided&_conflicting_classifications		ACADSB	Deficiency of 2-methylbutyryl-CoA dehydrogenase	AR	610006	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs11307362	chr10_123053169_AT_A	Female	01-Jan	Homozygous
chr11	535463	.	G	A	121.3	PASS	"FS=0;MQ=248.83;QD=4.67;SOR=0.941;FractionInformativeReads=0.962;MQRankSum=3.2;ReadPosRankSum=0.597;R2_5P_bias=8.88;DP=75;AF=0.5;AN=6;AC=4;CSQ=A|5_prime_UTR_variant|MODIFIER|HRAS|3265|Transcript|NM_005343.4|protein_coding|1/6||NM_005343.4:c.-101C>T||114|||||rs8176336||-1||SNV|EntrezGene||YES|||G|G|||||||0.131|||||||0.1667|0|0.1323|0.1042|0.07554|0.2214|0.08018|0.08893|0.1312|0.1186|0.09028|0.1169|0.09559|0.1874|0.2214|gnomADg_AMI|benign&uncertain_significance||1|||||||||||||||||||||||||||1226590||Conflicting_classifications_of_pathogenicity|not_provided&Noonan_syndrome_and_Noonan-related_syndrome|NC_000011.10:g.535463G>A||single_nucleotide_variant|HRAS:3265&LRRC56:115399|MedGen:C3661900&MONDO:MONDO:0020297&MedGen:C5681679&Orphanet:98733|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	1|1:0,25:1:25:0,13:0,12:71:159,74,0:121.3,71.299,2.5886e-07:0,34.77,37.77:0,0,14,11:0,0,10,15:535463	0|1:6,10:0.625:16:5,5:1,5:47:85,0,48:50,7.9471e-05,50.809:0,34.77,37.77:2,4,4,6:3,3,3,7:535463	0|1:13,18:0.581:31:4,9:9,9:48:85,0,48:50,7.4293e-05,51.48:0,34.77,37.77:7,6,9,9:4,9,10,8:535463	A	5_prime_UTR_variant	MODIFIER	HRAS	3265	Transcript	NM_005343.4	protein_coding	06-Jan		c.-101C>T		114					rs8176336	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	0.131	NA	NA	NA	NA	NA	NA	0.1667	0	0.1323	0.1042	0.07554	0.2214	0.08018	0.08893	0.1312	0.1186	0.09028	0.1169	0.09559	0.1874	0.2214	gnomADg_AMI	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				1226590	NA	Conflicting_classifications_of_pathogenicity	not_provided&Noonan_syndrome_and_Noonan-related_syndrome	NC_000011.10:g.535463G>A		single_nucleotide_variant	HRAS:3265&LRRC56:115399	MedGen:C3661900&MONDO:MONDO:0020297&MedGen:C5681679&Orphanet:98733	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		HRAS	Costello syndrome	AD	218040	Complex genetic syndromes	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs8176336	chr11_535463_G_A	Female	1|1	Homozygous
chr11	2159830	.	T	G	152.34	PASS	"FS=0;MQ=250;QD=4.58;SOR=1.329;FractionInformativeReads=1;DP=95;AF=1;AN=6;AC=6;CSQ=G|3_prime_UTR_variant|MODIFIER|INS|3630|Transcript|NM_000207.3|protein_coding|3/3||NM_000207.3:c.*22A>C||414|||||rs3842753||-1||SNV|EntrezGene||YES|||T|T||||||0.6492|0.7205|0.2412|0.7619|0.7051|0.9584|0.7934|0.79|0.7134|0.7161|0.8271|0.6102|0.26|0.6623|0.7248|0.7098|0.9488|0.7927|0.7979|0.7192|0.6749|0.8312|0.9584|gnomADe_EAS|benign&uncertain_significance||1||||||||||||36|42|42|-20|0.00|0.01|0.00|0.00|INS|||||||304051||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus_type_1&Autosomal_recessive_DOPA_responsive_dystonia&Maturity-onset_diabetes_of_the_young_type_10&Type_1_diabetes_mellitus_2&Diabetes_mellitus&_permanent_neonatal_4&Transient_Neonatal_Diabetes&_Dominant/Recessive&Hyperproinsulinemia&Maturity_onset_diabetes_mellitus_in_young&not_provided|NC_000011.10:g.2159830T>G||single_nucleotide_variant|INS:3630&TH:7054&INS-IGF2:723961|Human_Phenotype_Ontology:HP:0100651&MONDO:MONDO:0005147&MedGen:C0011854&OMIM:222100&MONDO:MONDO:0011551&MedGen:C2673535&OMIM:605407&Orphanet:101150&MONDO:MONDO:0013240&MedGen:C3150617&OMIM:613370&Orphanet:552&MONDO:MONDO:0007454&MedGen:C1852092&OMIM:125852&MONDO:MONDO:0030089&MedGen:C5394307&OMIM:618858&MedGen:CN239353&MONDO:MONDO:0014535&MedGen:C0342283&OMIM:616214&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900|Uncertain_significance(1)&Benign(10)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,30:1:30:0,15:0,15:87:175,90,0:137.29,87.294,0:0,34.77,37.77:0,0,19,11:0,0,12,18	1/1:0,30:1:30:0,11:0,19:87:175,90,0:137.3,87.3,0:0,34.77,37.77:0,0,12,18:0,0,15,15	1/1:0,35:1:35:0,19:0,16:102:190,105,0:152.34,102.34,0:0,34.77,37.77:0,0,22,13:0,0,16,19	G	3_prime_UTR_variant	MODIFIER	INS	3630	Transcript	NM_000207.3	protein_coding	03-Mar		c.*22A>C		414					rs3842753	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.6492	0.7205	0.2412	0.7619	0.7051	0.9584	0.7934	0.79	0.7134	0.7161	0.8271	0.6102	0.26	0.6623	0.7248	0.7098	0.9488	0.7927	0.7979	0.7192	0.6749	0.8312	0.9584	gnomADe_EAS	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		36	42	42	-20	0	0.01	0	0	INS			NA				304051	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus_type_1&Autosomal_recessive_DOPA_responsive_dystonia&Maturity-onset_diabetes_of_the_young_type_10&Type_1_diabetes_mellitus_2&Diabetes_mellitus&_permanent_neonatal_4&Transient_Neonatal_Diabetes&_Dominant/Recessive&Hyperproinsulinemia&Maturity_onset_diabetes_mellitus_in_young&not_provided	NC_000011.10:g.2159830T>G		single_nucleotide_variant	INS:3630&TH:7054&INS-IGF2:723961	Human_Phenotype_Ontology:HP:0100651&MONDO:MONDO:0005147&MedGen:C0011854&OMIM:222100&MONDO:MONDO:0011551&MedGen:C2673535&OMIM:605407&Orphanet:101150&MONDO:MONDO:0013240&MedGen:C3150617&OMIM:613370&Orphanet:552&MONDO:MONDO:0007454&MedGen:C1852092&OMIM:125852&MONDO:MONDO:0030089&MedGen:C5394307&OMIM:618858&MedGen:CN239353&MONDO:MONDO:0014535&MedGen:C0342283&OMIM:616214&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900	Uncertain_significance(1)&Benign(10)	criteria_provided&_conflicting_classifications		INS	Maturity-onset diabetes of the young type 10	AD	613370	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs3842753	chr11_2159830_T_G	Female	01-Jan	Homozygous
chr11	2159830	.	T	G	152.34	PASS	"FS=0;MQ=250;QD=4.58;SOR=1.329;FractionInformativeReads=1;DP=95;AF=1;AN=6;AC=6;CSQ=G|3_prime_UTR_variant|MODIFIER|INS|3630|Transcript|NM_000207.3|protein_coding|3/3||NM_000207.3:c.*22A>C||414|||||rs3842753||-1||SNV|EntrezGene||YES|||T|T||||||0.6492|0.7205|0.2412|0.7619|0.7051|0.9584|0.7934|0.79|0.7134|0.7161|0.8271|0.6102|0.26|0.6623|0.7248|0.7098|0.9488|0.7927|0.7979|0.7192|0.6749|0.8312|0.9584|gnomADe_EAS|benign&uncertain_significance||1||||||||||||36|42|42|-20|0.00|0.01|0.00|0.00|INS|||||||304051||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus_type_1&Autosomal_recessive_DOPA_responsive_dystonia&Maturity-onset_diabetes_of_the_young_type_10&Type_1_diabetes_mellitus_2&Diabetes_mellitus&_permanent_neonatal_4&Transient_Neonatal_Diabetes&_Dominant/Recessive&Hyperproinsulinemia&Maturity_onset_diabetes_mellitus_in_young&not_provided|NC_000011.10:g.2159830T>G||single_nucleotide_variant|INS:3630&TH:7054&INS-IGF2:723961|Human_Phenotype_Ontology:HP:0100651&MONDO:MONDO:0005147&MedGen:C0011854&OMIM:222100&MONDO:MONDO:0011551&MedGen:C2673535&OMIM:605407&Orphanet:101150&MONDO:MONDO:0013240&MedGen:C3150617&OMIM:613370&Orphanet:552&MONDO:MONDO:0007454&MedGen:C1852092&OMIM:125852&MONDO:MONDO:0030089&MedGen:C5394307&OMIM:618858&MedGen:CN239353&MONDO:MONDO:0014535&MedGen:C0342283&OMIM:616214&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900|Uncertain_significance(1)&Benign(10)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,30:1:30:0,15:0,15:87:175,90,0:137.29,87.294,0:0,34.77,37.77:0,0,19,11:0,0,12,18	1/1:0,30:1:30:0,11:0,19:87:175,90,0:137.3,87.3,0:0,34.77,37.77:0,0,12,18:0,0,15,15	1/1:0,35:1:35:0,19:0,16:102:190,105,0:152.34,102.34,0:0,34.77,37.77:0,0,22,13:0,0,16,19	G	3_prime_UTR_variant	MODIFIER	INS	3630	Transcript	NM_000207.3	protein_coding	03-Mar		c.*22A>C		414					rs3842753	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.6492	0.7205	0.2412	0.7619	0.7051	0.9584	0.7934	0.79	0.7134	0.7161	0.8271	0.6102	0.26	0.6623	0.7248	0.7098	0.9488	0.7927	0.7979	0.7192	0.6749	0.8312	0.9584	gnomADe_EAS	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		36	42	42	-20	0	0.01	0	0	INS			NA				304051	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus_type_1&Autosomal_recessive_DOPA_responsive_dystonia&Maturity-onset_diabetes_of_the_young_type_10&Type_1_diabetes_mellitus_2&Diabetes_mellitus&_permanent_neonatal_4&Transient_Neonatal_Diabetes&_Dominant/Recessive&Hyperproinsulinemia&Maturity_onset_diabetes_mellitus_in_young&not_provided	NC_000011.10:g.2159830T>G		single_nucleotide_variant	INS:3630&TH:7054&INS-IGF2:723961	Human_Phenotype_Ontology:HP:0100651&MONDO:MONDO:0005147&MedGen:C0011854&OMIM:222100&MONDO:MONDO:0011551&MedGen:C2673535&OMIM:605407&Orphanet:101150&MONDO:MONDO:0013240&MedGen:C3150617&OMIM:613370&Orphanet:552&MONDO:MONDO:0007454&MedGen:C1852092&OMIM:125852&MONDO:MONDO:0030089&MedGen:C5394307&OMIM:618858&MedGen:CN239353&MONDO:MONDO:0014535&MedGen:C0342283&OMIM:616214&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900	Uncertain_significance(1)&Benign(10)	criteria_provided&_conflicting_classifications		INS	Diabetes mellitus, permanent neonatal 4	Multiple and/or complex pattern	618858	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs3842753	chr11_2159830_T_G	Female	01-Jan	Homozygous
chr11	2159830	.	T	G	152.34	PASS	"FS=0;MQ=250;QD=4.58;SOR=1.329;FractionInformativeReads=1;DP=95;AF=1;AN=6;AC=6;CSQ=G|3_prime_UTR_variant|MODIFIER|INS|3630|Transcript|NM_000207.3|protein_coding|3/3||NM_000207.3:c.*22A>C||414|||||rs3842753||-1||SNV|EntrezGene||YES|||T|T||||||0.6492|0.7205|0.2412|0.7619|0.7051|0.9584|0.7934|0.79|0.7134|0.7161|0.8271|0.6102|0.26|0.6623|0.7248|0.7098|0.9488|0.7927|0.7979|0.7192|0.6749|0.8312|0.9584|gnomADe_EAS|benign&uncertain_significance||1||||||||||||36|42|42|-20|0.00|0.01|0.00|0.00|INS|||||||304051||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus_type_1&Autosomal_recessive_DOPA_responsive_dystonia&Maturity-onset_diabetes_of_the_young_type_10&Type_1_diabetes_mellitus_2&Diabetes_mellitus&_permanent_neonatal_4&Transient_Neonatal_Diabetes&_Dominant/Recessive&Hyperproinsulinemia&Maturity_onset_diabetes_mellitus_in_young&not_provided|NC_000011.10:g.2159830T>G||single_nucleotide_variant|INS:3630&TH:7054&INS-IGF2:723961|Human_Phenotype_Ontology:HP:0100651&MONDO:MONDO:0005147&MedGen:C0011854&OMIM:222100&MONDO:MONDO:0011551&MedGen:C2673535&OMIM:605407&Orphanet:101150&MONDO:MONDO:0013240&MedGen:C3150617&OMIM:613370&Orphanet:552&MONDO:MONDO:0007454&MedGen:C1852092&OMIM:125852&MONDO:MONDO:0030089&MedGen:C5394307&OMIM:618858&MedGen:CN239353&MONDO:MONDO:0014535&MedGen:C0342283&OMIM:616214&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900|Uncertain_significance(1)&Benign(10)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,30:1:30:0,15:0,15:87:175,90,0:137.29,87.294,0:0,34.77,37.77:0,0,19,11:0,0,12,18	1/1:0,30:1:30:0,11:0,19:87:175,90,0:137.3,87.3,0:0,34.77,37.77:0,0,12,18:0,0,15,15	1/1:0,35:1:35:0,19:0,16:102:190,105,0:152.34,102.34,0:0,34.77,37.77:0,0,22,13:0,0,16,19	G	3_prime_UTR_variant	MODIFIER	INS	3630	Transcript	NM_000207.3	protein_coding	03-Mar		c.*22A>C		414					rs3842753	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.6492	0.7205	0.2412	0.7619	0.7051	0.9584	0.7934	0.79	0.7134	0.7161	0.8271	0.6102	0.26	0.6623	0.7248	0.7098	0.9488	0.7927	0.7979	0.7192	0.6749	0.8312	0.9584	gnomADe_EAS	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		36	42	42	-20	0	0.01	0	0	INS			NA				304051	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus_type_1&Autosomal_recessive_DOPA_responsive_dystonia&Maturity-onset_diabetes_of_the_young_type_10&Type_1_diabetes_mellitus_2&Diabetes_mellitus&_permanent_neonatal_4&Transient_Neonatal_Diabetes&_Dominant/Recessive&Hyperproinsulinemia&Maturity_onset_diabetes_mellitus_in_young&not_provided	NC_000011.10:g.2159830T>G		single_nucleotide_variant	INS:3630&TH:7054&INS-IGF2:723961	Human_Phenotype_Ontology:HP:0100651&MONDO:MONDO:0005147&MedGen:C0011854&OMIM:222100&MONDO:MONDO:0011551&MedGen:C2673535&OMIM:605407&Orphanet:101150&MONDO:MONDO:0013240&MedGen:C3150617&OMIM:613370&Orphanet:552&MONDO:MONDO:0007454&MedGen:C1852092&OMIM:125852&MONDO:MONDO:0030089&MedGen:C5394307&OMIM:618858&MedGen:CN239353&MONDO:MONDO:0014535&MedGen:C0342283&OMIM:616214&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900	Uncertain_significance(1)&Benign(10)	criteria_provided&_conflicting_classifications		INS	Permanent neonatal diabetes mellitus 1	Multiple and/or complex pattern	606176	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs3842753	chr11_2159830_T_G	Female	01-Jan	Homozygous
chr11	17386857	.	C	T	119.23	PASS	"FS=0;MQ=250;QD=4.97;SOR=1.27;FractionInformativeReads=1;MQRankSum=4.113;ReadPosRankSum=3.534;R2_5P_bias=-9.784;DP=70;AF=0.5;AN=6;AC=4;CSQ=T|3_prime_UTR_variant|MODIFIER|KCNJ11|3767|Transcript|NM_000525.4|protein_coding|1/1||NM_000525.4:c.*62G>A||1803|||||rs5213&COSV60594111||-1||SNV|EntrezGene||YES|||C|C||||||0.7358|0.6509|0.9329|0.6277|0.6666|0.6333|0.5278|0.7238|0.65|0.6663|0.6293|0.7178|0.9199|0.5746|0.6767|0.6737|0.6457|0.5344|0.7041|0.649|0.6958|0.6272|0.9607|AFR|benign&uncertain_significance|0&1|1&1||||||||||||15|3|15|12|0.00|0.00|0.00|0.00|KCNJ11|||||||303731||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinemic_hypoglycemia&_familial&_2&Maturity-onset_diabetes_of_the_young_type_13&Diabetes_mellitus&_transient_neonatal&_3|NC_000011.10:g.17386857C>T||single_nucleotide_variant|KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886|Uncertain_significance(1)&Benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,24:1:24:0,13:0,11:69:157,72,0:119.23,69.227,5.1772e-07:0,34.77,37.77:0,0,9,15:0,0,10,14	0/1:11,13:0.542:24:5,9:6,4:48:85,0,50:50,6.7045e-05,52.639:0,34.77,37.77:5,6,7,6:7,4,5,8	0/1:13,9:0.409:22:7,1:6,8:47:83,0,50:48.223,8.7237e-05,53:0,34.77,37.77:7,6,7,2:3,10,3,6	T	3_prime_UTR_variant	MODIFIER	KCNJ11	3767	Transcript	NM_000525.4	protein_coding	01-Jan		c.*62G>A		1803					rs5213&COSV60594111	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.7358	0.6509	0.9329	0.6277	0.6666	0.6333	0.5278	0.7238	0.65	0.6663	0.6293	0.7178	0.9199	0.5746	0.6767	0.6737	0.6457	0.5344	0.7041	0.649	0.6958	0.6272	0.9607	AFR	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		15	3	15	12	0	0	0	0	KCNJ11			NA				303731	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinemic_hypoglycemia&_familial&_2&Maturity-onset_diabetes_of_the_young_type_13&Diabetes_mellitus&_transient_neonatal&_3	NC_000011.10:g.17386857C>T		single_nucleotide_variant	KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886	Uncertain_significance(1)&Benign(3)	criteria_provided&_conflicting_classifications		KCNJ11	Diabetes mellitus, transient neonatal, 3	AD	610582	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs5213	chr11_17386857_C_T	Female	01-Jan	Homozygous
chr11	17386857	.	C	T	119.23	PASS	"FS=0;MQ=250;QD=4.97;SOR=1.27;FractionInformativeReads=1;MQRankSum=4.113;ReadPosRankSum=3.534;R2_5P_bias=-9.784;DP=70;AF=0.5;AN=6;AC=4;CSQ=T|3_prime_UTR_variant|MODIFIER|KCNJ11|3767|Transcript|NM_000525.4|protein_coding|1/1||NM_000525.4:c.*62G>A||1803|||||rs5213&COSV60594111||-1||SNV|EntrezGene||YES|||C|C||||||0.7358|0.6509|0.9329|0.6277|0.6666|0.6333|0.5278|0.7238|0.65|0.6663|0.6293|0.7178|0.9199|0.5746|0.6767|0.6737|0.6457|0.5344|0.7041|0.649|0.6958|0.6272|0.9607|AFR|benign&uncertain_significance|0&1|1&1||||||||||||15|3|15|12|0.00|0.00|0.00|0.00|KCNJ11|||||||303731||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinemic_hypoglycemia&_familial&_2&Maturity-onset_diabetes_of_the_young_type_13&Diabetes_mellitus&_transient_neonatal&_3|NC_000011.10:g.17386857C>T||single_nucleotide_variant|KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886|Uncertain_significance(1)&Benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,24:1:24:0,13:0,11:69:157,72,0:119.23,69.227,5.1772e-07:0,34.77,37.77:0,0,9,15:0,0,10,14	0/1:11,13:0.542:24:5,9:6,4:48:85,0,50:50,6.7045e-05,52.639:0,34.77,37.77:5,6,7,6:7,4,5,8	0/1:13,9:0.409:22:7,1:6,8:47:83,0,50:48.223,8.7237e-05,53:0,34.77,37.77:7,6,7,2:3,10,3,6	T	3_prime_UTR_variant	MODIFIER	KCNJ11	3767	Transcript	NM_000525.4	protein_coding	01-Jan		c.*62G>A		1803					rs5213&COSV60594111	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.7358	0.6509	0.9329	0.6277	0.6666	0.6333	0.5278	0.7238	0.65	0.6663	0.6293	0.7178	0.9199	0.5746	0.6767	0.6737	0.6457	0.5344	0.7041	0.649	0.6958	0.6272	0.9607	AFR	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		15	3	15	12	0	0	0	0	KCNJ11			NA				303731	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinemic_hypoglycemia&_familial&_2&Maturity-onset_diabetes_of_the_young_type_13&Diabetes_mellitus&_transient_neonatal&_3	NC_000011.10:g.17386857C>T		single_nucleotide_variant	KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886	Uncertain_significance(1)&Benign(3)	criteria_provided&_conflicting_classifications		KCNJ11	Diabetes mellitus, permanent neonatal 2	AD	618856	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs5213	chr11_17386857_C_T	Female	01-Jan	Homozygous
chr11	17386857	.	C	T	119.23	PASS	"FS=0;MQ=250;QD=4.97;SOR=1.27;FractionInformativeReads=1;MQRankSum=4.113;ReadPosRankSum=3.534;R2_5P_bias=-9.784;DP=70;AF=0.5;AN=6;AC=4;CSQ=T|3_prime_UTR_variant|MODIFIER|KCNJ11|3767|Transcript|NM_000525.4|protein_coding|1/1||NM_000525.4:c.*62G>A||1803|||||rs5213&COSV60594111||-1||SNV|EntrezGene||YES|||C|C||||||0.7358|0.6509|0.9329|0.6277|0.6666|0.6333|0.5278|0.7238|0.65|0.6663|0.6293|0.7178|0.9199|0.5746|0.6767|0.6737|0.6457|0.5344|0.7041|0.649|0.6958|0.6272|0.9607|AFR|benign&uncertain_significance|0&1|1&1||||||||||||15|3|15|12|0.00|0.00|0.00|0.00|KCNJ11|||||||303731||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinemic_hypoglycemia&_familial&_2&Maturity-onset_diabetes_of_the_young_type_13&Diabetes_mellitus&_transient_neonatal&_3|NC_000011.10:g.17386857C>T||single_nucleotide_variant|KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886|Uncertain_significance(1)&Benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,24:1:24:0,13:0,11:69:157,72,0:119.23,69.227,5.1772e-07:0,34.77,37.77:0,0,9,15:0,0,10,14	0/1:11,13:0.542:24:5,9:6,4:48:85,0,50:50,6.7045e-05,52.639:0,34.77,37.77:5,6,7,6:7,4,5,8	0/1:13,9:0.409:22:7,1:6,8:47:83,0,50:48.223,8.7237e-05,53:0,34.77,37.77:7,6,7,2:3,10,3,6	T	3_prime_UTR_variant	MODIFIER	KCNJ11	3767	Transcript	NM_000525.4	protein_coding	01-Jan		c.*62G>A		1803					rs5213&COSV60594111	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.7358	0.6509	0.9329	0.6277	0.6666	0.6333	0.5278	0.7238	0.65	0.6663	0.6293	0.7178	0.9199	0.5746	0.6767	0.6737	0.6457	0.5344	0.7041	0.649	0.6958	0.6272	0.9607	AFR	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		15	3	15	12	0	0	0	0	KCNJ11			NA				303731	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinemic_hypoglycemia&_familial&_2&Maturity-onset_diabetes_of_the_young_type_13&Diabetes_mellitus&_transient_neonatal&_3	NC_000011.10:g.17386857C>T		single_nucleotide_variant	KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886	Uncertain_significance(1)&Benign(3)	criteria_provided&_conflicting_classifications		KCNJ11	Hyperinsulinemic hypoglycemia, familial, 2	Multiple and/or complex pattern	601820	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs5213	chr11_17386857_C_T	Female	01-Jan	Homozygous
chr11	17386857	.	C	T	119.23	PASS	"FS=0;MQ=250;QD=4.97;SOR=1.27;FractionInformativeReads=1;MQRankSum=4.113;ReadPosRankSum=3.534;R2_5P_bias=-9.784;DP=70;AF=0.5;AN=6;AC=4;CSQ=T|3_prime_UTR_variant|MODIFIER|KCNJ11|3767|Transcript|NM_000525.4|protein_coding|1/1||NM_000525.4:c.*62G>A||1803|||||rs5213&COSV60594111||-1||SNV|EntrezGene||YES|||C|C||||||0.7358|0.6509|0.9329|0.6277|0.6666|0.6333|0.5278|0.7238|0.65|0.6663|0.6293|0.7178|0.9199|0.5746|0.6767|0.6737|0.6457|0.5344|0.7041|0.649|0.6958|0.6272|0.9607|AFR|benign&uncertain_significance|0&1|1&1||||||||||||15|3|15|12|0.00|0.00|0.00|0.00|KCNJ11|||||||303731||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinemic_hypoglycemia&_familial&_2&Maturity-onset_diabetes_of_the_young_type_13&Diabetes_mellitus&_transient_neonatal&_3|NC_000011.10:g.17386857C>T||single_nucleotide_variant|KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886|Uncertain_significance(1)&Benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,24:1:24:0,13:0,11:69:157,72,0:119.23,69.227,5.1772e-07:0,34.77,37.77:0,0,9,15:0,0,10,14	0/1:11,13:0.542:24:5,9:6,4:48:85,0,50:50,6.7045e-05,52.639:0,34.77,37.77:5,6,7,6:7,4,5,8	0/1:13,9:0.409:22:7,1:6,8:47:83,0,50:48.223,8.7237e-05,53:0,34.77,37.77:7,6,7,2:3,10,3,6	T	3_prime_UTR_variant	MODIFIER	KCNJ11	3767	Transcript	NM_000525.4	protein_coding	01-Jan		c.*62G>A		1803					rs5213&COSV60594111	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.7358	0.6509	0.9329	0.6277	0.6666	0.6333	0.5278	0.7238	0.65	0.6663	0.6293	0.7178	0.9199	0.5746	0.6767	0.6737	0.6457	0.5344	0.7041	0.649	0.6958	0.6272	0.9607	AFR	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		15	3	15	12	0	0	0	0	KCNJ11			NA				303731	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinemic_hypoglycemia&_familial&_2&Maturity-onset_diabetes_of_the_young_type_13&Diabetes_mellitus&_transient_neonatal&_3	NC_000011.10:g.17386857C>T		single_nucleotide_variant	KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886	Uncertain_significance(1)&Benign(3)	criteria_provided&_conflicting_classifications		KCNJ11	Permanent neonatal diabetes mellitus 1	AD	606176	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs5213	chr11_17386857_C_T	Female	01-Jan	Homozygous
chr11	17387284	.	G	C	50	PASS	"FS=3.22;MQ=246.65;MQRankSum=4.236;QD=1.56;ReadPosRankSum=2.716;SOR=1.049;FractionInformativeReads=1;R2_5P_bias=4.601;DP=32;AF=0.5;AN=2;AC=1;CSQ=C|missense_variant|MODERATE|KCNJ11|3767|Transcript|NM_000525.4|protein_coding|1/1||NM_000525.4:c.808C>G|NP_000516.3:p.Leu270Val|1376|808|270|L/V|Ctg/Gtg|rs1800467&COSV60594359||-1||SNV|EntrezGene||YES|||G|G|||tolerated(0.25)|||0.0152|0.0405|0.006601|0.03014|0.06133|2.519e-05|0.1076|0.04109|0.04193|0.0412|0.01092|0.03731|0.007913|0.0636|0.0413|0.05991|0|0.1143|0.07823|0.04516|0.05208|0.008075|0.1143|gnomADg_FIN|benign&uncertain_significance&benign/likely_benign|0&1|1&1||||T|0.11873|-0.268952|T|0.61588|-0.122601|0.66582|0.344&0.344|13|-11|1|-44|0.01|0.00|0.00|0.00|KCNJ11|likely_benign|hg38|0.0808|L270V|ENST00000339994.4|Q14654|158685||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_3&Diabetes_mellitus&_permanent_neonatal_2&not_specified&Hyperinsulinemic_hypoglycemia&_familial&_2&Monogenic_diabetes&not_provided&Maturity-onset_diabetes_of_the_young_type_13|NC_000011.10:g.17387284G>C||single_nucleotide_variant|KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886&MONDO:MONDO:0030087&MedGen:C5394296&OMIM:618856&MedGen:CN169374&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0015967&MedGen:C3888631&Orphanet:183625&MedGen:C3661900&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552|Uncertain_significance(1)&Benign(12)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,18:0.562:32:6,7:8,11:48:85,0,49:50,7.1446e-05,51.911:0,34.77,37.77:8,6,7,11:8,6,12,6	C	missense_variant	MODERATE	KCNJ11	3767	Transcript	NM_000525.4	protein_coding	01-Jan		c.808C>G	p.Leu270Val	1376	808	270	L/V	Ctg/Gtg	rs1800467&COSV60594359	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	tolerated(0.25)		NA	0.0152	0.0405	0.006601	0.03014	0.06133	2.519e-05	0.1076	0.04109	0.04193	0.0412	0.01092	0.03731	0.007913	0.0636	0.0413	0.05991	0	0.1143	0.07823	0.04516	0.05208	0.008075	0.1143	gnomADg_FIN	benign&uncertain_significance&benign/likely_benign	0&1	1&1	NA	NA	NA	T	0.11873	-0.268952	T	0.61588	-0.122601	0.66582	0.344&0.344	13	-11	1	-44	0.01	0	0	0	KCNJ11	likely_benign	hg38	0.0808	L270V	ENST00000339994.4	Q14654	158685	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_3&Diabetes_mellitus&_permanent_neonatal_2&not_specified&Hyperinsulinemic_hypoglycemia&_familial&_2&Monogenic_diabetes&not_provided&Maturity-onset_diabetes_of_the_young_type_13	NC_000011.10:g.17387284G>C		single_nucleotide_variant	KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886&MONDO:MONDO:0030087&MedGen:C5394296&OMIM:618856&MedGen:CN169374&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0015967&MedGen:C3888631&Orphanet:183625&MedGen:C3661900&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552	Uncertain_significance(1)&Benign(12)&Likely_benign(1)	criteria_provided&_conflicting_classifications		KCNJ11	Diabetes mellitus, transient neonatal, 3	AD	610582	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs1800467	chr11_17387284_G_C	Female	./.	Other
chr11	17387284	.	G	C	50	PASS	"FS=3.22;MQ=246.65;MQRankSum=4.236;QD=1.56;ReadPosRankSum=2.716;SOR=1.049;FractionInformativeReads=1;R2_5P_bias=4.601;DP=32;AF=0.5;AN=2;AC=1;CSQ=C|missense_variant|MODERATE|KCNJ11|3767|Transcript|NM_000525.4|protein_coding|1/1||NM_000525.4:c.808C>G|NP_000516.3:p.Leu270Val|1376|808|270|L/V|Ctg/Gtg|rs1800467&COSV60594359||-1||SNV|EntrezGene||YES|||G|G|||tolerated(0.25)|||0.0152|0.0405|0.006601|0.03014|0.06133|2.519e-05|0.1076|0.04109|0.04193|0.0412|0.01092|0.03731|0.007913|0.0636|0.0413|0.05991|0|0.1143|0.07823|0.04516|0.05208|0.008075|0.1143|gnomADg_FIN|benign&uncertain_significance&benign/likely_benign|0&1|1&1||||T|0.11873|-0.268952|T|0.61588|-0.122601|0.66582|0.344&0.344|13|-11|1|-44|0.01|0.00|0.00|0.00|KCNJ11|likely_benign|hg38|0.0808|L270V|ENST00000339994.4|Q14654|158685||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_3&Diabetes_mellitus&_permanent_neonatal_2&not_specified&Hyperinsulinemic_hypoglycemia&_familial&_2&Monogenic_diabetes&not_provided&Maturity-onset_diabetes_of_the_young_type_13|NC_000011.10:g.17387284G>C||single_nucleotide_variant|KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886&MONDO:MONDO:0030087&MedGen:C5394296&OMIM:618856&MedGen:CN169374&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0015967&MedGen:C3888631&Orphanet:183625&MedGen:C3661900&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552|Uncertain_significance(1)&Benign(12)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,18:0.562:32:6,7:8,11:48:85,0,49:50,7.1446e-05,51.911:0,34.77,37.77:8,6,7,11:8,6,12,6	C	missense_variant	MODERATE	KCNJ11	3767	Transcript	NM_000525.4	protein_coding	01-Jan		c.808C>G	p.Leu270Val	1376	808	270	L/V	Ctg/Gtg	rs1800467&COSV60594359	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	tolerated(0.25)		NA	0.0152	0.0405	0.006601	0.03014	0.06133	2.519e-05	0.1076	0.04109	0.04193	0.0412	0.01092	0.03731	0.007913	0.0636	0.0413	0.05991	0	0.1143	0.07823	0.04516	0.05208	0.008075	0.1143	gnomADg_FIN	benign&uncertain_significance&benign/likely_benign	0&1	1&1	NA	NA	NA	T	0.11873	-0.268952	T	0.61588	-0.122601	0.66582	0.344&0.344	13	-11	1	-44	0.01	0	0	0	KCNJ11	likely_benign	hg38	0.0808	L270V	ENST00000339994.4	Q14654	158685	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_3&Diabetes_mellitus&_permanent_neonatal_2&not_specified&Hyperinsulinemic_hypoglycemia&_familial&_2&Monogenic_diabetes&not_provided&Maturity-onset_diabetes_of_the_young_type_13	NC_000011.10:g.17387284G>C		single_nucleotide_variant	KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886&MONDO:MONDO:0030087&MedGen:C5394296&OMIM:618856&MedGen:CN169374&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0015967&MedGen:C3888631&Orphanet:183625&MedGen:C3661900&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552	Uncertain_significance(1)&Benign(12)&Likely_benign(1)	criteria_provided&_conflicting_classifications		KCNJ11	Diabetes mellitus, permanent neonatal 2	AD	618856	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs1800467	chr11_17387284_G_C	Female	./.	Other
chr11	17387284	.	G	C	50	PASS	"FS=3.22;MQ=246.65;MQRankSum=4.236;QD=1.56;ReadPosRankSum=2.716;SOR=1.049;FractionInformativeReads=1;R2_5P_bias=4.601;DP=32;AF=0.5;AN=2;AC=1;CSQ=C|missense_variant|MODERATE|KCNJ11|3767|Transcript|NM_000525.4|protein_coding|1/1||NM_000525.4:c.808C>G|NP_000516.3:p.Leu270Val|1376|808|270|L/V|Ctg/Gtg|rs1800467&COSV60594359||-1||SNV|EntrezGene||YES|||G|G|||tolerated(0.25)|||0.0152|0.0405|0.006601|0.03014|0.06133|2.519e-05|0.1076|0.04109|0.04193|0.0412|0.01092|0.03731|0.007913|0.0636|0.0413|0.05991|0|0.1143|0.07823|0.04516|0.05208|0.008075|0.1143|gnomADg_FIN|benign&uncertain_significance&benign/likely_benign|0&1|1&1||||T|0.11873|-0.268952|T|0.61588|-0.122601|0.66582|0.344&0.344|13|-11|1|-44|0.01|0.00|0.00|0.00|KCNJ11|likely_benign|hg38|0.0808|L270V|ENST00000339994.4|Q14654|158685||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_3&Diabetes_mellitus&_permanent_neonatal_2&not_specified&Hyperinsulinemic_hypoglycemia&_familial&_2&Monogenic_diabetes&not_provided&Maturity-onset_diabetes_of_the_young_type_13|NC_000011.10:g.17387284G>C||single_nucleotide_variant|KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886&MONDO:MONDO:0030087&MedGen:C5394296&OMIM:618856&MedGen:CN169374&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0015967&MedGen:C3888631&Orphanet:183625&MedGen:C3661900&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552|Uncertain_significance(1)&Benign(12)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,18:0.562:32:6,7:8,11:48:85,0,49:50,7.1446e-05,51.911:0,34.77,37.77:8,6,7,11:8,6,12,6	C	missense_variant	MODERATE	KCNJ11	3767	Transcript	NM_000525.4	protein_coding	01-Jan		c.808C>G	p.Leu270Val	1376	808	270	L/V	Ctg/Gtg	rs1800467&COSV60594359	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	tolerated(0.25)		NA	0.0152	0.0405	0.006601	0.03014	0.06133	2.519e-05	0.1076	0.04109	0.04193	0.0412	0.01092	0.03731	0.007913	0.0636	0.0413	0.05991	0	0.1143	0.07823	0.04516	0.05208	0.008075	0.1143	gnomADg_FIN	benign&uncertain_significance&benign/likely_benign	0&1	1&1	NA	NA	NA	T	0.11873	-0.268952	T	0.61588	-0.122601	0.66582	0.344&0.344	13	-11	1	-44	0.01	0	0	0	KCNJ11	likely_benign	hg38	0.0808	L270V	ENST00000339994.4	Q14654	158685	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_3&Diabetes_mellitus&_permanent_neonatal_2&not_specified&Hyperinsulinemic_hypoglycemia&_familial&_2&Monogenic_diabetes&not_provided&Maturity-onset_diabetes_of_the_young_type_13	NC_000011.10:g.17387284G>C		single_nucleotide_variant	KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886&MONDO:MONDO:0030087&MedGen:C5394296&OMIM:618856&MedGen:CN169374&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0015967&MedGen:C3888631&Orphanet:183625&MedGen:C3661900&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552	Uncertain_significance(1)&Benign(12)&Likely_benign(1)	criteria_provided&_conflicting_classifications		KCNJ11	Hyperinsulinemic hypoglycemia, familial, 2	Multiple and/or complex pattern	601820	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs1800467	chr11_17387284_G_C	Female	./.	Other
chr11	17387284	.	G	C	50	PASS	"FS=3.22;MQ=246.65;MQRankSum=4.236;QD=1.56;ReadPosRankSum=2.716;SOR=1.049;FractionInformativeReads=1;R2_5P_bias=4.601;DP=32;AF=0.5;AN=2;AC=1;CSQ=C|missense_variant|MODERATE|KCNJ11|3767|Transcript|NM_000525.4|protein_coding|1/1||NM_000525.4:c.808C>G|NP_000516.3:p.Leu270Val|1376|808|270|L/V|Ctg/Gtg|rs1800467&COSV60594359||-1||SNV|EntrezGene||YES|||G|G|||tolerated(0.25)|||0.0152|0.0405|0.006601|0.03014|0.06133|2.519e-05|0.1076|0.04109|0.04193|0.0412|0.01092|0.03731|0.007913|0.0636|0.0413|0.05991|0|0.1143|0.07823|0.04516|0.05208|0.008075|0.1143|gnomADg_FIN|benign&uncertain_significance&benign/likely_benign|0&1|1&1||||T|0.11873|-0.268952|T|0.61588|-0.122601|0.66582|0.344&0.344|13|-11|1|-44|0.01|0.00|0.00|0.00|KCNJ11|likely_benign|hg38|0.0808|L270V|ENST00000339994.4|Q14654|158685||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_3&Diabetes_mellitus&_permanent_neonatal_2&not_specified&Hyperinsulinemic_hypoglycemia&_familial&_2&Monogenic_diabetes&not_provided&Maturity-onset_diabetes_of_the_young_type_13|NC_000011.10:g.17387284G>C||single_nucleotide_variant|KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886&MONDO:MONDO:0030087&MedGen:C5394296&OMIM:618856&MedGen:CN169374&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0015967&MedGen:C3888631&Orphanet:183625&MedGen:C3661900&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552|Uncertain_significance(1)&Benign(12)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,18:0.562:32:6,7:8,11:48:85,0,49:50,7.1446e-05,51.911:0,34.77,37.77:8,6,7,11:8,6,12,6	C	missense_variant	MODERATE	KCNJ11	3767	Transcript	NM_000525.4	protein_coding	01-Jan		c.808C>G	p.Leu270Val	1376	808	270	L/V	Ctg/Gtg	rs1800467&COSV60594359	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	tolerated(0.25)		NA	0.0152	0.0405	0.006601	0.03014	0.06133	2.519e-05	0.1076	0.04109	0.04193	0.0412	0.01092	0.03731	0.007913	0.0636	0.0413	0.05991	0	0.1143	0.07823	0.04516	0.05208	0.008075	0.1143	gnomADg_FIN	benign&uncertain_significance&benign/likely_benign	0&1	1&1	NA	NA	NA	T	0.11873	-0.268952	T	0.61588	-0.122601	0.66582	0.344&0.344	13	-11	1	-44	0.01	0	0	0	KCNJ11	likely_benign	hg38	0.0808	L270V	ENST00000339994.4	Q14654	158685	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_3&Diabetes_mellitus&_permanent_neonatal_2&not_specified&Hyperinsulinemic_hypoglycemia&_familial&_2&Monogenic_diabetes&not_provided&Maturity-onset_diabetes_of_the_young_type_13	NC_000011.10:g.17387284G>C		single_nucleotide_variant	KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MONDO:MONDO:0012522&MedGen:C1864623&OMIM:610582&Orphanet:99886&MONDO:MONDO:0030087&MedGen:C5394296&OMIM:618856&MedGen:CN169374&MONDO:MONDO:0011153&MedGen:C2931833&OMIM:601820&Orphanet:276580&Orphanet:276603&MONDO:MONDO:0015967&MedGen:C3888631&Orphanet:183625&MedGen:C3661900&MONDO:MONDO:0014589&MedGen:C4225365&OMIM:616329&Orphanet:552	Uncertain_significance(1)&Benign(12)&Likely_benign(1)	criteria_provided&_conflicting_classifications		KCNJ11	Permanent neonatal diabetes mellitus 1	AD	606176	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs1800467	chr11_17387284_G_C	Female	./.	Other
chr11	17393023	.	C	T	50	PASS	"FS=6.34;MQ=250;MQRankSum=5.907;QD=1.03;ReadPosRankSum=3.3;SOR=0.202;FractionInformativeReads=1;R2_5P_bias=15.322;DP=94;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|ABCC8|6833|Transcript|NM_000352.6|protein_coding|39/39||NM_000352.6:c.4714G>A|NP_000343.2:p.Val1572Ile|4783|4714|1572|V/I|Gtc/Atc|rs8192690&COSV56855126||-1||SNV|EntrezGene||YES|||C|C|||tolerated_low_confidence(0.08)|benign(0.001)||0.0312|0.05824|0.03047|0.03231|0.1453|0.00471|0.03931|0.1014|0.05969|0.06208|0.06819|0.05048|0.02977|0.04615|0.0475|0.151|0.001733|0.037|0.09184|0.06368|0.06144|0.05585|0.151|gnomADg_ASJ|uncertain_significance&likely_benign&benign/likely_benign&benign|0&1|1&1||||T|0.00412|-0.524791|T|0.24835|-0.476345|0.43662|.&.&0.172&0.172&.&.&.&.|-25|39|-14|-28|0.00|0.00|0.00|0.00|ABCC8|likely_benign|hg38|0.0695|V1572I|ENST00000389817.7|Q09428|157705||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Hereditary_hyperinsulinism&Neonatal_hypoglycemia&Permanent_neonatal_diabetes_mellitus&not_specified&Diabetes_mellitus&_permanent_neonatal_3&Hyperinsulinism&_Dominant/Recessive&Transient_Neonatal_Diabetes&_Dominant|NC_000011.10:g.17393023C>T||single_nucleotide_variant|ABCC8:6833&KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&.&Human_Phenotype_Ontology:HP:0001998&MedGen:C0158986&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN239464&MedGen:CN239283|Uncertain_significance(1)&Benign(12)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:26,22:0.458:48:16,14:10,8:48:84,0,50:49.273,7.2999e-05,53:0,34.77,37.77:7,19,10,12:11,15,10,12	0/1:20,26:0.565:46:10,12:10,14:48:85,0,48:50,7.4811e-05,51.398:0,34.77,37.77:6,14,11,15:10,10,13,13	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	ABCC8	6833	Transcript	NM_000352.6	protein_coding	39/39		c.4714G>A	p.Val1572Ile	4783	4714	1572	V/I	Gtc/Atc	rs8192690&COSV56855126	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated_low_confidence(0.08)	benign(0.001)	NA	0.0312	0.05824	0.03047	0.03231	0.1453	0.00471	0.03931	0.1014	0.05969	0.06208	0.06819	0.05048	0.02977	0.04615	0.0475	0.151	0.001733	0.037	0.09184	0.06368	0.06144	0.05585	0.151	gnomADg_ASJ	uncertain_significance&likely_benign&benign/likely_benign&benign	0&1	1&1	NA	NA	NA	T	0.00412	-0.524791	T	0.24835	-0.476345	0.43662	.&.&0.172&0.172&.&.&.&.	-25	39	-14	-28	0	0	0	0	ABCC8	likely_benign	hg38	0.0695	V1572I	ENST00000389817.7	Q09428	157705	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Hereditary_hyperinsulinism&Neonatal_hypoglycemia&Permanent_neonatal_diabetes_mellitus&not_specified&Diabetes_mellitus&_permanent_neonatal_3&Hyperinsulinism&_Dominant/Recessive&Transient_Neonatal_Diabetes&_Dominant	NC_000011.10:g.17393023C>T		single_nucleotide_variant	ABCC8:6833&KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&.&Human_Phenotype_Ontology:HP:0001998&MedGen:C0158986&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN239464&MedGen:CN239283	Uncertain_significance(1)&Benign(12)&Likely_benign(2)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs8192690	chr11_17393023_C_T	Female	0/1	Heterozygous
chr11	17393023	.	C	T	50	PASS	"FS=6.34;MQ=250;MQRankSum=5.907;QD=1.03;ReadPosRankSum=3.3;SOR=0.202;FractionInformativeReads=1;R2_5P_bias=15.322;DP=94;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|ABCC8|6833|Transcript|NM_000352.6|protein_coding|39/39||NM_000352.6:c.4714G>A|NP_000343.2:p.Val1572Ile|4783|4714|1572|V/I|Gtc/Atc|rs8192690&COSV56855126||-1||SNV|EntrezGene||YES|||C|C|||tolerated_low_confidence(0.08)|benign(0.001)||0.0312|0.05824|0.03047|0.03231|0.1453|0.00471|0.03931|0.1014|0.05969|0.06208|0.06819|0.05048|0.02977|0.04615|0.0475|0.151|0.001733|0.037|0.09184|0.06368|0.06144|0.05585|0.151|gnomADg_ASJ|uncertain_significance&likely_benign&benign/likely_benign&benign|0&1|1&1||||T|0.00412|-0.524791|T|0.24835|-0.476345|0.43662|.&.&0.172&0.172&.&.&.&.|-25|39|-14|-28|0.00|0.00|0.00|0.00|ABCC8|likely_benign|hg38|0.0695|V1572I|ENST00000389817.7|Q09428|157705||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Hereditary_hyperinsulinism&Neonatal_hypoglycemia&Permanent_neonatal_diabetes_mellitus&not_specified&Diabetes_mellitus&_permanent_neonatal_3&Hyperinsulinism&_Dominant/Recessive&Transient_Neonatal_Diabetes&_Dominant|NC_000011.10:g.17393023C>T||single_nucleotide_variant|ABCC8:6833&KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&.&Human_Phenotype_Ontology:HP:0001998&MedGen:C0158986&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN239464&MedGen:CN239283|Uncertain_significance(1)&Benign(12)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:26,22:0.458:48:16,14:10,8:48:84,0,50:49.273,7.2999e-05,53:0,34.77,37.77:7,19,10,12:11,15,10,12	0/1:20,26:0.565:46:10,12:10,14:48:85,0,48:50,7.4811e-05,51.398:0,34.77,37.77:6,14,11,15:10,10,13,13	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	ABCC8	6833	Transcript	NM_000352.6	protein_coding	39/39		c.4714G>A	p.Val1572Ile	4783	4714	1572	V/I	Gtc/Atc	rs8192690&COSV56855126	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated_low_confidence(0.08)	benign(0.001)	NA	0.0312	0.05824	0.03047	0.03231	0.1453	0.00471	0.03931	0.1014	0.05969	0.06208	0.06819	0.05048	0.02977	0.04615	0.0475	0.151	0.001733	0.037	0.09184	0.06368	0.06144	0.05585	0.151	gnomADg_ASJ	uncertain_significance&likely_benign&benign/likely_benign&benign	0&1	1&1	NA	NA	NA	T	0.00412	-0.524791	T	0.24835	-0.476345	0.43662	.&.&0.172&0.172&.&.&.&.	-25	39	-14	-28	0	0	0	0	ABCC8	likely_benign	hg38	0.0695	V1572I	ENST00000389817.7	Q09428	157705	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Hereditary_hyperinsulinism&Neonatal_hypoglycemia&Permanent_neonatal_diabetes_mellitus&not_specified&Diabetes_mellitus&_permanent_neonatal_3&Hyperinsulinism&_Dominant/Recessive&Transient_Neonatal_Diabetes&_Dominant	NC_000011.10:g.17393023C>T		single_nucleotide_variant	ABCC8:6833&KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&.&Human_Phenotype_Ontology:HP:0001998&MedGen:C0158986&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN239464&MedGen:CN239283	Uncertain_significance(1)&Benign(12)&Likely_benign(2)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs8192690	chr11_17393023_C_T	Female	0/1	Heterozygous
chr11	17393023	.	C	T	50	PASS	"FS=6.34;MQ=250;MQRankSum=5.907;QD=1.03;ReadPosRankSum=3.3;SOR=0.202;FractionInformativeReads=1;R2_5P_bias=15.322;DP=94;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|ABCC8|6833|Transcript|NM_000352.6|protein_coding|39/39||NM_000352.6:c.4714G>A|NP_000343.2:p.Val1572Ile|4783|4714|1572|V/I|Gtc/Atc|rs8192690&COSV56855126||-1||SNV|EntrezGene||YES|||C|C|||tolerated_low_confidence(0.08)|benign(0.001)||0.0312|0.05824|0.03047|0.03231|0.1453|0.00471|0.03931|0.1014|0.05969|0.06208|0.06819|0.05048|0.02977|0.04615|0.0475|0.151|0.001733|0.037|0.09184|0.06368|0.06144|0.05585|0.151|gnomADg_ASJ|uncertain_significance&likely_benign&benign/likely_benign&benign|0&1|1&1||||T|0.00412|-0.524791|T|0.24835|-0.476345|0.43662|.&.&0.172&0.172&.&.&.&.|-25|39|-14|-28|0.00|0.00|0.00|0.00|ABCC8|likely_benign|hg38|0.0695|V1572I|ENST00000389817.7|Q09428|157705||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Hereditary_hyperinsulinism&Neonatal_hypoglycemia&Permanent_neonatal_diabetes_mellitus&not_specified&Diabetes_mellitus&_permanent_neonatal_3&Hyperinsulinism&_Dominant/Recessive&Transient_Neonatal_Diabetes&_Dominant|NC_000011.10:g.17393023C>T||single_nucleotide_variant|ABCC8:6833&KCNJ11:3767|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&.&Human_Phenotype_Ontology:HP:0001998&MedGen:C0158986&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN239464&MedGen:CN239283|Uncertain_significance(1)&Benign(12)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:26,22:0.458:48:16,14:10,8:48:84,0,50:49.273,7.2999e-05,53:0,34.77,37.77:7,19,10,12:11,15,10,12	0/1:20,26:0.565:46:10,12:10,14:48:85,0,48:50,7.4811e-05,51.398:0,34.77,37.77:6,14,11,15:10,10,13,13	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	ABCC8	6833	Transcript	NM_000352.6	protein_coding	39/39		c.4714G>A	p.Val1572Ile	4783	4714	1572	V/I	Gtc/Atc	rs8192690&COSV56855126	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated_low_confidence(0.08)	benign(0.001)	NA	0.0312	0.05824	0.03047	0.03231	0.1453	0.00471	0.03931	0.1014	0.05969	0.06208	0.06819	0.05048	0.02977	0.04615	0.0475	0.151	0.001733	0.037	0.09184	0.06368	0.06144	0.05585	0.151	gnomADg_ASJ	uncertain_significance&likely_benign&benign/likely_benign&benign	0&1	1&1	NA	NA	NA	T	0.00412	-0.524791	T	0.24835	-0.476345	0.43662	.&.&0.172&0.172&.&.&.&.	-25	39	-14	-28	0	0	0	0	ABCC8	likely_benign	hg38	0.0695	V1572I	ENST00000389817.7	Q09428	157705	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Hereditary_hyperinsulinism&Neonatal_hypoglycemia&Permanent_neonatal_diabetes_mellitus&not_specified&Diabetes_mellitus&_permanent_neonatal_3&Hyperinsulinism&_Dominant/Recessive&Transient_Neonatal_Diabetes&_Dominant	NC_000011.10:g.17393023C>T		single_nucleotide_variant	ABCC8:6833&KCNJ11:3767	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&.&Human_Phenotype_Ontology:HP:0001998&MedGen:C0158986&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN239464&MedGen:CN239283	Uncertain_significance(1)&Benign(12)&Likely_benign(2)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs8192690	chr11_17393023_C_T	Female	0/1	Heterozygous
chr11	17393168	.	T	C	142.85	PASS	"FS=0;MQ=249.88;QD=4.46;SOR=0.818;FractionInformativeReads=1;MQRankSum=3.38;ReadPosRankSum=3.442;R2_5P_bias=-10.951;DP=82;AF=0.5;AN=6;AC=4;CSQ=C|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||38/38|NM_000352.6:c.4609-40A>G|||||||rs1109591&COSV56851613||-1||SNV|EntrezGene||YES|||T|T||||||0.3562|0.3344|0.4563|0.4588|0.3945|0.1494|0.2029|0.5002|0.3319|0.3431|0.3829|0.3623|0.4458|0.2301|0.4494|0.3942|0.1308|0.1965|0.4521|0.3337|0.3912|0.3652|0.5029|AMR|benign&likely_benign&uncertain_significance|0&1|1&1||||||||||||44|-25|38|3|0.03|0.00|0.00|0.00|ABCC8|||||||157704||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Diabetes_mellitus&_permanent_neonatal_3&Transitory_neonatal_diabetes_mellitus&not_specified|NC_000011.10:g.17393168T>C||single_nucleotide_variant|ABCC8:6833|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:CN169374|Uncertain_significance(2)&Benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,32:1:32:0,19:0,13:93:181,96,0:142.85,92.85,0:0,34.77,37.77:0,0,17,15:0,0,18,14	0/1:10,13:0.565:23:6,4:4,9:46:85,0,46:50,9.785e-05,49.019:0,34.77,37.78:2,8,8,5:4,6,7,6	0/1:19,8:0.296:27:13,3:6,5:40:75,0,50:40.498,0.00040902,53:0,34.77,37.77:12,7,3,5:6,13,6,2	C	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		38/38	c.4609-40A>G							rs1109591&COSV56851613	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.3562	0.3344	0.4563	0.4588	0.3945	0.1494	0.2029	0.5002	0.3319	0.3431	0.3829	0.3623	0.4458	0.2301	0.4494	0.3942	0.1308	0.1965	0.4521	0.3337	0.3912	0.3652	0.5029	AMR	benign&likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		44	-25	38	3	0.03	0	0	0	ABCC8			NA				157704	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Diabetes_mellitus&_permanent_neonatal_3&Transitory_neonatal_diabetes_mellitus&not_specified	NC_000011.10:g.17393168T>C		single_nucleotide_variant	ABCC8:6833	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:CN169374	Uncertain_significance(2)&Benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-20	Benign	BP4_Strong,BP6_Very_Strong,BA1	rs1109591	chr11_17393168_T_C	Female	01-Jan	Homozygous
chr11	17393168	.	T	C	142.85	PASS	"FS=0;MQ=249.88;QD=4.46;SOR=0.818;FractionInformativeReads=1;MQRankSum=3.38;ReadPosRankSum=3.442;R2_5P_bias=-10.951;DP=82;AF=0.5;AN=6;AC=4;CSQ=C|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||38/38|NM_000352.6:c.4609-40A>G|||||||rs1109591&COSV56851613||-1||SNV|EntrezGene||YES|||T|T||||||0.3562|0.3344|0.4563|0.4588|0.3945|0.1494|0.2029|0.5002|0.3319|0.3431|0.3829|0.3623|0.4458|0.2301|0.4494|0.3942|0.1308|0.1965|0.4521|0.3337|0.3912|0.3652|0.5029|AMR|benign&likely_benign&uncertain_significance|0&1|1&1||||||||||||44|-25|38|3|0.03|0.00|0.00|0.00|ABCC8|||||||157704||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Diabetes_mellitus&_permanent_neonatal_3&Transitory_neonatal_diabetes_mellitus&not_specified|NC_000011.10:g.17393168T>C||single_nucleotide_variant|ABCC8:6833|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:CN169374|Uncertain_significance(2)&Benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,32:1:32:0,19:0,13:93:181,96,0:142.85,92.85,0:0,34.77,37.77:0,0,17,15:0,0,18,14	0/1:10,13:0.565:23:6,4:4,9:46:85,0,46:50,9.785e-05,49.019:0,34.77,37.78:2,8,8,5:4,6,7,6	0/1:19,8:0.296:27:13,3:6,5:40:75,0,50:40.498,0.00040902,53:0,34.77,37.77:12,7,3,5:6,13,6,2	C	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		38/38	c.4609-40A>G							rs1109591&COSV56851613	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.3562	0.3344	0.4563	0.4588	0.3945	0.1494	0.2029	0.5002	0.3319	0.3431	0.3829	0.3623	0.4458	0.2301	0.4494	0.3942	0.1308	0.1965	0.4521	0.3337	0.3912	0.3652	0.5029	AMR	benign&likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		44	-25	38	3	0.03	0	0	0	ABCC8			NA				157704	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Diabetes_mellitus&_permanent_neonatal_3&Transitory_neonatal_diabetes_mellitus&not_specified	NC_000011.10:g.17393168T>C		single_nucleotide_variant	ABCC8:6833	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:CN169374	Uncertain_significance(2)&Benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-20	Benign	BP4_Strong,BP6_Very_Strong,BA1	rs1109591	chr11_17393168_T_C	Female	01-Jan	Homozygous
chr11	17393168	.	T	C	142.85	PASS	"FS=0;MQ=249.88;QD=4.46;SOR=0.818;FractionInformativeReads=1;MQRankSum=3.38;ReadPosRankSum=3.442;R2_5P_bias=-10.951;DP=82;AF=0.5;AN=6;AC=4;CSQ=C|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||38/38|NM_000352.6:c.4609-40A>G|||||||rs1109591&COSV56851613||-1||SNV|EntrezGene||YES|||T|T||||||0.3562|0.3344|0.4563|0.4588|0.3945|0.1494|0.2029|0.5002|0.3319|0.3431|0.3829|0.3623|0.4458|0.2301|0.4494|0.3942|0.1308|0.1965|0.4521|0.3337|0.3912|0.3652|0.5029|AMR|benign&likely_benign&uncertain_significance|0&1|1&1||||||||||||44|-25|38|3|0.03|0.00|0.00|0.00|ABCC8|||||||157704||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Diabetes_mellitus&_permanent_neonatal_3&Transitory_neonatal_diabetes_mellitus&not_specified|NC_000011.10:g.17393168T>C||single_nucleotide_variant|ABCC8:6833|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:CN169374|Uncertain_significance(2)&Benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,32:1:32:0,19:0,13:93:181,96,0:142.85,92.85,0:0,34.77,37.77:0,0,17,15:0,0,18,14	0/1:10,13:0.565:23:6,4:4,9:46:85,0,46:50,9.785e-05,49.019:0,34.77,37.78:2,8,8,5:4,6,7,6	0/1:19,8:0.296:27:13,3:6,5:40:75,0,50:40.498,0.00040902,53:0,34.77,37.77:12,7,3,5:6,13,6,2	C	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		38/38	c.4609-40A>G							rs1109591&COSV56851613	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.3562	0.3344	0.4563	0.4588	0.3945	0.1494	0.2029	0.5002	0.3319	0.3431	0.3829	0.3623	0.4458	0.2301	0.4494	0.3942	0.1308	0.1965	0.4521	0.3337	0.3912	0.3652	0.5029	AMR	benign&likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		44	-25	38	3	0.03	0	0	0	ABCC8			NA				157704	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided&Diabetes_mellitus&_permanent_neonatal_3&Transitory_neonatal_diabetes_mellitus&not_specified	NC_000011.10:g.17393168T>C		single_nucleotide_variant	ABCC8:6833	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:CN169374	Uncertain_significance(2)&Benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-20	Benign	BP4_Strong,BP6_Very_Strong,BA1	rs1109591	chr11_17393168_T_C	Female	01-Jan	Homozygous
chr11	17395957	.	A	G	125.26	PASS	"FS=0;MQ=250;QD=4.82;SOR=0.693;FractionInformativeReads=1;MQRankSum=3.841;ReadPosRankSum=2.356;R2_5P_bias=6.414;DP=95;AF=0.5;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||33/38|NM_000352.6:c.4120-27T>C|||||||rs739689||-1||SNV|EntrezGene||YES|||A|A||||||0.4215|0.3432|0.7497|0.4335|0.4145|0.1096|0.2056|0.4979|0.3368|0.3619|0.3678|0.44|0.7292|0.2325|0.448|0.4173|0.0892|0.1976|0.4286|0.3364|0.4347|0.3522|0.7874|AFR|benign&uncertain_significance&likely_benign||1||||||||||||14|0|-4|0|0.02|0.00|0.00|0.00|ABCC8|||||||157700||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified&Transitory_neonatal_diabetes_mellitus|NC_000011.10:g.17395957A>G||single_nucleotide_variant|ABCC8:6833|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273|Uncertain_significance(2)&Benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,26:1:26:0,9:0,17:75:163,78,0:125.26,75.256,2.5886e-07:0,34.77,37.77:0,0,13,13:0,0,12,14	0/1:15,8:0.348:23:7,4:8,4:45:80,0,50:45.302,0.00014988,53:0,34.77,37.77:11,4,5,3:9,6,5,3	0/1:20,26:0.565:46:9,11:11,15:47:85,0,48:50,7.7659e-05,51.039:0,34.77,37.77:7,13,11,15:10,10,14,12	G	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		33/38	c.4120-27T>C							rs739689	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.4215	0.3432	0.7497	0.4335	0.4145	0.1096	0.2056	0.4979	0.3368	0.3619	0.3678	0.44	0.7292	0.2325	0.448	0.4173	0.0892	0.1976	0.4286	0.3364	0.4347	0.3522	0.7874	AFR	benign&uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		14	0	-4	0	0.02	0	0	0	ABCC8			NA				157700	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified&Transitory_neonatal_diabetes_mellitus	NC_000011.10:g.17395957A>G		single_nucleotide_variant	ABCC8:6833	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273	Uncertain_significance(2)&Benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs739689	chr11_17395957_A_G	Female	01-Jan	Homozygous
chr11	17395957	.	A	G	125.26	PASS	"FS=0;MQ=250;QD=4.82;SOR=0.693;FractionInformativeReads=1;MQRankSum=3.841;ReadPosRankSum=2.356;R2_5P_bias=6.414;DP=95;AF=0.5;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||33/38|NM_000352.6:c.4120-27T>C|||||||rs739689||-1||SNV|EntrezGene||YES|||A|A||||||0.4215|0.3432|0.7497|0.4335|0.4145|0.1096|0.2056|0.4979|0.3368|0.3619|0.3678|0.44|0.7292|0.2325|0.448|0.4173|0.0892|0.1976|0.4286|0.3364|0.4347|0.3522|0.7874|AFR|benign&uncertain_significance&likely_benign||1||||||||||||14|0|-4|0|0.02|0.00|0.00|0.00|ABCC8|||||||157700||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified&Transitory_neonatal_diabetes_mellitus|NC_000011.10:g.17395957A>G||single_nucleotide_variant|ABCC8:6833|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273|Uncertain_significance(2)&Benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,26:1:26:0,9:0,17:75:163,78,0:125.26,75.256,2.5886e-07:0,34.77,37.77:0,0,13,13:0,0,12,14	0/1:15,8:0.348:23:7,4:8,4:45:80,0,50:45.302,0.00014988,53:0,34.77,37.77:11,4,5,3:9,6,5,3	0/1:20,26:0.565:46:9,11:11,15:47:85,0,48:50,7.7659e-05,51.039:0,34.77,37.77:7,13,11,15:10,10,14,12	G	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		33/38	c.4120-27T>C							rs739689	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.4215	0.3432	0.7497	0.4335	0.4145	0.1096	0.2056	0.4979	0.3368	0.3619	0.3678	0.44	0.7292	0.2325	0.448	0.4173	0.0892	0.1976	0.4286	0.3364	0.4347	0.3522	0.7874	AFR	benign&uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		14	0	-4	0	0.02	0	0	0	ABCC8			NA				157700	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified&Transitory_neonatal_diabetes_mellitus	NC_000011.10:g.17395957A>G		single_nucleotide_variant	ABCC8:6833	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273	Uncertain_significance(2)&Benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs739689	chr11_17395957_A_G	Female	01-Jan	Homozygous
chr11	17395957	.	A	G	125.26	PASS	"FS=0;MQ=250;QD=4.82;SOR=0.693;FractionInformativeReads=1;MQRankSum=3.841;ReadPosRankSum=2.356;R2_5P_bias=6.414;DP=95;AF=0.5;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||33/38|NM_000352.6:c.4120-27T>C|||||||rs739689||-1||SNV|EntrezGene||YES|||A|A||||||0.4215|0.3432|0.7497|0.4335|0.4145|0.1096|0.2056|0.4979|0.3368|0.3619|0.3678|0.44|0.7292|0.2325|0.448|0.4173|0.0892|0.1976|0.4286|0.3364|0.4347|0.3522|0.7874|AFR|benign&uncertain_significance&likely_benign||1||||||||||||14|0|-4|0|0.02|0.00|0.00|0.00|ABCC8|||||||157700||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified&Transitory_neonatal_diabetes_mellitus|NC_000011.10:g.17395957A>G||single_nucleotide_variant|ABCC8:6833|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273|Uncertain_significance(2)&Benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,26:1:26:0,9:0,17:75:163,78,0:125.26,75.256,2.5886e-07:0,34.77,37.77:0,0,13,13:0,0,12,14	0/1:15,8:0.348:23:7,4:8,4:45:80,0,50:45.302,0.00014988,53:0,34.77,37.77:11,4,5,3:9,6,5,3	0/1:20,26:0.565:46:9,11:11,15:47:85,0,48:50,7.7659e-05,51.039:0,34.77,37.77:7,13,11,15:10,10,14,12	G	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		33/38	c.4120-27T>C							rs739689	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.4215	0.3432	0.7497	0.4335	0.4145	0.1096	0.2056	0.4979	0.3368	0.3619	0.3678	0.44	0.7292	0.2325	0.448	0.4173	0.0892	0.1976	0.4286	0.3364	0.4347	0.3522	0.7874	AFR	benign&uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		14	0	-4	0	0.02	0	0	0	ABCC8			NA				157700	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified&Transitory_neonatal_diabetes_mellitus	NC_000011.10:g.17395957A>G		single_nucleotide_variant	ABCC8:6833	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273	Uncertain_significance(2)&Benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs739689	chr11_17395957_A_G	Female	01-Jan	Homozygous
chr11	17396823	.	C	A	50	PASS	"FS=2.958;MQ=250;MQRankSum=4.983;QD=1.43;ReadPosRankSum=2.083;SOR=1.057;FractionInformativeReads=1;R2_5P_bias=0.163;DP=74;AF=0.5;AN=4;AC=2;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||33/38|NM_000352.6:c.4119+93G>T|||||||rs4148644&COSV56851619||-1||SNV|EntrezGene||YES|||C|C||||||0.2159|0.1966|0.2811|0.1956|0.203|0.08147|0.1224|0.2608|0.1993|0.1943|0.2164|0.2111|0.2771|0.1327|0.2051|0.1967|0.07541|0.1226|0.2177|0.198|0.2055|0.2143|0.2912|AFR|benign&uncertain_significance&likely_benign|0&1|1&1||||||||||||-9|-41|-9|-38|0.02|0.00|0.00|0.00|ABCC8|||||||1177452||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided|NC_000011.10:g.17396823C>A||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900|Uncertain_significance(1)&Benign(2)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,20:0.571:35:5,12:10,8:48:85,0,48:50,7.4811e-05,51.411:0,34.77,37.77:8,7,8,12:4,11,8,12	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,20:0.513:39:9,10:10,10:48:85,0,50:50,6.5492e-05,52.945:0,34.77,37.77:9,10,13,7:9,10,13,7	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		33/38	c.4119+93G>T							rs4148644&COSV56851619	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.2159	0.1966	0.2811	0.1956	0.203	0.08147	0.1224	0.2608	0.1993	0.1943	0.2164	0.2111	0.2771	0.1327	0.2051	0.1967	0.07541	0.1226	0.2177	0.198	0.2055	0.2143	0.2912	AFR	benign&uncertain_significance&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-9	-41	-9	-38	0.02	0	0	0	ABCC8			NA				1177452	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided	NC_000011.10:g.17396823C>A		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900	Uncertain_significance(1)&Benign(2)&Likely_benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148644	chr11_17396823_C_A	Female	0/1	Heterozygous
chr11	17396823	.	C	A	50	PASS	"FS=2.958;MQ=250;MQRankSum=4.983;QD=1.43;ReadPosRankSum=2.083;SOR=1.057;FractionInformativeReads=1;R2_5P_bias=0.163;DP=74;AF=0.5;AN=4;AC=2;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||33/38|NM_000352.6:c.4119+93G>T|||||||rs4148644&COSV56851619||-1||SNV|EntrezGene||YES|||C|C||||||0.2159|0.1966|0.2811|0.1956|0.203|0.08147|0.1224|0.2608|0.1993|0.1943|0.2164|0.2111|0.2771|0.1327|0.2051|0.1967|0.07541|0.1226|0.2177|0.198|0.2055|0.2143|0.2912|AFR|benign&uncertain_significance&likely_benign|0&1|1&1||||||||||||-9|-41|-9|-38|0.02|0.00|0.00|0.00|ABCC8|||||||1177452||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided|NC_000011.10:g.17396823C>A||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900|Uncertain_significance(1)&Benign(2)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,20:0.571:35:5,12:10,8:48:85,0,48:50,7.4811e-05,51.411:0,34.77,37.77:8,7,8,12:4,11,8,12	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,20:0.513:39:9,10:10,10:48:85,0,50:50,6.5492e-05,52.945:0,34.77,37.77:9,10,13,7:9,10,13,7	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		33/38	c.4119+93G>T							rs4148644&COSV56851619	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.2159	0.1966	0.2811	0.1956	0.203	0.08147	0.1224	0.2608	0.1993	0.1943	0.2164	0.2111	0.2771	0.1327	0.2051	0.1967	0.07541	0.1226	0.2177	0.198	0.2055	0.2143	0.2912	AFR	benign&uncertain_significance&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-9	-41	-9	-38	0.02	0	0	0	ABCC8			NA				1177452	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided	NC_000011.10:g.17396823C>A		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900	Uncertain_significance(1)&Benign(2)&Likely_benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148644	chr11_17396823_C_A	Female	0/1	Heterozygous
chr11	17396823	.	C	A	50	PASS	"FS=2.958;MQ=250;MQRankSum=4.983;QD=1.43;ReadPosRankSum=2.083;SOR=1.057;FractionInformativeReads=1;R2_5P_bias=0.163;DP=74;AF=0.5;AN=4;AC=2;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||33/38|NM_000352.6:c.4119+93G>T|||||||rs4148644&COSV56851619||-1||SNV|EntrezGene||YES|||C|C||||||0.2159|0.1966|0.2811|0.1956|0.203|0.08147|0.1224|0.2608|0.1993|0.1943|0.2164|0.2111|0.2771|0.1327|0.2051|0.1967|0.07541|0.1226|0.2177|0.198|0.2055|0.2143|0.2912|AFR|benign&uncertain_significance&likely_benign|0&1|1&1||||||||||||-9|-41|-9|-38|0.02|0.00|0.00|0.00|ABCC8|||||||1177452||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided|NC_000011.10:g.17396823C>A||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900|Uncertain_significance(1)&Benign(2)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,20:0.571:35:5,12:10,8:48:85,0,48:50,7.4811e-05,51.411:0,34.77,37.77:8,7,8,12:4,11,8,12	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,20:0.513:39:9,10:10,10:48:85,0,50:50,6.5492e-05,52.945:0,34.77,37.77:9,10,13,7:9,10,13,7	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		33/38	c.4119+93G>T							rs4148644&COSV56851619	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.2159	0.1966	0.2811	0.1956	0.203	0.08147	0.1224	0.2608	0.1993	0.1943	0.2164	0.2111	0.2771	0.1327	0.2051	0.1967	0.07541	0.1226	0.2177	0.198	0.2055	0.2143	0.2912	AFR	benign&uncertain_significance&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-9	-41	-9	-38	0.02	0	0	0	ABCC8			NA				1177452	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided	NC_000011.10:g.17396823C>A		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900	Uncertain_significance(1)&Benign(2)&Likely_benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148644	chr11_17396823_C_A	Female	0/1	Heterozygous
chr11	17408375	.	T	C	49.35	PASS	"FS=4.185;MQ=248.07;MQRankSum=5.645;QD=1.1;ReadPosRankSum=-0.577;SOR=1.037;FractionInformativeReads=0.978;R2_5P_bias=31.082;DP=84;AF=0.5;AN=4;AC=2;CSQ=C|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||23/38|NM_000352.6:c.2820+17A>G|||||||rs2106865&COSV56847309||-1||SNV|EntrezGene||YES|||T|T||||||0.6146|0.6116|0.6184|0.6958|0.659|0.7147|0.5287|0.6211|0.6176|0.6245|0.4682|0.6174|0.6148|0.7252|0.6494|0.6653|0.7228|0.5244|0.6918|0.6235|0.634|0.4757|0.7252|gnomADg_AMI|benign&uncertain_significance|0&1|1&1||||||||||||-40|34|13|-29|0.00|0.00|0.00|0.00|ABCC8|||||||157694||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_specified&not_provided&Transitory_neonatal_diabetes_mellitus|NC_000011.10:g.17408375T>C||single_nucleotide_variant|ABCC8:6833|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273|Uncertain_significance(2)&Benign(8)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:24,20:0.455:44:10,9:14,11:48:84,0,50:49.353,7.2222e-05,53:0,34.77,37.77:13,11,8,12:13,11,7,13	0/1:23,16:0.41:39:14,9:9,7:46:82,0,50:47.252,0.00010355,53:0,34.77,37.77:12,11,6,10:13,10,9,7	C	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		23/38	c.2820+17A>G							rs2106865&COSV56847309	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.6146	0.6116	0.6184	0.6958	0.659	0.7147	0.5287	0.6211	0.6176	0.6245	0.4682	0.6174	0.6148	0.7252	0.6494	0.6653	0.7228	0.5244	0.6918	0.6235	0.634	0.4757	0.7252	gnomADg_AMI	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-40	34	13	-29	0	0	0	0	ABCC8			NA				157694	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_specified&not_provided&Transitory_neonatal_diabetes_mellitus	NC_000011.10:g.17408375T>C		single_nucleotide_variant	ABCC8:6833	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273	Uncertain_significance(2)&Benign(8)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs2106865	chr11_17408375_T_C	Female	./.	Other
chr11	17408375	.	T	C	49.35	PASS	"FS=4.185;MQ=248.07;MQRankSum=5.645;QD=1.1;ReadPosRankSum=-0.577;SOR=1.037;FractionInformativeReads=0.978;R2_5P_bias=31.082;DP=84;AF=0.5;AN=4;AC=2;CSQ=C|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||23/38|NM_000352.6:c.2820+17A>G|||||||rs2106865&COSV56847309||-1||SNV|EntrezGene||YES|||T|T||||||0.6146|0.6116|0.6184|0.6958|0.659|0.7147|0.5287|0.6211|0.6176|0.6245|0.4682|0.6174|0.6148|0.7252|0.6494|0.6653|0.7228|0.5244|0.6918|0.6235|0.634|0.4757|0.7252|gnomADg_AMI|benign&uncertain_significance|0&1|1&1||||||||||||-40|34|13|-29|0.00|0.00|0.00|0.00|ABCC8|||||||157694||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_specified&not_provided&Transitory_neonatal_diabetes_mellitus|NC_000011.10:g.17408375T>C||single_nucleotide_variant|ABCC8:6833|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273|Uncertain_significance(2)&Benign(8)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:24,20:0.455:44:10,9:14,11:48:84,0,50:49.353,7.2222e-05,53:0,34.77,37.77:13,11,8,12:13,11,7,13	0/1:23,16:0.41:39:14,9:9,7:46:82,0,50:47.252,0.00010355,53:0,34.77,37.77:12,11,6,10:13,10,9,7	C	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		23/38	c.2820+17A>G							rs2106865&COSV56847309	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.6146	0.6116	0.6184	0.6958	0.659	0.7147	0.5287	0.6211	0.6176	0.6245	0.4682	0.6174	0.6148	0.7252	0.6494	0.6653	0.7228	0.5244	0.6918	0.6235	0.634	0.4757	0.7252	gnomADg_AMI	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-40	34	13	-29	0	0	0	0	ABCC8			NA				157694	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_specified&not_provided&Transitory_neonatal_diabetes_mellitus	NC_000011.10:g.17408375T>C		single_nucleotide_variant	ABCC8:6833	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273	Uncertain_significance(2)&Benign(8)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs2106865	chr11_17408375_T_C	Female	./.	Other
chr11	17408375	.	T	C	49.35	PASS	"FS=4.185;MQ=248.07;MQRankSum=5.645;QD=1.1;ReadPosRankSum=-0.577;SOR=1.037;FractionInformativeReads=0.978;R2_5P_bias=31.082;DP=84;AF=0.5;AN=4;AC=2;CSQ=C|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||23/38|NM_000352.6:c.2820+17A>G|||||||rs2106865&COSV56847309||-1||SNV|EntrezGene||YES|||T|T||||||0.6146|0.6116|0.6184|0.6958|0.659|0.7147|0.5287|0.6211|0.6176|0.6245|0.4682|0.6174|0.6148|0.7252|0.6494|0.6653|0.7228|0.5244|0.6918|0.6235|0.634|0.4757|0.7252|gnomADg_AMI|benign&uncertain_significance|0&1|1&1||||||||||||-40|34|13|-29|0.00|0.00|0.00|0.00|ABCC8|||||||157694||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_specified&not_provided&Transitory_neonatal_diabetes_mellitus|NC_000011.10:g.17408375T>C||single_nucleotide_variant|ABCC8:6833|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273|Uncertain_significance(2)&Benign(8)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:24,20:0.455:44:10,9:14,11:48:84,0,50:49.353,7.2222e-05,53:0,34.77,37.77:13,11,8,12:13,11,7,13	0/1:23,16:0.41:39:14,9:9,7:46:82,0,50:47.252,0.00010355,53:0,34.77,37.77:12,11,6,10:13,10,9,7	C	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		23/38	c.2820+17A>G							rs2106865&COSV56847309	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.6146	0.6116	0.6184	0.6958	0.659	0.7147	0.5287	0.6211	0.6176	0.6245	0.4682	0.6174	0.6148	0.7252	0.6494	0.6653	0.7228	0.5244	0.6918	0.6235	0.634	0.4757	0.7252	gnomADg_AMI	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-40	34	13	-29	0	0	0	0	ABCC8			NA				157694	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3&not_specified&not_provided&Transitory_neonatal_diabetes_mellitus	NC_000011.10:g.17408375T>C		single_nucleotide_variant	ABCC8:6833	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273	Uncertain_significance(2)&Benign(8)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs2106865	chr11_17408375_T_C	Female	./.	Other
chr11	17414293	.	A	G	148.88	PASS	"FS=3.18;MQ=247.43;MQRankSum=3.943;QD=1.56;ReadPosRankSum=1.421;SOR=0.56;FractionInformativeReads=1;R2_5P_bias=15.244;DP=105;AF=1;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||19/38|NM_000352.6:c.2390+219T>C|||||||rs4148632||-1||SNV|EntrezGene||YES|||A|A||||||0.9042|||||||||||0.8922|0.9655|0.9134|0.898|0.8767|0.9122|0.8735|0.8163|0.8525|0.8925|0.8324|0.9834|AFR|benign&uncertain_significance||1||||||||||||-40|-38|-40|50|0.00|0.00|0.00|0.00|ABCC8|||||||1177448||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided|NC_000011.10:g.17414293A>G||single_nucleotide_variant|ABCC8:6833&LOC110121471:110121471|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900|Uncertain_significance(1)&Benign(6)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,13:0.419:31:7,7:11,6:47:83,0,50:48.484,8.3354e-05,53:0,34.77,37.77:7,11,7,6:14,4,7,6	0/1:13,27:0.675:40:8,14:5,13:39:85,0,36:50.001,0.00056642,39.194:0,34.77,37.78:7,6,12,15:8,5,13,14	1/1:0,34:1:34:0,16:0,18:99:187,102,0:148.88,98.875,0:0,34.77,37.77:0,0,14,20:0,0,18,16	G	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		19/38	c.2390+219T>C							rs4148632	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.9042	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.8922	0.9655	0.9134	0.898	0.8767	0.9122	0.8735	0.8163	0.8525	0.8925	0.8324	0.9834	AFR	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-40	-38	-40	50	0	0	0	0	ABCC8			NA				1177448	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided	NC_000011.10:g.17414293A>G		single_nucleotide_variant	ABCC8:6833&LOC110121471:110121471	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900	Uncertain_significance(1)&Benign(6)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148632	chr11_17414293_A_G	Female	0/1	Heterozygous
chr11	17414293	.	A	G	148.88	PASS	"FS=3.18;MQ=247.43;MQRankSum=3.943;QD=1.56;ReadPosRankSum=1.421;SOR=0.56;FractionInformativeReads=1;R2_5P_bias=15.244;DP=105;AF=1;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||19/38|NM_000352.6:c.2390+219T>C|||||||rs4148632||-1||SNV|EntrezGene||YES|||A|A||||||0.9042|||||||||||0.8922|0.9655|0.9134|0.898|0.8767|0.9122|0.8735|0.8163|0.8525|0.8925|0.8324|0.9834|AFR|benign&uncertain_significance||1||||||||||||-40|-38|-40|50|0.00|0.00|0.00|0.00|ABCC8|||||||1177448||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided|NC_000011.10:g.17414293A>G||single_nucleotide_variant|ABCC8:6833&LOC110121471:110121471|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900|Uncertain_significance(1)&Benign(6)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,13:0.419:31:7,7:11,6:47:83,0,50:48.484,8.3354e-05,53:0,34.77,37.77:7,11,7,6:14,4,7,6	0/1:13,27:0.675:40:8,14:5,13:39:85,0,36:50.001,0.00056642,39.194:0,34.77,37.78:7,6,12,15:8,5,13,14	1/1:0,34:1:34:0,16:0,18:99:187,102,0:148.88,98.875,0:0,34.77,37.77:0,0,14,20:0,0,18,16	G	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		19/38	c.2390+219T>C							rs4148632	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.9042	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.8922	0.9655	0.9134	0.898	0.8767	0.9122	0.8735	0.8163	0.8525	0.8925	0.8324	0.9834	AFR	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-40	-38	-40	50	0	0	0	0	ABCC8			NA				1177448	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided	NC_000011.10:g.17414293A>G		single_nucleotide_variant	ABCC8:6833&LOC110121471:110121471	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900	Uncertain_significance(1)&Benign(6)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148632	chr11_17414293_A_G	Female	0/1	Heterozygous
chr11	17414293	.	A	G	148.88	PASS	"FS=3.18;MQ=247.43;MQRankSum=3.943;QD=1.56;ReadPosRankSum=1.421;SOR=0.56;FractionInformativeReads=1;R2_5P_bias=15.244;DP=105;AF=1;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||19/38|NM_000352.6:c.2390+219T>C|||||||rs4148632||-1||SNV|EntrezGene||YES|||A|A||||||0.9042|||||||||||0.8922|0.9655|0.9134|0.898|0.8767|0.9122|0.8735|0.8163|0.8525|0.8925|0.8324|0.9834|AFR|benign&uncertain_significance||1||||||||||||-40|-38|-40|50|0.00|0.00|0.00|0.00|ABCC8|||||||1177448||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided|NC_000011.10:g.17414293A>G||single_nucleotide_variant|ABCC8:6833&LOC110121471:110121471|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900|Uncertain_significance(1)&Benign(6)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,13:0.419:31:7,7:11,6:47:83,0,50:48.484,8.3354e-05,53:0,34.77,37.77:7,11,7,6:14,4,7,6	0/1:13,27:0.675:40:8,14:5,13:39:85,0,36:50.001,0.00056642,39.194:0,34.77,37.78:7,6,12,15:8,5,13,14	1/1:0,34:1:34:0,16:0,18:99:187,102,0:148.88,98.875,0:0,34.77,37.77:0,0,14,20:0,0,18,16	G	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		19/38	c.2390+219T>C							rs4148632	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.9042	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.8922	0.9655	0.9134	0.898	0.8767	0.9122	0.8735	0.8163	0.8525	0.8925	0.8324	0.9834	AFR	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-40	-38	-40	50	0	0	0	0	ABCC8			NA				1177448	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided	NC_000011.10:g.17414293A>G		single_nucleotide_variant	ABCC8:6833&LOC110121471:110121471	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900	Uncertain_significance(1)&Benign(6)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148632	chr11_17414293_A_G	Female	0/1	Heterozygous
chr11	17414389	.	G	A	148.87	PASS	"FS=6.374;MQ=250;MQRankSum=4.243;QD=1.7;ReadPosRankSum=2.234;SOR=2.115;FractionInformativeReads=1;R2_5P_bias=0.629;DP=99;AF=1;AN=6;AC=4;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||19/38|NM_000352.6:c.2390+123C>T|||||||rs4148631||-1||SNV|EntrezGene||YES|||G|G||||||0.7470|0.7539|0.5784|0.8469|0.7895|0.8624|0.7273|0.7046|0.7512|0.7604|0.747|0.7155|0.5817|0.8136|0.7993|0.7954|0.8819|0.7282|0.7415|0.754|0.7427|0.7632|0.8968|EAS|likely_benign&uncertain_significance&benign||1||||||||||||7|-23|8|-44|0.01|0.00|0.01|0.00|ABCC8|||||||1177449||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1|NC_000011.10:g.17414389G>A||single_nucleotide_variant|ABCC8:6833&LOC110121471:110121471|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598|Uncertain_significance(1)&Benign(2)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,10:0.37:27:11,6:6,4:45:81,0,50:46.013,0.00013047,53:0,34.77,37.77:9,8,8,2:11,6,8,2	0/1:8,30:0.789:38:6,14:2,16:22:85,0,19:50.025,0.024563,22.495:0,34.77,37.77:6,2,14,16:6,2,16,14	1/1:0,34:1:34:0,17:0,17:99:187,102,0:148.87,98.871,0:0,34.77,37.77:0,0,22,12:0,0,19,15	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		19/38	c.2390+123C>T							rs4148631	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.747	0.7539	0.5784	0.8469	0.7895	0.8624	0.7273	0.7046	0.7512	0.7604	0.747	0.7155	0.5817	0.8136	0.7993	0.7954	0.8819	0.7282	0.7415	0.754	0.7427	0.7632	0.8968	EAS	likely_benign&uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		7	-23	8	-44	0.01	0	0.01	0	ABCC8			NA				1177449	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1	NC_000011.10:g.17414389G>A		single_nucleotide_variant	ABCC8:6833&LOC110121471:110121471	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598	Uncertain_significance(1)&Benign(2)&Likely_benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148631	chr11_17414389_G_A	Female	0/1	Heterozygous
chr11	17414389	.	G	A	148.87	PASS	"FS=6.374;MQ=250;MQRankSum=4.243;QD=1.7;ReadPosRankSum=2.234;SOR=2.115;FractionInformativeReads=1;R2_5P_bias=0.629;DP=99;AF=1;AN=6;AC=4;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||19/38|NM_000352.6:c.2390+123C>T|||||||rs4148631||-1||SNV|EntrezGene||YES|||G|G||||||0.7470|0.7539|0.5784|0.8469|0.7895|0.8624|0.7273|0.7046|0.7512|0.7604|0.747|0.7155|0.5817|0.8136|0.7993|0.7954|0.8819|0.7282|0.7415|0.754|0.7427|0.7632|0.8968|EAS|likely_benign&uncertain_significance&benign||1||||||||||||7|-23|8|-44|0.01|0.00|0.01|0.00|ABCC8|||||||1177449||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1|NC_000011.10:g.17414389G>A||single_nucleotide_variant|ABCC8:6833&LOC110121471:110121471|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598|Uncertain_significance(1)&Benign(2)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,10:0.37:27:11,6:6,4:45:81,0,50:46.013,0.00013047,53:0,34.77,37.77:9,8,8,2:11,6,8,2	0/1:8,30:0.789:38:6,14:2,16:22:85,0,19:50.025,0.024563,22.495:0,34.77,37.77:6,2,14,16:6,2,16,14	1/1:0,34:1:34:0,17:0,17:99:187,102,0:148.87,98.871,0:0,34.77,37.77:0,0,22,12:0,0,19,15	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		19/38	c.2390+123C>T							rs4148631	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.747	0.7539	0.5784	0.8469	0.7895	0.8624	0.7273	0.7046	0.7512	0.7604	0.747	0.7155	0.5817	0.8136	0.7993	0.7954	0.8819	0.7282	0.7415	0.754	0.7427	0.7632	0.8968	EAS	likely_benign&uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		7	-23	8	-44	0.01	0	0.01	0	ABCC8			NA				1177449	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1	NC_000011.10:g.17414389G>A		single_nucleotide_variant	ABCC8:6833&LOC110121471:110121471	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598	Uncertain_significance(1)&Benign(2)&Likely_benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148631	chr11_17414389_G_A	Female	0/1	Heterozygous
chr11	17414389	.	G	A	148.87	PASS	"FS=6.374;MQ=250;MQRankSum=4.243;QD=1.7;ReadPosRankSum=2.234;SOR=2.115;FractionInformativeReads=1;R2_5P_bias=0.629;DP=99;AF=1;AN=6;AC=4;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||19/38|NM_000352.6:c.2390+123C>T|||||||rs4148631||-1||SNV|EntrezGene||YES|||G|G||||||0.7470|0.7539|0.5784|0.8469|0.7895|0.8624|0.7273|0.7046|0.7512|0.7604|0.747|0.7155|0.5817|0.8136|0.7993|0.7954|0.8819|0.7282|0.7415|0.754|0.7427|0.7632|0.8968|EAS|likely_benign&uncertain_significance&benign||1||||||||||||7|-23|8|-44|0.01|0.00|0.01|0.00|ABCC8|||||||1177449||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1|NC_000011.10:g.17414389G>A||single_nucleotide_variant|ABCC8:6833&LOC110121471:110121471|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598|Uncertain_significance(1)&Benign(2)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,10:0.37:27:11,6:6,4:45:81,0,50:46.013,0.00013047,53:0,34.77,37.77:9,8,8,2:11,6,8,2	0/1:8,30:0.789:38:6,14:2,16:22:85,0,19:50.025,0.024563,22.495:0,34.77,37.77:6,2,14,16:6,2,16,14	1/1:0,34:1:34:0,17:0,17:99:187,102,0:148.87,98.871,0:0,34.77,37.77:0,0,22,12:0,0,19,15	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		19/38	c.2390+123C>T							rs4148631	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.747	0.7539	0.5784	0.8469	0.7895	0.8624	0.7273	0.7046	0.7512	0.7604	0.747	0.7155	0.5817	0.8136	0.7993	0.7954	0.8819	0.7282	0.7415	0.754	0.7427	0.7632	0.8968	EAS	likely_benign&uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		7	-23	8	-44	0.01	0	0.01	0	ABCC8			NA				1177449	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1	NC_000011.10:g.17414389G>A		single_nucleotide_variant	ABCC8:6833&LOC110121471:110121471	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598	Uncertain_significance(1)&Benign(2)&Likely_benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148631	chr11_17414389_G_A	Female	0/1	Heterozygous
chr11	17414419	.	G	A	171.55	PASS	"FS=5.859;MQ=250;MQRankSum=4.604;QD=1.62;ReadPosRankSum=-0.753;SOR=1.964;FractionInformativeReads=1;R2_5P_bias=0.213;DP=112;AF=1;AN=6;AC=4;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||19/38|NM_000352.6:c.2390+93C>T|||||||rs4148630&COSV107400436||-1||SNV|EntrezGene||YES|||G|G||||||0.7466|0.7523|0.5795|0.8463|0.7888|0.8627|0.7268|0.7049|0.7499|0.7602|0.7471|0.7153|0.5812|0.8136|0.7993|0.7953|0.8826|0.7283|0.7415|0.7538|0.7427|0.763|0.8968|EAS|uncertain_significance&likely_benign&benign|0&1|1&1||||||||||||2|-23|2|-22|0.00|0.01|0.00|0.01|ABCC8|||||||1177450||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1|NC_000011.10:g.17414419G>A||single_nucleotide_variant|ABCC8:6833&LOC110121471:110121471|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598|Uncertain_significance(1)&Benign(2)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,13:0.433:30:10,9:7,4:47:83,0,50:48.572,8.2059e-05,53:0,34.77,37.77:9,8,10,3:10,7,10,3	0/1:9,31:0.775:40:7,14:2,17:26:85,0,23:50.011,0.011249,25.889:0,34.77,37.77:6,3,15,16:8,1,18,13	1/1:0,42:1:42:0,27:0,15:122:209,125,0:171.55,121.55,0:0,34.77,37.77:0,0,28,14:0,0,27,15	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		19/38	c.2390+93C>T							rs4148630&COSV107400436	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.7466	0.7523	0.5795	0.8463	0.7888	0.8627	0.7268	0.7049	0.7499	0.7602	0.7471	0.7153	0.5812	0.8136	0.7993	0.7953	0.8826	0.7283	0.7415	0.7538	0.7427	0.763	0.8968	EAS	uncertain_significance&likely_benign&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		2	-23	2	-22	0	0.01	0	0.01	ABCC8			NA				1177450	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1	NC_000011.10:g.17414419G>A		single_nucleotide_variant	ABCC8:6833&LOC110121471:110121471	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598	Uncertain_significance(1)&Benign(2)&Likely_benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148630	chr11_17414419_G_A	Female	0/1	Heterozygous
chr11	17414419	.	G	A	171.55	PASS	"FS=5.859;MQ=250;MQRankSum=4.604;QD=1.62;ReadPosRankSum=-0.753;SOR=1.964;FractionInformativeReads=1;R2_5P_bias=0.213;DP=112;AF=1;AN=6;AC=4;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||19/38|NM_000352.6:c.2390+93C>T|||||||rs4148630&COSV107400436||-1||SNV|EntrezGene||YES|||G|G||||||0.7466|0.7523|0.5795|0.8463|0.7888|0.8627|0.7268|0.7049|0.7499|0.7602|0.7471|0.7153|0.5812|0.8136|0.7993|0.7953|0.8826|0.7283|0.7415|0.7538|0.7427|0.763|0.8968|EAS|uncertain_significance&likely_benign&benign|0&1|1&1||||||||||||2|-23|2|-22|0.00|0.01|0.00|0.01|ABCC8|||||||1177450||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1|NC_000011.10:g.17414419G>A||single_nucleotide_variant|ABCC8:6833&LOC110121471:110121471|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598|Uncertain_significance(1)&Benign(2)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,13:0.433:30:10,9:7,4:47:83,0,50:48.572,8.2059e-05,53:0,34.77,37.77:9,8,10,3:10,7,10,3	0/1:9,31:0.775:40:7,14:2,17:26:85,0,23:50.011,0.011249,25.889:0,34.77,37.77:6,3,15,16:8,1,18,13	1/1:0,42:1:42:0,27:0,15:122:209,125,0:171.55,121.55,0:0,34.77,37.77:0,0,28,14:0,0,27,15	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		19/38	c.2390+93C>T							rs4148630&COSV107400436	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.7466	0.7523	0.5795	0.8463	0.7888	0.8627	0.7268	0.7049	0.7499	0.7602	0.7471	0.7153	0.5812	0.8136	0.7993	0.7953	0.8826	0.7283	0.7415	0.7538	0.7427	0.763	0.8968	EAS	uncertain_significance&likely_benign&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		2	-23	2	-22	0	0.01	0	0.01	ABCC8			NA				1177450	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1	NC_000011.10:g.17414419G>A		single_nucleotide_variant	ABCC8:6833&LOC110121471:110121471	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598	Uncertain_significance(1)&Benign(2)&Likely_benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148630	chr11_17414419_G_A	Female	0/1	Heterozygous
chr11	17414419	.	G	A	171.55	PASS	"FS=5.859;MQ=250;MQRankSum=4.604;QD=1.62;ReadPosRankSum=-0.753;SOR=1.964;FractionInformativeReads=1;R2_5P_bias=0.213;DP=112;AF=1;AN=6;AC=4;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||19/38|NM_000352.6:c.2390+93C>T|||||||rs4148630&COSV107400436||-1||SNV|EntrezGene||YES|||G|G||||||0.7466|0.7523|0.5795|0.8463|0.7888|0.8627|0.7268|0.7049|0.7499|0.7602|0.7471|0.7153|0.5812|0.8136|0.7993|0.7953|0.8826|0.7283|0.7415|0.7538|0.7427|0.763|0.8968|EAS|uncertain_significance&likely_benign&benign|0&1|1&1||||||||||||2|-23|2|-22|0.00|0.01|0.00|0.01|ABCC8|||||||1177450||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1|NC_000011.10:g.17414419G>A||single_nucleotide_variant|ABCC8:6833&LOC110121471:110121471|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598|Uncertain_significance(1)&Benign(2)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,13:0.433:30:10,9:7,4:47:83,0,50:48.572,8.2059e-05,53:0,34.77,37.77:9,8,10,3:10,7,10,3	0/1:9,31:0.775:40:7,14:2,17:26:85,0,23:50.011,0.011249,25.889:0,34.77,37.77:6,3,15,16:8,1,18,13	1/1:0,42:1:42:0,27:0,15:122:209,125,0:171.55,121.55,0:0,34.77,37.77:0,0,28,14:0,0,27,15	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		19/38	c.2390+93C>T							rs4148630&COSV107400436	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.7466	0.7523	0.5795	0.8463	0.7888	0.8627	0.7268	0.7049	0.7499	0.7602	0.7471	0.7153	0.5812	0.8136	0.7993	0.7953	0.8826	0.7283	0.7415	0.7538	0.7427	0.763	0.8968	EAS	uncertain_significance&likely_benign&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		2	-23	2	-22	0	0.01	0	0.01	ABCC8			NA				1177450	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1	NC_000011.10:g.17414419G>A		single_nucleotide_variant	ABCC8:6833&LOC110121471:110121471	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598	Uncertain_significance(1)&Benign(2)&Likely_benign(5)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148630	chr11_17414419_G_A	Female	0/1	Heterozygous
chr11	17415389	.	A	G	142.39	PASS	"FS=14.012;MQ=247.35;MQRankSum=4.826;QD=1.42;ReadPosRankSum=1.949;SOR=1.078;FractionInformativeReads=0.971;R2_5P_bias=1.274;DP=97;AF=1;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||17/38|NM_000352.6:c.2256-50T>C|||||||rs4148626&COSV107400437||-1||SNV|EntrezGene||YES|||A|A||||||0.9038|0.8556|0.9669|0.9065|0.8766|0.8902|0.8652|0.8093|0.8498|0.8683|0.8281|0.8916|0.9632|0.9134|0.8977|0.8767|0.9121|0.8731|0.8163|0.8526|0.8931|0.8328|0.9818|AFR|benign&uncertain_significance|0&1|1&1||||||||||||15|-50|-19|47|0.00|0.02|0.00|0.00|ABCC8|||||||1177451||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided|NC_000011.10:g.17415389A>G||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900|Uncertain_significance(1)&Benign(7)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,14:0.424:33:9,6:10,8:47:83,0,50:48.314,8.5683e-05,53:0,34.77,37.77:5,14,9,5:7,12,7,7	0/1:14,17:0.548:31:9,5:5,12:48:85,0,49:50,6.9634e-05,52.181:0,34.77,37.77:6,8,8,9:5,9,10,7	1/1:0,32:1:32:0,15:0,17:92:180,95,0:142.39,92.392,0:0,34.77,37.77:0,0,15,17:0,0,20,12	G	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		17/38	c.2256-50T>C							rs4148626&COSV107400437	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.9038	0.8556	0.9669	0.9065	0.8766	0.8902	0.8652	0.8093	0.8498	0.8683	0.8281	0.8916	0.9632	0.9134	0.8977	0.8767	0.9121	0.8731	0.8163	0.8526	0.8931	0.8328	0.9818	AFR	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		15	-50	-19	47	0	0.02	0	0	ABCC8			NA				1177451	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided	NC_000011.10:g.17415389A>G		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900	Uncertain_significance(1)&Benign(7)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148626	chr11_17415389_A_G	Female	0/1	Heterozygous
chr11	17415389	.	A	G	142.39	PASS	"FS=14.012;MQ=247.35;MQRankSum=4.826;QD=1.42;ReadPosRankSum=1.949;SOR=1.078;FractionInformativeReads=0.971;R2_5P_bias=1.274;DP=97;AF=1;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||17/38|NM_000352.6:c.2256-50T>C|||||||rs4148626&COSV107400437||-1||SNV|EntrezGene||YES|||A|A||||||0.9038|0.8556|0.9669|0.9065|0.8766|0.8902|0.8652|0.8093|0.8498|0.8683|0.8281|0.8916|0.9632|0.9134|0.8977|0.8767|0.9121|0.8731|0.8163|0.8526|0.8931|0.8328|0.9818|AFR|benign&uncertain_significance|0&1|1&1||||||||||||15|-50|-19|47|0.00|0.02|0.00|0.00|ABCC8|||||||1177451||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided|NC_000011.10:g.17415389A>G||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900|Uncertain_significance(1)&Benign(7)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,14:0.424:33:9,6:10,8:47:83,0,50:48.314,8.5683e-05,53:0,34.77,37.77:5,14,9,5:7,12,7,7	0/1:14,17:0.548:31:9,5:5,12:48:85,0,49:50,6.9634e-05,52.181:0,34.77,37.77:6,8,8,9:5,9,10,7	1/1:0,32:1:32:0,15:0,17:92:180,95,0:142.39,92.392,0:0,34.77,37.77:0,0,15,17:0,0,20,12	G	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		17/38	c.2256-50T>C							rs4148626&COSV107400437	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.9038	0.8556	0.9669	0.9065	0.8766	0.8902	0.8652	0.8093	0.8498	0.8683	0.8281	0.8916	0.9632	0.9134	0.8977	0.8767	0.9121	0.8731	0.8163	0.8526	0.8931	0.8328	0.9818	AFR	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		15	-50	-19	47	0	0.02	0	0	ABCC8			NA				1177451	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided	NC_000011.10:g.17415389A>G		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900	Uncertain_significance(1)&Benign(7)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148626	chr11_17415389_A_G	Female	0/1	Heterozygous
chr11	17415389	.	A	G	142.39	PASS	"FS=14.012;MQ=247.35;MQRankSum=4.826;QD=1.42;ReadPosRankSum=1.949;SOR=1.078;FractionInformativeReads=0.971;R2_5P_bias=1.274;DP=97;AF=1;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||17/38|NM_000352.6:c.2256-50T>C|||||||rs4148626&COSV107400437||-1||SNV|EntrezGene||YES|||A|A||||||0.9038|0.8556|0.9669|0.9065|0.8766|0.8902|0.8652|0.8093|0.8498|0.8683|0.8281|0.8916|0.9632|0.9134|0.8977|0.8767|0.9121|0.8731|0.8163|0.8526|0.8931|0.8328|0.9818|AFR|benign&uncertain_significance|0&1|1&1||||||||||||15|-50|-19|47|0.00|0.02|0.00|0.00|ABCC8|||||||1177451||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided|NC_000011.10:g.17415389A>G||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900|Uncertain_significance(1)&Benign(7)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,14:0.424:33:9,6:10,8:47:83,0,50:48.314,8.5683e-05,53:0,34.77,37.77:5,14,9,5:7,12,7,7	0/1:14,17:0.548:31:9,5:5,12:48:85,0,49:50,6.9634e-05,52.181:0,34.77,37.77:6,8,8,9:5,9,10,7	1/1:0,32:1:32:0,15:0,17:92:180,95,0:142.39,92.392,0:0,34.77,37.77:0,0,15,17:0,0,20,12	G	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		17/38	c.2256-50T>C							rs4148626&COSV107400437	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.9038	0.8556	0.9669	0.9065	0.8766	0.8902	0.8652	0.8093	0.8498	0.8683	0.8281	0.8916	0.9632	0.9134	0.8977	0.8767	0.9121	0.8731	0.8163	0.8526	0.8931	0.8328	0.9818	AFR	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		15	-50	-19	47	0	0.02	0	0	ABCC8			NA				1177451	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_permanent_neonatal_3&Maturity_onset_diabetes_mellitus_in_young&Transitory_neonatal_diabetes_mellitus&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_provided	NC_000011.10:g.17415389A>G		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0008255&MONDO:MONDO:0020525&MedGen:C0342273&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:C3661900	Uncertain_significance(1)&Benign(7)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4148626	chr11_17415389_A_G	Female	0/1	Heterozygous
chr11	17428382	.	C	T	50	PASS	"FS=0;MQ=250;MQRankSum=5.038;QD=1.39;ReadPosRankSum=3.337;SOR=0.542;FractionInformativeReads=1;R2_5P_bias=-12.419;DP=71;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|ABCC8|6833|Transcript|NM_000352.6|protein_coding|14/39||NM_000352.6:c.1947G>A|NP_000343.2:p.Lys649%3D|2016|1947|649|K|aaG/aaA|rs1799858&CM035686&COSV56845625&COSV56849597||-1||SNV|EntrezGene||YES|||C|C||||||0.2021|0.1599|0.1811|0.1311|0.1863|0.1992|0.1981|0.1185|0.1471|0.166|0.2802|0.1659|0.1777|0.1187|0.1581|0.1907|0.1991|0.1888|0.09184|0.1457|0.1552|0.2891|0.3333|SAS|benign&uncertain_significance|0&1&1&1|1&1&1&1||||||||||||-8|15|15|5|0.02|0.01|0.00|0.00|ABCC8|||||||157686||Conflicting_classifications_of_pathogenicity|not_specified&Hereditary_hyperinsulinism&Permanent_neonatal_diabetes_mellitus&not_provided&Type_2_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3|NC_000011.10:g.17428382C>T||single_nucleotide_variant|ABCC8:6833|MedGen:CN169374&.&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:C3661900&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857|Uncertain_significance(1)&Benign(12)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,21:0.583:36:6,10:9,11:47:85,0,48:50,7.973e-05,50.773:0,34.77,37.77:5,10,8,13:8,7,17,4	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:18,17:0.486:35:10,11:8,6:48:85,0,50:49.938,6.5751e-05,53:0,34.77,37.77:10,8,8,9:8,10,10,7	T	synonymous_variant	LOW	ABCC8	6833	Transcript	NM_000352.6	protein_coding	14/39		c.1947G>A	p.Lys649%3D	2016	1947	649	K	aaG/aaA	rs1799858&CM035686&COSV56845625&COSV56849597	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.2021	0.1599	0.1811	0.1311	0.1863	0.1992	0.1981	0.1185	0.1471	0.166	0.2802	0.1659	0.1777	0.1187	0.1581	0.1907	0.1991	0.1888	0.09184	0.1457	0.1552	0.2891	0.3333	SAS	benign&uncertain_significance	0&1&1&1	1&1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-8	15	15	5	0.02	0.01	0	0	ABCC8			NA				157686	NA	Conflicting_classifications_of_pathogenicity	not_specified&Hereditary_hyperinsulinism&Permanent_neonatal_diabetes_mellitus&not_provided&Type_2_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3	NC_000011.10:g.17428382C>T		single_nucleotide_variant	ABCC8:6833	MedGen:CN169374&.&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:C3661900&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857	Uncertain_significance(1)&Benign(12)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-12	Benign	BP4_Moderate,BP6,BP7,BA1	rs1799858	chr11_17428382_C_T	Female	0/1	Heterozygous
chr11	17428382	.	C	T	50	PASS	"FS=0;MQ=250;MQRankSum=5.038;QD=1.39;ReadPosRankSum=3.337;SOR=0.542;FractionInformativeReads=1;R2_5P_bias=-12.419;DP=71;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|ABCC8|6833|Transcript|NM_000352.6|protein_coding|14/39||NM_000352.6:c.1947G>A|NP_000343.2:p.Lys649%3D|2016|1947|649|K|aaG/aaA|rs1799858&CM035686&COSV56845625&COSV56849597||-1||SNV|EntrezGene||YES|||C|C||||||0.2021|0.1599|0.1811|0.1311|0.1863|0.1992|0.1981|0.1185|0.1471|0.166|0.2802|0.1659|0.1777|0.1187|0.1581|0.1907|0.1991|0.1888|0.09184|0.1457|0.1552|0.2891|0.3333|SAS|benign&uncertain_significance|0&1&1&1|1&1&1&1||||||||||||-8|15|15|5|0.02|0.01|0.00|0.00|ABCC8|||||||157686||Conflicting_classifications_of_pathogenicity|not_specified&Hereditary_hyperinsulinism&Permanent_neonatal_diabetes_mellitus&not_provided&Type_2_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3|NC_000011.10:g.17428382C>T||single_nucleotide_variant|ABCC8:6833|MedGen:CN169374&.&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:C3661900&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857|Uncertain_significance(1)&Benign(12)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,21:0.583:36:6,10:9,11:47:85,0,48:50,7.973e-05,50.773:0,34.77,37.77:5,10,8,13:8,7,17,4	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:18,17:0.486:35:10,11:8,6:48:85,0,50:49.938,6.5751e-05,53:0,34.77,37.77:10,8,8,9:8,10,10,7	T	synonymous_variant	LOW	ABCC8	6833	Transcript	NM_000352.6	protein_coding	14/39		c.1947G>A	p.Lys649%3D	2016	1947	649	K	aaG/aaA	rs1799858&CM035686&COSV56845625&COSV56849597	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.2021	0.1599	0.1811	0.1311	0.1863	0.1992	0.1981	0.1185	0.1471	0.166	0.2802	0.1659	0.1777	0.1187	0.1581	0.1907	0.1991	0.1888	0.09184	0.1457	0.1552	0.2891	0.3333	SAS	benign&uncertain_significance	0&1&1&1	1&1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-8	15	15	5	0.02	0.01	0	0	ABCC8			NA				157686	NA	Conflicting_classifications_of_pathogenicity	not_specified&Hereditary_hyperinsulinism&Permanent_neonatal_diabetes_mellitus&not_provided&Type_2_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3	NC_000011.10:g.17428382C>T		single_nucleotide_variant	ABCC8:6833	MedGen:CN169374&.&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:C3661900&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857	Uncertain_significance(1)&Benign(12)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-12	Benign	BP4_Moderate,BP6,BP7,BA1	rs1799858	chr11_17428382_C_T	Female	0/1	Heterozygous
chr11	17428382	.	C	T	50	PASS	"FS=0;MQ=250;MQRankSum=5.038;QD=1.39;ReadPosRankSum=3.337;SOR=0.542;FractionInformativeReads=1;R2_5P_bias=-12.419;DP=71;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|ABCC8|6833|Transcript|NM_000352.6|protein_coding|14/39||NM_000352.6:c.1947G>A|NP_000343.2:p.Lys649%3D|2016|1947|649|K|aaG/aaA|rs1799858&CM035686&COSV56845625&COSV56849597||-1||SNV|EntrezGene||YES|||C|C||||||0.2021|0.1599|0.1811|0.1311|0.1863|0.1992|0.1981|0.1185|0.1471|0.166|0.2802|0.1659|0.1777|0.1187|0.1581|0.1907|0.1991|0.1888|0.09184|0.1457|0.1552|0.2891|0.3333|SAS|benign&uncertain_significance|0&1&1&1|1&1&1&1||||||||||||-8|15|15|5|0.02|0.01|0.00|0.00|ABCC8|||||||157686||Conflicting_classifications_of_pathogenicity|not_specified&Hereditary_hyperinsulinism&Permanent_neonatal_diabetes_mellitus&not_provided&Type_2_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3|NC_000011.10:g.17428382C>T||single_nucleotide_variant|ABCC8:6833|MedGen:CN169374&.&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:C3661900&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857|Uncertain_significance(1)&Benign(12)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,21:0.583:36:6,10:9,11:47:85,0,48:50,7.973e-05,50.773:0,34.77,37.77:5,10,8,13:8,7,17,4	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:18,17:0.486:35:10,11:8,6:48:85,0,50:49.938,6.5751e-05,53:0,34.77,37.77:10,8,8,9:8,10,10,7	T	synonymous_variant	LOW	ABCC8	6833	Transcript	NM_000352.6	protein_coding	14/39		c.1947G>A	p.Lys649%3D	2016	1947	649	K	aaG/aaA	rs1799858&CM035686&COSV56845625&COSV56849597	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.2021	0.1599	0.1811	0.1311	0.1863	0.1992	0.1981	0.1185	0.1471	0.166	0.2802	0.1659	0.1777	0.1187	0.1581	0.1907	0.1991	0.1888	0.09184	0.1457	0.1552	0.2891	0.3333	SAS	benign&uncertain_significance	0&1&1&1	1&1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-8	15	15	5	0.02	0.01	0	0	ABCC8			NA				157686	NA	Conflicting_classifications_of_pathogenicity	not_specified&Hereditary_hyperinsulinism&Permanent_neonatal_diabetes_mellitus&not_provided&Type_2_diabetes_mellitus&Leucine-induced_hypoglycemia&Diabetes_mellitus&_transient_neonatal&_2&Hyperinsulinemic_hypoglycemia&_familial&_1&Diabetes_mellitus&_permanent_neonatal_3	NC_000011.10:g.17428382C>T		single_nucleotide_variant	ABCC8:6833	MedGen:CN169374&.&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:C3661900&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857	Uncertain_significance(1)&Benign(12)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-12	Benign	BP4_Moderate,BP6,BP7,BA1	rs1799858	chr11_17428382_C_T	Female	0/1	Heterozygous
chr11	17430945	.	G	A	50	PASS	"FS=1.283;MQ=250;MQRankSum=5.137;QD=1.21;ReadPosRankSum=3.195;SOR=1.008;FractionInformativeReads=1;R2_5P_bias=7.745;DP=87;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|ABCC8|6833|Transcript|NM_000352.6|protein_coding|12/39||NM_000352.6:c.1686C>T|NP_000343.2:p.His562%3D|1755|1686|562|H|caC/caT|rs1799857&COSV56850686||-1||SNV|EntrezGene||YES|||G|G||||||0.4299|0.4459|0.4747|0.3195|0.4445|0.3087|0.4107|0.4108|0.4535|0.438|0.4959|0.4417|0.4801|0.3516|0.3803|0.4438|0.3002|0.4127|0.3537|0.4459|0.4296|0.4867|0.5225|SAS|uncertain_significance&benign|0&1|1&1||||||||||||-6|14|0|-18|0.00|0.00|0.00|0.00|ABCC8|||||||157684||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Cerebral_edema&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified|NC_000011.10:g.17430945G>A||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0002181&MONDO:MONDO:0006684&MedGen:C0006114&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(1)&Benign(11)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:23,15:0.395:38:15,9:8,6:45:81,0,50:46.091,0.00012866,53:0,34.77,37.77:12,11,9,6:6,17,3,12	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:24,25:0.51:49:6,12:18,13:48:85,0,50:50,6.5233e-05,52.972:0,34.77,37.77:11,13,14,11:17,7,9,16	A	synonymous_variant	LOW	ABCC8	6833	Transcript	NM_000352.6	protein_coding	12/39		c.1686C>T	p.His562%3D	1755	1686	562	H	caC/caT	rs1799857&COSV56850686	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.4299	0.4459	0.4747	0.3195	0.4445	0.3087	0.4107	0.4108	0.4535	0.438	0.4959	0.4417	0.4801	0.3516	0.3803	0.4438	0.3002	0.4127	0.3537	0.4459	0.4296	0.4867	0.5225	SAS	uncertain_significance&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-6	14	0	-18	0	0	0	0	ABCC8			NA				157684	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Cerebral_edema&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified	NC_000011.10:g.17430945G>A		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0002181&MONDO:MONDO:0006684&MedGen:C0006114&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(1)&Benign(11)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1799857	chr11_17430945_G_A	Female	0/1	Heterozygous
chr11	17430945	.	G	A	50	PASS	"FS=1.283;MQ=250;MQRankSum=5.137;QD=1.21;ReadPosRankSum=3.195;SOR=1.008;FractionInformativeReads=1;R2_5P_bias=7.745;DP=87;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|ABCC8|6833|Transcript|NM_000352.6|protein_coding|12/39||NM_000352.6:c.1686C>T|NP_000343.2:p.His562%3D|1755|1686|562|H|caC/caT|rs1799857&COSV56850686||-1||SNV|EntrezGene||YES|||G|G||||||0.4299|0.4459|0.4747|0.3195|0.4445|0.3087|0.4107|0.4108|0.4535|0.438|0.4959|0.4417|0.4801|0.3516|0.3803|0.4438|0.3002|0.4127|0.3537|0.4459|0.4296|0.4867|0.5225|SAS|uncertain_significance&benign|0&1|1&1||||||||||||-6|14|0|-18|0.00|0.00|0.00|0.00|ABCC8|||||||157684||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Cerebral_edema&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified|NC_000011.10:g.17430945G>A||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0002181&MONDO:MONDO:0006684&MedGen:C0006114&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(1)&Benign(11)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:23,15:0.395:38:15,9:8,6:45:81,0,50:46.091,0.00012866,53:0,34.77,37.77:12,11,9,6:6,17,3,12	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:24,25:0.51:49:6,12:18,13:48:85,0,50:50,6.5233e-05,52.972:0,34.77,37.77:11,13,14,11:17,7,9,16	A	synonymous_variant	LOW	ABCC8	6833	Transcript	NM_000352.6	protein_coding	12/39		c.1686C>T	p.His562%3D	1755	1686	562	H	caC/caT	rs1799857&COSV56850686	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.4299	0.4459	0.4747	0.3195	0.4445	0.3087	0.4107	0.4108	0.4535	0.438	0.4959	0.4417	0.4801	0.3516	0.3803	0.4438	0.3002	0.4127	0.3537	0.4459	0.4296	0.4867	0.5225	SAS	uncertain_significance&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-6	14	0	-18	0	0	0	0	ABCC8			NA				157684	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Cerebral_edema&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified	NC_000011.10:g.17430945G>A		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0002181&MONDO:MONDO:0006684&MedGen:C0006114&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(1)&Benign(11)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1799857	chr11_17430945_G_A	Female	0/1	Heterozygous
chr11	17430945	.	G	A	50	PASS	"FS=1.283;MQ=250;MQRankSum=5.137;QD=1.21;ReadPosRankSum=3.195;SOR=1.008;FractionInformativeReads=1;R2_5P_bias=7.745;DP=87;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|ABCC8|6833|Transcript|NM_000352.6|protein_coding|12/39||NM_000352.6:c.1686C>T|NP_000343.2:p.His562%3D|1755|1686|562|H|caC/caT|rs1799857&COSV56850686||-1||SNV|EntrezGene||YES|||G|G||||||0.4299|0.4459|0.4747|0.3195|0.4445|0.3087|0.4107|0.4108|0.4535|0.438|0.4959|0.4417|0.4801|0.3516|0.3803|0.4438|0.3002|0.4127|0.3537|0.4459|0.4296|0.4867|0.5225|SAS|uncertain_significance&benign|0&1|1&1||||||||||||-6|14|0|-18|0.00|0.00|0.00|0.00|ABCC8|||||||157684||Conflicting_classifications_of_pathogenicity|Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Cerebral_edema&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified|NC_000011.10:g.17430945G>A||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0002181&MONDO:MONDO:0006684&MedGen:C0006114&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(1)&Benign(11)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:23,15:0.395:38:15,9:8,6:45:81,0,50:46.091,0.00012866,53:0,34.77,37.77:12,11,9,6:6,17,3,12	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:24,25:0.51:49:6,12:18,13:48:85,0,50:50,6.5233e-05,52.972:0,34.77,37.77:11,13,14,11:17,7,9,16	A	synonymous_variant	LOW	ABCC8	6833	Transcript	NM_000352.6	protein_coding	12/39		c.1686C>T	p.His562%3D	1755	1686	562	H	caC/caT	rs1799857&COSV56850686	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.4299	0.4459	0.4747	0.3195	0.4445	0.3087	0.4107	0.4108	0.4535	0.438	0.4959	0.4417	0.4801	0.3516	0.3803	0.4438	0.3002	0.4127	0.3537	0.4459	0.4296	0.4867	0.5225	SAS	uncertain_significance&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-6	14	0	-18	0	0	0	0	ABCC8			NA				157684	NA	Conflicting_classifications_of_pathogenicity	Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Cerebral_edema&Diabetes_mellitus&_permanent_neonatal_3&not_provided&not_specified	NC_000011.10:g.17430945G>A		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0002181&MONDO:MONDO:0006684&MedGen:C0006114&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(1)&Benign(11)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1799857	chr11_17430945_G_A	Female	0/1	Heterozygous
chr11	17463424	.	G	A	50	PASS	"FS=0;MQ=246.84;MQRankSum=3.641;QD=1.85;ReadPosRankSum=0.769;SOR=1.002;FractionInformativeReads=0.963;R2_5P_bias=12.773;DP=63;AF=0.5;AN=4;AC=2;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||4/38|NM_000352.6:c.579+14C>T|||||||rs2301703&COSV56856529||-1||SNV|EntrezGene||YES|||G|G||||||0.4675|0.3874|0.7153|0.4086|0.4696|0.3885|0.2994|0.4663|0.3843|0.4145|0.2911|0.4703|0.7012|0.391|0.4287|0.4772|0.4001|0.291|0.534|0.3849|0.4706|0.2955|0.7474|AFR|uncertain_significance&benign|0&1|1&1||||||||||||20|14|20|35|0.00|0.00|0.02|0.00|ABCC8|||||||157707||Conflicting_classifications_of_pathogenicity|Permanent_neonatal_diabetes_mellitus&Type_2_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_specified&Diabetes_mellitus&_permanent_neonatal_3|NC_000011.10:g.17463424G>A||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857|Uncertain_significance(1)&Benign(11)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,13:0.5:26:5,3:8,10:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:6,7,5,8:6,7,7,6	0/1:21,15:0.417:36:9,11:12,4:47:83,0,50:47.773,9.4226e-05,53:0,34.77,37.77:11,10,11,4:9,12,9,6	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		4/38	c.579+14C>T							rs2301703&COSV56856529	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.4675	0.3874	0.7153	0.4086	0.4696	0.3885	0.2994	0.4663	0.3843	0.4145	0.2911	0.4703	0.7012	0.391	0.4287	0.4772	0.4001	0.291	0.534	0.3849	0.4706	0.2955	0.7474	AFR	uncertain_significance&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		20	14	20	35	0	0	0.02	0	ABCC8			NA				157707	NA	Conflicting_classifications_of_pathogenicity	Permanent_neonatal_diabetes_mellitus&Type_2_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_specified&Diabetes_mellitus&_permanent_neonatal_3	NC_000011.10:g.17463424G>A		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857	Uncertain_significance(1)&Benign(11)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs2301703	chr11_17463424_G_A	Female	./.	Other
chr11	17463424	.	G	A	50	PASS	"FS=0;MQ=246.84;MQRankSum=3.641;QD=1.85;ReadPosRankSum=0.769;SOR=1.002;FractionInformativeReads=0.963;R2_5P_bias=12.773;DP=63;AF=0.5;AN=4;AC=2;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||4/38|NM_000352.6:c.579+14C>T|||||||rs2301703&COSV56856529||-1||SNV|EntrezGene||YES|||G|G||||||0.4675|0.3874|0.7153|0.4086|0.4696|0.3885|0.2994|0.4663|0.3843|0.4145|0.2911|0.4703|0.7012|0.391|0.4287|0.4772|0.4001|0.291|0.534|0.3849|0.4706|0.2955|0.7474|AFR|uncertain_significance&benign|0&1|1&1||||||||||||20|14|20|35|0.00|0.00|0.02|0.00|ABCC8|||||||157707||Conflicting_classifications_of_pathogenicity|Permanent_neonatal_diabetes_mellitus&Type_2_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_specified&Diabetes_mellitus&_permanent_neonatal_3|NC_000011.10:g.17463424G>A||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857|Uncertain_significance(1)&Benign(11)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,13:0.5:26:5,3:8,10:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:6,7,5,8:6,7,7,6	0/1:21,15:0.417:36:9,11:12,4:47:83,0,50:47.773,9.4226e-05,53:0,34.77,37.77:11,10,11,4:9,12,9,6	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		4/38	c.579+14C>T							rs2301703&COSV56856529	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.4675	0.3874	0.7153	0.4086	0.4696	0.3885	0.2994	0.4663	0.3843	0.4145	0.2911	0.4703	0.7012	0.391	0.4287	0.4772	0.4001	0.291	0.534	0.3849	0.4706	0.2955	0.7474	AFR	uncertain_significance&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		20	14	20	35	0	0	0.02	0	ABCC8			NA				157707	NA	Conflicting_classifications_of_pathogenicity	Permanent_neonatal_diabetes_mellitus&Type_2_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_specified&Diabetes_mellitus&_permanent_neonatal_3	NC_000011.10:g.17463424G>A		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857	Uncertain_significance(1)&Benign(11)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs2301703	chr11_17463424_G_A	Female	./.	Other
chr11	17463424	.	G	A	50	PASS	"FS=0;MQ=246.84;MQRankSum=3.641;QD=1.85;ReadPosRankSum=0.769;SOR=1.002;FractionInformativeReads=0.963;R2_5P_bias=12.773;DP=63;AF=0.5;AN=4;AC=2;CSQ=A|intron_variant|MODIFIER|ABCC8|6833|Transcript|NM_000352.6|protein_coding||4/38|NM_000352.6:c.579+14C>T|||||||rs2301703&COSV56856529||-1||SNV|EntrezGene||YES|||G|G||||||0.4675|0.3874|0.7153|0.4086|0.4696|0.3885|0.2994|0.4663|0.3843|0.4145|0.2911|0.4703|0.7012|0.391|0.4287|0.4772|0.4001|0.291|0.534|0.3849|0.4706|0.2955|0.7474|AFR|uncertain_significance&benign|0&1|1&1||||||||||||20|14|20|35|0.00|0.00|0.02|0.00|ABCC8|||||||157707||Conflicting_classifications_of_pathogenicity|Permanent_neonatal_diabetes_mellitus&Type_2_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_specified&Diabetes_mellitus&_permanent_neonatal_3|NC_000011.10:g.17463424G>A||single_nucleotide_variant|ABCC8:6833|MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857|Uncertain_significance(1)&Benign(11)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,13:0.5:26:5,3:8,10:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:6,7,5,8:6,7,7,6	0/1:21,15:0.417:36:9,11:12,4:47:83,0,50:47.773,9.4226e-05,53:0,34.77,37.77:11,10,11,4:9,12,9,6	A	intron_variant	MODIFIER	ABCC8	6833	Transcript	NM_000352.6	protein_coding		4/38	c.579+14C>T							rs2301703&COSV56856529	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.4675	0.3874	0.7153	0.4086	0.4696	0.3885	0.2994	0.4663	0.3843	0.4145	0.2911	0.4703	0.7012	0.391	0.4287	0.4772	0.4001	0.291	0.534	0.3849	0.4706	0.2955	0.7474	AFR	uncertain_significance&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		20	14	20	35	0	0	0.02	0	ABCC8			NA				157707	NA	Conflicting_classifications_of_pathogenicity	Permanent_neonatal_diabetes_mellitus&Type_2_diabetes_mellitus&not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&not_specified&Diabetes_mellitus&_permanent_neonatal_3	NC_000011.10:g.17463424G>A		single_nucleotide_variant	ABCC8:6833	MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MedGen:CN169374&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857	Uncertain_significance(1)&Benign(11)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs2301703	chr11_17463424_G_A	Female	./.	Other
chr11	17474969	.	A	G	50	PASS	"FS=5.969;MQ=250;MQRankSum=4.375;QD=1.79;ReadPosRankSum=3.246;SOR=0.359;FractionInformativeReads=1;R2_5P_bias=-1.694;DP=52;AF=0.5;AN=4;AC=2;CSQ=G|synonymous_variant|LOW|ABCC8|6833|Transcript|NM_000352.6|protein_coding|2/39||NM_000352.6:c.207T>C|NP_000343.2:p.Pro69%3D|276|207|69|P|ccT/ccC|rs1048099&CM129527&COSV56850629||-1||SNV|EntrezGene||YES|||A|A||||||0.4393|0.4869|0.4017|0.562|0.5426|0.3763|0.3261|0.604|0.4976|0.4869|0.4688|0.4594|0.4018|0.5452|0.5197|0.5528|0.3808|0.3171|0.6497|0.5006|0.5081|0.4643|0.6497|gnomADg_MID|benign&uncertain_significance&benign/likely_benign|0&1&1|1&1&1||||||||||||44|-48|-48|36|0.00|0.00|0.01|0.00|ABCC8|||||||157687||Conflicting_classifications_of_pathogenicity|not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Hyperinsulinemia&Diabetes_mellitus&_permanent_neonatal_3&not_specified|NC_000011.10:g.17474969A>G||single_nucleotide_variant|ABCC8:6833|MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0000842&MONDO:MONDO:0002177&MedGen:C0020459&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374|Uncertain_significance(1)&Benign(12)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,17:0.607:28:5,10:6,7:47:85,0,47:50,8.7237e-05,49.958:0,34.77,37.77:8,3,8,9:6,5,5,12	0/1:14,10:0.417:24:7,6:7,4:47:83,0,50:48.545,8.2577e-05,53:0,34.77,37.77:10,4,7,3:9,5,7,3	G	synonymous_variant	LOW	ABCC8	6833	Transcript	NM_000352.6	protein_coding	2/39		c.207T>C	p.Pro69%3D	276	207	69	P	ccT/ccC	rs1048099&CM129527&COSV56850629	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.4393	0.4869	0.4017	0.562	0.5426	0.3763	0.3261	0.604	0.4976	0.4869	0.4688	0.4594	0.4018	0.5452	0.5197	0.5528	0.3808	0.3171	0.6497	0.5006	0.5081	0.4643	0.6497	gnomADg_MID	benign&uncertain_significance&benign/likely_benign	0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		44	-48	-48	36	0	0	0.01	0	ABCC8			NA				157687	NA	Conflicting_classifications_of_pathogenicity	not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Hyperinsulinemia&Diabetes_mellitus&_permanent_neonatal_3&not_specified	NC_000011.10:g.17474969A>G		single_nucleotide_variant	ABCC8:6833	MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0000842&MONDO:MONDO:0002177&MedGen:C0020459&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374	Uncertain_significance(1)&Benign(12)&Likely_benign(1)	criteria_provided&_conflicting_classifications		ABCC8	Type 2 diabetes mellitus	AD	125853	Endocrine disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1048099	chr11_17474969_A_G	Female	./.	Other
chr11	17474969	.	A	G	50	PASS	"FS=5.969;MQ=250;MQRankSum=4.375;QD=1.79;ReadPosRankSum=3.246;SOR=0.359;FractionInformativeReads=1;R2_5P_bias=-1.694;DP=52;AF=0.5;AN=4;AC=2;CSQ=G|synonymous_variant|LOW|ABCC8|6833|Transcript|NM_000352.6|protein_coding|2/39||NM_000352.6:c.207T>C|NP_000343.2:p.Pro69%3D|276|207|69|P|ccT/ccC|rs1048099&CM129527&COSV56850629||-1||SNV|EntrezGene||YES|||A|A||||||0.4393|0.4869|0.4017|0.562|0.5426|0.3763|0.3261|0.604|0.4976|0.4869|0.4688|0.4594|0.4018|0.5452|0.5197|0.5528|0.3808|0.3171|0.6497|0.5006|0.5081|0.4643|0.6497|gnomADg_MID|benign&uncertain_significance&benign/likely_benign|0&1&1|1&1&1||||||||||||44|-48|-48|36|0.00|0.00|0.01|0.00|ABCC8|||||||157687||Conflicting_classifications_of_pathogenicity|not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Hyperinsulinemia&Diabetes_mellitus&_permanent_neonatal_3&not_specified|NC_000011.10:g.17474969A>G||single_nucleotide_variant|ABCC8:6833|MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0000842&MONDO:MONDO:0002177&MedGen:C0020459&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374|Uncertain_significance(1)&Benign(12)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,17:0.607:28:5,10:6,7:47:85,0,47:50,8.7237e-05,49.958:0,34.77,37.77:8,3,8,9:6,5,5,12	0/1:14,10:0.417:24:7,6:7,4:47:83,0,50:48.545,8.2577e-05,53:0,34.77,37.77:10,4,7,3:9,5,7,3	G	synonymous_variant	LOW	ABCC8	6833	Transcript	NM_000352.6	protein_coding	2/39		c.207T>C	p.Pro69%3D	276	207	69	P	ccT/ccC	rs1048099&CM129527&COSV56850629	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.4393	0.4869	0.4017	0.562	0.5426	0.3763	0.3261	0.604	0.4976	0.4869	0.4688	0.4594	0.4018	0.5452	0.5197	0.5528	0.3808	0.3171	0.6497	0.5006	0.5081	0.4643	0.6497	gnomADg_MID	benign&uncertain_significance&benign/likely_benign	0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		44	-48	-48	36	0	0	0.01	0	ABCC8			NA				157687	NA	Conflicting_classifications_of_pathogenicity	not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Hyperinsulinemia&Diabetes_mellitus&_permanent_neonatal_3&not_specified	NC_000011.10:g.17474969A>G		single_nucleotide_variant	ABCC8:6833	MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0000842&MONDO:MONDO:0002177&MedGen:C0020459&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374	Uncertain_significance(1)&Benign(12)&Likely_benign(1)	criteria_provided&_conflicting_classifications		ABCC8	Hyperinsulinemic hypoglycemia, familial, 1	Multiple and/or complex pattern	256450	Endocrine disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1048099	chr11_17474969_A_G	Female	./.	Other
chr11	17474969	.	A	G	50	PASS	"FS=5.969;MQ=250;MQRankSum=4.375;QD=1.79;ReadPosRankSum=3.246;SOR=0.359;FractionInformativeReads=1;R2_5P_bias=-1.694;DP=52;AF=0.5;AN=4;AC=2;CSQ=G|synonymous_variant|LOW|ABCC8|6833|Transcript|NM_000352.6|protein_coding|2/39||NM_000352.6:c.207T>C|NP_000343.2:p.Pro69%3D|276|207|69|P|ccT/ccC|rs1048099&CM129527&COSV56850629||-1||SNV|EntrezGene||YES|||A|A||||||0.4393|0.4869|0.4017|0.562|0.5426|0.3763|0.3261|0.604|0.4976|0.4869|0.4688|0.4594|0.4018|0.5452|0.5197|0.5528|0.3808|0.3171|0.6497|0.5006|0.5081|0.4643|0.6497|gnomADg_MID|benign&uncertain_significance&benign/likely_benign|0&1&1|1&1&1||||||||||||44|-48|-48|36|0.00|0.00|0.01|0.00|ABCC8|||||||157687||Conflicting_classifications_of_pathogenicity|not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Hyperinsulinemia&Diabetes_mellitus&_permanent_neonatal_3&not_specified|NC_000011.10:g.17474969A>G||single_nucleotide_variant|ABCC8:6833|MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0000842&MONDO:MONDO:0002177&MedGen:C0020459&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374|Uncertain_significance(1)&Benign(12)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,17:0.607:28:5,10:6,7:47:85,0,47:50,8.7237e-05,49.958:0,34.77,37.77:8,3,8,9:6,5,5,12	0/1:14,10:0.417:24:7,6:7,4:47:83,0,50:48.545,8.2577e-05,53:0,34.77,37.77:10,4,7,3:9,5,7,3	G	synonymous_variant	LOW	ABCC8	6833	Transcript	NM_000352.6	protein_coding	2/39		c.207T>C	p.Pro69%3D	276	207	69	P	ccT/ccC	rs1048099&CM129527&COSV56850629	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.4393	0.4869	0.4017	0.562	0.5426	0.3763	0.3261	0.604	0.4976	0.4869	0.4688	0.4594	0.4018	0.5452	0.5197	0.5528	0.3808	0.3171	0.6497	0.5006	0.5081	0.4643	0.6497	gnomADg_MID	benign&uncertain_significance&benign/likely_benign	0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		44	-48	-48	36	0	0	0.01	0	ABCC8			NA				157687	NA	Conflicting_classifications_of_pathogenicity	not_provided&Diabetes_mellitus&_transient_neonatal&_2&Leucine-induced_hypoglycemia&Hyperinsulinemic_hypoglycemia&_familial&_1&Permanent_neonatal_diabetes_mellitus&Hereditary_hyperinsulinism&Hyperinsulinemia&Diabetes_mellitus&_permanent_neonatal_3&not_specified	NC_000011.10:g.17474969A>G		single_nucleotide_variant	ABCC8:6833	MedGen:C3661900&MONDO:MONDO:0012480&MedGen:C1835887&OMIM:610374&Orphanet:99886&MONDO:MONDO:0009415&MedGen:C0271714&OMIM:240800&MONDO:MONDO:0009734&MedGen:C2931832&OMIM:256450&Orphanet:276575&Orphanet:276598&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&.&Human_Phenotype_Ontology:HP:0000842&MONDO:MONDO:0002177&MedGen:C0020459&MONDO:MONDO:0030088&MedGen:C5394303&OMIM:618857&MedGen:CN169374	Uncertain_significance(1)&Benign(12)&Likely_benign(1)	criteria_provided&_conflicting_classifications		ABCC8	Diabetes mellitus, permanent neonatal 3	Multiple and/or complex pattern	618857	Endocrine disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1048099	chr11_17474969_A_G	Female	./.	Other
chr11	22279864	.	CTT	C	403.73	PASS	"FS=0;MQ=248.45;QD=4.01;SOR=1.609;FractionInformativeReads=0.919;DP=121;AF=0.5;AN=6;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|ANO5|203859|Transcript|NM_213599.3|protein_coding|22/22||NM_213599.3:c.*112_*113del||3250-3251|||||rs5790246||1||deletion|EntrezGene||YES|||TT|TT|||||12||0.4847|0.3369|0.4373|0.4965|0.3131|0.5284|0.4919|0.5022|0.4672|0.4755|0.547|0.36|0.7205|0.5649|0.6499|0.3285|0.7108|0.5906|0.6377|0.5639|0.5818|0.7205|gnomADg_AMI|uncertain_significance&benign||1||||||||||||-39|36|-47|-20|0.00|0.00|0.00|0.00|ANO5|||||||304113||Conflicting_classifications_of_pathogenicity|not_provided&Limb-girdle_muscular_dystrophy&_recessive&Miyoshi_myopathy|NC_000011.10:g.22279877_22279878del||Deletion|ANO5:203859|MedGen:C3661900&MedGen:CN239352&MONDO:MONDO:0009685&MedGen:C5553104&OMIM:PS254130&Orphanet:45448|Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:0,.:.:34:0,.:0,.:98:160,.,.:148.32,.,.:0,.,.:0,0,23,11:0,0,18,16	0/1:0,17:0.486:35:0,8:0,9:50:380,321,59:362.48,312.48,53:0,9,12:0,0,19,16:0,0,19,16	1/0:0,26:0.578:45:0,15:0,11:46:424,364,55:403.73,353.73,48.22:0,10,13.01:0,0,29,16:0,0,26,19	-	3_prime_UTR_variant	MODIFIER	ANO5	203859	Transcript	NM_213599.3	protein_coding	22/22		c.*112_*113del		3250-3251					rs5790246	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TT	TT	NA	NA			12	NA	0.4847	0.3369	0.4373	0.4965	0.3131	0.5284	0.4919	0.5022	0.4672	0.4755	0.547	0.36	0.7205	0.5649	0.6499	0.3285	0.7108	0.5906	0.6377	0.5639	0.5818	0.7205	gnomADg_AMI	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-39	36	-47	-20	0	0	0	0	ANO5			NA				304113	NA	Conflicting_classifications_of_pathogenicity	not_provided&Limb-girdle_muscular_dystrophy&_recessive&Miyoshi_myopathy	NC_000011.10:g.22279877_22279878del		Deletion	ANO5:203859	MedGen:C3661900&MedGen:CN239352&MONDO:MONDO:0009685&MedGen:C5553104&OMIM:PS254130&Orphanet:45448	Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		ANO5	Autosomal recessive limb-girdle muscular dystrophy type 2L	AR	611307	Neuromuscular and musculoskelettal disorders	NBScreening	-9	Benign	BP6,BA1	rs5790246	chr11_22279864_CTT_C	Female	0/0	Other
chr11	31793814	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=5.147;QD=1.25;ReadPosRankSum=3.19;SOR=0.527;FractionInformativeReads=1;R2_5P_bias=-14.252;DP=40;AF=0.5;AN=2;AC=1;CSQ=A|splice_polypyrimidine_tract_variant&intron_variant|LOW|PAX6|5080|Transcript|NM_001368894.2|protein_coding||10/13|NM_001368894.2:c.808-12C>T|||||||rs667773&COSV53795119&CS983704||-1||SNV|EntrezGene||YES|||G|G||||||0.0905|0.05792|0.04358|0.1929|0.07451|0.1485|0.05198|0.1245|0.04762|0.07086|0.06965|0.06159|0.04182|0.005482|0.13|0.07176|0.1929|0.04986|0.1497|0.04923|0.07102|0.06813|0.1929|gnomADe_AMR&gnomADg_EAS|uncertain_significance&benign|0&1&1|1&1&1|1.29466599534024E-5|0.0||||||||||-12|-32|-31|-11|0.00|0.01|0.00|0.00|PAX6|||||||258168||Conflicting_classifications_of_pathogenicity|carboxymethyl-dextran-A2-gadolinium-DOTA&not_provided&Aniridia_1&Anophthalmia-microphthalmia_syndrome&Foveal_hypoplasia_1&Autosomal_dominant_keratitis&11p_partial_monosomy_syndrome&Irido-corneo-trabecular_dysgenesis&not_specified&Abnormality_of_refraction&Aniridia&_Cerebellar_Ataxia&_And_Intellectual_Disability|NC_000011.10:g.31793814G>A||single_nucleotide_variant|PAX6:5080|.&MedGen:C3661900&MONDO:MONDO:0024507&MedGen:C0344542&OMIM:106210&Orphanet:250923&MedGen:C5680330&Orphanet:98555&MONDO:MONDO:0007628&MedGen:C3805604&OMIM:136520&Orphanet:2253&MONDO:MONDO:0007848&MedGen:C1835698&OMIM:148190&Orphanet:2334&MONDO:MONDO:0008681&MedGen:C0206115&OMIM:194072&Orphanet:893&Human_Phenotype_Ontology:HP:0000659&MONDO:MONDO:0011414&MedGen:C0344559&OMIM:604229&Orphanet:708&MedGen:CN169374&Human_Phenotype_Ontology:HP:0000539&MedGen:C4025843&MedGen:CN239197|Uncertain_significance(1)&Benign(11)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,26:0.65:40:6,14:8,12:44:85,0,42:50,0.00019027,44.707:0,34.77,37.77:3,11,7,19:5,9,13,13	./.:.:.:.:.:.:.:.:.:.:.:.	A	splice_polypyrimidine_tract_variant&intron_variant	LOW	PAX6	5080	Transcript	NM_001368894.2	protein_coding		13-Oct	c.808-12C>T							rs667773&COSV53795119&CS983704	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0905	0.05792	0.04358	0.1929	0.07451	0.1485	0.05198	0.1245	0.04762	0.07086	0.06965	0.06159	0.04182	0.005482	0.13	0.07176	0.1929	0.04986	0.1497	0.04923	0.07102	0.06813	0.1929	gnomADe_AMR&gnomADg_EAS	uncertain_significance&benign	0&1&1	1&1&1	1.29466599534024e-05	0	NA		NA	NA		NA	NA	NA		-12	-32	-31	-11	0	0.01	0	0	PAX6			NA				258168	NA	Conflicting_classifications_of_pathogenicity	carboxymethyl-dextran-A2-gadolinium-DOTA&not_provided&Aniridia_1&Anophthalmia-microphthalmia_syndrome&Foveal_hypoplasia_1&Autosomal_dominant_keratitis&11p_partial_monosomy_syndrome&Irido-corneo-trabecular_dysgenesis&not_specified&Abnormality_of_refraction&Aniridia&_Cerebellar_Ataxia&_And_Intellectual_Disability	NC_000011.10:g.31793814G>A		single_nucleotide_variant	PAX6:5080	.&MedGen:C3661900&MONDO:MONDO:0024507&MedGen:C0344542&OMIM:106210&Orphanet:250923&MedGen:C5680330&Orphanet:98555&MONDO:MONDO:0007628&MedGen:C3805604&OMIM:136520&Orphanet:2253&MONDO:MONDO:0007848&MedGen:C1835698&OMIM:148190&Orphanet:2334&MONDO:MONDO:0008681&MedGen:C0206115&OMIM:194072&Orphanet:893&Human_Phenotype_Ontology:HP:0000659&MONDO:MONDO:0011414&MedGen:C0344559&OMIM:604229&Orphanet:708&MedGen:CN169374&Human_Phenotype_Ontology:HP:0000539&MedGen:C4025843&MedGen:CN239197	Uncertain_significance(1)&Benign(11)	criteria_provided&_conflicting_classifications		PAX6	Aniridia 1	AD	106210	Eye disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs667773	chr11_31793814_G_A	Female	./.	Other
chr11	32388003	.	A	AACAC	3.24	DRAGENIndelHardQUAL	"FS=0;MQ=249.19;MQRankSum=1.733;QD=0.09;ReadPosRankSum=-0.48;SOR=0.693;FractionInformativeReads=0.263;R2_5P_bias=13.83;DP=38;AF=0.5;AN=2;AC=1;CSQ=ACAC|3_prime_UTR_variant|MODIFIER|WT1|7490|Transcript|NM_024426.6|protein_coding|10/10||NM_024426.6:c.*1051_*1054dup||2802-2803|||||rs58549495||-1||insertion|EntrezGene||YES|||||||||||0.008645|0.002569|0.01199|0.006453|0.006007|0.02133|0.00813|0.009734|0.007796|0.005747|0.009667|0.002585|0|0.01121|0.007375|0.001006|0.0194|0|0.0134|0.0133|0.004822|0.02133|gnomADe_FIN|||1|||||||||||||||||||||||||||304377||Uncertain_significance|11p_partial_monosomy_syndrome&Meacham_syndrome&Nephroblastoma&Nephrotic_syndrome&_type_4|NC_000011.10:g.32388004AC[19]||Microsatellite|WT1:7490|MONDO:MONDO:0008681&MedGen:C0206115&OMIM:194072&Orphanet:893&MONDO:MONDO:0012164&MedGen:C1837026&OMIM:608978&Orphanet:3097&Human_Phenotype_Ontology:HP:0000115&Human_Phenotype_Ontology:HP:0002667&MONDO:MONDO:0006058&MeSH:D009396&MedGen:C0027708&Orphanet:654&MONDO:MONDO:0009733&MedGen:C3151568&OMIM:256370&Orphanet:656||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:8,2:0.2:10:5,1:3,1:3:2,0,50:3.2449,2.7878,55.788:0,2,5:4,4,1,1:3,5,0,2	ACAC	3_prime_UTR_variant	MODIFIER	WT1	7490	Transcript	NM_024426.6	protein_coding	10-Oct		c.*1051_*1054dup		2802-2803					rs58549495	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.008645	0.002569	0.01199	0.006453	0.006007	0.02133	0.00813	0.009734	0.007796	0.005747	0.009667	0.002585	0	0.01121	0.007375	0.001006	0.0194	0	0.0134	0.0133	0.004822	0.02133	gnomADe_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				304377	NA	Uncertain_significance	11p_partial_monosomy_syndrome&Meacham_syndrome&Nephroblastoma&Nephrotic_syndrome&_type_4	NC_000011.10:g.32388004AC[19]		Microsatellite	WT1:7490	MONDO:MONDO:0008681&MedGen:C0206115&OMIM:194072&Orphanet:893&MONDO:MONDO:0012164&MedGen:C1837026&OMIM:608978&Orphanet:3097&Human_Phenotype_Ontology:HP:0000115&Human_Phenotype_Ontology:HP:0002667&MONDO:MONDO:0006058&MeSH:D009396&MedGen:C0027708&Orphanet:654&MONDO:MONDO:0009733&MedGen:C3151568&OMIM:256370&Orphanet:656		criteria_provided&_single_submitter		WT1	Frasier syndrome	AD	136680	"Complex genetic syndromes;Tumor predisposition syndromes"	NBScreening	-5	Likely_benign	BS1_Supporting,BS2	rs58549495	chr11_32388003_A_AACAC	Female	./.	Other
chr11	32388003	.	A	AACAC	3.24	DRAGENIndelHardQUAL	"FS=0;MQ=249.19;MQRankSum=1.733;QD=0.09;ReadPosRankSum=-0.48;SOR=0.693;FractionInformativeReads=0.263;R2_5P_bias=13.83;DP=38;AF=0.5;AN=2;AC=1;CSQ=ACAC|3_prime_UTR_variant|MODIFIER|WT1|7490|Transcript|NM_024426.6|protein_coding|10/10||NM_024426.6:c.*1051_*1054dup||2802-2803|||||rs58549495||-1||insertion|EntrezGene||YES|||||||||||0.008645|0.002569|0.01199|0.006453|0.006007|0.02133|0.00813|0.009734|0.007796|0.005747|0.009667|0.002585|0|0.01121|0.007375|0.001006|0.0194|0|0.0134|0.0133|0.004822|0.02133|gnomADe_FIN|||1|||||||||||||||||||||||||||304377||Uncertain_significance|11p_partial_monosomy_syndrome&Meacham_syndrome&Nephroblastoma&Nephrotic_syndrome&_type_4|NC_000011.10:g.32388004AC[19]||Microsatellite|WT1:7490|MONDO:MONDO:0008681&MedGen:C0206115&OMIM:194072&Orphanet:893&MONDO:MONDO:0012164&MedGen:C1837026&OMIM:608978&Orphanet:3097&Human_Phenotype_Ontology:HP:0000115&Human_Phenotype_Ontology:HP:0002667&MONDO:MONDO:0006058&MeSH:D009396&MedGen:C0027708&Orphanet:654&MONDO:MONDO:0009733&MedGen:C3151568&OMIM:256370&Orphanet:656||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:8,2:0.2:10:5,1:3,1:3:2,0,50:3.2449,2.7878,55.788:0,2,5:4,4,1,1:3,5,0,2	ACAC	3_prime_UTR_variant	MODIFIER	WT1	7490	Transcript	NM_024426.6	protein_coding	10-Oct		c.*1051_*1054dup		2802-2803					rs58549495	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.008645	0.002569	0.01199	0.006453	0.006007	0.02133	0.00813	0.009734	0.007796	0.005747	0.009667	0.002585	0	0.01121	0.007375	0.001006	0.0194	0	0.0134	0.0133	0.004822	0.02133	gnomADe_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				304377	NA	Uncertain_significance	11p_partial_monosomy_syndrome&Meacham_syndrome&Nephroblastoma&Nephrotic_syndrome&_type_4	NC_000011.10:g.32388004AC[19]		Microsatellite	WT1:7490	MONDO:MONDO:0008681&MedGen:C0206115&OMIM:194072&Orphanet:893&MONDO:MONDO:0012164&MedGen:C1837026&OMIM:608978&Orphanet:3097&Human_Phenotype_Ontology:HP:0000115&Human_Phenotype_Ontology:HP:0002667&MONDO:MONDO:0006058&MeSH:D009396&MedGen:C0027708&Orphanet:654&MONDO:MONDO:0009733&MedGen:C3151568&OMIM:256370&Orphanet:656		criteria_provided&_single_submitter		WT1	Drash syndrome	AD	194080	"Complex genetic syndromes;Tumor predisposition syndromes"	NBScreening	-5	Likely_benign	BS1_Supporting,BS2	rs58549495	chr11_32388003_A_AACAC	Female	./.	Other
chr11	32388003	.	A	AACAC	3.24	DRAGENIndelHardQUAL	"FS=0;MQ=249.19;MQRankSum=1.733;QD=0.09;ReadPosRankSum=-0.48;SOR=0.693;FractionInformativeReads=0.263;R2_5P_bias=13.83;DP=38;AF=0.5;AN=2;AC=1;CSQ=ACAC|3_prime_UTR_variant|MODIFIER|WT1|7490|Transcript|NM_024426.6|protein_coding|10/10||NM_024426.6:c.*1051_*1054dup||2802-2803|||||rs58549495||-1||insertion|EntrezGene||YES|||||||||||0.008645|0.002569|0.01199|0.006453|0.006007|0.02133|0.00813|0.009734|0.007796|0.005747|0.009667|0.002585|0|0.01121|0.007375|0.001006|0.0194|0|0.0134|0.0133|0.004822|0.02133|gnomADe_FIN|||1|||||||||||||||||||||||||||304377||Uncertain_significance|11p_partial_monosomy_syndrome&Meacham_syndrome&Nephroblastoma&Nephrotic_syndrome&_type_4|NC_000011.10:g.32388004AC[19]||Microsatellite|WT1:7490|MONDO:MONDO:0008681&MedGen:C0206115&OMIM:194072&Orphanet:893&MONDO:MONDO:0012164&MedGen:C1837026&OMIM:608978&Orphanet:3097&Human_Phenotype_Ontology:HP:0000115&Human_Phenotype_Ontology:HP:0002667&MONDO:MONDO:0006058&MeSH:D009396&MedGen:C0027708&Orphanet:654&MONDO:MONDO:0009733&MedGen:C3151568&OMIM:256370&Orphanet:656||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:8,2:0.2:10:5,1:3,1:3:2,0,50:3.2449,2.7878,55.788:0,2,5:4,4,1,1:3,5,0,2	ACAC	3_prime_UTR_variant	MODIFIER	WT1	7490	Transcript	NM_024426.6	protein_coding	10-Oct		c.*1051_*1054dup		2802-2803					rs58549495	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.008645	0.002569	0.01199	0.006453	0.006007	0.02133	0.00813	0.009734	0.007796	0.005747	0.009667	0.002585	0	0.01121	0.007375	0.001006	0.0194	0	0.0134	0.0133	0.004822	0.02133	gnomADe_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				304377	NA	Uncertain_significance	11p_partial_monosomy_syndrome&Meacham_syndrome&Nephroblastoma&Nephrotic_syndrome&_type_4	NC_000011.10:g.32388004AC[19]		Microsatellite	WT1:7490	MONDO:MONDO:0008681&MedGen:C0206115&OMIM:194072&Orphanet:893&MONDO:MONDO:0012164&MedGen:C1837026&OMIM:608978&Orphanet:3097&Human_Phenotype_Ontology:HP:0000115&Human_Phenotype_Ontology:HP:0002667&MONDO:MONDO:0006058&MeSH:D009396&MedGen:C0027708&Orphanet:654&MONDO:MONDO:0009733&MedGen:C3151568&OMIM:256370&Orphanet:656		criteria_provided&_single_submitter		WT1	Wilms tumor 1	AD	194070	"Complex genetic syndromes;Tumor predisposition syndromes"	NBScreening	-5	Likely_benign	BS1_Supporting,BS2	rs58549495	chr11_32388003_A_AACAC	Female	./.	Other
chr11	74456155	.	AATATAT	A	237.29	PASS	"FS=0;MQ=219.95;QD=6.38;SOR=1.085;FractionInformativeReads=0.833;DP=45;AF=0.5;AN=6;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|KCNE3|10008|Transcript|NM_005472.5|protein_coding|3/3||NM_005472.5:c.*1091_*1096del||1744-1749|||||rs113583236||-1||deletion|EntrezGene||YES|||ATATAT|ATATAT|||||||||||||||||0.5994|0.6669|0.7315|0.6568|0.6075|0.4789|0.7044|0.6571|0.5335|0.6156|0.6958|0.7315|gnomADg_AMI|||1|||||||||||||||||||||||||||306054||Uncertain_significance|Brugada_syndrome&not_provided|NC_000011.10:g.74456157TA[9]||Microsatellite|KCNE3:10008|MONDO:MONDO:0015263&MedGen:C1142166&OMIM:PS601144&Orphanet:130&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:0,.:.:10:0,.:0,.:27:85,.,.:76.575,.,.:0,.,.:0,0,6,4:0,0,4,6	0/0:0,.:.:8:0,.:0,.:50:173,.,.:162.58,.,.:0,.,.:0,0,5,3:0,0,6,2	1/0:0,12:0.632:19:0,9:0,3:48:247,192,52:237.29,187.29,50.105:0,5,8:0,0,10,9:0,0,14,5	-	3_prime_UTR_variant	MODIFIER	KCNE3	10008	Transcript	NM_005472.5	protein_coding	03-Mar		c.*1091_*1096del		1744-1749					rs113583236	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	ATATAT	ATATAT	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.5994	0.6669	0.7315	0.6568	0.6075	0.4789	0.7044	0.6571	0.5335	0.6156	0.6958	0.7315	gnomADg_AMI			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				306054	NA	Uncertain_significance	Brugada_syndrome&not_provided	NC_000011.10:g.74456157TA[9]		Microsatellite	KCNE3:10008	MONDO:MONDO:0015263&MedGen:C1142166&OMIM:PS601144&Orphanet:130&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		KCNE3	Brugada syndrome 6	AD	613119	Cardiac and vascular disorders	NBScreening	-8	Benign	BA1	rs113583236	chr11_74456155_AATATAT_A	Female	0/0	Other
chr11	89284793	.	G	A	47.5	PASS	"FS=2.886;MQ=108.35;MQRankSum=0.885;QD=1.19;ReadPosRankSum=3.779;SOR=0.327;FractionInformativeReads=0.975;R2_5P_bias=12.704;DP=85;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|TYR|7299|Transcript|NM_000372.5|protein_coding|4/5||NM_000372.5:c.1205G>A|NP_000363.1:p.Arg402Gln|1284|1205|402|R/Q|cGa/cAa|rs1126809&CM041478&CM971555&COSV54472906||1||SNV|EntrezGene||YES|||G|G|||deleterious(0.01)|probably_damaging(0.994)||0.0813|0.2537|0.04098|0.1059|0.2429|0.0002521|0.1687|0.192|0.2948|0.2402|0.06865|0.1771|0.04987|0.2104|0.1593|0.2389|0.001563|0.1587|0.2109|0.2791|0.1856|0.06208|0.2948|gnomADe_NFE|uncertain_significance&likely_benign&no_classifications_from_unflagged_records&risk_factor&likely_pathogenic&pathogenic&other&conflicting_interpretations_of_pathogenicity&association|0&1&1&1|1&1&1&1||||T|0.49629|-0.0145316|D|0.90322|0.35017|0.88960|0.695|21|-20|3|22|0.00|0.00|0.00|0.00|TYR|likely_benign|hg38|0.1427|R402Q|ENST00000263321.6|P14679|3779||Conflicting_classifications_of_pathogenicity&other|SKIN/HAIR/EYE_PIGMENTATION_3&_LIGHT/DARK_SKIN&Melanoma&_cutaneous_malignant&_susceptibility_to&_8&Skin/hair/eye_pigmentation_3&_blue/green_eyes&Oculocutaneous_albinism_type_1B&Malignant_tumor_of_breast&Oculocutaneous_albinism_type_1A&not_provided&Oculocutaneous_albinism_type_1&Albinism_or_congenital_nystagmus&Autosomal_recessive_ocular_albinism&Abnormality_of_metabolism/homeostasis&Slow_decrease_in_visual_acuity&Foveal_hypoplasia&Elevated_circulating_hepatic_transaminase_concentration&Choroidal_neovascularization&Albinism&Temperature-sensitive_oculocutaneous_albinism_type_1&not_specified|NC_000011.10:g.89284793G>A|1301878:Likely_pathogenic|single_nucleotide_variant|TYR:7299|MedGen:C2677190&OMIM:601800&MONDO:MONDO:0013759&MedGen:C3152204&OMIM:614456&Orphanet:293822&MedGen:C3149136&MONDO:MONDO:0011749&MedGen:C1847024&OMIM:606952&Orphanet:352731&Orphanet:352737&Orphanet:79434&MONDO:MONDO:0007254&MedGen:C0006142&MONDO:MONDO:0008745&MedGen:C4551504&OMIM:203100&Orphanet:352731&Orphanet:79431&MedGen:C3661900&MONDO:MONDO:0018135&MedGen:C0268494&Orphanet:352731&.&MONDO:MONDO:0040653&MedGen:C0268503&Human_Phenotype_Ontology:HP:0001939&Human_Phenotype_Ontology:HP:0002146&MedGen:C4021768&Human_Phenotype_Ontology:HP:0007652&Human_Phenotype_Ontology:HP:0007924&MedGen:C1853141&Human_Phenotype_Ontology:HP:0007750&MONDO:MONDO:0044203&MedGen:C2673946&OMIM:PS136520&Human_Phenotype_Ontology:HP:0001411&Human_Phenotype_Ontology:HP:0002910&Human_Phenotype_Ontology:HP:0003143&Human_Phenotype_Ontology:HP:0003156&Human_Phenotype_Ontology:HP:0003293&Human_Phenotype_Ontology:HP:0006567&Human_Phenotype_Ontology:HP:0006578&Human_Phenotype_Ontology:HP:0008267&Human_Phenotype_Ontology:HP:0008342&MedGen:C0235996&Human_Phenotype_Ontology:HP:0011506&MONDO:MONDO:0810000&MedGen:C0600518&Human_Phenotype_Ontology:HP:0001022&MONDO:MONDO:0043209&MedGen:C0001916&MONDO:MONDO:0018137&MedGen:C1847132&Orphanet:352737&MedGen:CN169374|Pathogenic(1)&Likely_pathogenic(1)&Uncertain_significance(6)&Benign(1)&Likely_benign(2)|criteria_provided&_conflicting_classifications|Oculocutaneous_albinism_type_1A&Oculocutaneous_albinism_type_1B"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:20,19:0.487:39:13,7:7,12:45:82,0,47:47.495,0.0001227,49.8:0,34.77,37.77:6,14,8,11:13,7,12,7	0/1:24,21:0.467:45:11,11:13,10:45:82,0,47:47.108,0.0001284,49.95:0,34.77,37.77:6,18,10,11:11,13,12,9	./.:.:.:.:.:.:.:.:.:.:.:.	A	missense_variant	MODERATE	TYR	7299	Transcript	NM_000372.5	protein_coding	05-Apr		c.1205G>A	p.Arg402Gln	1284	1205	402	R/Q	cGa/cAa	rs1126809&CM041478&CM971555&COSV54472906	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0.01)	probably_damaging(0.994)	NA	0.0813	0.2537	0.04098	0.1059	0.2429	0.0002521	0.1687	0.192	0.2948	0.2402	0.06865	0.1771	0.04987	0.2104	0.1593	0.2389	0.001563	0.1587	0.2109	0.2791	0.1856	0.06208	0.2948	gnomADe_NFE	uncertain_significance&likely_benign&no_classifications_from_unflagged_records&risk_factor&likely_pathogenic&pathogenic&other&conflicting_interpretations_of_pathogenicity&association	0&1&1&1	1&1&1&1	NA	NA	NA	T	0.49629	-0.0145316	D	0.90322	0.35017	0.8896	0.695	21	-20	3	22	0	0	0	0	TYR	likely_benign	hg38	0.1427	R402Q	ENST00000263321.6	P14679	3779	NA	Conflicting_classifications_of_pathogenicity	SKIN/HAIR/EYE_PIGMENTATION_3&_LIGHT/DARK_SKIN&Melanoma&_cutaneous_malignant&_susceptibility_to&_8&Skin/hair/eye_pigmentation_3&_blue/green_eyes&Oculocutaneous_albinism_type_1B&Malignant_tumor_of_breast&Oculocutaneous_albinism_type_1A&not_provided&Oculocutaneous_albinism_type_1&Albinism_or_congenital_nystagmus&Autosomal_recessive_ocular_albinism&Abnormality_of_metabolism/homeostasis&Slow_decrease_in_visual_acuity&Foveal_hypoplasia&Elevated_circulating_hepatic_transaminase_concentration&Choroidal_neovascularization&Albinism&Temperature-sensitive_oculocutaneous_albinism_type_1&not_specified	NC_000011.10:g.89284793G>A	1301878:Likely_pathogenic	single_nucleotide_variant	TYR:7299	MedGen:C2677190&OMIM:601800&MONDO:MONDO:0013759&MedGen:C3152204&OMIM:614456&Orphanet:293822&MedGen:C3149136&MONDO:MONDO:0011749&MedGen:C1847024&OMIM:606952&Orphanet:352731&Orphanet:352737&Orphanet:79434&MONDO:MONDO:0007254&MedGen:C0006142&MONDO:MONDO:0008745&MedGen:C4551504&OMIM:203100&Orphanet:352731&Orphanet:79431&MedGen:C3661900&MONDO:MONDO:0018135&MedGen:C0268494&Orphanet:352731&.&MONDO:MONDO:0040653&MedGen:C0268503&Human_Phenotype_Ontology:HP:0001939&Human_Phenotype_Ontology:HP:0002146&MedGen:C4021768&Human_Phenotype_Ontology:HP:0007652&Human_Phenotype_Ontology:HP:0007924&MedGen:C1853141&Human_Phenotype_Ontology:HP:0007750&MONDO:MONDO:0044203&MedGen:C2673946&OMIM:PS136520&Human_Phenotype_Ontology:HP:0001411&Human_Phenotype_Ontology:HP:0002910&Human_Phenotype_Ontology:HP:0003143&Human_Phenotype_Ontology:HP:0003156&Human_Phenotype_Ontology:HP:0003293&Human_Phenotype_Ontology:HP:0006567&Human_Phenotype_Ontology:HP:0006578&Human_Phenotype_Ontology:HP:0008267&Human_Phenotype_Ontology:HP:0008342&MedGen:C0235996&Human_Phenotype_Ontology:HP:0011506&MONDO:MONDO:0810000&MedGen:C0600518&Human_Phenotype_Ontology:HP:0001022&MONDO:MONDO:0043209&MedGen:C0001916&MONDO:MONDO:0018137&MedGen:C1847132&Orphanet:352737&MedGen:CN169374	Pathogenic(1)&Likely_pathogenic(1)&Uncertain_significance(6)&Benign(1)&Likely_benign(2)	criteria_provided&_conflicting_classifications	Oculocutaneous_albinism_type_1A&Oculocutaneous_albinism_type_1B	TYR	Albinism, oculocutaneous 1	AR	606574	Eye disorders	NBScreening	-9	Benign	PM1,PP2,BP4_Strong,BA1	rs1126809	chr11_89284793_G_A	Female	0/1	Heterozygous
chr11	108368599	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=5.733;QD=1.11;ReadPosRankSum=5.256;SOR=0.616;FractionInformativeReads=1;R2_5P_bias=9.254;DP=108;AF=0.5;AN=6;AC=3;CSQ=A|3_prime_UTR_variant|MODIFIER|ATM|472|Transcript|NM_000051.4|protein_coding|63/63||NM_000051.4:c.*3091G>A||12412|||||rs886047629||1||SNV|EntrezGene||YES|||G|G|||||||6.049e-05|0|0|0|0|0|0|4.902e-05|0.0001799|0.001859|0.0001051|0|0|0|0|0|0|0|0.0001323|0|0.001453|0.001859|gnomADe_SAS|uncertain_significance||1||||||||||||26|-6|40|-44|0.00|0.00|0.00|0.00|ATM|||||||302293||Uncertain_significance|Ataxia-telangiectasia_syndrome|NC_000011.10:g.108368599G>A||single_nucleotide_variant|ATM:472&C11orf65:160140|MONDO:MONDO:0008840&MedGen:C0004135&OMIM:208900&Orphanet:100||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:23,22:0.489:45:14,8:9,14:48:85,0,50:49.971,6.5492e-05,53:0,34.77,37.77:11,12,11,11:12,11,11,11	0/1:16,16:0.5:32:10,9:6,7:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:9,7,9,7:11,5,12,4	0/1:16,14:0.467:30:7,6:9,8:48:85,0,50:49.765,6.7563e-05,53:0,34.77,37.77:12,4,8,6:7,9,6,8	A	3_prime_UTR_variant	MODIFIER	ATM	472	Transcript	NM_000051.4	protein_coding	63/63		c.*3091G>A		12412					rs886047629	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	6.049e-05	0	0	0	0	0	0	4.902e-05	0.0001799	0.001859	0.0001051	0	0	0	0	0	0	0	0.0001323	0	0.001453	0.001859	gnomADe_SAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		26	-6	40	-44	0	0	0	0	ATM			NA				302293	NA	Uncertain_significance	Ataxia-telangiectasia_syndrome	NC_000011.10:g.108368599G>A		single_nucleotide_variant	ATM:472&C11orf65:160140	MONDO:MONDO:0008840&MedGen:C0004135&OMIM:208900&Orphanet:100		criteria_provided&_single_submitter		ATM	Ataxia-telangiectasia syndrome	AR	208900	Tumor predisposition syndromes	NBScreening	-4	Likely_benign	BP4_Strong	rs886047629	chr11_108368599_G_A	Female	0/1	Heterozygous
chr11	110230554	.	T	TTCTC	182.42	PASS	"FS=0;MQ=243.85;MQRankSum=-0.938;QD=1.66;ReadPosRankSum=-1.986;SOR=0.61;FractionInformativeReads=0.967;R2_5P_bias=17.462;DP=116;AF=1;AN=6;AC=4;CSQ=TCTC|3_prime_UTR_variant|MODIFIER|RDX|5962|Transcript|NM_002906.4|protein_coding|14/14||NM_002906.4:c.*1311_*1314dup||3278-3279|||||rs149832663||-1||insertion|EntrezGene||YES|||||||||||0.4583|||||0.4773||0.25|0.25||0.4814|0.6384|0.4977|0.4117|0.3464|0.6085|0.4504|0.3116|0.4107|0.4441|0.4129|0.6384|gnomADg_AFR|||1|||||||||||||||||||||||||||302307||Uncertain_significance|not_provided&Hearing_loss&_autosomal_recessive|NC_000011.10:g.110230555TC[7]||Microsatellite|RDX:5962|MedGen:C3661900&MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,14:0.483:29:3,9:12,5:48:70,0,50:49.924,6.601e-05,53:0,20,23:4,11,4,10:10,5,7,7	0/1:19,22:0.537:41:9,11:10,11:48:71,0,50:50,6.7822e-05,52.523:0,21,24:5,14,6,16:7,12,11,11	1/1:0,45:1:45:0,19:0,26:132:205,135,0:182.42,132.42,0:0,20,23:0,0,8,37:0,0,26,19	TCTC	3_prime_UTR_variant	MODIFIER	RDX	5962	Transcript	NM_002906.4	protein_coding	14/14		c.*1311_*1314dup		3278-3279					rs149832663	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.4583	NA	NA	NA	NA	0.4773	NA	0.25	0.25	NA	0.4814	0.6384	0.4977	0.4117	0.3464	0.6085	0.4504	0.3116	0.4107	0.4441	0.4129	0.6384	gnomADg_AFR			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				302307	NA	Uncertain_significance	not_provided&Hearing_loss&_autosomal_recessive	NC_000011.10:g.110230555TC[7]		Microsatellite	RDX:5962	MedGen:C3661900&MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636		criteria_provided&_multiple_submitters&_no_conflicts		RDX	Autosomal recessive nonsyndromic hearing loss 24	AR	611022	Hearing disorders	NBScreening	-8	Benign	BA1	rs149832663	chr11_110230554_T_TTCTC	Female	0/1	Heterozygous
chr11	119206289	.	C	CCGG	50	PASS	"FS=0;MQ=250;MQRankSum=3.532;QD=2.5;ReadPosRankSum=0.971;SOR=0.758;FractionInformativeReads=0.9;R2_5P_bias=8.308;DP=74;AF=0.5;AN=6;AC=3;CSQ=CGG|upstream_gene_variant|MODIFIER|CBL|867|Transcript|NM_005188.4|protein_coding||||||||||rs57028199|49|1||insertion|EntrezGene||YES|||||||||||0.07485|0.04535|0.05269|0.1|0.02977|0.1014|0.1098|0.0775|0.08523|0.05046|0.08221|0.05136|0.1291|0.07259|0.1182|0.04228|0.1004|0.1586|0.1017|0.09547|0.06186|0.1586|gnomADg_MID|||1|||||||||||||||||||||||||||302758||Conflicting_classifications_of_pathogenicity|not_provided&Noonan_syndrome_and_Noonan-related_syndrome&Noonan-like_syndrome|NC_000011.10:g.119206291GGC[12]||Microsatellite|CBL:867&FRA11B:109280160&LOC130006894:130006894|MedGen:C3661900&MONDO:MONDO:0020297&MedGen:C5681679&Orphanet:98733&MedGen:C1834120|Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:9,9:0.5:18:5,3:4,6:48:54,0,50:50,6.5233e-05,53:0,4,7:5,4,4,5:7,2,6,3	0/1:12,10:0.455:22:8,4:4,6:47:54,0,47:49.575,9.1378e-05,50:0,4,7.01:5,7,4,6:5,7,6,4	0/1:5,16:0.762:21:2,9:3,7:40:54,0,37:50,0.00045173,40.267:0,4,7.01:4,1,7,9:3,2,10,6	CGG	upstream_gene_variant	MODIFIER	CBL	867	Transcript	NM_005188.4	protein_coding										rs57028199	49	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.07485	0.04535	0.05269	0.1	0.02977	0.1014	0.1098	0.0775	0.08523	0.05046	0.08221	0.05136	0.1291	0.07259	0.1182	0.04228	0.1004	0.1586	0.1017	0.09547	0.06186	0.1586	gnomADg_MID			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				302758	NA	Conflicting_classifications_of_pathogenicity	not_provided&Noonan_syndrome_and_Noonan-related_syndrome&Noonan-like_syndrome	NC_000011.10:g.119206291GGC[12]		Microsatellite	CBL:867&FRA11B:109280160&LOC130006894:130006894	MedGen:C3661900&MONDO:MONDO:0020297&MedGen:C5681679&Orphanet:98733&MedGen:C1834120	Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		CBL	Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	AD	613563	Complex genetic syndromes	NBScreening	-9	Benign	BP6,BA1	rs57028199	chr11_119206289_C_CCGG	Female	0/1	Heterozygous
chr11	128891437	.	C	G	59.91	PASS	"FS=0;MQ=223.23;QD=3.52;SOR=0.693;FractionInformativeReads=0.235;MQRankSum=0.244;ReadPosRankSum=1.788;R2_5P_bias=-7.197;DP=72;AF=0.5;AN=6;AC=4;CSQ=G|5_prime_UTR_variant|MODIFIER|KCNJ5|3762|Transcript|NM_000890.5|protein_coding|1/3||NM_000890.5:c.-295C>G||82|||||rs372328307&COSV57965279||1||SNV|EntrezGene||YES|||C|C|||||||0|||0|0|0||0|0|0|0.228|0.3675|0.2784|0.1852|0.3425|0.1517|0.1121|0.1481|0.1933|0.2315|0.1587|0.3675|gnomADg_AFR|benign&uncertain_significance|0&1|1&1||||||||||||1|7|-50|-6|0.00|0.00|0.00|0.00|KCNJ5|||||||303601||Conflicting_classifications_of_pathogenicity|Familial_hyperaldosteronism_type_III&not_provided&Congenital_long_QT_syndrome|NC_000011.10:g.128891437C>G||single_nucleotide_variant|KCNJ5:3762|MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0019171&MedGen:C1141890&OMIM:PS192500&Orphanet:101016&Orphanet:768|Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	1|1:0,4:1:4:0,2:0,2:10:97,12,0:59.906,9.9059,0.46816:0,34.77,37.77:0,0,2,2:0,0,2,2:128891437	0/1:7,5:0.417:12:2,1:5,4:48:84,0,50:49.367,7.1964e-05,53:0,34.77,37.77:4,3,2,3:3,4,4,1:.	0/1:8,4:0.333:12:5,2:3,2:39:73,0,50:38.696,0.0006081,53.001:0,34.77,37.77:4,4,3,1:3,5,3,1:.	G	5_prime_UTR_variant	MODIFIER	KCNJ5	3762	Transcript	NM_000890.5	protein_coding	03-Jan		c.-295C>G		82					rs372328307&COSV57965279	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0	NA	NA	0	0	0	NA	0	0	0	0.228	0.3675	0.2784	0.1852	0.3425	0.1517	0.1121	0.1481	0.1933	0.2315	0.1587	0.3675	gnomADg_AFR	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		1	7	-50	-6	0	0	0	0	KCNJ5			NA				303601	NA	Conflicting_classifications_of_pathogenicity	Familial_hyperaldosteronism_type_III&not_provided&Congenital_long_QT_syndrome	NC_000011.10:g.128891437C>G		single_nucleotide_variant	KCNJ5:3762	MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0019171&MedGen:C1141890&OMIM:PS192500&Orphanet:101016&Orphanet:768	Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		KCNJ5	Familial hyperaldosteronism type III	AD	613677	"Endocrine disorders;Cardiac and vascular disorders"	NBScreening	-5	Likely_benign	BP4_Strong,BP6	rs372328307	chr11_128891437_C_G	Female	1|1	Homozygous
chr11	128891437	.	C	G	59.91	PASS	"FS=0;MQ=223.23;QD=3.52;SOR=0.693;FractionInformativeReads=0.235;MQRankSum=0.244;ReadPosRankSum=1.788;R2_5P_bias=-7.197;DP=72;AF=0.5;AN=6;AC=4;CSQ=G|5_prime_UTR_variant|MODIFIER|KCNJ5|3762|Transcript|NM_000890.5|protein_coding|1/3||NM_000890.5:c.-295C>G||82|||||rs372328307&COSV57965279||1||SNV|EntrezGene||YES|||C|C|||||||0|||0|0|0||0|0|0|0.228|0.3675|0.2784|0.1852|0.3425|0.1517|0.1121|0.1481|0.1933|0.2315|0.1587|0.3675|gnomADg_AFR|benign&uncertain_significance|0&1|1&1||||||||||||1|7|-50|-6|0.00|0.00|0.00|0.00|KCNJ5|||||||303601||Conflicting_classifications_of_pathogenicity|Familial_hyperaldosteronism_type_III&not_provided&Congenital_long_QT_syndrome|NC_000011.10:g.128891437C>G||single_nucleotide_variant|KCNJ5:3762|MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0019171&MedGen:C1141890&OMIM:PS192500&Orphanet:101016&Orphanet:768|Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	1|1:0,4:1:4:0,2:0,2:10:97,12,0:59.906,9.9059,0.46816:0,34.77,37.77:0,0,2,2:0,0,2,2:128891437	0/1:7,5:0.417:12:2,1:5,4:48:84,0,50:49.367,7.1964e-05,53:0,34.77,37.77:4,3,2,3:3,4,4,1:.	0/1:8,4:0.333:12:5,2:3,2:39:73,0,50:38.696,0.0006081,53.001:0,34.77,37.77:4,4,3,1:3,5,3,1:.	G	5_prime_UTR_variant	MODIFIER	KCNJ5	3762	Transcript	NM_000890.5	protein_coding	03-Jan		c.-295C>G		82					rs372328307&COSV57965279	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0	NA	NA	0	0	0	NA	0	0	0	0.228	0.3675	0.2784	0.1852	0.3425	0.1517	0.1121	0.1481	0.1933	0.2315	0.1587	0.3675	gnomADg_AFR	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		1	7	-50	-6	0	0	0	0	KCNJ5			NA				303601	NA	Conflicting_classifications_of_pathogenicity	Familial_hyperaldosteronism_type_III&not_provided&Congenital_long_QT_syndrome	NC_000011.10:g.128891437C>G		single_nucleotide_variant	KCNJ5:3762	MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0019171&MedGen:C1141890&OMIM:PS192500&Orphanet:101016&Orphanet:768	Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		KCNJ5	Long QT syndrome 13	AD	613485	"Endocrine disorders;Cardiac and vascular disorders"	NBScreening	-5	Likely_benign	BP4_Strong,BP6	rs372328307	chr11_128891437_C_G	Female	1|1	Homozygous
chr11	128891439	.	C	G	60.05	PASS	"FS=0;MQ=223.23;QD=3.53;SOR=0.693;FractionInformativeReads=0.235;MQRankSum=0.244;ReadPosRankSum=1.788;R2_5P_bias=-7.197;DP=72;AF=0.5;AN=6;AC=4;CSQ=G|5_prime_UTR_variant|MODIFIER|KCNJ5|3762|Transcript|NM_000890.5|protein_coding|1/3||NM_000890.5:c.-293C>G||84|||||rs376640553&COSV57965281||1||SNV|EntrezGene||YES|||C|C|||||||0||||0|0||0|0|0|0.3902|0.503|0.4375|0.3187|0.5399|0.3414|0.2166|0.2609|0.3699|0.3857|0.3636|0.5399|gnomADg_ASJ|benign&uncertain_significance|0&1|1&1||||||||||||1|5|27|-6|0.00|0.00|0.00|0.00|KCNJ5|||||||303610||Conflicting_classifications_of_pathogenicity|Familial_hyperaldosteronism_type_III&not_provided&Congenital_long_QT_syndrome|NC_000011.10:g.128891439C>G||single_nucleotide_variant|KCNJ5:3762|MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0019171&MedGen:C1141890&OMIM:PS192500&Orphanet:101016&Orphanet:768|Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	1|1:0,4:1:4:0,2:0,2:10:97,13,0:60.053,10.053,0.45173:0,34.77,37.77:0,0,2,2:0,0,2,2:128891437	0/1:7,5:0.417:12:2,1:5,4:48:84,0,50:49.423,7.1446e-05,53:0,34.77,37.77:4,3,2,3:3,4,4,1:.	0/1:8,4:0.333:12:5,2:3,2:45:82,0,46:47.476,0.00013176,49.043:0,34.77,37.77:4,4,3,1:3,5,3,1:.	G	5_prime_UTR_variant	MODIFIER	KCNJ5	3762	Transcript	NM_000890.5	protein_coding	03-Jan		c.-293C>G		84					rs376640553&COSV57965281	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0	NA	NA	NA	0	0	NA	0	0	0	0.3902	0.503	0.4375	0.3187	0.5399	0.3414	0.2166	0.2609	0.3699	0.3857	0.3636	0.5399	gnomADg_ASJ	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		1	5	27	-6	0	0	0	0	KCNJ5			NA				303610	NA	Conflicting_classifications_of_pathogenicity	Familial_hyperaldosteronism_type_III&not_provided&Congenital_long_QT_syndrome	NC_000011.10:g.128891439C>G		single_nucleotide_variant	KCNJ5:3762	MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0019171&MedGen:C1141890&OMIM:PS192500&Orphanet:101016&Orphanet:768	Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		KCNJ5	Familial hyperaldosteronism type III	AD	613677	"Endocrine disorders;Cardiac and vascular disorders"	NBScreening	-5	Likely_benign	BP4_Strong,BP6	rs376640553	chr11_128891439_C_G	Female	1|1	Homozygous
chr11	128891439	.	C	G	60.05	PASS	"FS=0;MQ=223.23;QD=3.53;SOR=0.693;FractionInformativeReads=0.235;MQRankSum=0.244;ReadPosRankSum=1.788;R2_5P_bias=-7.197;DP=72;AF=0.5;AN=6;AC=4;CSQ=G|5_prime_UTR_variant|MODIFIER|KCNJ5|3762|Transcript|NM_000890.5|protein_coding|1/3||NM_000890.5:c.-293C>G||84|||||rs376640553&COSV57965281||1||SNV|EntrezGene||YES|||C|C|||||||0||||0|0||0|0|0|0.3902|0.503|0.4375|0.3187|0.5399|0.3414|0.2166|0.2609|0.3699|0.3857|0.3636|0.5399|gnomADg_ASJ|benign&uncertain_significance|0&1|1&1||||||||||||1|5|27|-6|0.00|0.00|0.00|0.00|KCNJ5|||||||303610||Conflicting_classifications_of_pathogenicity|Familial_hyperaldosteronism_type_III&not_provided&Congenital_long_QT_syndrome|NC_000011.10:g.128891439C>G||single_nucleotide_variant|KCNJ5:3762|MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0019171&MedGen:C1141890&OMIM:PS192500&Orphanet:101016&Orphanet:768|Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	1|1:0,4:1:4:0,2:0,2:10:97,13,0:60.053,10.053,0.45173:0,34.77,37.77:0,0,2,2:0,0,2,2:128891437	0/1:7,5:0.417:12:2,1:5,4:48:84,0,50:49.423,7.1446e-05,53:0,34.77,37.77:4,3,2,3:3,4,4,1:.	0/1:8,4:0.333:12:5,2:3,2:45:82,0,46:47.476,0.00013176,49.043:0,34.77,37.77:4,4,3,1:3,5,3,1:.	G	5_prime_UTR_variant	MODIFIER	KCNJ5	3762	Transcript	NM_000890.5	protein_coding	03-Jan		c.-293C>G		84					rs376640553&COSV57965281	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0	NA	NA	NA	0	0	NA	0	0	0	0.3902	0.503	0.4375	0.3187	0.5399	0.3414	0.2166	0.2609	0.3699	0.3857	0.3636	0.5399	gnomADg_ASJ	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		1	5	27	-6	0	0	0	0	KCNJ5			NA				303610	NA	Conflicting_classifications_of_pathogenicity	Familial_hyperaldosteronism_type_III&not_provided&Congenital_long_QT_syndrome	NC_000011.10:g.128891439C>G		single_nucleotide_variant	KCNJ5:3762	MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0019171&MedGen:C1141890&OMIM:PS192500&Orphanet:101016&Orphanet:768	Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		KCNJ5	Long QT syndrome 13	AD	613485	"Endocrine disorders;Cardiac and vascular disorders"	NBScreening	-5	Likely_benign	BP4_Strong,BP6	rs376640553	chr11_128891439_C_G	Female	1|1	Homozygous
chr11	128891441	.	C	G	118.81	PASS	"FS=0;MQ=223.23;QD=5.39;SOR=1.473;FractionInformativeReads=0.882;DP=68;AF=1;AN=6;AC=6;CSQ=G|5_prime_UTR_variant|MODIFIER|KCNJ5|3762|Transcript|NM_000890.5|protein_coding|1/3||NM_000890.5:c.-291C>G||86|||||rs10893931&COSV57971553||1||SNV|EntrezGene||YES|||C|C|||||||0||||0|||0|0|0|0.5079|0.6249|0.5497|0.4649|0.643|0.5521|0.2898|0.4211|0.4768|0.4985|0.4596|0.643|gnomADg_ASJ|uncertain_significance|0&1|1&1||||||||||||1|3|-50|-6|0.00|0.00|0.00|0.00|KCNJ5|||||||879671||Uncertain_significance|Familial_hyperaldosteronism_type_III&not_provided&Long_QT_syndrome_13|NC_000011.10:g.128891441C>G||single_nucleotide_variant|KCNJ5:3762|MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0013279&MedGen:C3150733&OMIM:613485&Orphanet:101016&Orphanet:768||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,15:1:15:0,7:0,8:42:129,45,0:91.637,41.637,0.00029796:0,34.77,37.77:0,0,10,5:0,0,8,7	1/1:0,24:1:24:0,3:0,21:69:157,72,0:118.81,68.813,5.1772e-07:0,34.77,37.77:0,0,13,11:0,0,12,12	1/1:0,20:1:20:0,14:0,6:54:141,57,0:103.66,53.664,1.8638e-05:0,34.77,37.77:0,0,16,4:0,0,12,8	G	5_prime_UTR_variant	MODIFIER	KCNJ5	3762	Transcript	NM_000890.5	protein_coding	03-Jan		c.-291C>G		86					rs10893931&COSV57971553	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0	NA	NA	NA	0	NA	NA	0	0	0	0.5079	0.6249	0.5497	0.4649	0.643	0.5521	0.2898	0.4211	0.4768	0.4985	0.4596	0.643	gnomADg_ASJ	uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		1	3	-50	-6	0	0	0	0	KCNJ5			NA				879671	NA	Uncertain_significance	Familial_hyperaldosteronism_type_III&not_provided&Long_QT_syndrome_13	NC_000011.10:g.128891441C>G		single_nucleotide_variant	KCNJ5:3762	MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0013279&MedGen:C3150733&OMIM:613485&Orphanet:101016&Orphanet:768		criteria_provided&_multiple_submitters&_no_conflicts		KCNJ5	Familial hyperaldosteronism type III	AD	613677	"Endocrine disorders;Cardiac and vascular disorders"	NBScreening	-12	Benign	BP4_Strong,BA1	rs10893931	chr11_128891441_C_G	Female	01-Jan	Homozygous
chr11	128891441	.	C	G	118.81	PASS	"FS=0;MQ=223.23;QD=5.39;SOR=1.473;FractionInformativeReads=0.882;DP=68;AF=1;AN=6;AC=6;CSQ=G|5_prime_UTR_variant|MODIFIER|KCNJ5|3762|Transcript|NM_000890.5|protein_coding|1/3||NM_000890.5:c.-291C>G||86|||||rs10893931&COSV57971553||1||SNV|EntrezGene||YES|||C|C|||||||0||||0|||0|0|0|0.5079|0.6249|0.5497|0.4649|0.643|0.5521|0.2898|0.4211|0.4768|0.4985|0.4596|0.643|gnomADg_ASJ|uncertain_significance|0&1|1&1||||||||||||1|3|-50|-6|0.00|0.00|0.00|0.00|KCNJ5|||||||879671||Uncertain_significance|Familial_hyperaldosteronism_type_III&not_provided&Long_QT_syndrome_13|NC_000011.10:g.128891441C>G||single_nucleotide_variant|KCNJ5:3762|MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0013279&MedGen:C3150733&OMIM:613485&Orphanet:101016&Orphanet:768||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,15:1:15:0,7:0,8:42:129,45,0:91.637,41.637,0.00029796:0,34.77,37.77:0,0,10,5:0,0,8,7	1/1:0,24:1:24:0,3:0,21:69:157,72,0:118.81,68.813,5.1772e-07:0,34.77,37.77:0,0,13,11:0,0,12,12	1/1:0,20:1:20:0,14:0,6:54:141,57,0:103.66,53.664,1.8638e-05:0,34.77,37.77:0,0,16,4:0,0,12,8	G	5_prime_UTR_variant	MODIFIER	KCNJ5	3762	Transcript	NM_000890.5	protein_coding	03-Jan		c.-291C>G		86					rs10893931&COSV57971553	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0	NA	NA	NA	0	NA	NA	0	0	0	0.5079	0.6249	0.5497	0.4649	0.643	0.5521	0.2898	0.4211	0.4768	0.4985	0.4596	0.643	gnomADg_ASJ	uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		1	3	-50	-6	0	0	0	0	KCNJ5			NA				879671	NA	Uncertain_significance	Familial_hyperaldosteronism_type_III&not_provided&Long_QT_syndrome_13	NC_000011.10:g.128891441C>G		single_nucleotide_variant	KCNJ5:3762	MONDO:MONDO:0013359&MedGen:C3838758&OMIM:613677&Orphanet:251274&MedGen:C3661900&MONDO:MONDO:0013279&MedGen:C3150733&OMIM:613485&Orphanet:101016&Orphanet:768		criteria_provided&_multiple_submitters&_no_conflicts		KCNJ5	Long QT syndrome 13	AD	613485	"Endocrine disorders;Cardiac and vascular disorders"	NBScreening	-12	Benign	BP4_Strong,BA1	rs10893931	chr11_128891441_C_G	Female	01-Jan	Homozygous
chr12	4369970	.	CTTTTTT	C	155.91	PASS	"FS=0;MQ=236.54;MQRankSum=0.589;QD=3.34;ReadPosRankSum=-0.118;SOR=1.155;FractionInformativeReads=0.733;R2_5P_bias=4.039;DP=69;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|FGF23|8074|Transcript|NM_020638.3|protein_coding|3/3||NM_020638.3:c.*367_*372del||1253-1258|||||rs58735464||-1||deletion|EntrezGene||YES|||TTTTTT|TTTTTT|||||||0.03311|0.03617|0.004502|0.05901|0.1264|0|0.02542|0.02178|0.03111|0.002228|0.2382|0.1447|0.3134|0.2513|0.3018|0.3477|0.1148|0.2917|0.2656|0.2387|0.2232|0.3477|gnomADg_EAS|uncertain_significance||1|||||||||||||||||||||||||||308793||Uncertain_significance|not_provided&Hypophosphatemic_Rickets&_Dominant&Familial_hyperphosphatemic_tumoral_calcinosis/hyperphosphatemic_hyperostosis_syndrome|NC_000012.12:g.4369997_4370002del||Deletion|FGF23:8074|MedGen:C3661900&MedGen:CN239437&MONDO:MONDO:0100251&MedGen:C1876187&Orphanet:306661||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:2,9:0.818:11:2,6:0,3:15:54,0,12:50.146,0.14558,14.821:0,4,7:2,0,3,6:2,0,4,5	0/1:10,20:0.667:30:6,7:4,13:14:55,0,11:50.173,0.17311,14.082:0,5,8.01:10,0,8,12:6,4,11,9	1/0:0,10:0.625:16:0,4:0,6:50:164,110,54:155.91,105.91,53:0,4,7:0,0,6,10:0,0,6,10	-	3_prime_UTR_variant	MODIFIER	FGF23	8074	Transcript	NM_020638.3	protein_coding	03-Mar		c.*367_*372del		1253-1258					rs58735464	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	TTTTTT	TTTTTT	NA	NA			NA	NA	0.03311	0.03617	0.004502	0.05901	0.1264	0	0.02542	0.02178	0.03111	0.002228	0.2382	0.1447	0.3134	0.2513	0.3018	0.3477	0.1148	0.2917	0.2656	0.2387	0.2232	0.3477	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				308793	NA	Uncertain_significance	not_provided&Hypophosphatemic_Rickets&_Dominant&Familial_hyperphosphatemic_tumoral_calcinosis/hyperphosphatemic_hyperostosis_syndrome	NC_000012.12:g.4369997_4370002del		Deletion	FGF23:8074	MedGen:C3661900&MedGen:CN239437&MONDO:MONDO:0100251&MedGen:C1876187&Orphanet:306661		criteria_provided&_multiple_submitters&_no_conflicts		FGF23	Tumoral calcinosis, hyperphosphatemic, familial, 2	AR	617993	Skelettal, skin, and connective tissue disorders	NBScreening	0	Uncertain_significance		rs58735464	chr12_4369970_CTTTTTT_C	Female	0/1	Heterozygous
chr12	4369970	.	CTTTTTT	C	155.91	PASS	"FS=0;MQ=236.54;MQRankSum=0.589;QD=3.34;ReadPosRankSum=-0.118;SOR=1.155;FractionInformativeReads=0.733;R2_5P_bias=4.039;DP=69;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|FGF23|8074|Transcript|NM_020638.3|protein_coding|3/3||NM_020638.3:c.*367_*372del||1253-1258|||||rs58735464||-1||deletion|EntrezGene||YES|||TTTTTT|TTTTTT|||||||0.03311|0.03617|0.004502|0.05901|0.1264|0|0.02542|0.02178|0.03111|0.002228|0.2382|0.1447|0.3134|0.2513|0.3018|0.3477|0.1148|0.2917|0.2656|0.2387|0.2232|0.3477|gnomADg_EAS|uncertain_significance||1|||||||||||||||||||||||||||308793||Uncertain_significance|not_provided&Hypophosphatemic_Rickets&_Dominant&Familial_hyperphosphatemic_tumoral_calcinosis/hyperphosphatemic_hyperostosis_syndrome|NC_000012.12:g.4369997_4370002del||Deletion|FGF23:8074|MedGen:C3661900&MedGen:CN239437&MONDO:MONDO:0100251&MedGen:C1876187&Orphanet:306661||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:2,9:0.818:11:2,6:0,3:15:54,0,12:50.146,0.14558,14.821:0,4,7:2,0,3,6:2,0,4,5	0/1:10,20:0.667:30:6,7:4,13:14:55,0,11:50.173,0.17311,14.082:0,5,8.01:10,0,8,12:6,4,11,9	1/0:0,10:0.625:16:0,4:0,6:50:164,110,54:155.91,105.91,53:0,4,7:0,0,6,10:0,0,6,10	-	3_prime_UTR_variant	MODIFIER	FGF23	8074	Transcript	NM_020638.3	protein_coding	03-Mar		c.*367_*372del		1253-1258					rs58735464	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	TTTTTT	TTTTTT	NA	NA			NA	NA	0.03311	0.03617	0.004502	0.05901	0.1264	0	0.02542	0.02178	0.03111	0.002228	0.2382	0.1447	0.3134	0.2513	0.3018	0.3477	0.1148	0.2917	0.2656	0.2387	0.2232	0.3477	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				308793	NA	Uncertain_significance	not_provided&Hypophosphatemic_Rickets&_Dominant&Familial_hyperphosphatemic_tumoral_calcinosis/hyperphosphatemic_hyperostosis_syndrome	NC_000012.12:g.4369997_4370002del		Deletion	FGF23:8074	MedGen:C3661900&MedGen:CN239437&MONDO:MONDO:0100251&MedGen:C1876187&Orphanet:306661		criteria_provided&_multiple_submitters&_no_conflicts		FGF23	Autosomal dominant hypophosphatemic rickets	AD	193100	Skelettal, skin, and connective tissue disorders	NBScreening	0	Uncertain_significance		rs58735464	chr12_4369970_CTTTTTT_C	Female	0/1	Heterozygous
chr12	6347577	.	G	A	47.39	PASS	"FS=0;MQ=249.67;MQRankSum=4.75;QD=1.16;ReadPosRankSum=2.554;SOR=0.701;FractionInformativeReads=1;R2_5P_bias=-2.259;DP=41;AF=0.5;AN=2;AC=1;CSQ=A|3_prime_UTR_variant|MODIFIER|SCNN1A|6337|Transcript|NM_001038.6|protein_coding|13/13||NM_001038.6:c.*296C>T||2419|||||rs55981728||-1||SNV|EntrezGene||YES|||G|G||||||0.0026|0.008877|0.002294|0.004502|0.003208|0|0.008711|0.00289|0.0118|0.008705|0.003793|0.008219|0.002525|0.02851|0.005686|0.003746|0.0001928|0.009979|0.003401|0.01301|0.007096|0.002692|0.02851|gnomADg_AMI|uncertain_significance&benign/likely_benign&benign||1||||||||||||-35|5|33|5|0.00|0.04|0.00|0.00|SCNN1A|||||||310126||Conflicting_classifications_of_pathogenicity|not_provided&Bronchiectasis_with_or_without_elevated_sweat_chloride_2&Pseudohypoaldosteronism&_type_IB1&_autosomal_recessive|NC_000012.12:g.6347577G>A||single_nucleotide_variant|SCNN1A:6337|MedGen:C3661900&MONDO:MONDO:0013087&MedGen:C2751666&OMIM:613021&Orphanet:60033&MONDO:MONDO:0009917&MedGen:C5774176&OMIM:264350&Orphanet:171876&Orphanet:756|Uncertain_significance(1)&Benign(2)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:24,17:0.415:41:11,11:13,6:46:82,0,50:47.393,0.00010096,53:0,34.77,37.77:10,14,7,10:9,15,7,10	A	3_prime_UTR_variant	MODIFIER	SCNN1A	6337	Transcript	NM_001038.6	protein_coding	13/13		c.*296C>T		2419					rs55981728	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0026	0.008877	0.002294	0.004502	0.003208	0	0.008711	0.00289	0.0118	0.008705	0.003793	0.008219	0.002525	0.02851	0.005686	0.003746	0.0001928	0.009979	0.003401	0.01301	0.007096	0.002692	0.02851	gnomADg_AMI	uncertain_significance&benign/likely_benign&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-35	5	33	5	0	0.04	0	0	SCNN1A			NA				310126	NA	Conflicting_classifications_of_pathogenicity	not_provided&Bronchiectasis_with_or_without_elevated_sweat_chloride_2&Pseudohypoaldosteronism&_type_IB1&_autosomal_recessive	NC_000012.12:g.6347577G>A		single_nucleotide_variant	SCNN1A:6337	MedGen:C3661900&MONDO:MONDO:0013087&MedGen:C2751666&OMIM:613021&Orphanet:60033&MONDO:MONDO:0009917&MedGen:C5774176&OMIM:264350&Orphanet:171876&Orphanet:756	Uncertain_significance(1)&Benign(2)&Likely_benign(1)	criteria_provided&_conflicting_classifications		SCNN1A	Autosomal recessive pseudohypoaldosteronism type 1	AR	264350	"Endocrine disorders;Respiratory system disorders"	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs55981728	chr12_6347577_G_A	Female	./.	Other
chr12	6347577	.	G	A	47.39	PASS	"FS=0;MQ=249.67;MQRankSum=4.75;QD=1.16;ReadPosRankSum=2.554;SOR=0.701;FractionInformativeReads=1;R2_5P_bias=-2.259;DP=41;AF=0.5;AN=2;AC=1;CSQ=A|3_prime_UTR_variant|MODIFIER|SCNN1A|6337|Transcript|NM_001038.6|protein_coding|13/13||NM_001038.6:c.*296C>T||2419|||||rs55981728||-1||SNV|EntrezGene||YES|||G|G||||||0.0026|0.008877|0.002294|0.004502|0.003208|0|0.008711|0.00289|0.0118|0.008705|0.003793|0.008219|0.002525|0.02851|0.005686|0.003746|0.0001928|0.009979|0.003401|0.01301|0.007096|0.002692|0.02851|gnomADg_AMI|uncertain_significance&benign/likely_benign&benign||1||||||||||||-35|5|33|5|0.00|0.04|0.00|0.00|SCNN1A|||||||310126||Conflicting_classifications_of_pathogenicity|not_provided&Bronchiectasis_with_or_without_elevated_sweat_chloride_2&Pseudohypoaldosteronism&_type_IB1&_autosomal_recessive|NC_000012.12:g.6347577G>A||single_nucleotide_variant|SCNN1A:6337|MedGen:C3661900&MONDO:MONDO:0013087&MedGen:C2751666&OMIM:613021&Orphanet:60033&MONDO:MONDO:0009917&MedGen:C5774176&OMIM:264350&Orphanet:171876&Orphanet:756|Uncertain_significance(1)&Benign(2)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:24,17:0.415:41:11,11:13,6:46:82,0,50:47.393,0.00010096,53:0,34.77,37.77:10,14,7,10:9,15,7,10	A	3_prime_UTR_variant	MODIFIER	SCNN1A	6337	Transcript	NM_001038.6	protein_coding	13/13		c.*296C>T		2419					rs55981728	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0026	0.008877	0.002294	0.004502	0.003208	0	0.008711	0.00289	0.0118	0.008705	0.003793	0.008219	0.002525	0.02851	0.005686	0.003746	0.0001928	0.009979	0.003401	0.01301	0.007096	0.002692	0.02851	gnomADg_AMI	uncertain_significance&benign/likely_benign&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-35	5	33	5	0	0.04	0	0	SCNN1A			NA				310126	NA	Conflicting_classifications_of_pathogenicity	not_provided&Bronchiectasis_with_or_without_elevated_sweat_chloride_2&Pseudohypoaldosteronism&_type_IB1&_autosomal_recessive	NC_000012.12:g.6347577G>A		single_nucleotide_variant	SCNN1A:6337	MedGen:C3661900&MONDO:MONDO:0013087&MedGen:C2751666&OMIM:613021&Orphanet:60033&MONDO:MONDO:0009917&MedGen:C5774176&OMIM:264350&Orphanet:171876&Orphanet:756	Uncertain_significance(1)&Benign(2)&Likely_benign(1)	criteria_provided&_conflicting_classifications		SCNN1A	Bronchiectasis with or without elevated sweat chloride 2	AD	613021	"Respiratory system disorders;Endocrine disorders"	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs55981728	chr12_6347577_G_A	Female	./.	Other
chr12	6347577	.	G	A	47.39	PASS	"FS=0;MQ=249.67;MQRankSum=4.75;QD=1.16;ReadPosRankSum=2.554;SOR=0.701;FractionInformativeReads=1;R2_5P_bias=-2.259;DP=41;AF=0.5;AN=2;AC=1;CSQ=A|3_prime_UTR_variant|MODIFIER|SCNN1A|6337|Transcript|NM_001038.6|protein_coding|13/13||NM_001038.6:c.*296C>T||2419|||||rs55981728||-1||SNV|EntrezGene||YES|||G|G||||||0.0026|0.008877|0.002294|0.004502|0.003208|0|0.008711|0.00289|0.0118|0.008705|0.003793|0.008219|0.002525|0.02851|0.005686|0.003746|0.0001928|0.009979|0.003401|0.01301|0.007096|0.002692|0.02851|gnomADg_AMI|uncertain_significance&benign/likely_benign&benign||1||||||||||||-35|5|33|5|0.00|0.04|0.00|0.00|SCNN1A|||||||310126||Conflicting_classifications_of_pathogenicity|not_provided&Bronchiectasis_with_or_without_elevated_sweat_chloride_2&Pseudohypoaldosteronism&_type_IB1&_autosomal_recessive|NC_000012.12:g.6347577G>A||single_nucleotide_variant|SCNN1A:6337|MedGen:C3661900&MONDO:MONDO:0013087&MedGen:C2751666&OMIM:613021&Orphanet:60033&MONDO:MONDO:0009917&MedGen:C5774176&OMIM:264350&Orphanet:171876&Orphanet:756|Uncertain_significance(1)&Benign(2)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:24,17:0.415:41:11,11:13,6:46:82,0,50:47.393,0.00010096,53:0,34.77,37.77:10,14,7,10:9,15,7,10	A	3_prime_UTR_variant	MODIFIER	SCNN1A	6337	Transcript	NM_001038.6	protein_coding	13/13		c.*296C>T		2419					rs55981728	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0026	0.008877	0.002294	0.004502	0.003208	0	0.008711	0.00289	0.0118	0.008705	0.003793	0.008219	0.002525	0.02851	0.005686	0.003746	0.0001928	0.009979	0.003401	0.01301	0.007096	0.002692	0.02851	gnomADg_AMI	uncertain_significance&benign/likely_benign&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-35	5	33	5	0	0.04	0	0	SCNN1A			NA				310126	NA	Conflicting_classifications_of_pathogenicity	not_provided&Bronchiectasis_with_or_without_elevated_sweat_chloride_2&Pseudohypoaldosteronism&_type_IB1&_autosomal_recessive	NC_000012.12:g.6347577G>A		single_nucleotide_variant	SCNN1A:6337	MedGen:C3661900&MONDO:MONDO:0013087&MedGen:C2751666&OMIM:613021&Orphanet:60033&MONDO:MONDO:0009917&MedGen:C5774176&OMIM:264350&Orphanet:171876&Orphanet:756	Uncertain_significance(1)&Benign(2)&Likely_benign(1)	criteria_provided&_conflicting_classifications		SCNN1A	Pseudohypoaldosteronism type I, autosomal dominant	AR	177735	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs55981728	chr12_6347577_G_A	Female	./.	Other
chr12	7190512	.	GGCCTCTGAGGCAGTGAGTGTTCTTGAGGTGGAAAGCCCAGGTGCA	G	107.67	PASS	"FS=0;MQ=226.33;QD=2.69;SOR=0.693;FractionInformativeReads=0.45;MQRankSum=-0.41;ReadPosRankSum=-0.634;R2_5P_bias=-5.202;DP=85;AF=0.5;AN=4;AC=3;CSQ=-|splice_donor_variant&splice_donor_5th_base_variant&coding_sequence_variant&intron_variant|HIGH|PEX5|5830|Transcript|NM_001351132.2|protein_coding|2/16|2/15|NM_001351132.2:c.147+77_147+121del||217-?|136-?|46-?|||||1||deletion|EntrezGene||YES|||GCCTCTGAGGCAGTGAGTGTTCTTGAGGTGGAAAGCCCAGGTGCA|GCCTCTGAGGCAGTGAGTGTTCTTGAGGTGGAAAGCCCAGGTGCA|||||88||||||||||||||||||||||||||||||||||||||||||||||||||||||768511||Conflicting_classifications_of_pathogenicity|Peroxisome_biogenesis_disorder_2B&not_provided&Peroxisome_biogenesis_disorder_2A_(Zellweger)&Rhizomelic_chondrodysplasia_punctata_type_5|NC_000012.12:g.7190556CAGCCTCTGAGGCAGTGAGTGTTCTTGAGGTGGAAAGCCCAGGTG[1]||Microsatellite|PEX5:5830|MONDO:MONDO:0008736&MedGen:C3550234&OMIM:202370&Orphanet:44&MedGen:C3661900&MONDO:MONDO:0008954&MedGen:C3550273&OMIM:214110&Orphanet:912&MONDO:MONDO:0014743&MedGen:C4225237&OMIM:616716&Orphanet:468717|Uncertain_significance(1)&Benign(5)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,18:1:18:0,9:0,9:58:140,61,0:107.67,57.668,7.5069e-06:0,29,32:0,0,9,9:0,0,6,12	0/1:14,7:0.333:21:12,6:2,1:46:76,0,50:47.418,0.00010044,53:0,29,32:7,7,3,4:7,7,4,3	./.:.:.:.:.:.:.:.:.:.:.:.	-	splice_donor_variant&splice_donor_5th_base_variant&coding_sequence_variant&intron_variant	HIGH	PEX5	5830	Transcript	NM_001351132.2	protein_coding	16-Feb	15-Feb	c.147+77_147+121del		217-?	136-?	46-?				NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	GCCTCTGAGGCAGTGAGTGTTCTTGAGGTGGAAAGCCCAGGTGCA	GCCTCTGAGGCAGTGAGTGTTCTTGAGGTGGAAAGCCCAGGTGCA	NA	NA			88	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA					NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				768511	NA	Conflicting_classifications_of_pathogenicity	Peroxisome_biogenesis_disorder_2B&not_provided&Peroxisome_biogenesis_disorder_2A_(Zellweger)&Rhizomelic_chondrodysplasia_punctata_type_5	NC_000012.12:g.7190556CAGCCTCTGAGGCAGTGAGTGTTCTTGAGGTGGAAAGCCCAGGTG[1]		Microsatellite	PEX5:5830	MONDO:MONDO:0008736&MedGen:C3550234&OMIM:202370&Orphanet:44&MedGen:C3661900&MONDO:MONDO:0008954&MedGen:C3550273&OMIM:214110&Orphanet:912&MONDO:MONDO:0014743&MedGen:C4225237&OMIM:616716&Orphanet:468717	Uncertain_significance(1)&Benign(5)&Likely_benign(1)	criteria_provided&_conflicting_classifications		PEX5	Peroxisome biogenesis disorder 2A (Zellweger)	AR	214110	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1		chr12_7190512_GGCCTCTGAGGCAGTGAGTGTTCTTGAGGTGGAAAGCCCAGGTGCA_G	Female	01-Jan	Homozygous
chr12	47845054	.	C	A	118.06	PASS	"FS=1.623;MQ=244.71;MQRankSum=4.215;QD=2;ReadPosRankSum=1.169;SOR=0.339;FractionInformativeReads=1;R2_5P_bias=-13.16;DP=56;AF=1;AN=4;AC=3;CSQ=A|intron_variant|MODIFIER|VDR|7421|Transcript|NM_000376.3|protein_coding||9/9|NM_000376.3:c.1025-49G>T|||||||rs7975232&COSV57467972||-1||SNV|EntrezGene||YES|||C|C||||||0.5154|0.5254|0.6365|0.4233|0.5667|0.3056|0.5525|0.6244|0.5274|0.5314|0.5759|0.5491|0.6267|0.5894|0.5041|0.5828|0.2901|0.5503|0.5548|0.5281|0.5518|0.5587|0.6407|AFR|benign&likely_pathogenic|0&1|1&1||||||||||||-7|-10|30|34|0.00|0.00|0.00|0.00|VDR|||||||1252227||Conflicting_classifications_of_pathogenicity|not_provided&Periodontitis&Hepatocellular_carcinoma&Vitamin_D-dependent_rickets_type_II_with_alopecia|NC_000012.12:g.47845054C>A||single_nucleotide_variant|VDR:7421|MedGen:C3661900&Human_Phenotype_Ontology:HP:0000165&Human_Phenotype_Ontology:HP:0000704&Human_Phenotype_Ontology:HP:0006301&MONDO:MONDO:0005076&MedGen:C0031099&Human_Phenotype_Ontology:HP:0001402&Human_Phenotype_Ontology:HP:0002899&Human_Phenotype_Ontology:HP:0003007&Human_Phenotype_Ontology:HP:0006750&MONDO:MONDO:0007256&MedGen:C2239176&OMIM:114550&Orphanet:88673&MONDO:MONDO:0010186&MedGen:C0342646&OMIM:277440&Orphanet:93160|Uncertain_significance(1)&Benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,13:0.52:25:8,6:4,7:48:85,0,50:50,6.5492e-05,52.945:0,34.77,37.77:4,8,6,7:6,6,9,4	./.:.:.:.:.:.:.:.:.:.:.:.	1/1:2,29:0.935:31:1,14:1,15:68:156,71,0:118.06,68.062,7.7658e-07:0,34.77,37.77:2,0,10,19:1,1,11,18	A	intron_variant	MODIFIER	VDR	7421	Transcript	NM_000376.3	protein_coding		09-Sep	c.1025-49G>T							rs7975232&COSV57467972	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.5154	0.5254	0.6365	0.4233	0.5667	0.3056	0.5525	0.6244	0.5274	0.5314	0.5759	0.5491	0.6267	0.5894	0.5041	0.5828	0.2901	0.5503	0.5548	0.5281	0.5518	0.5587	0.6407	AFR	benign&likely_pathogenic	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-7	-10	30	34	0	0	0	0	VDR			NA				1252227	NA	Conflicting_classifications_of_pathogenicity	not_provided&Periodontitis&Hepatocellular_carcinoma&Vitamin_D-dependent_rickets_type_II_with_alopecia	NC_000012.12:g.47845054C>A		single_nucleotide_variant	VDR:7421	MedGen:C3661900&Human_Phenotype_Ontology:HP:0000165&Human_Phenotype_Ontology:HP:0000704&Human_Phenotype_Ontology:HP:0006301&MONDO:MONDO:0005076&MedGen:C0031099&Human_Phenotype_Ontology:HP:0001402&Human_Phenotype_Ontology:HP:0002899&Human_Phenotype_Ontology:HP:0003007&Human_Phenotype_Ontology:HP:0006750&MONDO:MONDO:0007256&MedGen:C2239176&OMIM:114550&Orphanet:88673&MONDO:MONDO:0010186&MedGen:C0342646&OMIM:277440&Orphanet:93160	Uncertain_significance(1)&Benign(3)	criteria_provided&_conflicting_classifications		VDR	Rickets, vitamin D-resistant, type IIA	AR	277440	Inherited disorders of metabolism	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs7975232	chr12_47845054_C_A	Female	0/1	Heterozygous
chr12	47845054	.	C	A	118.06	PASS	"FS=1.623;MQ=244.71;MQRankSum=4.215;QD=2;ReadPosRankSum=1.169;SOR=0.339;FractionInformativeReads=1;R2_5P_bias=-13.16;DP=56;AF=1;AN=4;AC=3;CSQ=A|intron_variant|MODIFIER|VDR|7421|Transcript|NM_000376.3|protein_coding||9/9|NM_000376.3:c.1025-49G>T|||||||rs7975232&COSV57467972||-1||SNV|EntrezGene||YES|||C|C||||||0.5154|0.5254|0.6365|0.4233|0.5667|0.3056|0.5525|0.6244|0.5274|0.5314|0.5759|0.5491|0.6267|0.5894|0.5041|0.5828|0.2901|0.5503|0.5548|0.5281|0.5518|0.5587|0.6407|AFR|benign&likely_pathogenic|0&1|1&1||||||||||||-7|-10|30|34|0.00|0.00|0.00|0.00|VDR|||||||1252227||Conflicting_classifications_of_pathogenicity|not_provided&Periodontitis&Hepatocellular_carcinoma&Vitamin_D-dependent_rickets_type_II_with_alopecia|NC_000012.12:g.47845054C>A||single_nucleotide_variant|VDR:7421|MedGen:C3661900&Human_Phenotype_Ontology:HP:0000165&Human_Phenotype_Ontology:HP:0000704&Human_Phenotype_Ontology:HP:0006301&MONDO:MONDO:0005076&MedGen:C0031099&Human_Phenotype_Ontology:HP:0001402&Human_Phenotype_Ontology:HP:0002899&Human_Phenotype_Ontology:HP:0003007&Human_Phenotype_Ontology:HP:0006750&MONDO:MONDO:0007256&MedGen:C2239176&OMIM:114550&Orphanet:88673&MONDO:MONDO:0010186&MedGen:C0342646&OMIM:277440&Orphanet:93160|Uncertain_significance(1)&Benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,13:0.52:25:8,6:4,7:48:85,0,50:50,6.5492e-05,52.945:0,34.77,37.77:4,8,6,7:6,6,9,4	./.:.:.:.:.:.:.:.:.:.:.:.	1/1:2,29:0.935:31:1,14:1,15:68:156,71,0:118.06,68.062,7.7658e-07:0,34.77,37.77:2,0,10,19:1,1,11,18	A	intron_variant	MODIFIER	VDR	7421	Transcript	NM_000376.3	protein_coding		09-Sep	c.1025-49G>T							rs7975232&COSV57467972	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.5154	0.5254	0.6365	0.4233	0.5667	0.3056	0.5525	0.6244	0.5274	0.5314	0.5759	0.5491	0.6267	0.5894	0.5041	0.5828	0.2901	0.5503	0.5548	0.5281	0.5518	0.5587	0.6407	AFR	benign&likely_pathogenic	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-7	-10	30	34	0	0	0	0	VDR			NA				1252227	NA	Conflicting_classifications_of_pathogenicity	not_provided&Periodontitis&Hepatocellular_carcinoma&Vitamin_D-dependent_rickets_type_II_with_alopecia	NC_000012.12:g.47845054C>A		single_nucleotide_variant	VDR:7421	MedGen:C3661900&Human_Phenotype_Ontology:HP:0000165&Human_Phenotype_Ontology:HP:0000704&Human_Phenotype_Ontology:HP:0006301&MONDO:MONDO:0005076&MedGen:C0031099&Human_Phenotype_Ontology:HP:0001402&Human_Phenotype_Ontology:HP:0002899&Human_Phenotype_Ontology:HP:0003007&Human_Phenotype_Ontology:HP:0006750&MONDO:MONDO:0007256&MedGen:C2239176&OMIM:114550&Orphanet:88673&MONDO:MONDO:0010186&MedGen:C0342646&OMIM:277440&Orphanet:93160	Uncertain_significance(1)&Benign(3)	criteria_provided&_conflicting_classifications		VDR	Vitamin D-dependent rickets, type 2B	AR	600785	Inherited disorders of metabolism	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs7975232	chr12_47845054_C_A	Female	0/1	Heterozygous
chr12	47879112	.	A	G	49.08	PASS	"FS=3.132;MQ=248.81;MQRankSum=5.226;QD=1.29;ReadPosRankSum=3.699;SOR=1.445;FractionInformativeReads=1;R2_5P_bias=-12.217;DP=38;AF=0.5;AN=2;AC=1;CSQ=G|start_lost|HIGH|VDR|7421|Transcript|NM_000376.3|protein_coding|3/10||NM_000376.3:c.2T>C|NP_000367.1:p.Met1?|125|2|1|M/T|aTg/aCg|rs2228570&CM972826&COSV57470959||-1||SNV|EntrezGene||YES|||A|A|||deleterious_low_confidence(0)|benign(0.283)||0.6715|0.6253|0.7904|0.5345|0.5612|0.5913|0.6341|0.7321|0.6142|0.6362|0.766|0.6621|0.7801|0.7368|0.5776|0.5716|0.5697|0.644|0.6939|0.6163|0.6895|0.7391|0.8109|AFR|benign|0&1&1|1&1&1||||T|0.10255|-0.283926|D|0.67917|-0.036796|0.78538|0.503&0.503&0.503&0.503&0.503&0.503&0.503|-5|3|4|-4|0.00|0.00|0.00|0.00|VDR|||||||308887||Conflicting_classifications_of_pathogenicity|not_specified&Vitamin_D-dependent_rickets_type_II_with_alopecia&not_provided&Periodontitis|NC_000012.12:g.47879112A>G||single_nucleotide_variant|VDR:7421|MedGen:CN169374&MONDO:MONDO:0010186&MedGen:C0342646&OMIM:277440&Orphanet:93160&MedGen:C3661900&Human_Phenotype_Ontology:HP:0000165&Human_Phenotype_Ontology:HP:0000704&Human_Phenotype_Ontology:HP:0006301&MONDO:MONDO:0005076&MedGen:C0031099|Likely_pathogenic(1)&Benign(7)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:21,17:0.447:38:8,3:13,14:48:84,0,50:49.083,7.5329e-05,53:0,34.77,37.77:8,13,4,13:13,8,14,3	G	start_lost	HIGH	VDR	7421	Transcript	NM_000376.3	protein_coding	10-Mar		c.2T>C	p.Met1?	125	2	1	M/T	aTg/aCg	rs2228570&CM972826&COSV57470959	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	deleterious_low_confidence(0)	benign(0.283)	NA	0.6715	0.6253	0.7904	0.5345	0.5612	0.5913	0.6341	0.7321	0.6142	0.6362	0.766	0.6621	0.7801	0.7368	0.5776	0.5716	0.5697	0.644	0.6939	0.6163	0.6895	0.7391	0.8109	AFR	benign	0&1&1	1&1&1	NA	NA	NA	T	0.10255	-0.283926	D	0.67917	-0.036796	0.78538	0.503&0.503&0.503&0.503&0.503&0.503&0.503	-5	3	4	-4	0	0	0	0	VDR			NA				308887	NA	Conflicting_classifications_of_pathogenicity	not_specified&Vitamin_D-dependent_rickets_type_II_with_alopecia&not_provided&Periodontitis	NC_000012.12:g.47879112A>G		single_nucleotide_variant	VDR:7421	MedGen:CN169374&MONDO:MONDO:0010186&MedGen:C0342646&OMIM:277440&Orphanet:93160&MedGen:C3661900&Human_Phenotype_Ontology:HP:0000165&Human_Phenotype_Ontology:HP:0000704&Human_Phenotype_Ontology:HP:0006301&MONDO:MONDO:0005076&MedGen:C0031099	Likely_pathogenic(1)&Benign(7)	criteria_provided&_conflicting_classifications		VDR	Rickets, vitamin D-resistant, type IIA	AR	277440	Inherited disorders of metabolism	NBScreening	-8	Benign	PVS1_Supporting,BP6,BA1	rs2228570	chr12_47879112_A_G	Female	./.	Other
chr12	47879112	.	A	G	49.08	PASS	"FS=3.132;MQ=248.81;MQRankSum=5.226;QD=1.29;ReadPosRankSum=3.699;SOR=1.445;FractionInformativeReads=1;R2_5P_bias=-12.217;DP=38;AF=0.5;AN=2;AC=1;CSQ=G|start_lost|HIGH|VDR|7421|Transcript|NM_000376.3|protein_coding|3/10||NM_000376.3:c.2T>C|NP_000367.1:p.Met1?|125|2|1|M/T|aTg/aCg|rs2228570&CM972826&COSV57470959||-1||SNV|EntrezGene||YES|||A|A|||deleterious_low_confidence(0)|benign(0.283)||0.6715|0.6253|0.7904|0.5345|0.5612|0.5913|0.6341|0.7321|0.6142|0.6362|0.766|0.6621|0.7801|0.7368|0.5776|0.5716|0.5697|0.644|0.6939|0.6163|0.6895|0.7391|0.8109|AFR|benign|0&1&1|1&1&1||||T|0.10255|-0.283926|D|0.67917|-0.036796|0.78538|0.503&0.503&0.503&0.503&0.503&0.503&0.503|-5|3|4|-4|0.00|0.00|0.00|0.00|VDR|||||||308887||Conflicting_classifications_of_pathogenicity|not_specified&Vitamin_D-dependent_rickets_type_II_with_alopecia&not_provided&Periodontitis|NC_000012.12:g.47879112A>G||single_nucleotide_variant|VDR:7421|MedGen:CN169374&MONDO:MONDO:0010186&MedGen:C0342646&OMIM:277440&Orphanet:93160&MedGen:C3661900&Human_Phenotype_Ontology:HP:0000165&Human_Phenotype_Ontology:HP:0000704&Human_Phenotype_Ontology:HP:0006301&MONDO:MONDO:0005076&MedGen:C0031099|Likely_pathogenic(1)&Benign(7)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:21,17:0.447:38:8,3:13,14:48:84,0,50:49.083,7.5329e-05,53:0,34.77,37.77:8,13,4,13:13,8,14,3	G	start_lost	HIGH	VDR	7421	Transcript	NM_000376.3	protein_coding	10-Mar		c.2T>C	p.Met1?	125	2	1	M/T	aTg/aCg	rs2228570&CM972826&COSV57470959	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	deleterious_low_confidence(0)	benign(0.283)	NA	0.6715	0.6253	0.7904	0.5345	0.5612	0.5913	0.6341	0.7321	0.6142	0.6362	0.766	0.6621	0.7801	0.7368	0.5776	0.5716	0.5697	0.644	0.6939	0.6163	0.6895	0.7391	0.8109	AFR	benign	0&1&1	1&1&1	NA	NA	NA	T	0.10255	-0.283926	D	0.67917	-0.036796	0.78538	0.503&0.503&0.503&0.503&0.503&0.503&0.503	-5	3	4	-4	0	0	0	0	VDR			NA				308887	NA	Conflicting_classifications_of_pathogenicity	not_specified&Vitamin_D-dependent_rickets_type_II_with_alopecia&not_provided&Periodontitis	NC_000012.12:g.47879112A>G		single_nucleotide_variant	VDR:7421	MedGen:CN169374&MONDO:MONDO:0010186&MedGen:C0342646&OMIM:277440&Orphanet:93160&MedGen:C3661900&Human_Phenotype_Ontology:HP:0000165&Human_Phenotype_Ontology:HP:0000704&Human_Phenotype_Ontology:HP:0006301&MONDO:MONDO:0005076&MedGen:C0031099	Likely_pathogenic(1)&Benign(7)	criteria_provided&_conflicting_classifications		VDR	Vitamin D-dependent rickets, type 2B	AR	600785	Inherited disorders of metabolism	NBScreening	-8	Benign	PVS1_Supporting,BP6,BA1	rs2228570	chr12_47879112_A_G	Female	./.	Other
chr12	101765172	.	T	G	49.94	PASS	"FS=2.864;MQ=250;MQRankSum=5.181;QD=1.35;ReadPosRankSum=3.57;SOR=0.721;FractionInformativeReads=1;R2_5P_bias=14.102;DP=37;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|GNPTAB|79158|Transcript|NM_024312.5|protein_coding|13/21||NM_024312.5:c.1745A>C|NP_077288.2:p.Asp582Ala|2029|1745|582|D/A|gAc/gCc|||-1||SNV|EntrezGene||YES|||T|T|||deleterious(0)|benign(0.437)||||||||||||||||||||||||||||||||D|0.94655|0.51284|D|0.94577|0.498883|0.87479|0.664|30|44|2|13|0.00|0.00|0.00|0.00|GNPTAB|likely_benign|hg38|0.2277|D582A|ENST00000299314.12|Q3T906||||||||||||"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	./.:.:.:.:.:.:.:.:.:.:.:.:.	0|1:19,18:0.486:37:11,12:8,6:47:85,0,47:49.941,8.7495e-05,50:0,34.77,37.78:11,8,8,10:11,8,10,8:101765172	./.:.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	GNPTAB	79158	Transcript	NM_024312.5	protein_coding	13/21		c.1745A>C	p.Asp582Ala	2029	1745	582	D/A	gAc/gCc		NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	deleterious(0)	benign(0.437)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA					NA	NA	NA	D	0.94655	0.51284	D	0.94577	0.498883	0.87479	0.664	30	44	2	13	0	0	0	0	GNPTAB	likely_benign	hg38	0.2277	D582A	ENST00000299314.12	Q3T906	NA	NA	NA										GNPTAB	Mucolipidosis type II	AR	252500	Inherited disorders of metabolism	NBScreening	4	Uncertain_significance	PM1,PM2		chr12_101765172_T_G	Female	./.	Other
chr12	101765173	.	C	A	49.94	PASS	"FS=1.356;MQ=250;MQRankSum=4.96;QD=1.47;ReadPosRankSum=3.789;SOR=0.993;FractionInformativeReads=1;R2_5P_bias=13.343;DP=34;AF=0.5;AN=2;AC=1;CSQ=A|missense_variant|MODERATE|GNPTAB|79158|Transcript|NM_024312.5|protein_coding|13/21||NM_024312.5:c.1744G>T|NP_077288.2:p.Asp582Tyr|2028|1744|582|D/Y|Gac/Tac|||-1||SNV|EntrezGene||YES|||C|C|||deleterious(0)|probably_damaging(0.91)||||||||||||||||||||||||||||||||D|0.95001|0.523077|D|0.94927|0.513587|0.92087|0.766|-39|43|12|43|0.00|0.04|0.00|0.00|GNPTAB|likely_benign|hg38|0.3056|D582Y|ENST00000299314.12|Q3T906||||||||||||"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	./.:.:.:.:.:.:.:.:.:.:.:.:.	0|1:17,17:0.5:34:10,11:7,6:47:85,0,47:49.941,8.7495e-05,50:0,34.77,37.78:9,8,7,10:10,7,9,8:101765172	./.:.:.:.:.:.:.:.:.:.:.:.:.	A	missense_variant	MODERATE	GNPTAB	79158	Transcript	NM_024312.5	protein_coding	13/21		c.1744G>T	p.Asp582Tyr	2028	1744	582	D/Y	Gac/Tac		NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious(0)	probably_damaging(0.91)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA					NA	NA	NA	D	0.95001	0.523077	D	0.94927	0.513587	0.92087	0.766	-39	43	12	43	0	0.04	0	0	GNPTAB	likely_benign	hg38	0.3056	D582Y	ENST00000299314.12	Q3T906	NA	NA	NA										GNPTAB	Mucolipidosis type II	AR	252500	Inherited disorders of metabolism	NBScreening	5	Uncertain_significance	PM1,PM2,PP3		chr12_101765173_C_A	Female	./.	Other
chr12	102400131	.	C	CT	171.87	PASS	"FS=0;MQ=249.62;QD=3.58;SOR=1.259;FractionInformativeReads=0.875;MQRankSum=2.511;ReadPosRankSum=-1.13;R2_5P_bias=-8.024;DP=116;AF=1;AN=6;AC=5;CSQ=T|3_prime_UTR_variant|MODIFIER|IGF1|3479|Transcript|NM_000618.5|protein_coding|4/4||NM_000618.5:c.*2375dup||3019-3020|||||rs35306040||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.6537|0.533|0.6909|0.7294|0.6148|0.8202|0.7935|0.6667|0.6742|0.6483|0.7467|0.8202|gnomADg_EAS|uncertain_significance||1||||||||||||27|41|27|39|0.00|0.00|0.00|0.00|IGF1|||||||306886||Uncertain_significance|Growth_delay_due_to_insulin-like_growth_factor_type_1_deficiency|NC_000012.12:g.102400145dup||Duplication|IGF1:3479&LINC02456:105369942|MONDO:MONDO:0012110&MedGen:C1837475&OMIM:608747&Orphanet:73272||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,42:1:42:0,19:0,23:122:185,125,0:171.87,121.87,0:0,10,13.01:0,0,26,16:0,0,23,19	0/1:17,13:0.433:30:8,8:9,5:47:58,0,50:48.868,7.8176e-05,53:0,9,12:11,6,6,7:8,9,5,8	1/1:0,32:1:32:0,24:0,8:92:155,95,0:142.15,92.152,0:0,10,13.01:0,0,20,12:0,0,22,10	T	3_prime_UTR_variant	MODIFIER	IGF1	3479	Transcript	NM_000618.5	protein_coding	04-Apr		c.*2375dup		3019-3020					rs35306040	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.6537	0.533	0.6909	0.7294	0.6148	0.8202	0.7935	0.6667	0.6742	0.6483	0.7467	0.8202	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		27	41	27	39	0	0	0	0	IGF1			NA				306886	NA	Uncertain_significance	Growth_delay_due_to_insulin-like_growth_factor_type_1_deficiency	NC_000012.12:g.102400145dup		Duplication	IGF1:3479&LINC02456:105369942	MONDO:MONDO:0012110&MedGen:C1837475&OMIM:608747&Orphanet:73272		criteria_provided&_single_submitter		IGF1	Growth delay due to insulin-like growth factor type 1 deficiency	AR	608747	Endocrine disorders	NBScreening	-8	Benign	BA1	rs35306040	chr12_102400131_C_CT	Female	01-Jan	Homozygous
chr12	109555449	.	AT	A	142.81	PASS	"FS=1.377;MQ=235.12;MQRankSum=-0.717;QD=1.28;ReadPosRankSum=-0.192;SOR=0.432;FractionInformativeReads=0.872;R2_5P_bias=16.404;DP=104;AF=1;AN=6;AC=4;CSQ=-|3_prime_UTR_variant|MODIFIER|MMAB|326625|Transcript|NM_052845.4|protein_coding|9/9||NM_052845.4:c.*1578del||2355|||||rs34507867||-1||deletion|EntrezGene||YES|||T|T|||||||0.2478|0.2274|0.2175|0.2232|0.2132|0.2633|0.2213|0.2508|0.2427|0.2588|0.3865|0.4138|0.3816|0.3298|0.4201|0.2447|0.371|0.4008|0.3925|0.367|0.4106|0.4201|gnomADg_ASJ|uncertain_significance||1||||||||||||-37|-5|10|43|0.00|0.00|0.00|0.00|MMAB|||||||307030||Uncertain_significance|Methylmalonic_acidemia|NC_000012.12:g.109555473del||Deletion|MMAB:326625|Human_Phenotype_Ontology:HP:0002912&Human_Phenotype_Ontology:HP:0003123&Human_Phenotype_Ontology:HP:0008295&MONDO:MONDO:0002012&MeSH:C537358&MedGen:C0268583||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:20,14:0.412:34:11,6:9,8:47:55,0,47:49.884,8.8013e-05,50:0,5,8.01:13,7,8,6:8,12,8,6	0/1:12,13:0.52:25:6,9:6,4:48:54,0,50:50,6.5492e-05,52.929:0,4,7:6,6,3,10:6,6,7,6	1/1:0,33:1:33:0,14:0,19:93:151,96,0:142.81,92.813,0:0,5,8.01:0,0,17,16:0,0,12,21	-	3_prime_UTR_variant	MODIFIER	MMAB	326625	Transcript	NM_052845.4	protein_coding	09-Sep		c.*1578del		2355					rs34507867	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	0.2478	0.2274	0.2175	0.2232	0.2132	0.2633	0.2213	0.2508	0.2427	0.2588	0.3865	0.4138	0.3816	0.3298	0.4201	0.2447	0.371	0.4008	0.3925	0.367	0.4106	0.4201	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-37	-5	10	43	0	0	0	0	MMAB			NA				307030	NA	Uncertain_significance	Methylmalonic_acidemia	NC_000012.12:g.109555473del		Deletion	MMAB:326625	Human_Phenotype_Ontology:HP:0002912&Human_Phenotype_Ontology:HP:0003123&Human_Phenotype_Ontology:HP:0008295&MONDO:MONDO:0002012&MeSH:C537358&MedGen:C0268583		criteria_provided&_single_submitter		MMAB	Methylmalonic aciduria, cblB type	AR	251110	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs34507867	chr12_109555449_AT_A	Female	0/1	Heterozygous
chr12	109556648	.	TCACACA	T	113.78	PASS	"FS=0;MQ=243.95;QD=3.79;SOR=0.859;FractionInformativeReads=0.524;MQRankSum=3.2;ReadPosRankSum=-0.38;R2_5P_bias=-13.414;DP=70;AF=0.5;AN=6;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|MMAB|326625|Transcript|NM_052845.4|protein_coding|9/9||NM_052845.4:c.*374_*379del||1151-1156|||||rs67024670||-1||deletion|EntrezGene||YES|||CACACA|CACACA|||||||0.01612|0.01116|0.008799|0.02491|0.00817|0.01076|0.02152|0.01953|0.01643|0.01217|0.005641|0.01246|0.02586|0.002249|0.0007981|0.00619|0.001574|0|0.003389|0.004021|0.002128|0.02586|gnomADg_AMI|||1|||||||||||||||||||||||||||307066||Uncertain_significance|not_provided&Methylmalonic_acidemia|NC_000012.12:g.109556650AC[19]||Microsatellite|MMAB:326625|MedGen:C3661900&Human_Phenotype_Ontology:HP:0002912&Human_Phenotype_Ontology:HP:0003123&Human_Phenotype_Ontology:HP:0008295&MONDO:MONDO:0002012&MeSH:C537358&MedGen:C0268583||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:0,.:.:11:0,.:0,.:30:85,.,.:79.537,.,.:0,.,.:0,0,6,5:0,0,3,8	0/0:6,.:.:16:4,.:2,.:45:52,.,.:50,.,.:0,.,.:5,1,3,7:3,3,8,2	1/0:0,8:0.667:12:0,4:0,4:49:118,66,50:113.78,63.781,51.283:0,2,5:0,0,5,7:0,0,7,5	-	3_prime_UTR_variant	MODIFIER	MMAB	326625	Transcript	NM_052845.4	protein_coding	09-Sep		c.*374_*379del		1151-1156					rs67024670	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	CACACA	CACACA	NA	NA			NA	NA	0.01612	0.01116	0.008799	0.02491	0.00817	0.01076	0.02152	0.01953	0.01643	0.01217	0.005641	0.01246	0.02586	0.002249	0.0007981	0.00619	0.001574	0	0.003389	0.004021	0.002128	0.02586	gnomADg_AMI			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				307066	NA	Uncertain_significance	not_provided&Methylmalonic_acidemia	NC_000012.12:g.109556650AC[19]		Microsatellite	MMAB:326625	MedGen:C3661900&Human_Phenotype_Ontology:HP:0002912&Human_Phenotype_Ontology:HP:0003123&Human_Phenotype_Ontology:HP:0008295&MONDO:MONDO:0002012&MeSH:C537358&MedGen:C0268583		criteria_provided&_multiple_submitters&_no_conflicts		MMAB	Methylmalonic aciduria, cblB type	AR	251110	Inherited disorders of metabolism	NBScreening	-5	Likely_benign	BS1_Supporting,BS2	rs67024670	chr12_109556648_TCACACA_T	Female	0/0	Other
chr12	120978819	.	C	G	134.28	PASS	"FS=0;MQ=250;QD=4.63;SOR=1.071;FractionInformativeReads=1;MQRankSum=4.551;ReadPosRankSum=3.112;R2_5P_bias=25.945;DP=98;AF=0.5;AN=6;AC=4;CSQ=G|synonymous_variant|LOW|HNF1A|6927|Transcript|NM_000545.8|protein_coding|1/10||NM_000545.8:c.51C>G|NP_000536.6:p.Leu17%3D|277|51|17|L|ctC/ctG|rs1169289&COSV57459740||1||SNV|EntrezGene||YES|||C|C||||||0.4285|0.4566|0.3411|0.4475|0.584|0.4311|0.4803|0.6297|0.4472|0.4625|0.5707|0.4301|0.3324|0.4382|0.4585|0.5786|0.3892|0.4991|0.6293|0.4561|0.4691|0.5691|0.6297|gnomADe_MID|benign/likely_benign&uncertain_significance&benign|0&1|1&1||||||||||||-29|8|40|2|0.00|0.00|0.00|0.00|HNF1A|||||||129234||Conflicting_classifications_of_pathogenicity|Maturity-onset_diabetes_of_the_young_type_3&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&Type_2_diabetes_mellitus&not_specified&not_provided|NC_000012.12:g.120978819C>G||single_nucleotide_variant|HNF1A:6927|MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:CN169374&MedGen:C3661900|Uncertain_significance(1)&Benign(9)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,29:1:29:0,15:0,14:84:172,87,0:134.28,84.277,0:0,34.77,37.77:0,0,12,17:0,0,16,13	0/1:18,12:0.4:30:12,10:6,2:46:82,0,50:47.375,0.00010122,53:0,34.77,37.77:10,8,2,10:14,4,4,8	0/1:14,25:0.641:39:10,10:4,15:45:85,0,43:50,0.00014807,46.176:0,34.77,37.77:7,7,13,12:5,9,14,11	G	synonymous_variant	LOW	HNF1A	6927	Transcript	NM_000545.8	protein_coding	10-Jan		c.51C>G	p.Leu17%3D	277	51	17	L	ctC/ctG	rs1169289&COSV57459740	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.4285	0.4566	0.3411	0.4475	0.584	0.4311	0.4803	0.6297	0.4472	0.4625	0.5707	0.4301	0.3324	0.4382	0.4585	0.5786	0.3892	0.4991	0.6293	0.4561	0.4691	0.5691	0.6297	gnomADe_MID	benign/likely_benign&uncertain_significance&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-29	8	40	2	0	0	0	0	HNF1A			NA				129234	NA	Conflicting_classifications_of_pathogenicity	Maturity-onset_diabetes_of_the_young_type_3&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&Type_2_diabetes_mellitus&not_specified&not_provided	NC_000012.12:g.120978819C>G		single_nucleotide_variant	HNF1A:6927	MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:CN169374&MedGen:C3661900	Uncertain_significance(1)&Benign(9)&Likely_benign(1)	criteria_provided&_conflicting_classifications		HNF1A	Maturity-onset diabetes of the young type 3	AD	600496	Endocrine disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1169289	chr12_120978819_C_G	Female	01-Jan	Homozygous
chr12	120978819	.	C	G	134.28	PASS	"FS=0;MQ=250;QD=4.63;SOR=1.071;FractionInformativeReads=1;MQRankSum=4.551;ReadPosRankSum=3.112;R2_5P_bias=25.945;DP=98;AF=0.5;AN=6;AC=4;CSQ=G|synonymous_variant|LOW|HNF1A|6927|Transcript|NM_000545.8|protein_coding|1/10||NM_000545.8:c.51C>G|NP_000536.6:p.Leu17%3D|277|51|17|L|ctC/ctG|rs1169289&COSV57459740||1||SNV|EntrezGene||YES|||C|C||||||0.4285|0.4566|0.3411|0.4475|0.584|0.4311|0.4803|0.6297|0.4472|0.4625|0.5707|0.4301|0.3324|0.4382|0.4585|0.5786|0.3892|0.4991|0.6293|0.4561|0.4691|0.5691|0.6297|gnomADe_MID|benign/likely_benign&uncertain_significance&benign|0&1|1&1||||||||||||-29|8|40|2|0.00|0.00|0.00|0.00|HNF1A|||||||129234||Conflicting_classifications_of_pathogenicity|Maturity-onset_diabetes_of_the_young_type_3&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&Type_2_diabetes_mellitus&not_specified&not_provided|NC_000012.12:g.120978819C>G||single_nucleotide_variant|HNF1A:6927|MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:CN169374&MedGen:C3661900|Uncertain_significance(1)&Benign(9)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,29:1:29:0,15:0,14:84:172,87,0:134.28,84.277,0:0,34.77,37.77:0,0,12,17:0,0,16,13	0/1:18,12:0.4:30:12,10:6,2:46:82,0,50:47.375,0.00010122,53:0,34.77,37.77:10,8,2,10:14,4,4,8	0/1:14,25:0.641:39:10,10:4,15:45:85,0,43:50,0.00014807,46.176:0,34.77,37.77:7,7,13,12:5,9,14,11	G	synonymous_variant	LOW	HNF1A	6927	Transcript	NM_000545.8	protein_coding	10-Jan		c.51C>G	p.Leu17%3D	277	51	17	L	ctC/ctG	rs1169289&COSV57459740	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.4285	0.4566	0.3411	0.4475	0.584	0.4311	0.4803	0.6297	0.4472	0.4625	0.5707	0.4301	0.3324	0.4382	0.4585	0.5786	0.3892	0.4991	0.6293	0.4561	0.4691	0.5691	0.6297	gnomADe_MID	benign/likely_benign&uncertain_significance&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-29	8	40	2	0	0	0	0	HNF1A			NA				129234	NA	Conflicting_classifications_of_pathogenicity	Maturity-onset_diabetes_of_the_young_type_3&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&Type_2_diabetes_mellitus&not_specified&not_provided	NC_000012.12:g.120978819C>G		single_nucleotide_variant	HNF1A:6927	MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:CN169374&MedGen:C3661900	Uncertain_significance(1)&Benign(9)&Likely_benign(1)	criteria_provided&_conflicting_classifications		HNF1A	Hyperinsulinism due to HNF1A deficiency	AD	NA	Endocrine disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1169289	chr12_120978819_C_G	Female	01-Jan	Homozygous
chr12	120994314	.	G	C	47.06	PASS	"FS=5.29;MQ=250;MQRankSum=4.933;QD=1.24;ReadPosRankSum=1.128;SOR=1.737;FractionInformativeReads=0.921;R2_5P_bias=-10.073;DP=38;AF=0.5;AN=2;AC=1;CSQ=C|synonymous_variant|LOW|HNF1A|6927|Transcript|NM_000545.8|protein_coding|4/10||NM_000545.8:c.864G>C|NP_000536.6:p.Gly288%3D|1090|864|288|G|ggG/ggC|rs56348580&CD1413687&CM067044&COSV104568481&COSV57458899&COSV57459764&COSV57467482&CX1310026||1||SNV|EntrezGene||YES|||G|G||||||0.1811|0.2836|0.2029|0.4254|0.3119|0.001137|0.2745|0.2413|0.3053|0.2696|0.1032|0.2624|0.2065|0.2297|0.367|0.3111|0.003486|0.2655|0.2828|0.3009|0.2792|0.1005|0.4254|gnomADe_AMR|uncertain_significance&benign|0&1&1&1&1&1&1&1|1&1&1&1&1&1&1&1||||||||||||11|-40|-10|-3|0.00|0.00|0.00|0.00|HNF1A|||||||129236||Conflicting_classifications_of_pathogenicity|not_provided&Maturity-onset_diabetes_of_the_young_type_3&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&not_specified&Type_2_diabetes_mellitus|NC_000012.12:g.120994314G>C||single_nucleotide_variant|HNF1A:6927|MedGen:C3661900&MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&MedGen:CN169374&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853|Uncertain_significance(1)&Benign(10)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:21,14:0.4:35:8,6:13,8:46:82,0,50:47.059,0.00010717,53:0,34.77,37.77:11,10,4,10:10,11,8,6	./.:.:.:.:.:.:.:.:.:.:.:.	C	synonymous_variant	LOW	HNF1A	6927	Transcript	NM_000545.8	protein_coding	10-Apr		c.864G>C	p.Gly288%3D	1090	864	288	G	ggG/ggC	rs56348580&CD1413687&CM067044&COSV104568481&COSV57458899&COSV57459764&COSV57467482&CX1310026	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.1811	0.2836	0.2029	0.4254	0.3119	0.001137	0.2745	0.2413	0.3053	0.2696	0.1032	0.2624	0.2065	0.2297	0.367	0.3111	0.003486	0.2655	0.2828	0.3009	0.2792	0.1005	0.4254	gnomADe_AMR	uncertain_significance&benign	0&1&1&1&1&1&1&1	1&1&1&1&1&1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		11	-40	-10	-3	0	0	0	0	HNF1A			NA				129236	NA	Conflicting_classifications_of_pathogenicity	not_provided&Maturity-onset_diabetes_of_the_young_type_3&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&not_specified&Type_2_diabetes_mellitus	NC_000012.12:g.120994314G>C		single_nucleotide_variant	HNF1A:6927	MedGen:C3661900&MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&MedGen:CN169374&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853	Uncertain_significance(1)&Benign(10)	criteria_provided&_conflicting_classifications		HNF1A	Maturity-onset diabetes of the young type 3	AD	600496	Endocrine disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs56348580	chr12_120994314_G_C	Female	./.	Other
chr12	120994314	.	G	C	47.06	PASS	"FS=5.29;MQ=250;MQRankSum=4.933;QD=1.24;ReadPosRankSum=1.128;SOR=1.737;FractionInformativeReads=0.921;R2_5P_bias=-10.073;DP=38;AF=0.5;AN=2;AC=1;CSQ=C|synonymous_variant|LOW|HNF1A|6927|Transcript|NM_000545.8|protein_coding|4/10||NM_000545.8:c.864G>C|NP_000536.6:p.Gly288%3D|1090|864|288|G|ggG/ggC|rs56348580&CD1413687&CM067044&COSV104568481&COSV57458899&COSV57459764&COSV57467482&CX1310026||1||SNV|EntrezGene||YES|||G|G||||||0.1811|0.2836|0.2029|0.4254|0.3119|0.001137|0.2745|0.2413|0.3053|0.2696|0.1032|0.2624|0.2065|0.2297|0.367|0.3111|0.003486|0.2655|0.2828|0.3009|0.2792|0.1005|0.4254|gnomADe_AMR|uncertain_significance&benign|0&1&1&1&1&1&1&1|1&1&1&1&1&1&1&1||||||||||||11|-40|-10|-3|0.00|0.00|0.00|0.00|HNF1A|||||||129236||Conflicting_classifications_of_pathogenicity|not_provided&Maturity-onset_diabetes_of_the_young_type_3&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&not_specified&Type_2_diabetes_mellitus|NC_000012.12:g.120994314G>C||single_nucleotide_variant|HNF1A:6927|MedGen:C3661900&MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&MedGen:CN169374&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853|Uncertain_significance(1)&Benign(10)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:21,14:0.4:35:8,6:13,8:46:82,0,50:47.059,0.00010717,53:0,34.77,37.77:11,10,4,10:10,11,8,6	./.:.:.:.:.:.:.:.:.:.:.:.	C	synonymous_variant	LOW	HNF1A	6927	Transcript	NM_000545.8	protein_coding	10-Apr		c.864G>C	p.Gly288%3D	1090	864	288	G	ggG/ggC	rs56348580&CD1413687&CM067044&COSV104568481&COSV57458899&COSV57459764&COSV57467482&CX1310026	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.1811	0.2836	0.2029	0.4254	0.3119	0.001137	0.2745	0.2413	0.3053	0.2696	0.1032	0.2624	0.2065	0.2297	0.367	0.3111	0.003486	0.2655	0.2828	0.3009	0.2792	0.1005	0.4254	gnomADe_AMR	uncertain_significance&benign	0&1&1&1&1&1&1&1	1&1&1&1&1&1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		11	-40	-10	-3	0	0	0	0	HNF1A			NA				129236	NA	Conflicting_classifications_of_pathogenicity	not_provided&Maturity-onset_diabetes_of_the_young_type_3&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&not_specified&Type_2_diabetes_mellitus	NC_000012.12:g.120994314G>C		single_nucleotide_variant	HNF1A:6927	MedGen:C3661900&MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&MedGen:CN169374&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853	Uncertain_significance(1)&Benign(10)	criteria_provided&_conflicting_classifications		HNF1A	Hyperinsulinism due to HNF1A deficiency	AD	NA	Endocrine disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs56348580	chr12_120994314_G_C	Female	./.	Other
chr12	120997672	.	G	A	131.28	PASS	"FS=0;MQ=250;QD=4.69;SOR=2.468;FractionInformativeReads=1;MQRankSum=5.264;ReadPosRankSum=0.203;R2_5P_bias=6.472;DP=110;AF=0.5;AN=6;AC=4;CSQ=A|splice_region_variant&intron_variant|LOW|HNF1A|6927|Transcript|NM_000545.8|protein_coding||7/9|NM_000545.8:c.1501+7G>A|||||||rs2464195&COSV99982163||1||SNV|EntrezGene||YES|||G|G||||||0.3596|0.3682|0.1357|0.4026|0.5062|0.5242|0.3648|0.553|0.3524|0.3779|0.5169|0.3174|0.1444|0.3786|0.3918|0.5026|0.4905|0.3844|0.5748|0.3557|0.3706|0.5133|0.5748|gnomADg_MID|benign&uncertain_significance|0&1|1&1|1.42005417025298E-5|0.002||||||||||2|18|-7|35|0.00|0.00|0.00|0.03|HNF1A|||||||129231||Conflicting_classifications_of_pathogenicity|Maturity-onset_diabetes_of_the_young_type_3&not_specified&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&Type_2_diabetes_mellitus&not_provided|NC_000012.12:g.120997672G>A||single_nucleotide_variant|HNF1A:6927|MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&MedGen:CN169374&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:C3661900|Uncertain_significance(1)&Benign(9)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,28:1:28:0,14:0,14:81:169,84,0:131.28,81.276,0:0,34.77,37.77:0,0,6,22:0,0,18,10	0/1:15,26:0.634:41:8,17:7,9:45:85,0,43:50,0.00014729,46.21:0,34.77,37.77:11,4,15,11:8,7,10,16	0/1:13,27:0.675:40:4,15:9,12:42:85,0,39:50,0.00029563,42.36:0,34.77,37.77:6,7,7,20:7,6,13,14	A	splice_region_variant&intron_variant	LOW	HNF1A	6927	Transcript	NM_000545.8	protein_coding		09-Jul	c.1501+7G>A							rs2464195&COSV99982163	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.3596	0.3682	0.1357	0.4026	0.5062	0.5242	0.3648	0.553	0.3524	0.3779	0.5169	0.3174	0.1444	0.3786	0.3918	0.5026	0.4905	0.3844	0.5748	0.3557	0.3706	0.5133	0.5748	gnomADg_MID	benign&uncertain_significance	0&1	1&1	1.42005417025298e-05	0.002	NA		NA	NA		NA	NA	NA		2	18	-7	35	0	0	0	0.03	HNF1A			NA				129231	NA	Conflicting_classifications_of_pathogenicity	Maturity-onset_diabetes_of_the_young_type_3&not_specified&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&Type_2_diabetes_mellitus&not_provided	NC_000012.12:g.120997672G>A		single_nucleotide_variant	HNF1A:6927	MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&MedGen:CN169374&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:C3661900	Uncertain_significance(1)&Benign(9)	criteria_provided&_conflicting_classifications		HNF1A	Maturity-onset diabetes of the young type 3	AD	600496	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs2464195	chr12_120997672_G_A	Female	01-Jan	Homozygous
chr12	120997672	.	G	A	131.28	PASS	"FS=0;MQ=250;QD=4.69;SOR=2.468;FractionInformativeReads=1;MQRankSum=5.264;ReadPosRankSum=0.203;R2_5P_bias=6.472;DP=110;AF=0.5;AN=6;AC=4;CSQ=A|splice_region_variant&intron_variant|LOW|HNF1A|6927|Transcript|NM_000545.8|protein_coding||7/9|NM_000545.8:c.1501+7G>A|||||||rs2464195&COSV99982163||1||SNV|EntrezGene||YES|||G|G||||||0.3596|0.3682|0.1357|0.4026|0.5062|0.5242|0.3648|0.553|0.3524|0.3779|0.5169|0.3174|0.1444|0.3786|0.3918|0.5026|0.4905|0.3844|0.5748|0.3557|0.3706|0.5133|0.5748|gnomADg_MID|benign&uncertain_significance|0&1|1&1|1.42005417025298E-5|0.002||||||||||2|18|-7|35|0.00|0.00|0.00|0.03|HNF1A|||||||129231||Conflicting_classifications_of_pathogenicity|Maturity-onset_diabetes_of_the_young_type_3&not_specified&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&Type_2_diabetes_mellitus&not_provided|NC_000012.12:g.120997672G>A||single_nucleotide_variant|HNF1A:6927|MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&MedGen:CN169374&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:C3661900|Uncertain_significance(1)&Benign(9)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,28:1:28:0,14:0,14:81:169,84,0:131.28,81.276,0:0,34.77,37.77:0,0,6,22:0,0,18,10	0/1:15,26:0.634:41:8,17:7,9:45:85,0,43:50,0.00014729,46.21:0,34.77,37.77:11,4,15,11:8,7,10,16	0/1:13,27:0.675:40:4,15:9,12:42:85,0,39:50,0.00029563,42.36:0,34.77,37.77:6,7,7,20:7,6,13,14	A	splice_region_variant&intron_variant	LOW	HNF1A	6927	Transcript	NM_000545.8	protein_coding		09-Jul	c.1501+7G>A							rs2464195&COSV99982163	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.3596	0.3682	0.1357	0.4026	0.5062	0.5242	0.3648	0.553	0.3524	0.3779	0.5169	0.3174	0.1444	0.3786	0.3918	0.5026	0.4905	0.3844	0.5748	0.3557	0.3706	0.5133	0.5748	gnomADg_MID	benign&uncertain_significance	0&1	1&1	1.42005417025298e-05	0.002	NA		NA	NA		NA	NA	NA		2	18	-7	35	0	0	0	0.03	HNF1A			NA				129231	NA	Conflicting_classifications_of_pathogenicity	Maturity-onset_diabetes_of_the_young_type_3&not_specified&Maturity_onset_diabetes_mellitus_in_young&Nonpapillary_renal_cell_carcinoma&Type_2_diabetes_mellitus&not_provided	NC_000012.12:g.120997672G>A		single_nucleotide_variant	HNF1A:6927	MONDO:MONDO:0010894&MedGen:C1838100&OMIM:600496&Orphanet:552&MedGen:CN169374&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:C3661900	Uncertain_significance(1)&Benign(9)	criteria_provided&_conflicting_classifications		HNF1A	Hyperinsulinism due to HNF1A deficiency	AD	NA	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs2464195	chr12_120997672_G_A	Female	01-Jan	Homozygous
chr13	23354532	.	C	T	50	PASS	"FS=0;MQ=250;MQRankSum=4.427;QD=1.67;ReadPosRankSum=3.079;SOR=0.741;FractionInformativeReads=0.967;R2_5P_bias=8.4;DP=30;AF=0.5;AN=2;AC=1;CSQ=T|missense_variant|MODERATE|SACS|26278|Transcript|NM_014363.6|protein_coding|8/10||NM_014363.6:c.2080G>A|NP_055178.3:p.Ala694Thr|2669|2080|694|A/T|Gca/Aca|rs17325713&COSV99063575||-1||SNV|EntrezGene||YES|||C|C|||deleterious(0.01)|benign(0)||0.0082|0.03217|0.004391|0.008944|0.0101|7.557e-05|0.04641|0.003645|0.03722|0.0268|0.008278|0.02443|0.005777|0.002198|0.01649|0.01354|0.0001928|0.04341|0.003401|0.03903|0.01373|0.006841|0.04641|gnomADe_FIN|benign|0&1|1&1||||T|0.00254|-0.559848|T|0.17966|-0.543379|0.24469|0.084&.&0.084|-4|26|-13|-17|0.00|0.00|0.02|0.00|SACS|likely_benign|hg38|0.0706|A694T|ENST00000382292.9|Q9NZJ4|240895||Conflicting_classifications_of_pathogenicity|Charlevoix-Saguenay_spastic_ataxia&not_specified&Spastic_paraplegia&not_provided&Hereditary_spastic_paraplegia|NC_000013.11:g.23354532C>T||single_nucleotide_variant|SACS:26278|MONDO:MONDO:0010041&MedGen:C1849140&OMIM:270550&Orphanet:98&MedGen:CN169374&Human_Phenotype_Ontology:HP:0001258&Human_Phenotype_Ontology:HP:0007062&Human_Phenotype_Ontology:HP:0007124&Human_Phenotype_Ontology:HP:0007216&MedGen:C0037772&MedGen:C3661900&MONDO:MONDO:0019064&MedGen:C0037773&OMIM:PS303350&Orphanet:685|Likely_pathogenic(1)&Benign(8)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,18:0.621:29:6,11:5,7:47:85,0,47:50,9.0602e-05,49.642:0,34.77,37.77:6,5,10,8:3,8,9,9	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	SACS	26278	Transcript	NM_014363.6	protein_coding	10-Aug		c.2080G>A	p.Ala694Thr	2669	2080	694	A/T	Gca/Aca	rs17325713&COSV99063575	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious(0.01)	benign(0)	NA	0.0082	0.03217	0.004391	0.008944	0.0101	7.557e-05	0.04641	0.003645	0.03722	0.0268	0.008278	0.02443	0.005777	0.002198	0.01649	0.01354	0.0001928	0.04341	0.003401	0.03903	0.01373	0.006841	0.04641	gnomADe_FIN	benign	0&1	1&1	NA	NA	NA	T	0.00254	-0.559848	T	0.17966	-0.543379	0.24469	0.084&.&0.084	-4	26	-13	-17	0	0	0.02	0	SACS	likely_benign	hg38	0.0706	A694T	ENST00000382292.9	Q9NZJ4	240895	NA	Conflicting_classifications_of_pathogenicity	Charlevoix-Saguenay_spastic_ataxia&not_specified&Spastic_paraplegia&not_provided&Hereditary_spastic_paraplegia	NC_000013.11:g.23354532C>T		single_nucleotide_variant	SACS:26278	MONDO:MONDO:0010041&MedGen:C1849140&OMIM:270550&Orphanet:98&MedGen:CN169374&Human_Phenotype_Ontology:HP:0001258&Human_Phenotype_Ontology:HP:0007062&Human_Phenotype_Ontology:HP:0007124&Human_Phenotype_Ontology:HP:0007216&MedGen:C0037772&MedGen:C3661900&MONDO:MONDO:0019064&MedGen:C0037773&OMIM:PS303350&Orphanet:685	Likely_pathogenic(1)&Benign(8)	criteria_provided&_conflicting_classifications		SACS	Charlevoix-Saguenay spastic ataxia	AR	270550	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-20	Benign	BP4_Strong,BP6_Very_Strong,BS1,BS2	rs17325713	chr13_23354532_C_T	Female	./.	Other
chr13	23433644	.	C	T	50	PASS	"FS=3.799;MQ=250;MQRankSum=4.181;QD=1.79;ReadPosRankSum=2.509;SOR=0.223;FractionInformativeReads=1;R2_5P_bias=15.381;DP=28;AF=0.5;AN=2;AC=1;CSQ=T|5_prime_UTR_variant|MODIFIER|SACS|26278|Transcript|NM_014363.6|protein_coding|1/10||NM_014363.6:c.-531G>A||59|||||rs73154650||-1||SNV|EntrezGene||YES|||C|C||||||0.0300|0.02857|0|0|0.25|0|0|0|0.02778|0|0|0.02987|0.03367|0.05482|0.02529|0.0629|0.02449|0.007533|0.09184|0.02874|0.03733|0.04722|0.25|gnomADe_ASJ|uncertain_significance||1||||||||||||-24|-48|-29|-40|0.00|0.00|0.00|0.00|SACS|||||||311583||Uncertain_significance|Charlevoix-Saguenay_spastic_ataxia&not_provided|NC_000013.11:g.23433644C>T||single_nucleotide_variant|SACS:26278|MONDO:MONDO:0010041&MedGen:C1849140&OMIM:270550&Orphanet:98&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:9,19:0.679:28:5,8:4,11:44:85,0,43:50,0.00016464,45.54:0,34.77,37.77:7,2,11,8:3,6,4,15	./.:.:.:.:.:.:.:.:.:.:.:.	T	5_prime_UTR_variant	MODIFIER	SACS	26278	Transcript	NM_014363.6	protein_coding	10-Jan		c.-531G>A		59					rs73154650	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.03	0.02857	0	0	0.25	0	0	0	0.02778	0	0	0.02987	0.03367	0.05482	0.02529	0.0629	0.02449	0.007533	0.09184	0.02874	0.03733	0.04722	0.25	gnomADe_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-24	-48	-29	-40	0	0	0	0	SACS			NA				311583	NA	Uncertain_significance	Charlevoix-Saguenay_spastic_ataxia&not_provided	NC_000013.11:g.23433644C>T		single_nucleotide_variant	SACS:26278	MONDO:MONDO:0010041&MedGen:C1849140&OMIM:270550&Orphanet:98&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		SACS	Charlevoix-Saguenay spastic ataxia	AR	270550	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-9	Benign	BP4_Strong,BS1_Supporting,BS2	rs73154650	chr13_23433644_C_T	Female	./.	Other
chr13	36819427	.	C	G	50	PASS	"FS=0;MQ=249.53;MQRankSum=4.603;QD=1.61;ReadPosRankSum=3.346;SOR=0.793;FractionInformativeReads=1;R2_5P_bias=-18.337;DP=31;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|RFXAP|5994|Transcript|NM_000538.4|protein_coding|1/3||NM_000538.4:c.70C>G|NP_000529.1:p.Leu24Val|206|70|24|L/V|Cta/Gta|rs537036389||1||SNV|EntrezGene||YES|||C|C|||tolerated_low_confidence(0.19)|benign(0)|||7.013e-06|0|0|0|0.0002661|0|0|0|1.89e-05|0||||||||||||0.0002661|gnomADe_EAS|uncertain_significance||1||||T|0.32118|-0.12616|T|0.31189|-0.418997|0.11924|0.044|46|34|38|-19|0.00|0.00|0.00|0.00|RFXAP|likely_benign|hg38|0.0598|L24V|ENST00000255476.2|O00287|2592097||Uncertain_significance|not_specified|NC_000013.11:g.36819427C>G||single_nucleotide_variant|RFXAP:5994&LOC130009573:130009573|MedGen:CN169374||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:12,19:0.613:31:7,10:5,9:47:85,0,46:50,9.4485e-05,49.296:0,34.77,37.77:6,6,10,9:7,5,15,4	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	RFXAP	5994	Transcript	NM_000538.4	protein_coding	03-Jan		c.70C>G	p.Leu24Val	206	70	24	L/V	Cta/Gta	rs537036389	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated_low_confidence(0.19)	benign(0)	NA	NA	7.013e-06	0	0	0	0.0002661	0	0	0	1.89e-05	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0002661	gnomADe_EAS	uncertain_significance		1	NA	NA	NA	T	0.32118	-0.12616	T	0.31189	-0.418997	0.11924	0.044	46	34	38	-19	0	0	0	0	RFXAP	likely_benign	hg38	0.0598	L24V	ENST00000255476.2	O00287	2592097	NA	Uncertain_significance	not_specified	NC_000013.11:g.36819427C>G		single_nucleotide_variant	RFXAP:5994&LOC130009573:130009573	MedGen:CN169374		criteria_provided&_single_submitter		RFXAP	Bare lymphocyte syndrome, type ll, complementation group D	AR	620818	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-4	Likely_benign	BP4_Strong	rs537036389	chr13_36819427_C_G	Female	./.	Other
chr13	36819427	.	C	G	50	PASS	"FS=0;MQ=249.53;MQRankSum=4.603;QD=1.61;ReadPosRankSum=3.346;SOR=0.793;FractionInformativeReads=1;R2_5P_bias=-18.337;DP=31;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|RFXAP|5994|Transcript|NM_000538.4|protein_coding|1/3||NM_000538.4:c.70C>G|NP_000529.1:p.Leu24Val|206|70|24|L/V|Cta/Gta|rs537036389||1||SNV|EntrezGene||YES|||C|C|||tolerated_low_confidence(0.19)|benign(0)|||7.013e-06|0|0|0|0.0002661|0|0|0|1.89e-05|0||||||||||||0.0002661|gnomADe_EAS|uncertain_significance||1||||T|0.32118|-0.12616|T|0.31189|-0.418997|0.11924|0.044|46|34|38|-19|0.00|0.00|0.00|0.00|RFXAP|likely_benign|hg38|0.0598|L24V|ENST00000255476.2|O00287|2592097||Uncertain_significance|not_specified|NC_000013.11:g.36819427C>G||single_nucleotide_variant|RFXAP:5994&LOC130009573:130009573|MedGen:CN169374||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:12,19:0.613:31:7,10:5,9:47:85,0,46:50,9.4485e-05,49.296:0,34.77,37.77:6,6,10,9:7,5,15,4	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	RFXAP	5994	Transcript	NM_000538.4	protein_coding	03-Jan		c.70C>G	p.Leu24Val	206	70	24	L/V	Cta/Gta	rs537036389	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated_low_confidence(0.19)	benign(0)	NA	NA	7.013e-06	0	0	0	0.0002661	0	0	0	1.89e-05	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0002661	gnomADe_EAS	uncertain_significance		1	NA	NA	NA	T	0.32118	-0.12616	T	0.31189	-0.418997	0.11924	0.044	46	34	38	-19	0	0	0	0	RFXAP	likely_benign	hg38	0.0598	L24V	ENST00000255476.2	O00287	2592097	NA	Uncertain_significance	not_specified	NC_000013.11:g.36819427C>G		single_nucleotide_variant	RFXAP:5994&LOC130009573:130009573	MedGen:CN169374		criteria_provided&_single_submitter		RFXAP	Bare lymphocyte syndrome, type II, complementation group D	AR	620815	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-4	Likely_benign	BP4_Strong	rs537036389	chr13_36819427_C_G	Female	./.	Other
chr13	36845114	.	GTA	G	50	PASS	"FS=1.585;MQ=232.47;MQRankSum=2.989;QD=1.29;ReadPosRankSum=0.876;SOR=1.179;FractionInformativeReads=0.806;R2_5P_bias=5.593;DP=82;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|SMAD9|4093|Transcript|NM_001127217.3|protein_coding|7/7||NM_001127217.3:c.*3560_*3561del||5273-5274|||||rs71084449||-1||deletion|EntrezGene||YES|||TA|TA|||||||||||||||||0.3329|0.1824|0.2932|0.3534|0.2636|0.1937|0.4939|0.2045|0.3635|0.3086|0.218|0.4939|gnomADg_FIN|||1||||||||||||23|-16|21|25|0.00|0.00|0.00|0.00|SMAD9|||||||311823||Uncertain_significance|Pulmonary_hypertension&_primary&_1&not_provided|NC_000013.11:g.36845115TA[9]||Microsatellite|SMAD9:4093|MONDO:MONDO:0024533&MedGen:C4552070&OMIM:178600&Orphanet:422&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,11:0.379:29:9,9:9,2:45:53,0,50:46.303,0.00012348,53:0,7,10:7,11,3,8:8,10,5,6	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,20:0.571:35:12,11:3,9:48:57,0,49:50,7.3776e-05,51.544:0,7,10:9,6,11,9:12,3,12,8	-	3_prime_UTR_variant	MODIFIER	SMAD9	4093	Transcript	NM_001127217.3	protein_coding	07-Jul		c.*3560_*3561del		5273-5274					rs71084449	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	TA	TA	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.3329	0.1824	0.2932	0.3534	0.2636	0.1937	0.4939	0.2045	0.3635	0.3086	0.218	0.4939	gnomADg_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		23	-16	21	25	0	0	0	0	SMAD9			NA				311823	NA	Uncertain_significance	Pulmonary_hypertension&_primary&_1&not_provided	NC_000013.11:g.36845115TA[9]		Microsatellite	SMAD9:4093	MONDO:MONDO:0024533&MedGen:C4552070&OMIM:178600&Orphanet:422&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		SMAD9	Pulmonary hypertension, primary, 2	AD	615342	Respiratory system disorders	NBScreening	-8	Benign	BA1	rs71084449	chr13_36845114_GTA_G	Female	0/1	Heterozygous
chr13	36846473	.	CAA	C	113.62	PASS	"FS=0;MQ=234.22;QD=4.61;SOR=2.093;FractionInformativeReads=0.87;MQRankSum=0.867;ReadPosRankSum=1.609;R2_5P_bias=0;DP=77;AF=1;AN=6;AC=6;CSQ=-|3_prime_UTR_variant|MODIFIER|SMAD9|4093|Transcript|NM_001127217.3|protein_coding|7/7||NM_001127217.3:c.*2201_*2202del||3914-3915|||||rs10579121||-1||deletion|EntrezGene||YES|||AA|AA|||||||0|||||||0|||0.437|0.2879|0.5141|0.5425|0.3983|0.4112|0.5479|0.4051|0.4957|0.4314|0.4389|0.5479|gnomADg_FIN|uncertain_significance||1||||||||||||-10|-4|-4|29|0.00|0.01|0.00|0.00|SMAD9|||||||311845||Uncertain_significance|Pulmonary_hypertension&_primary&_1|NC_000013.11:g.36846495_36846496del||Deletion|SMAD9:4093|MONDO:MONDO:0024533&MedGen:C4552070&OMIM:178600&Orphanet:422||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,20:1:20:0,10:0,10:56:114,59,0:106.12,56.124,1.0613e-05:0,5,8.01:0,0,15,5:0,0,11,9	1/1:1,27:0.964:28:0,10:1,17:64:122,67,0:113.62,63.622,1.812e-06:0,5,8.01:0,1,21,6:1,0,14,13	1/1:0,21:1:21:0,10:0,11:59:116,62,0:109.4,59.4,4.9183e-06:0,4,7:0,0,13,8:0,0,10,11	-	3_prime_UTR_variant	MODIFIER	SMAD9	4093	Transcript	NM_001127217.3	protein_coding	07-Jul		c.*2201_*2202del		3914-3915					rs10579121	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	AA	AA	NA	NA			NA	NA	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.437	0.2879	0.5141	0.5425	0.3983	0.4112	0.5479	0.4051	0.4957	0.4314	0.4389	0.5479	gnomADg_FIN	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-10	-4	-4	29	0	0.01	0	0	SMAD9			NA				311845	NA	Uncertain_significance	Pulmonary_hypertension&_primary&_1	NC_000013.11:g.36846495_36846496del		Deletion	SMAD9:4093	MONDO:MONDO:0024533&MedGen:C4552070&OMIM:178600&Orphanet:422		criteria_provided&_single_submitter		SMAD9	Pulmonary hypertension, primary, 2	AD	615342	Respiratory system disorders	NBScreening	0	Uncertain_significance		rs10579121	chr13_36846473_CAA_C	Female	01-Jan	Homozygous
chr13	36920187	.	AGCGGCG	A	101.3	PASS	"FS=0;MQ=250;QD=4.69;SOR=1.061;FractionInformativeReads=0.81;MQRankSum=3.873;ReadPosRankSum=1.269;R2_5P_bias=37.067;DP=71;AF=1;AN=6;AC=5;CSQ=-|5_prime_UTR_variant|MODIFIER|SMAD9|4093|Transcript|NM_001127217.3|protein_coding|1/7||NM_001127217.3:c.-264_-259del||46-51|||||rs770040180||-1||deletion|EntrezGene||YES|||GCGGCG|GCGGCG|||||||0.5419|0.3049|0.3415|0.4375|0.2447|0.5746|0.5862|0.566|0.5|0.5459|0.595|0.3853|0.7042|0.6052|0.6136|0.3938|0.7262|0.6202|0.6997|0.6002|0.6137|0.7262|gnomADg_FIN|||1|||||||||||||||||||||||||||311920||Uncertain_significance|Pulmonary_hypertension&_primary&_1&not_provided|NC_000013.11:g.36920190GGC[7]||Microsatellite|SMAD9:4093&LOC130009576:130009576|MONDO:MONDO:0024533&MedGen:C4552070&OMIM:178600&Orphanet:422&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,17:1:17:0,6:0,11:48:108,51,0:98.391,48.391,6.2903e-05:0,7,10:0,0,7,10:0,0,10,7	0/1:13,9:0.409:22:4,5:9,4:47:55,0,50:48.479,8.3354e-05,53:0,7,10:5,8,7,2:8,5,7,2	1/1:0,18:1:18:0,9:0,9:51:111,54,0:101.3,51.303,3.2099e-05:0,7,10:0,0,11,7:0,0,12,6	-	5_prime_UTR_variant	MODIFIER	SMAD9	4093	Transcript	NM_001127217.3	protein_coding	07-Jan		c.-264_-259del		46-51					rs770040180	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	GCGGCG	GCGGCG	NA	NA			NA	NA	0.5419	0.3049	0.3415	0.4375	0.2447	0.5746	0.5862	0.566	0.5	0.5459	0.595	0.3853	0.7042	0.6052	0.6136	0.3938	0.7262	0.6202	0.6997	0.6002	0.6137	0.7262	gnomADg_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				311920	NA	Uncertain_significance	Pulmonary_hypertension&_primary&_1&not_provided	NC_000013.11:g.36920190GGC[7]		Microsatellite	SMAD9:4093&LOC130009576:130009576	MONDO:MONDO:0024533&MedGen:C4552070&OMIM:178600&Orphanet:422&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		SMAD9	Pulmonary hypertension, primary, 2	AD	615342	Respiratory system disorders	NBScreening	-8	Benign	BA1	rs770040180	chr13_36920187_AGCGGCG_A	Female	01-Jan	Homozygous
chr14	23415801	.	C	T	48.97	PASS	"FS=0;MQ=202.55;MQRankSum=-0.182;QD=1.48;ReadPosRankSum=3.914;SOR=0.801;FractionInformativeReads=1;R2_5P_bias=-5.004;DP=65;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|MYH7|4625|Transcript|NM_000257.4|protein_coding|35/40||NM_000257.4:c.4985G>A|NP_000248.2:p.Arg1662His|5090|4985|1662|R/H|cGt/cAt|rs370328209&CM115875&CM146976&COSV62520651||-1||SNV|EntrezGene||YES|||C|C|||deleterious_low_confidence(0.03)|benign(0.012)|||3.078e-05|0|4.472e-05|0.0001148|5.038e-05|0|0.0001734|2.428e-05|8.279e-05|5.797e-05|4.599e-05|4.824e-05|0|0|0.0002882|0|0|0|5.879e-05|0|0|0.0002882|gnomADg_ASJ|uncertain_significance&conflicting_interpretations_of_pathogenicity|0&1&1&1|1&1&1&1||||T|0.47623|-0.0285781|T|0.63940|-0.0929231|0.80782|0.540|22|3|-19|5|0.00|0.00|0.00|0.00|MYH7|likely_benign|hg38|0.0731|R1662H|ENST00000355349.4|P12883|43049||Conflicting_classifications_of_pathogenicity|Primary_dilated_cardiomyopathy&not_specified&Cardiovascular_phenotype&not_provided&Hypertrophic_cardiomyopathy&Cardiomyopathy|NC_000014.9:g.23415801C>T||single_nucleotide_variant|MYH7:4625&MHRT:104564225&LOC126861897:126861897|EFO:EFO_0000407&Human_Phenotype_Ontology:HP:0001644&Human_Phenotype_Ontology:HP:0001725&Human_Phenotype_Ontology:HP:0005159&Human_Phenotype_Ontology:HP:0200130&MONDO:MONDO:0005021&MeSH:D002311&MedGen:C0007193&Orphanet:217604&MedGen:CN169374&MedGen:CN230736&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848|Uncertain_significance(8)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,12:0.387:31:11,7:8,5:45:81,0,50:45.794,0.00013616,53:0,34.77,37.77:7,12,4,8:7,12,5,7	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,15:0.441:34:12,6:7,9:48:84,0,50:48.974,7.6623e-05,53:0,34.77,37.77:8,11,8,7:7,12,7,8	T	missense_variant	MODERATE	MYH7	4625	Transcript	NM_000257.4	protein_coding	35/40		c.4985G>A	p.Arg1662His	5090	4985	1662	R/H	cGt/cAt	rs370328209&CM115875&CM146976&COSV62520651	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious_low_confidence(0.03)	benign(0.012)	NA	NA	3.078e-05	0	4.472e-05	0.0001148	5.038e-05	0	0.0001734	2.428e-05	8.279e-05	5.797e-05	4.599e-05	4.824e-05	0	0	0.0002882	0	0	0	5.879e-05	0	0	0.0002882	gnomADg_ASJ	uncertain_significance&conflicting_interpretations_of_pathogenicity	0&1&1&1	1&1&1&1	NA	NA	NA	T	0.47623	-0.0285781	T	0.6394	-0.0929231	0.80782	0.540	22	3	-19	5	0	0	0	0	MYH7	likely_benign	hg38	0.0731	R1662H	ENST00000355349.4	P12883	43049	NA	Conflicting_classifications_of_pathogenicity	Primary_dilated_cardiomyopathy&not_specified&Cardiovascular_phenotype&not_provided&Hypertrophic_cardiomyopathy&Cardiomyopathy	NC_000014.9:g.23415801C>T		single_nucleotide_variant	MYH7:4625&MHRT:104564225&LOC126861897:126861897	EFO:EFO_0000407&Human_Phenotype_Ontology:HP:0001644&Human_Phenotype_Ontology:HP:0001725&Human_Phenotype_Ontology:HP:0005159&Human_Phenotype_Ontology:HP:0200130&MONDO:MONDO:0005021&MeSH:D002311&MedGen:C0007193&Orphanet:217604&MedGen:CN169374&MedGen:CN230736&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848	Uncertain_significance(8)&Likely_benign(1)	criteria_provided&_conflicting_classifications		MYH7	Myosin storage myopathy	AD	608358	Cardiac and vascular disorders	NBScreening	2	Uncertain_significance	PP2,PP3	rs370328209	chr14_23415801_C_T	Female	0/1	Heterozygous
chr14	23415801	.	C	T	48.97	PASS	"FS=0;MQ=202.55;MQRankSum=-0.182;QD=1.48;ReadPosRankSum=3.914;SOR=0.801;FractionInformativeReads=1;R2_5P_bias=-5.004;DP=65;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|MYH7|4625|Transcript|NM_000257.4|protein_coding|35/40||NM_000257.4:c.4985G>A|NP_000248.2:p.Arg1662His|5090|4985|1662|R/H|cGt/cAt|rs370328209&CM115875&CM146976&COSV62520651||-1||SNV|EntrezGene||YES|||C|C|||deleterious_low_confidence(0.03)|benign(0.012)|||3.078e-05|0|4.472e-05|0.0001148|5.038e-05|0|0.0001734|2.428e-05|8.279e-05|5.797e-05|4.599e-05|4.824e-05|0|0|0.0002882|0|0|0|5.879e-05|0|0|0.0002882|gnomADg_ASJ|uncertain_significance&conflicting_interpretations_of_pathogenicity|0&1&1&1|1&1&1&1||||T|0.47623|-0.0285781|T|0.63940|-0.0929231|0.80782|0.540|22|3|-19|5|0.00|0.00|0.00|0.00|MYH7|likely_benign|hg38|0.0731|R1662H|ENST00000355349.4|P12883|43049||Conflicting_classifications_of_pathogenicity|Primary_dilated_cardiomyopathy&not_specified&Cardiovascular_phenotype&not_provided&Hypertrophic_cardiomyopathy&Cardiomyopathy|NC_000014.9:g.23415801C>T||single_nucleotide_variant|MYH7:4625&MHRT:104564225&LOC126861897:126861897|EFO:EFO_0000407&Human_Phenotype_Ontology:HP:0001644&Human_Phenotype_Ontology:HP:0001725&Human_Phenotype_Ontology:HP:0005159&Human_Phenotype_Ontology:HP:0200130&MONDO:MONDO:0005021&MeSH:D002311&MedGen:C0007193&Orphanet:217604&MedGen:CN169374&MedGen:CN230736&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848|Uncertain_significance(8)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,12:0.387:31:11,7:8,5:45:81,0,50:45.794,0.00013616,53:0,34.77,37.77:7,12,4,8:7,12,5,7	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,15:0.441:34:12,6:7,9:48:84,0,50:48.974,7.6623e-05,53:0,34.77,37.77:8,11,8,7:7,12,7,8	T	missense_variant	MODERATE	MYH7	4625	Transcript	NM_000257.4	protein_coding	35/40		c.4985G>A	p.Arg1662His	5090	4985	1662	R/H	cGt/cAt	rs370328209&CM115875&CM146976&COSV62520651	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious_low_confidence(0.03)	benign(0.012)	NA	NA	3.078e-05	0	4.472e-05	0.0001148	5.038e-05	0	0.0001734	2.428e-05	8.279e-05	5.797e-05	4.599e-05	4.824e-05	0	0	0.0002882	0	0	0	5.879e-05	0	0	0.0002882	gnomADg_ASJ	uncertain_significance&conflicting_interpretations_of_pathogenicity	0&1&1&1	1&1&1&1	NA	NA	NA	T	0.47623	-0.0285781	T	0.6394	-0.0929231	0.80782	0.540	22	3	-19	5	0	0	0	0	MYH7	likely_benign	hg38	0.0731	R1662H	ENST00000355349.4	P12883	43049	NA	Conflicting_classifications_of_pathogenicity	Primary_dilated_cardiomyopathy&not_specified&Cardiovascular_phenotype&not_provided&Hypertrophic_cardiomyopathy&Cardiomyopathy	NC_000014.9:g.23415801C>T		single_nucleotide_variant	MYH7:4625&MHRT:104564225&LOC126861897:126861897	EFO:EFO_0000407&Human_Phenotype_Ontology:HP:0001644&Human_Phenotype_Ontology:HP:0001725&Human_Phenotype_Ontology:HP:0005159&Human_Phenotype_Ontology:HP:0200130&MONDO:MONDO:0005021&MeSH:D002311&MedGen:C0007193&Orphanet:217604&MedGen:CN169374&MedGen:CN230736&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848	Uncertain_significance(8)&Likely_benign(1)	criteria_provided&_conflicting_classifications		MYH7	Hypertrophic cardiomyopathy 1	AD	192600	Cardiac and vascular disorders	NBScreening	2	Uncertain_significance	PP2,PP3	rs370328209	chr14_23415801_C_T	Female	0/1	Heterozygous
chr14	23415801	.	C	T	48.97	PASS	"FS=0;MQ=202.55;MQRankSum=-0.182;QD=1.48;ReadPosRankSum=3.914;SOR=0.801;FractionInformativeReads=1;R2_5P_bias=-5.004;DP=65;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|MYH7|4625|Transcript|NM_000257.4|protein_coding|35/40||NM_000257.4:c.4985G>A|NP_000248.2:p.Arg1662His|5090|4985|1662|R/H|cGt/cAt|rs370328209&CM115875&CM146976&COSV62520651||-1||SNV|EntrezGene||YES|||C|C|||deleterious_low_confidence(0.03)|benign(0.012)|||3.078e-05|0|4.472e-05|0.0001148|5.038e-05|0|0.0001734|2.428e-05|8.279e-05|5.797e-05|4.599e-05|4.824e-05|0|0|0.0002882|0|0|0|5.879e-05|0|0|0.0002882|gnomADg_ASJ|uncertain_significance&conflicting_interpretations_of_pathogenicity|0&1&1&1|1&1&1&1||||T|0.47623|-0.0285781|T|0.63940|-0.0929231|0.80782|0.540|22|3|-19|5|0.00|0.00|0.00|0.00|MYH7|likely_benign|hg38|0.0731|R1662H|ENST00000355349.4|P12883|43049||Conflicting_classifications_of_pathogenicity|Primary_dilated_cardiomyopathy&not_specified&Cardiovascular_phenotype&not_provided&Hypertrophic_cardiomyopathy&Cardiomyopathy|NC_000014.9:g.23415801C>T||single_nucleotide_variant|MYH7:4625&MHRT:104564225&LOC126861897:126861897|EFO:EFO_0000407&Human_Phenotype_Ontology:HP:0001644&Human_Phenotype_Ontology:HP:0001725&Human_Phenotype_Ontology:HP:0005159&Human_Phenotype_Ontology:HP:0200130&MONDO:MONDO:0005021&MeSH:D002311&MedGen:C0007193&Orphanet:217604&MedGen:CN169374&MedGen:CN230736&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848|Uncertain_significance(8)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,12:0.387:31:11,7:8,5:45:81,0,50:45.794,0.00013616,53:0,34.77,37.77:7,12,4,8:7,12,5,7	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,15:0.441:34:12,6:7,9:48:84,0,50:48.974,7.6623e-05,53:0,34.77,37.77:8,11,8,7:7,12,7,8	T	missense_variant	MODERATE	MYH7	4625	Transcript	NM_000257.4	protein_coding	35/40		c.4985G>A	p.Arg1662His	5090	4985	1662	R/H	cGt/cAt	rs370328209&CM115875&CM146976&COSV62520651	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious_low_confidence(0.03)	benign(0.012)	NA	NA	3.078e-05	0	4.472e-05	0.0001148	5.038e-05	0	0.0001734	2.428e-05	8.279e-05	5.797e-05	4.599e-05	4.824e-05	0	0	0.0002882	0	0	0	5.879e-05	0	0	0.0002882	gnomADg_ASJ	uncertain_significance&conflicting_interpretations_of_pathogenicity	0&1&1&1	1&1&1&1	NA	NA	NA	T	0.47623	-0.0285781	T	0.6394	-0.0929231	0.80782	0.540	22	3	-19	5	0	0	0	0	MYH7	likely_benign	hg38	0.0731	R1662H	ENST00000355349.4	P12883	43049	NA	Conflicting_classifications_of_pathogenicity	Primary_dilated_cardiomyopathy&not_specified&Cardiovascular_phenotype&not_provided&Hypertrophic_cardiomyopathy&Cardiomyopathy	NC_000014.9:g.23415801C>T		single_nucleotide_variant	MYH7:4625&MHRT:104564225&LOC126861897:126861897	EFO:EFO_0000407&Human_Phenotype_Ontology:HP:0001644&Human_Phenotype_Ontology:HP:0001725&Human_Phenotype_Ontology:HP:0005159&Human_Phenotype_Ontology:HP:0200130&MONDO:MONDO:0005021&MeSH:D002311&MedGen:C0007193&Orphanet:217604&MedGen:CN169374&MedGen:CN230736&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848	Uncertain_significance(8)&Likely_benign(1)	criteria_provided&_conflicting_classifications		MYH7	Dilated cardiomyopathy 1S	AD	613426	Cardiac and vascular disorders	NBScreening	2	Uncertain_significance	PP2,PP3	rs370328209	chr14_23415801_C_T	Female	0/1	Heterozygous
chr14	23415801	.	C	T	48.97	PASS	"FS=0;MQ=202.55;MQRankSum=-0.182;QD=1.48;ReadPosRankSum=3.914;SOR=0.801;FractionInformativeReads=1;R2_5P_bias=-5.004;DP=65;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|MYH7|4625|Transcript|NM_000257.4|protein_coding|35/40||NM_000257.4:c.4985G>A|NP_000248.2:p.Arg1662His|5090|4985|1662|R/H|cGt/cAt|rs370328209&CM115875&CM146976&COSV62520651||-1||SNV|EntrezGene||YES|||C|C|||deleterious_low_confidence(0.03)|benign(0.012)|||3.078e-05|0|4.472e-05|0.0001148|5.038e-05|0|0.0001734|2.428e-05|8.279e-05|5.797e-05|4.599e-05|4.824e-05|0|0|0.0002882|0|0|0|5.879e-05|0|0|0.0002882|gnomADg_ASJ|uncertain_significance&conflicting_interpretations_of_pathogenicity|0&1&1&1|1&1&1&1||||T|0.47623|-0.0285781|T|0.63940|-0.0929231|0.80782|0.540|22|3|-19|5|0.00|0.00|0.00|0.00|MYH7|likely_benign|hg38|0.0731|R1662H|ENST00000355349.4|P12883|43049||Conflicting_classifications_of_pathogenicity|Primary_dilated_cardiomyopathy&not_specified&Cardiovascular_phenotype&not_provided&Hypertrophic_cardiomyopathy&Cardiomyopathy|NC_000014.9:g.23415801C>T||single_nucleotide_variant|MYH7:4625&MHRT:104564225&LOC126861897:126861897|EFO:EFO_0000407&Human_Phenotype_Ontology:HP:0001644&Human_Phenotype_Ontology:HP:0001725&Human_Phenotype_Ontology:HP:0005159&Human_Phenotype_Ontology:HP:0200130&MONDO:MONDO:0005021&MeSH:D002311&MedGen:C0007193&Orphanet:217604&MedGen:CN169374&MedGen:CN230736&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848|Uncertain_significance(8)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,12:0.387:31:11,7:8,5:45:81,0,50:45.794,0.00013616,53:0,34.77,37.77:7,12,4,8:7,12,5,7	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,15:0.441:34:12,6:7,9:48:84,0,50:48.974,7.6623e-05,53:0,34.77,37.77:8,11,8,7:7,12,7,8	T	missense_variant	MODERATE	MYH7	4625	Transcript	NM_000257.4	protein_coding	35/40		c.4985G>A	p.Arg1662His	5090	4985	1662	R/H	cGt/cAt	rs370328209&CM115875&CM146976&COSV62520651	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious_low_confidence(0.03)	benign(0.012)	NA	NA	3.078e-05	0	4.472e-05	0.0001148	5.038e-05	0	0.0001734	2.428e-05	8.279e-05	5.797e-05	4.599e-05	4.824e-05	0	0	0.0002882	0	0	0	5.879e-05	0	0	0.0002882	gnomADg_ASJ	uncertain_significance&conflicting_interpretations_of_pathogenicity	0&1&1&1	1&1&1&1	NA	NA	NA	T	0.47623	-0.0285781	T	0.6394	-0.0929231	0.80782	0.540	22	3	-19	5	0	0	0	0	MYH7	likely_benign	hg38	0.0731	R1662H	ENST00000355349.4	P12883	43049	NA	Conflicting_classifications_of_pathogenicity	Primary_dilated_cardiomyopathy&not_specified&Cardiovascular_phenotype&not_provided&Hypertrophic_cardiomyopathy&Cardiomyopathy	NC_000014.9:g.23415801C>T		single_nucleotide_variant	MYH7:4625&MHRT:104564225&LOC126861897:126861897	EFO:EFO_0000407&Human_Phenotype_Ontology:HP:0001644&Human_Phenotype_Ontology:HP:0001725&Human_Phenotype_Ontology:HP:0005159&Human_Phenotype_Ontology:HP:0200130&MONDO:MONDO:0005021&MeSH:D002311&MedGen:C0007193&Orphanet:217604&MedGen:CN169374&MedGen:CN230736&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848	Uncertain_significance(8)&Likely_benign(1)	criteria_provided&_conflicting_classifications		MYH7	Laing distal myopathy	AD	160500	Cardiac and vascular disorders	NBScreening	2	Uncertain_significance	PP2,PP3	rs370328209	chr14_23415801_C_T	Female	0/1	Heterozygous
chr14	23419114	.	T	TG	152.35	PASS	"FS=0;MQ=250;QD=4.35;SOR=1.148;FractionInformativeReads=1;MQRankSum=4.551;ReadPosRankSum=-0.783;R2_5P_bias=5.774;DP=93;AF=0.5;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|MYH7|4625|Transcript|NM_000257.4|protein_coding||29/39|NM_000257.4:c.3972+62_3972+63insC|||||||rs34598192||-1||insertion|EntrezGene||YES||||||||||0.3371|0.3369|0.6339|0.196|0.3975|0.05485|0.2711|0.3041|0.3586|0.342|0.2235|0.4076|0.6311|0.4068|0.2827|0.3834|0.07968|0.2623|0.3103|0.3624|0.4006|0.2148|0.6641|AFR|benign&uncertain_significance||1||||||||||||-17|3|-17|-23|0.01|0.00|0.00|0.00|MYH7|||||||36640||Conflicting_classifications_of_pathogenicity|not_provided&Primary_familial_hypertrophic_cardiomyopathy|NC_000014.9:g.23419114_23419115insG||Insertion|MYH7:4625|MedGen:C3661900&MONDO:MONDO:0024573&MeSH:D024741&MedGen:C0949658&OMIM:PS192600&Orphanet:155|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,35:1:35:0,20:0,15:102:184,105,0:152.35,102.35,0:0,29,32:0,0,14,21:0,0,17,18	0/1:12,18:0.6:30:7,11:5,7:47:79,0,47:50,8.3354e-05,50.377:0,29,32:3,9,5,13:6,6,10,8	0/1:10,18:0.643:28:5,12:5,6:46:79,0,45:50,0.00011286,47.967:0,29,32:6,4,10,8:7,3,8,10	G	intron_variant	MODIFIER	MYH7	4625	Transcript	NM_000257.4	protein_coding		29/39	c.3972+62_3972+63insC							rs34598192	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.3371	0.3369	0.6339	0.196	0.3975	0.05485	0.2711	0.3041	0.3586	0.342	0.2235	0.4076	0.6311	0.4068	0.2827	0.3834	0.07968	0.2623	0.3103	0.3624	0.4006	0.2148	0.6641	AFR	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-17	3	-17	-23	0.01	0	0	0	MYH7			NA				36640	NA	Conflicting_classifications_of_pathogenicity	not_provided&Primary_familial_hypertrophic_cardiomyopathy	NC_000014.9:g.23419114_23419115insG		Insertion	MYH7:4625	MedGen:C3661900&MONDO:MONDO:0024573&MeSH:D024741&MedGen:C0949658&OMIM:PS192600&Orphanet:155	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		MYH7	Myosin storage myopathy	AD	608358	Cardiac and vascular disorders	NBScreening	-9	Benign	BP6,BA1	rs34598192	chr14_23419114_T_TG	Female	01-Jan	Homozygous
chr14	23419114	.	T	TG	152.35	PASS	"FS=0;MQ=250;QD=4.35;SOR=1.148;FractionInformativeReads=1;MQRankSum=4.551;ReadPosRankSum=-0.783;R2_5P_bias=5.774;DP=93;AF=0.5;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|MYH7|4625|Transcript|NM_000257.4|protein_coding||29/39|NM_000257.4:c.3972+62_3972+63insC|||||||rs34598192||-1||insertion|EntrezGene||YES||||||||||0.3371|0.3369|0.6339|0.196|0.3975|0.05485|0.2711|0.3041|0.3586|0.342|0.2235|0.4076|0.6311|0.4068|0.2827|0.3834|0.07968|0.2623|0.3103|0.3624|0.4006|0.2148|0.6641|AFR|benign&uncertain_significance||1||||||||||||-17|3|-17|-23|0.01|0.00|0.00|0.00|MYH7|||||||36640||Conflicting_classifications_of_pathogenicity|not_provided&Primary_familial_hypertrophic_cardiomyopathy|NC_000014.9:g.23419114_23419115insG||Insertion|MYH7:4625|MedGen:C3661900&MONDO:MONDO:0024573&MeSH:D024741&MedGen:C0949658&OMIM:PS192600&Orphanet:155|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,35:1:35:0,20:0,15:102:184,105,0:152.35,102.35,0:0,29,32:0,0,14,21:0,0,17,18	0/1:12,18:0.6:30:7,11:5,7:47:79,0,47:50,8.3354e-05,50.377:0,29,32:3,9,5,13:6,6,10,8	0/1:10,18:0.643:28:5,12:5,6:46:79,0,45:50,0.00011286,47.967:0,29,32:6,4,10,8:7,3,8,10	G	intron_variant	MODIFIER	MYH7	4625	Transcript	NM_000257.4	protein_coding		29/39	c.3972+62_3972+63insC							rs34598192	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.3371	0.3369	0.6339	0.196	0.3975	0.05485	0.2711	0.3041	0.3586	0.342	0.2235	0.4076	0.6311	0.4068	0.2827	0.3834	0.07968	0.2623	0.3103	0.3624	0.4006	0.2148	0.6641	AFR	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-17	3	-17	-23	0.01	0	0	0	MYH7			NA				36640	NA	Conflicting_classifications_of_pathogenicity	not_provided&Primary_familial_hypertrophic_cardiomyopathy	NC_000014.9:g.23419114_23419115insG		Insertion	MYH7:4625	MedGen:C3661900&MONDO:MONDO:0024573&MeSH:D024741&MedGen:C0949658&OMIM:PS192600&Orphanet:155	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		MYH7	Hypertrophic cardiomyopathy 1	AD	192600	Cardiac and vascular disorders	NBScreening	-9	Benign	BP6,BA1	rs34598192	chr14_23419114_T_TG	Female	01-Jan	Homozygous
chr14	23419114	.	T	TG	152.35	PASS	"FS=0;MQ=250;QD=4.35;SOR=1.148;FractionInformativeReads=1;MQRankSum=4.551;ReadPosRankSum=-0.783;R2_5P_bias=5.774;DP=93;AF=0.5;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|MYH7|4625|Transcript|NM_000257.4|protein_coding||29/39|NM_000257.4:c.3972+62_3972+63insC|||||||rs34598192||-1||insertion|EntrezGene||YES||||||||||0.3371|0.3369|0.6339|0.196|0.3975|0.05485|0.2711|0.3041|0.3586|0.342|0.2235|0.4076|0.6311|0.4068|0.2827|0.3834|0.07968|0.2623|0.3103|0.3624|0.4006|0.2148|0.6641|AFR|benign&uncertain_significance||1||||||||||||-17|3|-17|-23|0.01|0.00|0.00|0.00|MYH7|||||||36640||Conflicting_classifications_of_pathogenicity|not_provided&Primary_familial_hypertrophic_cardiomyopathy|NC_000014.9:g.23419114_23419115insG||Insertion|MYH7:4625|MedGen:C3661900&MONDO:MONDO:0024573&MeSH:D024741&MedGen:C0949658&OMIM:PS192600&Orphanet:155|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,35:1:35:0,20:0,15:102:184,105,0:152.35,102.35,0:0,29,32:0,0,14,21:0,0,17,18	0/1:12,18:0.6:30:7,11:5,7:47:79,0,47:50,8.3354e-05,50.377:0,29,32:3,9,5,13:6,6,10,8	0/1:10,18:0.643:28:5,12:5,6:46:79,0,45:50,0.00011286,47.967:0,29,32:6,4,10,8:7,3,8,10	G	intron_variant	MODIFIER	MYH7	4625	Transcript	NM_000257.4	protein_coding		29/39	c.3972+62_3972+63insC							rs34598192	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.3371	0.3369	0.6339	0.196	0.3975	0.05485	0.2711	0.3041	0.3586	0.342	0.2235	0.4076	0.6311	0.4068	0.2827	0.3834	0.07968	0.2623	0.3103	0.3624	0.4006	0.2148	0.6641	AFR	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-17	3	-17	-23	0.01	0	0	0	MYH7			NA				36640	NA	Conflicting_classifications_of_pathogenicity	not_provided&Primary_familial_hypertrophic_cardiomyopathy	NC_000014.9:g.23419114_23419115insG		Insertion	MYH7:4625	MedGen:C3661900&MONDO:MONDO:0024573&MeSH:D024741&MedGen:C0949658&OMIM:PS192600&Orphanet:155	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		MYH7	Dilated cardiomyopathy 1S	AD	613426	Cardiac and vascular disorders	NBScreening	-9	Benign	BP6,BA1	rs34598192	chr14_23419114_T_TG	Female	01-Jan	Homozygous
chr14	23419114	.	T	TG	152.35	PASS	"FS=0;MQ=250;QD=4.35;SOR=1.148;FractionInformativeReads=1;MQRankSum=4.551;ReadPosRankSum=-0.783;R2_5P_bias=5.774;DP=93;AF=0.5;AN=6;AC=4;CSQ=G|intron_variant|MODIFIER|MYH7|4625|Transcript|NM_000257.4|protein_coding||29/39|NM_000257.4:c.3972+62_3972+63insC|||||||rs34598192||-1||insertion|EntrezGene||YES||||||||||0.3371|0.3369|0.6339|0.196|0.3975|0.05485|0.2711|0.3041|0.3586|0.342|0.2235|0.4076|0.6311|0.4068|0.2827|0.3834|0.07968|0.2623|0.3103|0.3624|0.4006|0.2148|0.6641|AFR|benign&uncertain_significance||1||||||||||||-17|3|-17|-23|0.01|0.00|0.00|0.00|MYH7|||||||36640||Conflicting_classifications_of_pathogenicity|not_provided&Primary_familial_hypertrophic_cardiomyopathy|NC_000014.9:g.23419114_23419115insG||Insertion|MYH7:4625|MedGen:C3661900&MONDO:MONDO:0024573&MeSH:D024741&MedGen:C0949658&OMIM:PS192600&Orphanet:155|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,35:1:35:0,20:0,15:102:184,105,0:152.35,102.35,0:0,29,32:0,0,14,21:0,0,17,18	0/1:12,18:0.6:30:7,11:5,7:47:79,0,47:50,8.3354e-05,50.377:0,29,32:3,9,5,13:6,6,10,8	0/1:10,18:0.643:28:5,12:5,6:46:79,0,45:50,0.00011286,47.967:0,29,32:6,4,10,8:7,3,8,10	G	intron_variant	MODIFIER	MYH7	4625	Transcript	NM_000257.4	protein_coding		29/39	c.3972+62_3972+63insC							rs34598192	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.3371	0.3369	0.6339	0.196	0.3975	0.05485	0.2711	0.3041	0.3586	0.342	0.2235	0.4076	0.6311	0.4068	0.2827	0.3834	0.07968	0.2623	0.3103	0.3624	0.4006	0.2148	0.6641	AFR	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-17	3	-17	-23	0.01	0	0	0	MYH7			NA				36640	NA	Conflicting_classifications_of_pathogenicity	not_provided&Primary_familial_hypertrophic_cardiomyopathy	NC_000014.9:g.23419114_23419115insG		Insertion	MYH7:4625	MedGen:C3661900&MONDO:MONDO:0024573&MeSH:D024741&MedGen:C0949658&OMIM:PS192600&Orphanet:155	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		MYH7	Laing distal myopathy	AD	160500	Cardiac and vascular disorders	NBScreening	-9	Benign	BP6,BA1	rs34598192	chr14_23419114_T_TG	Female	01-Jan	Homozygous
chr14	30885555	.	G	C	50	PASS	"FS=1.44;MQ=250;MQRankSum=4.767;QD=1.56;ReadPosRankSum=1.804;SOR=1.127;FractionInformativeReads=1;R2_5P_bias=-10.392;DP=32;AF=0.5;AN=2;AC=1;CSQ=C|missense_variant|MODERATE|COCH|1690|Transcript|NM_004086.3|protein_coding|10/12||NM_004086.3:c.895G>C|NP_004077.1:p.Val299Leu|951|895|299|V/L|Gtt/Ctt|rs1895757539||1||SNV|EntrezGene||YES|||G|G|||deleterious(0.03)|probably_damaging(0.988)||||||||||||||||||||||||||uncertain_significance||1||||D|0.87762|0.366692|D|0.87607|0.288951|0.62510|0.304&0.304&.&.&0.304&0.304&0.304&.|15|1|-10|1|0.00|0.01|0.00|0.00|COCH|ambiguous|hg38|0.5449|V299L|ENST00000643575.1|O43405|2484017||Uncertain_significance|Inborn_genetic_diseases|NC_000014.9:g.30885555G>C||single_nucleotide_variant|COCH:1690&LOC100506071:100506071|MeSH:D030342&MedGen:C0950123||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,18:0.562:32:8,10:6,8:48:85,0,49:50,7.1446e-05,51.912:0,34.77,37.77:6,8,6,12:8,6,10,8	./.:.:.:.:.:.:.:.:.:.:.:.	C	missense_variant	MODERATE	COCH	1690	Transcript	NM_004086.3	protein_coding	12-Oct		c.895G>C	p.Val299Leu	951	895	299	V/L	Gtt/Ctt	rs1895757539	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0.03)	probably_damaging(0.988)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		uncertain_significance		1	NA	NA	NA	D	0.87762	0.366692	D	0.87607	0.288951	0.6251	0.304&0.304&.&.&0.304&0.304&0.304&.	15	1	-10	1	0	0.01	0	0	COCH	ambiguous	hg38	0.5449	V299L	ENST00000643575.1	O43405	2484017	NA	Uncertain_significance	Inborn_genetic_diseases	NC_000014.9:g.30885555G>C		single_nucleotide_variant	COCH:1690&LOC100506071:100506071	MeSH:D030342&MedGen:C0950123		criteria_provided&_single_submitter		COCH	Autosomal dominant nonsyndromic hearing loss 9	AD	601369	Hearing disorders	NBScreening	2	Uncertain_significance	PM2	rs1895757539	chr14_30885555_G_C	Female	./.	Other
chr14	36516817	.	CA	C	125.08	PASS	"FS=6.862;MQ=250;MQRankSum=4.113;QD=2.08;ReadPosRankSum=-0.637;SOR=2.116;FractionInformativeReads=1;R2_5P_bias=7.574;DP=94;AF=0.5;AN=6;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|NKX2-1|7080|Transcript|NM_001079668.3|protein_coding|3/3||NM_001079668.3:c.*460del||1769|||||rs5807883||-1||deletion|EntrezGene||YES|||A|A|||||||0.1937|0.173|0.2753|0.1649|0.2868|0.1786|0.1488|0.1741|0.1792|0.2454|0.1228|0.04892|0.09297|0.2542|0.09689|0.2776|0.1603|0.04444|0.1179|0.1134|0.1835|0.2868|gnomADe_EAS|uncertain_significance||1||||||||||||-5|-2|45|28|0.00|0.00|0.00|0.00|NKX2-1|||||||313128||Uncertain_significance|not_provided&Benign_hereditary_chorea&Brain-lung-thyroid_syndrome|NC_000014.9:g.36516832del||Deletion|NKX2-1:7080&SFTA3:253970|MedGen:C3661900&MONDO:MONDO:0021011&MedGen:C0393584&OMIM:118700&Orphanet:1429&MONDO:MONDO:0012593&MedGen:C1970269&OMIM:610978&Orphanet:209905||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:11,.:.:24:3,.:8,.:48:58,.,.:50,.,.:0,.,.:5,6,10,3:5,6,8,5	0/1:15,21:0.583:36:7,11:8,10:47:58,0,48:50,7.9212e-05,50.848:0,8,11:7,8,17,4:11,4,13,8	0/0:1,.:.:33:0,.:1,.:75:136,.,.:125.08,.,.:0,.,.:0,1,12,20:1,0,15,17	-	3_prime_UTR_variant	MODIFIER	NKX2-1	7080	Transcript	NM_001079668.3	protein_coding	03-Mar		c.*460del		1769					rs5807883	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.1937	0.173	0.2753	0.1649	0.2868	0.1786	0.1488	0.1741	0.1792	0.2454	0.1228	0.04892	0.09297	0.2542	0.09689	0.2776	0.1603	0.04444	0.1179	0.1134	0.1835	0.2868	gnomADe_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-5	-2	45	28	0	0	0	0	NKX2-1			NA				313128	NA	Uncertain_significance	not_provided&Benign_hereditary_chorea&Brain-lung-thyroid_syndrome	NC_000014.9:g.36516832del		Deletion	NKX2-1:7080&SFTA3:253970	MedGen:C3661900&MONDO:MONDO:0021011&MedGen:C0393584&OMIM:118700&Orphanet:1429&MONDO:MONDO:0012593&MedGen:C1970269&OMIM:610978&Orphanet:209905		criteria_provided&_multiple_submitters&_no_conflicts		NKX2-1	Brain-lung-thyroid syndrome	AD	610978	Complex genetic syndromes	NBScreening	-8	Benign	BA1	rs5807883	chr14_36516817_CA_C	Female	0/0	Other
chr14	45159080	.	TTA	T	48.44	PASS	"FS=0;MQ=250;MQRankSum=3.873;QD=1.47;ReadPosRankSum=-0.601;SOR=0.569;FractionInformativeReads=0.667;R2_5P_bias=10.865;DP=78;AF=0.5;AN=4;AC=2;CSQ=-|splice_polypyrimidine_tract_variant&intron_variant|LOW|FANCM|57697|Transcript|NM_020937.4|protein_coding||8/22|NM_020937.4:c.1397-3_1397-2del|||||||rs112326758||1||deletion|EntrezGene||YES|||TA|TA|||||12|0.1182|0.1122|0.04012|0.1465|0.1445|0.1311|0.127|0.1417|0.1046|0.1161|0.1935|0.09109|0.03828|0.1634|0.1126|0.1321|0.118|0.1093|0.1103|0.1032|0.1164|0.183|0.2086|SAS|||1||||||||||||-4|3|30|38|0.03|0.00|0.00|0.00|FANCM|||||||261381||Conflicting_classifications_of_pathogenicity|not_specified&not_provided&Premature_ovarian_failure_15&Spermatogenic_failure_28&Fanconi_anemia|NC_000014.9:g.45159081TA[6]||Microsatellite|FANCM:57697|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0054862&MedGen:C4748170&OMIM:618096&MONDO:MONDO:0054732&MedGen:C4748117&OMIM:618086&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84|Uncertain_significance(1)&Benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:13,9:0.409:22:8,5:5,4:47:63,0,50:48.44,8.3871e-05,53:0,15,18:4,9,3,6:7,6,7,2	0/1:30,10:0.25:40:13,4:17,6:27:41,0,50:27.267,0.0081776,53.008:0,14,17:11,19,3,7:20,10,5,5	./.:.:.:.:.:.:.:.:.:.:.:.	-	splice_polypyrimidine_tract_variant&intron_variant	LOW	FANCM	57697	Transcript	NM_020937.4	protein_coding		22-Aug	c.1397-3_1397-2del							rs112326758	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TA	TA	NA	NA			12	0.1182	0.1122	0.04012	0.1465	0.1445	0.1311	0.127	0.1417	0.1046	0.1161	0.1935	0.09109	0.03828	0.1634	0.1126	0.1321	0.118	0.1093	0.1103	0.1032	0.1164	0.183	0.2086	SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		-4	3	30	38	0.03	0	0	0	FANCM			NA				261381	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided&Premature_ovarian_failure_15&Spermatogenic_failure_28&Fanconi_anemia	NC_000014.9:g.45159081TA[6]		Microsatellite	FANCM:57697	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0054862&MedGen:C4748170&OMIM:618096&MONDO:MONDO:0054732&MedGen:C4748117&OMIM:618086&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84	Uncertain_significance(1)&Benign(5)	criteria_provided&_conflicting_classifications		FANCM	Fanconi-Anemia-Associated Polypeptide	AR	NA	Complex genetic syndromes	NBScreening	-7	Benign	PVS1_Moderate,BP6,BA1	rs112326758	chr14_45159080_TTA_T	Female	0/1	Heterozygous
chr14	45173152	.	A	G	50	PASS	"FS=5.447;MQ=247.26;MQRankSum=4.487;QD=1.43;ReadPosRankSum=2.103;SOR=0.195;FractionInformativeReads=1;R2_5P_bias=3.469;DP=35;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|FANCM|57697|Transcript|NM_020937.4|protein_coding|13/23||NM_020937.4:c.2258A>G|NP_065988.1:p.Asp753Gly|2360|2258|753|D/G|gAt/gGt|rs756438082||1||SNV|EntrezGene||YES|||A|A|||deleterious(0.02)|benign(0.034)|||4.585e-05|0|0|0|0|0|0.0001735|2.699e-06|1.656e-05|0.0007189|1.314e-05|0|0|0|0|0|0|0|0|0|0.0004134|0.0007189|gnomADe_SAS|uncertain_significance||1||||T|0.01428|-0.432701|T|0.23576|-0.488236|0.29403|0.103&0.103&0.103|-1|-47|-1|-14|0.00|0.02|0.31|0.00|FANCM|likely_benign|hg38|0.1897|D753G|ENST00000267430.10|Q8IYD8|526349||Uncertain_significance|not_specified&Fanconi_anemia|NC_000014.9:g.45173152A>G||single_nucleotide_variant|FANCM:57697|MedGen:CN169374&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,19:0.543:35:9,8:7,11:48:85,0,49:50,6.8598e-05,52.361:0,34.77,37.77:13,3,12,7:6,10,11,8	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	FANCM	57697	Transcript	NM_020937.4	protein_coding	13/23		c.2258A>G	p.Asp753Gly	2360	2258	753	D/G	gAt/gGt	rs756438082	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	deleterious(0.02)	benign(0.034)	NA	NA	4.585e-05	0	0	0	0	0	0.0001735	2.699e-06	1.656e-05	0.0007189	1.314e-05	0	0	0	0	0	0	0	0	0	0.0004134	0.0007189	gnomADe_SAS	uncertain_significance		1	NA	NA	NA	T	0.01428	-0.432701	T	0.23576	-0.488236	0.29403	0.103&0.103&0.103	-1	-47	-1	-14	0	0.02	0.31	0	FANCM	likely_benign	hg38	0.1897	D753G	ENST00000267430.10	Q8IYD8	526349	NA	Uncertain_significance	not_specified&Fanconi_anemia	NC_000014.9:g.45173152A>G		single_nucleotide_variant	FANCM:57697	MedGen:CN169374&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84		criteria_provided&_multiple_submitters&_no_conflicts		FANCM	Fanconi-Anemia-Associated Polypeptide	AR	NA	Complex genetic syndromes	NBScreening	-5	Likely_benign	BS1_Supporting,BS2	rs756438082	chr14_45173152_A_G	Female	./.	Other
chr14	73697743	.	TA	T	50	PASS	"FS=0;MQ=236.06;MQRankSum=3.019;QD=1.66;ReadPosRankSum=-0.299;SOR=0.582;FractionInformativeReads=0.833;R2_5P_bias=6.546;DP=56;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|DNAL1|83544|Transcript|NM_031427.4|protein_coding|8/8||NM_031427.4:c.*1823del||2429|||||rs59065500||1||deletion|EntrezGene||YES|||A|A|||||21||0.5|||||||0.5|||0.1236|0.09359|0.2139|0.1103|0.1513|0.09565|0.09638|0.1858|0.1442|0.1369|0.1268|0.5|gnomADe_NFE|uncertain_significance||1||||||||||||14|43|33|49|0.00|0.00|0.00|0.00|DNAL1|||||||314043||Uncertain_significance|Primary_ciliary_dyskinesia&not_provided|NC_000014.9:g.73697765del||Deletion|DNAL1:83544|Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,12:0.48:25:7,6:6,6:48:54,0,50:49.863,6.6527e-05,53:0,4,7:8,5,7,5:4,9,3,9	0/1:12,14:0.538:26:6,6:6,8:48:54,0,50:50,6.6786e-05,52.701:0,4,7:4,8,9,5:6,6,7,7	-	3_prime_UTR_variant	MODIFIER	DNAL1	83544	Transcript	NM_031427.4	protein_coding	08-Aug		c.*1823del		2429					rs59065500	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			21	NA	0.5	NA	NA	NA	NA	NA	NA	0.5	NA	NA	0.1236	0.09359	0.2139	0.1103	0.1513	0.09565	0.09638	0.1858	0.1442	0.1369	0.1268	0.5	gnomADe_NFE	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		14	43	33	49	0	0	0	0	DNAL1			NA				314043	NA	Uncertain_significance	Primary_ciliary_dyskinesia&not_provided	NC_000014.9:g.73697765del		Deletion	DNAL1:83544	Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		DNAL1	Primary ciliary dyskinesia 16	AR	614017	Respiratory system disorders	NBScreening	-8	Benign	BA1	rs59065500	chr14_73697743_TA_T	Female	./.	Other
chr14	73702078	.	G	GGT	50	PASS	"FS=0;MQ=250;MQRankSum=4.19;QD=0.89;ReadPosRankSum=-1.449;SOR=0.941;FractionInformativeReads=0.464;R2_5P_bias=-9.655;DP=99;AF=0.5;AN=4;AC=2;CSQ=GT|3_prime_UTR_variant|MODIFIER|DNAL1|83544|Transcript|NM_031427.4|protein_coding|8/8||NM_031427.4:c.*6162_*6163dup||6763-6764|||||rs10679978||1||insertion|EntrezGene||YES|||||||||27||0|||||||0|||0.114|0.1752|0.06541|0.09229|0.1206|0.1816|0.04367|0.1483|0.09045|0.1273|0.08546|0.1816|gnomADg_EAS|||1|||||||||||||||||||||||||||314116||Uncertain_significance|Primary_ciliary_dyskinesia|NC_000014.9:g.73702080TG[14]||Microsatellite|DNAL1:83544|Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:10,16:0.615:26:2,9:8,7:45:55,0,44:50,0.00012658,47.173:0,5,8.01:5,5,9,7:5,5,8,8	0/1:13,12:0.48:25:3,5:10,7:48:54,0,50:49.896,6.6269e-05,53:0,4,7:6,7,2,10:6,7,9,3	GT	3_prime_UTR_variant	MODIFIER	DNAL1	83544	Transcript	NM_031427.4	protein_coding	08-Aug		c.*6162_*6163dup		6763-6764					rs10679978	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			27	NA	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.114	0.1752	0.06541	0.09229	0.1206	0.1816	0.04367	0.1483	0.09045	0.1273	0.08546	0.1816	gnomADg_EAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				314116	NA	Uncertain_significance	Primary_ciliary_dyskinesia	NC_000014.9:g.73702080TG[14]		Microsatellite	DNAL1:83544	Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244		criteria_provided&_single_submitter		DNAL1	Primary ciliary dyskinesia 16	AR	614017	Respiratory system disorders	NBScreening	-8	Benign	BA1	rs10679978	chr14_73702078_G_GGT	Female	./.	Other
chr14	95090171	.	CA	C	155.63	PASS	"FS=5.846;MQ=240.48;MQRankSum=-0.833;QD=1.25;ReadPosRankSum=0.248;SOR=0.157;FractionInformativeReads=0.95;R2_5P_bias=10.849;DP=113;AF=1;AN=6;AC=4;CSQ=-|3_prime_UTR_variant|MODIFIER|DICER1|23405|Transcript|NM_177438.3|protein_coding|27/27||NM_177438.3:c.*326del||6440|||||rs35649919||-1||deletion|EntrezGene||YES|||A|A|||||||0.5052|0.3915|0.5151|0.4936|0.545|0.5096|0.4989|0.5007|0.4973|0.5391|0.696|0.4805|0.7568|0.7905|0.7243|0.9545|0.7422|0.7071|0.759|0.6972|0.9054|0.9545|gnomADg_EAS|uncertain_significance||1||||||||||||-4|18|19|-4|0.00|0.00|0.00|0.00|DICER1|||||||315096||Uncertain_significance|not_provided&Pleuropulmonary_blastoma|NC_000014.9:g.95090184del||Deletion|DICER1:23405|MedGen:C3661900&Human_Phenotype_Ontology:HP:0100528&MONDO:MONDO:0011014&MedGen:C1266144&OMIM:601200&Orphanet:64742||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:20,18:0.474:38:9,5:11,13:47:61,0,47:50,8.9566e-05,49.737:0,11,14.01:17,3,12,6:8,12,9,9	0/1:12,17:0.586:29:7,10:5,7:46:61,0,45:50,0.00011028,48.126:0,11,14.01:10,2,14,3:7,5,7,10	1/1:1,43:0.977:44:0,24:1,19:106:169,109,0:155.63,105.63,0:0,10,13:0,1,25,18:1,0,20,23	-	3_prime_UTR_variant	MODIFIER	DICER1	23405	Transcript	NM_177438.3	protein_coding	27/27		c.*326del		6440					rs35649919	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.5052	0.3915	0.5151	0.4936	0.545	0.5096	0.4989	0.5007	0.4973	0.5391	0.696	0.4805	0.7568	0.7905	0.7243	0.9545	0.7422	0.7071	0.759	0.6972	0.9054	0.9545	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-4	18	19	-4	0	0	0	0	DICER1			NA				315096	NA	Uncertain_significance	not_provided&Pleuropulmonary_blastoma	NC_000014.9:g.95090184del		Deletion	DICER1:23405	MedGen:C3661900&Human_Phenotype_Ontology:HP:0100528&MONDO:MONDO:0011014&MedGen:C1266144&OMIM:601200&Orphanet:64742		criteria_provided&_multiple_submitters&_no_conflicts		DICER1	Pleuropulmonary blastoma	AD	601200	"Tumor predisposition syndromes;Respiratory system disorders"	NBScreening	-8	Benign	BA1	rs35649919	chr14_95090171_CA_C	Female	0/1	Heterozygous
chr15	34231586	.	TTCTTTC	T	50	PASS	"FS=5.041;MQ=229.44;MQRankSum=0.106;QD=1.35;ReadPosRankSum=-0.684;SOR=0.214;FractionInformativeReads=1;R2_5P_bias=-7.473;DP=98;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|SLC12A6|9990|Transcript|NM_001365088.1|protein_coding|26/26||NM_001365088.1:c.*2289_*2294del||6264-6269|||||rs377402786||-1||deletion|EntrezGene||YES|||TCTTTC|TCTTTC|||||||0.01852|0|0|0|0||0|0.02381|0||0.1148|0.09871|0.1234|0.1279|0.1236|0.262|0.06123|0.2125|0.1105|0.1331|0.1866|0.262|gnomADg_EAS|uncertain_significance||1|||||||||||||||||||||||||||315573||Uncertain_significance|Agenesis_of_the_corpus_callosum_with_peripheral_neuropathy|NC_000015.10:g.34231588_34231593del||Deletion|SLC12A6:9990|MONDO:MONDO:0000902&MedGen:C0795950&OMIM:218000&Orphanet:1496||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,18:0.486:37:11,10:8,8:48:69,0,50:49.942,6.5751e-05,53:0,19,22:5,14,8,10:9,10,8,10	0/1:22,14:0.389:36:14,9:8,5:45:64,0,50:46.108,0.00012814,53:0,18,21:13,9,6,8:9,13,9,5	0/1:11,14:0.56:25:4,7:7,7:46:69,0,45:50,0.00011778,47.658:0,19,22.01:4,7,6,8:7,4,5,9	-	3_prime_UTR_variant	MODIFIER	SLC12A6	9990	Transcript	NM_001365088.1	protein_coding	26/26		c.*2289_*2294del		6264-6269					rs377402786	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	TCTTTC	TCTTTC	NA	NA			NA	NA	0.01852	0	0	0	0	NA	0	0.02381	0	NA	0.1148	0.09871	0.1234	0.1279	0.1236	0.262	0.06123	0.2125	0.1105	0.1331	0.1866	0.262	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				315573	NA	Uncertain_significance	Agenesis_of_the_corpus_callosum_with_peripheral_neuropathy	NC_000015.10:g.34231588_34231593del		Deletion	SLC12A6:9990	MONDO:MONDO:0000902&MedGen:C0795950&OMIM:218000&Orphanet:1496		criteria_provided&_single_submitter		SLC12A6	Agenesis of the corpus callosum with peripheral neuropathy	AR	218000	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-8	Benign	BA1	rs377402786	chr15_34231586_TTCTTTC_T	Female	0/1	Heterozygous
chr15	38352241	.	G	GATAT	50	PASS	"FS=13.776;MQ=246.86;MQRankSum=4.254;QD=1.25;ReadPosRankSum=-1.267;SOR=2.123;FractionInformativeReads=0.75;R2_5P_bias=-5.837;DP=108;AF=0.5;AN=6;AC=3;CSQ=ATAT|3_prime_UTR_variant|MODIFIER|SPRED1|161742|Transcript|NM_152594.3|protein_coding|7/7||NM_152594.3:c.*592_*595dup||2262-2263|||||rs147547509||1||insertion|EntrezGene||YES|||||||||18||0.005427|0|0||0|0.0197||0|0|0|0.1218|0.1588|0.1398|0.1351|0.09251|0.1979|0.06909|0.1536|0.1005|0.1358|0.09734|0.1979|gnomADg_EAS|||1|||||||||||||||||||||||||||315744||Uncertain_significance|not_provided&Legius_syndrome|NC_000015.10:g.38352242AT[11]||Microsatellite|SPRED1:161742|MedGen:C3661900&MONDO:MONDO:0012669&MedGen:C1969623&OMIM:611431&Orphanet:137605||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:9,21:0.7:30:5,10:4,11:42:59,0,40:50,0.00026327,42.958:0,9,12:6,3,5,16:4,5,12,9	0/1:10,13:0.565:23:4,5:6,8:48:59,0,49:50,6.9375e-05,52.217:0,9,12:5,5,2,11:7,3,6,7	0/1:9,17:0.654:26:5,7:4,10:46:59,0,44:50,0.00012244,47.404:0,9,12:3,6,6,11:5,4,8,9	ATAT	3_prime_UTR_variant	MODIFIER	SPRED1	161742	Transcript	NM_152594.3	protein_coding	07-Jul		c.*592_*595dup		2262-2263					rs147547509	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			18	NA	0.005427	0	0	NA	0	0.0197	NA	0	0	0	0.1218	0.1588	0.1398	0.1351	0.09251	0.1979	0.06909	0.1536	0.1005	0.1358	0.09734	0.1979	gnomADg_EAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				315744	NA	Uncertain_significance	not_provided&Legius_syndrome	NC_000015.10:g.38352242AT[11]		Microsatellite	SPRED1:161742	MedGen:C3661900&MONDO:MONDO:0012669&MedGen:C1969623&OMIM:611431&Orphanet:137605		criteria_provided&_multiple_submitters&_no_conflicts		SPRED1	Legius syndrome	AD	611431	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs147547509	chr15_38352241_G_GATAT	Female	0/1	Heterozygous
chr15	42736531	.	G	A	50	PASS	"FS=1.808;MQ=250;MQRankSum=3.618;QD=2.38;ReadPosRankSum=2.126;SOR=0.83;FractionInformativeReads=1;R2_5P_bias=-9.3;DP=21;AF=0.5;AN=2;AC=1;CSQ=A|missense_variant|MODERATE|CDAN1|146059|Transcript|NM_138477.4|protein_coding|2/28||NM_138477.4:c.340C>T|NP_612486.2:p.Pro114Ser|366|340|114|P/S|Cct/Tct|rs937231408||-1||SNV|EntrezGene||YES|||G|G|||tolerated(0.19)|probably_damaging(0.935)|||2.306e-06|0|4.16e-05|0|0|0|0|9.648e-07|1.87e-05|0||||||||||||4.16e-05|gnomADe_AMR|uncertain_significance||1||||T|0.37256|-0.0949621|T|0.36400|-0.374183|0.16321|0.057|24|-5|-18|25|0.00|0.00|0.00|0.00|CDAN1|likely_benign|hg38|0.0784|P114S|ENST00000356231.4|Q8IWY9|1943298||Uncertain_significance|not_provided|NC_000015.10:g.42736531G>A||single_nucleotide_variant|CDAN1:146059&LOC130056931:130056931|MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:7,14:0.667:21:3,9:4,5:46:85,0,44:50,0.00012218,47.417:0,34.77,37.77:4,3,6,8:2,5,9,5	./.:.:.:.:.:.:.:.:.:.:.:.	A	missense_variant	MODERATE	CDAN1	146059	Transcript	NM_138477.4	protein_coding	28-Feb		c.340C>T	p.Pro114Ser	366	340	114	P/S	Cct/Tct	rs937231408	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	tolerated(0.19)	probably_damaging(0.935)	NA	NA	2.306e-06	0	4.16e-05	0	0	0	0	9.648e-07	1.87e-05	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	4.16e-05	gnomADe_AMR	uncertain_significance		1	NA	NA	NA	T	0.37256	-0.0949621	T	0.364	-0.374183	0.16321	0.057	24	-5	-18	25	0	0	0	0	CDAN1	likely_benign	hg38	0.0784	P114S	ENST00000356231.4	Q8IWY9	1943298	NA	Uncertain_significance	not_provided	NC_000015.10:g.42736531G>A		single_nucleotide_variant	CDAN1:146059&LOC130056931:130056931	MedGen:C3661900		criteria_provided&_single_submitter		CDAN1	Anemia, congenital dyserythropoietic, type 1a	AR	224120	Haematological disorders	NBScreening	0	Uncertain_significance	PM2,BP4_Moderate	rs937231408	chr15_42736531_G_A	Female	./.	Other
chr15	45097326	.	C	T	49.22	PASS	"FS=0;MQ=223.73;MQRankSum=-2.491;QD=1.97;ReadPosRankSum=4.188;SOR=0.859;FractionInformativeReads=1;R2_5P_bias=20.466;DP=25;AF=0.5;AN=2;AC=1;CSQ=T|synonymous_variant|LOW|DUOX2|50506|Transcript|NM_001363711.2|protein_coding|29/34||NM_001363711.2:c.3759G>A|NP_001350640.1:p.Pro1253%3D|3973|3759|1253|P|ccG/ccA|rs140663764&COSV104692290||-1||SNV|EntrezGene||YES|||C|C||||||0.0024|0.004073|0.0005078|0.002437|0.03543|0|0.0002059|0.02895|0.002611|0.007269|0.01602|0.003485|0.0004809|0|0.005553|0.03399|0|0.0001883|0.006803|0.003307|0.007096|0.01327|0.03543|gnomADe_ASJ|benign&uncertain_significance|0&1|1&1||||||||||||-2|32|-2|-27|0.72|0.08|0.00|0.00|DUOX2|||||||316145||Conflicting_classifications_of_pathogenicity|Thyroid_dyshormonogenesis_6&DUOX2-related_disorder&not_provided|NC_000015.10:g.45097326C>T||single_nucleotide_variant|DUOX2:50506|MONDO:MONDO:0011792&MedGen:C1846632&OMIM:607200&Orphanet:95716&.&MedGen:C3661900|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,11:0.44:25:1,5:13,6:48:84,0,50:49.216,7.3776e-05,53:0,34.77,37.77:7,7,6,5:6,8,6,5	T	synonymous_variant	LOW	DUOX2	50506	Transcript	NM_001363711.2	protein_coding	29/34		c.3759G>A	p.Pro1253%3D	3973	3759	1253	P	ccG/ccA	rs140663764&COSV104692290	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0024	0.004073	0.0005078	0.002437	0.03543	0	0.0002059	0.02895	0.002611	0.007269	0.01602	0.003485	0.0004809	0	0.005553	0.03399	0	0.0001883	0.006803	0.003307	0.007096	0.01327	0.03543	gnomADe_ASJ	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-2	32	-2	-27	0.72	0.08	0	0	DUOX2			NA				316145	NA	Conflicting_classifications_of_pathogenicity	Thyroid_dyshormonogenesis_6&DUOX2-related_disorder&not_provided	NC_000015.10:g.45097326C>T		single_nucleotide_variant	DUOX2:50506	MONDO:MONDO:0011792&MedGen:C1846632&OMIM:607200&Orphanet:95716&.&MedGen:C3661900	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		DUOX2	Thyroid dyshormonogenesis 6	AR	607200	Endocrine disorders	NBScreening	-5	Likely_benign	PP3,BP6,BS1,BS2_Supporting	rs140663764	chr15_45097326_C_T	Female	./.	Other
chr15	53515008	.	C	CATATAT	119.03	PASS	"FS=0;MQ=247.14;MQRankSum=1.708;QD=2.78;ReadPosRankSum=-0.566;SOR=0.693;FractionInformativeReads=0.611;R2_5P_bias=-3.542;DP=45;AF=1;AN=4;AC=3;CSQ=ATATAT|3_prime_UTR_variant|MODIFIER|WDR72|256764|Transcript|NM_182758.4|protein_coding|20/20||NM_182758.4:c.*2685_*2690dup||6042-6043|||||rs201133545||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.2897|0.1235|0.2911|0.2191|0.4029|0.1203|0.3966|0.363|0.3856|0.2758|0.3328|0.4029|gnomADg_ASJ|||1|||||||||||||||||||||||||||316508||Uncertain_significance|not_provided&Amelogenesis_Imperfecta&_Recessive|NC_000015.10:g.53515010TA[11]||Microsatellite|WDR72:256764|MedGen:C3661900&MedGen:CN239209||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:3,8:0.727:11:1,4:2,4:46:61,0,45:50,0.00010898,48.22:0,11,14:1,2,3,5:1,2,3,5	./.:.:.:.:.:.:.:.:.:.:.:.	1/1:0,24:1:24:0,11:0,13:69:133,72,0:119.03,69.033,5.1772e-07:0,11,14:0,0,7,17:0,0,16,8	ATATAT	3_prime_UTR_variant	MODIFIER	WDR72	256764	Transcript	NM_182758.4	protein_coding	20/20		c.*2685_*2690dup		6042-6043					rs201133545	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.2897	0.1235	0.2911	0.2191	0.4029	0.1203	0.3966	0.363	0.3856	0.2758	0.3328	0.4029	gnomADg_ASJ			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				316508	NA	Uncertain_significance	not_provided&Amelogenesis_Imperfecta&_Recessive	NC_000015.10:g.53515010TA[11]		Microsatellite	WDR72:256764	MedGen:C3661900&MedGen:CN239209		criteria_provided&_multiple_submitters&_no_conflicts		WDR72	Amelogenesis imperfecta hypomaturation type 2A3	AR	613211	Skelettal, skin, and connective tissue disorders	NBScreening	-8	Benign	BA1	rs201133545	chr15_53515008_C_CATATAT	Female	0/1	Heterozygous
chr15	53515086	.	T	TACACACAC	37.12	PASS	"FS=8.081;MQ=233.42;MQRankSum=1.688;QD=1;ReadPosRankSum=0.692;SOR=0.039;FractionInformativeReads=0.73;R2_5P_bias=6.217;DP=37;AF=0.5;AN=2;AC=1;CSQ=ACACACAC|3_prime_UTR_variant|MODIFIER|WDR72|256764|Transcript|NM_182758.4|protein_coding|20/20||NM_182758.4:c.*2605_*2612dup||5964-5965|||||rs1555402422||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.08201|0.02805|0.1348|0.09009|0.1806|0.07788|0.09547|0.1316|0.1067|0.104|0.1511|0.1806|gnomADg_ASJ|||1|||||||||||||||||||||||||||316524||Uncertain_significance|not_provided&Amelogenesis_Imperfecta&_Recessive|NC_000015.10:g.53515088CA[14]||Microsatellite|WDR72:256764|MedGen:C3661900&MedGen:CN239209||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:20,7:0.259:27:13,4:7,3:36:45,0,42:37.119,0.00098844,44.76:0,8,11.01:19,1,5,2:14,6,4,3	./.:.:.:.:.:.:.:.:.:.:.:.	ACACACAC	3_prime_UTR_variant	MODIFIER	WDR72	256764	Transcript	NM_182758.4	protein_coding	20/20		c.*2605_*2612dup		5964-5965					rs1555402422	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.08201	0.02805	0.1348	0.09009	0.1806	0.07788	0.09547	0.1316	0.1067	0.104	0.1511	0.1806	gnomADg_ASJ			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				316524	NA	Uncertain_significance	not_provided&Amelogenesis_Imperfecta&_Recessive	NC_000015.10:g.53515088CA[14]		Microsatellite	WDR72:256764	MedGen:C3661900&MedGen:CN239209		criteria_provided&_multiple_submitters&_no_conflicts		WDR72	Amelogenesis imperfecta hypomaturation type 2A3	AR	613211	Skelettal, skin, and connective tissue disorders	NBScreening	-8	Benign	BA1	rs1555402422	chr15_53515086_T_TACACACAC	Female	./.	Other
chr15	68207979	.	GACAC	G	291.25	PASS	"FS=0;MQ=250;QD=4.94;SOR=1.609;FractionInformativeReads=0.905;DP=89;AF=0.5;AN=6;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|CLN6|54982|Transcript|NM_017882.3|protein_coding|7/7||NM_017882.3:c.*157_*160del||1237-1240|||||rs3837692||-1||deletion|EntrezGene||YES|||ACAC|ACAC|||||||0.4732|0.3809|0.4432|0.4817|0.1587|0.4999|0.4595|0.53|0.4818|0.3368|0.4804|0.3924|0.4592|0.4948|0.491|0.1749|0.5171|0.5274|0.5565|0.4919|0.3444|0.5565|gnomADg_NFE|||1||||||||||||-36|-49|12|8|0.00|0.00|0.00|0.00|CLN6|||||||316987||Conflicting_classifications_of_pathogenicity|Neuronal_Ceroid-Lipofuscinosis&_Recessive&not_provided|NC_000015.10:g.68207980AC[8]||Microsatellite|CLN6:54982|MedGen:CN239323&MedGen:CN517202|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:0,.:.:19:0,.:0,.:54:114,.,.:103.65,.,.:0,.,.:0,0,6,13:0,0,10,9	0/0:0,.:.:22:0,.:0,.:50:261,.,.:246.86,.,.:0,.,.:0,0,9,13:0,0,11,11	1/0:0,15:0.556:27:0,7:0,8:50:305,248,56:291.25,241.25,52.439:0,7,10:0,0,10,17:0,0,15,12	-	3_prime_UTR_variant	MODIFIER	CLN6	54982	Transcript	NM_017882.3	protein_coding	07-Jul		c.*157_*160del		1237-1240					rs3837692	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	ACAC	ACAC	NA	NA			NA	NA	0.4732	0.3809	0.4432	0.4817	0.1587	0.4999	0.4595	0.53	0.4818	0.3368	0.4804	0.3924	0.4592	0.4948	0.491	0.1749	0.5171	0.5274	0.5565	0.4919	0.3444	0.5565	gnomADg_NFE			1	NA	NA	NA		NA	NA		NA	NA	NA		-36	-49	12	8	0	0	0	0	CLN6			NA				316987	NA	Conflicting_classifications_of_pathogenicity	Neuronal_Ceroid-Lipofuscinosis&_Recessive&not_provided	NC_000015.10:g.68207980AC[8]		Microsatellite	CLN6:54982	MedGen:CN239323&MedGen:CN517202	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		CLN6	Ceroid lipofuscinosis, neuronal, 6A	AR	601780	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs3837692	chr15_68207979_GACAC_G	Female	0/0	Other
chr15	68229767	.	A	AGCGGAGCGGAGGGAGGCGGG	116.66	PASS	"FS=0;MQ=246.99;QD=3.76;SOR=1.802;FractionInformativeReads=0.774;MQRankSum=2.942;ReadPosRankSum=-0.437;R2_5P_bias=9.655;DP=89;AF=0.5;AN=6;AC=5;CSQ=GCGGAGCGGAGGGAGGCGGG|upstream_gene_variant|MODIFIER|CLN6|54982|Transcript|NM_017882.3|protein_coding||||||||||rs71145145|39|-1||insertion|EntrezGene||YES|||||||||||0.3484|0.08363|0.2291|0.38|0.5969|0.3855|0.3466|0.3308|0.331|0.3989|0.3007|0.09364|0.4837|0.2606|0.4164|0.5668|0.4158|0.309|0.3738|0.308|0.5215|0.5969|gnomADe_EAS|uncertain_significance||1|||||||||||||||||||||||||||1049714||Uncertain_significance|not_provided|NC_000015.10:g.68229774_68229793dup||Duplication|CLN6:54982|MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,24:1:24:0,14:0,10:67:134,70,0:116.66,66.662,1.0354e-06:0,14,17.01:0,0,7,17:0,0,13,11	1/1:0,23:1:23:0,12:0,11:65:131,68,0:114.79,64.792,1.5532e-06:0,13,16:0,0,7,16:0,0,16,7	0/1:17,8:0.32:25:10,5:7,3:47:64,0,47:49.578,9.1378e-05,50:0,14,17.01:8,9,4,4:7,10,5,3	GCGGAGCGGAGGGAGGCGGG	upstream_gene_variant	MODIFIER	CLN6	54982	Transcript	NM_017882.3	protein_coding										rs71145145	39	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.3484	0.08363	0.2291	0.38	0.5969	0.3855	0.3466	0.3308	0.331	0.3989	0.3007	0.09364	0.4837	0.2606	0.4164	0.5668	0.4158	0.309	0.3738	0.308	0.5215	0.5969	gnomADe_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				1049714	NA	Uncertain_significance	not_provided	NC_000015.10:g.68229774_68229793dup		Duplication	CLN6:54982	MedGen:C3661900		criteria_provided&_single_submitter		CLN6	Ceroid lipofuscinosis, neuronal, 6A	AR	601780	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs71145145	chr15_68229767_A_AGCGGAGCGGAGGGAGGCGGG	Female	01-Jan	Homozygous
chr15	71888068	.	T	A	188.46	PASS	"FS=0;MQ=249.48;QD=4.01;SOR=1.514;FractionInformativeReads=1;MQRankSum=5.385;ReadPosRankSum=0.992;R2_5P_bias=11.58;DP=133;AF=0.5;AN=6;AC=4;CSQ=A|missense_variant|MODERATE|MYO9A|4649|Transcript|NM_006901.4|protein_coding|27/42||NM_006901.4:c.5191A>T|NP_008832.2:p.Thr1731Ser|5733|5191|1731|T/S|Act/Tct|rs142639438||-1||SNV|EntrezGene||YES|||T|T|||deleterious_low_confidence(0.02)|benign(0.18)|||0.0001611|0|2.253e-05|0.004842|0|0|0.0001743|7.474e-05|0.0003982|0|0.0002037|4.824e-05|0|0|0.004899|0|0|0|0.0001765|0|0|0.004899|gnomADg_ASJ|uncertain_significance||1||||T|0.25528|-0.168056|T|0.47351|-0.274627|0.65522|0.333&.&0.333|-13|48|32|-32|0.00|0.12|0.00|0.00|MYO9A|likely_benign|hg38|0.1691|T1731S|ENST00000444904.5|B2RTY4|871414||Uncertain_significance|Inborn_genetic_diseases&not_provided|NC_000015.10:g.71888068T>A||single_nucleotide_variant|MYO9A:4649|MeSH:D030342&MedGen:C0950123&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,47:1:47:0,25:0,22:138:226,141,0:188.46,138.46,0:0,34.77,37.77:0,0,31,16:0,0,23,24	0/1:24,17:0.415:41:11,6:13,11:46:82,0,50:47.389,0.00010096,53:0,34.77,37.77:14,10,10,7:13,11,11,6	0/1:25,20:0.444:45:12,13:13,7:47:83,0,50:48.683,8.0506e-05,53:0,34.77,37.77:18,7,14,6:11,14,11,9	A	missense_variant	MODERATE	MYO9A	4649	Transcript	NM_006901.4	protein_coding	27/42		c.5191A>T	p.Thr1731Ser	5733	5191	1731	T/S	Act/Tct	rs142639438	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	deleterious_low_confidence(0.02)	benign(0.18)	NA	NA	0.0001611	0	2.253e-05	0.004842	0	0	0.0001743	7.474e-05	0.0003982	0	0.0002037	4.824e-05	0	0	0.004899	0	0	0	0.0001765	0	0	0.004899	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA	T	0.25528	-0.168056	T	0.47351	-0.274627	0.65522	0.333&.&0.333	-13	48	32	-32	0	0.12	0	0	MYO9A	likely_benign	hg38	0.1691	T1731S	ENST00000444904.5	B2RTY4	871414	NA	Uncertain_significance	Inborn_genetic_diseases&not_provided	NC_000015.10:g.71888068T>A		single_nucleotide_variant	MYO9A:4649	MeSH:D030342&MedGen:C0950123&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		MYO9A	Myasthenic syndrome, congenital, 24, presynaptic	AR	618198	Neuromuscular and musculoskelettal disorders	NBScreening	-4	Likely_benign	BP4_Strong	rs142639438	chr15_71888068_T_A	Female	01-Jan	Homozygous
chr15	72340841	.	T	TCACACACACACA	112.29	PASS	"FS=0;MQ=244.78;QD=2.81;SOR=0.941;FractionInformativeReads=0.485;DP=105;AF=1;AN=6;AC=6;CSQ=CACACACACACA|downstream_gene_variant|MODIFIER|HEXA|3073|Transcript|NM_000520.6|protein_coding||||||||||rs59612514|82|-1||insertion|EntrezGene||YES|||||||||||0|||||||0|||0.3995|0.2629|0.379|0.4891|0.4376|0.3292|0.3953|0.4489|0.4576|0.4016|0.5012|0.5012|gnomADg_SAS|||1|||||||||||||||||||||||||||1049750||Uncertain_significance|not_provided|NC_000015.10:g.72340843AC[22]||Microsatellite|HEXA:3073|MedGen:C3661900||no_assertion_criteria_provided|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,16:1:16:0,9:0,7:43:98,46,0:92.755,42.755,0.00023039:0,2,5:0,0,9,7:0,0,10,6	1/1:0,24:1:24:0,12:0,12:62:118,65,0:112.29,62.293,2.5886e-06:0,3,6.01:0,0,16,8:0,0,14,10	1/1:0,15:1:15:0,7:0,8:40:95,43,0:89.852,39.852,0.0004494:0,2,5:0,0,10,5:0,0,6,9	CACACACACACA	downstream_gene_variant	MODIFIER	HEXA	3073	Transcript	NM_000520.6	protein_coding										rs59612514	82	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.3995	0.2629	0.379	0.4891	0.4376	0.3292	0.3953	0.4489	0.4576	0.4016	0.5012	0.5012	gnomADg_SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				1049750	NA	Uncertain_significance	not_provided	NC_000015.10:g.72340843AC[22]		Microsatellite	HEXA:3073	MedGen:C3661900		no_assertion_criteria_provided		HEXA	Tay-Sachs disease	AR	272800	"Neurodevelopmental, neurodegenerative, and neurogenetic disorders;Inherited disorders of metabolism"	NBScreening	-8	Benign	BA1	rs59612514	chr15_72340841_T_TCACACACACACA	Female	01-Jan	Homozygous
chr15	74897859	.	G	C	143.32	PASS	"FS=0;MQ=250;QD=4.48;SOR=0.818;FractionInformativeReads=1;MQRankSum=4.468;ReadPosRankSum=2.948;R2_5P_bias=5.082;DP=102;AF=0.5;AN=6;AC=4;CSQ=C|3_prime_UTR_variant|MODIFIER|MPI|4351|Transcript|NM_002435.3|protein_coding|8/8||NM_002435.3:c.*129G>C||1433|||||rs80226376||1||SNV|EntrezGene||YES|||G|G||||||0.0024|0.002427|0.0001548|5.716e-05|0.004309|0.03518|0.001976|0|0.0008128|0.00119|0.0005122|0.001129|7.219e-05|0|6.538e-05|0.003749|0.01119|0.002261|0|0.001029|0.0009461|0.0002076|0.03518|gnomADe_EAS|uncertain_significance||1||||||||||||-23|45|20|-24|0.00|0.00|0.01|0.09|MPI|||||||887016||Uncertain_significance|MPI-congenital_disorder_of_glycosylation|NC_000015.10:g.74897859G>C||single_nucleotide_variant|MPI:4351|MONDO:MONDO:0011257&MedGen:C1865145&OMIM:602579&Orphanet:79319||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,32:1:32:0,16:0,16:93:181,96,0:143.32,93.316,0:0,34.77,37.77:0,0,15,17:0,0,19,13	0/1:15,13:0.464:28:7,8:8,5:48:84,0,50:49.689,6.8339e-05,53:0,34.77,37.77:5,10,8,5:5,10,7,6	0/1:20,22:0.524:42:11,9:9,13:48:85,0,50:50,6.6269e-05,52.793:0,34.77,37.77:13,7,10,12:10,10,15,7	C	3_prime_UTR_variant	MODIFIER	MPI	4351	Transcript	NM_002435.3	protein_coding	08-Aug		c.*129G>C		1433					rs80226376	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0024	0.002427	0.0001548	5.716e-05	0.004309	0.03518	0.001976	0	0.0008128	0.00119	0.0005122	0.001129	7.219e-05	0	6.538e-05	0.003749	0.01119	0.002261	0	0.001029	0.0009461	0.0002076	0.03518	gnomADe_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-23	45	20	-24	0	0	0.01	0.09	MPI			NA				887016	NA	Uncertain_significance	MPI-congenital_disorder_of_glycosylation	NC_000015.10:g.74897859G>C		single_nucleotide_variant	MPI:4351	MONDO:MONDO:0011257&MedGen:C1865145&OMIM:602579&Orphanet:79319		criteria_provided&_multiple_submitters&_no_conflicts		MPI	MPI-congenital disorder of glycosylation	AR	602579	Inherited disorders of metabolism	NBScreening	-9	Benign	BP4_Strong,BS1_Supporting,BS2	rs80226376	chr15_74897859_G_C	Female	01-Jan	Homozygous
chr15	78165014	.	G	A	146.32	PASS	"FS=0;MQ=250;QD=4.3;SOR=1.352;FractionInformativeReads=0.971;MQRankSum=4.485;ReadPosRankSum=2.213;R2_5P_bias=5.335;DP=112;AF=0.5;AN=6;AC=4;CSQ=A|missense_variant|MODERATE|IDH3A|3419|Transcript|NM_005530.3|protein_coding|9/11||NM_005530.3:c.802G>A|NP_005521.1:p.Gly268Arg|844|802|268|G/R|Gga/Aga|rs1429951757||1||SNV|EntrezGene||YES|||G|G|||deleterious_low_confidence(0.03)|probably_damaging(1)|||2.053e-06|0|0|0|2.519e-05|0|0|1.799e-06|0|0||||||||||||2.519e-05|gnomADe_EAS|uncertain_significance||1||||D|0.91706|0.433514|D|0.94253|0.481791|0.98851|0.944&.|2|-22|-22|9|0.00|0.06|0.00|0.00|IDH3A|likely_pathogenic|hg38|0.9949|G268R|ENST00000299518.7|P50213|1383523||Uncertain_significance|not_provided|NC_000015.10:g.78165014G>A||single_nucleotide_variant|IDH3A:3419|MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,33:1:33:0,26:0,7:96:184,99,0:146.32,96.322,0:0,34.77,37.77:0,0,12,21:0,0,13,20	0/1:10,23:0.697:33:2,13:8,10:41:85,0,39:50,0.00032851,41.828:0,34.77,37.77:4,6,6,17:4,6,12,11	0/1:19,26:0.578:45:5,10:14,16:47:85,0,48:50,7.9988e-05,50.748:0,34.77,37.77:4,15,8,18:14,5,14,12	A	missense_variant	MODERATE	IDH3A	3419	Transcript	NM_005530.3	protein_coding	11-Sep		c.802G>A	p.Gly268Arg	844	802	268	G/R	Gga/Aga	rs1429951757	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious_low_confidence(0.03)	probably_damaging(1)	NA	NA	2.053e-06	0	0	0	2.519e-05	0	0	1.799e-06	0	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2.519e-05	gnomADe_EAS	uncertain_significance		1	NA	NA	NA	D	0.91706	0.433514	D	0.94253	0.481791	0.98851	0.944&.	2	-22	-22	9	0	0.06	0	0	IDH3A	likely_pathogenic	hg38	0.9949	G268R	ENST00000299518.7	P50213	1383523	NA	Uncertain_significance	not_provided	NC_000015.10:g.78165014G>A		single_nucleotide_variant	IDH3A:3419	MedGen:C3661900		criteria_provided&_single_submitter		IDH3A	IDH3A-related mitochondrialencephalopathy	AR	601149	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	Customized	6	Likely_pathogenic	PM2,PP3_Strong	rs1429951757	chr15_78165014_G_A	Female	01-Jan	Homozygous
chr15	82252727	.	T	G	47.55	PASS	"FS=0;MQ=111.55;MQRankSum=-0.9;QD=1.16;ReadPosRankSum=2.804;SOR=0.776;FractionInformativeReads=1;R2_5P_bias=-6.875;DP=41;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|EFL1|79631|Transcript|NM_024580.6|protein_coding|4/20||NM_024580.6:c.208A>C|NP_078856.4:p.Met70Leu|348|208|70|M/L|Atg/Ctg|rs746154488||-1||SNV|EntrezGene||YES|||T|T|||deleterious(0)|probably_damaging(0.953)|||1.848e-05|0|0|0|0|0|0.0001734|2.249e-05|0|1.16e-05|1.313e-05|0|0|6.533e-05|0|0|0|0|0|0|0.000207|0.000207|gnomADg_SAS|uncertain_significance||1||||T|0.53338|0.0122967|T|0.61534|-0.123259|0.80247|0.531||||||||||likely_pathogenic|hg38|0.8661|M70L|ENST00000268206.12|Q7Z2Z2|1933993||Uncertain_significance|not_provided|NC_000015.10:g.82252727T>G||single_nucleotide_variant|EFL1:79631|MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:20,21:0.512:41:6,13:14,8:46:82,0,49:47.55,0.0001051,51.797:0,34.77,37.77:9,11,9,12:13,7,13,8	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	EFL1	79631	Transcript	NM_024580.6	protein_coding	20-Apr		c.208A>C	p.Met70Leu	348	208	70	M/L	Atg/Ctg	rs746154488	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	deleterious(0)	probably_damaging(0.953)	NA	NA	1.848e-05	0	0	0	0	0	0.0001734	2.249e-05	0	1.16e-05	1.313e-05	0	0	6.533e-05	0	0	0	0	0	0	0.000207	0.000207	gnomADg_SAS	uncertain_significance		1	NA	NA	NA	T	0.53338	0.0122967	T	0.61534	-0.123259	0.80247	0.531	NA	NA	NA	NA	NA	NA	NA	NA		likely_pathogenic	hg38	0.8661	M70L	ENST00000268206.12	Q7Z2Z2	1933993	NA	Uncertain_significance	not_provided	NC_000015.10:g.82252727T>G		single_nucleotide_variant	EFL1:79631	MedGen:C3661900		criteria_provided&_single_submitter		EFL1	Shwachman-Diamond syndrome 2	AR	617941	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	3	Uncertain_significance	PM2,PP3	rs746154488	chr15_82252727_T_G	Female	./.	Other
chr15	82538982	.	A	G	191.47	PASS	"FS=0;MQ=242.39;QD=4.63;SOR=1.071;FractionInformativeReads=1;MQRankSum=3.908;ReadPosRankSum=2.251;R2_5P_bias=-8.037;DP=110;AF=0.5;AN=6;AC=5;CSQ=G|synonymous_variant|LOW|RPS17|6218|Transcript|NM_001021.6|protein_coding|3/5||NM_001021.6:c.159T>C|NP_001012.1:p.Tyr53%3D|188|159|53|Y|taT/taC|rs6991&CM1313014||-1||SNV|EntrezGene||YES|||A|A|||||||0.3098|0.1579|0.1629|0.3116|0.279|0.3769|0.3362|0.3093|0.3116|0.4205|0.2641|0.1651|0.3936|0.2043|0.2966|0.2364|0.3693|0.3605|0.3087|0.2768|0.4165|0.4205|gnomADe_SAS|likely_benign&uncertain_significance|0&1|1&1||||||||||||3|-19|-43|-19|0.00|0.00|0.00|0.00|RPS17|||||||419839||Conflicting_classifications_of_pathogenicity|not_specified&Diamond-Blackfan_anemia|NC_000015.10:g.82538982A>G||single_nucleotide_variant|RPS17:6218|MedGen:CN169374&Human_Phenotype_Ontology:HP:0004810&Human_Phenotype_Ontology:HP:0005545&MONDO:MONDO:0015253&MeSH:D029503&MedGen:C1260899&OMIM:PS105650&Orphanet:124|Uncertain_significance(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,29:1:29:0,16:0,13:84:172,87,0:134.28,84.277,0:0,34.77,37.77:0,0,12,17:0,0,13,16	1/1:0,48:1:48:0,23:0,25:141:229,144,0:191.47,141.47,0:0,34.77,37.77:0,0,21,27:0,0,26,22	0/1:17,16:0.485:33:4,6:13,10:48:85,0,50:49.934,6.5751e-05,53:0,34.77,37.77:4,13,3,13:11,6,7,9	G	synonymous_variant	LOW	RPS17	6218	Transcript	NM_001021.6	protein_coding	05-Mar		c.159T>C	p.Tyr53%3D	188	159	53	Y	taT/taC	rs6991&CM1313014	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.3098	0.1579	0.1629	0.3116	0.279	0.3769	0.3362	0.3093	0.3116	0.4205	0.2641	0.1651	0.3936	0.2043	0.2966	0.2364	0.3693	0.3605	0.3087	0.2768	0.4165	0.4205	gnomADe_SAS	likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		3	-19	-43	-19	0	0	0	0	RPS17			NA				419839	NA	Conflicting_classifications_of_pathogenicity	not_specified&Diamond-Blackfan_anemia	NC_000015.10:g.82538982A>G		single_nucleotide_variant	RPS17:6218	MedGen:CN169374&Human_Phenotype_Ontology:HP:0004810&Human_Phenotype_Ontology:HP:0005545&MONDO:MONDO:0015253&MeSH:D029503&MedGen:C1260899&OMIM:PS105650&Orphanet:124	Uncertain_significance(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		RPS17	Diamond-Blackfan anemia 4	AD	612527	Haematological disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs6991	chr15_82538982_A_G	Female	01-Jan	Homozygous
chr15	89318587	.	G	A	47.21	PASS	"FS=0;MQ=250;MQRankSum=5.975;QD=0.93;ReadPosRankSum=1.867;SOR=0.632;FractionInformativeReads=0.98;R2_5P_bias=8.741;DP=51;AF=0.5;AN=2;AC=1;CSQ=A|missense_variant|MODERATE|POLG|5428|Transcript|NM_002693.3|protein_coding|21/23||NM_002693.3:c.3436C>T|NP_002684.1:p.Arg1146Cys|3747|3436|1146|R/C|Cgc/Tgc|rs2307440&CM060433&COSV51525791||-1||SNV|EntrezGene||YES|||G|G|||deleterious_low_confidence(0.01)|probably_damaging(0.999)||0.0002|0.0001491|5.974e-05|6.708e-05|0|0.0001763|0|0.0001762|0.0001601|0.0001159|0.0002319|0.000151|4.813e-05|0|6.533e-05|0|0.0001934|0|0|0.0002499|0.0004726|0.0002071|0.001|EAS|uncertain_significance&conflicting_interpretations_of_pathogenicity|0&1&1|1&1&1||||D|0.83057|0.30109|D|0.94918|0.512792|0.97776|0.915&0.915|-27|40|28|-46|0.00|0.00|0.00|0.00|POLG|likely_benign|hg38|0.134|R1146C|ENST00000442287.6|P54098|21313||Conflicting_classifications_of_pathogenicity|Progressive_sclerosing_poliodystrophy&not_provided&not_specified|NC_000015.10:g.89318587G>A||single_nucleotide_variant|POLG:5428|MONDO:MONDO:0008758&MedGen:C0205710&OMIM:203700&Orphanet:726&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(7)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:29,21:0.42:50:13,10:16,11:46:82,0,50:47.209,0.00010432,53:0,34.77,37.77:12,17,9,12:20,9,10,11	A	missense_variant	MODERATE	POLG	5428	Transcript	NM_002693.3	protein_coding	21/23		c.3436C>T	p.Arg1146Cys	3747	3436	1146	R/C	Cgc/Tgc	rs2307440&CM060433&COSV51525791	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious_low_confidence(0.01)	probably_damaging(0.999)	NA	2,00E-04	0.0001491	5.974e-05	6.708e-05	0	0.0001763	0	0.0001762	0.0001601	0.0001159	0.0002319	0.000151	4.813e-05	0	6.533e-05	0	0.0001934	0	0	0.0002499	0.0004726	0.0002071	0.001	EAS	uncertain_significance&conflicting_interpretations_of_pathogenicity	0&1&1	1&1&1	NA	NA	NA	D	0.83057	0.30109	D	0.94918	0.512792	0.97776	0.915&0.915	-27	40	28	-46	0	0	0	0	POLG	likely_benign	hg38	0.134	R1146C	ENST00000442287.6	P54098	21313	NA	Conflicting_classifications_of_pathogenicity	Progressive_sclerosing_poliodystrophy&not_provided&not_specified	NC_000015.10:g.89318587G>A		single_nucleotide_variant	POLG:5428	MONDO:MONDO:0008758&MedGen:C0205710&OMIM:203700&Orphanet:726&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(7)&Benign(1)	criteria_provided&_conflicting_classifications		POLG	POLG-Related Ataxia Neuropathy Spectrum Disorders	AR	NA	Neuromuscular and musculoskelettal disorders	NBScreening	0	Uncertain_significance		rs2307440	chr15_89318587_G_A	Female	./.	Other
chr16	2088669	.	TAA	T	152.33	PASS	"FS=8.852;MQ=250;MQRankSum=4.256;QD=1.92;ReadPosRankSum=-0.467;SOR=0.806;FractionInformativeReads=1;R2_5P_bias=7.229;DP=61;AF=1;AN=4;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|TSC2|7249|Transcript|NM_000548.5|protein_coding|42/42||NM_000548.5:c.*61_*62del||5594-5595|||||rs36032671||1||deletion|EntrezGene||YES|||AA|AA|||||1||0.08819|0.01453|0.03644|0.09416|0.0002185|0.139|0.05446|0.09614|0.08007|0.05769|0.06529|0.01714|0.03077|0.05209|0.08266|0.0005848|0.1363|0.03061|0.09178|0.05916|0.05692|0.139|gnomADe_FIN|uncertain_significance&not_provided&benign||1||||||||||||-10|-25|-16|-25|0.00|0.00|0.00|0.00|TSC2|||||||50172||Conflicting_classifications_of_pathogenicity|not_provided&Lymphangiomyomatosis&Tuberous_sclerosis_syndrome&not_specified|NC_000016.10:g.2088671_2088672del||Deletion|TSC2:7249|MedGen:C3661900&MONDO:MONDO:0011705&MedGen:C0751674&OMIM:606690&Orphanet:538&MONDO:MONDO:0001734&MedGen:C0041341&OMIM:PS191100&Orphanet:805&MedGen:CN169374|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,15:0.577:26:6,10:5,5:48:79,0,49:50,7.2999e-05,51.661:0,29,32:3,8,9,6:6,5,10,5	1/1:0,35:1:35:0,23:0,12:102:184,105,0:152.33,102.33,0:0,29,32:0,0,22,13:0,0,16,19	./.:.:.:.:.:.:.:.:.:.:.:.	-	3_prime_UTR_variant	MODIFIER	TSC2	7249	Transcript	NM_000548.5	protein_coding	42/42		c.*61_*62del		5594-5595					rs36032671	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	AA	AA	NA	NA			1	NA	0.08819	0.01453	0.03644	0.09416	0.0002185	0.139	0.05446	0.09614	0.08007	0.05769	0.06529	0.01714	0.03077	0.05209	0.08266	0.0005848	0.1363	0.03061	0.09178	0.05916	0.05692	0.139	gnomADe_FIN	uncertain_significance&not_provided&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-10	-25	-16	-25	0	0	0	0	TSC2			NA				50172	NA	Conflicting_classifications_of_pathogenicity	not_provided&Lymphangiomyomatosis&Tuberous_sclerosis_syndrome&not_specified	NC_000016.10:g.2088671_2088672del		Deletion	TSC2:7249	MedGen:C3661900&MONDO:MONDO:0011705&MedGen:C0751674&OMIM:606690&Orphanet:538&MONDO:MONDO:0001734&MedGen:C0041341&OMIM:PS191100&Orphanet:805&MedGen:CN169374	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		TSC2	Tuberous sclerosis 2	AD	613254	Tumor predisposition syndromes	NBScreening	-9	Benign	BP6,BA1	rs36032671	chr16_2088669_TAA_T	Female	0/1	Heterozygous
chr16	30740075	.	CT	C	50	PASS	"FS=6.862;MQ=250;MQRankSum=3.995;QD=2.08;ReadPosRankSum=0.119;SOR=1.305;FractionInformativeReads=1;R2_5P_bias=2.59;DP=56;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|SRCAP|10847|Transcript|NM_006662.3|protein_coding|34/34||NM_006662.3:c.*358del||10391|||||rs397854666||1||deletion|EntrezGene||YES|||T|T|||||15||0.1842|0.3866|0.1667|0.1895|0.09399|0.2238|0.1667|0.1846|0.1678|0.3696|0.3913|0.6625|0.4311|0.2723|0.2916|0.1154|0.2299|0.3467|0.2789|0.3603|0.6888|0.6888|gnomADg_SAS|uncertain_significance||1||||||||||||-27|19|13|-10|0.00|0.00|0.00|0.00|SRCAP|||||||318926||Uncertain_significance|Floating-Harbor_syndrome&not_provided|NC_000016.10:g.30740091del||Deletion|SRCAP:10847|MONDO:MONDO:0007621&MedGen:C0729582&OMIM:136140&Orphanet:2044&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:9,15:0.625:24:6,10:3,5:47:57,0,47:50,8.7754e-05,49.905:0,7,10:3,6,10,5:4,5,9,6	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:18,13:0.419:31:13,8:5,5:47:55,0,50:48.039,9.0084e-05,53:0,7,10:10,8,10,3:9,9,5,8	-	3_prime_UTR_variant	MODIFIER	SRCAP	10847	Transcript	NM_006662.3	protein_coding	34/34		c.*358del		10391					rs397854666	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			15	NA	0.1842	0.3866	0.1667	0.1895	0.09399	0.2238	0.1667	0.1846	0.1678	0.3696	0.3913	0.6625	0.4311	0.2723	0.2916	0.1154	0.2299	0.3467	0.2789	0.3603	0.6888	0.6888	gnomADg_SAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-27	19	13	-10	0	0	0	0	SRCAP			NA				318926	NA	Uncertain_significance	Floating-Harbor_syndrome&not_provided	NC_000016.10:g.30740091del		Deletion	SRCAP:10847	MONDO:MONDO:0007621&MedGen:C0729582&OMIM:136140&Orphanet:2044&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		SRCAP	Floating-Harbor syndrome	AD	136140	Skelettal, skin, and connective tissue disorders	NBScreening	-8	Benign	BA1	rs397854666	chr16_30740075_CT_C	Female	0/1	Heterozygous
chr16	68833708	.	C	CT	50	PASS	"FS=0;MQ=249.2;MQRankSum=4.031;QD=2.17;ReadPosRankSum=0.831;SOR=0.551;FractionInformativeReads=1;R2_5P_bias=-9.095;DP=23;AF=0.5;AN=2;AC=1;CSQ=T|3_prime_UTR_variant|MODIFIER|CDH1|999|Transcript|NM_004360.5|protein_coding|16/16||NM_004360.5:c.*221dup||2982-2983|||||rs145920869||1||insertion|EntrezGene||YES|||||||||12||0.1617|0.1905|0.1668|0.1575|0.135|0.1753|0.161|0.1707|0.1656|0.1105|0.1943|0.2016|0.1163|0.186|0.1874|0.1637|0.2121|0.2465|0.1988|0.1769|0.1136|0.2465|gnomADg_MID|uncertain_significance&benign||1||||||||||||47|-1|-38|-36|0.00|0.00|0.00|0.00|CDH1|||||||320271||Conflicting_classifications_of_pathogenicity|Hereditary_diffuse_gastric_adenocarcinoma&not_provided|NC_000016.10:g.68833720dup||Duplication|CDH1:999|MONDO:MONDO:0007648&MedGen:C1708349&OMIM:137215&Orphanet:26106&MedGen:C3661900|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,12:0.522:23:6,5:5,7:48:61,0,50:50,6.5751e-05,52.904:0,11,14:5,6,6,6:8,3,5,7	./.:.:.:.:.:.:.:.:.:.:.:.	T	3_prime_UTR_variant	MODIFIER	CDH1	999	Transcript	NM_004360.5	protein_coding	16/16		c.*221dup		2982-2983					rs145920869	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			12	NA	0.1617	0.1905	0.1668	0.1575	0.135	0.1753	0.161	0.1707	0.1656	0.1105	0.1943	0.2016	0.1163	0.186	0.1874	0.1637	0.2121	0.2465	0.1988	0.1769	0.1136	0.2465	gnomADg_MID	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		47	-1	-38	-36	0	0	0	0	CDH1			NA				320271	NA	Conflicting_classifications_of_pathogenicity	Hereditary_diffuse_gastric_adenocarcinoma&not_provided	NC_000016.10:g.68833720dup		Duplication	CDH1:999	MONDO:MONDO:0007648&MedGen:C1708349&OMIM:137215&Orphanet:26106&MedGen:C3661900	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		CDH1	Hereditary diffuse gastric adenocarcinoma	AD	137215	Tumor predisposition syndromes	NBScreening	-9	Benign	BP6,BA1	rs145920869	chr16_68833708_C_CT	Female	./.	Other
chr16	68833708	.	C	CT	50	PASS	"FS=0;MQ=249.2;MQRankSum=4.031;QD=2.17;ReadPosRankSum=0.831;SOR=0.551;FractionInformativeReads=1;R2_5P_bias=-9.095;DP=23;AF=0.5;AN=2;AC=1;CSQ=T|3_prime_UTR_variant|MODIFIER|CDH1|999|Transcript|NM_004360.5|protein_coding|16/16||NM_004360.5:c.*221dup||2982-2983|||||rs145920869||1||insertion|EntrezGene||YES|||||||||12||0.1617|0.1905|0.1668|0.1575|0.135|0.1753|0.161|0.1707|0.1656|0.1105|0.1943|0.2016|0.1163|0.186|0.1874|0.1637|0.2121|0.2465|0.1988|0.1769|0.1136|0.2465|gnomADg_MID|uncertain_significance&benign||1||||||||||||47|-1|-38|-36|0.00|0.00|0.00|0.00|CDH1|||||||320271||Conflicting_classifications_of_pathogenicity|Hereditary_diffuse_gastric_adenocarcinoma&not_provided|NC_000016.10:g.68833720dup||Duplication|CDH1:999|MONDO:MONDO:0007648&MedGen:C1708349&OMIM:137215&Orphanet:26106&MedGen:C3661900|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,12:0.522:23:6,5:5,7:48:61,0,50:50,6.5751e-05,52.904:0,11,14:5,6,6,6:8,3,5,7	./.:.:.:.:.:.:.:.:.:.:.:.	T	3_prime_UTR_variant	MODIFIER	CDH1	999	Transcript	NM_004360.5	protein_coding	16/16		c.*221dup		2982-2983					rs145920869	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			12	NA	0.1617	0.1905	0.1668	0.1575	0.135	0.1753	0.161	0.1707	0.1656	0.1105	0.1943	0.2016	0.1163	0.186	0.1874	0.1637	0.2121	0.2465	0.1988	0.1769	0.1136	0.2465	gnomADg_MID	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		47	-1	-38	-36	0	0	0	0	CDH1			NA				320271	NA	Conflicting_classifications_of_pathogenicity	Hereditary_diffuse_gastric_adenocarcinoma&not_provided	NC_000016.10:g.68833720dup		Duplication	CDH1:999	MONDO:MONDO:0007648&MedGen:C1708349&OMIM:137215&Orphanet:26106&MedGen:C3661900	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		CDH1	Gastric cancer	AD	613659	Tumor predisposition syndromes	NBScreening	-9	Benign	BP6,BA1	rs145920869	chr16_68833708_C_CT	Female	./.	Other
chr16	81379479	.	C	G	50	PASS	"FS=1.137;MQ=250;MQRankSum=5.699;QD=1.11;ReadPosRankSum=3.643;SOR=0.904;FractionInformativeReads=1;R2_5P_bias=11.384;DP=45;AF=0.5;AN=2;AC=1;CSQ=G|3_prime_UTR_variant|MODIFIER|GAN|8139|Transcript|NM_022041.4|protein_coding|11/11||NM_022041.4:c.*1883C>G||3829|||||rs76019247||1||SNV|EntrezGene||YES|||C|C||||||0.0006|0|||||||0|||0.0003021|2.406e-05|0|0.0001307|0|0.00289|0.001415|0.003401|0.0001617|0.000473|0|0.003401|gnomADg_MID|uncertain_significance||1||||||||||||-7|27|-35|-15|0.00|0.00|0.00|0.00|GAN|||||||320702||Uncertain_significance|Giant_axonal_neuropathy_1|NC_000016.10:g.81379479C>G||single_nucleotide_variant|GAN:8139|MONDO:MONDO:0009749&MedGen:C1850386&OMIM:256850&Orphanet:643||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:20,25:0.556:45:11,12:9,13:48:85,0,49:50,7.1705e-05,51.878:0,34.77,37.77:11,9,15,10:12,8,12,13	./.:.:.:.:.:.:.:.:.:.:.:.	G	3_prime_UTR_variant	MODIFIER	GAN	8139	Transcript	NM_022041.4	protein_coding	11-Nov		c.*1883C>G		3829					rs76019247	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	6,00E-04	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.0003021	2.406e-05	0	0.0001307	0	0.00289	0.001415	0.003401	0.0001617	0.000473	0	0.003401	gnomADg_MID	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-7	27	-35	-15	0	0	0	0	GAN			NA				320702	NA	Uncertain_significance	Giant_axonal_neuropathy_1	NC_000016.10:g.81379479C>G		single_nucleotide_variant	GAN:8139	MONDO:MONDO:0009749&MedGen:C1850386&OMIM:256850&Orphanet:643		criteria_provided&_single_submitter		GAN	Giant axonal neuropathy 1	AR	256850	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-5	Likely_benign	BP4_Strong,BS1_Supporting	rs76019247	chr16_81379479_C_G	Female	./.	Other
chr16	86514249	.	CT	C	157.63	PASS	"FS=0;MQ=250;QD=4.97;SOR=0.784;FractionInformativeReads=0.955;DP=94;AF=1;AN=6;AC=6;CSQ=-|3_prime_UTR_variant|MODIFIER|FOXF1|2294|Transcript|NM_001451.3|protein_coding|2/2||NM_001451.3:c.*1176del||2348|||||rs397854726||1||deletion|EntrezGene||YES|||T|T|||||11|0.5383|||||||||||0.5316|0.3087|0.5843|0.6498|0.5557|0.8136|0.6429|0.4464|0.6041|0.5555|0.5023|0.8136|gnomADg_EAS|uncertain_significance&benign||1||||||||||||-11|35|-27|46|0.00|0.00|0.00|0.00|FOXF1|||||||320830||Conflicting_classifications_of_pathogenicity|Alveolar_capillary_dysplasia_with_pulmonary_venous_misalignment&not_provided|NC_000016.10:g.86514261del||Deletion|FOXF1:2294|MONDO:MONDO:0009934&MedGen:C2960310&OMIM:265380&Orphanet:210122&MedGen:C3661900|Uncertain_significance(1)&Benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,21:1:21:0,12:0,9:59:122,62,0:109.44,59.44,4.9183e-06:0,10,13:0,0,10,11:0,0,7,14	1/1:0,35:1:35:0,19:0,16:102:166,105,0:151.66,101.66,0:0,11,14:0,0,12,23:0,0,18,17	1/1:0,37:1:37:0,20:0,17:108:171,111,0:157.63,107.63,0:0,10,13:0,0,18,19:0,0,17,20	-	3_prime_UTR_variant	MODIFIER	FOXF1	2294	Transcript	NM_001451.3	protein_coding	02-Feb		c.*1176del		2348					rs397854726	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			11	0.5383	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.5316	0.3087	0.5843	0.6498	0.5557	0.8136	0.6429	0.4464	0.6041	0.5555	0.5023	0.8136	gnomADg_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-11	35	-27	46	0	0	0	0	FOXF1			NA				320830	NA	Conflicting_classifications_of_pathogenicity	Alveolar_capillary_dysplasia_with_pulmonary_venous_misalignment&not_provided	NC_000016.10:g.86514261del		Deletion	FOXF1:2294	MONDO:MONDO:0009934&MedGen:C2960310&OMIM:265380&Orphanet:210122&MedGen:C3661900	Uncertain_significance(1)&Benign(2)	criteria_provided&_conflicting_classifications		FOXF1	Alveolar capillary dysplasia with pulmonary venous misalignment	AD	265380	Respiratory system disorders	NBScreening	-9	Benign	BP6,BA1	rs397854726	chr16_86514249_CT_C	Female	01-Jan	Homozygous
chr16	89816740	.	A	AGGCCTTGCGTCGT	50	PASS	"FS=1.922;MQ=250;MQRankSum=3.423;QD=2.17;ReadPosRankSum=0.701;SOR=0.307;FractionInformativeReads=0.87;R2_5P_bias=-9.632;DP=91;AF=0.5;AN=6;AC=3;CSQ=GGCCTTGCGTCGT|upstream_gene_variant|MODIFIER|FANCA|2175|Transcript|NM_000135.4|protein_coding||||||||||rs11275235|93|-1||insertion|EntrezGene||YES||||||||||0.5230|0.2739|0.4104|0.4624|0.1766|0.9576|0.3603|0.2057|0.2121|0.303|0.4074|0.3957|0.4731|0.2539|0.465|0.1948|0.9688|0.3791|0.1747|0.3009|0.3658|0.4746|0.9688|gnomADg_EAS|uncertain_significance&benign||1|||||||||||||||||||||||||||210970||Conflicting_classifications_of_pathogenicity|not_specified&not_provided|NC_000016.10:g.89816745_89816757dup||Duplication|FANCA:2175&LOC112486223:112486223|MedGen:CN169374&MedGen:C3661900|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:6,14:0.7:20:3,8:3,6:45:79,0,43:50,0.00015221,46.009:0,29,32:2,4,7,7:3,3,5,9	0/1:18,16:0.471:34:9,8:9,8:48:79,0,50:49.715,6.8081e-05,53:0,29,32:11,7,4,12:8,10,8,8	0/1:8,17:0.68:25:5,9:3,8:45:79,0,43:50,0.00015169,46.037:0,29,32:4,4,9,8:3,5,5,12	GGCCTTGCGTCGT	upstream_gene_variant	MODIFIER	FANCA	2175	Transcript	NM_000135.4	protein_coding										rs11275235	93	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.523	0.2739	0.4104	0.4624	0.1766	0.9576	0.3603	0.2057	0.2121	0.303	0.4074	0.3957	0.4731	0.2539	0.465	0.1948	0.9688	0.3791	0.1747	0.3009	0.3658	0.4746	0.9688	gnomADg_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				210970	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided	NC_000016.10:g.89816745_89816757dup		Duplication	FANCA:2175&LOC112486223:112486223	MedGen:CN169374&MedGen:C3661900	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		FANCA	Fanconi anemia complementation group A	AR	227650	Tumor predisposition syndromes	NBScreening	-9	Benign	BP6,BA1	rs11275235	chr16_89816740_A_AGGCCTTGCGTCGT	Female	0/1	Heterozygous
chr17	7668836	.	GA	G	147.51	PASS	"FS=22.897;MQ=249.19;MQRankSum=2.951;QD=4.1;ReadPosRankSum=-1.241;SOR=2.468;FractionInformativeReads=0.917;R2_5P_bias=0;DP=100;AF=0.5;AN=6;AC=5;CSQ=-|3_prime_UTR_variant|MODIFIER|TP53|7157|Transcript|NM_000546.6|protein_coding|11/11||NM_000546.6:c.*772del||2096|||||rs200757381||-1||deletion|EntrezGene||YES|||A|A|||||||0.4483|0.4651|0.4565|0.4551|0.4402|0.5|0.4558|0.4484|0.4493|0.4046|0.6659|0.7251|0.5889|0.7065|0.6477|0.5543|0.6479|0.6368|0.6448|0.6641|0.5297|0.7251|gnomADg_AFR|uncertain_significance||1||||||||||||34|-38|-2|34|0.00|0.06|0.00|0.00|TP53|||||||325628||Uncertain_significance|not_provided&Li-Fraumeni_syndrome|NC_000017.11:g.7668854del||Deletion|TP53:7157|MedGen:C3661900&MONDO:MONDO:0018875&MedGen:C0085390&OMIM:PS151623&Orphanet:524||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:4,29:0.879:33:2,14:2,15:98:158,101,0:147.51,97.513,0:0,7,10.01:0,4,23,6:2,2,14,15	1/1:1,23:0.958:24:0,7:1,16:64:124,67,0:113.84,63.835,1.812e-06:0,7,10.01:0,1,18,5:1,0,8,15	0/1:14,17:0.548:31:6,5:8,12:48:56,0,49:50,6.9893e-05,52.159:0,6,9:10,4,9,8:6,8,9,8	-	3_prime_UTR_variant	MODIFIER	TP53	7157	Transcript	NM_000546.6	protein_coding	11-Nov		c.*772del		2096					rs200757381	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.4483	0.4651	0.4565	0.4551	0.4402	0.5	0.4558	0.4484	0.4493	0.4046	0.6659	0.7251	0.5889	0.7065	0.6477	0.5543	0.6479	0.6368	0.6448	0.6641	0.5297	0.7251	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		34	-38	-2	34	0	0.06	0	0	TP53			NA				325628	NA	Uncertain_significance	not_provided&Li-Fraumeni_syndrome	NC_000017.11:g.7668854del		Deletion	TP53:7157	MedGen:C3661900&MONDO:MONDO:0018875&MedGen:C0085390&OMIM:PS151623&Orphanet:524		criteria_provided&_multiple_submitters&_no_conflicts		TP53	Li-Fraumeni syndrome 1	AD	151623	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs200757381	chr17_7668836_GA_G	Female	01-Jan	Homozygous
chr17	10638240	.	C	T	45.72	PASS	"FS=0;MQ=247.37;MQRankSum=3.389;QD=1.69;ReadPosRankSum=2.736;SOR=0.711;FractionInformativeReads=1;R2_5P_bias=10.703;DP=27;AF=0.5;AN=2;AC=1;CSQ=T|missense_variant|MODERATE|MYH3|4621|Transcript|NM_002470.4|protein_coding|27/41||NM_002470.4:c.3532G>A|NP_002461.2:p.Asp1178Asn|3620|3532|1178|D/N|Gac/Aac|rs199834077||-1||SNV|EntrezGene||YES|||C|C|||deleterious_low_confidence(0)|probably_damaging(0.991)|||0.0005274|0.0001195|4.472e-05|0|0|0|0.0001734|0.0006592|0.0004802|2.319e-05|0.0002697|0.0001209|0|0|0|0|0|0|0.0005146|0.0004794|0|0.0006592|gnomADe_NFE|uncertain_significance&likely_benign||1||||T|0.12710|-0.261629|T|0.48638|-0.26187|||1|-24|-35|49|0.00|0.00|0.00|0.00|MYH3|likely_benign|hg38|0.2297|D1178N|ENST00000583535.6|P11055|885219||Conflicting_classifications_of_pathogenicity|Freeman-Sheldon_syndrome&Distal_arthrogryposis_type_2B1&Contractures&_pterygia&_and_variable_skeletal_fusions_syndrome_1B&Arthrogryposis&_distal&_type_2B3&Contractures&_pterygia&_and_spondylocarpotarsal_fusion_syndrome_1A&not_provided|NC_000017.11:g.10638240C>T||single_nucleotide_variant|MYH3:4621|MONDO:MONDO:0008675&MedGen:C0265224&OMIM:193700&Orphanet:2053&MONDO:MONDO:0020820&MedGen:C5193014&OMIM:601680&Orphanet:1147&MONDO:MONDO:0020746&MedGen:C5193114&OMIM:618469&MONDO:MONDO:0032751&MedGen:C5193098&OMIM:618436&MONDO:MONDO:0008338&MedGen:C1867440&OMIM:178110&Orphanet:65743&MedGen:C3661900|Uncertain_significance(3)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:17,10:0.37:27:9,8:8,2:45:80,0,50:45.721,0.00013797,53:0,34.77,37.77:10,7,6,4:10,7,6,4	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	MYH3	4621	Transcript	NM_002470.4	protein_coding	27/41		c.3532G>A	p.Asp1178Asn	3620	3532	1178	D/N	Gac/Aac	rs199834077	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious_low_confidence(0)	probably_damaging(0.991)	NA	NA	0.0005274	0.0001195	4.472e-05	0	0	0	0.0001734	0.0006592	0.0004802	2.319e-05	0.0002697	0.0001209	0	0	0	0	0	0	0.0005146	0.0004794	0	0.0006592	gnomADe_NFE	uncertain_significance&likely_benign		1	NA	NA	NA	T	0.1271	-0.261629	T	0.48638	-0.26187	NA		1	-24	-35	49	0	0	0	0	MYH3	likely_benign	hg38	0.2297	D1178N	ENST00000583535.6	P11055	885219	NA	Conflicting_classifications_of_pathogenicity	Freeman-Sheldon_syndrome&Distal_arthrogryposis_type_2B1&Contractures&_pterygia&_and_variable_skeletal_fusions_syndrome_1B&Arthrogryposis&_distal&_type_2B3&Contractures&_pterygia&_and_spondylocarpotarsal_fusion_syndrome_1A&not_provided	NC_000017.11:g.10638240C>T		single_nucleotide_variant	MYH3:4621	MONDO:MONDO:0008675&MedGen:C0265224&OMIM:193700&Orphanet:2053&MONDO:MONDO:0020820&MedGen:C5193014&OMIM:601680&Orphanet:1147&MONDO:MONDO:0020746&MedGen:C5193114&OMIM:618469&MONDO:MONDO:0032751&MedGen:C5193098&OMIM:618436&MONDO:MONDO:0008338&MedGen:C1867440&OMIM:178110&Orphanet:65743&MedGen:C3661900	Uncertain_significance(3)&Likely_benign(1)	criteria_provided&_conflicting_classifications		MYH3	Arthrogryposis, distal, type 2B3	AD	618436	Skelettal, skin, and connective tissue disorders	NBScreening	0	Uncertain_significance		rs199834077	chr17_10638240_C_T	Female	./.	Other
chr17	11669635	.	A	G	50	PASS	"FS=0;MQ=250;MQRankSum=4.865;QD=1.29;ReadPosRankSum=2.441;SOR=0.593;FractionInformativeReads=1;R2_5P_bias=12.278;DP=63;AF=0.5;AN=4;AC=2;CSQ=G|missense_variant|MODERATE|DNAH9|1770|Transcript|NM_001372.4|protein_coding|17/69||NM_001372.4:c.3194A>G|NP_001363.2:p.Tyr1065Cys|3223|3194|1065|Y/C|tAt/tGt|rs745715542||1||SNV|EntrezGene||YES|||A|A|||deleterious_low_confidence(0.01)|benign(0.439)|||9.577e-06|0|6.708e-05|0|5.038e-05|0|0|2.698e-06|4.967e-05|3.478e-05|1.314e-05|0|0|6.546e-05|0|0|0|0|1.47e-05|0|0|6.708e-05|gnomADe_AMR|uncertain_significance||1||||T|0.54710|0.0224432|D|0.68389|-0.0296915|0.77142|0.481&0.481|-22|18|19|43|0.00|0.00|0.00|0.00|DNAH9|likely_benign|hg38|0.1474|Y1065C|ENST00000262442.9|Q9NYC9|2887665||Uncertain_significance|not_provided|NC_000017.11:g.11669635A>G||single_nucleotide_variant|DNAH9:1770&LOC126862505:126862505|MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:22,13:0.371:35:12,8:10,5:44:80,0,50:45.102,0.00015584,53:0,34.77,37.77:8,14,5,8:12,10,4,9	0/1:13,15:0.536:28:9,10:4,5:48:85,0,50:50,6.7304e-05,52.613:0,34.77,37.77:7,6,7,8:7,6,10,5	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	DNAH9	1770	Transcript	NM_001372.4	protein_coding	17/69		c.3194A>G	p.Tyr1065Cys	3223	3194	1065	Y/C	tAt/tGt	rs745715542	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	deleterious_low_confidence(0.01)	benign(0.439)	NA	NA	9.577e-06	0	6.708e-05	0	5.038e-05	0	0	2.698e-06	4.967e-05	3.478e-05	1.314e-05	0	0	6.546e-05	0	0	0	0	1.47e-05	0	0	6.708e-05	gnomADe_AMR	uncertain_significance		1	NA	NA	NA	T	0.5471	0.0224432	D	0.68389	-0.0296915	0.77142	0.481&0.481	-22	18	19	43	0	0	0	0	DNAH9	likely_benign	hg38	0.1474	Y1065C	ENST00000262442.9	Q9NYC9	2887665	NA	Uncertain_significance	not_provided	NC_000017.11:g.11669635A>G		single_nucleotide_variant	DNAH9:1770&LOC126862505:126862505	MedGen:C3661900		criteria_provided&_single_submitter		DNAH9	Ciliary dyskinesia, primary, 40	AR	618300	Respiratory system disorders	NBScreening	1	Uncertain_significance	PP3	rs745715542	chr17_11669635_A_G	Female	0/1	Heterozygous
chr17	17236983	.	G	A	136.83	PASS	"FS=1.412;MQ=247.61;MQRankSum=4.704;QD=1.6;ReadPosRankSum=1.687;SOR=0.901;FractionInformativeReads=1;R2_5P_bias=10.509;DP=89;AF=0.5;AN=6;AC=4;CSQ=A|5_prime_UTR_variant|MODIFIER|FLCN|201163|Transcript|NM_144997.7|protein_coding|1/14||NM_144997.7:c.-299C>T||186|||||rs1708629||-1||SNV|EntrezGene||YES|||G|G||||||0.4283|0.5833|||||||0.587|0.5||0.4523|0.1501|0.6897|0.5279|0.5265|0.6252|0.7318|0.3537|0.5601|0.436|0.4094|0.7318|gnomADg_FIN|benign||1||||||||||||-42|27|2|-41|0.00|0.00|0.01|0.04|FLCN|||||||322082||Conflicting_classifications_of_pathogenicity|not_provided&Familial_spontaneous_pneumothorax&Nonpapillary_renal_cell_carcinoma&Birt-Hogg-Dube_syndrome_1&Colorectal_cancer&Birt-Hogg-Dube_syndrome&FLCN-related_disorder|NC_000017.11:g.17236983G>A||single_nucleotide_variant|FLCN:201163|MedGen:C3661900&MONDO:MONDO:0008259&MedGen:C1868193&OMIM:173600&Orphanet:2903&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&MONDO:MONDO:0800445&MedGen:CN375946&OMIM:135150&Orphanet:122&MONDO:MONDO:0005575&MedGen:C0346629&OMIM:114500&MONDO:MONDO:0800444&MedGen:C0346010&OMIM:PS135150&Orphanet:122&.|Uncertain_significance(1)&Benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	0/1:17,14:0.452:31:7,9:10,5:48:84,0,50:49.447,7.1187e-05,53:0,34.77,37.77:9,8,6,8:9,8,7,7:.	1/1:0,30:1:30:0,18:0,12:87:175,90,0:136.83,86.832,0:0,34.77,37.77:0,0,11,19:0,0,11,19:.	0|1:17,11:0.393:28:6,6:11,5:44:80,0,47:45.31,0.00017137,50:0,34.77,37.78:6,11,5,6:9,8,4,7:17236983	A	5_prime_UTR_variant	MODIFIER	FLCN	201163	Transcript	NM_144997.7	protein_coding	14-Jan		c.-299C>T		186					rs1708629	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.4283	0.5833	NA	NA	NA	NA	NA	NA	0.587	0.5	NA	0.4523	0.1501	0.6897	0.5279	0.5265	0.6252	0.7318	0.3537	0.5601	0.436	0.4094	0.7318	gnomADg_FIN	benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-42	27	2	-41	0	0	0.01	0.04	FLCN			NA				322082	NA	Conflicting_classifications_of_pathogenicity	not_provided&Familial_spontaneous_pneumothorax&Nonpapillary_renal_cell_carcinoma&Birt-Hogg-Dube_syndrome_1&Colorectal_cancer&Birt-Hogg-Dube_syndrome&FLCN-related_disorder	NC_000017.11:g.17236983G>A		single_nucleotide_variant	FLCN:201163	MedGen:C3661900&MONDO:MONDO:0008259&MedGen:C1868193&OMIM:173600&Orphanet:2903&MONDO:MONDO:0007763&MedGen:CN074294&OMIM:144700&Orphanet:422526&MONDO:MONDO:0800445&MedGen:CN375946&OMIM:135150&Orphanet:122&MONDO:MONDO:0005575&MedGen:C0346629&OMIM:114500&MONDO:MONDO:0800444&MedGen:C0346010&OMIM:PS135150&Orphanet:122&.	Uncertain_significance(1)&Benign(4)	criteria_provided&_conflicting_classifications		FLCN	Birt-Hogg-Dube syndrome 1	AD	135150	Tumor predisposition syndromes	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs1708629	chr17_17236983_G_A	Female	0/1	Heterozygous
chr17	43044804	.	CTT	C	173.5	PASS	"FS=5.076;MQ=249.74;MQRankSum=3.94;QD=2.08;ReadPosRankSum=1.248;SOR=2.551;FractionInformativeReads=0.917;R2_5P_bias=26.313;DP=68;AF=1;AN=4;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|BRCA1|672|Transcript|NM_007294.4|protein_coding|23/23||NM_007294.4:c.*872_*873del||6577-6578|||||rs59541324||-1||deletion|EntrezGene||YES|||TT|TT|||||||0.2795|0.2167|0.2111|0.262|0.277|0.2924|0.2816|0.27|0.2708|0.3397|0.2775|0.2099|0.247|0.243|0.3317|0.3219|0.3512|0.3288|0.2982|0.2999|0.4323|0.4323|gnomADg_SAS|||1|||||||||||||||||||||||||||323411||Uncertain_significance|Hereditary_breast_ovarian_cancer_syndrome&not_provided|NC_000017.11:g.43044822_43044823del||Deletion|BRCA1:672|MONDO:MONDO:0003582&MeSH:D061325&MedGen:C0677776&Orphanet:145&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,11:0.5:22:7,4:4,7:48:56,0,50:50,6.5233e-05,53:0,6,9:4,7,1,10:2,9,8,3	1/1:1,43:0.977:44:0,25:1,18:124:183,127,0:173.5,123.5,0:0,6,9:1,0,8,35:0,1,18,25	./.:.:.:.:.:.:.:.:.:.:.:.	-	3_prime_UTR_variant	MODIFIER	BRCA1	672	Transcript	NM_007294.4	protein_coding	23/23		c.*872_*873del		6577-6578					rs59541324	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	TT	TT	NA	NA			NA	NA	0.2795	0.2167	0.2111	0.262	0.277	0.2924	0.2816	0.27	0.2708	0.3397	0.2775	0.2099	0.247	0.243	0.3317	0.3219	0.3512	0.3288	0.2982	0.2999	0.4323	0.4323	gnomADg_SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				323411	NA	Uncertain_significance	Hereditary_breast_ovarian_cancer_syndrome&not_provided	NC_000017.11:g.43044822_43044823del		Deletion	BRCA1:672	MONDO:MONDO:0003582&MeSH:D061325&MedGen:C0677776&Orphanet:145&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		BRCA1	Breast-ovarian cancer, familial, susceptibility to, 1	AD	604370	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs59541324	chr17_43044804_CTT_C	Female	0/1	Heterozygous
chr17	44248849	.	GT	G	50	PASS	"FS=2.158;MQ=215.24;MQRankSum=0.772;QD=3.13;ReadPosRankSum=0.209;SOR=1.501;FractionInformativeReads=0.938;R2_5P_bias=14.57;DP=16;AF=0.5;AN=2;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|SLC4A1|6521|Transcript|NM_000342.4|protein_coding|20/20||NM_000342.4:c.*1608del||4494|||||rs57466226||-1||deletion|EntrezGene||YES|||T|T|||||||0.0009074|0|0|0|0|0.001724|0|0.000695|0.003774|0.001133|0.06027|0.05493|0.08088|0.05589|0.08179|0.07026|0.01185|0.07692|0.06534|0.06184|0.01732|0.08179|gnomADg_ASJ|uncertain_significance||1||||||||||||-7|2|-49|-40|0.00|0.00|0.00|0.00|SLC4A1|||||||323479||Uncertain_significance|Hemolytic_anemia&Distal_Renal_Tubular_Acidosis&_Dominant&Spherocytosis&_Dominant&not_provided|NC_000017.11:g.44248877del||Deletion|SLC4A1:6521|Human_Phenotype_Ontology:HP:0001878&Human_Phenotype_Ontology:HP:0001910&Human_Phenotype_Ontology:HP:0004827&Human_Phenotype_Ontology:HP:0004853&Human_Phenotype_Ontology:HP:0004868&Human_Phenotype_Ontology:HP:0005503&MONDO:MONDO:0003664&MedGen:C0002878&MedGen:CN239155&MedGen:CN239455&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:7,8:0.533:15:4,4:3,4:36:55,0,33:50.001,0.0010467,36.364:0,5,8.01:3,4,2,6:4,3,2,6	-	3_prime_UTR_variant	MODIFIER	SLC4A1	6521	Transcript	NM_000342.4	protein_coding	20/20		c.*1608del		4494					rs57466226	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	0.0009074	0	0	0	0	0.001724	0	0.000695	0.003774	0.001133	0.06027	0.05493	0.08088	0.05589	0.08179	0.07026	0.01185	0.07692	0.06534	0.06184	0.01732	0.08179	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-7	2	-49	-40	0	0	0	0	SLC4A1			NA				323479	NA	Uncertain_significance	Hemolytic_anemia&Distal_Renal_Tubular_Acidosis&_Dominant&Spherocytosis&_Dominant&not_provided	NC_000017.11:g.44248877del		Deletion	SLC4A1:6521	Human_Phenotype_Ontology:HP:0001878&Human_Phenotype_Ontology:HP:0001910&Human_Phenotype_Ontology:HP:0004827&Human_Phenotype_Ontology:HP:0004853&Human_Phenotype_Ontology:HP:0004868&Human_Phenotype_Ontology:HP:0005503&MONDO:MONDO:0003664&MedGen:C0002878&MedGen:CN239155&MedGen:CN239455&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		SLC4A1	Renal tubular acidosis, distal, 4, with hemolytic anemia	AR	611590	Renal disorders	NBScreening	-4	Likely_benign	BS2	rs57466226	chr17_44248849_GT_G	Female	./.	Other
chr17	44248849	.	GT	G	50	PASS	"FS=2.158;MQ=215.24;MQRankSum=0.772;QD=3.13;ReadPosRankSum=0.209;SOR=1.501;FractionInformativeReads=0.938;R2_5P_bias=14.57;DP=16;AF=0.5;AN=2;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|SLC4A1|6521|Transcript|NM_000342.4|protein_coding|20/20||NM_000342.4:c.*1608del||4494|||||rs57466226||-1||deletion|EntrezGene||YES|||T|T|||||||0.0009074|0|0|0|0|0.001724|0|0.000695|0.003774|0.001133|0.06027|0.05493|0.08088|0.05589|0.08179|0.07026|0.01185|0.07692|0.06534|0.06184|0.01732|0.08179|gnomADg_ASJ|uncertain_significance||1||||||||||||-7|2|-49|-40|0.00|0.00|0.00|0.00|SLC4A1|||||||323479||Uncertain_significance|Hemolytic_anemia&Distal_Renal_Tubular_Acidosis&_Dominant&Spherocytosis&_Dominant&not_provided|NC_000017.11:g.44248877del||Deletion|SLC4A1:6521|Human_Phenotype_Ontology:HP:0001878&Human_Phenotype_Ontology:HP:0001910&Human_Phenotype_Ontology:HP:0004827&Human_Phenotype_Ontology:HP:0004853&Human_Phenotype_Ontology:HP:0004868&Human_Phenotype_Ontology:HP:0005503&MONDO:MONDO:0003664&MedGen:C0002878&MedGen:CN239155&MedGen:CN239455&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:7,8:0.533:15:4,4:3,4:36:55,0,33:50.001,0.0010467,36.364:0,5,8.01:3,4,2,6:4,3,2,6	-	3_prime_UTR_variant	MODIFIER	SLC4A1	6521	Transcript	NM_000342.4	protein_coding	20/20		c.*1608del		4494					rs57466226	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	0.0009074	0	0	0	0	0.001724	0	0.000695	0.003774	0.001133	0.06027	0.05493	0.08088	0.05589	0.08179	0.07026	0.01185	0.07692	0.06534	0.06184	0.01732	0.08179	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-7	2	-49	-40	0	0	0	0	SLC4A1			NA				323479	NA	Uncertain_significance	Hemolytic_anemia&Distal_Renal_Tubular_Acidosis&_Dominant&Spherocytosis&_Dominant&not_provided	NC_000017.11:g.44248877del		Deletion	SLC4A1:6521	Human_Phenotype_Ontology:HP:0001878&Human_Phenotype_Ontology:HP:0001910&Human_Phenotype_Ontology:HP:0004827&Human_Phenotype_Ontology:HP:0004853&Human_Phenotype_Ontology:HP:0004868&Human_Phenotype_Ontology:HP:0005503&MONDO:MONDO:0003664&MedGen:C0002878&MedGen:CN239155&MedGen:CN239455&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		SLC4A1	Autosomal dominant distal renal tubular acidosis	AD	179800	Renal disorders	NBScreening	-4	Likely_benign	BS2	rs57466226	chr17_44248849_GT_G	Female	./.	Other
chr17	44248849	.	GT	G	50	PASS	"FS=2.158;MQ=215.24;MQRankSum=0.772;QD=3.13;ReadPosRankSum=0.209;SOR=1.501;FractionInformativeReads=0.938;R2_5P_bias=14.57;DP=16;AF=0.5;AN=2;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|SLC4A1|6521|Transcript|NM_000342.4|protein_coding|20/20||NM_000342.4:c.*1608del||4494|||||rs57466226||-1||deletion|EntrezGene||YES|||T|T|||||||0.0009074|0|0|0|0|0.001724|0|0.000695|0.003774|0.001133|0.06027|0.05493|0.08088|0.05589|0.08179|0.07026|0.01185|0.07692|0.06534|0.06184|0.01732|0.08179|gnomADg_ASJ|uncertain_significance||1||||||||||||-7|2|-49|-40|0.00|0.00|0.00|0.00|SLC4A1|||||||323479||Uncertain_significance|Hemolytic_anemia&Distal_Renal_Tubular_Acidosis&_Dominant&Spherocytosis&_Dominant&not_provided|NC_000017.11:g.44248877del||Deletion|SLC4A1:6521|Human_Phenotype_Ontology:HP:0001878&Human_Phenotype_Ontology:HP:0001910&Human_Phenotype_Ontology:HP:0004827&Human_Phenotype_Ontology:HP:0004853&Human_Phenotype_Ontology:HP:0004868&Human_Phenotype_Ontology:HP:0005503&MONDO:MONDO:0003664&MedGen:C0002878&MedGen:CN239155&MedGen:CN239455&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:7,8:0.533:15:4,4:3,4:36:55,0,33:50.001,0.0010467,36.364:0,5,8.01:3,4,2,6:4,3,2,6	-	3_prime_UTR_variant	MODIFIER	SLC4A1	6521	Transcript	NM_000342.4	protein_coding	20/20		c.*1608del		4494					rs57466226	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	0.0009074	0	0	0	0	0.001724	0	0.000695	0.003774	0.001133	0.06027	0.05493	0.08088	0.05589	0.08179	0.07026	0.01185	0.07692	0.06534	0.06184	0.01732	0.08179	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-7	2	-49	-40	0	0	0	0	SLC4A1			NA				323479	NA	Uncertain_significance	Hemolytic_anemia&Distal_Renal_Tubular_Acidosis&_Dominant&Spherocytosis&_Dominant&not_provided	NC_000017.11:g.44248877del		Deletion	SLC4A1:6521	Human_Phenotype_Ontology:HP:0001878&Human_Phenotype_Ontology:HP:0001910&Human_Phenotype_Ontology:HP:0004827&Human_Phenotype_Ontology:HP:0004853&Human_Phenotype_Ontology:HP:0004868&Human_Phenotype_Ontology:HP:0005503&MONDO:MONDO:0003664&MedGen:C0002878&MedGen:CN239155&MedGen:CN239455&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		SLC4A1	Spherocytosis, type 1	AD	182900	Haematological disorders	NBScreening	-4	Likely_benign	BS2	rs57466226	chr17_44248849_GT_G	Female	./.	Other
chr17	44913798	.	C	T	50	PASS	"FS=1.423;MQ=250;MQRankSum=5.282;QD=1.28;ReadPosRankSum=2.591;SOR=1.071;FractionInformativeReads=1;R2_5P_bias=13.815;DP=81;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|GFAP|2670|Transcript|NM_002055.5|protein_coding|3/9||NM_002055.5:c.548G>A|NP_002046.1:p.Arg183His|562|548|183|R/H|cGt/cAt|rs769613792||-1||SNV|EntrezGene||YES|||C|C|||deleterious(0.01)|benign(0.415)|||5.541e-05|2.987e-05|8.944e-05|0|0|3.744e-05|0|5.846e-05|0.000149|0|3.284e-05|0|0|0.0001962|0|0|0|0|2.939e-05|0|0|0.0001962|gnomADg_AMR|uncertain_significance||1||||D|0.77776|0.241225|D|0.88216|0.300409|0.93699|.&.&0.806&.&0.806&.&.&.|25|21|-19|-45|0.00|0.00|0.00|0.00|GFAP|likely_benign|hg38|0.1944|R183H|ENST00000588735.3|P14136|2181293||Uncertain_significance|not_provided|NC_000017.11:g.44913798C>T||single_nucleotide_variant|GFAP:2670|MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,22:0.564:39:7,13:10,9:48:85,0,49:50,7.274e-05,51.704:0,34.77,37.77:5,12,5,17:9,8,6,16	0/1:19,23:0.548:42:13,10:6,13:48:85,0,49:50,6.9375e-05,52.252:0,34.77,37.77:7,12,11,12:5,14,10,13	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	GFAP	2670	Transcript	NM_002055.5	protein_coding	09-Mar		c.548G>A	p.Arg183His	562	548	183	R/H	cGt/cAt	rs769613792	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious(0.01)	benign(0.415)	NA	NA	5.541e-05	2.987e-05	8.944e-05	0	0	3.744e-05	0	5.846e-05	0.000149	0	3.284e-05	0	0	0.0001962	0	0	0	0	2.939e-05	0	0	0.0001962	gnomADg_AMR	uncertain_significance		1	NA	NA	NA	D	0.77776	0.241225	D	0.88216	0.300409	0.93699	.&.&0.806&.&0.806&.&.&.	25	21	-19	-45	0	0	0	0	GFAP	likely_benign	hg38	0.1944	R183H	ENST00000588735.3	P14136	2181293	NA	Uncertain_significance	not_provided	NC_000017.11:g.44913798C>T		single_nucleotide_variant	GFAP:2670	MedGen:C3661900		criteria_provided&_single_submitter		GFAP	Alexander disease	AD	203450	Inherited disorders of metabolism	NBScreening	-4	Likely_benign	PP3,BS1_Supporting,BS2	rs769613792	chr17_44913798_C_T	Female	0/1	Heterozygous
chr17	47947425	.	C	CTT	101.05	PASS	"FS=3.873;MQ=247.67;MQRankSum=4.182;QD=1.4;ReadPosRankSum=-0.507;SOR=0.214;FractionInformativeReads=1;R2_5P_bias=-1.173;DP=85;AF=1;AN=6;AC=4;CSQ=TT|3_prime_UTR_variant|MODIFIER|PNPO|55163|Transcript|NM_018129.4|protein_coding|7/7||NM_018129.4:c.*656_*657dup||1534-1535|||||rs35312568||1||insertion|EntrezGene||YES|||||||||14||0.1429|||||||0.1667||0|0.3594|0.3299|0.259|0.378|0.3781|0.5267|0.3335|0.3704|0.3604|0.3977|0.3891|0.5267|gnomADg_EAS|uncertain_significance||1|||||||||||||||||||||||||||323920||Uncertain_significance|not_provided&Pyridoxal_phosphate-responsive_seizures|NC_000017.11:g.47947438_47947439dup||Duplication|PNPO:55163|MedGen:C3661900&MONDO:MONDO:0012407&MedGen:C1864723&OMIM:610090&Orphanet:79096||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:20,14:0.412:34:11,8:9,6:47:57,0,50:47.631,9.6556e-05,53:0,9,12:17,3,10,4:10,10,8,6	0/1:19,12:0.387:31:6,9:13,3:45:57,0,47:46.686,0.00013668,50:0,10,13.01:17,2,11,1:8,11,8,4	1/1:0,18:1:18:0,8:0,10:51:113,54,0:101.05,51.045,3.417e-05:0,9,12:0,0,11,7:0,0,5,13	TT	3_prime_UTR_variant	MODIFIER	PNPO	55163	Transcript	NM_018129.4	protein_coding	07-Jul		c.*656_*657dup		1534-1535					rs35312568	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			14	NA	0.1429	NA	NA	NA	NA	NA	NA	0.1667	NA	0	0.3594	0.3299	0.259	0.378	0.3781	0.5267	0.3335	0.3704	0.3604	0.3977	0.3891	0.5267	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				323920	NA	Uncertain_significance	not_provided&Pyridoxal_phosphate-responsive_seizures	NC_000017.11:g.47947438_47947439dup		Duplication	PNPO:55163	MedGen:C3661900&MONDO:MONDO:0012407&MedGen:C1864723&OMIM:610090&Orphanet:79096		criteria_provided&_multiple_submitters&_no_conflicts		PNPO	Pyridoxal phosphate-responsive seizures	AR	610090	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs35312568	chr17_47947425_C_CTT	Female	0/1	Heterozygous
chr17	47947425	.	C	CTT	101.05	PASS	"FS=3.873;MQ=247.67;MQRankSum=4.182;QD=1.4;ReadPosRankSum=-0.507;SOR=0.214;FractionInformativeReads=1;R2_5P_bias=-1.173;DP=85;AF=1;AN=6;AC=4;CSQ=TT|3_prime_UTR_variant|MODIFIER|PNPO|55163|Transcript|NM_018129.4|protein_coding|7/7||NM_018129.4:c.*656_*657dup||1534-1535|||||rs35312568||1||insertion|EntrezGene||YES|||||||||14||0.1429|||||||0.1667||0|0.3594|0.3299|0.259|0.378|0.3781|0.5267|0.3335|0.3704|0.3604|0.3977|0.3891|0.5267|gnomADg_EAS|uncertain_significance||1|||||||||||||||||||||||||||323920||Uncertain_significance|not_provided&Pyridoxal_phosphate-responsive_seizures|NC_000017.11:g.47947438_47947439dup||Duplication|PNPO:55163|MedGen:C3661900&MONDO:MONDO:0012407&MedGen:C1864723&OMIM:610090&Orphanet:79096||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:20,14:0.412:34:11,8:9,6:47:57,0,50:47.631,9.6556e-05,53:0,9,12:17,3,10,4:10,10,8,6	0/1:19,12:0.387:31:6,9:13,3:45:57,0,47:46.686,0.00013668,50:0,10,13.01:17,2,11,1:8,11,8,4	1/1:0,18:1:18:0,8:0,10:51:113,54,0:101.05,51.045,3.417e-05:0,9,12:0,0,11,7:0,0,5,13	TT	3_prime_UTR_variant	MODIFIER	PNPO	55163	Transcript	NM_018129.4	protein_coding	07-Jul		c.*656_*657dup		1534-1535					rs35312568	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			14	NA	0.1429	NA	NA	NA	NA	NA	NA	0.1667	NA	0	0.3594	0.3299	0.259	0.378	0.3781	0.5267	0.3335	0.3704	0.3604	0.3977	0.3891	0.5267	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				323920	NA	Uncertain_significance	not_provided&Pyridoxal_phosphate-responsive_seizures	NC_000017.11:g.47947438_47947439dup		Duplication	PNPO:55163	MedGen:C3661900&MONDO:MONDO:0012407&MedGen:C1864723&OMIM:610090&Orphanet:79096		criteria_provided&_multiple_submitters&_no_conflicts		PNPO	Encephalopathy, neonatal severe	AR	300673	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs35312568	chr17_47947425_C_CTT	Female	0/1	Heterozygous
chr17	50184491	.	A	G	171.63	PASS	"FS=0;MQ=248.89;QD=3.9;SOR=1.179;FractionInformativeReads=0.977;MQRankSum=5.248;ReadPosRankSum=2.353;R2_5P_bias=10.96;DP=116;AF=0.5;AN=6;AC=4;CSQ=G|3_prime_UTR_variant|MODIFIER|COL1A1|1277|Transcript|NM_000088.4|protein_coding|51/51||NM_000088.4:c.*1011T>C||5524|||||rs1061970||-1||SNV|EntrezGene||YES|||A|A|||||||0.1386|0.09193|0.09564|0.1092|0.3314|0.1242|0.119|0.1075|0.1113|0.2056|0.1328|0.1009|0.03728|0.102|0.1153|0.484|0.1265|0.137|0.1273|0.1404|0.2483|0.484|gnomADg_EAS|uncertain_significance&benign||1||||||||||||-46|-20|-45|-1|0.00|0.00|0.00|0.00|COL1A1|||||||889152||Conflicting_classifications_of_pathogenicity|Infantile_cortical_hyperostosis&not_provided&Ehlers-Danlos_syndrome&_arthrochalasia_type&Osteogenesis_imperfecta|NC_000017.11:g.50184491A>G||single_nucleotide_variant|COL1A1:1277|MONDO:MONDO:0007244&MedGen:C0020497&OMIM:114000&Orphanet:1310&MedGen:C3661900&MONDO:MONDO:0007525&MedGen:C4551623&OMIM:130060&Orphanet:1899&Orphanet:99875&Orphanet:99876&MONDO:MONDO:0019019&MeSH:D010013&MedGen:C0029434&OMIM:PS166200&Orphanet:666|Uncertain_significance(3)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,43:1:43:0,17:0,26:122:209,125,0:171.63,121.63,0:0,34.77,37.77:0,0,17,26:0,0,21,22	0/1:18,20:0.526:38:7,7:11,13:47:85,0,47:50,8.7754e-05,49.904:0,34.77,37.78:8,10,8,12:11,7,11,9	0/1:14,19:0.576:33:3,2:11,17:46:85,0,45:50,0.00010691,48.347:0,34.77,37.78:5,9,9,10:10,4,10,9	G	3_prime_UTR_variant	MODIFIER	COL1A1	1277	Transcript	NM_000088.4	protein_coding	51/51		c.*1011T>C		5524					rs1061970	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.1386	0.09193	0.09564	0.1092	0.3314	0.1242	0.119	0.1075	0.1113	0.2056	0.1328	0.1009	0.03728	0.102	0.1153	0.484	0.1265	0.137	0.1273	0.1404	0.2483	0.484	gnomADg_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-46	-20	-45	-1	0	0	0	0	COL1A1			NA				889152	NA	Conflicting_classifications_of_pathogenicity	Infantile_cortical_hyperostosis&not_provided&Ehlers-Danlos_syndrome&_arthrochalasia_type&Osteogenesis_imperfecta	NC_000017.11:g.50184491A>G		single_nucleotide_variant	COL1A1:1277	MONDO:MONDO:0007244&MedGen:C0020497&OMIM:114000&Orphanet:1310&MedGen:C3661900&MONDO:MONDO:0007525&MedGen:C4551623&OMIM:130060&Orphanet:1899&Orphanet:99875&Orphanet:99876&MONDO:MONDO:0019019&MeSH:D010013&MedGen:C0029434&OMIM:PS166200&Orphanet:666	Uncertain_significance(3)&Benign(1)	criteria_provided&_conflicting_classifications		COL1A1	Osteogenesis imperfecta type I	AD	166200	Skelettal, skin, and connective tissue disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs1061970	chr17_50184491_A_G	Female	01-Jan	Homozygous
chr17	50184491	.	A	G	171.63	PASS	"FS=0;MQ=248.89;QD=3.9;SOR=1.179;FractionInformativeReads=0.977;MQRankSum=5.248;ReadPosRankSum=2.353;R2_5P_bias=10.96;DP=116;AF=0.5;AN=6;AC=4;CSQ=G|3_prime_UTR_variant|MODIFIER|COL1A1|1277|Transcript|NM_000088.4|protein_coding|51/51||NM_000088.4:c.*1011T>C||5524|||||rs1061970||-1||SNV|EntrezGene||YES|||A|A|||||||0.1386|0.09193|0.09564|0.1092|0.3314|0.1242|0.119|0.1075|0.1113|0.2056|0.1328|0.1009|0.03728|0.102|0.1153|0.484|0.1265|0.137|0.1273|0.1404|0.2483|0.484|gnomADg_EAS|uncertain_significance&benign||1||||||||||||-46|-20|-45|-1|0.00|0.00|0.00|0.00|COL1A1|||||||889152||Conflicting_classifications_of_pathogenicity|Infantile_cortical_hyperostosis&not_provided&Ehlers-Danlos_syndrome&_arthrochalasia_type&Osteogenesis_imperfecta|NC_000017.11:g.50184491A>G||single_nucleotide_variant|COL1A1:1277|MONDO:MONDO:0007244&MedGen:C0020497&OMIM:114000&Orphanet:1310&MedGen:C3661900&MONDO:MONDO:0007525&MedGen:C4551623&OMIM:130060&Orphanet:1899&Orphanet:99875&Orphanet:99876&MONDO:MONDO:0019019&MeSH:D010013&MedGen:C0029434&OMIM:PS166200&Orphanet:666|Uncertain_significance(3)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,43:1:43:0,17:0,26:122:209,125,0:171.63,121.63,0:0,34.77,37.77:0,0,17,26:0,0,21,22	0/1:18,20:0.526:38:7,7:11,13:47:85,0,47:50,8.7754e-05,49.904:0,34.77,37.78:8,10,8,12:11,7,11,9	0/1:14,19:0.576:33:3,2:11,17:46:85,0,45:50,0.00010691,48.347:0,34.77,37.78:5,9,9,10:10,4,10,9	G	3_prime_UTR_variant	MODIFIER	COL1A1	1277	Transcript	NM_000088.4	protein_coding	51/51		c.*1011T>C		5524					rs1061970	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.1386	0.09193	0.09564	0.1092	0.3314	0.1242	0.119	0.1075	0.1113	0.2056	0.1328	0.1009	0.03728	0.102	0.1153	0.484	0.1265	0.137	0.1273	0.1404	0.2483	0.484	gnomADg_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-46	-20	-45	-1	0	0	0	0	COL1A1			NA				889152	NA	Conflicting_classifications_of_pathogenicity	Infantile_cortical_hyperostosis&not_provided&Ehlers-Danlos_syndrome&_arthrochalasia_type&Osteogenesis_imperfecta	NC_000017.11:g.50184491A>G		single_nucleotide_variant	COL1A1:1277	MONDO:MONDO:0007244&MedGen:C0020497&OMIM:114000&Orphanet:1310&MedGen:C3661900&MONDO:MONDO:0007525&MedGen:C4551623&OMIM:130060&Orphanet:1899&Orphanet:99875&Orphanet:99876&MONDO:MONDO:0019019&MeSH:D010013&MedGen:C0029434&OMIM:PS166200&Orphanet:666	Uncertain_significance(3)&Benign(1)	criteria_provided&_conflicting_classifications		COL1A1	Infantile cortical hyperostosis	AD	114000	Skelettal, skin, and connective tissue disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs1061970	chr17_50184491_A_G	Female	01-Jan	Homozygous
chr17	50185257	.	C	CTT	115.52	PASS	"FS=0;MQ=242.64;QD=4.47;SOR=1.022;FractionInformativeReads=0.826;DP=78;AF=1;AN=6;AC=6;CSQ=TT|3_prime_UTR_variant|MODIFIER|COL1A1|1277|Transcript|NM_000088.4|protein_coding|51/51||NM_000088.4:c.*243_*244dup||4757-4758|||||rs56302025||-1||insertion|EntrezGene||YES||||||||||0.6082|0.2512|0.2914|0.1786|0.3232|0.3708|0.153|0.3436|0.2544|0.2975|0.117|0.9258|0.891|0.921|0.9386|0.8889|0.9472|0.956|0.9286|0.9373|0.9374|0.9624|0.9624|gnomADg_SAS|uncertain_significance&likely_benign||1|||||||||||||||||||||||||||324088||Conflicting_classifications_of_pathogenicity|Osteogenesis_Imperfecta&_Dominant&COL1A1-related_disorder&Ehlers-Danlos_syndrome_type_7A&Infantile_cortical_hyperostosis|NC_000017.11:g.50185275_50185276dup||Duplication|COL1A1:1277|MedGen:CN239427&.&MONDO:MONDO:0020521&MedGen:C3508773&MONDO:MONDO:0007244&MedGen:C0020497&OMIM:114000&Orphanet:1310|Uncertain_significance(3)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,19:1:19:0,9:0,10:53:113,56,0:102.7,52.701,2.3297e-05:0,7,10.01:0,0,11,8:0,0,13,6	1/1:0,22:1:22:0,17:0,5:63:123,66,0:112.57,62.571,2.3297e-06:0,7,10.01:0,0,14,8:0,0,15,7	1/1:0,22:1:22:0,13:0,9:66:125,69,0:115.52,65.523,1.2943e-06:0,6,9.01:0,0,16,6:0,0,15,7	TT	3_prime_UTR_variant	MODIFIER	COL1A1	1277	Transcript	NM_000088.4	protein_coding	51/51		c.*243_*244dup		4757-4758					rs56302025	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.6082	0.2512	0.2914	0.1786	0.3232	0.3708	0.153	0.3436	0.2544	0.2975	0.117	0.9258	0.891	0.921	0.9386	0.8889	0.9472	0.956	0.9286	0.9373	0.9374	0.9624	0.9624	gnomADg_SAS	uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				324088	NA	Conflicting_classifications_of_pathogenicity	Osteogenesis_Imperfecta&_Dominant&COL1A1-related_disorder&Ehlers-Danlos_syndrome_type_7A&Infantile_cortical_hyperostosis	NC_000017.11:g.50185275_50185276dup		Duplication	COL1A1:1277	MedGen:CN239427&.&MONDO:MONDO:0020521&MedGen:C3508773&MONDO:MONDO:0007244&MedGen:C0020497&OMIM:114000&Orphanet:1310	Uncertain_significance(3)&Likely_benign(3)	criteria_provided&_conflicting_classifications		COL1A1	Osteogenesis imperfecta type I	AD	166200	Skelettal, skin, and connective tissue disorders	NBScreening	-9	Benign	BP6,BA1	rs56302025	chr17_50185257_C_CTT	Female	01-Jan	Homozygous
chr17	50185257	.	C	CTT	115.52	PASS	"FS=0;MQ=242.64;QD=4.47;SOR=1.022;FractionInformativeReads=0.826;DP=78;AF=1;AN=6;AC=6;CSQ=TT|3_prime_UTR_variant|MODIFIER|COL1A1|1277|Transcript|NM_000088.4|protein_coding|51/51||NM_000088.4:c.*243_*244dup||4757-4758|||||rs56302025||-1||insertion|EntrezGene||YES||||||||||0.6082|0.2512|0.2914|0.1786|0.3232|0.3708|0.153|0.3436|0.2544|0.2975|0.117|0.9258|0.891|0.921|0.9386|0.8889|0.9472|0.956|0.9286|0.9373|0.9374|0.9624|0.9624|gnomADg_SAS|uncertain_significance&likely_benign||1|||||||||||||||||||||||||||324088||Conflicting_classifications_of_pathogenicity|Osteogenesis_Imperfecta&_Dominant&COL1A1-related_disorder&Ehlers-Danlos_syndrome_type_7A&Infantile_cortical_hyperostosis|NC_000017.11:g.50185275_50185276dup||Duplication|COL1A1:1277|MedGen:CN239427&.&MONDO:MONDO:0020521&MedGen:C3508773&MONDO:MONDO:0007244&MedGen:C0020497&OMIM:114000&Orphanet:1310|Uncertain_significance(3)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,19:1:19:0,9:0,10:53:113,56,0:102.7,52.701,2.3297e-05:0,7,10.01:0,0,11,8:0,0,13,6	1/1:0,22:1:22:0,17:0,5:63:123,66,0:112.57,62.571,2.3297e-06:0,7,10.01:0,0,14,8:0,0,15,7	1/1:0,22:1:22:0,13:0,9:66:125,69,0:115.52,65.523,1.2943e-06:0,6,9.01:0,0,16,6:0,0,15,7	TT	3_prime_UTR_variant	MODIFIER	COL1A1	1277	Transcript	NM_000088.4	protein_coding	51/51		c.*243_*244dup		4757-4758					rs56302025	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.6082	0.2512	0.2914	0.1786	0.3232	0.3708	0.153	0.3436	0.2544	0.2975	0.117	0.9258	0.891	0.921	0.9386	0.8889	0.9472	0.956	0.9286	0.9373	0.9374	0.9624	0.9624	gnomADg_SAS	uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				324088	NA	Conflicting_classifications_of_pathogenicity	Osteogenesis_Imperfecta&_Dominant&COL1A1-related_disorder&Ehlers-Danlos_syndrome_type_7A&Infantile_cortical_hyperostosis	NC_000017.11:g.50185275_50185276dup		Duplication	COL1A1:1277	MedGen:CN239427&.&MONDO:MONDO:0020521&MedGen:C3508773&MONDO:MONDO:0007244&MedGen:C0020497&OMIM:114000&Orphanet:1310	Uncertain_significance(3)&Likely_benign(3)	criteria_provided&_conflicting_classifications		COL1A1	Infantile cortical hyperostosis	AD	114000	Skelettal, skin, and connective tissue disorders	NBScreening	-9	Benign	BP6,BA1	rs56302025	chr17_50185257_C_CTT	Female	01-Jan	Homozygous
chr17	61680480	.	C	CTTTCTT	224.04	PASS	"FS=4.419;MQ=227.25;MQRankSum=-1.303;QD=2.08;ReadPosRankSum=1.655;SOR=0.162;FractionInformativeReads=0.875;R2_5P_bias=-1.677;DP=77;AF=0.5;AN=6;AC=2;CSQ=TTTCTT|3_prime_UTR_variant|MODIFIER|BRIP1|83990|Transcript|NM_032043.3|protein_coding|20/20||NM_032043.3:c.*2815_*2816insAAGAAA||6840-6841|||||rs1555571892||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.2405|0.2028|0.09242|0.4442|0.2779|0.2275|0.1539|0.18|0.2337|0.2624|0.1911|0.4442|gnomADg_AMR|||1|||||||||||||||||||||||||||210534||Uncertain_significance|Breast_neoplasm&Fanconi_anemia&not_specified|NC_000017.11:g.61680483_61680484insCTTTTT||Insertion|BRIP1:83990|Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84&MedGen:CN169374||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,10:0.476:21:3,4:8,6:48:57,0,50:49.883,6.6269e-05,53:0,7,10:2,9,4,6:8,3,4,6	0/1:1,13:0.542:24:0,9:1,4:50:238,181,56:224.04,174.04,52.229:0,7,10:1,0,7,16:0,1,11,12	0/0:10,.:.:18:5,.:5,.:48:56,.,.:49.464,.,.:0,.,.:3,7,2,6:6,4,4,4	TTTCTT	3_prime_UTR_variant	MODIFIER	BRIP1	83990	Transcript	NM_032043.3	protein_coding	20/20		c.*2815_*2816insAAGAAA		6840-6841					rs1555571892	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.2405	0.2028	0.09242	0.4442	0.2779	0.2275	0.1539	0.18	0.2337	0.2624	0.1911	0.4442	gnomADg_AMR			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				210534	NA	Uncertain_significance	Breast_neoplasm&Fanconi_anemia&not_specified	NC_000017.11:g.61680483_61680484insCTTTTT		Insertion	BRIP1:83990	Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84&MedGen:CN169374		criteria_provided&_multiple_submitters&_no_conflicts		BRIP1	Fanconi anemia complementation group J	AR	609054	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs1555571892	chr17_61680480_C_CTTTCTT	Female	0/1	Heterozygous
chr17	61680480	.	C	CTTTCTT	224.04	PASS	"FS=4.419;MQ=227.25;MQRankSum=-1.303;QD=2.08;ReadPosRankSum=1.655;SOR=0.162;FractionInformativeReads=0.875;R2_5P_bias=-1.677;DP=77;AF=0.5;AN=6;AC=2;CSQ=TTTCTT|3_prime_UTR_variant|MODIFIER|BRIP1|83990|Transcript|NM_032043.3|protein_coding|20/20||NM_032043.3:c.*2815_*2816insAAGAAA||6840-6841|||||rs1555571892||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.2405|0.2028|0.09242|0.4442|0.2779|0.2275|0.1539|0.18|0.2337|0.2624|0.1911|0.4442|gnomADg_AMR|||1|||||||||||||||||||||||||||210534||Uncertain_significance|Breast_neoplasm&Fanconi_anemia&not_specified|NC_000017.11:g.61680483_61680484insCTTTTT||Insertion|BRIP1:83990|Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84&MedGen:CN169374||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,10:0.476:21:3,4:8,6:48:57,0,50:49.883,6.6269e-05,53:0,7,10:2,9,4,6:8,3,4,6	0/1:1,13:0.542:24:0,9:1,4:50:238,181,56:224.04,174.04,52.229:0,7,10:1,0,7,16:0,1,11,12	0/0:10,.:.:18:5,.:5,.:48:56,.,.:49.464,.,.:0,.,.:3,7,2,6:6,4,4,4	TTTCTT	3_prime_UTR_variant	MODIFIER	BRIP1	83990	Transcript	NM_032043.3	protein_coding	20/20		c.*2815_*2816insAAGAAA		6840-6841					rs1555571892	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.2405	0.2028	0.09242	0.4442	0.2779	0.2275	0.1539	0.18	0.2337	0.2624	0.1911	0.4442	gnomADg_AMR			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				210534	NA	Uncertain_significance	Breast_neoplasm&Fanconi_anemia&not_specified	NC_000017.11:g.61680483_61680484insCTTTTT		Insertion	BRIP1:83990	Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84&MedGen:CN169374		criteria_provided&_multiple_submitters&_no_conflicts		BRIP1	Familial cancer of breast	AD	114480	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs1555571892	chr17_61680480_C_CTTTCTT	Female	0/1	Heterozygous
chr17	61680480	.	C	CTTTCTTT	224.04	PASS	"FS=4.419;MQ=227.25;MQRankSum=-1.303;QD=2.08;ReadPosRankSum=1.655;SOR=0.162;FractionInformativeReads=0.875;R2_5P_bias=-1.677;DP=77;AF=0.5;AN=6;AC=1;CSQ=TTTCTTT|3_prime_UTR_variant|MODIFIER|BRIP1|83990|Transcript|NM_032043.3|protein_coding|20/20||NM_032043.3:c.*2815_*2816insAAAGAAA||6840-6841|||||rs1555571892||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.05514|0.01984|0.08412|0.04981|0.08106|0.1535|0.06562|0.1313|0.05417|0.06589|0.2177|0.2177|gnomADg_SAS|||1|||||||||||||||||||||||||||324310||Uncertain_significance|Breast_neoplasm&Fanconi_anemia|NC_000017.11:g.61680483_61680484insCTTTTTT||Insertion|BRIP1:83990|Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:11,.:.:21:3,.:8,.:48:57,.,.:49.883,.,.:0,.,.:2,9,4,6:8,3,4,6	1/0:1,10:0.417:24:0,6:1,4:50:238,222,57:224.04,214.78,53:0,7,10:1,0,7,16:0,1,11,12	0/0:10,.:.:18:5,.:5,.:48:56,.,.:49.464,.,.:0,.,.:3,7,2,6:6,4,4,4	TTTCTTT	3_prime_UTR_variant	MODIFIER	BRIP1	83990	Transcript	NM_032043.3	protein_coding	20/20		c.*2815_*2816insAAAGAAA		6840-6841					rs1555571892	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.05514	0.01984	0.08412	0.04981	0.08106	0.1535	0.06562	0.1313	0.05417	0.06589	0.2177	0.2177	gnomADg_SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				324310	NA	Uncertain_significance	Breast_neoplasm&Fanconi_anemia	NC_000017.11:g.61680483_61680484insCTTTTTT		Insertion	BRIP1:83990	Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84		criteria_provided&_single_submitter		BRIP1	Fanconi anemia complementation group J	AR	609054	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs1555571892	chr17_61680480_C_CTTTCTTT	Female	0/0	Other
chr17	61680480	.	C	CTTTCTTT	224.04	PASS	"FS=4.419;MQ=227.25;MQRankSum=-1.303;QD=2.08;ReadPosRankSum=1.655;SOR=0.162;FractionInformativeReads=0.875;R2_5P_bias=-1.677;DP=77;AF=0.5;AN=6;AC=1;CSQ=TTTCTTT|3_prime_UTR_variant|MODIFIER|BRIP1|83990|Transcript|NM_032043.3|protein_coding|20/20||NM_032043.3:c.*2815_*2816insAAAGAAA||6840-6841|||||rs1555571892||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.05514|0.01984|0.08412|0.04981|0.08106|0.1535|0.06562|0.1313|0.05417|0.06589|0.2177|0.2177|gnomADg_SAS|||1|||||||||||||||||||||||||||324310||Uncertain_significance|Breast_neoplasm&Fanconi_anemia|NC_000017.11:g.61680483_61680484insCTTTTTT||Insertion|BRIP1:83990|Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:11,.:.:21:3,.:8,.:48:57,.,.:49.883,.,.:0,.,.:2,9,4,6:8,3,4,6	1/0:1,10:0.417:24:0,6:1,4:50:238,222,57:224.04,214.78,53:0,7,10:1,0,7,16:0,1,11,12	0/0:10,.:.:18:5,.:5,.:48:56,.,.:49.464,.,.:0,.,.:3,7,2,6:6,4,4,4	TTTCTTT	3_prime_UTR_variant	MODIFIER	BRIP1	83990	Transcript	NM_032043.3	protein_coding	20/20		c.*2815_*2816insAAAGAAA		6840-6841					rs1555571892	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.05514	0.01984	0.08412	0.04981	0.08106	0.1535	0.06562	0.1313	0.05417	0.06589	0.2177	0.2177	gnomADg_SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				324310	NA	Uncertain_significance	Breast_neoplasm&Fanconi_anemia	NC_000017.11:g.61680483_61680484insCTTTTTT		Insertion	BRIP1:83990	Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155&MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84		criteria_provided&_single_submitter		BRIP1	Familial cancer of breast	AD	114480	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs1555571892	chr17_61680480_C_CTTTCTTT	Female	0/0	Other
chr17	61680480	.	C	CTTTTT	224.04	PASS	"FS=4.419;MQ=227.25;MQRankSum=-1.303;QD=2.08;ReadPosRankSum=1.655;SOR=0.162;FractionInformativeReads=0.875;R2_5P_bias=-1.677;DP=77;AF=0.5;AN=6;AC=1;CSQ=TTTTT|3_prime_UTR_variant|MODIFIER|BRIP1|83990|Transcript|NM_032043.3|protein_coding|20/20||NM_032043.3:c.*2811_*2815dup||6840-6841|||||rs768910110||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.01684|0.009774|0.005924|0.007561|0.002477|0.03459|0.01778|0.025|0.02138|0.0203|0.02182|0.03459|gnomADg_EAS|uncertain_significance||1|||||||||||||||||||||||||||324312||Uncertain_significance|Fanconi_anemia&Breast_neoplasm|NC_000017.11:g.61680493_61680497dup||Duplication|BRIP1:83990|MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84&Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:11,.:.:21:3,.:8,.:48:57,.,.:49.883,.,.:0,.,.:2,9,4,6:8,3,4,6	0/0:1,.:.:24:0,.:1,.:50:238,.,.:224.04,.,.:0,.,.:1,0,7,16:0,1,11,12	0/1:10,8:0.444:18:5,6:5,2:48:56,0,50:49.464,7.0928e-05,53:0,7,10:3,7,2,6:6,4,4,4	TTTTT	3_prime_UTR_variant	MODIFIER	BRIP1	83990	Transcript	NM_032043.3	protein_coding	20/20		c.*2811_*2815dup		6840-6841					rs768910110	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.01684	0.009774	0.005924	0.007561	0.002477	0.03459	0.01778	0.025	0.02138	0.0203	0.02182	0.03459	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				324312	NA	Uncertain_significance	Fanconi_anemia&Breast_neoplasm	NC_000017.11:g.61680493_61680497dup		Duplication	BRIP1:83990	MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84&Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155		criteria_provided&_single_submitter		BRIP1	Fanconi anemia complementation group J	AR	609054	Tumor predisposition syndromes	NBScreening	-5	Likely_benign	BS1_Supporting,BS2	rs768910110	chr17_61680480_C_CTTTTT	Female	0/0	Other
chr17	61680480	.	C	CTTTTT	224.04	PASS	"FS=4.419;MQ=227.25;MQRankSum=-1.303;QD=2.08;ReadPosRankSum=1.655;SOR=0.162;FractionInformativeReads=0.875;R2_5P_bias=-1.677;DP=77;AF=0.5;AN=6;AC=1;CSQ=TTTTT|3_prime_UTR_variant|MODIFIER|BRIP1|83990|Transcript|NM_032043.3|protein_coding|20/20||NM_032043.3:c.*2811_*2815dup||6840-6841|||||rs768910110||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.01684|0.009774|0.005924|0.007561|0.002477|0.03459|0.01778|0.025|0.02138|0.0203|0.02182|0.03459|gnomADg_EAS|uncertain_significance||1|||||||||||||||||||||||||||324312||Uncertain_significance|Fanconi_anemia&Breast_neoplasm|NC_000017.11:g.61680493_61680497dup||Duplication|BRIP1:83990|MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84&Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:11,.:.:21:3,.:8,.:48:57,.,.:49.883,.,.:0,.,.:2,9,4,6:8,3,4,6	0/0:1,.:.:24:0,.:1,.:50:238,.,.:224.04,.,.:0,.,.:1,0,7,16:0,1,11,12	0/1:10,8:0.444:18:5,6:5,2:48:56,0,50:49.464,7.0928e-05,53:0,7,10:3,7,2,6:6,4,4,4	TTTTT	3_prime_UTR_variant	MODIFIER	BRIP1	83990	Transcript	NM_032043.3	protein_coding	20/20		c.*2811_*2815dup		6840-6841					rs768910110	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.01684	0.009774	0.005924	0.007561	0.002477	0.03459	0.01778	0.025	0.02138	0.0203	0.02182	0.03459	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				324312	NA	Uncertain_significance	Fanconi_anemia&Breast_neoplasm	NC_000017.11:g.61680493_61680497dup		Duplication	BRIP1:83990	MONDO:MONDO:0019391&MeSH:D005199&MedGen:C0015625&OMIM:PS227650&Orphanet:84&Human_Phenotype_Ontology:HP:0010623&Human_Phenotype_Ontology:HP:0100013&MONDO:MONDO:0021100&MeSH:D001943&MedGen:C1458155		criteria_provided&_single_submitter		BRIP1	Familial cancer of breast	AD	114480	Tumor predisposition syndromes	NBScreening	-5	Likely_benign	BS1_Supporting,BS2	rs768910110	chr17_61680480_C_CTTTTT	Female	0/0	Other
chr17	70178027	.	C	CT	128.6	PASS	"FS=0;MQ=250;MQRankSum=3.723;QD=2.36;ReadPosRankSum=0.684;SOR=0.446;FractionInformativeReads=0.952;R2_5P_bias=8.645;DP=92;AF=1;AN=6;AC=3;CSQ=T|3_prime_UTR_variant|MODIFIER|KCNJ2|3759|Transcript|NM_000891.3|protein_coding|2/2||NM_000891.3:c.*1721dup||3374-3375|||||rs35753731||1||insertion|EntrezGene||YES|||||||||17||0.03337||||0|0.03358||0|0.05556||0.2947|0.2919|0.2324|0.3272|0.2681|0.3165|0.1977|0.3496|0.3019|0.3089|0.2683|0.3496|gnomADg_MID|uncertain_significance&benign&likely_benign||1|||||||||||||||||||||||||||324865||Conflicting_classifications_of_pathogenicity|not_provided&Familial_atrial_fibrillation&Short_QT_syndrome&Andersen_Tawil_syndrome|NC_000017.11:g.70178044dup||Duplication|KCNJ2:3759|MedGen:C3661900&MONDO:MONDO:0018054&MedGen:C3468561&OMIM:PS608583&Orphanet:334&MONDO:MONDO:0000453&MedGen:C2348199&OMIM:PS609620&Orphanet:51083&MONDO:MONDO:0008222&MedGen:C1563715&OMIM:170390&Orphanet:37553|Uncertain_significance(3)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,9:0.45:20:3,3:8,6:48:57,0,50:49.565,6.9634e-05,53:0,7,10:4,7,4,5:8,3,4,5	1/1:1,33:0.971:34:0,17:1,16:79:139,82,0:128.6,78.604,0:0,7,10:1,0,10,23:0,1,14,19	0/0:24,.:0.971:35:16,.:8,.:39:46,.,.:39.23,.,.:0,.,.:11,13,7,4:9,15,4,7	T	3_prime_UTR_variant	MODIFIER	KCNJ2	3759	Transcript	NM_000891.3	protein_coding	02-Feb		c.*1721dup		3374-3375					rs35753731	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			17	NA	0.03337	NA	NA	NA	0	0.03358	NA	0	0.05556	NA	0.2947	0.2919	0.2324	0.3272	0.2681	0.3165	0.1977	0.3496	0.3019	0.3089	0.2683	0.3496	gnomADg_MID	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				324865	NA	Conflicting_classifications_of_pathogenicity	not_provided&Familial_atrial_fibrillation&Short_QT_syndrome&Andersen_Tawil_syndrome	NC_000017.11:g.70178044dup		Duplication	KCNJ2:3759	MedGen:C3661900&MONDO:MONDO:0018054&MedGen:C3468561&OMIM:PS608583&Orphanet:334&MONDO:MONDO:0000453&MedGen:C2348199&OMIM:PS609620&Orphanet:51083&MONDO:MONDO:0008222&MedGen:C1563715&OMIM:170390&Orphanet:37553	Uncertain_significance(3)&Benign(1)	criteria_provided&_conflicting_classifications		KCNJ2	Andersen Tawil syndrome	AD	170390	Cardiac and vascular disorders	NBScreening	-9	Benign	BP6,BA1	rs35753731	chr17_70178027_C_CT	Female	0/1	Heterozygous
chr17	70178027	.	C	CTT	128.6	PASS	"FS=0;MQ=250;MQRankSum=3.723;QD=2.36;ReadPosRankSum=0.684;SOR=0.446;FractionInformativeReads=0.952;R2_5P_bias=8.645;DP=92;AF=0.5;AN=6;AC=1;CSQ=TT|3_prime_UTR_variant|MODIFIER|KCNJ2|3759|Transcript|NM_000891.3|protein_coding|2/2||NM_000891.3:c.*1720_*1721dup||3374-3375|||||rs35753731||1||insertion|EntrezGene||YES|||||||||17||0.006162||||0|0.006254||0|0||0.08614|0.09898|0.09507|0.06837|0.09757|0.124|0.06445|0.06098|0.07866|0.08551|0.1281|0.1281|gnomADg_SAS|uncertain_significance&benign&likely_benign||1|||||||||||||||||||||||||||324866||Uncertain_significance|not_provided&Familial_atrial_fibrillation&Short_QT_syndrome&Andersen_Tawil_syndrome|NC_000017.11:g.70178043_70178044dup||Duplication|KCNJ2:3759|MedGen:C3661900&MONDO:MONDO:0018054&MedGen:C3468561&OMIM:PS608583&Orphanet:334&MONDO:MONDO:0000453&MedGen:C2348199&OMIM:PS609620&Orphanet:51083&MONDO:MONDO:0008222&MedGen:C1563715&OMIM:170390&Orphanet:37553||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:11,.:.:20:3,.:8,.:48:57,.,.:49.565,.,.:0,.,.:4,7,4,5:8,3,4,5	0/0:1,.:.:34:0,.:1,.:79:139,.,.:128.6,.,.:0,.,.:1,0,10,23:0,1,14,19	0/1:24,11:0.314:35:16,4:8,7:39:46,0,50:39.23,0.00054027,53.001:0,7,10:11,13,7,4:9,15,4,7	TT	3_prime_UTR_variant	MODIFIER	KCNJ2	3759	Transcript	NM_000891.3	protein_coding	02-Feb		c.*1720_*1721dup		3374-3375					rs35753731	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			17	NA	0.006162	NA	NA	NA	0	0.006254	NA	0	0	NA	0.08614	0.09898	0.09507	0.06837	0.09757	0.124	0.06445	0.06098	0.07866	0.08551	0.1281	0.1281	gnomADg_SAS	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				324866	NA	Uncertain_significance	not_provided&Familial_atrial_fibrillation&Short_QT_syndrome&Andersen_Tawil_syndrome	NC_000017.11:g.70178043_70178044dup		Duplication	KCNJ2:3759	MedGen:C3661900&MONDO:MONDO:0018054&MedGen:C3468561&OMIM:PS608583&Orphanet:334&MONDO:MONDO:0000453&MedGen:C2348199&OMIM:PS609620&Orphanet:51083&MONDO:MONDO:0008222&MedGen:C1563715&OMIM:170390&Orphanet:37553		criteria_provided&_multiple_submitters&_no_conflicts		KCNJ2	Andersen Tawil syndrome	AD	170390	Cardiac and vascular disorders	NBScreening	-8	Benign	BA1	rs35753731	chr17_70178027_C_CTT	Female	0/0	Other
chr17	70179064	.	ATTTTT	A	140.38	PASS	"FS=5.798;MQ=245.56;MQRankSum=2.185;QD=4.53;ReadPosRankSum=1.48;SOR=0.086;FractionInformativeReads=0.71;R2_5P_bias=0;DP=76;AF=0.5;AN=6;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|KCNJ2|3759|Transcript|NM_000891.3|protein_coding|2/2||NM_000891.3:c.*2771_*2775del||4412-4416|||||rs35656864||1||deletion|EntrezGene||YES|||TTTTT|TTTTT|||||29||0.000162|0|||0.5|0|0|0|0||0.1008|0.1772|0.06364|0.0943|0.06071|0.2375|0.01829|0.119|0.03788|0.09366|0.2258|0.5|gnomADe_EAS|uncertain_significance||1|||||||||||||||||||||||||||324882||Uncertain_significance|Familial_atrial_fibrillation&Short_QT_syndrome&Andersen_Tawil_syndrome&not_provided|NC_000017.11:g.70179094_70179098del||Deletion|KCNJ2:3759|MONDO:MONDO:0018054&MedGen:C3468561&OMIM:PS608583&Orphanet:334&MONDO:MONDO:0000453&MedGen:C2348199&OMIM:PS609620&Orphanet:51083&MONDO:MONDO:0008222&MedGen:C1563715&OMIM:170390&Orphanet:37553&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:7,.:.:22:4,.:3,.:47:150,.,.:140.38,.,.:0,.,.:0,7,4,11:3,4,10,5	0/0:0,.:0.364:14:0,.:0,.:50:140,.,.:131.52,.,.:0,.,.:0,0,4,10:0,0,9,5	0/1:10,9:0.409:22:7,3:3,6:42:104,50,52:93.764,45.211,50:0,5,8.01:6,4,4,8:7,3,7,5	-	3_prime_UTR_variant	MODIFIER	KCNJ2	3759	Transcript	NM_000891.3	protein_coding	02-Feb		c.*2771_*2775del		4412-4416					rs35656864	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TTTTT	TTTTT	NA	NA			29	NA	0.000162	0	NA	NA	0.5	0	0	0	0	NA	0.1008	0.1772	0.06364	0.0943	0.06071	0.2375	0.01829	0.119	0.03788	0.09366	0.2258	0.5	gnomADe_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				324882	NA	Uncertain_significance	Familial_atrial_fibrillation&Short_QT_syndrome&Andersen_Tawil_syndrome&not_provided	NC_000017.11:g.70179094_70179098del		Deletion	KCNJ2:3759	MONDO:MONDO:0018054&MedGen:C3468561&OMIM:PS608583&Orphanet:334&MONDO:MONDO:0000453&MedGen:C2348199&OMIM:PS609620&Orphanet:51083&MONDO:MONDO:0008222&MedGen:C1563715&OMIM:170390&Orphanet:37553&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		KCNJ2	Andersen Tawil syndrome	AD	170390	Cardiac and vascular disorders	NBScreening	2	Uncertain_significance	PM2	rs35656864	chr17_70179064_ATTTTT_A	Female	0/0	Other
chr17	72125554	.	CT	C	50	PASS	"FS=0;MQ=247.28;MQRankSum=5.033;QD=1.35;ReadPosRankSum=0.809;SOR=0.793;FractionInformativeReads=0.946;R2_5P_bias=11.712;DP=37;AF=0.5;AN=2;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|SOX9|6662|Transcript|NM_000346.4|protein_coding|3/3||NM_000346.4:c.*1183del||3070|||||rs796896836&COSV55426840||1||deletion|EntrezGene||YES|||T|T|||||15||0.3609|0.4396|0.3707|0.3757|0.3563|0.3393|0.39|0.3527|0.3663|0.3714|0.3588|0.5579|0.2956|0.3206|0.2858|0.2884|0.3596|0.3051|0.2556|0.3367|0.3504|0.5579|gnomADg_AFR|uncertain_significance|0&1|1&1||||||||||||-7|40|-32|-37|0.00|0.00|0.00|0.00|SOX9|||||||324941||Uncertain_significance|Camptomelic_dysplasia&not_provided|NC_000017.11:g.72125570del||Deletion|SOX9:6662|MONDO:MONDO:0007251&MedGen:C1861922&OMIM:114290&Orphanet:140&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:17,18:0.514:35:11,10:6,8:47:58,0,47:50,8.7495e-05,49.927:0,8,11.01:8,9,8,10:10,7,10,8	-	3_prime_UTR_variant	MODIFIER	SOX9	6662	Transcript	NM_000346.4	protein_coding	03-Mar		c.*1183del		3070					rs796896836&COSV55426840	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			15	NA	0.3609	0.4396	0.3707	0.3757	0.3563	0.3393	0.39	0.3527	0.3663	0.3714	0.3588	0.5579	0.2956	0.3206	0.2858	0.2884	0.3596	0.3051	0.2556	0.3367	0.3504	0.5579	gnomADg_AFR	uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-7	40	-32	-37	0	0	0	0	SOX9			NA				324941	NA	Uncertain_significance	Camptomelic_dysplasia&not_provided	NC_000017.11:g.72125570del		Deletion	SOX9:6662	MONDO:MONDO:0007251&MedGen:C1861922&OMIM:114290&Orphanet:140&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		SOX9	Campomelic dysplasia	AD	114290	Skelettal, skin, and connective tissue disorders	NBScreening	-8	Benign	BA1	rs796896836	chr17_72125554_CT_C	Female	./.	Other
chr17	75516562	.	T	TGGAGCC	49.95	PASS	"FS=6.064;MQ=248.27;MQRankSum=3.575;QD=1.77;ReadPosRankSum=0.334;SOR=1.981;FractionInformativeReads=0.929;R2_5P_bias=-1.985;DP=73;AF=0.5;AN=4;AC=2;CSQ=GGAGCC|inframe_insertion&start_retained_variant|MODERATE|TSEN54|283989|Transcript|NM_207346.3|protein_coding|1/11||NM_207346.3:c.3_8dup|NP_997229.2:p.Glu6_Pro7dup|35-36|2-3|1|M/MEP|atg/atGGAGCCg|rs398124622||1||insertion|EntrezGene||YES|||||||||6|0.0591|0.06469|0.08614|0.06128|0.05363|0.0004684|0.06483|0.09984|0.06514|0.06671|0.07839|0.06952|0.08242|0.07489|0.06346|0.06447|0.0007852|0.06598|0.07534|0.06788|0.06895|0.08351|0.09984|gnomADe_MID|uncertain_significance&benign&likely_benign||1|||||||||||||||||||||||||||96674||Conflicting_classifications_of_pathogenicity|Pontocerebellar_hypoplasia_type_4&not_provided&not_specified&Pontoneocerebellar_hypoplasia|NC_000017.11:g.75516563_75516568dup||Duplication|TSEN54:283989&LOC112533671:112533671|MONDO:MONDO:0009166&MedGen:C1856974&OMIM:225753&Orphanet:166063&MedGen:C3661900&MedGen:CN169374&MONDO:MONDO:0020135&MedGen:C1261175&OMIM:PS607596&Orphanet:98523|Uncertain_significance(1)&Benign(5)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,12:0.462:26:5,5:9,7:48:79,0,50:49.653,6.8857e-05,53:0,29,32:7,7,9,3:4,10,8,4	0/1:22,17:0.436:39:8,8:14,9:47:80,0,47:49.946,8.7495e-05,50:0,30,33.01:12,10,10,7:10,12,7,10	GGAGCC	inframe_insertion&start_retained_variant	MODERATE	TSEN54	283989	Transcript	NM_207346.3	protein_coding	11-Jan		c.3_8dup	p.Glu6_Pro7dup	35-36	03-Feb	1	M/MEP	atg/atGGAGCCg	rs398124622	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			6	0.0591	0.06469	0.08614	0.06128	0.05363	0.0004684	0.06483	0.09984	0.06514	0.06671	0.07839	0.06952	0.08242	0.07489	0.06346	0.06447	0.0007852	0.06598	0.07534	0.06788	0.06895	0.08351	0.09984	gnomADe_MID	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				96674	NA	Conflicting_classifications_of_pathogenicity	Pontocerebellar_hypoplasia_type_4&not_provided&not_specified&Pontoneocerebellar_hypoplasia	NC_000017.11:g.75516563_75516568dup		Duplication	TSEN54:283989&LOC112533671:112533671	MONDO:MONDO:0009166&MedGen:C1856974&OMIM:225753&Orphanet:166063&MedGen:C3661900&MedGen:CN169374&MONDO:MONDO:0020135&MedGen:C1261175&OMIM:PS607596&Orphanet:98523	Uncertain_significance(1)&Benign(5)&Likely_benign(2)	criteria_provided&_conflicting_classifications		TSEN54	Pontocerebellar hypoplasia type 4	AR	225753	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-7	Benign	PM4,BP6,BA1	rs398124622	chr17_75516562_T_TGGAGCC	Female	./.	Other
chr18	10763031	.	C	T	49.52	PASS	"FS=2.499;MQ=246.58;MQRankSum=4.786;QD=1.05;ReadPosRankSum=3.656;SOR=0.394;FractionInformativeReads=1;R2_5P_bias=-15.249;DP=120;AF=0.5;AN=6;AC=3;CSQ=T|missense_variant|MODERATE|PIEZO2|63895|Transcript|NM_001378183.1|protein_coding|22/56||NM_001378183.1:c.3014G>A|NP_001365112.1:p.Arg1005His|3995|3014|1005|R/H|cGt/cAt|rs200121260&COSV100124441||-1||SNV|EntrezGene||YES|||C|C|||deleterious_low_confidence(0.01)|possibly_damaging(0.851)||0.0008|0.000265|0.0004431|0.0007002|0|0.0001679|5.711e-05|0.002107|0.0002187|0.000328|0.0006689|0.0004005|0.0002886|0.007692|0.000588|0|0.000193|0|0.003401|0.0003087|0.002841|0.0008285|0.007692|gnomADg_AMI|likely_benign|0&1|1&1||||T|0.01565|-0.426113|T|0.26288|-0.462846|0.32913|0.118&0.118&.&.|7|-13|7|-30|0.01|0.00|0.00|0.00|PIEZO2|||||||782162||Conflicting_classifications_of_pathogenicity|not_provided&Inborn_genetic_diseases|NC_000018.10:g.10763031C>T||single_nucleotide_variant|PIEZO2:63895|MedGen:C3661900&MeSH:D030342&MedGen:C0950123|Uncertain_significance(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	0|1:25,22:0.468:47:10,13:15,9:48:84,0,50:49.523,7.0152e-05,53:0,34.77,37.77:16,9,12,10:11,14,17,5:10763009	0/1:18,14:0.438:32:4,6:14,8:47:84,0,50:48.91,7.7659e-05,53:0,34.77,37.77:13,5,8,6:5,13,10,4:.	0/1:23,18:0.439:41:10,10:13,8:47:84,0,50:48.863,7.8176e-05,53:0,34.77,37.77:13,10,11,7:14,9,13,5:.	T	missense_variant	MODERATE	PIEZO2	63895	Transcript	NM_001378183.1	protein_coding	22/56		c.3014G>A	p.Arg1005His	3995	3014	1005	R/H	cGt/cAt	rs200121260&COSV100124441	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious_low_confidence(0.01)	possibly_damaging(0.851)	NA	8,00E-04	0.000265	0.0004431	0.0007002	0	0.0001679	5.711e-05	0.002107	0.0002187	0.000328	0.0006689	0.0004005	0.0002886	0.007692	0.000588	0	0.000193	0	0.003401	0.0003087	0.002841	0.0008285	0.007692	gnomADg_AMI	likely_benign	0&1	1&1	NA	NA	NA	T	0.01565	-0.426113	T	0.26288	-0.462846	0.32913	0.118&0.118&.&.	7	-13	7	-30	0.01	0	0	0	PIEZO2			NA				782162	NA	Conflicting_classifications_of_pathogenicity	not_provided&Inborn_genetic_diseases	NC_000018.10:g.10763031C>T		single_nucleotide_variant	PIEZO2:63895	MedGen:C3661900&MeSH:D030342&MedGen:C0950123	Uncertain_significance(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		PIEZO2	Arthrogryposis, distal, type 3	AD	114300	Skelettal, skin, and connective tissue disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs200121260	chr18_10763031_C_T	Female	0|1	Heterozygous
chr18	13883576	.	TACACAC	T	120.29	PASS	"FS=0;MQ=239.49;MQRankSum=-1.3;QD=1.92;ReadPosRankSum=-1.754;SOR=1.179;FractionInformativeReads=0.269;R2_5P_bias=7.132;DP=111;AF=1;AN=6;AC=4;CSQ=-|3_prime_UTR_variant|MODIFIER|MC2R|4158|Transcript|NM_000529.2|protein_coding|2/2||NM_000529.2:c.*1043_*1048del||2114-2119|||||rs67239935||-1||deletion|EntrezGene||YES|||ACACAC|ACACAC|||||||0|0|0||0|0||0|0|0|0.03393|0.05734|0.04522|0.02647|0.05487|0.09554|0.005512|0.04167|0.01773|0.04477|0.09656|0.09656|gnomADg_SAS|||1|||||||||||||||||||||||||||326154||Uncertain_significance|Glucocorticoid_Deficiency&not_provided|NC_000018.10:g.13883577AC[23]||Microsatellite|MC2R:4158|MedGen:C1955741&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:4,3:0.429:7:2,3:2,0:47:53,0,47:49.995,8.6978e-05,50:0,3,6.01:2,2,2,1:2,2,2,1	0/1:11,5:0.312:16:6,4:5,1:45:50,0,47:46.923,0.00013176,50:0,3,6.01:3,8,4,1:4,7,5,0	1/1:0,24:1:24:0,13:0,11:70:125,73,0:120.29,70.29,5.1772e-07:0,2,5:0,0,12,12:0,0,13,11	-	3_prime_UTR_variant	MODIFIER	MC2R	4158	Transcript	NM_000529.2	protein_coding	02-Feb		c.*1043_*1048del		2114-2119					rs67239935	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	ACACAC	ACACAC	NA	NA			NA	NA	0	0	0	NA	0	0	NA	0	0	0	0.03393	0.05734	0.04522	0.02647	0.05487	0.09554	0.005512	0.04167	0.01773	0.04477	0.09656	0.09656	gnomADg_SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				326154	NA	Uncertain_significance	Glucocorticoid_Deficiency&not_provided	NC_000018.10:g.13883577AC[23]		Microsatellite	MC2R:4158	MedGen:C1955741&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		MC2R	Glucocorticoid deficiency 1	AR	202200	Endocrine disorders	NBScreening	-8	Benign	BA1	rs67239935	chr18_13883576_TACACAC_T	Female	0/1	Heterozygous
chr18	13883627	.	A	T	50	PASS	"FS=0;MQ=223.2;MQRankSum=0.385;QD=1;ReadPosRankSum=1.776;SOR=0.663;FractionInformativeReads=0.86;R2_5P_bias=-1.935;DP=50;AF=0.5;AN=2;AC=1;CSQ=T|3_prime_UTR_variant|MODIFIER|MC2R|4158|Transcript|NM_000529.2|protein_coding|2/2||NM_000529.2:c.*998T>A||2069|||||rs4797823||-1||SNV|EntrezGene||YES|||A|A|||||||0|||||||0|||0.1268|0.3094|0.01408|0.0757|0.07955|0.03818|0.02635|0.07692|0.02883|0.104|0.05029|0.3094|gnomADg_AFR|uncertain_significance||1||||||||||||-15|0|-14|2|0.00|0.00|0.00|0.00|MC2R|||||||326164||Uncertain_significance|Glucocorticoid_deficiency_1&not_provided|NC_000018.10:g.13883627A>T||single_nucleotide_variant|MC2R:4158|MONDO:MONDO:0024536&MedGen:C4049650&OMIM:202200&Orphanet:361&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:17,26:0.605:43:7,15:10,11:46:85,0,46:50,0.00010458,48.519:0,34.77,37.77:10,7,15,11:12,5,14,12	T	3_prime_UTR_variant	MODIFIER	MC2R	4158	Transcript	NM_000529.2	protein_coding	02-Feb		c.*998T>A		2069					rs4797823	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.1268	0.3094	0.01408	0.0757	0.07955	0.03818	0.02635	0.07692	0.02883	0.104	0.05029	0.3094	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-15	0	-14	2	0	0	0	0	MC2R			NA				326164	NA	Uncertain_significance	Glucocorticoid_deficiency_1&not_provided	NC_000018.10:g.13883627A>T		single_nucleotide_variant	MC2R:4158	MONDO:MONDO:0024536&MedGen:C4049650&OMIM:202200&Orphanet:361&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		MC2R	Glucocorticoid deficiency 1	AR	202200	Endocrine disorders	NBScreening	-12	Benign	BP4_Strong,BA1	rs4797823	chr18_13883627_A_T	Female	./.	Other
chr18	23534476	.	C	A	50	PASS	"FS=1.515;MQ=250;MQRankSum=4.308;QD=1.92;ReadPosRankSum=2.205;SOR=1.022;FractionInformativeReads=1;R2_5P_bias=12.85;DP=61;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|NPC1|4864|Transcript|NM_000271.5|protein_coding|23/25||NM_000271.5:c.3561G>T|NP_000262.2:p.Ala1187%3D|3724|3561|1187|A|gcG/gcT|rs55724504||-1||SNV|EntrezGene||YES|||C|C||||||0.0022|0.0022|0.002569|0.003376|0.008992|0|0.0009791|0.009189|0.002201|0.00308|5.797e-05|0.00252|0.002573|0|0.004769|0.006624|0|0.001412|0.02041|0.002205|0.00473|0|0.02041|gnomADg_MID|conflicting_interpretations_of_pathogenicity&benign&likely_benign||1||||||||||||-27|-48|33|-30|0.00|0.00|0.02|0.01|NPC1|||||||211683||Conflicting_classifications_of_pathogenicity|not_provided&not_specified&Inborn_genetic_diseases&NPC1-related_disorder&Niemann-Pick_disease&_type_C1|NC_000018.10:g.23534476C>A||single_nucleotide_variant|NPC1:4864|MedGen:C3661900&MedGen:CN169374&MeSH:D030342&MedGen:C0950123&.&MONDO:MONDO:0009757&MedGen:C3179455&OMIM:257220&Orphanet:646|Uncertain_significance(2)&Benign(1)&Likely_benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:13,13:0.5:26:9,9:4,4:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:5,8,4,9:9,4,4,9	0/1:15,20:0.571:35:9,6:6,14:48:85,0,48:50,7.4552e-05,51.445:0,34.77,37.77:10,5,12,8:6,9,6,14	./.:.:.:.:.:.:.:.:.:.:.:.	A	synonymous_variant	LOW	NPC1	4864	Transcript	NM_000271.5	protein_coding	23/25		c.3561G>T	p.Ala1187%3D	3724	3561	1187	A	gcG/gcT	rs55724504	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0022	0.0022	0.002569	0.003376	0.008992	0	0.0009791	0.009189	0.002201	0.00308	5.797e-05	0.00252	0.002573	0	0.004769	0.006624	0	0.001412	0.02041	0.002205	0.00473	0	0.02041	gnomADg_MID	conflicting_interpretations_of_pathogenicity&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-27	-48	33	-30	0	0	0.02	0.01	NPC1			NA				211683	NA	Conflicting_classifications_of_pathogenicity	not_provided&not_specified&Inborn_genetic_diseases&NPC1-related_disorder&Niemann-Pick_disease&_type_C1	NC_000018.10:g.23534476C>A		single_nucleotide_variant	NPC1:4864	MedGen:C3661900&MedGen:CN169374&MeSH:D030342&MedGen:C0950123&.&MONDO:MONDO:0009757&MedGen:C3179455&OMIM:257220&Orphanet:646	Uncertain_significance(2)&Benign(1)&Likely_benign(4)	criteria_provided&_conflicting_classifications		NPC1	Niemann-Pick disease, type C1	AR	257220	Inherited disorders of metabolism	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BS1,BS2	rs55724504	chr18_23534476_C_A	Female	0/1	Heterozygous
chr18	23905606	.	C	A	50	PASS	"FS=1.431;MQ=250;MQRankSum=4.826;QD=1.52;ReadPosRankSum=3.042;SOR=0.435;FractionInformativeReads=1;R2_5P_bias=13.583;DP=61;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|LAMA3|3909|Transcript|NM_198129.4|protein_coding|52/75||NM_198129.4:c.6700C>A|NP_937762.2:p.Gln2234Lys|6931|6700|2234|Q/K|Caa/Aaa|rs774924039&COSV52534796||1||SNV|EntrezGene||YES|||C|C|||tolerated(0.19)|benign(0.005)|||9.279e-05|0|0|0|0|0|0|0.0001193|4.991e-05|0|5.917e-05|2.415e-05|0|0.0001963|0|0|0|0|7.352e-05|0|0|0.0001963|gnomADg_AMR|uncertain_significance|0&1|1&1||||T|0.06443|-0.325687|T|0.19759|-0.525307|0.14996|0.053&0.053&.&0.053&.|18|-6|-23|18|0.00|0.00|0.00|0.00|LAMA3|likely_benign|hg38|0.0894|Q2234K|ENST00000313654.13|Q16787|2459310||Uncertain_significance|Inborn_genetic_diseases|NC_000018.10:g.23905606C>A||single_nucleotide_variant|LAMA3:3909|MeSH:D030342&MedGen:C0950123||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:14,19:0.576:33:8,11:6,8:48:85,0,49:50,7.3517e-05,51.583:0,34.77,37.77:4,10,7,12:10,4,7,12	0/1:13,15:0.536:28:5,7:8,8:48:85,0,50:50,6.6786e-05,52.689:0,34.77,37.77:4,9,5,10:8,5,5,10	./.:.:.:.:.:.:.:.:.:.:.:.	A	missense_variant	MODERATE	LAMA3	3909	Transcript	NM_198129.4	protein_coding	52/75		c.6700C>A	p.Gln2234Lys	6931	6700	2234	Q/K	Caa/Aaa	rs774924039&COSV52534796	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated(0.19)	benign(0.005)	NA	NA	9.279e-05	0	0	0	0	0	0	0.0001193	4.991e-05	0	5.917e-05	2.415e-05	0	0.0001963	0	0	0	0	7.352e-05	0	0	0.0001963	gnomADg_AMR	uncertain_significance	0&1	1&1	NA	NA	NA	T	0.06443	-0.325687	T	0.19759	-0.525307	0.14996	0.053&0.053&.&0.053&.	18	-6	-23	18	0	0	0	0	LAMA3	likely_benign	hg38	0.0894	Q2234K	ENST00000313654.13	Q16787	2459310	NA	Uncertain_significance	Inborn_genetic_diseases	NC_000018.10:g.23905606C>A		single_nucleotide_variant	LAMA3:3909	MeSH:D030342&MedGen:C0950123		criteria_provided&_single_submitter		LAMA3	Epidermolysis bullosa, junctional 2B, severe	AR	619784	Skelettal, skin, and connective tissue disorders	NBScreening	-4	Likely_benign	BP4_Strong	rs774924039	chr18_23905606_C_A	Female	0/1	Heterozygous
chr18	23905606	.	C	A	50	PASS	"FS=1.431;MQ=250;MQRankSum=4.826;QD=1.52;ReadPosRankSum=3.042;SOR=0.435;FractionInformativeReads=1;R2_5P_bias=13.583;DP=61;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|LAMA3|3909|Transcript|NM_198129.4|protein_coding|52/75||NM_198129.4:c.6700C>A|NP_937762.2:p.Gln2234Lys|6931|6700|2234|Q/K|Caa/Aaa|rs774924039&COSV52534796||1||SNV|EntrezGene||YES|||C|C|||tolerated(0.19)|benign(0.005)|||9.279e-05|0|0|0|0|0|0|0.0001193|4.991e-05|0|5.917e-05|2.415e-05|0|0.0001963|0|0|0|0|7.352e-05|0|0|0.0001963|gnomADg_AMR|uncertain_significance|0&1|1&1||||T|0.06443|-0.325687|T|0.19759|-0.525307|0.14996|0.053&0.053&.&0.053&.|18|-6|-23|18|0.00|0.00|0.00|0.00|LAMA3|likely_benign|hg38|0.0894|Q2234K|ENST00000313654.13|Q16787|2459310||Uncertain_significance|Inborn_genetic_diseases|NC_000018.10:g.23905606C>A||single_nucleotide_variant|LAMA3:3909|MeSH:D030342&MedGen:C0950123||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:14,19:0.576:33:8,11:6,8:48:85,0,49:50,7.3517e-05,51.583:0,34.77,37.77:4,10,7,12:10,4,7,12	0/1:13,15:0.536:28:5,7:8,8:48:85,0,50:50,6.6786e-05,52.689:0,34.77,37.77:4,9,5,10:8,5,5,10	./.:.:.:.:.:.:.:.:.:.:.:.	A	missense_variant	MODERATE	LAMA3	3909	Transcript	NM_198129.4	protein_coding	52/75		c.6700C>A	p.Gln2234Lys	6931	6700	2234	Q/K	Caa/Aaa	rs774924039&COSV52534796	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated(0.19)	benign(0.005)	NA	NA	9.279e-05	0	0	0	0	0	0	0.0001193	4.991e-05	0	5.917e-05	2.415e-05	0	0.0001963	0	0	0	0	7.352e-05	0	0	0.0001963	gnomADg_AMR	uncertain_significance	0&1	1&1	NA	NA	NA	T	0.06443	-0.325687	T	0.19759	-0.525307	0.14996	0.053&0.053&.&0.053&.	18	-6	-23	18	0	0	0	0	LAMA3	likely_benign	hg38	0.0894	Q2234K	ENST00000313654.13	Q16787	2459310	NA	Uncertain_significance	Inborn_genetic_diseases	NC_000018.10:g.23905606C>A		single_nucleotide_variant	LAMA3:3909	MeSH:D030342&MedGen:C0950123		criteria_provided&_single_submitter		LAMA3	Epidermolysis bullosa, junctional 2A, intermediate	AR	619783	Skelettal, skin, and connective tissue disorders	NBScreening	-4	Likely_benign	BP4_Strong	rs774924039	chr18_23905606_C_A	Female	0/1	Heterozygous
chr18	51084012	.	G	GCA	184.38	PASS	"FS=2.92;MQ=248.79;MQRankSum=1.944;QD=6.43;ReadPosRankSum=0.085;SOR=1.492;FractionInformativeReads=0.481;R2_5P_bias=0;DP=87;AF=0.5;AN=6;AC=3;CSQ=CA|3_prime_UTR_variant|MODIFIER|SMAD4|4089|Transcript|NM_005359.6|protein_coding|12/12||NM_005359.6:c.*5576_*5577dup||7742-7743|||||rs56017493||1||insertion|EntrezGene||YES|||||||||32||0.1303|0.1695|0.1231|0.1343|0.09087|0.05882|0.1136|0.1342|0.1394|0.1631|0.1538|0.1893|0.06987|0.138|0.1634|0.1039|0.1189|0.2136|0.1416|0.1587|0.1715|0.2136|gnomADg_MID|||1|||||||||||||||||||||||||||327190||Uncertain_significance|Myhre_syndrome&Telangiectasia&_hereditary_hemorrhagic&_type_1&not_provided&Juvenile_Polyposis|NC_000018.10:g.51084013CA[17]||Microsatellite|SMAD4:4089|MONDO:MONDO:0007688&MedGen:C0796081&OMIM:139210&Orphanet:2588&MONDO:MONDO:0008535&MedGen:C4551861&OMIM:187300&Orphanet:774&MedGen:C3661900&MedGen:CN239474||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:3,5:0.385:13:2,2:1,3:46:180,128,50:173.62,125.01,50:0,3,6.01:1,2,7,3:2,1,4,6	1/0:0,8:0.571:14:0,1:0,7:47:190,138,50:184.38,134.55,50:0,3,6.01:0,0,7,7:0,0,5,9	0/1:10,10:0.5:20:5,4:5,6:45:50,0,47:47.209,0.00012607,50:0,3,6.01:6,4,8,2:7,3,6,4	CA	3_prime_UTR_variant	MODIFIER	SMAD4	4089	Transcript	NM_005359.6	protein_coding	12-Dec		c.*5576_*5577dup		7742-7743					rs56017493	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			32	NA	0.1303	0.1695	0.1231	0.1343	0.09087	0.05882	0.1136	0.1342	0.1394	0.1631	0.1538	0.1893	0.06987	0.138	0.1634	0.1039	0.1189	0.2136	0.1416	0.1587	0.1715	0.2136	gnomADg_MID			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				327190	NA	Uncertain_significance	Myhre_syndrome&Telangiectasia&_hereditary_hemorrhagic&_type_1&not_provided&Juvenile_Polyposis	NC_000018.10:g.51084013CA[17]		Microsatellite	SMAD4:4089	MONDO:MONDO:0007688&MedGen:C0796081&OMIM:139210&Orphanet:2588&MONDO:MONDO:0008535&MedGen:C4551861&OMIM:187300&Orphanet:774&MedGen:C3661900&MedGen:CN239474		criteria_provided&_multiple_submitters&_no_conflicts		SMAD4	Juvenile polyposis syndrome	AD	174900	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs56017493	chr18_51084012_G_GCA	Female	1/0	Heterozygous
chr18	51084012	.	G	GCA	184.38	PASS	"FS=2.92;MQ=248.79;MQRankSum=1.944;QD=6.43;ReadPosRankSum=0.085;SOR=1.492;FractionInformativeReads=0.481;R2_5P_bias=0;DP=87;AF=0.5;AN=6;AC=3;CSQ=CA|3_prime_UTR_variant|MODIFIER|SMAD4|4089|Transcript|NM_005359.6|protein_coding|12/12||NM_005359.6:c.*5576_*5577dup||7742-7743|||||rs56017493||1||insertion|EntrezGene||YES|||||||||32||0.1303|0.1695|0.1231|0.1343|0.09087|0.05882|0.1136|0.1342|0.1394|0.1631|0.1538|0.1893|0.06987|0.138|0.1634|0.1039|0.1189|0.2136|0.1416|0.1587|0.1715|0.2136|gnomADg_MID|||1|||||||||||||||||||||||||||327190||Uncertain_significance|Myhre_syndrome&Telangiectasia&_hereditary_hemorrhagic&_type_1&not_provided&Juvenile_Polyposis|NC_000018.10:g.51084013CA[17]||Microsatellite|SMAD4:4089|MONDO:MONDO:0007688&MedGen:C0796081&OMIM:139210&Orphanet:2588&MONDO:MONDO:0008535&MedGen:C4551861&OMIM:187300&Orphanet:774&MedGen:C3661900&MedGen:CN239474||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:3,5:0.385:13:2,2:1,3:46:180,128,50:173.62,125.01,50:0,3,6.01:1,2,7,3:2,1,4,6	1/0:0,8:0.571:14:0,1:0,7:47:190,138,50:184.38,134.55,50:0,3,6.01:0,0,7,7:0,0,5,9	0/1:10,10:0.5:20:5,4:5,6:45:50,0,47:47.209,0.00012607,50:0,3,6.01:6,4,8,2:7,3,6,4	CA	3_prime_UTR_variant	MODIFIER	SMAD4	4089	Transcript	NM_005359.6	protein_coding	12-Dec		c.*5576_*5577dup		7742-7743					rs56017493	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			32	NA	0.1303	0.1695	0.1231	0.1343	0.09087	0.05882	0.1136	0.1342	0.1394	0.1631	0.1538	0.1893	0.06987	0.138	0.1634	0.1039	0.1189	0.2136	0.1416	0.1587	0.1715	0.2136	gnomADg_MID			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				327190	NA	Uncertain_significance	Myhre_syndrome&Telangiectasia&_hereditary_hemorrhagic&_type_1&not_provided&Juvenile_Polyposis	NC_000018.10:g.51084013CA[17]		Microsatellite	SMAD4:4089	MONDO:MONDO:0007688&MedGen:C0796081&OMIM:139210&Orphanet:2588&MONDO:MONDO:0008535&MedGen:C4551861&OMIM:187300&Orphanet:774&MedGen:C3661900&MedGen:CN239474		criteria_provided&_multiple_submitters&_no_conflicts		SMAD4	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	AD	175050	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs56017493	chr18_51084012_G_GCA	Female	1/0	Heterozygous
chr18	51084012	.	G	GCGCA	184.38	PASS	"FS=2.92;MQ=248.79;MQRankSum=1.944;QD=6.43;ReadPosRankSum=0.085;SOR=1.492;FractionInformativeReads=0.481;R2_5P_bias=0;DP=87;AF=0.5;AN=6;AC=2;CSQ=CGCA|3_prime_UTR_variant|MODIFIER|SMAD4|4089|Transcript|NM_005359.6|protein_coding|12/12||NM_005359.6:c.*5546_*5547insGCAC||7742-7743|||||rs1555688055||1||insertion|EntrezGene||YES|||||||||1||0.06359|0.01482|0.03342|0.04575|0.02836|0.08824|0.03333|0.07985|0.06392|0.05462|0.07294|0.01989|0.09649|0.05355|0.06507|0.03326|0.09224|0.02427|0.112|0.07236|0.07329|0.112|gnomADg_NFE|||1|||||||||||||||||||||||||||327193||Uncertain_significance|not_provided&Myhre_syndrome&Juvenile_Polyposis&Telangiectasia&_hereditary_hemorrhagic&_type_1|NC_000018.10:g.51084013_51084014insGCAC||Insertion|SMAD4:4089|MedGen:C3661900&MONDO:MONDO:0007688&MedGen:C0796081&OMIM:139210&Orphanet:2588&MedGen:CN239474&MONDO:MONDO:0008535&MedGen:C4551861&OMIM:187300&Orphanet:774||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:3,5:0.385:13:2,1:1,4:46:180,132,48:173.62,129.24,48.495:0,3,6.01:1,2,7,3:2,1,4,6	0/1:0,6:0.429:14:0,3:0,3:47:190,152,50:184.38,148.59,50.036:0,3,6.01:0,0,7,7:0,0,5,9	0/0:10,.:0.571:20:5,.:5,.:45:50,.,.:47.209,.,.:0,.,.:6,4,8,2:7,3,6,4	CGCA	3_prime_UTR_variant	MODIFIER	SMAD4	4089	Transcript	NM_005359.6	protein_coding	12-Dec		c.*5546_*5547insGCAC		7742-7743					rs1555688055	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			1	NA	0.06359	0.01482	0.03342	0.04575	0.02836	0.08824	0.03333	0.07985	0.06392	0.05462	0.07294	0.01989	0.09649	0.05355	0.06507	0.03326	0.09224	0.02427	0.112	0.07236	0.07329	0.112	gnomADg_NFE			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				327193	NA	Uncertain_significance	not_provided&Myhre_syndrome&Juvenile_Polyposis&Telangiectasia&_hereditary_hemorrhagic&_type_1	NC_000018.10:g.51084013_51084014insGCAC		Insertion	SMAD4:4089	MedGen:C3661900&MONDO:MONDO:0007688&MedGen:C0796081&OMIM:139210&Orphanet:2588&MedGen:CN239474&MONDO:MONDO:0008535&MedGen:C4551861&OMIM:187300&Orphanet:774		criteria_provided&_multiple_submitters&_no_conflicts		SMAD4	Juvenile polyposis syndrome	AD	174900	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs1555688055	chr18_51084012_G_GCGCA	Female	0/1	Heterozygous
chr18	51084012	.	G	GCGCA	184.38	PASS	"FS=2.92;MQ=248.79;MQRankSum=1.944;QD=6.43;ReadPosRankSum=0.085;SOR=1.492;FractionInformativeReads=0.481;R2_5P_bias=0;DP=87;AF=0.5;AN=6;AC=2;CSQ=CGCA|3_prime_UTR_variant|MODIFIER|SMAD4|4089|Transcript|NM_005359.6|protein_coding|12/12||NM_005359.6:c.*5546_*5547insGCAC||7742-7743|||||rs1555688055||1||insertion|EntrezGene||YES|||||||||1||0.06359|0.01482|0.03342|0.04575|0.02836|0.08824|0.03333|0.07985|0.06392|0.05462|0.07294|0.01989|0.09649|0.05355|0.06507|0.03326|0.09224|0.02427|0.112|0.07236|0.07329|0.112|gnomADg_NFE|||1|||||||||||||||||||||||||||327193||Uncertain_significance|not_provided&Myhre_syndrome&Juvenile_Polyposis&Telangiectasia&_hereditary_hemorrhagic&_type_1|NC_000018.10:g.51084013_51084014insGCAC||Insertion|SMAD4:4089|MedGen:C3661900&MONDO:MONDO:0007688&MedGen:C0796081&OMIM:139210&Orphanet:2588&MedGen:CN239474&MONDO:MONDO:0008535&MedGen:C4551861&OMIM:187300&Orphanet:774||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:3,5:0.385:13:2,1:1,4:46:180,132,48:173.62,129.24,48.495:0,3,6.01:1,2,7,3:2,1,4,6	0/1:0,6:0.429:14:0,3:0,3:47:190,152,50:184.38,148.59,50.036:0,3,6.01:0,0,7,7:0,0,5,9	0/0:10,.:0.571:20:5,.:5,.:45:50,.,.:47.209,.,.:0,.,.:6,4,8,2:7,3,6,4	CGCA	3_prime_UTR_variant	MODIFIER	SMAD4	4089	Transcript	NM_005359.6	protein_coding	12-Dec		c.*5546_*5547insGCAC		7742-7743					rs1555688055	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			1	NA	0.06359	0.01482	0.03342	0.04575	0.02836	0.08824	0.03333	0.07985	0.06392	0.05462	0.07294	0.01989	0.09649	0.05355	0.06507	0.03326	0.09224	0.02427	0.112	0.07236	0.07329	0.112	gnomADg_NFE			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				327193	NA	Uncertain_significance	not_provided&Myhre_syndrome&Juvenile_Polyposis&Telangiectasia&_hereditary_hemorrhagic&_type_1	NC_000018.10:g.51084013_51084014insGCAC		Insertion	SMAD4:4089	MedGen:C3661900&MONDO:MONDO:0007688&MedGen:C0796081&OMIM:139210&Orphanet:2588&MedGen:CN239474&MONDO:MONDO:0008535&MedGen:C4551861&OMIM:187300&Orphanet:774		criteria_provided&_multiple_submitters&_no_conflicts		SMAD4	Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	AD	175050	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs1555688055	chr18_51084012_G_GCGCA	Female	0/1	Heterozygous
chr18	57580222	.	G	A	47.39	PASS	"FS=0;MQ=250;MQRankSum=3.73;QD=2.26;ReadPosRankSum=0.616;SOR=0.569;FractionInformativeReads=1;R2_5P_bias=9.444;DP=21;AF=0.5;AN=2;AC=1;CSQ=A|intron_variant|MODIFIER|FECH|2235|Transcript|NM_000140.5|protein_coding||1/10|NM_000140.5:c.68-23C>T|||||||rs2269219&COSV50490971&CS920753||-1||SNV|EntrezGene||YES|||G|G||||||0.3347|0.1942|0.4542|0.3983|0.2246|0.3662|0.2313|0.2387|0.1638|0.2062|0.2567|0.2741|0.447|0.08224|0.3025|0.2145|0.324|0.2456|0.3027|0.1704|0.2623|0.2512|0.4834|AFR|likely_benign&benign&conflicting_interpretations_of_pathogenicity|0&1&1|1&1&1||||||||||||-36|-23|2|-23|0.00|0.01|0.00|0.00|FECH|||||||550||Conflicting_classifications_of_pathogenicity|Jaundice&Erythema&Protoporphyria&_erythropoietic&_1&not_provided|NC_000018.10:g.57580222G>A||single_nucleotide_variant|FECH:2235&LOC130062555:130062555|Human_Phenotype_Ontology:HP:0000952&MedGen:C0022346&Human_Phenotype_Ontology:HP:0010783&MedGen:C0041834&MONDO:MONDO:0008319&MedGen:C4692546&OMIM:177000&Orphanet:79278&MedGen:C3661900|Uncertain_significance(1)&Benign(5)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,8:0.381:21:6,4:7,4:46:82,0,50:47.393,0.00010096,53:0,34.77,37.77:6,7,4,4:3,10,4,4	./.:.:.:.:.:.:.:.:.:.:.:.	A	intron_variant	MODIFIER	FECH	2235	Transcript	NM_000140.5	protein_coding		10-Jan	c.68-23C>T							rs2269219&COSV50490971&CS920753	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.3347	0.1942	0.4542	0.3983	0.2246	0.3662	0.2313	0.2387	0.1638	0.2062	0.2567	0.2741	0.447	0.08224	0.3025	0.2145	0.324	0.2456	0.3027	0.1704	0.2623	0.2512	0.4834	AFR	likely_benign&benign&conflicting_interpretations_of_pathogenicity	0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-36	-23	2	-23	0	0.01	0	0	FECH			NA				550	NA	Conflicting_classifications_of_pathogenicity	Jaundice&Erythema&Protoporphyria&_erythropoietic&_1&not_provided	NC_000018.10:g.57580222G>A		single_nucleotide_variant	FECH:2235&LOC130062555:130062555	Human_Phenotype_Ontology:HP:0000952&MedGen:C0022346&Human_Phenotype_Ontology:HP:0010783&MedGen:C0041834&MONDO:MONDO:0008319&MedGen:C4692546&OMIM:177000&Orphanet:79278&MedGen:C3661900	Uncertain_significance(1)&Benign(5)&Likely_benign(1)	criteria_provided&_conflicting_classifications		FECH	Protoporphyria, erythropoietic, 1	AR	177000	Inherited disorders of metabolism	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs2269219	chr18_57580222_G_A	Female	./.	Other
chr19	1611724	.	G	T	49.81	PASS	"FS=1.412;MQ=243.56;MQRankSum=3.459;QD=1.56;ReadPosRankSum=0.059;SOR=1.112;FractionInformativeReads=0.969;R2_5P_bias=14.276;DP=87;AF=0.5;AN=6;AC=3;CSQ=T|missense_variant|MODERATE|TCF3|6929|Transcript|NM_003200.5|protein_coding|19/19||NM_003200.5:c.1948C>A|NP_003191.1:p.Pro650Thr|2303|1948|650|P/T|Ccc/Acc|rs7252811&COSV53647056||-1||SNV|EntrezGene||YES|||G|G|||deleterious(0)|probably_damaging(0.996)||0.0006|0.000193|0|6.714e-05|0|0.005694|1.88e-05|0|1.079e-05|0.0003478|0.0002203|0.0001248|0|0|6.543e-05|0|0.002895|9.422e-05|0|0|0|0.0004143|0.005694|gnomADe_EAS|likely_benign&uncertain_significance|0&1|1&1||||T|0.05628|-0.336588|T|0.48862|-0.259627|0.55201|0.245&0.245&.&.&0.245&.&.&.&0.245|45|-21|-20|43|0.00|0.00|0.11|0.00|TCF3|likely_benign|hg38|0.0826|P650T|ENST00000262965.11|P15923|709097||Conflicting_classifications_of_pathogenicity|Agammaglobulinemia_8&_autosomal_dominant&Agammaglobulinemia_8b&_autosomal_recessive&Inborn_genetic_diseases&not_provided|NC_000019.10:g.1611724G>T||single_nucleotide_variant|TCF3:6929|MONDO:MONDO:0014840&MedGen:C4310786&OMIM:616941&MONDO:MONDO:0859234&MedGen:C5676958&OMIM:619824&MeSH:D030342&MedGen:C0950123&MedGen:C3661900|Uncertain_significance(2)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,15:0.484:31:10,9:6,6:48:85,0,50:49.813,6.7045e-05,53:0,34.77,37.77:8,8,9,6:8,8,7,8	0/1:13,8:0.381:21:10,6:3,2:47:83,0,50:47.732,9.5003e-05,53:0,34.77,37.77:7,6,4,4:10,3,6,2	0/1:19,15:0.441:34:11,12:8,3:46:84,0,47:48.975,9.8368e-05,50:0,34.77,37.78:8,11,7,8:12,7,8,7	T	missense_variant	MODERATE	TCF3	6929	Transcript	NM_003200.5	protein_coding	19/19		c.1948C>A	p.Pro650Thr	2303	1948	650	P/T	Ccc/Acc	rs7252811&COSV53647056	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0)	probably_damaging(0.996)	NA	6,00E-04	0.000193	0	6.714e-05	0	0.005694	1.88e-05	0	1.079e-05	0.0003478	0.0002203	0.0001248	0	0	6.543e-05	0	0.002895	9.422e-05	0	0	0	0.0004143	0.005694	gnomADe_EAS	likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA	T	0.05628	-0.336588	T	0.48862	-0.259627	0.55201	0.245&0.245&.&.&0.245&.&.&.&0.245	45	-21	-20	43	0	0	0.11	0	TCF3	likely_benign	hg38	0.0826	P650T	ENST00000262965.11	P15923	709097	NA	Conflicting_classifications_of_pathogenicity	Agammaglobulinemia_8&_autosomal_dominant&Agammaglobulinemia_8b&_autosomal_recessive&Inborn_genetic_diseases&not_provided	NC_000019.10:g.1611724G>T		single_nucleotide_variant	TCF3:6929	MONDO:MONDO:0014840&MedGen:C4310786&OMIM:616941&MONDO:MONDO:0859234&MedGen:C5676958&OMIM:619824&MeSH:D030342&MedGen:C0950123&MedGen:C3661900	Uncertain_significance(2)&Likely_benign(2)	criteria_provided&_conflicting_classifications		TCF3	Agammaglobulinemia 8, autosomal dominant	AD	616941	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-9	Benign	BP4_Strong,BP6,BS1	rs7252811	chr19_1611724_G_T	Female	0/1	Heterozygous
chr19	1611724	.	G	T	49.81	PASS	"FS=1.412;MQ=243.56;MQRankSum=3.459;QD=1.56;ReadPosRankSum=0.059;SOR=1.112;FractionInformativeReads=0.969;R2_5P_bias=14.276;DP=87;AF=0.5;AN=6;AC=3;CSQ=T|missense_variant|MODERATE|TCF3|6929|Transcript|NM_003200.5|protein_coding|19/19||NM_003200.5:c.1948C>A|NP_003191.1:p.Pro650Thr|2303|1948|650|P/T|Ccc/Acc|rs7252811&COSV53647056||-1||SNV|EntrezGene||YES|||G|G|||deleterious(0)|probably_damaging(0.996)||0.0006|0.000193|0|6.714e-05|0|0.005694|1.88e-05|0|1.079e-05|0.0003478|0.0002203|0.0001248|0|0|6.543e-05|0|0.002895|9.422e-05|0|0|0|0.0004143|0.005694|gnomADe_EAS|likely_benign&uncertain_significance|0&1|1&1||||T|0.05628|-0.336588|T|0.48862|-0.259627|0.55201|0.245&0.245&.&.&0.245&.&.&.&0.245|45|-21|-20|43|0.00|0.00|0.11|0.00|TCF3|likely_benign|hg38|0.0826|P650T|ENST00000262965.11|P15923|709097||Conflicting_classifications_of_pathogenicity|Agammaglobulinemia_8&_autosomal_dominant&Agammaglobulinemia_8b&_autosomal_recessive&Inborn_genetic_diseases&not_provided|NC_000019.10:g.1611724G>T||single_nucleotide_variant|TCF3:6929|MONDO:MONDO:0014840&MedGen:C4310786&OMIM:616941&MONDO:MONDO:0859234&MedGen:C5676958&OMIM:619824&MeSH:D030342&MedGen:C0950123&MedGen:C3661900|Uncertain_significance(2)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,15:0.484:31:10,9:6,6:48:85,0,50:49.813,6.7045e-05,53:0,34.77,37.77:8,8,9,6:8,8,7,8	0/1:13,8:0.381:21:10,6:3,2:47:83,0,50:47.732,9.5003e-05,53:0,34.77,37.77:7,6,4,4:10,3,6,2	0/1:19,15:0.441:34:11,12:8,3:46:84,0,47:48.975,9.8368e-05,50:0,34.77,37.78:8,11,7,8:12,7,8,7	T	missense_variant	MODERATE	TCF3	6929	Transcript	NM_003200.5	protein_coding	19/19		c.1948C>A	p.Pro650Thr	2303	1948	650	P/T	Ccc/Acc	rs7252811&COSV53647056	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0)	probably_damaging(0.996)	NA	6,00E-04	0.000193	0	6.714e-05	0	0.005694	1.88e-05	0	1.079e-05	0.0003478	0.0002203	0.0001248	0	0	6.543e-05	0	0.002895	9.422e-05	0	0	0	0.0004143	0.005694	gnomADe_EAS	likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA	T	0.05628	-0.336588	T	0.48862	-0.259627	0.55201	0.245&0.245&.&.&0.245&.&.&.&0.245	45	-21	-20	43	0	0	0.11	0	TCF3	likely_benign	hg38	0.0826	P650T	ENST00000262965.11	P15923	709097	NA	Conflicting_classifications_of_pathogenicity	Agammaglobulinemia_8&_autosomal_dominant&Agammaglobulinemia_8b&_autosomal_recessive&Inborn_genetic_diseases&not_provided	NC_000019.10:g.1611724G>T		single_nucleotide_variant	TCF3:6929	MONDO:MONDO:0014840&MedGen:C4310786&OMIM:616941&MONDO:MONDO:0859234&MedGen:C5676958&OMIM:619824&MeSH:D030342&MedGen:C0950123&MedGen:C3661900	Uncertain_significance(2)&Likely_benign(2)	criteria_provided&_conflicting_classifications		TCF3	Agammaglobulinemia 8b, autosomal recessive	AR	619824	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-9	Benign	BP4_Strong,BP6,BS1	rs7252811	chr19_1611724_G_T	Female	0/1	Heterozygous
chr19	7114047	.	CA	C	50	PASS	"FS=0;MQ=244.16;MQRankSum=4.427;QD=1.4;ReadPosRankSum=1.281;SOR=0.657;FractionInformativeReads=0.879;R2_5P_bias=5.377;DP=92;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|INSR|3643|Transcript|NM_000208.4|protein_coding|22/22||NM_000208.4:c.*3008del||7680|||||rs72149315||-1||deletion|EntrezGene||YES|||A|A|||||||||||||||||0.419|0.3609|0.4332|0.501|0.4144|0.4531|0.4054|0.3922|0.4313|0.4169|0.4345|0.501|gnomADg_AMR|uncertain_significance||1|||||||||||||||||||||||||||330375||Uncertain_significance|Insulin-resistant_diabetes_mellitus_AND_acanthosis_nigricans&not_provided&Leprechaunism_syndrome&Rabson-Mendenhall_syndrome|NC_000019.10:g.7114072del||Deletion|INSR:3643|MONDO:MONDO:0012520&MedGen:C0342278&OMIM:610549&Orphanet:2297&MedGen:C3661900&MONDO:MONDO:0009517&MedGen:C0265344&OMIM:246200&Orphanet:508&MONDO:MONDO:0009874&MedGen:C0271695&OMIM:262190&Orphanet:769||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,11:0.379:29:6,3:12,8:45:50,0,50:46.052,0.00012943,53:0,4,7:13,5,8,3:9,9,4,7	0/1:9,11:0.55:20:3,6:6,5:45:55,0,43:50,0.00014548,46.294:0,5,8.01:6,3,7,4:4,5,6,5	0/1:23,14:0.378:37:13,5:10,9:44:49,0,50:44.833,0.00016438,53:0,4,7:16,7,8,6:16,7,9,5	-	3_prime_UTR_variant	MODIFIER	INSR	3643	Transcript	NM_000208.4	protein_coding	22/22		c.*3008del		7680					rs72149315	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.419	0.3609	0.4332	0.501	0.4144	0.4531	0.4054	0.3922	0.4313	0.4169	0.4345	0.501	gnomADg_AMR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				330375	NA	Uncertain_significance	Insulin-resistant_diabetes_mellitus_AND_acanthosis_nigricans&not_provided&Leprechaunism_syndrome&Rabson-Mendenhall_syndrome	NC_000019.10:g.7114072del		Deletion	INSR:3643	MONDO:MONDO:0012520&MedGen:C0342278&OMIM:610549&Orphanet:2297&MedGen:C3661900&MONDO:MONDO:0009517&MedGen:C0265344&OMIM:246200&Orphanet:508&MONDO:MONDO:0009874&MedGen:C0271695&OMIM:262190&Orphanet:769		criteria_provided&_multiple_submitters&_no_conflicts		INSR	Leprechaunism syndrome	AR	246200	Endocrine disorders	NBScreening	0	Uncertain_significance		rs72149315	chr19_7114047_CA_C	Female	0/1	Heterozygous
chr19	7116700	.	C	CAAAAAAAA	168.25	PASS	"FS=0;MQ=240.74;QD=4.95;SOR=0.922;FractionInformativeReads=0.794;MQRankSum=2.887;ReadPosRankSum=-1.368;R2_5P_bias=-21.397;DP=69;AF=0.5;AN=6;AC=4;CSQ=AAAAAAAA|3_prime_UTR_variant|MODIFIER|INSR|3643|Transcript|NM_000208.4|protein_coding|22/22||NM_000208.4:c.*348_*355dup||5027-5028|||||rs71177157||-1||insertion|EntrezGene||YES|||||||||||0.03175|0|0|0||0.01923||0.04202|0.03571|0|0.2987|0.1775|0.345|0.3961|0.4744|0.4888|0.1611|0.3056|0.3335|0.3725|0.2689|0.4888|gnomADg_EAS|uncertain_significance||1|||||||||||||||||||||||||||330429||Uncertain_significance|Insulin-resistant_diabetes_mellitus_AND_acanthosis_nigricans&Rabson-Mendenhall_syndrome&Leprechaunism_syndrome|NC_000019.10:g.7116714_7116721dup||Duplication|INSR:3643|MONDO:MONDO:0012520&MedGen:C0342278&OMIM:610549&Orphanet:2297&MONDO:MONDO:0009874&MedGen:C0271695&OMIM:262190&Orphanet:769&MONDO:MONDO:0009517&MedGen:C0265344&OMIM:246200&Orphanet:508||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,22:0.815:27:0,9:0,13:8:176,122,9:168.25,118.25,8.4508:0,4,7:0,0,15,12:0,0,17,10	1/1:0,10:1:10:0,4:0,6:27:84,30,0:76.977,26.977,0.0087204:0,4,7:0,0,7,3:0,0,5,5	0/1:11,9:0.45:20:3,3:8,6:48:54,0,50:49.547,6.9893e-05,53:0,4,7:6,5,5,4:6,5,3,6	AAAAAAAA	3_prime_UTR_variant	MODIFIER	INSR	3643	Transcript	NM_000208.4	protein_coding	22/22		c.*348_*355dup		5027-5028					rs71177157	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.03175	0	0	0	NA	0.01923	NA	0.04202	0.03571	0	0.2987	0.1775	0.345	0.3961	0.4744	0.4888	0.1611	0.3056	0.3335	0.3725	0.2689	0.4888	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				330429	NA	Uncertain_significance	Insulin-resistant_diabetes_mellitus_AND_acanthosis_nigricans&Rabson-Mendenhall_syndrome&Leprechaunism_syndrome	NC_000019.10:g.7116714_7116721dup		Duplication	INSR:3643	MONDO:MONDO:0012520&MedGen:C0342278&OMIM:610549&Orphanet:2297&MONDO:MONDO:0009874&MedGen:C0271695&OMIM:262190&Orphanet:769&MONDO:MONDO:0009517&MedGen:C0265344&OMIM:246200&Orphanet:508		criteria_provided&_single_submitter		INSR	Leprechaunism syndrome	AR	246200	Endocrine disorders	NBScreening	-8	Benign	BA1	rs71177157	chr19_7116700_C_CAAAAAAAA	Female	1/0	Heterozygous
chr19	7647168	.	G	T	49.94	PASS	"FS=1.223;MQ=250;MQRankSum=5.6;QD=1.16;ReadPosRankSum=3.559;SOR=0.473;FractionInformativeReads=1;R2_5P_bias=2.746;DP=115;AF=0.5;AN=6;AC=3;CSQ=T|missense_variant|MODERATE|STXBP2|6813|Transcript|NM_006949.4|protein_coding|17/19||NM_006949.4:c.1459G>T|NP_008880.2:p.Val487Leu|1499|1459|487|V/L|Gtg/Ttg|rs150174842||1||SNV|EntrezGene||YES|||G|G|||deleterious(0.03)|benign(0.092)|||1.165e-05|0|0|0|0|0|0.0001888|9.893e-06|3.316e-05|3.479e-05|1.314e-05|0|0|0|0|0|0|0|2.94e-05|0|0|0.0001888|gnomADe_MID|uncertain_significance||1||||T|0.43971|-0.0531251|T|0.53364|-0.213457|0.68844|0.369&0.369&0.369&.|6|20|-2|35|0.00|0.00|0.00|0.00|STXBP2|likely_benign|hg38|0.1569|V487L|ENST00000221283.10|Q15833|330558||Uncertain_significance|Familial_hemophagocytic_lymphohistiocytosis_5|NC_000019.10:g.7647168G>T||single_nucleotide_variant|STXBP2:6813|MONDO:MONDO:0013135&MedGen:C2751293&OMIM:613101&Orphanet:540||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:22,21:0.488:43:10,7:12,14:48:85,0,50:49.887,6.6269e-05,53:0,34.77,37.77:7,15,8,13:9,13,12,9	0/1:20,17:0.459:37:6,9:14,8:48:84,0,50:49.167,7.4293e-05,53:0,34.77,37.77:8,12,8,9:10,10,8,9	0/1:18,17:0.486:35:10,12:8,5:48:85,0,50:49.938,6.5751e-05,53:0,34.77,37.77:8,10,9,8:10,8,10,7	T	missense_variant	MODERATE	STXBP2	6813	Transcript	NM_006949.4	protein_coding	17/19		c.1459G>T	p.Val487Leu	1499	1459	487	V/L	Gtg/Ttg	rs150174842	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0.03)	benign(0.092)	NA	NA	1.165e-05	0	0	0	0	0	0.0001888	9.893e-06	3.316e-05	3.479e-05	1.314e-05	0	0	0	0	0	0	0	2.94e-05	0	0	0.0001888	gnomADe_MID	uncertain_significance		1	NA	NA	NA	T	0.43971	-0.0531251	T	0.53364	-0.213457	0.68844	0.369&0.369&0.369&.	6	20	-2	35	0	0	0	0	STXBP2	likely_benign	hg38	0.1569	V487L	ENST00000221283.10	Q15833	330558	NA	Uncertain_significance	Familial_hemophagocytic_lymphohistiocytosis_5	NC_000019.10:g.7647168G>T		single_nucleotide_variant	STXBP2:6813	MONDO:MONDO:0013135&MedGen:C2751293&OMIM:613101&Orphanet:540		criteria_provided&_multiple_submitters&_no_conflicts		STXBP2	Familial hemophagocytic lymphohistiocytosis 5	AR	613101	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-2	Likely_benign	BP4_Moderate	rs150174842	chr19_7647168_G_T	Female	0/1	Heterozygous
chr19	19196988	.	C	T	50	PASS	"FS=1.657;MQ=249.05;MQRankSum=4.295;QD=1.92;ReadPosRankSum=1.312;SOR=1.314;FractionInformativeReads=1;R2_5P_bias=-0.173;DP=49;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|RFXANK|8625|Transcript|NM_003721.4|protein_coding|4/10||NM_003721.4:c.213C>T|NP_003712.1:p.Thr71%3D|659|213|71|T|acC/acT|rs72997200&COSV107238770||1||SNV|EntrezGene||YES|||C|C||||||0.0288|0.0628|0.009889|0.03337|0.08773|0.0001259|0.05828|0.07235|0.0681|0.06344|0.05323|0.04596|0.01121|0.008772|0.04617|0.08708|0.0005783|0.0525|0.1054|0.06745|0.05398|0.04658|0.1054|gnomADg_MID|benign&conflicting_interpretations_of_pathogenicity|0&1|1&1||||||||||||-18|-25|-18|30|0.00|0.00|0.00|0.00|RFXANK|||||||328642||Conflicting_classifications_of_pathogenicity|not_specified&MHC_class_II_deficiency|NC_000019.10:g.19196988C>T||single_nucleotide_variant|RFXANK:8625|MedGen:CN169374&MONDO:MONDO:0008855&MedGen:C5447452&OMIM:PS209920&Orphanet:572|Uncertain_significance(1)&Benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,14:0.538:26:8,5:4,9:48:85,0,50:50,6.6527e-05,52.727:0,34.77,37.77:5,7,4,10:3,9,9,5	0/1:8,15:0.652:23:2,8:6,7:46:85,0,46:50,0.00010458,48.512:0,34.77,37.77:4,4,1,14:2,6,8,7	./.:.:.:.:.:.:.:.:.:.:.:.	T	synonymous_variant	LOW	RFXANK	8625	Transcript	NM_003721.4	protein_coding	10-Apr		c.213C>T	p.Thr71%3D	659	213	71	T	acC/acT	rs72997200&COSV107238770	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0288	0.0628	0.009889	0.03337	0.08773	0.0001259	0.05828	0.07235	0.0681	0.06344	0.05323	0.04596	0.01121	0.008772	0.04617	0.08708	0.0005783	0.0525	0.1054	0.06745	0.05398	0.04658	0.1054	gnomADg_MID	benign&conflicting_interpretations_of_pathogenicity	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-18	-25	-18	30	0	0	0	0	RFXANK			NA				328642	NA	Conflicting_classifications_of_pathogenicity	not_specified&MHC_class_II_deficiency	NC_000019.10:g.19196988C>T		single_nucleotide_variant	RFXANK:8625	MedGen:CN169374&MONDO:MONDO:0008855&MedGen:C5447452&OMIM:PS209920&Orphanet:572	Uncertain_significance(1)&Benign(2)	criteria_provided&_conflicting_classifications		RFXANK	MHC class II deficiency 1	AR	209920	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs72997200	chr19_19196988_C_T	Female	0/1	Heterozygous
chr19	19196988	.	C	T	50	PASS	"FS=1.657;MQ=249.05;MQRankSum=4.295;QD=1.92;ReadPosRankSum=1.312;SOR=1.314;FractionInformativeReads=1;R2_5P_bias=-0.173;DP=49;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|RFXANK|8625|Transcript|NM_003721.4|protein_coding|4/10||NM_003721.4:c.213C>T|NP_003712.1:p.Thr71%3D|659|213|71|T|acC/acT|rs72997200&COSV107238770||1||SNV|EntrezGene||YES|||C|C||||||0.0288|0.0628|0.009889|0.03337|0.08773|0.0001259|0.05828|0.07235|0.0681|0.06344|0.05323|0.04596|0.01121|0.008772|0.04617|0.08708|0.0005783|0.0525|0.1054|0.06745|0.05398|0.04658|0.1054|gnomADg_MID|benign&conflicting_interpretations_of_pathogenicity|0&1|1&1||||||||||||-18|-25|-18|30|0.00|0.00|0.00|0.00|RFXANK|||||||328642||Conflicting_classifications_of_pathogenicity|not_specified&MHC_class_II_deficiency|NC_000019.10:g.19196988C>T||single_nucleotide_variant|RFXANK:8625|MedGen:CN169374&MONDO:MONDO:0008855&MedGen:C5447452&OMIM:PS209920&Orphanet:572|Uncertain_significance(1)&Benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,14:0.538:26:8,5:4,9:48:85,0,50:50,6.6527e-05,52.727:0,34.77,37.77:5,7,4,10:3,9,9,5	0/1:8,15:0.652:23:2,8:6,7:46:85,0,46:50,0.00010458,48.512:0,34.77,37.77:4,4,1,14:2,6,8,7	./.:.:.:.:.:.:.:.:.:.:.:.	T	synonymous_variant	LOW	RFXANK	8625	Transcript	NM_003721.4	protein_coding	10-Apr		c.213C>T	p.Thr71%3D	659	213	71	T	acC/acT	rs72997200&COSV107238770	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0288	0.0628	0.009889	0.03337	0.08773	0.0001259	0.05828	0.07235	0.0681	0.06344	0.05323	0.04596	0.01121	0.008772	0.04617	0.08708	0.0005783	0.0525	0.1054	0.06745	0.05398	0.04658	0.1054	gnomADg_MID	benign&conflicting_interpretations_of_pathogenicity	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-18	-25	-18	30	0	0	0	0	RFXANK			NA				328642	NA	Conflicting_classifications_of_pathogenicity	not_specified&MHC_class_II_deficiency	NC_000019.10:g.19196988C>T		single_nucleotide_variant	RFXANK:8625	MedGen:CN169374&MONDO:MONDO:0008855&MedGen:C5447452&OMIM:PS209920&Orphanet:572	Uncertain_significance(1)&Benign(2)	criteria_provided&_conflicting_classifications		RFXANK	Bare lymphocyte syndrome, type ll, complementation group B	AR	620818	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs72997200	chr19_19196988_C_T	Female	0/1	Heterozygous
chr19	19196988	.	C	T	50	PASS	"FS=1.657;MQ=249.05;MQRankSum=4.295;QD=1.92;ReadPosRankSum=1.312;SOR=1.314;FractionInformativeReads=1;R2_5P_bias=-0.173;DP=49;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|RFXANK|8625|Transcript|NM_003721.4|protein_coding|4/10||NM_003721.4:c.213C>T|NP_003712.1:p.Thr71%3D|659|213|71|T|acC/acT|rs72997200&COSV107238770||1||SNV|EntrezGene||YES|||C|C||||||0.0288|0.0628|0.009889|0.03337|0.08773|0.0001259|0.05828|0.07235|0.0681|0.06344|0.05323|0.04596|0.01121|0.008772|0.04617|0.08708|0.0005783|0.0525|0.1054|0.06745|0.05398|0.04658|0.1054|gnomADg_MID|benign&conflicting_interpretations_of_pathogenicity|0&1|1&1||||||||||||-18|-25|-18|30|0.00|0.00|0.00|0.00|RFXANK|||||||328642||Conflicting_classifications_of_pathogenicity|not_specified&MHC_class_II_deficiency|NC_000019.10:g.19196988C>T||single_nucleotide_variant|RFXANK:8625|MedGen:CN169374&MONDO:MONDO:0008855&MedGen:C5447452&OMIM:PS209920&Orphanet:572|Uncertain_significance(1)&Benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,14:0.538:26:8,5:4,9:48:85,0,50:50,6.6527e-05,52.727:0,34.77,37.77:5,7,4,10:3,9,9,5	0/1:8,15:0.652:23:2,8:6,7:46:85,0,46:50,0.00010458,48.512:0,34.77,37.77:4,4,1,14:2,6,8,7	./.:.:.:.:.:.:.:.:.:.:.:.	T	synonymous_variant	LOW	RFXANK	8625	Transcript	NM_003721.4	protein_coding	10-Apr		c.213C>T	p.Thr71%3D	659	213	71	T	acC/acT	rs72997200&COSV107238770	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0288	0.0628	0.009889	0.03337	0.08773	0.0001259	0.05828	0.07235	0.0681	0.06344	0.05323	0.04596	0.01121	0.008772	0.04617	0.08708	0.0005783	0.0525	0.1054	0.06745	0.05398	0.04658	0.1054	gnomADg_MID	benign&conflicting_interpretations_of_pathogenicity	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-18	-25	-18	30	0	0	0	0	RFXANK			NA				328642	NA	Conflicting_classifications_of_pathogenicity	not_specified&MHC_class_II_deficiency	NC_000019.10:g.19196988C>T		single_nucleotide_variant	RFXANK:8625	MedGen:CN169374&MONDO:MONDO:0008855&MedGen:C5447452&OMIM:PS209920&Orphanet:572	Uncertain_significance(1)&Benign(2)	criteria_provided&_conflicting_classifications		RFXANK	Bare lymphocyte syndrome, type II, complementation group B	AR	620815	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs72997200	chr19_19196988_C_T	Female	0/1	Heterozygous
chr19	45548790	.	C	CTTAT	50	PASS	"FS=5.294;MQ=246.53;MQRankSum=3.412;QD=1.47;ReadPosRankSum=0.577;SOR=0.188;FractionInformativeReads=1;R2_5P_bias=-1.793;DP=100;AF=0.5;AN=6;AC=3;CSQ=TTAT|3_prime_UTR_variant|MODIFIER|OPA3|80207|Transcript|NM_025136.4|protein_coding|2/2||NM_025136.4:c.*4720_*4723dup||5301-5302|||||rs58537694||-1||insertion|EntrezGene||YES||||||||||0.5302|0.2113|0.1666|0.25|0.2248|0.3717|0.2069|0.1901|0.2102|0.2118|0.2638|0.2814|0.2126|0.218|0.3331|0.3108|0.4466|0.3035|0.3138|0.2878|0.278|0.3834|0.7798|EAS|||1|||||||||||||||||||||||||||329598||Conflicting_classifications_of_pathogenicity|Optic_Atrophy&_Dominant&3-Methylglutaconic_aciduria_type_3|NC_000019.10:g.45548794TTTA[8]||Microsatellite|OPA3:80207|MedGen:CN239213&MONDO:MONDO:0009787&MedGen:C0574084&OMIM:258501&Orphanet:67047|Uncertain_significance(2)&Benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:14,20:0.588:34:10,12:4,8:47:57,0,48:50,7.8953e-05,50.868:0,7,10:10,4,10,10:8,6,8,12	0/1:17,14:0.452:31:9,10:8,4:48:56,0,50:49.373,7.1964e-05,53:0,7,10:7,10,7,7:9,8,9,5	0/1:20,13:0.394:33:13,7:7,6:45:55,0,47:46.816,0.00013383,50:0,8,11.01:13,7,6,7:6,14,8,5	TTAT	3_prime_UTR_variant	MODIFIER	OPA3	80207	Transcript	NM_025136.4	protein_coding	02-Feb		c.*4720_*4723dup		5301-5302					rs58537694	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.5302	0.2113	0.1666	0.25	0.2248	0.3717	0.2069	0.1901	0.2102	0.2118	0.2638	0.2814	0.2126	0.218	0.3331	0.3108	0.4466	0.3035	0.3138	0.2878	0.278	0.3834	0.7798	EAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				329598	NA	Conflicting_classifications_of_pathogenicity	Optic_Atrophy&_Dominant&3-Methylglutaconic_aciduria_type_3	NC_000019.10:g.45548794TTTA[8]		Microsatellite	OPA3:80207	MedGen:CN239213&MONDO:MONDO:0009787&MedGen:C0574084&OMIM:258501&Orphanet:67047	Uncertain_significance(2)&Benign(2)	criteria_provided&_conflicting_classifications		OPA3	3-Methylglutaconic aciduria type 3	AR	258501	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs58537694	chr19_45548790_C_CTTAT	Female	0/1	Heterozygous
chr19	49862520	.	A	AG	50	PASS	"FS=0;MQ=250;MQRankSum=5.264;QD=1.16;ReadPosRankSum=-0.068;SOR=0.877;FractionInformativeReads=0.953;R2_5P_bias=-7.643;DP=72;AF=0.5;AN=4;AC=2;CSQ=G|intron_variant|MODIFIER|PNKP|11284|Transcript|NM_007254.4|protein_coding||10/16|NM_007254.4:c.936+17dup|||||||rs3739200||-1||insertion|EntrezGene||YES||||||||||0.0066|0.0123|0.002703|0.018|0.03105|0|0.001601|0.03913|0.01313|0.0139|0.006007|0.01056|0.002335|0|0.02863|0.02679|0|0.0005649|0.01361|0.0132|0.01989|0.006421|0.03913|gnomADe_MID|uncertain_significance&benign||1||||||||||||-16|11|20|17|0.00|0.00|0.00|0.00|PNKP|||||||206371||Conflicting_classifications_of_pathogenicity|Developmental_and_epileptic_encephalopathy&_12&not_provided&not_specified|NC_000019.10:g.49862525dup||Duplication|PNKP:11284|MONDO:MONDO:0013389&MedGen:C3150988&OMIM:613722&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(1)&Benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,26:0.634:41:8,9:7,17:45:79,0,44:50,0.00014005,46.522:0,29,32:7,8,11,15:8,7,12,14	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:8,20:0.714:28:6,11:2,9:41:79,0,38:50,0.0003531,41.47:0,29,32:5,3,11,9:3,5,10,10	G	intron_variant	MODIFIER	PNKP	11284	Transcript	NM_007254.4	protein_coding		16-Oct	c.936+17dup							rs3739200	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.0066	0.0123	0.002703	0.018	0.03105	0	0.001601	0.03913	0.01313	0.0139	0.006007	0.01056	0.002335	0	0.02863	0.02679	0	0.0005649	0.01361	0.0132	0.01989	0.006421	0.03913	gnomADe_MID	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-16	11	20	17	0	0	0	0	PNKP			NA				206371	NA	Conflicting_classifications_of_pathogenicity	Developmental_and_epileptic_encephalopathy&_12&not_provided&not_specified	NC_000019.10:g.49862525dup		Duplication	PNKP:11284	MONDO:MONDO:0013389&MedGen:C3150988&OMIM:613722&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(1)&Benign(2)	criteria_provided&_conflicting_classifications		PNKP	Microcephaly, seizures, and developmental delay	AR	613402	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-9	Benign	BP6,BS1,BS2	rs3739200	chr19_49862520_A_AG	Female	0/1	Heterozygous
chr19	55154042	.	C	T	127.81	PASS	"FS=0;MQ=250;QD=4.73;SOR=1.101;FractionInformativeReads=1;MQRankSum=4.561;ReadPosRankSum=2.902;R2_5P_bias=14.565;DP=84;AF=0.5;AN=6;AC=4;CSQ=T|synonymous_variant|LOW|TNNI3|7137|Transcript|NM_000363.5|protein_coding|7/8||NM_000363.5:c.537G>A|NP_000354.4:p.Glu179%3D|680|537|179|E|gaG/gaA|rs3729841||-1||SNV|EntrezGene||YES|||C|C||||||0.0477|0.06784|0.01226|0.03604|0.09344|0.02595|0.06274|0.1603|0.06798|0.07445|0.1089|0.05099|0.01217|0.1086|0.04085|0.09683|0.04175|0.05975|0.1463|0.06858|0.0696|0.1023|0.1603|gnomADe_MID|likely_benign&benign&uncertain_significance||1||||||||||||14|44|-12|12|0.00|0.00|0.00|0.01|TNNI3|||||||43391||Conflicting_classifications_of_pathogenicity|Cardiomyopathy&_familial_restrictive&_1&Hypertrophic_cardiomyopathy_7&Primary_ciliary_dyskinesia&not_specified&Cardiovascular_phenotype&Dilated_cardiomyopathy_2A&Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&Hypertrophic_cardiomyopathy&Cardiomyopathy|NC_000019.10:g.55154042C>T||single_nucleotide_variant|TNNI3:7137&DNAAF3:352909|MONDO:MONDO:0007270&MedGen:C1861861&OMIM:115210&Orphanet:75249&MONDO:MONDO:0013369&MedGen:C1860752&OMIM:613690&Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:CN169374&MedGen:CN230736&MONDO:MONDO:0012746&MedGen:C2678474&OMIM:611880&Orphanet:154&MedGen:CN239247&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848|Uncertain_significance(1)&Benign(11)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,27:1:27:0,15:0,12:78:166,81,0:127.81,77.807,0:0,34.77,37.77:0,0,11,16:0,0,17,10	0/1:14,15:0.517:29:5,7:9,8:48:85,0,50:50,6.5751e-05,52.895:0,34.77,37.77:9,5,6,9:6,8,6,9	0/1:11,16:0.593:27:8,12:3,4:48:85,0,48:50,7.6882e-05,51.122:0,34.77,37.77:7,4,8,8:6,5,10,6	T	synonymous_variant	LOW	TNNI3	7137	Transcript	NM_000363.5	protein_coding	08-Jul		c.537G>A	p.Glu179%3D	680	537	179	E	gaG/gaA	rs3729841	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0477	0.06784	0.01226	0.03604	0.09344	0.02595	0.06274	0.1603	0.06798	0.07445	0.1089	0.05099	0.01217	0.1086	0.04085	0.09683	0.04175	0.05975	0.1463	0.06858	0.0696	0.1023	0.1603	gnomADe_MID	likely_benign&benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		14	44	-12	12	0	0	0	0.01	TNNI3			NA				43391	NA	Conflicting_classifications_of_pathogenicity	Cardiomyopathy&_familial_restrictive&_1&Hypertrophic_cardiomyopathy_7&Primary_ciliary_dyskinesia&not_specified&Cardiovascular_phenotype&Dilated_cardiomyopathy_2A&Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&Hypertrophic_cardiomyopathy&Cardiomyopathy	NC_000019.10:g.55154042C>T		single_nucleotide_variant	TNNI3:7137&DNAAF3:352909	MONDO:MONDO:0007270&MedGen:C1861861&OMIM:115210&Orphanet:75249&MONDO:MONDO:0013369&MedGen:C1860752&OMIM:613690&Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:CN169374&MedGen:CN230736&MONDO:MONDO:0012746&MedGen:C2678474&OMIM:611880&Orphanet:154&MedGen:CN239247&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848	Uncertain_significance(1)&Benign(11)&Likely_benign(1)	criteria_provided&_conflicting_classifications		TNNI3	Dilated cardiomyopathy 2A	AD	611880	Cardiac and vascular disorders	NBScreening	-12	Benign	BP4_Moderate,BP6,BP7,BA1	rs3729841	chr19_55154042_C_T	Female	01-Jan	Homozygous
chr19	55154042	.	C	T	127.81	PASS	"FS=0;MQ=250;QD=4.73;SOR=1.101;FractionInformativeReads=1;MQRankSum=4.561;ReadPosRankSum=2.902;R2_5P_bias=14.565;DP=84;AF=0.5;AN=6;AC=4;CSQ=T|synonymous_variant|LOW|TNNI3|7137|Transcript|NM_000363.5|protein_coding|7/8||NM_000363.5:c.537G>A|NP_000354.4:p.Glu179%3D|680|537|179|E|gaG/gaA|rs3729841||-1||SNV|EntrezGene||YES|||C|C||||||0.0477|0.06784|0.01226|0.03604|0.09344|0.02595|0.06274|0.1603|0.06798|0.07445|0.1089|0.05099|0.01217|0.1086|0.04085|0.09683|0.04175|0.05975|0.1463|0.06858|0.0696|0.1023|0.1603|gnomADe_MID|likely_benign&benign&uncertain_significance||1||||||||||||14|44|-12|12|0.00|0.00|0.00|0.01|TNNI3|||||||43391||Conflicting_classifications_of_pathogenicity|Cardiomyopathy&_familial_restrictive&_1&Hypertrophic_cardiomyopathy_7&Primary_ciliary_dyskinesia&not_specified&Cardiovascular_phenotype&Dilated_cardiomyopathy_2A&Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&Hypertrophic_cardiomyopathy&Cardiomyopathy|NC_000019.10:g.55154042C>T||single_nucleotide_variant|TNNI3:7137&DNAAF3:352909|MONDO:MONDO:0007270&MedGen:C1861861&OMIM:115210&Orphanet:75249&MONDO:MONDO:0013369&MedGen:C1860752&OMIM:613690&Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:CN169374&MedGen:CN230736&MONDO:MONDO:0012746&MedGen:C2678474&OMIM:611880&Orphanet:154&MedGen:CN239247&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848|Uncertain_significance(1)&Benign(11)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,27:1:27:0,15:0,12:78:166,81,0:127.81,77.807,0:0,34.77,37.77:0,0,11,16:0,0,17,10	0/1:14,15:0.517:29:5,7:9,8:48:85,0,50:50,6.5751e-05,52.895:0,34.77,37.77:9,5,6,9:6,8,6,9	0/1:11,16:0.593:27:8,12:3,4:48:85,0,48:50,7.6882e-05,51.122:0,34.77,37.77:7,4,8,8:6,5,10,6	T	synonymous_variant	LOW	TNNI3	7137	Transcript	NM_000363.5	protein_coding	08-Jul		c.537G>A	p.Glu179%3D	680	537	179	E	gaG/gaA	rs3729841	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0477	0.06784	0.01226	0.03604	0.09344	0.02595	0.06274	0.1603	0.06798	0.07445	0.1089	0.05099	0.01217	0.1086	0.04085	0.09683	0.04175	0.05975	0.1463	0.06858	0.0696	0.1023	0.1603	gnomADe_MID	likely_benign&benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		14	44	-12	12	0	0	0	0.01	TNNI3			NA				43391	NA	Conflicting_classifications_of_pathogenicity	Cardiomyopathy&_familial_restrictive&_1&Hypertrophic_cardiomyopathy_7&Primary_ciliary_dyskinesia&not_specified&Cardiovascular_phenotype&Dilated_cardiomyopathy_2A&Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&Hypertrophic_cardiomyopathy&Cardiomyopathy	NC_000019.10:g.55154042C>T		single_nucleotide_variant	TNNI3:7137&DNAAF3:352909	MONDO:MONDO:0007270&MedGen:C1861861&OMIM:115210&Orphanet:75249&MONDO:MONDO:0013369&MedGen:C1860752&OMIM:613690&Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:CN169374&MedGen:CN230736&MONDO:MONDO:0012746&MedGen:C2678474&OMIM:611880&Orphanet:154&MedGen:CN239247&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848	Uncertain_significance(1)&Benign(11)&Likely_benign(1)	criteria_provided&_conflicting_classifications		TNNI3	Dilated cardiomyopathy 1FF	AD	613286	Cardiac and vascular disorders	NBScreening	-12	Benign	BP4_Moderate,BP6,BP7,BA1	rs3729841	chr19_55154042_C_T	Female	01-Jan	Homozygous
chr19	55154042	.	C	T	127.81	PASS	"FS=0;MQ=250;QD=4.73;SOR=1.101;FractionInformativeReads=1;MQRankSum=4.561;ReadPosRankSum=2.902;R2_5P_bias=14.565;DP=84;AF=0.5;AN=6;AC=4;CSQ=T|synonymous_variant|LOW|TNNI3|7137|Transcript|NM_000363.5|protein_coding|7/8||NM_000363.5:c.537G>A|NP_000354.4:p.Glu179%3D|680|537|179|E|gaG/gaA|rs3729841||-1||SNV|EntrezGene||YES|||C|C||||||0.0477|0.06784|0.01226|0.03604|0.09344|0.02595|0.06274|0.1603|0.06798|0.07445|0.1089|0.05099|0.01217|0.1086|0.04085|0.09683|0.04175|0.05975|0.1463|0.06858|0.0696|0.1023|0.1603|gnomADe_MID|likely_benign&benign&uncertain_significance||1||||||||||||14|44|-12|12|0.00|0.00|0.00|0.01|TNNI3|||||||43391||Conflicting_classifications_of_pathogenicity|Cardiomyopathy&_familial_restrictive&_1&Hypertrophic_cardiomyopathy_7&Primary_ciliary_dyskinesia&not_specified&Cardiovascular_phenotype&Dilated_cardiomyopathy_2A&Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&Hypertrophic_cardiomyopathy&Cardiomyopathy|NC_000019.10:g.55154042C>T||single_nucleotide_variant|TNNI3:7137&DNAAF3:352909|MONDO:MONDO:0007270&MedGen:C1861861&OMIM:115210&Orphanet:75249&MONDO:MONDO:0013369&MedGen:C1860752&OMIM:613690&Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:CN169374&MedGen:CN230736&MONDO:MONDO:0012746&MedGen:C2678474&OMIM:611880&Orphanet:154&MedGen:CN239247&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848|Uncertain_significance(1)&Benign(11)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,27:1:27:0,15:0,12:78:166,81,0:127.81,77.807,0:0,34.77,37.77:0,0,11,16:0,0,17,10	0/1:14,15:0.517:29:5,7:9,8:48:85,0,50:50,6.5751e-05,52.895:0,34.77,37.77:9,5,6,9:6,8,6,9	0/1:11,16:0.593:27:8,12:3,4:48:85,0,48:50,7.6882e-05,51.122:0,34.77,37.77:7,4,8,8:6,5,10,6	T	synonymous_variant	LOW	TNNI3	7137	Transcript	NM_000363.5	protein_coding	08-Jul		c.537G>A	p.Glu179%3D	680	537	179	E	gaG/gaA	rs3729841	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0477	0.06784	0.01226	0.03604	0.09344	0.02595	0.06274	0.1603	0.06798	0.07445	0.1089	0.05099	0.01217	0.1086	0.04085	0.09683	0.04175	0.05975	0.1463	0.06858	0.0696	0.1023	0.1603	gnomADe_MID	likely_benign&benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		14	44	-12	12	0	0	0	0.01	TNNI3			NA				43391	NA	Conflicting_classifications_of_pathogenicity	Cardiomyopathy&_familial_restrictive&_1&Hypertrophic_cardiomyopathy_7&Primary_ciliary_dyskinesia&not_specified&Cardiovascular_phenotype&Dilated_cardiomyopathy_2A&Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&Hypertrophic_cardiomyopathy&Cardiomyopathy	NC_000019.10:g.55154042C>T		single_nucleotide_variant	TNNI3:7137&DNAAF3:352909	MONDO:MONDO:0007270&MedGen:C1861861&OMIM:115210&Orphanet:75249&MONDO:MONDO:0013369&MedGen:C1860752&OMIM:613690&Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:CN169374&MedGen:CN230736&MONDO:MONDO:0012746&MedGen:C2678474&OMIM:611880&Orphanet:154&MedGen:CN239247&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848	Uncertain_significance(1)&Benign(11)&Likely_benign(1)	criteria_provided&_conflicting_classifications		TNNI3	Hypertrophic cardiomyopathy 7	AD	613690	Cardiac and vascular disorders	NBScreening	-12	Benign	BP4_Moderate,BP6,BP7,BA1	rs3729841	chr19_55154042_C_T	Female	01-Jan	Homozygous
chr1	16051552	.	G	T	50	PASS	"FS=0;MQ=211.83;MQRankSum=1.607;QD=1.79;ReadPosRankSum=3.61;SOR=0.693;FractionInformativeReads=1;R2_5P_bias=-1.747;DP=53;AF=0.5;AN=4;AC=2;CSQ=T|splice_donor_5th_base_variant&intron_variant|LOW|CLCNKB|1188|Transcript|NM_000085.5|protein_coding||13/19|NM_000085.5:c.1297+5G>T|||||||rs35351345||1||SNV|EntrezGene||YES|||G|G||||||0.0036|0.007242|0.001434|0.004271|0.008341|2.519e-05|0.002565|0.008842|0.008413|0.006839|0.002006|0.005222|0.001782|0.001096|0.005033|0.009793|0|0.003203|0.003425|0.008161|0.007102|0.0008288|0.0109|EUR|uncertain_significance&conflicting_interpretations_of_pathogenicity||1|0.999788518147431|0.946||||||||||45|-30|-31|-5|0.00|0.00|0.11|0.73|CLCNKB|||||||447090||Conflicting_classifications_of_pathogenicity|not_specified&not_provided|NC_000001.11:g.16051552G>T||single_nucleotide_variant|CLCNKB:1188&LOC106501713:106501713|MedGen:CN169374&MedGen:C3661900|Uncertain_significance(3)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,10:0.385:26:8,4:8,6:46:81,0,50:46.623,0.00011623,53:0,34.77,37.77:8,8,5,5:8,8,5,5	0/1:12,15:0.556:27:5,7:7,8:48:85,0,49:50,6.9375e-05,52.254:0,34.77,37.77:7,5,6,9:2,10,10,5	T	splice_donor_5th_base_variant&intron_variant	LOW	CLCNKB	1188	Transcript	NM_000085.5	protein_coding		13/19	c.1297+5G>T							rs35351345	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0036	0.007242	0.001434	0.004271	0.008341	2.519e-05	0.002565	0.008842	0.008413	0.006839	0.002006	0.005222	0.001782	0.001096	0.005033	0.009793	0	0.003203	0.003425	0.008161	0.007102	0.0008288	0.0109	EUR	uncertain_significance&conflicting_interpretations_of_pathogenicity		1	0.999788518147431	0.946	NA		NA	NA		NA	NA	NA		45	-30	-31	-5	0	0	0.11	0.73	CLCNKB			NA				447090	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided	NC_000001.11:g.16051552G>T		single_nucleotide_variant	CLCNKB:1188&LOC106501713:106501713	MedGen:CN169374&MedGen:C3661900	Uncertain_significance(3)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		CLCNKB	Bartter disease type 3	AR	607364	Renal disorders	NBScreening	-7	Benign	PP3_Moderate,BP6,BS1,BS2	rs35351345	chr1_16051552_G_T	Female	./.	Other
chr1	17027802	.	A	G	49.54	PASS	"FS=1.273;MQ=250;MQRankSum=5.166;QD=1.34;ReadPosRankSum=3.977;SOR=0.657;FractionInformativeReads=1;R2_5P_bias=11.424;DP=61;AF=0.5;AN=4;AC=2;CSQ=G|missense_variant|MODERATE|SDHB|6390|Transcript|NM_003000.3|protein_coding|5/8||NM_003000.3:c.487T>C|NP_002991.2:p.Ser163Pro|500|487|163|S/P|Tct/Cct|rs33927012&CM056695&COSV64965186||-1||SNV|EntrezGene||YES|||A|A|||tolerated_low_confidence(0.13)|benign(0)||0.0094|0.01349|0.002151|0.003623|0.006124|2.519e-05|0.02153|0.01231|0.01433|0.01115|0.01745|0.009468|0.001781|0|0.004648|0.007493|0.0001933|0.0185|0.006803|0.01412|0.008523|0.01928|0.0245|SAS|uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_benign&benign/likely_benign|0&1&1|1&1&1||||T|0.38842|-0.0853516|D|0.78470|0.123546|0.74306|0.439&.&.|39|-42|-9|41|0.00|0.00|0.03|0.00|SDHB|likely_benign|hg38|0.1363|S163P|ENST00000375499.7|P21912|12792||Conflicting_classifications_of_pathogenicity|Malignant_tumor_of_breast&Paragangliomas_4&Cowden_syndrome&Hereditary_pheochromocytoma-paraganglioma&not_specified&Hereditary_cancer-predisposing_syndrome&not_provided&Carney-Stratakis_syndrome&Pheochromocytoma&Gastrointestinal_stromal_tumor|NC_000001.11:g.17027802A>G||single_nucleotide_variant|SDHB:6390|MONDO:MONDO:0007254&MedGen:C0006142&MONDO:MONDO:0007273&MedGen:C1861848&OMIM:115310&Orphanet:29072&MONDO:MONDO:0016063&MedGen:C0018553&OMIM:PS158350&Orphanet:201&MONDO:MONDO:0017366&MedGen:C1708353&Orphanet:29072&MedGen:CN169374&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:C3661900&MONDO:MONDO:0011740&MedGen:C1847319&OMIM:606864&Orphanet:97286&Human_Phenotype_Ontology:HP:0002666&MONDO:MONDO:0008233&MedGen:C0031511&OMIM:171300&Orphanet:29072&Human_Phenotype_Ontology:HP:0100723&MONDO:MONDO:0011719&MeSH:D046152&MedGen:C0238198&OMIM:606764&Orphanet:44890|Uncertain_significance(3)&Benign(19)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:20,17:0.459:37:8,10:12,7:48:84,0,50:49.537,7.0152e-05,53:0,34.77,37.77:9,11,9,8:9,11,6,11	0/1:14,10:0.417:24:5,6:9,4:46:83,0,47:48.545,0.00010406,50:0,34.77,37.78:5,9,5,5:8,6,3,7	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	SDHB	6390	Transcript	NM_003000.3	protein_coding	08-May		c.487T>C	p.Ser163Pro	500	487	163	S/P	Tct/Cct	rs33927012&CM056695&COSV64965186	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	tolerated_low_confidence(0.13)	benign(0)	NA	0.0094	0.01349	0.002151	0.003623	0.006124	2.519e-05	0.02153	0.01231	0.01433	0.01115	0.01745	0.009468	0.001781	0	0.004648	0.007493	0.0001933	0.0185	0.006803	0.01412	0.008523	0.01928	0.0245	SAS	uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_benign&benign/likely_benign	0&1&1	1&1&1	NA	NA	NA	T	0.38842	-0.0853516	D	0.7847	0.123546	0.74306	0.439&.&.	39	-42	-9	41	0	0	0.03	0	SDHB	likely_benign	hg38	0.1363	S163P	ENST00000375499.7	P21912	12792	NA	Conflicting_classifications_of_pathogenicity	Malignant_tumor_of_breast&Paragangliomas_4&Cowden_syndrome&Hereditary_pheochromocytoma-paraganglioma&not_specified&Hereditary_cancer-predisposing_syndrome&not_provided&Carney-Stratakis_syndrome&Pheochromocytoma&Gastrointestinal_stromal_tumor	NC_000001.11:g.17027802A>G		single_nucleotide_variant	SDHB:6390	MONDO:MONDO:0007254&MedGen:C0006142&MONDO:MONDO:0007273&MedGen:C1861848&OMIM:115310&Orphanet:29072&MONDO:MONDO:0016063&MedGen:C0018553&OMIM:PS158350&Orphanet:201&MONDO:MONDO:0017366&MedGen:C1708353&Orphanet:29072&MedGen:CN169374&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:C3661900&MONDO:MONDO:0011740&MedGen:C1847319&OMIM:606864&Orphanet:97286&Human_Phenotype_Ontology:HP:0002666&MONDO:MONDO:0008233&MedGen:C0031511&OMIM:171300&Orphanet:29072&Human_Phenotype_Ontology:HP:0100723&MONDO:MONDO:0011719&MeSH:D046152&MedGen:C0238198&OMIM:606764&Orphanet:44890	Uncertain_significance(3)&Benign(19)&Likely_benign(1)	criteria_provided&_conflicting_classifications		SDHB	Paragangliomas 4	AD	115310	Tumor predisposition syndromes	NBScreening	-11	Benign	PM1,BP4_Strong,BP6,BS1,BS2	rs33927012	chr1_17027802_A_G	Female	0/1	Heterozygous
chr1	17027802	.	A	G	49.54	PASS	"FS=1.273;MQ=250;MQRankSum=5.166;QD=1.34;ReadPosRankSum=3.977;SOR=0.657;FractionInformativeReads=1;R2_5P_bias=11.424;DP=61;AF=0.5;AN=4;AC=2;CSQ=G|missense_variant|MODERATE|SDHB|6390|Transcript|NM_003000.3|protein_coding|5/8||NM_003000.3:c.487T>C|NP_002991.2:p.Ser163Pro|500|487|163|S/P|Tct/Cct|rs33927012&CM056695&COSV64965186||-1||SNV|EntrezGene||YES|||A|A|||tolerated_low_confidence(0.13)|benign(0)||0.0094|0.01349|0.002151|0.003623|0.006124|2.519e-05|0.02153|0.01231|0.01433|0.01115|0.01745|0.009468|0.001781|0|0.004648|0.007493|0.0001933|0.0185|0.006803|0.01412|0.008523|0.01928|0.0245|SAS|uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_benign&benign/likely_benign|0&1&1|1&1&1||||T|0.38842|-0.0853516|D|0.78470|0.123546|0.74306|0.439&.&.|39|-42|-9|41|0.00|0.00|0.03|0.00|SDHB|likely_benign|hg38|0.1363|S163P|ENST00000375499.7|P21912|12792||Conflicting_classifications_of_pathogenicity|Malignant_tumor_of_breast&Paragangliomas_4&Cowden_syndrome&Hereditary_pheochromocytoma-paraganglioma&not_specified&Hereditary_cancer-predisposing_syndrome&not_provided&Carney-Stratakis_syndrome&Pheochromocytoma&Gastrointestinal_stromal_tumor|NC_000001.11:g.17027802A>G||single_nucleotide_variant|SDHB:6390|MONDO:MONDO:0007254&MedGen:C0006142&MONDO:MONDO:0007273&MedGen:C1861848&OMIM:115310&Orphanet:29072&MONDO:MONDO:0016063&MedGen:C0018553&OMIM:PS158350&Orphanet:201&MONDO:MONDO:0017366&MedGen:C1708353&Orphanet:29072&MedGen:CN169374&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:C3661900&MONDO:MONDO:0011740&MedGen:C1847319&OMIM:606864&Orphanet:97286&Human_Phenotype_Ontology:HP:0002666&MONDO:MONDO:0008233&MedGen:C0031511&OMIM:171300&Orphanet:29072&Human_Phenotype_Ontology:HP:0100723&MONDO:MONDO:0011719&MeSH:D046152&MedGen:C0238198&OMIM:606764&Orphanet:44890|Uncertain_significance(3)&Benign(19)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:20,17:0.459:37:8,10:12,7:48:84,0,50:49.537,7.0152e-05,53:0,34.77,37.77:9,11,9,8:9,11,6,11	0/1:14,10:0.417:24:5,6:9,4:46:83,0,47:48.545,0.00010406,50:0,34.77,37.78:5,9,5,5:8,6,3,7	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	SDHB	6390	Transcript	NM_003000.3	protein_coding	08-May		c.487T>C	p.Ser163Pro	500	487	163	S/P	Tct/Cct	rs33927012&CM056695&COSV64965186	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	tolerated_low_confidence(0.13)	benign(0)	NA	0.0094	0.01349	0.002151	0.003623	0.006124	2.519e-05	0.02153	0.01231	0.01433	0.01115	0.01745	0.009468	0.001781	0	0.004648	0.007493	0.0001933	0.0185	0.006803	0.01412	0.008523	0.01928	0.0245	SAS	uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_benign&benign/likely_benign	0&1&1	1&1&1	NA	NA	NA	T	0.38842	-0.0853516	D	0.7847	0.123546	0.74306	0.439&.&.	39	-42	-9	41	0	0	0.03	0	SDHB	likely_benign	hg38	0.1363	S163P	ENST00000375499.7	P21912	12792	NA	Conflicting_classifications_of_pathogenicity	Malignant_tumor_of_breast&Paragangliomas_4&Cowden_syndrome&Hereditary_pheochromocytoma-paraganglioma&not_specified&Hereditary_cancer-predisposing_syndrome&not_provided&Carney-Stratakis_syndrome&Pheochromocytoma&Gastrointestinal_stromal_tumor	NC_000001.11:g.17027802A>G		single_nucleotide_variant	SDHB:6390	MONDO:MONDO:0007254&MedGen:C0006142&MONDO:MONDO:0007273&MedGen:C1861848&OMIM:115310&Orphanet:29072&MONDO:MONDO:0016063&MedGen:C0018553&OMIM:PS158350&Orphanet:201&MONDO:MONDO:0017366&MedGen:C1708353&Orphanet:29072&MedGen:CN169374&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:C3661900&MONDO:MONDO:0011740&MedGen:C1847319&OMIM:606864&Orphanet:97286&Human_Phenotype_Ontology:HP:0002666&MONDO:MONDO:0008233&MedGen:C0031511&OMIM:171300&Orphanet:29072&Human_Phenotype_Ontology:HP:0100723&MONDO:MONDO:0011719&MeSH:D046152&MedGen:C0238198&OMIM:606764&Orphanet:44890	Uncertain_significance(3)&Benign(19)&Likely_benign(1)	criteria_provided&_conflicting_classifications		SDHB	Pheochromocytoma/paraganglioma syndrome 1	AD	168000	Tumor predisposition syndromes	NBScreening	-11	Benign	PM1,BP4_Strong,BP6,BS1,BS2	rs33927012	chr1_17027802_A_G	Female	0/1	Heterozygous
chr1	17027802	.	A	G	49.54	PASS	"FS=1.273;MQ=250;MQRankSum=5.166;QD=1.34;ReadPosRankSum=3.977;SOR=0.657;FractionInformativeReads=1;R2_5P_bias=11.424;DP=61;AF=0.5;AN=4;AC=2;CSQ=G|missense_variant|MODERATE|SDHB|6390|Transcript|NM_003000.3|protein_coding|5/8||NM_003000.3:c.487T>C|NP_002991.2:p.Ser163Pro|500|487|163|S/P|Tct/Cct|rs33927012&CM056695&COSV64965186||-1||SNV|EntrezGene||YES|||A|A|||tolerated_low_confidence(0.13)|benign(0)||0.0094|0.01349|0.002151|0.003623|0.006124|2.519e-05|0.02153|0.01231|0.01433|0.01115|0.01745|0.009468|0.001781|0|0.004648|0.007493|0.0001933|0.0185|0.006803|0.01412|0.008523|0.01928|0.0245|SAS|uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_benign&benign/likely_benign|0&1&1|1&1&1||||T|0.38842|-0.0853516|D|0.78470|0.123546|0.74306|0.439&.&.|39|-42|-9|41|0.00|0.00|0.03|0.00|SDHB|likely_benign|hg38|0.1363|S163P|ENST00000375499.7|P21912|12792||Conflicting_classifications_of_pathogenicity|Malignant_tumor_of_breast&Paragangliomas_4&Cowden_syndrome&Hereditary_pheochromocytoma-paraganglioma&not_specified&Hereditary_cancer-predisposing_syndrome&not_provided&Carney-Stratakis_syndrome&Pheochromocytoma&Gastrointestinal_stromal_tumor|NC_000001.11:g.17027802A>G||single_nucleotide_variant|SDHB:6390|MONDO:MONDO:0007254&MedGen:C0006142&MONDO:MONDO:0007273&MedGen:C1861848&OMIM:115310&Orphanet:29072&MONDO:MONDO:0016063&MedGen:C0018553&OMIM:PS158350&Orphanet:201&MONDO:MONDO:0017366&MedGen:C1708353&Orphanet:29072&MedGen:CN169374&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:C3661900&MONDO:MONDO:0011740&MedGen:C1847319&OMIM:606864&Orphanet:97286&Human_Phenotype_Ontology:HP:0002666&MONDO:MONDO:0008233&MedGen:C0031511&OMIM:171300&Orphanet:29072&Human_Phenotype_Ontology:HP:0100723&MONDO:MONDO:0011719&MeSH:D046152&MedGen:C0238198&OMIM:606764&Orphanet:44890|Uncertain_significance(3)&Benign(19)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:20,17:0.459:37:8,10:12,7:48:84,0,50:49.537,7.0152e-05,53:0,34.77,37.77:9,11,9,8:9,11,6,11	0/1:14,10:0.417:24:5,6:9,4:46:83,0,47:48.545,0.00010406,50:0,34.77,37.78:5,9,5,5:8,6,3,7	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	SDHB	6390	Transcript	NM_003000.3	protein_coding	08-May		c.487T>C	p.Ser163Pro	500	487	163	S/P	Tct/Cct	rs33927012&CM056695&COSV64965186	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	tolerated_low_confidence(0.13)	benign(0)	NA	0.0094	0.01349	0.002151	0.003623	0.006124	2.519e-05	0.02153	0.01231	0.01433	0.01115	0.01745	0.009468	0.001781	0	0.004648	0.007493	0.0001933	0.0185	0.006803	0.01412	0.008523	0.01928	0.0245	SAS	uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_benign&benign/likely_benign	0&1&1	1&1&1	NA	NA	NA	T	0.38842	-0.0853516	D	0.7847	0.123546	0.74306	0.439&.&.	39	-42	-9	41	0	0	0.03	0	SDHB	likely_benign	hg38	0.1363	S163P	ENST00000375499.7	P21912	12792	NA	Conflicting_classifications_of_pathogenicity	Malignant_tumor_of_breast&Paragangliomas_4&Cowden_syndrome&Hereditary_pheochromocytoma-paraganglioma&not_specified&Hereditary_cancer-predisposing_syndrome&not_provided&Carney-Stratakis_syndrome&Pheochromocytoma&Gastrointestinal_stromal_tumor	NC_000001.11:g.17027802A>G		single_nucleotide_variant	SDHB:6390	MONDO:MONDO:0007254&MedGen:C0006142&MONDO:MONDO:0007273&MedGen:C1861848&OMIM:115310&Orphanet:29072&MONDO:MONDO:0016063&MedGen:C0018553&OMIM:PS158350&Orphanet:201&MONDO:MONDO:0017366&MedGen:C1708353&Orphanet:29072&MedGen:CN169374&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:C3661900&MONDO:MONDO:0011740&MedGen:C1847319&OMIM:606864&Orphanet:97286&Human_Phenotype_Ontology:HP:0002666&MONDO:MONDO:0008233&MedGen:C0031511&OMIM:171300&Orphanet:29072&Human_Phenotype_Ontology:HP:0100723&MONDO:MONDO:0011719&MeSH:D046152&MedGen:C0238198&OMIM:606764&Orphanet:44890	Uncertain_significance(3)&Benign(19)&Likely_benign(1)	criteria_provided&_conflicting_classifications		SDHB	Pheochromocytoma	AD	171300	"Tumor predisposition syndromes;Endocrine disorders                                             "	NBScreening	-11	Benign	PM1,BP4_Strong,BP6,BS1,BS2	rs33927012	chr1_17027802_A_G	Female	0/1	Heterozygous
chr1	21884902	.	C	T	50	PASS	"FS=0;MQ=250;MQRankSum=3.995;QD=2.08;ReadPosRankSum=2.385;SOR=0.673;FractionInformativeReads=1;R2_5P_bias=6.715;DP=54;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|HSPG2|3339|Transcript|NM_005529.7|protein_coding|12/97||NM_005529.7:c.1372G>A|NP_005520.4:p.Glu458Lys|1465|1372|458|E/K|Gag/Aag|rs531029732||-1||SNV|EntrezGene||YES|||C|C|||tolerated(0.09)|probably_damaging(0.988)||0.0002|4.105e-05|5.974e-05|0|0.000153|0.0006801|0|0.0001734|2.158e-05|3.311e-05|0|0.0001313|0.0003127|0|0|0|0.0007713|0|0|4.41e-05|0|0|0.0008|AFR|uncertain_significance&likely_benign||1||||T|0.00905|-0.465677|T|0.27866|-0.448474|0.09474|0.037|8|16|-3|-32|0.01|0.00|0.00|0.00|HSPG2|likely_benign|hg38|0.0812|E458K|ENST00000374695.8|P98160|1505773||Uncertain_significance|HSPG2-related_disorder&not_provided|NC_000001.11:g.21884902C>T||single_nucleotide_variant|HSPG2:3339|.&MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:9,15:0.625:24:3,7:6,8:47:85,0,47:50,9.112e-05,49.6:0,34.77,37.77:4,5,8,7:2,7,6,9	0/1:12,17:0.586:29:4,8:8,9:48:85,0,48:50,7.6882e-05,51.12:0,34.77,37.77:4,8,7,10:6,6,10,7	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	HSPG2	3339	Transcript	NM_005529.7	protein_coding	12/97		c.1372G>A	p.Glu458Lys	1465	1372	458	E/K	Gag/Aag	rs531029732	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated(0.09)	probably_damaging(0.988)	NA	2,00E-04	4.105e-05	5.974e-05	0	0.000153	0.0006801	0	0.0001734	2.158e-05	3.311e-05	0	0.0001313	0.0003127	0	0	0	0.0007713	0	0	4.41e-05	0	0	8,00E-04	AFR	uncertain_significance&likely_benign		1	NA	NA	NA	T	0.00905	-0.465677	T	0.27866	-0.448474	0.09474	0.037	8	16	-3	-32	0.01	0	0	0	HSPG2	likely_benign	hg38	0.0812	E458K	ENST00000374695.8	P98160	1505773	NA	Uncertain_significance	HSPG2-related_disorder&not_provided	NC_000001.11:g.21884902C>T		single_nucleotide_variant	HSPG2:3339	.&MedGen:C3661900		criteria_provided&_single_submitter		HSPG2	Schwartz-Jampel syndrome type 1	AR	255800	Complex genetic syndromes	NBScreening	-5	Likely_benign	BP4_Strong,BS1_Supporting	rs531029732	chr1_21884902_C_T	Female	0/1	Heterozygous
chr1	55052517	.	AC	A	134.21	PASS	"FS=0;MQ=250;QD=4.63;SOR=0.76;FractionInformativeReads=1;DP=82;AF=1;AN=6;AC=6;CSQ=-|intron_variant|MODIFIER|PCSK9|255738|Transcript|NM_174936.4|protein_coding||4/11|NM_174936.4:c.657+114del|||||||rs397735050||1||deletion|EntrezGene||YES|||C|C|||||7||0.6749|0.2017|0.7049|0.5632|0.7357|0.7526|0.5332|0.6938|0.6484|0.5846|0.5536|0.2237|0.4747|0.6645|0.5714|0.7468|0.7673|0.4658|0.6778|0.5661|0.592|0.7673|gnomADg_FIN|uncertain_significance||1||||||||||||2|10|38|-48|0.00|0.00|0.00|0.00|PCSK9|||||||265928||Uncertain_significance|Hypercholesterolemia&_familial&_1|NC_000001.11:g.55052525del||Deletion|PCSK9:255738|MONDO:MONDO:0007750&MedGen:C0745103&OMIM:143890&Orphanet:391665||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,29:1:29:0,16:0,13:84:157,87,0:134.21,84.208,0:0,20,23:0,0,14,15:0,0,15,14	1/1:0,22:1:22:0,10:0,12:63:136,66,0:113.16,63.158,2.0709e-06:0,20,23:0,0,12,10:0,0,10,12	1/1:0,28:1:28:0,15:0,13:81:153,84,0:131.24,81.245,0:0,19,22:0,0,14,14:0,0,13,15	-	intron_variant	MODIFIER	PCSK9	255738	Transcript	NM_174936.4	protein_coding		11-Apr	c.657+114del							rs397735050	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			7	NA	0.6749	0.2017	0.7049	0.5632	0.7357	0.7526	0.5332	0.6938	0.6484	0.5846	0.5536	0.2237	0.4747	0.6645	0.5714	0.7468	0.7673	0.4658	0.6778	0.5661	0.592	0.7673	gnomADg_FIN	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		2	10	38	-48	0	0	0	0	PCSK9			NA				265928	NA	Uncertain_significance	Hypercholesterolemia&_familial&_1	NC_000001.11:g.55052525del		Deletion	PCSK9:255738	MONDO:MONDO:0007750&MedGen:C0745103&OMIM:143890&Orphanet:391665		criteria_provided&_single_submitter		PCSK9	Hypercholesterolemia, autosomal dominant, 3	AD	603776	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs397735050	chr1_55052517_AC_A	Female	01-Jan	Homozygous
chr1	92478757	.	CAG	C	301.84	PASS	"FS=0;MQ=236.49;QD=8.6;SOR=2.419;FractionInformativeReads=0.655;MQRankSum=1.486;ReadPosRankSum=-1.733;R2_5P_bias=0;DP=85;AF=0.5;AN=6;AC=1;CSQ=-|splice_region_variant&splice_polypyrimidine_tract_variant&intron_variant|LOW|GFI1|2672|Transcript|NM_005263.5|protein_coding||5/6|NM_005263.5:c.925-6_925-5del|||||||rs35896485||-1||deletion|EntrezGene||YES|||AG|AG|||||||0.117|0.11|0.06441|0.1056|0.02548|0.1368|0.1015|0.1278|0.1084|0.04387|0.1234|0.1139|0.1836|0.1008|0.1275|0.03022|0.1642|0.1213|0.1384|0.1332|0.04233|0.1836|gnomADg_AMI|||1||||||||||||46|-5|-20|-4|0.00|0.00|0.00|0.00|GFI1|||||||298182||Conflicting_classifications_of_pathogenicity|not_provided&Neutropenia&_severe_congenital&_2&_autosomal_dominant&Severe_congenital_neutropenia|NC_000001.11:g.92478759GA[17]||Microsatellite|GFI1:2672|MedGen:C3661900&MONDO:MONDO:0013139&MedGen:C2751288&OMIM:613107&Orphanet:486&MONDO:MONDO:0018542&MedGen:C1853118&OMIM:PS202700&Orphanet:42738|Uncertain_significance(2)&Benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:0,.:.:19:0,.:0,.:38:255,.,.:249.38,.,.:0,.,.:0,0,15,4:0,0,9,10	0/0:0,.:0.526:17:0,.:0,.:46:209,.,.:202.7,.,.:0,.,.:0,0,6,11:0,0,9,8	1/0:1,14:0.5:28:0,5:1,9:47:308,319,50:301.84,315.61,49.63:0,3,6.01:0,1,22,5:1,0,15,12	-	splice_region_variant&splice_polypyrimidine_tract_variant&intron_variant	LOW	GFI1	2672	Transcript	NM_005263.5	protein_coding		06-May	c.925-6_925-5del							rs35896485	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	AG	AG	NA	NA			NA	NA	0.117	0.11	0.06441	0.1056	0.02548	0.1368	0.1015	0.1278	0.1084	0.04387	0.1234	0.1139	0.1836	0.1008	0.1275	0.03022	0.1642	0.1213	0.1384	0.1332	0.04233	0.1836	gnomADg_AMI			1	NA	NA	NA		NA	NA		NA	NA	NA		46	-5	-20	-4	0	0	0	0	GFI1			NA				298182	NA	Conflicting_classifications_of_pathogenicity	not_provided&Neutropenia&_severe_congenital&_2&_autosomal_dominant&Severe_congenital_neutropenia	NC_000001.11:g.92478759GA[17]		Microsatellite	GFI1:2672	MedGen:C3661900&MONDO:MONDO:0013139&MedGen:C2751288&OMIM:613107&Orphanet:486&MONDO:MONDO:0018542&MedGen:C1853118&OMIM:PS202700&Orphanet:42738	Uncertain_significance(2)&Benign(3)	criteria_provided&_conflicting_classifications		GFI1	Neutropenia, severe congenital, 2, autosomal dominant	AD	613107	"Autoimmune, inflammatory, and immunogenetic disorders;Haematological disorders"	NBScreening	-9	Benign	BP6,BA1	rs35896485	chr1_92478757_CAG_C	Female	0/0	Other
chr1	94008290	.	G	A	47.82	PASS	"FS=0;MQ=250;MQRankSum=5.038;QD=1.33;ReadPosRankSum=2.31;SOR=0.871;FractionInformativeReads=1;R2_5P_bias=8.558;DP=36;AF=0.5;AN=2;AC=1;CSQ=A|missense_variant|MODERATE|ABCA4|24|Transcript|NM_000350.3|protein_coding|42/50||NM_000350.3:c.5843C>T|NP_000341.2:p.Pro1948Leu|5946|5843|1948|P/L|cCa/cTa|rs56142141&COSV64673479||-1||SNV|EntrezGene||YES|||G|G|||tolerated_low_confidence(0.2)|benign(0.009)||0.0166|0.04016|0.00699|0.02623|0.01481|5.038e-05|0.05639|0.01474|0.04591|0.03468|0.007745|0.03103|0.00775|0.05495|0.03473|0.01096|0.0001933|0.05653|0.01361|0.04521|0.03314|0.007051|0.05653|gnomADg_FIN|benign&uncertain_significance&likely_benign|0&1|1&1||||T|0.10530|-0.281294|T|0.59709|-0.1447|0.62838|0.307&0.307|37|7|7|-30|0.02|0.01|0.00|0.00|ABCA4|likely_benign|hg38|0.0826|P1948L|ENST00000370225.4|P78363|99413||Conflicting_classifications_of_pathogenicity|not_specified&Severe_early-childhood-onset_retinal_dystrophy&Age_related_macular_degeneration_2&Retinal_dystrophy&ABCA4-related_disorder&Stargardt_Disease&_Recessive&Cone-Rod_Dystrophy&_Recessive&Retinitis_Pigmentosa&_Recessive&Macular_degeneration&not_provided|NC_000001.11:g.94008290G>A||single_nucleotide_variant|ABCA4:24|MedGen:CN169374&MONDO:MONDO:0009549&MeSH:D000080362&MedGen:C1855465&OMIM:248200&Orphanet:364055&Orphanet:827&MONDO:MONDO:0007932&MedGen:C3495438&OMIM:153800&Human_Phenotype_Ontology:HP:0000556&Human_Phenotype_Ontology:HP:0007736&Human_Phenotype_Ontology:HP:0007910&Human_Phenotype_Ontology:HP:0007974&Human_Phenotype_Ontology:HP:0007982&MONDO:MONDO:0019118&MeSH:D058499&MedGen:C0854723&Orphanet:71862&MedGen:CN239167&MedGen:CN239312&MedGen:CN239309&MedGen:CN239466&Human_Phenotype_Ontology:HP:0000608&Human_Phenotype_Ontology:HP:0007694&MONDO:MONDO:0003004&MedGen:C0024437&MedGen:C3661900|Uncertain_significance(1)&Benign(5)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	./.:.:.:.:.:.:.:.:.:.:.:.:.	0|1:21,15:0.417:36:10,9:11,6:46:83,0,47:47.818,0.00011519,50:0,34.77,37.78:13,8,10,5:12,9,8,7:94008289	./.:.:.:.:.:.:.:.:.:.:.:.:.	A	missense_variant	MODERATE	ABCA4	24	Transcript	NM_000350.3	protein_coding	42/50		c.5843C>T	p.Pro1948Leu	5946	5843	1948	P/L	cCa/cTa	rs56142141&COSV64673479	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	tolerated_low_confidence(0.2)	benign(0.009)	NA	0.0166	0.04016	0.00699	0.02623	0.01481	5.038e-05	0.05639	0.01474	0.04591	0.03468	0.007745	0.03103	0.00775	0.05495	0.03473	0.01096	0.0001933	0.05653	0.01361	0.04521	0.03314	0.007051	0.05653	gnomADg_FIN	benign&uncertain_significance&likely_benign	0&1	1&1	NA	NA	NA	T	0.1053	-0.281294	T	0.59709	-0.1447	0.62838	0.307&0.307	37	7	7	-30	0.02	0.01	0	0	ABCA4	likely_benign	hg38	0.0826	P1948L	ENST00000370225.4	P78363	99413	NA	Conflicting_classifications_of_pathogenicity	not_specified&Severe_early-childhood-onset_retinal_dystrophy&Age_related_macular_degeneration_2&Retinal_dystrophy&ABCA4-related_disorder&Stargardt_Disease&_Recessive&Cone-Rod_Dystrophy&_Recessive&Retinitis_Pigmentosa&_Recessive&Macular_degeneration&not_provided	NC_000001.11:g.94008290G>A		single_nucleotide_variant	ABCA4:24	MedGen:CN169374&MONDO:MONDO:0009549&MeSH:D000080362&MedGen:C1855465&OMIM:248200&Orphanet:364055&Orphanet:827&MONDO:MONDO:0007932&MedGen:C3495438&OMIM:153800&Human_Phenotype_Ontology:HP:0000556&Human_Phenotype_Ontology:HP:0007736&Human_Phenotype_Ontology:HP:0007910&Human_Phenotype_Ontology:HP:0007974&Human_Phenotype_Ontology:HP:0007982&MONDO:MONDO:0019118&MeSH:D058499&MedGen:C0854723&Orphanet:71862&MedGen:CN239167&MedGen:CN239312&MedGen:CN239309&MedGen:CN239466&Human_Phenotype_Ontology:HP:0000608&Human_Phenotype_Ontology:HP:0007694&MONDO:MONDO:0003004&MedGen:C0024437&MedGen:C3661900	Uncertain_significance(1)&Benign(5)&Likely_benign(5)	criteria_provided&_conflicting_classifications		ABCA4	Stargardt disease 1	AR	248200	Eye disorders	NBScreening	-10	Benign	PM1,PP2,BP4_Strong,BP6,BS1,BS2	rs56142141	chr1_94008290_G_A	Female	./.	Other
chr1	94010911	.	T	A	50	PASS	"FS=1.643;MQ=250;MQRankSum=3.841;QD=2.17;ReadPosRankSum=1.388;SOR=1.112;FractionInformativeReads=1;R2_5P_bias=-16.216;DP=23;AF=0.5;AN=2;AC=1;CSQ=A|missense_variant|MODERATE|ABCA4|24|Transcript|NM_000350.3|protein_coding|40/50||NM_000350.3:c.5603A>T|NP_000341.2:p.Asn1868Ile|5706|5603|1868|N/I|aAt/aTt|rs1801466&CM015091&COSV107460998||-1||SNV|EntrezGene||YES|||T|T|||deleterious_low_confidence(0)|benign(0.181)||0.0208|0.05741|0.008604|0.02238|0.03195|5.038e-05|0.04019|0.04475|0.06739|0.04654|0.01902|0.04037|0.01123|0.05811|0.0261|0.03401|0|0.04061|0.05442|0.06633|0.03466|0.016|0.06739|gnomADe_NFE|established_risk_allele&conflicting_interpretations_of_pathogenicity&likely_benign&benign&uncertain_significance&likely_pathogenic|0&1&1|1&1&1||||T|0.12103|-0.266919|T|0.63123|-0.103538|0.71558|0.402&0.402|-29|18|19|-43|0.00|0.00|0.00|0.00|ABCA4|likely_benign|hg38|0.223|N1868I|ENST00000370225.4|P78363|99390||Conflicting_classifications_of_pathogenicity|Age_related_macular_degeneration_2&Stargardt_disease&Cone-rod_dystrophy_3&ABCA4-related_disorder&Stargardt_Disease&_Recessive&Retinitis_Pigmentosa&_Recessive&Cone-Rod_Dystrophy&_Recessive&ABCA4-related_retinopathy&not_specified&Retinitis_pigmentosa&Macular_degeneration&not_provided&Retinal_dystrophy&Severe_early-childhood-onset_retinal_dystrophy|NC_000001.11:g.94010911T>A|1048166:Likely_pathogenic&1048131:Likely_pathogenic&1048132:Likely_pathogenic&1048134:Likely_pathogenic&1048163:Likely_pathogenic|single_nucleotide_variant|ABCA4:24|MONDO:MONDO:0007932&MedGen:C3495438&OMIM:153800&MONDO:MONDO:0019353&MedGen:C0271093&Orphanet:827&MONDO:MONDO:0011395&MedGen:C1858806&OMIM:604116&Orphanet:1872&MedGen:CN239167&MedGen:CN239312&MedGen:CN239466&MedGen:CN239309&MONDO:MONDO:0800406&MedGen:CN322612&MedGen:CN169374&Human_Phenotype_Ontology:HP:0000547&MONDO:MONDO:0019200&MeSH:D012174&MedGen:C0035334&OMIM:268000&OMIM:PS268000&Orphanet:791&Human_Phenotype_Ontology:HP:0000608&Human_Phenotype_Ontology:HP:0007694&MONDO:MONDO:0003004&MedGen:C0024437&MedGen:C3661900&Human_Phenotype_Ontology:HP:0000556&Human_Phenotype_Ontology:HP:0007736&Human_Phenotype_Ontology:HP:0007910&Human_Phenotype_Ontology:HP:0007974&Human_Phenotype_Ontology:HP:0007982&MONDO:MONDO:0019118&MeSH:D058499&MedGen:C0854723&Orphanet:71862&MONDO:MONDO:0009549&MeSH:D000080362&MedGen:C1855465&OMIM:248200&Orphanet:364055&Orphanet:827|Likely_pathogenic(2)&Established_risk_allele(2)&Uncertain_significance(6)&Benign(3)&Likely_benign(6)|criteria_provided&_conflicting_classifications|Severe_early-childhood-onset_retinal_dystrophy"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:8,15:0.652:23:3,2:5,13:46:85,0,46:50,0.0001038,48.564:0,34.77,37.77:4,4,6,9:3,5,7,8	A	missense_variant	MODERATE	ABCA4	24	Transcript	NM_000350.3	protein_coding	40/50		c.5603A>T	p.Asn1868Ile	5706	5603	1868	N/I	aAt/aTt	rs1801466&CM015091&COSV107460998	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	deleterious_low_confidence(0)	benign(0.181)	NA	0.0208	0.05741	0.008604	0.02238	0.03195	5.038e-05	0.04019	0.04475	0.06739	0.04654	0.01902	0.04037	0.01123	0.05811	0.0261	0.03401	0	0.04061	0.05442	0.06633	0.03466	0.016	0.06739	gnomADe_NFE	established_risk_allele&conflicting_interpretations_of_pathogenicity&likely_benign&benign&uncertain_significance&likely_pathogenic	0&1&1	1&1&1	NA	NA	NA	T	0.12103	-0.266919	T	0.63123	-0.103538	0.71558	0.402&0.402	-29	18	19	-43	0	0	0	0	ABCA4	likely_benign	hg38	0.223	N1868I	ENST00000370225.4	P78363	99390	NA	Conflicting_classifications_of_pathogenicity	Age_related_macular_degeneration_2&Stargardt_disease&Cone-rod_dystrophy_3&ABCA4-related_disorder&Stargardt_Disease&_Recessive&Retinitis_Pigmentosa&_Recessive&Cone-Rod_Dystrophy&_Recessive&ABCA4-related_retinopathy&not_specified&Retinitis_pigmentosa&Macular_degeneration&not_provided&Retinal_dystrophy&Severe_early-childhood-onset_retinal_dystrophy	NC_000001.11:g.94010911T>A	1048166:Likely_pathogenic&1048131:Likely_pathogenic&1048132:Likely_pathogenic&1048134:Likely_pathogenic&1048163:Likely_pathogenic	single_nucleotide_variant	ABCA4:24	MONDO:MONDO:0007932&MedGen:C3495438&OMIM:153800&MONDO:MONDO:0019353&MedGen:C0271093&Orphanet:827&MONDO:MONDO:0011395&MedGen:C1858806&OMIM:604116&Orphanet:1872&MedGen:CN239167&MedGen:CN239312&MedGen:CN239466&MedGen:CN239309&MONDO:MONDO:0800406&MedGen:CN322612&MedGen:CN169374&Human_Phenotype_Ontology:HP:0000547&MONDO:MONDO:0019200&MeSH:D012174&MedGen:C0035334&OMIM:268000&OMIM:PS268000&Orphanet:791&Human_Phenotype_Ontology:HP:0000608&Human_Phenotype_Ontology:HP:0007694&MONDO:MONDO:0003004&MedGen:C0024437&MedGen:C3661900&Human_Phenotype_Ontology:HP:0000556&Human_Phenotype_Ontology:HP:0007736&Human_Phenotype_Ontology:HP:0007910&Human_Phenotype_Ontology:HP:0007974&Human_Phenotype_Ontology:HP:0007982&MONDO:MONDO:0019118&MeSH:D058499&MedGen:C0854723&Orphanet:71862&MONDO:MONDO:0009549&MeSH:D000080362&MedGen:C1855465&OMIM:248200&Orphanet:364055&Orphanet:827	Likely_pathogenic(2)&Established_risk_allele(2)&Uncertain_significance(6)&Benign(3)&Likely_benign(6)	criteria_provided&_conflicting_classifications	Severe_early-childhood-onset_retinal_dystrophy	ABCA4	Stargardt disease 1	AR	248200	Eye disorders	NBScreening	-9	Benign	PM1,PP2,BP4_Strong,BA1	rs1801466	chr1_94010911_T_A	Female	./.	Other
chr1	100196431	.	GAAAAA	G	141.34	PASS	"FS=15.735;MQ=245.62;MQRankSum=2.171;QD=4.16;ReadPosRankSum=-1.236;SOR=2.031;FractionInformativeReads=0.912;R2_5P_bias=0;DP=92;AF=1;AN=6;AC=6;CSQ=-|splice_polypyrimidine_tract_variant&intron_variant|LOW|DBT|1629|Transcript|NM_001918.5|protein_coding||10/10|NM_001918.5:c.1282-14_1282-10del|||||||rs752915898||-1||deletion|EntrezGene||YES|||AAAAA|AAAAA|||||||0.2509|0.1819|0.1956|0.2418|0.2549|0.2214|0.2604|0.2606|0.2479|0.2067|0.4488|0.3944|0.4656|0.5092|0.4787|0.4831|0.4988|0.5319|0.453|0.4726|0.5509|0.5509|gnomADg_SAS|uncertain_significance&benign&likely_benign||1|||||||||||||||||||||||||||281239||Conflicting_classifications_of_pathogenicity|not_specified&Maple_syrup_urine_disease|NC_000001.11:g.100196455_100196459del||Deletion|DBT:1629|MedGen:CN169374&MONDO:MONDO:0009563&MeSH:D008375&MedGen:C0024776&OMIM:PS248600&Orphanet:511|Uncertain_significance(1)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:3,28:0.903:31:1,11:2,17:91:149,94,0:141.34,91.34,0:0,5,8.01:0,3,21,7:2,1,18,10	1/1:5,21:0.808:26:0,13:5,8:65:123,68,0:115.15,65.15,1.2943e-06:0,5,8.01:3,2,13,8:2,3,11,10	1/1:3,21:0.875:24:2,9:1,12:66:124,69,0:116.27,66.267,1.0354e-06:0,5,8.01:0,3,17,4:1,2,11,10	-	splice_polypyrimidine_tract_variant&intron_variant	LOW	DBT	1629	Transcript	NM_001918.5	protein_coding		10-Oct	c.1282-14_1282-10del							rs752915898	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	AAAAA	AAAAA	NA	NA			NA	NA	0.2509	0.1819	0.1956	0.2418	0.2549	0.2214	0.2604	0.2606	0.2479	0.2067	0.4488	0.3944	0.4656	0.5092	0.4787	0.4831	0.4988	0.5319	0.453	0.4726	0.5509	0.5509	gnomADg_SAS	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				281239	NA	Conflicting_classifications_of_pathogenicity	not_specified&Maple_syrup_urine_disease	NC_000001.11:g.100196455_100196459del		Deletion	DBT:1629	MedGen:CN169374&MONDO:MONDO:0009563&MeSH:D008375&MedGen:C0024776&OMIM:PS248600&Orphanet:511	Uncertain_significance(1)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		DBT	Maple syrup urine disease type 2	AR	620699	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs752915898	chr1_100196431_GAAAAA_G	Female	01-Jan	Homozygous
chr1	100196431	.	GAAAAA	G	141.34	PASS	"FS=15.735;MQ=245.62;MQRankSum=2.171;QD=4.16;ReadPosRankSum=-1.236;SOR=2.031;FractionInformativeReads=0.912;R2_5P_bias=0;DP=92;AF=1;AN=6;AC=6;CSQ=-|splice_polypyrimidine_tract_variant&intron_variant|LOW|DBT|1629|Transcript|NM_001918.5|protein_coding||10/10|NM_001918.5:c.1282-14_1282-10del|||||||rs752915898||-1||deletion|EntrezGene||YES|||AAAAA|AAAAA|||||||0.2509|0.1819|0.1956|0.2418|0.2549|0.2214|0.2604|0.2606|0.2479|0.2067|0.4488|0.3944|0.4656|0.5092|0.4787|0.4831|0.4988|0.5319|0.453|0.4726|0.5509|0.5509|gnomADg_SAS|uncertain_significance&benign&likely_benign||1|||||||||||||||||||||||||||281239||Conflicting_classifications_of_pathogenicity|not_specified&Maple_syrup_urine_disease|NC_000001.11:g.100196455_100196459del||Deletion|DBT:1629|MedGen:CN169374&MONDO:MONDO:0009563&MeSH:D008375&MedGen:C0024776&OMIM:PS248600&Orphanet:511|Uncertain_significance(1)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:3,28:0.903:31:1,11:2,17:91:149,94,0:141.34,91.34,0:0,5,8.01:0,3,21,7:2,1,18,10	1/1:5,21:0.808:26:0,13:5,8:65:123,68,0:115.15,65.15,1.2943e-06:0,5,8.01:3,2,13,8:2,3,11,10	1/1:3,21:0.875:24:2,9:1,12:66:124,69,0:116.27,66.267,1.0354e-06:0,5,8.01:0,3,17,4:1,2,11,10	-	splice_polypyrimidine_tract_variant&intron_variant	LOW	DBT	1629	Transcript	NM_001918.5	protein_coding		10-Oct	c.1282-14_1282-10del							rs752915898	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	AAAAA	AAAAA	NA	NA			NA	NA	0.2509	0.1819	0.1956	0.2418	0.2549	0.2214	0.2604	0.2606	0.2479	0.2067	0.4488	0.3944	0.4656	0.5092	0.4787	0.4831	0.4988	0.5319	0.453	0.4726	0.5509	0.5509	gnomADg_SAS	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				281239	NA	Conflicting_classifications_of_pathogenicity	not_specified&Maple_syrup_urine_disease	NC_000001.11:g.100196455_100196459del		Deletion	DBT:1629	MedGen:CN169374&MONDO:MONDO:0009563&MeSH:D008375&MedGen:C0024776&OMIM:PS248600&Orphanet:511	Uncertain_significance(1)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		DBT	Maple syrup urine disease type 1A	AR	248600	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs752915898	chr1_100196431_GAAAAA_G	Female	01-Jan	Homozygous
chr1	115768745	.	G	GCACACACA	138.65	PASS	"FS=0;MQ=246.57;QD=3.48;SOR=1.508;FractionInformativeReads=0.568;MQRankSum=2.817;ReadPosRankSum=-0.694;R2_5P_bias=3.829;DP=96;AF=1;AN=6;AC=5;CSQ=CACACACA|upstream_gene_variant|MODIFIER|CASQ2|845|Transcript|NM_001232.4|protein_coding||||||||||rs72554067|31|-1||insertion|EntrezGene||YES|||||||||||0.1842|0.2111|0.2019|0.1468|0.3021|0.1712|0.2459|0.1677|0.1886|0.2083|0.2268|0.2535|0.4339|0.2294|0.1687|0.3736|0.2257|0.3|0.1986|0.2242|0.2367|0.4339|gnomADg_AMI|||1|||||||||||||||||||||||||||292138||Conflicting_classifications_of_pathogenicity|not_provided&Catecholaminergic_polymorphic_ventricular_tachycardia|NC_000001.11:g.115768747AC[12]||Microsatellite|CASQ2:845|MedGen:C3661900&MONDO:MONDO:0017990&MedGen:C5574922&OMIM:PS604772&Orphanet:3286|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,21:1:21:0,12:0,9:79:144,82,0:128.77,78.772,0:0,12,15.01:0,0,7,14:0,0,4,17	0/1:10,9:0.474:19:5,3:5,6:45:63,0,43:50,0.00014419,46.343:0,13,16.01:3,7,4,5:6,4,4,5	1/1:0,20:1:20:0,8:0,12:89:154,92,0:138.65,88.649,0:0,12,15.01:0,0,9,11:0,0,13,7	CACACACA	upstream_gene_variant	MODIFIER	CASQ2	845	Transcript	NM_001232.4	protein_coding										rs72554067	31	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.1842	0.2111	0.2019	0.1468	0.3021	0.1712	0.2459	0.1677	0.1886	0.2083	0.2268	0.2535	0.4339	0.2294	0.1687	0.3736	0.2257	0.3	0.1986	0.2242	0.2367	0.4339	gnomADg_AMI			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				292138	NA	Conflicting_classifications_of_pathogenicity	not_provided&Catecholaminergic_polymorphic_ventricular_tachycardia	NC_000001.11:g.115768747AC[12]		Microsatellite	CASQ2:845	MedGen:C3661900&MONDO:MONDO:0017990&MedGen:C5574922&OMIM:PS604772&Orphanet:3286	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		CASQ2	Catecholaminergic polymorphic ventricular tachycardia 1	AR	604772	Cardiac and vascular disorders	NBScreening	-9	Benign	BP6,BA1	rs72554067	chr1_115768745_G_GCACACACA	Female	01-Jan	Homozygous
chr1	115768745	.	G	GCACACACA	138.65	PASS	"FS=0;MQ=246.57;QD=3.48;SOR=1.508;FractionInformativeReads=0.568;MQRankSum=2.817;ReadPosRankSum=-0.694;R2_5P_bias=3.829;DP=96;AF=1;AN=6;AC=5;CSQ=CACACACA|upstream_gene_variant|MODIFIER|CASQ2|845|Transcript|NM_001232.4|protein_coding||||||||||rs72554067|31|-1||insertion|EntrezGene||YES|||||||||||0.1842|0.2111|0.2019|0.1468|0.3021|0.1712|0.2459|0.1677|0.1886|0.2083|0.2268|0.2535|0.4339|0.2294|0.1687|0.3736|0.2257|0.3|0.1986|0.2242|0.2367|0.4339|gnomADg_AMI|||1|||||||||||||||||||||||||||292138||Conflicting_classifications_of_pathogenicity|not_provided&Catecholaminergic_polymorphic_ventricular_tachycardia|NC_000001.11:g.115768747AC[12]||Microsatellite|CASQ2:845|MedGen:C3661900&MONDO:MONDO:0017990&MedGen:C5574922&OMIM:PS604772&Orphanet:3286|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,21:1:21:0,12:0,9:79:144,82,0:128.77,78.772,0:0,12,15.01:0,0,7,14:0,0,4,17	0/1:10,9:0.474:19:5,3:5,6:45:63,0,43:50,0.00014419,46.343:0,13,16.01:3,7,4,5:6,4,4,5	1/1:0,20:1:20:0,8:0,12:89:154,92,0:138.65,88.649,0:0,12,15.01:0,0,9,11:0,0,13,7	CACACACA	upstream_gene_variant	MODIFIER	CASQ2	845	Transcript	NM_001232.4	protein_coding										rs72554067	31	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.1842	0.2111	0.2019	0.1468	0.3021	0.1712	0.2459	0.1677	0.1886	0.2083	0.2268	0.2535	0.4339	0.2294	0.1687	0.3736	0.2257	0.3	0.1986	0.2242	0.2367	0.4339	gnomADg_AMI			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				292138	NA	Conflicting_classifications_of_pathogenicity	not_provided&Catecholaminergic_polymorphic_ventricular_tachycardia	NC_000001.11:g.115768747AC[12]		Microsatellite	CASQ2:845	MedGen:C3661900&MONDO:MONDO:0017990&MedGen:C5574922&OMIM:PS604772&Orphanet:3286	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		CASQ2	Catecholaminergic polymorphic ventricular tachycardia 2	Multiple and/or complex pattern 	611938	Cardiac and vascular disorders	NBScreening	-9	Benign	BP6,BA1	rs72554067	chr1_115768745_G_GCACACACA	Female	01-Jan	Homozygous
chr1	119735390	.	C	T	134.29	PASS	"FS=0;MQ=250;QD=4.63;SOR=0.76;FractionInformativeReads=1;MQRankSum=5.135;ReadPosRankSum=2.376;R2_5P_bias=14.662;DP=113;AF=0.5;AN=6;AC=4;CSQ=T|missense_variant|MODERATE|PHGDH|26227|Transcript|NM_006623.4|protein_coding|7/12||NM_006623.4:c.739C>T|NP_006614.2:p.Arg247Trp|828|739|247|R/W|Cgg/Tgg|rs768347730&COSV65572207||1||SNV|EntrezGene||YES|||C|C|||deleterious(0.02)|possibly_damaging(0.877)|||2.531e-05|0|0|0|0.0001008|0|0.0001734|2.068e-05|0.0001159|2.319e-05|5.255e-05|0|0|0|0|0.0003848|0|0|5.879e-05|0.0009551|0|0.0009551|gnomADg_REMAINING|uncertain_significance|0&1|1&1||||T|0.39147|-0.0834805|T|0.63916|-0.093262|0.79156|.&.&.&.&.&0.513&.|12|-11|50|19|0.00|0.00|0.00|0.00|PHGDH|likely_benign|hg38|0.2478|R247W|ENST00000641023.1|O43175|1370916||Uncertain_significance|PHGDH_deficiency|NC_000001.11:g.119735390C>T||single_nucleotide_variant|PHGDH:26227|MONDO:MONDO:0011152&MedGen:C1866174&OMIM:601815&Orphanet:79351||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,29:1:29:0,17:0,12:84:172,87,0:134.29,84.286,0:0,34.77,37.77:0,0,15,14:0,0,17,12	0/1:21,16:0.432:37:16,10:5,6:47:83,0,50:48.631,8.1283e-05,53:0,34.77,37.77:11,10,7,9:12,9,5,11	0/1:27,19:0.413:46:11,6:16,13:46:82,0,50:47.096,0.00010639,53:0,34.77,37.77:15,12,7,12:13,14,10,9	T	missense_variant	MODERATE	PHGDH	26227	Transcript	NM_006623.4	protein_coding	12-Jul		c.739C>T	p.Arg247Trp	828	739	247	R/W	Cgg/Tgg	rs768347730&COSV65572207	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious(0.02)	possibly_damaging(0.877)	NA	NA	2.531e-05	0	0	0	0.0001008	0	0.0001734	2.068e-05	0.0001159	2.319e-05	5.255e-05	0	0	0	0	0.0003848	0	0	5.879e-05	0.0009551	0	0.0009551	gnomADg_REMAINING	uncertain_significance	0&1	1&1	NA	NA	NA	T	0.39147	-0.0834805	T	0.63916	-0.093262	0.79156	.&.&.&.&.&0.513&.	12	-11	50	19	0	0	0	0	PHGDH	likely_benign	hg38	0.2478	R247W	ENST00000641023.1	O43175	1370916	NA	Uncertain_significance	PHGDH_deficiency	NC_000001.11:g.119735390C>T		single_nucleotide_variant	PHGDH:26227	MONDO:MONDO:0011152&MedGen:C1866174&OMIM:601815&Orphanet:79351		criteria_provided&_single_submitter		PHGDH	PHGDH deficiency	AR	601815	Inherited disorders of metabolism	NBScreening	2	Uncertain_significance	PM2	rs768347730	chr1_119735390_C_T	Female	01-Jan	Homozygous
chr1	158668075	.	GAAA	G	312.88	PASS	"FS=0;MQ=248.2;QD=6.9;SOR=1.885;FractionInformativeReads=0.875;MQRankSum=2.037;ReadPosRankSum=1.554;R2_5P_bias=0;DP=111;AF=0.5;AN=6;AC=3;CSQ=-|splice_polypyrimidine_tract_variant&intron_variant|LOW|SPTA1|6708|Transcript|NM_003126.4|protein_coding||14/51|NM_003126.4:c.1834-16_1834-14del|||||||rs3039789||-1||deletion|EntrezGene||YES|||AAA|AAA||||||0.2614|0.2835|0.1824|0.3211|0.3004|0.3201|0.3428|0.3048|0.2886|0.2864|0.1756|0.3122|0.1942|0.451|0.396|0.361|0.4553|0.4283|0.3444|0.3419|0.3398|0.2111|0.4553|gnomADg_EAS|uncertain_significance&benign||1||||||||||||22|-23|23|-23|0.01|0.03|0.00|0.00|SPTA1|||||||293028||Conflicting_classifications_of_pathogenicity|Spherocytosis&_Recessive&Pyropoikilocytosis&_hereditary&Elliptocytosis&not_provided|NC_000001.11:g.158668089_158668091del||Deletion|SPTA1:6708|MedGen:CN239472&Human_Phenotype_Ontology:HP:0004805&Human_Phenotype_Ontology:HP:0004839&MONDO:MONDO:0009948&MedGen:C0520739&OMIM:266140&Orphanet:98867&Human_Phenotype_Ontology:HP:0004445&Human_Phenotype_Ontology:HP:0004837&MedGen:C0427480&MedGen:C3661900|Uncertain_significance(3)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,23:0.657:35:0,15:0,8:45:290,233,50:275.95,225.95,45.523:0,7,10:0,0,25,10:0,0,15,20	1/0:2,19:0.528:36:1,10:1,9:46:329,271,54:312.88,262.88,48.946:0,8,11.01:1,1,20,14:0,2,17,17	0/1:0,8:0.333:24:0,4:0,4:46:291,312,57:277.49,305.19,53:0,7,10:0,0,15,9:0,0,12,12	-	splice_polypyrimidine_tract_variant&intron_variant	LOW	SPTA1	6708	Transcript	NM_003126.4	protein_coding		14/51	c.1834-16_1834-14del							rs3039789	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	AAA	AAA	NA	NA			NA	0.2614	0.2835	0.1824	0.3211	0.3004	0.3201	0.3428	0.3048	0.2886	0.2864	0.1756	0.3122	0.1942	0.451	0.396	0.361	0.4553	0.4283	0.3444	0.3419	0.3398	0.2111	0.4553	gnomADg_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		22	-23	23	-23	0.01	0.03	0	0	SPTA1			NA				293028	NA	Conflicting_classifications_of_pathogenicity	Spherocytosis&_Recessive&Pyropoikilocytosis&_hereditary&Elliptocytosis&not_provided	NC_000001.11:g.158668089_158668091del		Deletion	SPTA1:6708	MedGen:CN239472&Human_Phenotype_Ontology:HP:0004805&Human_Phenotype_Ontology:HP:0004839&MONDO:MONDO:0009948&MedGen:C0520739&OMIM:266140&Orphanet:98867&Human_Phenotype_Ontology:HP:0004445&Human_Phenotype_Ontology:HP:0004837&MedGen:C0427480&MedGen:C3661900	Uncertain_significance(3)&Benign(1)	criteria_provided&_conflicting_classifications		SPTA1	Elliptocytosis 2	AD	130600	Haematological disorders	NBScreening	-9	Benign	BP6,BA1	rs3039789	chr1_158668075_GAAA_G	Female	1/0	Heterozygous
chr1	168293284	.	AGT	A	134.77	PASS	"FS=0;MQ=242.75;QD=4.81;SOR=1.112;FractionInformativeReads=0.536;MQRankSum=1.432;ReadPosRankSum=-0.678;R2_5P_bias=0;DP=98;AF=0.5;AN=6;AC=1;CSQ=-|splice_region_variant&intron_variant|LOW|TBX19|9095|Transcript|NM_005149.3|protein_coding||3/7|NM_005149.3:c.603+47_603+48del|||||||rs57039241||1||deletion|EntrezGene||YES|||GT|GT|||||40||0.06374|0.03632|0.04065|0.06753|0.0484|0.1057|0.03927|0.0672|0.06254|0.0262|0.04064|0.06184|0.01617|0.03635|0.01098|0.02955|0.05501|0.02703|0.0338|0.04177|0.02168|0.1057|gnomADe_FIN|||1||||||||||||-39|-32|-7|-3|0.00|0.00|0.03|0.00|TBX19|||||||293467||Conflicting_classifications_of_pathogenicity|Congenital_isolated_adrenocorticotropic_hormone_deficiency&not_provided|NC_000001.11:g.168293285GT[20]||Microsatellite|TBX19:9095|Human_Phenotype_Ontology:HP:0011748&MONDO:MONDO:0008720&MedGen:C0342388&OMIM:201400&Orphanet:199296&MedGen:C3661900|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:0,.:.:15:0,.:0,.:32:141,.,.:134.77,.,.:0,.,.:0,0,9,6:0,0,6,9	1/0:1,17:0.739:23:1,11:0,6:37:117,65,37:113.3,63.297,37.604:0,2,5:1,0,15,7:1,0,13,9	0/0:0,.:.:15:0,.:0,.:41:96,.,.:91.193,.,.:0,.,.:0,0,10,5:0,0,9,6	-	splice_region_variant&intron_variant	LOW	TBX19	9095	Transcript	NM_005149.3	protein_coding		07-Mar	c.603+47_603+48del							rs57039241	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	GT	GT	NA	NA			40	NA	0.06374	0.03632	0.04065	0.06753	0.0484	0.1057	0.03927	0.0672	0.06254	0.0262	0.04064	0.06184	0.01617	0.03635	0.01098	0.02955	0.05501	0.02703	0.0338	0.04177	0.02168	0.1057	gnomADe_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		-39	-32	-7	-3	0	0	0.03	0	TBX19			NA				293467	NA	Conflicting_classifications_of_pathogenicity	Congenital_isolated_adrenocorticotropic_hormone_deficiency&not_provided	NC_000001.11:g.168293285GT[20]		Microsatellite	TBX19:9095	Human_Phenotype_Ontology:HP:0011748&MONDO:MONDO:0008720&MedGen:C0342388&OMIM:201400&Orphanet:199296&MedGen:C3661900	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		TBX19	Congenital isolated adrenocorticotropic hormone deficiency	AR	201400	Endocrine disorders	NBScreening	-9	Benign	BP6,BA1	rs57039241	chr1_168293284_AGT_A	Female	0/0	Other
chr1	169513837	.	G	A	49.72	PASS	"FS=6.789;MQ=250;MQRankSum=4.796;QD=1.55;ReadPosRankSum=1.737;SOR=0.112;FractionInformativeReads=1;R2_5P_bias=12.412;DP=66;AF=0.5;AN=4;AC=2;CSQ=A|3_prime_UTR_variant|MODIFIER|F5|2153|Transcript|NM_000130.5|protein_coding|25/25||NM_000130.5:c.*476C>T||7246|||||rs72708017||-1||SNV|EntrezGene||YES|||G|G||||||0.0076|||||||||||0.01298|0.01186|0.002193|0.007346|0.01326|0|0.008991|0|0.01701|0.007102|0.01141|0.01701|gnomADg_NFE|uncertain_significance&likely_benign||1|||||||||||||||||||||||||||293561||Conflicting_classifications_of_pathogenicity|Thrombophilia_due_to_thrombin_defect&Thrombophilia_due_to_activated_protein_C_resistance&Factor_V_deficiency&Budd-Chiari_syndrome|NC_000001.11:g.169513837G>A||single_nucleotide_variant|F5:2153|MONDO:MONDO:0008559&MedGen:C3160733&OMIM:188050&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&Human_Phenotype_Ontology:HP:0003225&MONDO:MONDO:0020586&MedGen:C4317320&Orphanet:326&Human_Phenotype_Ontology:HP:0002639&MONDO:MONDO:0010947&MedGen:C0856761&OMIM:600880&Orphanet:131|Uncertain_significance(2)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,15:0.469:32:8,7:9,8:48:84,0,50:49.722,6.8081e-05,53:0,34.77,37.77:15,2,10,5:8,9,4,11	0/1:21,13:0.382:34:12,9:9,4:45:81,0,50:45.87,0.00013409,53:0,34.77,37.77:14,7,7,6:11,10,5,8	./.:.:.:.:.:.:.:.:.:.:.:.	A	3_prime_UTR_variant	MODIFIER	F5	2153	Transcript	NM_000130.5	protein_coding	25/25		c.*476C>T		7246					rs72708017	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0076	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.01298	0.01186	0.002193	0.007346	0.01326	0	0.008991	0	0.01701	0.007102	0.01141	0.01701	gnomADg_NFE	uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				293561	NA	Conflicting_classifications_of_pathogenicity	Thrombophilia_due_to_thrombin_defect&Thrombophilia_due_to_activated_protein_C_resistance&Factor_V_deficiency&Budd-Chiari_syndrome	NC_000001.11:g.169513837G>A		single_nucleotide_variant	F5:2153	MONDO:MONDO:0008559&MedGen:C3160733&OMIM:188050&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&Human_Phenotype_Ontology:HP:0003225&MONDO:MONDO:0020586&MedGen:C4317320&Orphanet:326&Human_Phenotype_Ontology:HP:0002639&MONDO:MONDO:0010947&MedGen:C0856761&OMIM:600880&Orphanet:131	Uncertain_significance(2)&Likely_benign(3)	criteria_provided&_conflicting_classifications		F5	Congenital factor V deficiency	AR	227400	Haematological disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72708017	chr1_169513837_G_A	Female	0/1	Heterozygous
chr1	169513837	.	G	A	49.72	PASS	"FS=6.789;MQ=250;MQRankSum=4.796;QD=1.55;ReadPosRankSum=1.737;SOR=0.112;FractionInformativeReads=1;R2_5P_bias=12.412;DP=66;AF=0.5;AN=4;AC=2;CSQ=A|3_prime_UTR_variant|MODIFIER|F5|2153|Transcript|NM_000130.5|protein_coding|25/25||NM_000130.5:c.*476C>T||7246|||||rs72708017||-1||SNV|EntrezGene||YES|||G|G||||||0.0076|||||||||||0.01298|0.01186|0.002193|0.007346|0.01326|0|0.008991|0|0.01701|0.007102|0.01141|0.01701|gnomADg_NFE|uncertain_significance&likely_benign||1|||||||||||||||||||||||||||293561||Conflicting_classifications_of_pathogenicity|Thrombophilia_due_to_thrombin_defect&Thrombophilia_due_to_activated_protein_C_resistance&Factor_V_deficiency&Budd-Chiari_syndrome|NC_000001.11:g.169513837G>A||single_nucleotide_variant|F5:2153|MONDO:MONDO:0008559&MedGen:C3160733&OMIM:188050&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&Human_Phenotype_Ontology:HP:0003225&MONDO:MONDO:0020586&MedGen:C4317320&Orphanet:326&Human_Phenotype_Ontology:HP:0002639&MONDO:MONDO:0010947&MedGen:C0856761&OMIM:600880&Orphanet:131|Uncertain_significance(2)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,15:0.469:32:8,7:9,8:48:84,0,50:49.722,6.8081e-05,53:0,34.77,37.77:15,2,10,5:8,9,4,11	0/1:21,13:0.382:34:12,9:9,4:45:81,0,50:45.87,0.00013409,53:0,34.77,37.77:14,7,7,6:11,10,5,8	./.:.:.:.:.:.:.:.:.:.:.:.	A	3_prime_UTR_variant	MODIFIER	F5	2153	Transcript	NM_000130.5	protein_coding	25/25		c.*476C>T		7246					rs72708017	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0076	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.01298	0.01186	0.002193	0.007346	0.01326	0	0.008991	0	0.01701	0.007102	0.01141	0.01701	gnomADg_NFE	uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				293561	NA	Conflicting_classifications_of_pathogenicity	Thrombophilia_due_to_thrombin_defect&Thrombophilia_due_to_activated_protein_C_resistance&Factor_V_deficiency&Budd-Chiari_syndrome	NC_000001.11:g.169513837G>A		single_nucleotide_variant	F5:2153	MONDO:MONDO:0008559&MedGen:C3160733&OMIM:188050&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&Human_Phenotype_Ontology:HP:0003225&MONDO:MONDO:0020586&MedGen:C4317320&Orphanet:326&Human_Phenotype_Ontology:HP:0002639&MONDO:MONDO:0010947&MedGen:C0856761&OMIM:600880&Orphanet:131	Uncertain_significance(2)&Likely_benign(3)	criteria_provided&_conflicting_classifications		F5	Thrombophilia due to activated protein C resistance	AD	188055	Haematological disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72708017	chr1_169513837_G_A	Female	0/1	Heterozygous
chr1	169529737	.	T	C	50	PASS	"FS=1.45;MQ=250;MQRankSum=4.697;QD=1.52;ReadPosRankSum=2.788;SOR=1.091;FractionInformativeReads=1;R2_5P_bias=-5.477;DP=74;AF=0.5;AN=4;AC=2;CSQ=C|missense_variant|MODERATE|F5|2153|Transcript|NM_000130.5|protein_coding|16/25||NM_000130.5:c.5290A>G|NP_000121.2:p.Met1764Val|5385|5290|1764|M/V|Atg/Gtg|rs6030&CM070090&COSV63121507||-1||SNV|EntrezGene||YES|||T|T|||tolerated(1)|benign(0)||0.3087|0.332|0.1908|0.5036|0.2433|0.2974|0.2961|0.3432|0.3294|0.3217|0.4015|0.2994|0.1962|0.1919|0.4414|0.2414|0.2702|0.2903|0.3129|0.3306|0.3275|0.4006|0.5036|gnomADe_AMR|likely_benign&benign&conflicting_interpretations_of_pathogenicity|0&1&1|1&1&1||||T|0.00258|-0.558879|T|0.29737|-0.431747|0.53062|0.230&0.230|29|-36|1|3|0.00|0.00|0.00|0.00|F5|likely_benign|hg38|0.0515|M1764V|ENST00000367797.8|P12259|255210||Conflicting_classifications_of_pathogenicity|Congenital_factor_V_deficiency&Thrombophilia_due_to_activated_protein_C_resistance&not_provided&not_specified|NC_000001.11:g.169529737T>C||single_nucleotide_variant|F5:2153|MONDO:MONDO:0009210&MedGen:C0015499&OMIM:227400&Orphanet:326&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(1)&Benign(4)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,21:0.636:33:5,13:7,8:46:85,0,45:50,0.00011882,47.6:0,34.77,37.77:5,7,7,14:6,6,11,10	0/1:18,22:0.55:40:7,10:11,12:48:85,0,49:50,7.0669e-05,52.036:0,34.77,37.77:12,6,6,16:11,7,10,12	./.:.:.:.:.:.:.:.:.:.:.:.	C	missense_variant	MODERATE	F5	2153	Transcript	NM_000130.5	protein_coding	16/25		c.5290A>G	p.Met1764Val	5385	5290	1764	M/V	Atg/Gtg	rs6030&CM070090&COSV63121507	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	tolerated(1)	benign(0)	NA	0.3087	0.332	0.1908	0.5036	0.2433	0.2974	0.2961	0.3432	0.3294	0.3217	0.4015	0.2994	0.1962	0.1919	0.4414	0.2414	0.2702	0.2903	0.3129	0.3306	0.3275	0.4006	0.5036	gnomADe_AMR	likely_benign&benign&conflicting_interpretations_of_pathogenicity	0&1&1	1&1&1	NA	NA	NA	T	0.00258	-0.558879	T	0.29737	-0.431747	0.53062	0.230&0.230	29	-36	1	3	0	0	0	0	F5	likely_benign	hg38	0.0515	M1764V	ENST00000367797.8	P12259	255210	NA	Conflicting_classifications_of_pathogenicity	Congenital_factor_V_deficiency&Thrombophilia_due_to_activated_protein_C_resistance&not_provided&not_specified	NC_000001.11:g.169529737T>C		single_nucleotide_variant	F5:2153	MONDO:MONDO:0009210&MedGen:C0015499&OMIM:227400&Orphanet:326&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(1)&Benign(4)&Likely_benign(1)	criteria_provided&_conflicting_classifications		F5	Congenital factor V deficiency	AR	227400	Haematological disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs6030	chr1_169529737_T_C	Female	0/1	Heterozygous
chr1	169529737	.	T	C	50	PASS	"FS=1.45;MQ=250;MQRankSum=4.697;QD=1.52;ReadPosRankSum=2.788;SOR=1.091;FractionInformativeReads=1;R2_5P_bias=-5.477;DP=74;AF=0.5;AN=4;AC=2;CSQ=C|missense_variant|MODERATE|F5|2153|Transcript|NM_000130.5|protein_coding|16/25||NM_000130.5:c.5290A>G|NP_000121.2:p.Met1764Val|5385|5290|1764|M/V|Atg/Gtg|rs6030&CM070090&COSV63121507||-1||SNV|EntrezGene||YES|||T|T|||tolerated(1)|benign(0)||0.3087|0.332|0.1908|0.5036|0.2433|0.2974|0.2961|0.3432|0.3294|0.3217|0.4015|0.2994|0.1962|0.1919|0.4414|0.2414|0.2702|0.2903|0.3129|0.3306|0.3275|0.4006|0.5036|gnomADe_AMR|likely_benign&benign&conflicting_interpretations_of_pathogenicity|0&1&1|1&1&1||||T|0.00258|-0.558879|T|0.29737|-0.431747|0.53062|0.230&0.230|29|-36|1|3|0.00|0.00|0.00|0.00|F5|likely_benign|hg38|0.0515|M1764V|ENST00000367797.8|P12259|255210||Conflicting_classifications_of_pathogenicity|Congenital_factor_V_deficiency&Thrombophilia_due_to_activated_protein_C_resistance&not_provided&not_specified|NC_000001.11:g.169529737T>C||single_nucleotide_variant|F5:2153|MONDO:MONDO:0009210&MedGen:C0015499&OMIM:227400&Orphanet:326&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(1)&Benign(4)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,21:0.636:33:5,13:7,8:46:85,0,45:50,0.00011882,47.6:0,34.77,37.77:5,7,7,14:6,6,11,10	0/1:18,22:0.55:40:7,10:11,12:48:85,0,49:50,7.0669e-05,52.036:0,34.77,37.77:12,6,6,16:11,7,10,12	./.:.:.:.:.:.:.:.:.:.:.:.	C	missense_variant	MODERATE	F5	2153	Transcript	NM_000130.5	protein_coding	16/25		c.5290A>G	p.Met1764Val	5385	5290	1764	M/V	Atg/Gtg	rs6030&CM070090&COSV63121507	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	tolerated(1)	benign(0)	NA	0.3087	0.332	0.1908	0.5036	0.2433	0.2974	0.2961	0.3432	0.3294	0.3217	0.4015	0.2994	0.1962	0.1919	0.4414	0.2414	0.2702	0.2903	0.3129	0.3306	0.3275	0.4006	0.5036	gnomADe_AMR	likely_benign&benign&conflicting_interpretations_of_pathogenicity	0&1&1	1&1&1	NA	NA	NA	T	0.00258	-0.558879	T	0.29737	-0.431747	0.53062	0.230&0.230	29	-36	1	3	0	0	0	0	F5	likely_benign	hg38	0.0515	M1764V	ENST00000367797.8	P12259	255210	NA	Conflicting_classifications_of_pathogenicity	Congenital_factor_V_deficiency&Thrombophilia_due_to_activated_protein_C_resistance&not_provided&not_specified	NC_000001.11:g.169529737T>C		single_nucleotide_variant	F5:2153	MONDO:MONDO:0009210&MedGen:C0015499&OMIM:227400&Orphanet:326&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(1)&Benign(4)&Likely_benign(1)	criteria_provided&_conflicting_classifications		F5	Thrombophilia due to activated protein C resistance	AD	188055	Haematological disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs6030	chr1_169529737_T_C	Female	0/1	Heterozygous
chr1	169542517	.	T	C	50	PASS	"FS=0;MQ=250;MQRankSum=4.796;QD=1.56;ReadPosRankSum=2.492;SOR=0.892;FractionInformativeReads=1;R2_5P_bias=9.328;DP=53;AF=0.5;AN=4;AC=2;CSQ=C|missense_variant|MODERATE|F5|2153|Transcript|NM_000130.5|protein_coding|13/25||NM_000130.5:c.2573A>G|NP_000121.2:p.Lys858Arg|2668|2573|858|K/R|aAa/aGa|rs4524&CM101722&COSV63120699||-1||SNV|EntrezGene||YES|||T|T|||tolerated(1)|benign(0)||0.2668|0.2731|0.1804|0.4087|0.176|0.2265|0.2171|0.2765|0.2718|0.2651|0.3467|0.2462|0.1831|0.1908|0.3418|0.1685|0.2342|0.2115|0.2381|0.2667|0.2614|0.3449|0.4087|gnomADe_AMR|likely_benign&benign&conflicting_interpretations_of_pathogenicity|0&1&1|1&1&1||||T|0.00001|-0.869542|T|0.00671|-0.877993|0.00846|0.009&0.009|-34|-2|-34|-2|0.00|0.00|0.00|0.00|F5|likely_benign|hg38|0.0726|K858R|ENST00000367797.8|P12259|255200||Conflicting_classifications_of_pathogenicity|Congenital_factor_V_deficiency&not_provided&Thrombophilia_due_to_activated_protein_C_resistance&not_specified|NC_000001.11:g.169542517T>C||single_nucleotide_variant|F5:2153|MONDO:MONDO:0009210&MedGen:C0015499&OMIM:227400&Orphanet:326&MedGen:C3661900&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&MedGen:CN169374|Uncertain_significance(1)&Benign(3)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	0/1:15,17:0.531:32:12,9:3,8:48:85,0,50:50,6.6527e-05,52.728:0,34.77,37.77:6,9,6,11:5,10,10,7:.	0|1:11,10:0.476:21:3,5:8,5:48:85,0,50:49.897,6.6269e-05,53:0,34.77,37.77:5,6,5,5:5,6,6,4:169542496	./.:.:.:.:.:.:.:.:.:.:.:.:.	C	missense_variant	MODERATE	F5	2153	Transcript	NM_000130.5	protein_coding	13/25		c.2573A>G	p.Lys858Arg	2668	2573	858	K/R	aAa/aGa	rs4524&CM101722&COSV63120699	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	tolerated(1)	benign(0)	NA	0.2668	0.2731	0.1804	0.4087	0.176	0.2265	0.2171	0.2765	0.2718	0.2651	0.3467	0.2462	0.1831	0.1908	0.3418	0.1685	0.2342	0.2115	0.2381	0.2667	0.2614	0.3449	0.4087	gnomADe_AMR	likely_benign&benign&conflicting_interpretations_of_pathogenicity	0&1&1	1&1&1	NA	NA	NA	T	1,00E-05	-0.869542	T	0.00671	-0.877993	0.00846	0.009&0.009	-34	-2	-34	-2	0	0	0	0	F5	likely_benign	hg38	0.0726	K858R	ENST00000367797.8	P12259	255200	NA	Conflicting_classifications_of_pathogenicity	Congenital_factor_V_deficiency&not_provided&Thrombophilia_due_to_activated_protein_C_resistance&not_specified	NC_000001.11:g.169542517T>C		single_nucleotide_variant	F5:2153	MONDO:MONDO:0009210&MedGen:C0015499&OMIM:227400&Orphanet:326&MedGen:C3661900&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&MedGen:CN169374	Uncertain_significance(1)&Benign(3)&Likely_benign(1)	criteria_provided&_conflicting_classifications		F5	Congenital factor V deficiency	AR	227400	Haematological disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4524	chr1_169542517_T_C	Female	0/1	Heterozygous
chr1	169542517	.	T	C	50	PASS	"FS=0;MQ=250;MQRankSum=4.796;QD=1.56;ReadPosRankSum=2.492;SOR=0.892;FractionInformativeReads=1;R2_5P_bias=9.328;DP=53;AF=0.5;AN=4;AC=2;CSQ=C|missense_variant|MODERATE|F5|2153|Transcript|NM_000130.5|protein_coding|13/25||NM_000130.5:c.2573A>G|NP_000121.2:p.Lys858Arg|2668|2573|858|K/R|aAa/aGa|rs4524&CM101722&COSV63120699||-1||SNV|EntrezGene||YES|||T|T|||tolerated(1)|benign(0)||0.2668|0.2731|0.1804|0.4087|0.176|0.2265|0.2171|0.2765|0.2718|0.2651|0.3467|0.2462|0.1831|0.1908|0.3418|0.1685|0.2342|0.2115|0.2381|0.2667|0.2614|0.3449|0.4087|gnomADe_AMR|likely_benign&benign&conflicting_interpretations_of_pathogenicity|0&1&1|1&1&1||||T|0.00001|-0.869542|T|0.00671|-0.877993|0.00846|0.009&0.009|-34|-2|-34|-2|0.00|0.00|0.00|0.00|F5|likely_benign|hg38|0.0726|K858R|ENST00000367797.8|P12259|255200||Conflicting_classifications_of_pathogenicity|Congenital_factor_V_deficiency&not_provided&Thrombophilia_due_to_activated_protein_C_resistance&not_specified|NC_000001.11:g.169542517T>C||single_nucleotide_variant|F5:2153|MONDO:MONDO:0009210&MedGen:C0015499&OMIM:227400&Orphanet:326&MedGen:C3661900&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&MedGen:CN169374|Uncertain_significance(1)&Benign(3)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	0/1:15,17:0.531:32:12,9:3,8:48:85,0,50:50,6.6527e-05,52.728:0,34.77,37.77:6,9,6,11:5,10,10,7:.	0|1:11,10:0.476:21:3,5:8,5:48:85,0,50:49.897,6.6269e-05,53:0,34.77,37.77:5,6,5,5:5,6,6,4:169542496	./.:.:.:.:.:.:.:.:.:.:.:.:.	C	missense_variant	MODERATE	F5	2153	Transcript	NM_000130.5	protein_coding	13/25		c.2573A>G	p.Lys858Arg	2668	2573	858	K/R	aAa/aGa	rs4524&CM101722&COSV63120699	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	tolerated(1)	benign(0)	NA	0.2668	0.2731	0.1804	0.4087	0.176	0.2265	0.2171	0.2765	0.2718	0.2651	0.3467	0.2462	0.1831	0.1908	0.3418	0.1685	0.2342	0.2115	0.2381	0.2667	0.2614	0.3449	0.4087	gnomADe_AMR	likely_benign&benign&conflicting_interpretations_of_pathogenicity	0&1&1	1&1&1	NA	NA	NA	T	1,00E-05	-0.869542	T	0.00671	-0.877993	0.00846	0.009&0.009	-34	-2	-34	-2	0	0	0	0	F5	likely_benign	hg38	0.0726	K858R	ENST00000367797.8	P12259	255200	NA	Conflicting_classifications_of_pathogenicity	Congenital_factor_V_deficiency&not_provided&Thrombophilia_due_to_activated_protein_C_resistance&not_specified	NC_000001.11:g.169542517T>C		single_nucleotide_variant	F5:2153	MONDO:MONDO:0009210&MedGen:C0015499&OMIM:227400&Orphanet:326&MedGen:C3661900&MONDO:MONDO:0008560&MedGen:C1861171&OMIM:188055&MedGen:CN169374	Uncertain_significance(1)&Benign(3)&Likely_benign(1)	criteria_provided&_conflicting_classifications		F5	Thrombophilia due to activated protein C resistance	AD	188055	Haematological disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs4524	chr1_169542517_T_C	Female	0/1	Heterozygous
chr1	196690107	.	C	T	49.6	PASS	"FS=0;MQ=166.89;MQRankSum=-2.708;QD=1.46;ReadPosRankSum=2.708;SOR=0.928;FractionInformativeReads=0.971;R2_5P_bias=11.787;DP=34;AF=0.5;AN=2;AC=1;CSQ=T|missense_variant|MODERATE|CFH|3075|Transcript|NM_000186.4|protein_coding|9/22||NM_000186.4:c.1204C>T|NP_000177.2:p.His402Tyr|1279|1204|402|H/Y|Cat/Tat|rs1061170&CM051020&COSV62776341||1||SNV|EntrezGene||YES|||C|C|||tolerated(1)|benign(0)||0.7334|0.6361|0.6297|0.8237|0.6536|0.9401|0.5593|0.6309|0.6163|0.6436|0.6942|0.6445|0.6288|0.5187|0.7377|0.6614|0.9486|0.5626|0.6541|0.6177|0.6641|0.7199|0.9514|EAS|conflicting_interpretations_of_pathogenicity&benign|0&1&1|1&1&1||||T|0.00015|-0.761617|T|0.04654|-0.722967|0.25016|0.086&.&0.086|12|-44|12|21|0.01|0.01|0.00|0.00|CFH|likely_benign|hg38|0.0755|H402Y|ENST00000367429.8|P08603|294490||Conflicting_classifications_of_pathogenicity|Basal_laminar_drusen&Factor_H_deficiency&CFH-Related_Dense_Deposit_Disease_/_Membranoproliferative_Glomerulonephritis_Type_II&not_provided&Atypical_hemolytic-uremic_syndrome&Hemolytic_uremic_syndrome&_atypical&_susceptibility_to&_1&Age_related_macular_degeneration_4|NC_000001.11:g.196690107C>T||single_nucleotide_variant|CFH:3075|MONDO:MONDO:0007472&MedGen:C0730295&OMIM:126700&Orphanet:75376&MONDO:MONDO:0012350&MedGen:C0398777&OMIM:609814&MedGen:CN071292&MedGen:C3661900&MONDO:MONDO:0016244&MedGen:C2931788&Orphanet:2134&MONDO:MONDO:0009335&MedGen:C2749604&OMIM:235400&Orphanet:2134&Orphanet:90038&MONDO:MONDO:0012540&MedGen:C1853147&OMIM:610698|Uncertain_significance(1)&Benign(12)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,20:0.606:33:9,7:4,13:47:84,0,47:49.6,9.3708e-05,49.753:0,34.77,37.77:3,10,4,16:7,6,11,9	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	CFH	3075	Transcript	NM_000186.4	protein_coding	22-Sep		c.1204C>T	p.His402Tyr	1279	1204	402	H/Y	Cat/Tat	rs1061170&CM051020&COSV62776341	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated(1)	benign(0)	NA	0.7334	0.6361	0.6297	0.8237	0.6536	0.9401	0.5593	0.6309	0.6163	0.6436	0.6942	0.6445	0.6288	0.5187	0.7377	0.6614	0.9486	0.5626	0.6541	0.6177	0.6641	0.7199	0.9514	EAS	conflicting_interpretations_of_pathogenicity&benign	0&1&1	1&1&1	NA	NA	NA	T	0.00015	-0.761617	T	0.04654	-0.722967	0.25016	0.086&.&0.086	12	-44	12	21	0.01	0.01	0	0	CFH	likely_benign	hg38	0.0755	H402Y	ENST00000367429.8	P08603	294490	NA	Conflicting_classifications_of_pathogenicity	Basal_laminar_drusen&Factor_H_deficiency&CFH-Related_Dense_Deposit_Disease_/_Membranoproliferative_Glomerulonephritis_Type_II&not_provided&Atypical_hemolytic-uremic_syndrome&Hemolytic_uremic_syndrome&_atypical&_susceptibility_to&_1&Age_related_macular_degeneration_4	NC_000001.11:g.196690107C>T		single_nucleotide_variant	CFH:3075	MONDO:MONDO:0007472&MedGen:C0730295&OMIM:126700&Orphanet:75376&MONDO:MONDO:0012350&MedGen:C0398777&OMIM:609814&MedGen:CN071292&MedGen:C3661900&MONDO:MONDO:0016244&MedGen:C2931788&Orphanet:2134&MONDO:MONDO:0009335&MedGen:C2749604&OMIM:235400&Orphanet:2134&Orphanet:90038&MONDO:MONDO:0012540&MedGen:C1853147&OMIM:610698	Uncertain_significance(1)&Benign(12)	criteria_provided&_conflicting_classifications		CFH	Factor H deficiency	Multiple and/or complex pattern	609814	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs1061170	chr1_196690107_C_T	Female	./.	Other
chr1	204160610	.	G	A	50	PASS	"FS=9.486;MQ=250;MQRankSum=4.778;QD=1.43;ReadPosRankSum=2.589;SOR=0.061;FractionInformativeReads=1;R2_5P_bias=3.212;DP=70;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|REN|5972|Transcript|NM_000537.4|protein_coding|4/10||NM_000537.4:c.442C>T|NP_000528.1:p.Arg148Cys|486|442|148|R/C|Cgc/Tgc|rs191049685&COSV65817317||-1||SNV|EntrezGene||YES|||G|G|||deleterious(0.01)|probably_damaging(0.937)||0.0002|2.121e-05|0|8.944e-05|0.000153|0.0001259|0|0|1.259e-05|3.312e-05|2.319e-05|2.626e-05|0|0|0|0.000288|0.0003857|0|0|0|0.0004735|0|0.001|EAS|uncertain_significance|0&1|1&1||||T|0.09540|-0.290952|T|0.29935|-0.430007|0.47942|0.197&.|-13|31|-13|-50|0.12|0.05|0.00|0.01|REN|likely_benign|hg38|0.2695|R148C|ENST00000272190.9|P00797|1904098||Uncertain_significance|not_provided|NC_000001.11:g.204160610G>A||single_nucleotide_variant|REN:5972|MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,23:0.657:35:4,11:8,12:44:85,0,42:50,0.00016982,45.36:0,34.77,37.77:1,11,9,14:7,5,13,10	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:9,26:0.743:35:6,14:3,12:34:85,0,31:50.002,0.0018396,33.835:0,34.77,37.77:3,6,12,14:6,3,14,12	A	missense_variant	MODERATE	REN	5972	Transcript	NM_000537.4	protein_coding	10-Apr		c.442C>T	p.Arg148Cys	486	442	148	R/C	Cgc/Tgc	rs191049685&COSV65817317	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0.01)	probably_damaging(0.937)	NA	2,00E-04	2.121e-05	0	8.944e-05	0.000153	0.0001259	0	0	1.259e-05	3.312e-05	2.319e-05	2.626e-05	0	0	0	0.000288	0.0003857	0	0	0	0.0004735	0	0.001	EAS	uncertain_significance	0&1	1&1	NA	NA	NA	T	0.0954	-0.290952	T	0.29935	-0.430007	0.47942	0.197&.	-13	31	-13	-50	0.12	0.05	0	0.01	REN	likely_benign	hg38	0.2695	R148C	ENST00000272190.9	P00797	1904098	NA	Uncertain_significance	not_provided	NC_000001.11:g.204160610G>A		single_nucleotide_variant	REN:5972	MedGen:C3661900		criteria_provided&_single_submitter		REN	Renal tubular dysgenesis	AR	267430	Renal disorders	NBScreening	-1	Likely_benign	BP4	rs191049685	chr1_204160610_G_A	Female	0/1	Heterozygous
chr1	216325569	.	A	C	169.95	PASS	"FS=2.864;MQ=249.69;MQRankSum=4.634;QD=1.32;ReadPosRankSum=2.628;SOR=0.895;FractionInformativeReads=0.974;R2_5P_bias=14.486;DP=79;AF=1;AN=4;AC=3;CSQ=C|synonymous_variant|LOW|USH2A|7399|Transcript|NM_206933.4|protein_coding|6/72||NM_206933.4:c.879T>G|NP_996816.3:p.Leu293%3D|1318|879|293|L|ctT/ctG|rs3767698&COSV56383380||-1||SNV|EntrezGene||YES|||A|A||||||0.0108|0.002327|0.0002093|0.006474|0.00111|0.06745|1.873e-05|0.0001737|2.159e-05|0.002635|0.002528|0.0028|0.0004335|0|0.002881|0.0008646|0.06474|0|0|4.411e-05|0.001898|0.004359|0.06745|gnomADe_EAS|benign&uncertain_significance|0&1|1&1||||||||||||32|30|5|30|0.00|0.02|0.00|0.00|USH2A|||||||48609||Conflicting_classifications_of_pathogenicity|Usher_syndrome_type_2A&not_specified&Retinitis_pigmentosa&not_provided&Retinal_dystrophy|NC_000001.11:g.216325569A>C||single_nucleotide_variant|USH2A:7399|MONDO:MONDO:0010169&MedGen:C1848634&OMIM:276901&Orphanet:231178&Orphanet:886&MedGen:CN169374&Human_Phenotype_Ontology:HP:0000547&MONDO:MONDO:0019200&MeSH:D012174&MedGen:C0035334&OMIM:268000&OMIM:PS268000&Orphanet:791&MedGen:C3661900&Human_Phenotype_Ontology:HP:0000556&Human_Phenotype_Ontology:HP:0007736&Human_Phenotype_Ontology:HP:0007910&Human_Phenotype_Ontology:HP:0007974&Human_Phenotype_Ontology:HP:0007982&MONDO:MONDO:0019118&MeSH:D058499&MedGen:C0854723&Orphanet:71862|Uncertain_significance(2)&Benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,19:0.514:37:3,9:15,10:48:85,0,50:50,6.5492e-05,52.941:0,34.77,37.77:10,8,8,11:7,11,8,11	1/1:0,41:1:41:0,17:0,24:120:208,123,0:169.95,119.95,0:0,34.77,37.77:0,0,23,18:0,0,21,20	./.:.:.:.:.:.:.:.:.:.:.:.	C	synonymous_variant	LOW	USH2A	7399	Transcript	NM_206933.4	protein_coding	6/72		c.879T>G	p.Leu293%3D	1318	879	293	L	ctT/ctG	rs3767698&COSV56383380	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.0108	0.002327	0.0002093	0.006474	0.00111	0.06745	1.873e-05	0.0001737	2.159e-05	0.002635	0.002528	0.0028	0.0004335	0	0.002881	0.0008646	0.06474	0	0	4.411e-05	0.001898	0.004359	0.06745	gnomADe_EAS	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		32	30	5	30	0	0.02	0	0	USH2A			NA				48609	NA	Conflicting_classifications_of_pathogenicity	Usher_syndrome_type_2A&not_specified&Retinitis_pigmentosa&not_provided&Retinal_dystrophy	NC_000001.11:g.216325569A>C		single_nucleotide_variant	USH2A:7399	MONDO:MONDO:0010169&MedGen:C1848634&OMIM:276901&Orphanet:231178&Orphanet:886&MedGen:CN169374&Human_Phenotype_Ontology:HP:0000547&MONDO:MONDO:0019200&MeSH:D012174&MedGen:C0035334&OMIM:268000&OMIM:PS268000&Orphanet:791&MedGen:C3661900&Human_Phenotype_Ontology:HP:0000556&Human_Phenotype_Ontology:HP:0007736&Human_Phenotype_Ontology:HP:0007910&Human_Phenotype_Ontology:HP:0007974&Human_Phenotype_Ontology:HP:0007982&MONDO:MONDO:0019118&MeSH:D058499&MedGen:C0854723&Orphanet:71862	Uncertain_significance(2)&Benign(4)	criteria_provided&_conflicting_classifications		USH2A	Usher syndrome type 2A	AR	276901	Hearing disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs3767698	chr1_216325569_A_C	Female	0/1	Heterozygous
chr1	216325569	.	A	C	169.95	PASS	"FS=2.864;MQ=249.69;MQRankSum=4.634;QD=1.32;ReadPosRankSum=2.628;SOR=0.895;FractionInformativeReads=0.974;R2_5P_bias=14.486;DP=79;AF=1;AN=4;AC=3;CSQ=C|synonymous_variant|LOW|USH2A|7399|Transcript|NM_206933.4|protein_coding|6/72||NM_206933.4:c.879T>G|NP_996816.3:p.Leu293%3D|1318|879|293|L|ctT/ctG|rs3767698&COSV56383380||-1||SNV|EntrezGene||YES|||A|A||||||0.0108|0.002327|0.0002093|0.006474|0.00111|0.06745|1.873e-05|0.0001737|2.159e-05|0.002635|0.002528|0.0028|0.0004335|0|0.002881|0.0008646|0.06474|0|0|4.411e-05|0.001898|0.004359|0.06745|gnomADe_EAS|benign&uncertain_significance|0&1|1&1||||||||||||32|30|5|30|0.00|0.02|0.00|0.00|USH2A|||||||48609||Conflicting_classifications_of_pathogenicity|Usher_syndrome_type_2A&not_specified&Retinitis_pigmentosa&not_provided&Retinal_dystrophy|NC_000001.11:g.216325569A>C||single_nucleotide_variant|USH2A:7399|MONDO:MONDO:0010169&MedGen:C1848634&OMIM:276901&Orphanet:231178&Orphanet:886&MedGen:CN169374&Human_Phenotype_Ontology:HP:0000547&MONDO:MONDO:0019200&MeSH:D012174&MedGen:C0035334&OMIM:268000&OMIM:PS268000&Orphanet:791&MedGen:C3661900&Human_Phenotype_Ontology:HP:0000556&Human_Phenotype_Ontology:HP:0007736&Human_Phenotype_Ontology:HP:0007910&Human_Phenotype_Ontology:HP:0007974&Human_Phenotype_Ontology:HP:0007982&MONDO:MONDO:0019118&MeSH:D058499&MedGen:C0854723&Orphanet:71862|Uncertain_significance(2)&Benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,19:0.514:37:3,9:15,10:48:85,0,50:50,6.5492e-05,52.941:0,34.77,37.77:10,8,8,11:7,11,8,11	1/1:0,41:1:41:0,17:0,24:120:208,123,0:169.95,119.95,0:0,34.77,37.77:0,0,23,18:0,0,21,20	./.:.:.:.:.:.:.:.:.:.:.:.	C	synonymous_variant	LOW	USH2A	7399	Transcript	NM_206933.4	protein_coding	6/72		c.879T>G	p.Leu293%3D	1318	879	293	L	ctT/ctG	rs3767698&COSV56383380	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.0108	0.002327	0.0002093	0.006474	0.00111	0.06745	1.873e-05	0.0001737	2.159e-05	0.002635	0.002528	0.0028	0.0004335	0	0.002881	0.0008646	0.06474	0	0	4.411e-05	0.001898	0.004359	0.06745	gnomADe_EAS	benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		32	30	5	30	0	0.02	0	0	USH2A			NA				48609	NA	Conflicting_classifications_of_pathogenicity	Usher_syndrome_type_2A&not_specified&Retinitis_pigmentosa&not_provided&Retinal_dystrophy	NC_000001.11:g.216325569A>C		single_nucleotide_variant	USH2A:7399	MONDO:MONDO:0010169&MedGen:C1848634&OMIM:276901&Orphanet:231178&Orphanet:886&MedGen:CN169374&Human_Phenotype_Ontology:HP:0000547&MONDO:MONDO:0019200&MeSH:D012174&MedGen:C0035334&OMIM:268000&OMIM:PS268000&Orphanet:791&MedGen:C3661900&Human_Phenotype_Ontology:HP:0000556&Human_Phenotype_Ontology:HP:0007736&Human_Phenotype_Ontology:HP:0007910&Human_Phenotype_Ontology:HP:0007974&Human_Phenotype_Ontology:HP:0007982&MONDO:MONDO:0019118&MeSH:D058499&MedGen:C0854723&Orphanet:71862	Uncertain_significance(2)&Benign(4)	criteria_provided&_conflicting_classifications		USH2A	Usher syndrome 2	AR	276900	Hearing disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs3767698	chr1_216325569_A_C	Female	0/1	Heterozygous
chr1	228159235	.	G	A	50	PASS	"FS=0;MQ=249.67;MQRankSum=4.483;QD=1.43;ReadPosRankSum=3.55;SOR=0.648;FractionInformativeReads=1;R2_5P_bias=13.46;DP=71;AF=0.5;AN=4;AC=2;CSQ=A|3_prime_UTR_variant|MODIFIER|GJC2|57165|Transcript|NM_020435.4|protein_coding|2/2||NM_020435.4:c.*157G>A||1574|||||rs45491398||1||SNV|EntrezGene||YES|||G|G||||||0.0234|0.07784|0.01442|0.03163|0.06578|9.45e-05|0.07844|0.01856|0.09395|0.06218|0.02924|0.05758|0.01597|0.0625|0.04056|0.05789|0.0007725|0.07943|0.01701|0.09062|0.04962|0.02235|0.09395|gnomADe_NFE|benign&uncertain_significance||1||||||||||||2|-48|21|39|0.00|0.00|0.00|0.00|GJC2|||||||1265470||Conflicting_classifications_of_pathogenicity|Hereditary_spastic_paraplegia&not_provided|NC_000001.11:g.228159235G>A||single_nucleotide_variant|GJC2:57165|MONDO:MONDO:0019064&MedGen:C0037773&OMIM:PS303350&Orphanet:685&MedGen:C3661900|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,20:0.571:35:7,10:8,10:48:85,0,49:50,7.3776e-05,51.553:0,34.77,37.77:5,10,7,13:9,6,7,13	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:18,18:0.5:36:10,10:8,8:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:6,12,7,11:10,8,9,9	A	3_prime_UTR_variant	MODIFIER	GJC2	57165	Transcript	NM_020435.4	protein_coding	02-Feb		c.*157G>A		1574					rs45491398	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0234	0.07784	0.01442	0.03163	0.06578	9.45e-05	0.07844	0.01856	0.09395	0.06218	0.02924	0.05758	0.01597	0.0625	0.04056	0.05789	0.0007725	0.07943	0.01701	0.09062	0.04962	0.02235	0.09395	gnomADe_NFE	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		2	-48	21	39	0	0	0	0	GJC2			NA				1265470	NA	Conflicting_classifications_of_pathogenicity	Hereditary_spastic_paraplegia&not_provided	NC_000001.11:g.228159235G>A		single_nucleotide_variant	GJC2:57165	MONDO:MONDO:0019064&MedGen:C0037773&OMIM:PS303350&Orphanet:685&MedGen:C3661900	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		GJC2	Pelizaeus-Merzbacher-like disease	AR	312080	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs45491398	chr1_228159235_G_A	Female	0/1	Heterozygous
chr1	236897645	.	CT	C	49.15	PASS	"FS=3.471;MQ=246.36;MQRankSum=4.427;QD=1.54;ReadPosRankSum=0.742;SOR=1.172;FractionInformativeReads=0.967;R2_5P_bias=13.728;DP=95;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|MTR|4548|Transcript|NM_000254.3|protein_coding|33/33||NM_000254.3:c.*16del||4212|||||rs67705775||1||deletion|EntrezGene||YES|||T|T|||||14||0.3806|0.3737|0.4057|0.396|0.4064|0.406|0.3404|0.3749|0.3825|0.414|0.1799|0.1961|0.1859|0.1366|0.1658|0.08248|0.1872|0.1187|0.1867|0.1519|0.1962|0.414|gnomADe_SAS|uncertain_significance&benign||1||||||||||||-6|43|-18|-47|0.00|0.02|0.00|0.02|MTR|||||||296586||Conflicting_classifications_of_pathogenicity|not_provided&Disorders_of_Intracellular_Cobalamin_Metabolism&Methylcobalamin_deficiency_type_cblG|NC_000001.11:g.236897660del||Deletion|MTR:4548|MedGen:C3661900&MedGen:CN043592&MONDO:MONDO:0009609&MedGen:C1855128&OMIM:250940&Orphanet:2170&Orphanet:622|Uncertain_significance(1)&Benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,11:0.379:29:10,6:8,5:45:54,0,50:46.291,0.00012374,53:0,8,11:10,8,4,7:8,10,3,8	0/1:15,12:0.444:27:9,6:6,6:48:57,0,50:49.154,7.4552e-05,53:0,8,11:5,10,6,6:7,8,2,10	0/1:23,14:0.378:37:10,6:13,8:44:53,0,50:45.155,0.00015428,53:0,8,11:11,12,8,6:16,7,4,10	-	3_prime_UTR_variant	MODIFIER	MTR	4548	Transcript	NM_000254.3	protein_coding	33/33		c.*16del		4212					rs67705775	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			14	NA	0.3806	0.3737	0.4057	0.396	0.4064	0.406	0.3404	0.3749	0.3825	0.414	0.1799	0.1961	0.1859	0.1366	0.1658	0.08248	0.1872	0.1187	0.1867	0.1519	0.1962	0.414	gnomADe_SAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-6	43	-18	-47	0	0.02	0	0.02	MTR			NA				296586	NA	Conflicting_classifications_of_pathogenicity	not_provided&Disorders_of_Intracellular_Cobalamin_Metabolism&Methylcobalamin_deficiency_type_cblG	NC_000001.11:g.236897660del		Deletion	MTR:4548	MedGen:C3661900&MedGen:CN043592&MONDO:MONDO:0009609&MedGen:C1855128&OMIM:250940&Orphanet:2170&Orphanet:622	Uncertain_significance(1)&Benign(2)	criteria_provided&_conflicting_classifications		MTR	Methylcobalamin deficiency type cblG	AR	250940	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs67705775	chr1_236897645_CT_C	Female	0/1	Heterozygous
chr1	236897645	.	CT	C	49.15	PASS	"FS=3.471;MQ=246.36;MQRankSum=4.427;QD=1.54;ReadPosRankSum=0.742;SOR=1.172;FractionInformativeReads=0.967;R2_5P_bias=13.728;DP=95;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|MTR|4548|Transcript|NM_000254.3|protein_coding|33/33||NM_000254.3:c.*16del||4212|||||rs67705775||1||deletion|EntrezGene||YES|||T|T|||||14||0.3806|0.3737|0.4057|0.396|0.4064|0.406|0.3404|0.3749|0.3825|0.414|0.1799|0.1961|0.1859|0.1366|0.1658|0.08248|0.1872|0.1187|0.1867|0.1519|0.1962|0.414|gnomADe_SAS|uncertain_significance&benign||1||||||||||||-6|43|-18|-47|0.00|0.02|0.00|0.02|MTR|||||||296586||Conflicting_classifications_of_pathogenicity|not_provided&Disorders_of_Intracellular_Cobalamin_Metabolism&Methylcobalamin_deficiency_type_cblG|NC_000001.11:g.236897660del||Deletion|MTR:4548|MedGen:C3661900&MedGen:CN043592&MONDO:MONDO:0009609&MedGen:C1855128&OMIM:250940&Orphanet:2170&Orphanet:622|Uncertain_significance(1)&Benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,11:0.379:29:10,6:8,5:45:54,0,50:46.291,0.00012374,53:0,8,11:10,8,4,7:8,10,3,8	0/1:15,12:0.444:27:9,6:6,6:48:57,0,50:49.154,7.4552e-05,53:0,8,11:5,10,6,6:7,8,2,10	0/1:23,14:0.378:37:10,6:13,8:44:53,0,50:45.155,0.00015428,53:0,8,11:11,12,8,6:16,7,4,10	-	3_prime_UTR_variant	MODIFIER	MTR	4548	Transcript	NM_000254.3	protein_coding	33/33		c.*16del		4212					rs67705775	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			14	NA	0.3806	0.3737	0.4057	0.396	0.4064	0.406	0.3404	0.3749	0.3825	0.414	0.1799	0.1961	0.1859	0.1366	0.1658	0.08248	0.1872	0.1187	0.1867	0.1519	0.1962	0.414	gnomADe_SAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-6	43	-18	-47	0	0.02	0	0.02	MTR			NA				296586	NA	Conflicting_classifications_of_pathogenicity	not_provided&Disorders_of_Intracellular_Cobalamin_Metabolism&Methylcobalamin_deficiency_type_cblG	NC_000001.11:g.236897660del		Deletion	MTR:4548	MedGen:C3661900&MedGen:CN043592&MONDO:MONDO:0009609&MedGen:C1855128&OMIM:250940&Orphanet:2170&Orphanet:622	Uncertain_significance(1)&Benign(2)	criteria_provided&_conflicting_classifications		MTR	Methylmalonic aciduria and homocystinuria	AR	277380	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs67705775	chr1_236897645_CT_C	Female	0/1	Heterozygous
chr1	237833351	.	GC	G	50	PASS	"FS=0;MQ=246.12;MQRankSum=2.054;QD=4.55;ReadPosRankSum=-1.203;SOR=1.402;FractionInformativeReads=0.818;R2_5P_bias=-5.594;DP=23;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|RYR2|6262|Transcript|NM_001035.3|protein_coding|105/105||NM_001035.3:c.*716del||15947|||||rs397983403||1||deletion|EntrezGene||YES|||C|C|||||11||0|||||||0|||0.08484|0.1551|0.1061|0.05686|0.07474|0.04304|0.03663|0.1211|0.06272|0.08729|0.08236|0.1551|gnomADg_AFR|uncertain_significance||1||||||||||||-15|35|-15|45|0.00|0.00|0.00|0.00|RYR2|||||||296793||Uncertain_significance|Arrhythmogenic_right_ventricular_cardiomyopathy&Catecholaminergic_polymorphic_ventricular_tachycardia&not_provided|NC_000001.11:g.237833363del||Deletion|RYR2:6262|MONDO:MONDO:0016587&MeSH:D019571&MedGen:C0349788&Orphanet:247&MONDO:MONDO:0017990&MedGen:C5574922&OMIM:PS604772&Orphanet:3286&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:3,6:0.667:9:2,2:1,4:34:61,0,31:50.002,0.0017223,34.129:0,11,14.01:0,3,0,6:1,2,4,2	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:4,7:0.636:11:1,2:3,5:46:61,0,45:50,0.00010898,48.204:0,11,14.01:0,4,0,7:3,1,5,2	-	3_prime_UTR_variant	MODIFIER	RYR2	6262	Transcript	NM_001035.3	protein_coding	105/105		c.*716del		15947					rs397983403	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			11	NA	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.08484	0.1551	0.1061	0.05686	0.07474	0.04304	0.03663	0.1211	0.06272	0.08729	0.08236	0.1551	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-15	35	-15	45	0	0	0	0	RYR2			NA				296793	NA	Uncertain_significance	Arrhythmogenic_right_ventricular_cardiomyopathy&Catecholaminergic_polymorphic_ventricular_tachycardia&not_provided	NC_000001.11:g.237833363del		Deletion	RYR2:6262	MONDO:MONDO:0016587&MeSH:D019571&MedGen:C0349788&Orphanet:247&MONDO:MONDO:0017990&MedGen:C5574922&OMIM:PS604772&Orphanet:3286&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		RYR2	Catecholaminergic polymorphic ventricular tachycardia 1	AD	604772	Cardiac and vascular disorders	NBScreening	0	Uncertain_significance		rs397983403	chr1_237833351_GC_G	Female	0/1	Heterozygous
chr1	237833351	.	GC	G	50	PASS	"FS=0;MQ=246.12;MQRankSum=2.054;QD=4.55;ReadPosRankSum=-1.203;SOR=1.402;FractionInformativeReads=0.818;R2_5P_bias=-5.594;DP=23;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|RYR2|6262|Transcript|NM_001035.3|protein_coding|105/105||NM_001035.3:c.*716del||15947|||||rs397983403||1||deletion|EntrezGene||YES|||C|C|||||11||0|||||||0|||0.08484|0.1551|0.1061|0.05686|0.07474|0.04304|0.03663|0.1211|0.06272|0.08729|0.08236|0.1551|gnomADg_AFR|uncertain_significance||1||||||||||||-15|35|-15|45|0.00|0.00|0.00|0.00|RYR2|||||||296793||Uncertain_significance|Arrhythmogenic_right_ventricular_cardiomyopathy&Catecholaminergic_polymorphic_ventricular_tachycardia&not_provided|NC_000001.11:g.237833363del||Deletion|RYR2:6262|MONDO:MONDO:0016587&MeSH:D019571&MedGen:C0349788&Orphanet:247&MONDO:MONDO:0017990&MedGen:C5574922&OMIM:PS604772&Orphanet:3286&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:3,6:0.667:9:2,2:1,4:34:61,0,31:50.002,0.0017223,34.129:0,11,14.01:0,3,0,6:1,2,4,2	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:4,7:0.636:11:1,2:3,5:46:61,0,45:50,0.00010898,48.204:0,11,14.01:0,4,0,7:3,1,5,2	-	3_prime_UTR_variant	MODIFIER	RYR2	6262	Transcript	NM_001035.3	protein_coding	105/105		c.*716del		15947					rs397983403	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			11	NA	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.08484	0.1551	0.1061	0.05686	0.07474	0.04304	0.03663	0.1211	0.06272	0.08729	0.08236	0.1551	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-15	35	-15	45	0	0	0	0	RYR2			NA				296793	NA	Uncertain_significance	Arrhythmogenic_right_ventricular_cardiomyopathy&Catecholaminergic_polymorphic_ventricular_tachycardia&not_provided	NC_000001.11:g.237833363del		Deletion	RYR2:6262	MONDO:MONDO:0016587&MeSH:D019571&MedGen:C0349788&Orphanet:247&MONDO:MONDO:0017990&MedGen:C5574922&OMIM:PS604772&Orphanet:3286&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		RYR2	Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome	AD	115000	Cardiac and vascular disorders	NBScreening	0	Uncertain_significance		rs397983403	chr1_237833351_GC_G	Female	0/1	Heterozygous
chr1	237833351	.	GC	G	50	PASS	"FS=0;MQ=246.12;MQRankSum=2.054;QD=4.55;ReadPosRankSum=-1.203;SOR=1.402;FractionInformativeReads=0.818;R2_5P_bias=-5.594;DP=23;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|RYR2|6262|Transcript|NM_001035.3|protein_coding|105/105||NM_001035.3:c.*716del||15947|||||rs397983403||1||deletion|EntrezGene||YES|||C|C|||||11||0|||||||0|||0.08484|0.1551|0.1061|0.05686|0.07474|0.04304|0.03663|0.1211|0.06272|0.08729|0.08236|0.1551|gnomADg_AFR|uncertain_significance||1||||||||||||-15|35|-15|45|0.00|0.00|0.00|0.00|RYR2|||||||296793||Uncertain_significance|Arrhythmogenic_right_ventricular_cardiomyopathy&Catecholaminergic_polymorphic_ventricular_tachycardia&not_provided|NC_000001.11:g.237833363del||Deletion|RYR2:6262|MONDO:MONDO:0016587&MeSH:D019571&MedGen:C0349788&Orphanet:247&MONDO:MONDO:0017990&MedGen:C5574922&OMIM:PS604772&Orphanet:3286&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:3,6:0.667:9:2,2:1,4:34:61,0,31:50.002,0.0017223,34.129:0,11,14.01:0,3,0,6:1,2,4,2	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:4,7:0.636:11:1,2:3,5:46:61,0,45:50,0.00010898,48.204:0,11,14.01:0,4,0,7:3,1,5,2	-	3_prime_UTR_variant	MODIFIER	RYR2	6262	Transcript	NM_001035.3	protein_coding	105/105		c.*716del		15947					rs397983403	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			11	NA	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.08484	0.1551	0.1061	0.05686	0.07474	0.04304	0.03663	0.1211	0.06272	0.08729	0.08236	0.1551	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-15	35	-15	45	0	0	0	0	RYR2			NA				296793	NA	Uncertain_significance	Arrhythmogenic_right_ventricular_cardiomyopathy&Catecholaminergic_polymorphic_ventricular_tachycardia&not_provided	NC_000001.11:g.237833363del		Deletion	RYR2:6262	MONDO:MONDO:0016587&MeSH:D019571&MedGen:C0349788&Orphanet:247&MONDO:MONDO:0017990&MedGen:C5574922&OMIM:PS604772&Orphanet:3286&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		RYR2	Arrhythmogenic right ventricular dysplasia 2	AD	602086	Cardiac and vascular disorders	NBScreening	0	Uncertain_significance		rs397983403	chr1_237833351_GC_G	Female	0/1	Heterozygous
chr1	241500602	.	T	TGAGAGAGAGA	242.19	PASS	"FS=0;MQ=208.85;QD=5.2;SOR=2.303;FractionInformativeReads=0.474;MQRankSum=1.476;ReadPosRankSum=1.348;R2_5P_bias=0;DP=102;AF=0.5;AN=6;AC=2;CSQ=GAGAGAGAGA|splice_polypyrimidine_tract_variant&intron_variant|LOW|FH|2271|Transcript|NM_000143.4|protein_coding||8/9|NM_000143.4:c.1237-22_1237-13dup|||||||rs144131869||-1||insertion|EntrezGene||YES|||||||||||0.02857|0.04194|0.01466|0.01411|0.01768|0.02115|0.02921|0.02896|0.02938|0.03805|0.04009|0.05739|0|0.02943|0.01804|0.03481|0.03389|0.04851|0.03417|0.03735|0.06253|0.06253|gnomADg_SAS|||1|||||||||||||||||||||||||||296869||Conflicting_classifications_of_pathogenicity|not_specified&not_provided&Fumarase_deficiency&Hereditary_leiomyomatosis_and_renal_cell_cancer|NC_000001.11:g.241500603GA[24]||Microsatellite|FH:2271|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0011730&MedGen:C0342770&OMIM:606812&Orphanet:24&Human_Phenotype_Ontology:HP:0007437&MONDO:MONDO:0007888&MedGen:C1708350&OMIM:150800&Orphanet:523|Uncertain_significance(3)&Benign(3)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,11:0.611:18:0,4:0,7:46:204,151,48:197.59,147.59,47.664:0,3,6.01:0,0,14,4:0,0,8,10	0/0:1,.:0.389:27:0,.:1,.:68:123,.,.:117.85,.,.:0,.,.:1,0,18,8:0,1,14,12	1/0:0,7:0.438:16:0,5:0,2:47:248,194,50:242.19,191.44,50:0,3,6.01:0,0,10,6:0,0,12,4	GAGAGAGAGA	splice_polypyrimidine_tract_variant&intron_variant	LOW	FH	2271	Transcript	NM_000143.4	protein_coding		09-Aug	c.1237-22_1237-13dup							rs144131869	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.02857	0.04194	0.01466	0.01411	0.01768	0.02115	0.02921	0.02896	0.02938	0.03805	0.04009	0.05739	0	0.02943	0.01804	0.03481	0.03389	0.04851	0.03417	0.03735	0.06253	0.06253	gnomADg_SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				296869	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided&Fumarase_deficiency&Hereditary_leiomyomatosis_and_renal_cell_cancer	NC_000001.11:g.241500603GA[24]		Microsatellite	FH:2271	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0011730&MedGen:C0342770&OMIM:606812&Orphanet:24&Human_Phenotype_Ontology:HP:0007437&MONDO:MONDO:0007888&MedGen:C1708350&OMIM:150800&Orphanet:523	Uncertain_significance(3)&Benign(3)&Likely_benign(1)	criteria_provided&_conflicting_classifications		FH	Fumarase deficiency	AR	606812	Tumor predisposition syndromes	NBScreening	-9	Benign	BP6,BA1	rs144131869	chr1_241500602_T_TGAGAGAGAGA	Female	1/0	Heterozygous
chr1	241500602	.	T	TGAGAGAGAGA	242.19	PASS	"FS=0;MQ=208.85;QD=5.2;SOR=2.303;FractionInformativeReads=0.474;MQRankSum=1.476;ReadPosRankSum=1.348;R2_5P_bias=0;DP=102;AF=0.5;AN=6;AC=2;CSQ=GAGAGAGAGA|splice_polypyrimidine_tract_variant&intron_variant|LOW|FH|2271|Transcript|NM_000143.4|protein_coding||8/9|NM_000143.4:c.1237-22_1237-13dup|||||||rs144131869||-1||insertion|EntrezGene||YES|||||||||||0.02857|0.04194|0.01466|0.01411|0.01768|0.02115|0.02921|0.02896|0.02938|0.03805|0.04009|0.05739|0|0.02943|0.01804|0.03481|0.03389|0.04851|0.03417|0.03735|0.06253|0.06253|gnomADg_SAS|||1|||||||||||||||||||||||||||296869||Conflicting_classifications_of_pathogenicity|not_specified&not_provided&Fumarase_deficiency&Hereditary_leiomyomatosis_and_renal_cell_cancer|NC_000001.11:g.241500603GA[24]||Microsatellite|FH:2271|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0011730&MedGen:C0342770&OMIM:606812&Orphanet:24&Human_Phenotype_Ontology:HP:0007437&MONDO:MONDO:0007888&MedGen:C1708350&OMIM:150800&Orphanet:523|Uncertain_significance(3)&Benign(3)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,11:0.611:18:0,4:0,7:46:204,151,48:197.59,147.59,47.664:0,3,6.01:0,0,14,4:0,0,8,10	0/0:1,.:0.389:27:0,.:1,.:68:123,.,.:117.85,.,.:0,.,.:1,0,18,8:0,1,14,12	1/0:0,7:0.438:16:0,5:0,2:47:248,194,50:242.19,191.44,50:0,3,6.01:0,0,10,6:0,0,12,4	GAGAGAGAGA	splice_polypyrimidine_tract_variant&intron_variant	LOW	FH	2271	Transcript	NM_000143.4	protein_coding		09-Aug	c.1237-22_1237-13dup							rs144131869	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.02857	0.04194	0.01466	0.01411	0.01768	0.02115	0.02921	0.02896	0.02938	0.03805	0.04009	0.05739	0	0.02943	0.01804	0.03481	0.03389	0.04851	0.03417	0.03735	0.06253	0.06253	gnomADg_SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				296869	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided&Fumarase_deficiency&Hereditary_leiomyomatosis_and_renal_cell_cancer	NC_000001.11:g.241500603GA[24]		Microsatellite	FH:2271	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0011730&MedGen:C0342770&OMIM:606812&Orphanet:24&Human_Phenotype_Ontology:HP:0007437&MONDO:MONDO:0007888&MedGen:C1708350&OMIM:150800&Orphanet:523	Uncertain_significance(3)&Benign(3)&Likely_benign(1)	criteria_provided&_conflicting_classifications		FH	Hereditary leiomyomatosis and renal cell cancer	AD	150800	Tumor predisposition syndromes	NBScreening	-9	Benign	BP6,BA1	rs144131869	chr1_241500602_T_TGAGAGAGAGA	Female	1/0	Heterozygous
chr1	241500602	.	T	TGAGA	242.19	PASS	"FS=0;MQ=208.85;QD=5.2;SOR=2.303;FractionInformativeReads=0.474;MQRankSum=1.476;ReadPosRankSum=1.348;R2_5P_bias=0;DP=102;AF=0.5;AN=6;AC=4;CSQ=GAGA|splice_polypyrimidine_tract_variant&intron_variant|LOW|FH|2271|Transcript|NM_000143.4|protein_coding||8/9|NM_000143.4:c.1237-16_1237-13dup|||||||rs144131869||-1||insertion|EntrezGene||YES|||||||||||0.239|0.1455|0.2328|0.2278|0.1589|0.2024|0.2171|0.2445|0.2281|0.2745|0.2551|0.1524|0.2864|0.3169|0.2763|0.1697|0.2757|0.2852|0.2931|0.2723|0.3681|0.3681|gnomADg_SAS|||1|||||||||||||||||||||||||||296866||Conflicting_classifications_of_pathogenicity|not_provided&Hereditary_leiomyomatosis_and_renal_cell_cancer&Fumarase_deficiency&Hereditary_cancer-predisposing_syndrome&not_specified|NC_000001.11:g.241500603GA[21]||Microsatellite|FH:2271|MedGen:C3661900&Human_Phenotype_Ontology:HP:0007437&MONDO:MONDO:0007888&MedGen:C1708350&OMIM:150800&Orphanet:523&MONDO:MONDO:0011730&MedGen:C0342770&OMIM:606812&Orphanet:24&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:CN169374|Uncertain_significance(4)&Benign(2)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:0,7:0.389:18:0,2:0,5:46:204,303,50:197.59,299.57,50:0,3,6.01:0,0,14,4:0,0,8,10	1/1:1,26:0.963:27:0,10:1,16:68:123,71,0:117.85,67.851,7.7658e-07:0,2,5:1,0,18,8:0,1,14,12	0/1:0,9:0.562:16:0,3:0,6:47:248,230,49:242.19,226.62,49.312:0,3,6.01:0,0,10,6:0,0,12,4	GAGA	splice_polypyrimidine_tract_variant&intron_variant	LOW	FH	2271	Transcript	NM_000143.4	protein_coding		09-Aug	c.1237-16_1237-13dup							rs144131869	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.239	0.1455	0.2328	0.2278	0.1589	0.2024	0.2171	0.2445	0.2281	0.2745	0.2551	0.1524	0.2864	0.3169	0.2763	0.1697	0.2757	0.2852	0.2931	0.2723	0.3681	0.3681	gnomADg_SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				296866	NA	Conflicting_classifications_of_pathogenicity	not_provided&Hereditary_leiomyomatosis_and_renal_cell_cancer&Fumarase_deficiency&Hereditary_cancer-predisposing_syndrome&not_specified	NC_000001.11:g.241500603GA[21]		Microsatellite	FH:2271	MedGen:C3661900&Human_Phenotype_Ontology:HP:0007437&MONDO:MONDO:0007888&MedGen:C1708350&OMIM:150800&Orphanet:523&MONDO:MONDO:0011730&MedGen:C0342770&OMIM:606812&Orphanet:24&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:CN169374	Uncertain_significance(4)&Benign(2)&Likely_benign(3)	criteria_provided&_conflicting_classifications		FH	Fumarase deficiency	AR	606812	Tumor predisposition syndromes	NBScreening	-1	Likely_benign	BP6	rs144131869	chr1_241500602_T_TGAGA	Female	0/1	Heterozygous
chr1	241500602	.	T	TGAGA	242.19	PASS	"FS=0;MQ=208.85;QD=5.2;SOR=2.303;FractionInformativeReads=0.474;MQRankSum=1.476;ReadPosRankSum=1.348;R2_5P_bias=0;DP=102;AF=0.5;AN=6;AC=4;CSQ=GAGA|splice_polypyrimidine_tract_variant&intron_variant|LOW|FH|2271|Transcript|NM_000143.4|protein_coding||8/9|NM_000143.4:c.1237-16_1237-13dup|||||||rs144131869||-1||insertion|EntrezGene||YES|||||||||||0.239|0.1455|0.2328|0.2278|0.1589|0.2024|0.2171|0.2445|0.2281|0.2745|0.2551|0.1524|0.2864|0.3169|0.2763|0.1697|0.2757|0.2852|0.2931|0.2723|0.3681|0.3681|gnomADg_SAS|||1|||||||||||||||||||||||||||296866||Conflicting_classifications_of_pathogenicity|not_provided&Hereditary_leiomyomatosis_and_renal_cell_cancer&Fumarase_deficiency&Hereditary_cancer-predisposing_syndrome&not_specified|NC_000001.11:g.241500603GA[21]||Microsatellite|FH:2271|MedGen:C3661900&Human_Phenotype_Ontology:HP:0007437&MONDO:MONDO:0007888&MedGen:C1708350&OMIM:150800&Orphanet:523&MONDO:MONDO:0011730&MedGen:C0342770&OMIM:606812&Orphanet:24&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:CN169374|Uncertain_significance(4)&Benign(2)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:0,7:0.389:18:0,2:0,5:46:204,303,50:197.59,299.57,50:0,3,6.01:0,0,14,4:0,0,8,10	1/1:1,26:0.963:27:0,10:1,16:68:123,71,0:117.85,67.851,7.7658e-07:0,2,5:1,0,18,8:0,1,14,12	0/1:0,9:0.562:16:0,3:0,6:47:248,230,49:242.19,226.62,49.312:0,3,6.01:0,0,10,6:0,0,12,4	GAGA	splice_polypyrimidine_tract_variant&intron_variant	LOW	FH	2271	Transcript	NM_000143.4	protein_coding		09-Aug	c.1237-16_1237-13dup							rs144131869	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.239	0.1455	0.2328	0.2278	0.1589	0.2024	0.2171	0.2445	0.2281	0.2745	0.2551	0.1524	0.2864	0.3169	0.2763	0.1697	0.2757	0.2852	0.2931	0.2723	0.3681	0.3681	gnomADg_SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				296866	NA	Conflicting_classifications_of_pathogenicity	not_provided&Hereditary_leiomyomatosis_and_renal_cell_cancer&Fumarase_deficiency&Hereditary_cancer-predisposing_syndrome&not_specified	NC_000001.11:g.241500603GA[21]		Microsatellite	FH:2271	MedGen:C3661900&Human_Phenotype_Ontology:HP:0007437&MONDO:MONDO:0007888&MedGen:C1708350&OMIM:150800&Orphanet:523&MONDO:MONDO:0011730&MedGen:C0342770&OMIM:606812&Orphanet:24&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:CN169374	Uncertain_significance(4)&Benign(2)&Likely_benign(3)	criteria_provided&_conflicting_classifications		FH	Hereditary leiomyomatosis and renal cell cancer	AD	150800	Tumor predisposition syndromes	NBScreening	-1	Likely_benign	BP6	rs144131869	chr1_241500602_T_TGAGA	Female	0/1	Heterozygous
chr20	3229251	.	C	T	50	PASS	"FS=3.11;MQ=250;MQRankSum=4.907;QD=1.22;ReadPosRankSum=3.557;SOR=1.053;FractionInformativeReads=1;R2_5P_bias=20.683;DP=67;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|SLC4A11|83959|Transcript|NM_001174089.2|protein_coding|16/20||NM_001174089.2:c.1862G>A|NP_001167560.1:p.Arg621His|1915|1862|621|R/H|cGc/cAc|rs751797233||-1||SNV|EntrezGene||YES|||C|C|||tolerated_low_confidence(0.11)|benign(0.049)|||4.655e-05|0|2.236e-05|0|0.0003023|0|0|4.407e-05|6.624e-05|2.319e-05|4.6e-05|4.825e-05|0|0|0|0.0003857|0|0|4.41e-05|0|0|0.0003857|gnomADg_EAS|uncertain_significance||1||||T|0.07592|-0.311779|T|0.42291|-0.322592|0.53788|0.235&0.235&.&.&.&.&0.235|-13|29|-14|-13|0.15|0.01|0.00|0.00|SLC4A11|||||||338243||Uncertain_significance|Corneal_dystrophy&Inborn_genetic_diseases&Corneal_dystrophy&_Fuchs_endothelial&_4&Congenital_hereditary_endothelial_dystrophy_of_cornea&Corneal_dystrophy-perceptive_deafness_syndrome|NC_000020.11:g.3229251C>T||single_nucleotide_variant|SLC4A11:83959|Human_Phenotype_Ontology:HP:0001131&Human_Phenotype_Ontology:HP:0007775&MONDO:MONDO:0018102&MedGen:C0010036&Orphanet:34533&MeSH:D030342&MedGen:C0950123&MONDO:MONDO:0013204&MedGen:C2750450&OMIM:613268&Orphanet:98974&MONDO:MONDO:0009019&MedGen:C1857569&OMIM:217700&Orphanet:293603&MONDO:MONDO:0009015&MedGen:C1857572&OMIM:217400&Orphanet:1490||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:23,13:0.361:36:10,6:13,7:43:79,0,50:43.887,0.00019933,53:0,34.77,37.77:10,13,8,5:11,12,7,6	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,19:0.633:30:4,9:7,10:46:85,0,45:50,0.00010743,48.311:0,34.77,37.77:6,5,12,7:7,4,14,5	T	missense_variant	MODERATE	SLC4A11	83959	Transcript	NM_001174089.2	protein_coding	16/20		c.1862G>A	p.Arg621His	1915	1862	621	R/H	cGc/cAc	rs751797233	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated_low_confidence(0.11)	benign(0.049)	NA	NA	4.655e-05	0	2.236e-05	0	0.0003023	0	0	4.407e-05	6.624e-05	2.319e-05	4.6e-05	4.825e-05	0	0	0	0.0003857	0	0	4.41e-05	0	0	0.0003857	gnomADg_EAS	uncertain_significance		1	NA	NA	NA	T	0.07592	-0.311779	T	0.42291	-0.322592	0.53788	0.235&0.235&.&.&.&.&0.235	-13	29	-14	-13	0.15	0.01	0	0	SLC4A11			NA				338243	NA	Uncertain_significance	Corneal_dystrophy&Inborn_genetic_diseases&Corneal_dystrophy&_Fuchs_endothelial&_4&Congenital_hereditary_endothelial_dystrophy_of_cornea&Corneal_dystrophy-perceptive_deafness_syndrome	NC_000020.11:g.3229251C>T		single_nucleotide_variant	SLC4A11:83959	Human_Phenotype_Ontology:HP:0001131&Human_Phenotype_Ontology:HP:0007775&MONDO:MONDO:0018102&MedGen:C0010036&Orphanet:34533&MeSH:D030342&MedGen:C0950123&MONDO:MONDO:0013204&MedGen:C2750450&OMIM:613268&Orphanet:98974&MONDO:MONDO:0009019&MedGen:C1857569&OMIM:217700&Orphanet:293603&MONDO:MONDO:0009015&MedGen:C1857572&OMIM:217400&Orphanet:1490		criteria_provided&_multiple_submitters&_no_conflicts		SLC4A11	Corneal dystrophy, Fuchs endothelial, 4	AR	613268	Eye disorders	NBScreening	-2	Likely_benign	BP4_Moderate	rs751797233	chr20_3229251_C_T	Female	0/1	Heterozygous
chr20	3234173	.	T	G	50	PASS	"FS=3.356;MQ=250;MQRankSum=4.82;QD=1.47;ReadPosRankSum=2.941;SOR=1.609;FractionInformativeReads=1;R2_5P_bias=-14.102;DP=75;AF=0.5;AN=4;AC=2;CSQ=G|synonymous_variant|LOW|SLC4A11|83959|Transcript|NM_001174089.2|protein_coding|5/20||NM_001174089.2:c.433A>C|NP_001167560.1:p.Arg145%3D|486|433|145|R|Agg/Cgg|rs3827075&COSV66261640&CX082312||-1||SNV|EntrezGene||YES|||T|T||||||0.4798|0.411|0.6526|0.4601|0.3812|0.5478|0.5051|0.3844|0.3997|0.4275|0.3151|0.4855|0.6474|0.4582|0.472|0.3725|0.5688|0.5216|0.3596|0.3968|0.4409|0.3309|0.671|AFR|benign&conflicting_interpretations_of_pathogenicity|0&1&1|1&1&1||||||||||||-14|-2|-14|31|0.00|0.04|0.00|0.00|SLC4A11|||||||262001||Conflicting_classifications_of_pathogenicity|Corneal_dystrophy-perceptive_deafness_syndrome&Congenital_hereditary_endothelial_dystrophy_of_cornea&not_provided&Corneal_dystrophy&not_specified|NC_000020.11:g.3234173T>G||single_nucleotide_variant|SLC4A11:83959|MONDO:MONDO:0009015&MedGen:C1857572&OMIM:217400&Orphanet:1490&MONDO:MONDO:0009019&MedGen:C1857569&OMIM:217700&Orphanet:293603&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001131&Human_Phenotype_Ontology:HP:0007775&MONDO:MONDO:0018102&MedGen:C0010036&Orphanet:34533&MedGen:CN169374|Uncertain_significance(1)&Benign(8)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:13,21:0.618:34:10,7:3,14:46:85,0,46:50,9.9662e-05,48.872:0,34.77,37.77:7,6,15,6:6,7,7,14	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:17,24:0.585:41:6,12:11,12:47:85,0,47:50,8.3612e-05,50.345:0,34.77,37.77:11,6,11,13:8,9,11,13	G	synonymous_variant	LOW	SLC4A11	83959	Transcript	NM_001174089.2	protein_coding	20-May		c.433A>C	p.Arg145%3D	486	433	145	R	Agg/Cgg	rs3827075&COSV66261640&CX082312	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.4798	0.411	0.6526	0.4601	0.3812	0.5478	0.5051	0.3844	0.3997	0.4275	0.3151	0.4855	0.6474	0.4582	0.472	0.3725	0.5688	0.5216	0.3596	0.3968	0.4409	0.3309	0.671	AFR	benign&conflicting_interpretations_of_pathogenicity	0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-14	-2	-14	31	0	0.04	0	0	SLC4A11			NA				262001	NA	Conflicting_classifications_of_pathogenicity	Corneal_dystrophy-perceptive_deafness_syndrome&Congenital_hereditary_endothelial_dystrophy_of_cornea&not_provided&Corneal_dystrophy&not_specified	NC_000020.11:g.3234173T>G		single_nucleotide_variant	SLC4A11:83959	MONDO:MONDO:0009015&MedGen:C1857572&OMIM:217400&Orphanet:1490&MONDO:MONDO:0009019&MedGen:C1857569&OMIM:217700&Orphanet:293603&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001131&Human_Phenotype_Ontology:HP:0007775&MONDO:MONDO:0018102&MedGen:C0010036&Orphanet:34533&MedGen:CN169374	Uncertain_significance(1)&Benign(8)	criteria_provided&_conflicting_classifications		SLC4A11	Corneal dystrophy, Fuchs endothelial, 4	AR	613268	Eye disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs3827075	chr20_3234173_T_G	Female	0/1	Heterozygous
chr20	32798579	.	G	A	46.78	PASS	"FS=2.593;MQ=250;MQRankSum=5.711;QD=1.02;ReadPosRankSum=1.316;SOR=0.535;FractionInformativeReads=1;R2_5P_bias=10.558;DP=95;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|DNMT3B|1789|Transcript|NM_006892.4|protein_coding|15/23||NM_006892.4:c.1610G>A|NP_008823.1:p.Arg537Gln|1931|1610|537|R/Q|cGg/cAg|rs544333946&COSV52423688||1||SNV|EntrezGene||YES|||G|G|||tolerated(0.54)|benign(0)||0.0004|4.036e-05|2.987e-05|2.236e-05|0|0.0006297|3.746e-05|0|2.158e-05|6.623e-05|2.319e-05|4.594e-05|0|0|0|0|0.00135|0|0|0|0|0|0.002|EAS|uncertain_significance|0&1|1&1||||T|0.02215|-0.402942|T|0.36821|-0.370589|0.36157|0.133&0.133&0.133&0.133&0.133&0.133|2|-19|2|44|0.01|0.06|0.00|0.00|DNMT3B|likely_benign|hg38|0.0643|R537Q|ENST00000328111.6|Q9UBC3|643527||Uncertain_significance|Centromeric_instability_of_chromosomes_1&9_and_16_and_immunodeficiency|NC_000020.11:g.32798579G>A||single_nucleotide_variant|DNMT3B:1789&LOC126863014:126863014|MONDO:MONDO:0000133&MedGen:C0398788&OMIM:PS242860&Orphanet:2268||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:27,19:0.413:46:14,10:13,9:46:82,0,50:46.784,0.00011286,53:0,34.77,37.77:16,11,9,10:13,14,6,13	0/1:31,18:0.367:49:13,7:18,11:42:77,0,50:42.116,0.00028864,53:0,34.77,37.77:18,13,8,10:10,21,7,11	A	missense_variant	MODERATE	DNMT3B	1789	Transcript	NM_006892.4	protein_coding	15/23		c.1610G>A	p.Arg537Gln	1931	1610	537	R/Q	cGg/cAg	rs544333946&COSV52423688	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	tolerated(0.54)	benign(0)	NA	4,00E-04	4.036e-05	2.987e-05	2.236e-05	0	0.0006297	3.746e-05	0	2.158e-05	6.623e-05	2.319e-05	4.594e-05	0	0	0	0	0.00135	0	0	0	0	0	0.002	EAS	uncertain_significance	0&1	1&1	NA	NA	NA	T	0.02215	-0.402942	T	0.36821	-0.370589	0.36157	0.133&0.133&0.133&0.133&0.133&0.133	2	-19	2	44	0.01	0.06	0	0	DNMT3B	likely_benign	hg38	0.0643	R537Q	ENST00000328111.6	Q9UBC3	643527	NA	Uncertain_significance	Centromeric_instability_of_chromosomes_1&9_and_16_and_immunodeficiency	NC_000020.11:g.32798579G>A		single_nucleotide_variant	DNMT3B:1789&LOC126863014:126863014	MONDO:MONDO:0000133&MedGen:C0398788&OMIM:PS242860&Orphanet:2268		criteria_provided&_single_submitter		DNMT3B	Immunodeficiency-centromeric instability-facial anomalies syndrome 1	AR	242860	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-5	Likely_benign	BP4_Strong,BS1_Supporting	rs544333946	chr20_32798579_G_A	Female	./.	Other
chr20	44430955	.	ATCCTCCCT	A	50	PASS	"FS=4.32;MQ=248.06;MQRankSum=3.742;QD=2.27;ReadPosRankSum=1.625;SOR=1.506;FractionInformativeReads=0.909;R2_5P_bias=12.459;DP=65;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|HNF4A|3172|Transcript|NM_175914.5|protein_coding|10/10||NM_175914.5:c.*1299_*1306del||2756-2763|||||rs3834658||1||deletion|EntrezGene||YES|||TCCTCCCT|TCCTCCCT|||||8|0.0517|0.02|0||0||0||0.03333|0||0.06276|0.02443|0.01319|0.04115|0.0326|0.09064|0.09413|0.02721|0.08589|0.05745|0.07146|0.09413|gnomADg_FIN|||1|||||||||||||||||||||||||||338459||Conflicting_classifications_of_pathogenicity|Hyperinsulinism&_Dominant&Maturity_onset_diabetes_mellitus_in_young&not_provided|NC_000020.11:g.44430956TCCTCCCT[1]||Microsatellite|HNF4A:3172|MedGen:CN239341&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900|Uncertain_significance(1)&Benign(1)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:10,10:0.5:20:9,7:1,3:48:79,0,50:50,6.5233e-05,53:0,29,32:6,4,3,7:7,3,6,4	0/1:9,4:0.308:13:6,2:3,2:45:75,0,50:45.715,0.00013823,53:0,29,32:4,5,1,3:7,2,1,3	0/1:15,15:0.5:30:9,6:6,9:48:79,0,50:50,6.5233e-05,53:0,29,32:5,10,6,9:9,6,9,6	-	3_prime_UTR_variant	MODIFIER	HNF4A	3172	Transcript	NM_175914.5	protein_coding	10-Oct		c.*1299_*1306del		2756-2763					rs3834658	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TCCTCCCT	TCCTCCCT	NA	NA			8	0.0517	0.02	0	NA	0	NA	0	NA	0.03333	0	NA	0.06276	0.02443	0.01319	0.04115	0.0326	0.09064	0.09413	0.02721	0.08589	0.05745	0.07146	0.09413	gnomADg_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				338459	NA	Conflicting_classifications_of_pathogenicity	Hyperinsulinism&_Dominant&Maturity_onset_diabetes_mellitus_in_young&not_provided	NC_000020.11:g.44430956TCCTCCCT[1]		Microsatellite	HNF4A:3172	MedGen:CN239341&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900	Uncertain_significance(1)&Benign(1)&Likely_benign(2)	criteria_provided&_conflicting_classifications		HNF4A	Maturity-onset diabetes of the young type 1	AD	125850	"Renal disorders;Endocrine disorders"	NBScreening	-9	Benign	BP6,BA1	rs3834658	chr20_44430955_ATCCTCCCT_A	Female	0/1	Heterozygous
chr20	44430955	.	ATCCTCCCT	A	50	PASS	"FS=4.32;MQ=248.06;MQRankSum=3.742;QD=2.27;ReadPosRankSum=1.625;SOR=1.506;FractionInformativeReads=0.909;R2_5P_bias=12.459;DP=65;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|HNF4A|3172|Transcript|NM_175914.5|protein_coding|10/10||NM_175914.5:c.*1299_*1306del||2756-2763|||||rs3834658||1||deletion|EntrezGene||YES|||TCCTCCCT|TCCTCCCT|||||8|0.0517|0.02|0||0||0||0.03333|0||0.06276|0.02443|0.01319|0.04115|0.0326|0.09064|0.09413|0.02721|0.08589|0.05745|0.07146|0.09413|gnomADg_FIN|||1|||||||||||||||||||||||||||338459||Conflicting_classifications_of_pathogenicity|Hyperinsulinism&_Dominant&Maturity_onset_diabetes_mellitus_in_young&not_provided|NC_000020.11:g.44430956TCCTCCCT[1]||Microsatellite|HNF4A:3172|MedGen:CN239341&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900|Uncertain_significance(1)&Benign(1)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:10,10:0.5:20:9,7:1,3:48:79,0,50:50,6.5233e-05,53:0,29,32:6,4,3,7:7,3,6,4	0/1:9,4:0.308:13:6,2:3,2:45:75,0,50:45.715,0.00013823,53:0,29,32:4,5,1,3:7,2,1,3	0/1:15,15:0.5:30:9,6:6,9:48:79,0,50:50,6.5233e-05,53:0,29,32:5,10,6,9:9,6,9,6	-	3_prime_UTR_variant	MODIFIER	HNF4A	3172	Transcript	NM_175914.5	protein_coding	10-Oct		c.*1299_*1306del		2756-2763					rs3834658	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TCCTCCCT	TCCTCCCT	NA	NA			8	0.0517	0.02	0	NA	0	NA	0	NA	0.03333	0	NA	0.06276	0.02443	0.01319	0.04115	0.0326	0.09064	0.09413	0.02721	0.08589	0.05745	0.07146	0.09413	gnomADg_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				338459	NA	Conflicting_classifications_of_pathogenicity	Hyperinsulinism&_Dominant&Maturity_onset_diabetes_mellitus_in_young&not_provided	NC_000020.11:g.44430956TCCTCCCT[1]		Microsatellite	HNF4A:3172	MedGen:CN239341&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900	Uncertain_significance(1)&Benign(1)&Likely_benign(2)	criteria_provided&_conflicting_classifications		HNF4A	Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young	AD	616026	"Renal disorders;Endocrine disorders"	NBScreening	-9	Benign	BP6,BA1	rs3834658	chr20_44430955_ATCCTCCCT_A	Female	0/1	Heterozygous
chr20	44430955	.	ATCCTCCCT	A	50	PASS	"FS=4.32;MQ=248.06;MQRankSum=3.742;QD=2.27;ReadPosRankSum=1.625;SOR=1.506;FractionInformativeReads=0.909;R2_5P_bias=12.459;DP=65;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|HNF4A|3172|Transcript|NM_175914.5|protein_coding|10/10||NM_175914.5:c.*1299_*1306del||2756-2763|||||rs3834658||1||deletion|EntrezGene||YES|||TCCTCCCT|TCCTCCCT|||||8|0.0517|0.02|0||0||0||0.03333|0||0.06276|0.02443|0.01319|0.04115|0.0326|0.09064|0.09413|0.02721|0.08589|0.05745|0.07146|0.09413|gnomADg_FIN|||1|||||||||||||||||||||||||||338459||Conflicting_classifications_of_pathogenicity|Hyperinsulinism&_Dominant&Maturity_onset_diabetes_mellitus_in_young&not_provided|NC_000020.11:g.44430956TCCTCCCT[1]||Microsatellite|HNF4A:3172|MedGen:CN239341&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900|Uncertain_significance(1)&Benign(1)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:10,10:0.5:20:9,7:1,3:48:79,0,50:50,6.5233e-05,53:0,29,32:6,4,3,7:7,3,6,4	0/1:9,4:0.308:13:6,2:3,2:45:75,0,50:45.715,0.00013823,53:0,29,32:4,5,1,3:7,2,1,3	0/1:15,15:0.5:30:9,6:6,9:48:79,0,50:50,6.5233e-05,53:0,29,32:5,10,6,9:9,6,9,6	-	3_prime_UTR_variant	MODIFIER	HNF4A	3172	Transcript	NM_175914.5	protein_coding	10-Oct		c.*1299_*1306del		2756-2763					rs3834658	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TCCTCCCT	TCCTCCCT	NA	NA			8	0.0517	0.02	0	NA	0	NA	0	NA	0.03333	0	NA	0.06276	0.02443	0.01319	0.04115	0.0326	0.09064	0.09413	0.02721	0.08589	0.05745	0.07146	0.09413	gnomADg_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				338459	NA	Conflicting_classifications_of_pathogenicity	Hyperinsulinism&_Dominant&Maturity_onset_diabetes_mellitus_in_young&not_provided	NC_000020.11:g.44430956TCCTCCCT[1]		Microsatellite	HNF4A:3172	MedGen:CN239341&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:C3661900	Uncertain_significance(1)&Benign(1)&Likely_benign(2)	criteria_provided&_conflicting_classifications		HNF4A	Hyperinsulinism due to HNF4A deficiency	AD	NA	"Renal disorders;Endocrine disorders"	NBScreening	-9	Benign	BP6,BA1	rs3834658	chr20_44430955_ATCCTCCCT_A	Female	0/1	Heterozygous
chr20	44432344	.	C	CT	144.87	PASS	"FS=0;MQ=239.78;MQRankSum=1.203;QD=3.97;ReadPosRankSum=0.401;SOR=1.872;FractionInformativeReads=0.722;R2_5P_bias=0;DP=72;AF=1;AN=6;AC=6;CSQ=T|3_prime_UTR_variant|MODIFIER|HNF4A|3172|Transcript|NM_175914.5|protein_coding|10/10||NM_175914.5:c.*2703dup||4144-4145|||||rs11450239||1||insertion|EntrezGene||YES|||||||||24||||||||||||0.5302|0.355|0.6044|0.6006|0.6129|0.7004|0.4518|0.6562|0.5899|0.5689|0.6299|0.7004|gnomADg_EAS|uncertain_significance||1||||||||||||35|21|13|14|0.00|0.00|0.00|0.00|HNF4A|||||||338481||Uncertain_significance|not_provided&Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinism&_Dominant|NC_000020.11:g.44432368dup||Duplication|HNF4A:3172|MedGen:C3661900&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:CN239341||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:1,12:0.923:13:1,8:0,4:22:79,24,0:71.51,21.51,0.030781:0,5,8.01:1,0,3,9:1,0,5,7	1/1:0,17:1:17:0,9:0,8:46:103,49,0:95.931,45.931,0.00011079:0,4,7:0,0,8,9:0,0,6,11	1/1:0,34:1:34:0,17:0,17:95:153,98,0:144.87,94.87,0:0,5,8.01:0,0,10,24:0,0,21,13	T	3_prime_UTR_variant	MODIFIER	HNF4A	3172	Transcript	NM_175914.5	protein_coding	10-Oct		c.*2703dup		4144-4145					rs11450239	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			24	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.5302	0.355	0.6044	0.6006	0.6129	0.7004	0.4518	0.6562	0.5899	0.5689	0.6299	0.7004	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		35	21	13	14	0	0	0	0	HNF4A			NA				338481	NA	Uncertain_significance	not_provided&Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinism&_Dominant	NC_000020.11:g.44432368dup		Duplication	HNF4A:3172	MedGen:C3661900&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:CN239341		criteria_provided&_multiple_submitters&_no_conflicts		HNF4A	Maturity-onset diabetes of the young type 1	AD	125850	"Renal disorders;Endocrine disorders"	NBScreening	-8	Benign	BA1	rs11450239	chr20_44432344_C_CT	Female	01-Jan	Homozygous
chr20	44432344	.	C	CT	144.87	PASS	"FS=0;MQ=239.78;MQRankSum=1.203;QD=3.97;ReadPosRankSum=0.401;SOR=1.872;FractionInformativeReads=0.722;R2_5P_bias=0;DP=72;AF=1;AN=6;AC=6;CSQ=T|3_prime_UTR_variant|MODIFIER|HNF4A|3172|Transcript|NM_175914.5|protein_coding|10/10||NM_175914.5:c.*2703dup||4144-4145|||||rs11450239||1||insertion|EntrezGene||YES|||||||||24||||||||||||0.5302|0.355|0.6044|0.6006|0.6129|0.7004|0.4518|0.6562|0.5899|0.5689|0.6299|0.7004|gnomADg_EAS|uncertain_significance||1||||||||||||35|21|13|14|0.00|0.00|0.00|0.00|HNF4A|||||||338481||Uncertain_significance|not_provided&Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinism&_Dominant|NC_000020.11:g.44432368dup||Duplication|HNF4A:3172|MedGen:C3661900&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:CN239341||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:1,12:0.923:13:1,8:0,4:22:79,24,0:71.51,21.51,0.030781:0,5,8.01:1,0,3,9:1,0,5,7	1/1:0,17:1:17:0,9:0,8:46:103,49,0:95.931,45.931,0.00011079:0,4,7:0,0,8,9:0,0,6,11	1/1:0,34:1:34:0,17:0,17:95:153,98,0:144.87,94.87,0:0,5,8.01:0,0,10,24:0,0,21,13	T	3_prime_UTR_variant	MODIFIER	HNF4A	3172	Transcript	NM_175914.5	protein_coding	10-Oct		c.*2703dup		4144-4145					rs11450239	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			24	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.5302	0.355	0.6044	0.6006	0.6129	0.7004	0.4518	0.6562	0.5899	0.5689	0.6299	0.7004	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		35	21	13	14	0	0	0	0	HNF4A			NA				338481	NA	Uncertain_significance	not_provided&Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinism&_Dominant	NC_000020.11:g.44432368dup		Duplication	HNF4A:3172	MedGen:C3661900&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:CN239341		criteria_provided&_multiple_submitters&_no_conflicts		HNF4A	Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young	AD	616026	"Renal disorders;Endocrine disorders"	NBScreening	-8	Benign	BA1	rs11450239	chr20_44432344_C_CT	Female	01-Jan	Homozygous
chr20	44432344	.	C	CT	144.87	PASS	"FS=0;MQ=239.78;MQRankSum=1.203;QD=3.97;ReadPosRankSum=0.401;SOR=1.872;FractionInformativeReads=0.722;R2_5P_bias=0;DP=72;AF=1;AN=6;AC=6;CSQ=T|3_prime_UTR_variant|MODIFIER|HNF4A|3172|Transcript|NM_175914.5|protein_coding|10/10||NM_175914.5:c.*2703dup||4144-4145|||||rs11450239||1||insertion|EntrezGene||YES|||||||||24||||||||||||0.5302|0.355|0.6044|0.6006|0.6129|0.7004|0.4518|0.6562|0.5899|0.5689|0.6299|0.7004|gnomADg_EAS|uncertain_significance||1||||||||||||35|21|13|14|0.00|0.00|0.00|0.00|HNF4A|||||||338481||Uncertain_significance|not_provided&Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinism&_Dominant|NC_000020.11:g.44432368dup||Duplication|HNF4A:3172|MedGen:C3661900&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:CN239341||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:1,12:0.923:13:1,8:0,4:22:79,24,0:71.51,21.51,0.030781:0,5,8.01:1,0,3,9:1,0,5,7	1/1:0,17:1:17:0,9:0,8:46:103,49,0:95.931,45.931,0.00011079:0,4,7:0,0,8,9:0,0,6,11	1/1:0,34:1:34:0,17:0,17:95:153,98,0:144.87,94.87,0:0,5,8.01:0,0,10,24:0,0,21,13	T	3_prime_UTR_variant	MODIFIER	HNF4A	3172	Transcript	NM_175914.5	protein_coding	10-Oct		c.*2703dup		4144-4145					rs11450239	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			24	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.5302	0.355	0.6044	0.6006	0.6129	0.7004	0.4518	0.6562	0.5899	0.5689	0.6299	0.7004	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		35	21	13	14	0	0	0	0	HNF4A			NA				338481	NA	Uncertain_significance	not_provided&Maturity_onset_diabetes_mellitus_in_young&Hyperinsulinism&_Dominant	NC_000020.11:g.44432368dup		Duplication	HNF4A:3172	MedGen:C3661900&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MedGen:CN239341		criteria_provided&_multiple_submitters&_no_conflicts		HNF4A	Hyperinsulinism due to HNF4A deficiency	AD	NA	"Renal disorders;Endocrine disorders"	NBScreening	-8	Benign	BA1	rs11450239	chr20_44432344_C_CT	Female	01-Jan	Homozygous
chr20	46129218	.	G	A	50	PASS	"FS=20.258;MQ=244.7;MQRankSum=4.031;QD=2.08;ReadPosRankSum=2.308;SOR=3.594;FractionInformativeReads=0.958;R2_5P_bias=2.703;DP=90;AF=0.5;AN=6;AC=3;CSQ=A|3_prime_UTR_variant|MODIFIER|CD40|958|Transcript|NM_001250.6|protein_coding|9/9||NM_001250.6:c.*178G>A||1042|||||rs565941222||1||SNV|EntrezGene||YES|||G|G||||||0.0012|0.001403|0.0001936|0.0005597|0.004898|0|0|0.008235|0.0006607|0.001334|0.006556|0.0006629|9.619e-05|0|0.0007188|0.004608|0|0|0|0.0006173|0.001419|0.005172|0.008235|gnomADe_MID|uncertain_significance||1||||||||||||13|-36|45|-1|0.00|0.00|0.00|0.00|CD40|||||||338580||Uncertain_significance|not_provided&Hyper-IgM_syndrome_type_3|NC_000020.11:g.46129218G>A||single_nucleotide_variant|CD40:958|MedGen:C3661900&MONDO:MONDO:0011735&MedGen:C1720957&OMIM:606843&Orphanet:101090||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,12:0.522:23:6,5:5,7:48:85,0,50:50,6.5492e-05,52.942:0,34.77,37.77:4,7,11,1:5,6,4,8	0/1:12,14:0.538:26:6,8:6,6:48:85,0,50:50,6.7045e-05,52.665:0,34.77,37.77:5,7,4,10:7,5,6,8	0/1:24,15:0.385:39:11,8:13,7:44:80,0,50:44.942,0.00016101,53:0,34.77,37.77:14,10,8,7:15,9,7,8	A	3_prime_UTR_variant	MODIFIER	CD40	958	Transcript	NM_001250.6	protein_coding	09-Sep		c.*178G>A		1042					rs565941222	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0012	0.001403	0.0001936	0.0005597	0.004898	0	0	0.008235	0.0006607	0.001334	0.006556	0.0006629	9.619e-05	0	0.0007188	0.004608	0	0	0	0.0006173	0.001419	0.005172	0.008235	gnomADe_MID	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		13	-36	45	-1	0	0	0	0	CD40			NA				338580	NA	Uncertain_significance	not_provided&Hyper-IgM_syndrome_type_3	NC_000020.11:g.46129218G>A		single_nucleotide_variant	CD40:958	MedGen:C3661900&MONDO:MONDO:0011735&MedGen:C1720957&OMIM:606843&Orphanet:101090		criteria_provided&_multiple_submitters&_no_conflicts		CD40	Hyper-IgM syndrome type 3	AR	606843	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-9	Benign	BP4_Strong,BS1_Supporting,BS2	rs565941222	chr20_46129218_G_A	Female	0/1	Heterozygous
chr21	34792308	.	A	C	12.54	PASS	"FS=2.363;MQ=245.68;MQRankSum=2.933;QD=0.78;ReadPosRankSum=-0.667;SOR=0.744;FractionInformativeReads=0.875;R2_5P_bias=-9.417;DP=16;AF=0.5;AN=2;AC=1;CSQ=C|missense_variant|MODERATE|RUNX1|861|Transcript|NM_001754.5|protein_coding|9/9||NM_001754.5:c.1270T>G|NP_001745.2:p.Ser424Ala|1464|1270|424|S/A|Tcg/Gcg|rs2056451534&COSV99038603&COSV99038622||-1||SNV|EntrezGene||YES|||A|A|||deleterious_low_confidence(0)||||0.003106|0.00497|0.003271|0.009196|0.01258|0.00804|0.004074|0.002543|0.006049|0.0005872|0.0001997|0.0001995|0|0.0001357|0|0.0009368|0.0004223|0|6.069e-05|0|0.001697|0.01258|gnomADe_EAS|likely_pathogenic&uncertain_significance|0&1&1|1&1&1||||T|0.51642|-8.53092e-05|T|0.51004|-0.237899|0.60219|0.284&0.284&0.284&0.284|-2|24|16|-9|0.00|0.00|0.00|0.00|RUNX1|||||||988867||Uncertain_significance|Thrombocytopenia&Abnormal_bleeding&not_provided&Hereditary_thrombocytopenia_and_hematologic_cancer_predisposition_syndrome&Aggressive_systemic_mastocytosis|NC_000021.9:g.34792308A>C||single_nucleotide_variant|RUNX1:861|Human_Phenotype_Ontology:HP:0001873&Human_Phenotype_Ontology:HP:0001906&Human_Phenotype_Ontology:HP:0004838&Human_Phenotype_Ontology:HP:0008175&Human_Phenotype_Ontology:HP:0008268&Human_Phenotype_Ontology:HP:0008302&MONDO:MONDO:0002049&MeSH:D013921&MedGen:C0040034&Human_Phenotype_Ontology:HP:0001892&Human_Phenotype_Ontology:HP:0004830&Human_Phenotype_Ontology:HP:0004834&Human_Phenotype_Ontology:HP:0004849&Human_Phenotype_Ontology:HP:0004862&Human_Phenotype_Ontology:HP:0004865&Human_Phenotype_Ontology:HP:0008183&MedGen:C1458140&MedGen:C3661900&MONDO:MONDO:0011071&MedGen:CN281654&Orphanet:71290&MONDO:MONDO:0020333&MedGen:C1112486&Orphanet:98850||reviewed_by_expert_panel|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:9,5:0.357:14:2,4:7,1:13:47,0,50:12.539,0.24909,53.249:0,34.77,37.77:6,3,2,3:1,8,1,4	C	missense_variant	MODERATE	RUNX1	861	Transcript	NM_001754.5	protein_coding	09-Sep		c.1270T>G	p.Ser424Ala	1464	1270	424	S/A	Tcg/Gcg	rs2056451534&COSV99038603&COSV99038622	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	deleterious_low_confidence(0)		NA	NA	0.003106	0.00497	0.003271	0.009196	0.01258	0.00804	0.004074	0.002543	0.006049	0.0005872	0.0001997	0.0001995	0	0.0001357	0	0.0009368	0.0004223	0	6.069e-05	0	0.001697	0.01258	gnomADe_EAS	likely_pathogenic&uncertain_significance	0&1&1	1&1&1	NA	NA	NA	T	0.51642	-8.53092e-05	T	0.51004	-0.237899	0.60219	0.284&0.284&0.284&0.284	-2	24	16	-9	0	0	0	0	RUNX1			NA				988867	NA	Uncertain_significance	Thrombocytopenia&Abnormal_bleeding&not_provided&Hereditary_thrombocytopenia_and_hematologic_cancer_predisposition_syndrome&Aggressive_systemic_mastocytosis	NC_000021.9:g.34792308A>C		single_nucleotide_variant	RUNX1:861	Human_Phenotype_Ontology:HP:0001873&Human_Phenotype_Ontology:HP:0001906&Human_Phenotype_Ontology:HP:0004838&Human_Phenotype_Ontology:HP:0008175&Human_Phenotype_Ontology:HP:0008268&Human_Phenotype_Ontology:HP:0008302&MONDO:MONDO:0002049&MeSH:D013921&MedGen:C0040034&Human_Phenotype_Ontology:HP:0001892&Human_Phenotype_Ontology:HP:0004830&Human_Phenotype_Ontology:HP:0004834&Human_Phenotype_Ontology:HP:0004849&Human_Phenotype_Ontology:HP:0004862&Human_Phenotype_Ontology:HP:0004865&Human_Phenotype_Ontology:HP:0008183&MedGen:C1458140&MedGen:C3661900&MONDO:MONDO:0011071&MedGen:CN281654&Orphanet:71290&MONDO:MONDO:0020333&MedGen:C1112486&Orphanet:98850		reviewed_by_expert_panel		RUNX1	Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1	AD	601399	Haematological disorders	NBScreening	-1	Uncertain_significance	BP4	rs2056451534	chr21_34792308_A_C	Female	./.	Other
chr21	36751019	.	C	CA	152.49	PASS	"FS=0;MQ=249.91;MQRankSum=1.564;QD=3.63;ReadPosRankSum=1.395;SOR=1.061;FractionInformativeReads=0.976;R2_5P_bias=0;DP=120;AF=0.5;AN=6;AC=4;CSQ=A|3_prime_UTR_variant|MODIFIER|HLCS|3141|Transcript|NM_001352514.2|protein_coding|11/11||NM_001352514.2:c.*3226dup||5879-5880|||||rs35955622||-1||insertion|EntrezGene||YES|||||||||||0.02941|||||0.02941|||||0.08524|0.1057|0.1831|0.07003|0.1316|0.057|0.06948|0.1971|0.07778|0.1003|0.05608|0.1971|gnomADg_MID|uncertain_significance||1||||||||||||-27|-12|-13|43|0.00|0.00|0.00|0.00|HLCS|||||||339910||Uncertain_significance|not_provided&Holocarboxylase_synthetase_deficiency|NC_000021.9:g.36751030dup||Duplication|HLCS:3141|MedGen:C3661900&MONDO:MONDO:0009666&MedGen:C0268581&OMIM:253270&Orphanet:79242||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:1,40:0.976:41:1,19:0,21:102:167,105,0:152.49,102.49,0:0,12,15:1,0,15,25:1,0,22,18	0/1:13,21:0.618:34:6,11:7,10:46:62,0,46:50,9.9921e-05,48.864:0,12,15:7,6,10,11:6,7,8,13	0/1:24,14:0.368:38:10,7:14,7:43:57,0,47:44.263,0.00020606,50:0,13,16.01:13,11,10,4:9,15,7,7	A	3_prime_UTR_variant	MODIFIER	HLCS	3141	Transcript	NM_001352514.2	protein_coding	11-Nov		c.*3226dup		5879-5880					rs35955622	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.02941	NA	NA	NA	NA	0.02941	NA	NA	NA	NA	0.08524	0.1057	0.1831	0.07003	0.1316	0.057	0.06948	0.1971	0.07778	0.1003	0.05608	0.1971	gnomADg_MID	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-27	-12	-13	43	0	0	0	0	HLCS			NA				339910	NA	Uncertain_significance	not_provided&Holocarboxylase_synthetase_deficiency	NC_000021.9:g.36751030dup		Duplication	HLCS:3141	MedGen:C3661900&MONDO:MONDO:0009666&MedGen:C0268581&OMIM:253270&Orphanet:79242		criteria_provided&_multiple_submitters&_no_conflicts		HLCS	Holocarboxylase synthetase deficiency	AR	253270	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs35955622	chr21_36751019_C_CA	Female	01-Jan	Homozygous
chr21	43056832	.	A	G	3.58	DRAGENSnpHardQUAL	"FS=0;MQ=14;MQRankSum=0.804;QD=1.79;ReadPosRankSum=0.804;SOR=0.693;FractionInformativeReads=1;R2_5P_bias=-8.044;DP=2;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|CBS|875|Transcript|NM_000071.3|protein_coding|16/17||NM_000071.3:c.1523T>C|NP_000062.1:p.Phe508Ser|1673|1523|508|F/S|tTc/tCc|||-1||SNV|EntrezGene||YES|||A|A|||deleterious(0)|benign(0.219)||||||||||||||||||||||||||||||||D|0.94092|0.493331|D|0.94014|0.470859|0.92948|0.787&0.787&0.787&0.787|-29|29|-27|-29|0.00|0.00|0.00|0.00|CBS|likely_pathogenic|hg38|0.8923|F508S|ENST00000352178.9|P35520||||||||||||"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:1,1:0.5:2:0,0:1,1:3:36,0,14:3.5764,2.5954,19.595:0,34.77,37.77:1,0,1,0:0,1,0,1	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	CBS	875	Transcript	NM_000071.3	protein_coding	16/17		c.1523T>C	p.Phe508Ser	1673	1523	508	F/S	tTc/tCc		NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	deleterious(0)	benign(0.219)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA					NA	NA	NA	D	0.94092	0.493331	D	0.94014	0.470859	0.92948	0.787&0.787&0.787&0.787	-29	29	-27	-29	0	0	0	0	CBS	likely_pathogenic	hg38	0.8923	F508S	ENST00000352178.9	P35520	NA	NA	NA										CBS	Classic homocystinuria	AR	236200	Inherited disorders of metabolism	NBScreening	3	Uncertain_significance	PP2,PP3_Moderate		chr21_43056832_A_G	Female	./.	Other
chr21	44296453	.	C	T	132.89	PASS	"FS=0;MQ=248.58;QD=4.58;SOR=1.688;FractionInformativeReads=1;MQRankSum=4.188;ReadPosRankSum=2.436;R2_5P_bias=4.648;DP=86;AF=0.5;AN=6;AC=4;CSQ=T|splice_region_variant&intron_variant|LOW|AIRE|326|Transcript|NM_000383.4|protein_coding||13/13|NM_000383.4:c.1566+8C>T|||||||rs72650680||1||SNV|EntrezGene||YES|||C|C||||||0.0004|0.002539|0.0004784|0.001879|0.0003831|0|0.0008831|0.005047|0.002853|0.00209|0.00261|0.002083|0.0005784|0|0.002288|0|0.000193|0.0003762|0|0.003385|0.001419|0.004155|0.005047|gnomADe_MID|conflicting_interpretations_of_pathogenicity&likely_benign&benign||1|1.62177695973576E-5|0.014||||||||||47|-35|-8|15|0.00|0.00|0.01|0.00|AIRE|||||||446817||Conflicting_classifications_of_pathogenicity|not_provided&Polyglandular_autoimmune_syndrome&_type_1&not_specified|NC_000021.9:g.44296453C>T||single_nucleotide_variant|AIRE:326|MedGen:C3661900&MONDO:MONDO:0009411&MedGen:C0085859&OMIM:240300&Orphanet:3453&MedGen:CN169374|Uncertain_significance(1)&Benign(2)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,29:1:29:0,15:0,14:83:171,86,0:132.89,82.894,0:0,34.77,37.77:0,0,20,9:0,0,16,13	0/1:14,11:0.44:25:10,9:4,2:48:84,0,50:49.192,7.4034e-05,53:0,34.77,37.77:7,7,7,4:7,7,7,4	0/1:12,18:0.6:30:9,10:3,8:47:85,0,48:50,8.0506e-05,50.677:0,34.77,37.77:6,6,11,7:7,5,7,11	T	splice_region_variant&intron_variant	LOW	AIRE	326	Transcript	NM_000383.4	protein_coding		13/13	c.1566+8C>T							rs72650680	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	4,00E-04	0.002539	0.0004784	0.001879	0.0003831	0	0.0008831	0.005047	0.002853	0.00209	0.00261	0.002083	0.0005784	0	0.002288	0	0.000193	0.0003762	0	0.003385	0.001419	0.004155	0.005047	gnomADe_MID	conflicting_interpretations_of_pathogenicity&likely_benign&benign		1	1.62177695973576e-05	0.014	NA		NA	NA		NA	NA	NA		47	-35	-8	15	0	0	0.01	0	AIRE			NA				446817	NA	Conflicting_classifications_of_pathogenicity	not_provided&Polyglandular_autoimmune_syndrome&_type_1&not_specified	NC_000021.9:g.44296453C>T		single_nucleotide_variant	AIRE:326	MedGen:C3661900&MONDO:MONDO:0009411&MedGen:C0085859&OMIM:240300&Orphanet:3453&MedGen:CN169374	Uncertain_significance(1)&Benign(2)&Likely_benign(2)	criteria_provided&_conflicting_classifications		AIRE	Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	AR	240300	Endocrine disorders	NBScreening	-9	Benign	BP4_Strong,BP6,BS2	rs72650680	chr21_44296453_C_T	Female	01-Jan	Homozygous
chr21	44521992	.	G	A	49.87	PASS	"FS=11.439;MQ=250;MQRankSum=5.528;QD=1.19;ReadPosRankSum=-0.869;SOR=1.63;FractionInformativeReads=1;R2_5P_bias=6.158;DP=42;AF=0.5;AN=2;AC=1;CSQ=A|missense_variant|MODERATE|TSPEAR|54084|Transcript|NM_144991.3|protein_coding|9/12||NM_144991.3:c.1457C>T|NP_659428.2:p.Pro486Leu|1515|1457|486|P/L|cCc/cTc|rs782176336||-1||SNV|EntrezGene||YES|||G|G|||deleterious(0)|possibly_damaging(0.844)|||1.368e-06|0|0|0|0|0|0|1.799e-06|0|0||||||||||||1.799e-06|gnomADe_NFE|||||||D|0.73978|0.200916|D|0.73638|0.0508255|0.74935|.&0.448|8|25|-49|0|0.00|0.00|0.00|0.00|TSPEAR|likely_benign|hg38|0.1692|P486L|ENST00000323084.9|Q8WU66||||||||||||"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:22,20:0.476:42:11,15:11,5:48:85,0,50:49.872,6.6527e-05,53:0,34.77,37.77:13,9,6,14:10,12,9,11	A	missense_variant	MODERATE	TSPEAR	54084	Transcript	NM_144991.3	protein_coding	12-Sep		c.1457C>T	p.Pro486Leu	1515	1457	486	P/L	cCc/cTc	rs782176336	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0)	possibly_damaging(0.844)	NA	NA	1.368e-06	0	0	0	0	0	0	1.799e-06	0	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1.799e-06	gnomADe_NFE				NA	NA	NA	D	0.73978	0.200916	D	0.73638	0.0508255	0.74935	.&0.448	8	25	-49	0	0	0	0	0	TSPEAR	likely_benign	hg38	0.1692	P486L	ENST00000323084.9	Q8WU66	NA	NA	NA										TSPEAR	Autosomal recessive nonsyndromic hearing loss 98	AR	614861	Hearing disorders	NBScreening	3	Uncertain_significance	PM2,PP3	rs782176336	chr21_44521992_G_A	Female	./.	Other
chr21	45537761	.	A	G	28.6	PASS	"FS=0;MQ=198.43;MQRankSum=-2.335;QD=2.04;ReadPosRankSum=-1.246;SOR=0.892;FractionInformativeReads=1;R2_5P_bias=21.661;DP=14;AF=0.5;AN=2;AC=1;CSQ=G|intron_variant|MODIFIER|SLC19A1|6573|Transcript|NM_194255.4|protein_coding||2/5|NM_194255.4:c.189+10T>C|||||||rs1378174841||-1||SNV|EntrezGene||YES|||A|A|||||||6.11e-05|0|0.0001512|0|0|0.0001084|0|4.128e-05|7.878e-05|0.0005272|0.003365|0.002492|0|0.00723|0.004289|0.00265|0.005993|0|0.002998|0.00591|0.006338|0.00723|gnomADg_AMR|||||||||||||||10|6|10|6|0.00|0.00|0.37|0.66|SLC19A1||||||||||||||||||"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,3:0.214:14:4,0:7,3:29:63,0,50:28.596,0.0060268,53.006:0,34.77,37.77:2,9,0,3:7,4,3,0	G	intron_variant	MODIFIER	SLC19A1	6573	Transcript	NM_194255.4	protein_coding		05-Feb	c.189+10T>C							rs1378174841	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	6.11e-05	0	0.0001512	0	0	0.0001084	0	4.128e-05	7.878e-05	0.0005272	0.003365	0.002492	0	0.00723	0.004289	0.00265	0.005993	0	0.002998	0.00591	0.006338	0.00723	gnomADg_AMR				NA	NA	NA		NA	NA		NA	NA	NA		10	6	10	6	0	0	0.37	0.66	SLC19A1			NA				NA	NA	NA										SLC19A1	Megaloblastic anemia, folate-responsive	AR	601775	Haematological disorders	NBScreening	-4	Likely_benign	BP4_Strong	rs1378174841	chr21_45537761_A_G	Female	./.	Other
chr21	46357070	.	A	G	50	PASS	"FS=0;MQ=250;MQRankSum=5.017;QD=1.43;ReadPosRankSum=1.738;SOR=0.727;FractionInformativeReads=1;R2_5P_bias=25.563;DP=35;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|PCNT|5116|Transcript|NM_006031.6|protein_coding|13/47||NM_006031.6:c.2033A>G|NP_006022.3:p.Lys678Arg|2106|2033|678|K/R|aAg/aGg|rs149623054&COSV100856315||1||SNV|EntrezGene||YES|||A|A|||tolerated(0.19)|benign(0.071)||0.0014|0.0007839|0|0.0001118|0.001645|0|0.007488|0.001387|0.0001439|0.0009935|0.005449|0.0009846|4.81e-05|0|0.0002613|0.002017|0|0.008376|0.003401|0.0003381|0.0004726|0.004768|0.008376|gnomADg_FIN|likely_benign&conflicting_interpretations_of_pathogenicity|0&1|1&1||||T|0.00201|-0.577116|T|0.12825|-0.599844|0.05648|0.026|1|23|-19|1|0.00|0.01|0.00|0.01|PCNT|likely_benign|hg38|0.0867|K678R|ENST00000359568.10|O95613|281569||Conflicting_classifications_of_pathogenicity|PCNT-related_disorder&not_specified&not_provided&Microcephalic_osteodysplastic_primordial_dwarfism_type_II|NC_000021.9:g.46357070A>G||single_nucleotide_variant|PCNT:5116|.&MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0008872&MedGen:C0432246&OMIM:210720&Orphanet:2637|Uncertain_significance(1)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,19:0.543:35:7,14:9,5:48:85,0,49:50,6.8081e-05,52.441:0,34.77,37.77:10,6,12,7:11,5,7,12	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	PCNT	5116	Transcript	NM_006031.6	protein_coding	13/47		c.2033A>G	p.Lys678Arg	2106	2033	678	K/R	aAg/aGg	rs149623054&COSV100856315	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	tolerated(0.19)	benign(0.071)	NA	0.0014	0.0007839	0	0.0001118	0.001645	0	0.007488	0.001387	0.0001439	0.0009935	0.005449	0.0009846	4.81e-05	0	0.0002613	0.002017	0	0.008376	0.003401	0.0003381	0.0004726	0.004768	0.008376	gnomADg_FIN	likely_benign&conflicting_interpretations_of_pathogenicity	0&1	1&1	NA	NA	NA	T	0.00201	-0.577116	T	0.12825	-0.599844	0.05648	0.026	1	23	-19	1	0	0.01	0	0.01	PCNT	likely_benign	hg38	0.0867	K678R	ENST00000359568.10	O95613	281569	NA	Conflicting_classifications_of_pathogenicity	PCNT-related_disorder&not_specified&not_provided&Microcephalic_osteodysplastic_primordial_dwarfism_type_II	NC_000021.9:g.46357070A>G		single_nucleotide_variant	PCNT:5116	.&MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0008872&MedGen:C0432246&OMIM:210720&Orphanet:2637	Uncertain_significance(1)&Likely_benign(3)	criteria_provided&_conflicting_classifications		PCNT	Microcephalic osteodysplastic primordial dwarfism type II	AR	210720	Skelettal, skin, and connective tissue disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs149623054	chr21_46357070_A_G	Female	./.	Other
chr22	26451986	.	ACGCGCGCG	A	520.98	PASS	"FS=0;MQ=241.76;QD=15.27;SOR=1.911;FractionInformativeReads=0.577;DP=91;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|HPS4|89781|Transcript|NM_022081.6|protein_coding|14/14||NM_022081.6:c.*1239_*1246del||3954-3961|||||rs10573454||-1||deletion|EntrezGene||YES|||CGCGCGCG|CGCGCGCG|||||||0.08651|0.05414|0.06479|0.05063|0.1014|0.0917|0.1364|0.08859|0.07762|0.09454|0.1425|0.1598|0.19|0.1342|0.06822|0.09061|0.1166|0.08333|0.1451|0.1326|0.1619|0.19|gnomADg_AMI|||1|||||||||||||||||||||||||||340977||Uncertain_significance|Hermansky-Pudlak_syndrome|NC_000022.11:g.26451988GC[5]||Microsatellite|HPS4:89781|MONDO:MONDO:0019312&MedGen:C0079504&OMIM:PS203300&Orphanet:79430||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,7:0.467:15:0,5:0,2:47:417,395,57:397.01,385.1,50:0,10,13.01:0,0,11,4:0,0,9,6	1/0:0,8:0.533:15:0,3:0,5:45:404,344,54:383.92,333.92,47.326:0,10,13.01:0,0,10,5:0,0,10,5	1/0:0,10:0.5:20:0,5:0,5:47:541,481,57:450,450,50:0,10,13.01:0,0,13,7:0,0,10,10	-	3_prime_UTR_variant	MODIFIER	HPS4	89781	Transcript	NM_022081.6	protein_coding	14/14		c.*1239_*1246del		3954-3961					rs10573454	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	CGCGCGCG	CGCGCGCG	NA	NA			NA	NA	0.08651	0.05414	0.06479	0.05063	0.1014	0.0917	0.1364	0.08859	0.07762	0.09454	0.1425	0.1598	0.19	0.1342	0.06822	0.09061	0.1166	0.08333	0.1451	0.1326	0.1619	0.19	gnomADg_AMI			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				340977	NA	Uncertain_significance	Hermansky-Pudlak_syndrome	NC_000022.11:g.26451988GC[5]		Microsatellite	HPS4:89781	MONDO:MONDO:0019312&MedGen:C0079504&OMIM:PS203300&Orphanet:79430		criteria_provided&_single_submitter		HPS4	Hermansky-Pudlak syndrome 4	AR	614073	Eye disorders	NBScreening	-8	Benign	BA1	rs10573454	chr22_26451986_ACGCGCGCG_A	Female	1/0	Heterozygous
chr22	26452002	.	G	A	50	PASS	"FS=2.447;MQ=241.42;MQRankSum=-0.053;QD=2;ReadPosRankSum=0.998;SOR=0.132;FractionInformativeReads=0.64;R2_5P_bias=-12.906;DP=84;AF=0.5;AN=6;AC=3;CSQ=A|3_prime_UTR_variant|MODIFIER|HPS4|89781|Transcript|NM_022081.6|protein_coding|14/14||NM_022081.6:c.*1231C>T||3946|||||rs56271395||-1||SNV|EntrezGene||YES|||G|G|||||||0.1813|0.186|0.196|0.3026|0.216|0.2315|0.1364|0.1698|0.1573|0.1909|0.3576|0.4037|0.1871|0.3556|0.4407|0.4711|0.3929|0.4231|0.3231|0.3726|0.3439|0.4711|gnomADg_EAS|uncertain_significance||1||||||||||||-12|40|2|-48|0.00|0.00|0.00|0.00|HPS4|||||||340984||Uncertain_significance|not_provided&Hermansky-Pudlak_syndrome|NC_000022.11:g.26452002G>A||single_nucleotide_variant|HPS4:89781|MedGen:C3661900&MONDO:MONDO:0019312&MedGen:C0079504&OMIM:PS203300&Orphanet:79430||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:8,8:0.5:16:5,4:3,4:47:85,0,47:50,9.0084e-05,49.693:0,34.77,37.78:7,1,5,3:4,4,5,3	0/1:9,7:0.438:16:4,4:5,3:45:82,0,47:47.326,0.00012374,50:0,34.77,37.78:4,5,7,0:7,2,4,3	0/1:12,10:0.455:22:6,4:6,6:47:85,0,47:50,8.6978e-05,50:0,34.77,37.78:9,3,6,4:5,7,6,4	A	3_prime_UTR_variant	MODIFIER	HPS4	89781	Transcript	NM_022081.6	protein_coding	14/14		c.*1231C>T		3946					rs56271395	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	0.1813	0.186	0.196	0.3026	0.216	0.2315	0.1364	0.1698	0.1573	0.1909	0.3576	0.4037	0.1871	0.3556	0.4407	0.4711	0.3929	0.4231	0.3231	0.3726	0.3439	0.4711	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-12	40	2	-48	0	0	0	0	HPS4			NA				340984	NA	Uncertain_significance	not_provided&Hermansky-Pudlak_syndrome	NC_000022.11:g.26452002G>A		single_nucleotide_variant	HPS4:89781	MedGen:C3661900&MONDO:MONDO:0019312&MedGen:C0079504&OMIM:PS203300&Orphanet:79430		criteria_provided&_multiple_submitters&_no_conflicts		HPS4	Hermansky-Pudlak syndrome 4	AR	614073	Eye disorders	NBScreening	-12	Benign	BP4_Strong,BA1	rs56271395	chr22_26452002_G_A	Female	0/1	Heterozygous
chr22	26452004	.	G	A	50	PASS	"FS=8.193;MQ=241.06;MQRankSum=0.666;QD=2.08;ReadPosRankSum=0.578;SOR=0.061;FractionInformativeReads=0.75;R2_5P_bias=-14.73;DP=83;AF=0.5;AN=6;AC=3;CSQ=A|3_prime_UTR_variant|MODIFIER|HPS4|89781|Transcript|NM_022081.6|protein_coding|14/14||NM_022081.6:c.*1229C>T||3944|||||rs6147576||-1||SNV|EntrezGene||YES|||G|G|||||||0.3792|0.3222|0.2564|0.4359|0.4133|0.464|0.3182|0.3733|0.3884|0.4355|0.4804|0.4955|0.4|0.4274|0.502|0.5483|0.5216|0.484|0.4737|0.4789|0.4984|0.5483|gnomADg_EAS|uncertain_significance||1||||||||||||-14|38|-50|49|0.00|0.00|0.00|0.00|HPS4|||||||340985||Uncertain_significance|not_provided&Hermansky-Pudlak_syndrome|NC_000022.11:g.26452004G>A||single_nucleotide_variant|HPS4:89781|MedGen:C3661900&MONDO:MONDO:0019312&MedGen:C0079504&OMIM:PS203300&Orphanet:79430||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:8,10:0.556:18:5,5:3,5:47:85,0,47:50,9.0084e-05,49.693:0,34.77,37.78:7,1,5,5:4,4,6,4	0/1:9,9:0.5:18:4,5:5,4:45:82,0,47:47.328,0.00012374,50:0,34.77,37.78:4,5,8,1:7,2,6,3	0/1:12,12:0.5:24:6,6:6,6:47:85,0,47:50,8.6978e-05,50:0,34.77,37.78:9,3,8,4:5,7,8,4	A	3_prime_UTR_variant	MODIFIER	HPS4	89781	Transcript	NM_022081.6	protein_coding	14/14		c.*1229C>T		3944					rs6147576	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	0.3792	0.3222	0.2564	0.4359	0.4133	0.464	0.3182	0.3733	0.3884	0.4355	0.4804	0.4955	0.4	0.4274	0.502	0.5483	0.5216	0.484	0.4737	0.4789	0.4984	0.5483	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-14	38	-50	49	0	0	0	0	HPS4			NA				340985	NA	Uncertain_significance	not_provided&Hermansky-Pudlak_syndrome	NC_000022.11:g.26452004G>A		single_nucleotide_variant	HPS4:89781	MedGen:C3661900&MONDO:MONDO:0019312&MedGen:C0079504&OMIM:PS203300&Orphanet:79430		criteria_provided&_multiple_submitters&_no_conflicts		HPS4	Hermansky-Pudlak syndrome 4	AR	614073	Eye disorders	NBScreening	-12	Benign	BP4_Strong,BA1	rs6147576	chr22_26452004_G_A	Female	0/1	Heterozygous
chr22	29628627	.	CT	C	50	PASS	"FS=11.29;MQ=241.93;MQRankSum=-0.429;QD=1.72;ReadPosRankSum=0.363;SOR=3.258;FractionInformativeReads=0.88;R2_5P_bias=5.022;DP=82;AF=0.5;AN=6;AC=3;CSQ=-|intron_variant|MODIFIER|NF2|4771|Transcript|NM_000268.4|protein_coding||1/15|NM_000268.4:c.115-8101del|||||||rs5844863||1||deletion|EntrezGene||YES|||T|T|||||22||||||||||||0.644|0.5144|0.6926|0.6956|0.6725|0.6341|0.707|0.7284|0.7039|0.664|0.645|0.7284|gnomADg_MID|uncertain_significance||1||||||||||||30|49|24|26|0.02|0.00|0.00|0.00|NF2|||||||1050057||Uncertain_significance|Neurofibromatosis&_type_2|NC_000022.11:g.29628650del||Deletion|NF2:4771|MONDO:MONDO:0007039&MedGen:C0027832&OMIM:101000&Orphanet:637||no_assertion_criteria_provided|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,10:0.455:22:5,6:7,4:42:48,0,47:43.095,0.00025628,50:0,5,8.01:6,6,1,9:5,7,5,5	0/1:11,15:0.577:26:5,8:6,7:47:55,0,46:50,9.4226e-05,49.33:0,5,8.01:1,10,5,10:7,4,12,3	0/1:22,8:0.267:30:9,3:13,5:25:29,0,50:25.123,0.013393,53.013:0,4,7:9,13,1,7:14,8,4,4	-	intron_variant	MODIFIER	NF2	4771	Transcript	NM_000268.4	protein_coding		15-Jan	c.115-8101del							rs5844863	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			22	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.644	0.5144	0.6926	0.6956	0.6725	0.6341	0.707	0.7284	0.7039	0.664	0.645	0.7284	gnomADg_MID	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		30	49	24	26	0.02	0	0	0	NF2			NA				1050057	NA	Uncertain_significance	Neurofibromatosis&_type_2	NC_000022.11:g.29628650del		Deletion	NF2:4771	MONDO:MONDO:0007039&MedGen:C0027832&OMIM:101000&Orphanet:637		no_assertion_criteria_provided		NF2	Neurofibromatosis, type 2	AD	101000	Tumor predisposition syndromes	NBScreening	0	Uncertain_significance		rs5844863	chr22_29628627_CT_C	Female	0/1	Heterozygous
chr22	29696066	.	C	CT	49.21	PASS	"FS=0;MQ=249.04;MQRankSum=1.845;QD=1.99;ReadPosRankSum=-0.158;SOR=0.693;FractionInformativeReads=0.773;R2_5P_bias=-5.528;DP=81;AF=0.5;AN=6;AC=3;CSQ=T|3_prime_UTR_variant|MODIFIER|NF2|4771|Transcript|NM_000268.4|protein_coding|16/16||NM_000268.4:c.*1287dup||3418-3419|||||rs886057354||1||insertion|EntrezGene||YES|||||||||23||0.09648|0.1209|0.09938|0.09326|0.06715|0|0.08594|0.1025|0.09941|0.1133|0.08925|0.1027|0.1064|0.0487|0.08038|0.04286|0.01971|0.03684|0.1013|0.0587|0.09155|0.1209|gnomADe_AFR|uncertain_significance||1||||||||||||28|22|28|-27|0.00|0.00|0.00|0.00|NF2|||||||341104||Uncertain_significance|Neurofibromatosis&_type_2|NC_000022.11:g.29696089dup||Duplication|NF2:4771|MONDO:MONDO:0007039&MedGen:C0027832&OMIM:101000&Orphanet:637||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,5:0.294:17:6,3:6,2:43:49,0,47:43.744,0.00022677,50:0,5,8.01:7,5,3,2:7,5,3,2	0/1:13,10:0.435:23:6,7:7,3:48:53,0,50:49.207,7.3776e-05,53:0,4,7:8,5,7,3:7,6,4,6	0/1:12,7:0.368:19:4,3:8,4:43:49,0,47:43.609,0.00023272,50:0,5,8.01:6,6,1,6:4,8,3,4	T	3_prime_UTR_variant	MODIFIER	NF2	4771	Transcript	NM_000268.4	protein_coding	16/16		c.*1287dup		3418-3419					rs886057354	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			23	NA	0.09648	0.1209	0.09938	0.09326	0.06715	0	0.08594	0.1025	0.09941	0.1133	0.08925	0.1027	0.1064	0.0487	0.08038	0.04286	0.01971	0.03684	0.1013	0.0587	0.09155	0.1209	gnomADe_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		28	22	28	-27	0	0	0	0	NF2			NA				341104	NA	Uncertain_significance	Neurofibromatosis&_type_2	NC_000022.11:g.29696089dup		Duplication	NF2:4771	MONDO:MONDO:0007039&MedGen:C0027832&OMIM:101000&Orphanet:637		criteria_provided&_single_submitter		NF2	Neurofibromatosis, type 2	AD	101000	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs886057354	chr22_29696066_C_CT	Female	0/1	Heterozygous
chr22	42058489	.	GA	G	160.86	PASS	"FS=0;MQ=250;QD=4.26;SOR=1.302;FractionInformativeReads=0.9;DP=96;AF=1;AN=6;AC=6;CSQ=-|3_prime_UTR_variant|MODIFIER|NAGA|4668|Transcript|NM_000262.3|protein_coding|9/9||NM_000262.3:c.*1789del||3540|||||rs10713176||-1||deletion|EntrezGene||YES|||A|A||||||0.8966|||||||||||0.8871|0.7339|0.9956|0.9538|0.9497|0.9984|0.9304|0.9075|0.9373|0.9161|0.9897|0.9984|gnomADg_EAS|uncertain_significance&benign||1||||||||||||-4|9|-27|-30|0.00|0.00|0.00|0.00|NAGA|||||||341887||Uncertain_significance|Alpha-N-acetylgalactosaminidase_deficiency_type_1&Alpha-N-acetylgalactosaminidase_deficiency_type_2&not_provided|NC_000022.11:g.42058500del||Deletion|NAGA:4668|MONDO:MONDO:0012221&MedGen:C1836544&OMIM:609241&Orphanet:3137&Orphanet:79279&Orphanet:79281&MONDO:MONDO:0012222&MedGen:C1836522&OMIM:609242&Orphanet:3137&Orphanet:79280&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,27:1:27:0,11:0,16:78:143,81,0:127.91,77.915,0:0,12,15:0,0,17,10:0,0,13,14	1/1:0,21:1:21:0,12:0,9:60:125,63,0:109.9,59.904,4.4006e-06:0,12,15:0,0,6,15:0,0,13,8	1/1:0,38:1:38:0,25:0,13:111:176,114,0:160.86,110.86,0:0,12,15:0,0,16,22:0,0,19,19	-	3_prime_UTR_variant	MODIFIER	NAGA	4668	Transcript	NM_000262.3	protein_coding	09-Sep		c.*1789del		3540					rs10713176	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.8966	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.8871	0.7339	0.9956	0.9538	0.9497	0.9984	0.9304	0.9075	0.9373	0.9161	0.9897	0.9984	gnomADg_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-4	9	-27	-30	0	0	0	0	NAGA			NA				341887	NA	Uncertain_significance	Alpha-N-acetylgalactosaminidase_deficiency_type_1&Alpha-N-acetylgalactosaminidase_deficiency_type_2&not_provided	NC_000022.11:g.42058500del		Deletion	NAGA:4668	MONDO:MONDO:0012221&MedGen:C1836544&OMIM:609241&Orphanet:3137&Orphanet:79279&Orphanet:79281&MONDO:MONDO:0012222&MedGen:C1836522&OMIM:609242&Orphanet:3137&Orphanet:79280&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		NAGA	Alpha-N-acetylgalactosaminidase deficiency type 1	AR	609241	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs10713176	chr22_42058489_GA_G	Female	01-Jan	Homozygous
chr22	42058489	.	GA	G	160.86	PASS	"FS=0;MQ=250;QD=4.26;SOR=1.302;FractionInformativeReads=0.9;DP=96;AF=1;AN=6;AC=6;CSQ=-|3_prime_UTR_variant|MODIFIER|NAGA|4668|Transcript|NM_000262.3|protein_coding|9/9||NM_000262.3:c.*1789del||3540|||||rs10713176||-1||deletion|EntrezGene||YES|||A|A||||||0.8966|||||||||||0.8871|0.7339|0.9956|0.9538|0.9497|0.9984|0.9304|0.9075|0.9373|0.9161|0.9897|0.9984|gnomADg_EAS|uncertain_significance&benign||1||||||||||||-4|9|-27|-30|0.00|0.00|0.00|0.00|NAGA|||||||341887||Uncertain_significance|Alpha-N-acetylgalactosaminidase_deficiency_type_1&Alpha-N-acetylgalactosaminidase_deficiency_type_2&not_provided|NC_000022.11:g.42058500del||Deletion|NAGA:4668|MONDO:MONDO:0012221&MedGen:C1836544&OMIM:609241&Orphanet:3137&Orphanet:79279&Orphanet:79281&MONDO:MONDO:0012222&MedGen:C1836522&OMIM:609242&Orphanet:3137&Orphanet:79280&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,27:1:27:0,11:0,16:78:143,81,0:127.91,77.915,0:0,12,15:0,0,17,10:0,0,13,14	1/1:0,21:1:21:0,12:0,9:60:125,63,0:109.9,59.904,4.4006e-06:0,12,15:0,0,6,15:0,0,13,8	1/1:0,38:1:38:0,25:0,13:111:176,114,0:160.86,110.86,0:0,12,15:0,0,16,22:0,0,19,19	-	3_prime_UTR_variant	MODIFIER	NAGA	4668	Transcript	NM_000262.3	protein_coding	09-Sep		c.*1789del		3540					rs10713176	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.8966	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.8871	0.7339	0.9956	0.9538	0.9497	0.9984	0.9304	0.9075	0.9373	0.9161	0.9897	0.9984	gnomADg_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-4	9	-27	-30	0	0	0	0	NAGA			NA				341887	NA	Uncertain_significance	Alpha-N-acetylgalactosaminidase_deficiency_type_1&Alpha-N-acetylgalactosaminidase_deficiency_type_2&not_provided	NC_000022.11:g.42058500del		Deletion	NAGA:4668	MONDO:MONDO:0012221&MedGen:C1836544&OMIM:609241&Orphanet:3137&Orphanet:79279&Orphanet:79281&MONDO:MONDO:0012222&MedGen:C1836522&OMIM:609242&Orphanet:3137&Orphanet:79280&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		NAGA	Alpha-N-acetylgalactosaminidase deficiency type 2	AR	609242	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs10713176	chr22_42058489_GA_G	Female	01-Jan	Homozygous
chr22	42068820	.	G	GCTGGAATTAGCAAAACTAACAC	109.15	PASS	"FS=0;MQ=249.65;QD=4.37;SOR=0.784;FractionInformativeReads=0.84;MQRankSum=2.839;ReadPosRankSum=-0.869;R2_5P_bias=-2.54;DP=84;AF=0.5;AN=6;AC=4;CSQ=CTGGAATTAGCAAAACTAACAC|intron_variant|MODIFIER|NAGA|4668|Transcript|NM_000262.3|protein_coding||1/8|NM_000262.3:c.17-268_17-247dup|||||||rs140490511||-1||insertion|EntrezGene||YES||||||||||0.7620|||||||||||0.7258|0.8579|0.7829|0.7022|0.6543|0.8473|0.6126|0.5646|0.6718|0.6891|0.6199|0.888|AFR||||||||||||||||||||||||||||||3041766||Uncertain_significance|NAGA-related_disorder|NC_000022.11:g.42068823_42068844dup||Duplication|NAGA:4668|MedGen:CN378768||no_assertion_criteria_provided|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,21:1:21:0,12:0,9:59:141,62,0:109.15,59.148,5.1772e-06:0,29,32:0,0,11,10:0,0,8,13	0/1:11,13:0.542:24:5,6:6,7:48:79,0,50:50,6.6786e-05,52.681:0,29,32:7,4,4,9:5,6,7,6	0/1:14,16:0.533:30:10,8:4,8:48:79,0,50:50,6.6527e-05,52.763:0,29,32:6,8,8,8:6,8,12,4	CTGGAATTAGCAAAACTAACAC	intron_variant	MODIFIER	NAGA	4668	Transcript	NM_000262.3	protein_coding		08-Jan	c.17-268_17-247dup							rs140490511	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.7258	0.8579	0.7829	0.7022	0.6543	0.8473	0.6126	0.5646	0.6718	0.6891	0.6199	0.888	AFR				NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				3041766	NA	Uncertain_significance	NAGA-related_disorder	NC_000022.11:g.42068823_42068844dup		Duplication	NAGA:4668	MedGen:CN378768		no_assertion_criteria_provided		NAGA	Alpha-N-acetylgalactosaminidase deficiency type 1	AR	609241	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs140490511	chr22_42068820_G_GCTGGAATTAGCAAAACTAACAC	Female	01-Jan	Homozygous
chr22	42068820	.	G	GCTGGAATTAGCAAAACTAACAC	109.15	PASS	"FS=0;MQ=249.65;QD=4.37;SOR=0.784;FractionInformativeReads=0.84;MQRankSum=2.839;ReadPosRankSum=-0.869;R2_5P_bias=-2.54;DP=84;AF=0.5;AN=6;AC=4;CSQ=CTGGAATTAGCAAAACTAACAC|intron_variant|MODIFIER|NAGA|4668|Transcript|NM_000262.3|protein_coding||1/8|NM_000262.3:c.17-268_17-247dup|||||||rs140490511||-1||insertion|EntrezGene||YES||||||||||0.7620|||||||||||0.7258|0.8579|0.7829|0.7022|0.6543|0.8473|0.6126|0.5646|0.6718|0.6891|0.6199|0.888|AFR||||||||||||||||||||||||||||||3041766||Uncertain_significance|NAGA-related_disorder|NC_000022.11:g.42068823_42068844dup||Duplication|NAGA:4668|MedGen:CN378768||no_assertion_criteria_provided|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,21:1:21:0,12:0,9:59:141,62,0:109.15,59.148,5.1772e-06:0,29,32:0,0,11,10:0,0,8,13	0/1:11,13:0.542:24:5,6:6,7:48:79,0,50:50,6.6786e-05,52.681:0,29,32:7,4,4,9:5,6,7,6	0/1:14,16:0.533:30:10,8:4,8:48:79,0,50:50,6.6527e-05,52.763:0,29,32:6,8,8,8:6,8,12,4	CTGGAATTAGCAAAACTAACAC	intron_variant	MODIFIER	NAGA	4668	Transcript	NM_000262.3	protein_coding		08-Jan	c.17-268_17-247dup							rs140490511	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	0.762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.7258	0.8579	0.7829	0.7022	0.6543	0.8473	0.6126	0.5646	0.6718	0.6891	0.6199	0.888	AFR				NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				3041766	NA	Uncertain_significance	NAGA-related_disorder	NC_000022.11:g.42068823_42068844dup		Duplication	NAGA:4668	MedGen:CN378768		no_assertion_criteria_provided		NAGA	Alpha-N-acetylgalactosaminidase deficiency type 2	AR	609242	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs140490511	chr22_42068820_G_GCTGGAATTAGCAAAACTAACAC	Female	01-Jan	Homozygous
chr22	50579775	.	T	C	50	PASS	"FS=1.8;MQ=250;MQRankSum=3.932;QD=2;ReadPosRankSum=0.495;SOR=0.298;FractionInformativeReads=1;R2_5P_bias=-6.077;DP=25;AF=0.5;AN=2;AC=1;CSQ=C|missense_variant|MODERATE|CHKB|1120|Transcript|NM_005198.5|protein_coding|9/11||NM_005198.5:c.983A>G|NP_005189.2:p.Gln328Arg|1051|983|328|Q/R|cAa/cGa|rs141381896||-1||SNV|EntrezGene||YES|||T|T|||tolerated(0.34)|benign(0)||0.0020|0.00485|0.0009558|0.003086|0.00264|7.557e-05|0.001388|0.008842|0.005266|0.005448|0.006237|0.003349|0.0008424|0|0.002483|0.002595|0.0001928|0.001224|0.02041|0.005365|0.005198|0.006628|0.02041|gnomADg_MID|benign/likely_benign&conflicting_interpretations_of_pathogenicity&likely_benign||1||||T|0.00094|-0.63138|T|0.07171|-0.676959|0.11227|0.042|27|-3|-40|16|0.04|0.00|0.04|0.01|CHKB|likely_benign|hg38|0.0599|Q328R|ENST00000406938.2|Q9Y259|128730||Conflicting_classifications_of_pathogenicity|not_specified&not_provided&Megaconial_type_congenital_muscular_dystrophy|NC_000022.11:g.50579775T>C||single_nucleotide_variant|CHKB:1120&CHKB-CPT1B:386593|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0011246&MedGen:C1865233&OMIM:602541&Orphanet:280671|Uncertain_significance(1)&Benign(2)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:8,17:0.68:25:5,7:3,10:44:85,0,43:50,0.00015765,45.804:0,34.77,37.77:6,2,10,7:5,3,8,9	./.:.:.:.:.:.:.:.:.:.:.:.	C	missense_variant	MODERATE	CHKB	1120	Transcript	NM_005198.5	protein_coding	11-Sep		c.983A>G	p.Gln328Arg	1051	983	328	Q/R	cAa/cGa	rs141381896	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	tolerated(0.34)	benign(0)	NA	0.002	0.00485	0.0009558	0.003086	0.00264	7.557e-05	0.001388	0.008842	0.005266	0.005448	0.006237	0.003349	0.0008424	0	0.002483	0.002595	0.0001928	0.001224	0.02041	0.005365	0.005198	0.006628	0.02041	gnomADg_MID	benign/likely_benign&conflicting_interpretations_of_pathogenicity&likely_benign		1	NA	NA	NA	T	0.00094	-0.63138	T	0.07171	-0.676959	0.11227	0.042	27	-3	-40	16	0.04	0	0.04	0.01	CHKB	likely_benign	hg38	0.0599	Q328R	ENST00000406938.2	Q9Y259	128730	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided&Megaconial_type_congenital_muscular_dystrophy	NC_000022.11:g.50579775T>C		single_nucleotide_variant	CHKB:1120&CHKB-CPT1B:386593	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0011246&MedGen:C1865233&OMIM:602541&Orphanet:280671	Uncertain_significance(1)&Benign(2)&Likely_benign(3)	criteria_provided&_conflicting_classifications		CHKB	Megaconial type congenital muscular dystrophy	AR	602541	Neuromuscular and musculoskelettal disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs141381896	chr22_50579775_T_C	Female	./.	Other
chr2	21009256	.	G	A	50	PASS	"FS=5.123;MQ=250;MQRankSum=5.078;QD=1.39;ReadPosRankSum=2.117;SOR=1.721;FractionInformativeReads=1;R2_5P_bias=-11.48;DP=112;AF=0.5;AN=6;AC=3;CSQ=A|synonymous_variant|LOW|APOB|338|Transcript|NM_000384.3|protein_coding|26/29||NM_000384.3:c.7612C>T|NP_000375.3:p.Leu2538%3D|7740|7612|2538|L|Ctg/Ttg|rs72653093||-1||SNV|EntrezGene||YES|||G|G||||||0.0004|0.001543|0.0001494|0.0006486|0.0031|0|0.0006741|0.001041|0.001791|0.00159|0.0001159|0.001031|0.0002886|0|0.0007848|0.004323|0|0.001036|0|0.001514|0.00189|0|0.004323|gnomADg_ASJ|uncertain_significance&likely_benign&conflicting_interpretations_of_pathogenicity&benign/likely_benign&benign||1||||||||||||-12|-2|44|-2|0.00|0.00|0.00|0.00|APOB|||||||255988||Conflicting_classifications_of_pathogenicity|Hypercholesterolemia&_familial&_1&Familial_hypercholesterolemia&Cardiovascular_phenotype&Familial_hypobetalipoproteinemia_1&Hypercholesterolemia&_autosomal_dominant&_type_B&not_provided&not_specified|NC_000002.12:g.21009256G>A||single_nucleotide_variant|APOB:338|MONDO:MONDO:0007750&MedGen:C0745103&OMIM:143890&Orphanet:391665&MONDO:MONDO:0005439&MedGen:C0020445&OMIM:PS143890&MedGen:CN230736&MONDO:MONDO:0014252&MedGen:C4551990&OMIM:615558&MONDO:MONDO:0007751&MedGen:C1704417&OMIM:144010&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(3)&Benign(3)&Likely_benign(8)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,20:0.556:36:8,15:8,5:48:85,0,49:50,7.0152e-05,52.122:0,34.77,37.77:8,8,14,6:6,10,13,7	0/1:20,20:0.5:40:14,11:6,9:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:10,10,12,8:10,10,13,7	0/1:23,13:0.361:36:7,5:16,8:43:79,0,50:43.892,0.00019907,53:0,34.77,37.77:14,9,11,2:10,13,5,8	A	synonymous_variant	LOW	APOB	338	Transcript	NM_000384.3	protein_coding	26/29		c.7612C>T	p.Leu2538%3D	7740	7612	2538	L	Ctg/Ttg	rs72653093	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	4,00E-04	0.001543	0.0001494	0.0006486	0.0031	0	0.0006741	0.001041	0.001791	0.00159	0.0001159	0.001031	0.0002886	0	0.0007848	0.004323	0	0.001036	0	0.001514	0.00189	0	0.004323	gnomADg_ASJ	uncertain_significance&likely_benign&conflicting_interpretations_of_pathogenicity&benign/likely_benign&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-12	-2	44	-2	0	0	0	0	APOB			NA				255988	NA	Conflicting_classifications_of_pathogenicity	Hypercholesterolemia&_familial&_1&Familial_hypercholesterolemia&Cardiovascular_phenotype&Familial_hypobetalipoproteinemia_1&Hypercholesterolemia&_autosomal_dominant&_type_B&not_provided&not_specified	NC_000002.12:g.21009256G>A		single_nucleotide_variant	APOB:338	MONDO:MONDO:0007750&MedGen:C0745103&OMIM:143890&Orphanet:391665&MONDO:MONDO:0005439&MedGen:C0020445&OMIM:PS143890&MedGen:CN230736&MONDO:MONDO:0014252&MedGen:C4551990&OMIM:615558&MONDO:MONDO:0007751&MedGen:C1704417&OMIM:144010&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(3)&Benign(3)&Likely_benign(8)	criteria_provided&_conflicting_classifications		APOB	Hypercholesterolemia, autosomal dominant, type B	AD	144010	Inherited disorders of metabolism	NBScreening	-6	Likely_benign	BP4_Strong,BP6,BP7	rs72653093	chr2_21009256_G_A	Female	0/1	Heterozygous
chr2	21009256	.	G	A	50	PASS	"FS=5.123;MQ=250;MQRankSum=5.078;QD=1.39;ReadPosRankSum=2.117;SOR=1.721;FractionInformativeReads=1;R2_5P_bias=-11.48;DP=112;AF=0.5;AN=6;AC=3;CSQ=A|synonymous_variant|LOW|APOB|338|Transcript|NM_000384.3|protein_coding|26/29||NM_000384.3:c.7612C>T|NP_000375.3:p.Leu2538%3D|7740|7612|2538|L|Ctg/Ttg|rs72653093||-1||SNV|EntrezGene||YES|||G|G||||||0.0004|0.001543|0.0001494|0.0006486|0.0031|0|0.0006741|0.001041|0.001791|0.00159|0.0001159|0.001031|0.0002886|0|0.0007848|0.004323|0|0.001036|0|0.001514|0.00189|0|0.004323|gnomADg_ASJ|uncertain_significance&likely_benign&conflicting_interpretations_of_pathogenicity&benign/likely_benign&benign||1||||||||||||-12|-2|44|-2|0.00|0.00|0.00|0.00|APOB|||||||255988||Conflicting_classifications_of_pathogenicity|Hypercholesterolemia&_familial&_1&Familial_hypercholesterolemia&Cardiovascular_phenotype&Familial_hypobetalipoproteinemia_1&Hypercholesterolemia&_autosomal_dominant&_type_B&not_provided&not_specified|NC_000002.12:g.21009256G>A||single_nucleotide_variant|APOB:338|MONDO:MONDO:0007750&MedGen:C0745103&OMIM:143890&Orphanet:391665&MONDO:MONDO:0005439&MedGen:C0020445&OMIM:PS143890&MedGen:CN230736&MONDO:MONDO:0014252&MedGen:C4551990&OMIM:615558&MONDO:MONDO:0007751&MedGen:C1704417&OMIM:144010&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(3)&Benign(3)&Likely_benign(8)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,20:0.556:36:8,15:8,5:48:85,0,49:50,7.0152e-05,52.122:0,34.77,37.77:8,8,14,6:6,10,13,7	0/1:20,20:0.5:40:14,11:6,9:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:10,10,12,8:10,10,13,7	0/1:23,13:0.361:36:7,5:16,8:43:79,0,50:43.892,0.00019907,53:0,34.77,37.77:14,9,11,2:10,13,5,8	A	synonymous_variant	LOW	APOB	338	Transcript	NM_000384.3	protein_coding	26/29		c.7612C>T	p.Leu2538%3D	7740	7612	2538	L	Ctg/Ttg	rs72653093	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	4,00E-04	0.001543	0.0001494	0.0006486	0.0031	0	0.0006741	0.001041	0.001791	0.00159	0.0001159	0.001031	0.0002886	0	0.0007848	0.004323	0	0.001036	0	0.001514	0.00189	0	0.004323	gnomADg_ASJ	uncertain_significance&likely_benign&conflicting_interpretations_of_pathogenicity&benign/likely_benign&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-12	-2	44	-2	0	0	0	0	APOB			NA				255988	NA	Conflicting_classifications_of_pathogenicity	Hypercholesterolemia&_familial&_1&Familial_hypercholesterolemia&Cardiovascular_phenotype&Familial_hypobetalipoproteinemia_1&Hypercholesterolemia&_autosomal_dominant&_type_B&not_provided&not_specified	NC_000002.12:g.21009256G>A		single_nucleotide_variant	APOB:338	MONDO:MONDO:0007750&MedGen:C0745103&OMIM:143890&Orphanet:391665&MONDO:MONDO:0005439&MedGen:C0020445&OMIM:PS143890&MedGen:CN230736&MONDO:MONDO:0014252&MedGen:C4551990&OMIM:615558&MONDO:MONDO:0007751&MedGen:C1704417&OMIM:144010&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(3)&Benign(3)&Likely_benign(8)	criteria_provided&_conflicting_classifications		APOB	Apolipoprotein B deficiency	AR	614028	Inherited disorders of metabolism	NBScreening	-6	Likely_benign	BP4_Strong,BP6,BP7	rs72653093	chr2_21009256_G_A	Female	0/1	Heterozygous
chr2	21009256	.	G	A	50	PASS	"FS=5.123;MQ=250;MQRankSum=5.078;QD=1.39;ReadPosRankSum=2.117;SOR=1.721;FractionInformativeReads=1;R2_5P_bias=-11.48;DP=112;AF=0.5;AN=6;AC=3;CSQ=A|synonymous_variant|LOW|APOB|338|Transcript|NM_000384.3|protein_coding|26/29||NM_000384.3:c.7612C>T|NP_000375.3:p.Leu2538%3D|7740|7612|2538|L|Ctg/Ttg|rs72653093||-1||SNV|EntrezGene||YES|||G|G||||||0.0004|0.001543|0.0001494|0.0006486|0.0031|0|0.0006741|0.001041|0.001791|0.00159|0.0001159|0.001031|0.0002886|0|0.0007848|0.004323|0|0.001036|0|0.001514|0.00189|0|0.004323|gnomADg_ASJ|uncertain_significance&likely_benign&conflicting_interpretations_of_pathogenicity&benign/likely_benign&benign||1||||||||||||-12|-2|44|-2|0.00|0.00|0.00|0.00|APOB|||||||255988||Conflicting_classifications_of_pathogenicity|Hypercholesterolemia&_familial&_1&Familial_hypercholesterolemia&Cardiovascular_phenotype&Familial_hypobetalipoproteinemia_1&Hypercholesterolemia&_autosomal_dominant&_type_B&not_provided&not_specified|NC_000002.12:g.21009256G>A||single_nucleotide_variant|APOB:338|MONDO:MONDO:0007750&MedGen:C0745103&OMIM:143890&Orphanet:391665&MONDO:MONDO:0005439&MedGen:C0020445&OMIM:PS143890&MedGen:CN230736&MONDO:MONDO:0014252&MedGen:C4551990&OMIM:615558&MONDO:MONDO:0007751&MedGen:C1704417&OMIM:144010&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(3)&Benign(3)&Likely_benign(8)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,20:0.556:36:8,15:8,5:48:85,0,49:50,7.0152e-05,52.122:0,34.77,37.77:8,8,14,6:6,10,13,7	0/1:20,20:0.5:40:14,11:6,9:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:10,10,12,8:10,10,13,7	0/1:23,13:0.361:36:7,5:16,8:43:79,0,50:43.892,0.00019907,53:0,34.77,37.77:14,9,11,2:10,13,5,8	A	synonymous_variant	LOW	APOB	338	Transcript	NM_000384.3	protein_coding	26/29		c.7612C>T	p.Leu2538%3D	7740	7612	2538	L	Ctg/Ttg	rs72653093	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	4,00E-04	0.001543	0.0001494	0.0006486	0.0031	0	0.0006741	0.001041	0.001791	0.00159	0.0001159	0.001031	0.0002886	0	0.0007848	0.004323	0	0.001036	0	0.001514	0.00189	0	0.004323	gnomADg_ASJ	uncertain_significance&likely_benign&conflicting_interpretations_of_pathogenicity&benign/likely_benign&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-12	-2	44	-2	0	0	0	0	APOB			NA				255988	NA	Conflicting_classifications_of_pathogenicity	Hypercholesterolemia&_familial&_1&Familial_hypercholesterolemia&Cardiovascular_phenotype&Familial_hypobetalipoproteinemia_1&Hypercholesterolemia&_autosomal_dominant&_type_B&not_provided&not_specified	NC_000002.12:g.21009256G>A		single_nucleotide_variant	APOB:338	MONDO:MONDO:0007750&MedGen:C0745103&OMIM:143890&Orphanet:391665&MONDO:MONDO:0005439&MedGen:C0020445&OMIM:PS143890&MedGen:CN230736&MONDO:MONDO:0014252&MedGen:C4551990&OMIM:615558&MONDO:MONDO:0007751&MedGen:C1704417&OMIM:144010&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(3)&Benign(3)&Likely_benign(8)	criteria_provided&_conflicting_classifications		APOB	Hypercholesterolemia, familial, 2 autosomal recessive	AR	NA	Inherited disorders of metabolism	NBScreening	-6	Likely_benign	BP4_Strong,BP6,BP7	rs72653093	chr2_21009256_G_A	Female	0/1	Heterozygous
chr2	44320435	.	G	A	50	PASS	"FS=0;MQ=249.38;MQRankSum=4.347;QD=1.17;ReadPosRankSum=3.765;SOR=0.558;FractionInformativeReads=1;R2_5P_bias=-11.017;DP=122;AF=0.5;AN=6;AC=3;CSQ=A|missense_variant|MODERATE|SLC3A1|6519|Transcript|NM_000341.4|protein_coding|10/10||NM_000341.4:c.1854G>A|NP_000332.2:p.Met618Ile|1910|1854|618|M/I|atG/atA|rs698761&COSV53215689||1||SNV|EntrezGene||YES|||G|G|||tolerated(0.31)|benign(0)||0.4609|0.6599|0.2617|0.5192|0.6836|0.3574|0.5978|0.6804|0.6922|0.6241|0.6645|0.5342|0.2722|0.7697|0.5563|0.6862|0.314|0.5823|0.6327|0.678|0.5629|0.6495|0.7697|gnomADg_AMI|benign&conflicting_interpretations_of_pathogenicity|0&1|1&1||||T|0.00476|-0.514041|T|0.37200|-0.367341|0.40340|0.154&0.154&0.154|3|-31|-3|8|0.00|0.00|0.00|0.00|SLC3A1|likely_benign|hg38|0.1655|M618I|ENST00000260649.11|Q07837|336214||Conflicting_classifications_of_pathogenicity|not_provided&Cystinuria|NC_000002.12:g.44320435G>A||single_nucleotide_variant|SLC3A1:6519&PREPL:9581|MedGen:C3661900&Human_Phenotype_Ontology:HP:0003131&MONDO:MONDO:0009067&MedGen:C0010691&OMIM:220100&Orphanet:214|Pathogenic(1)&Benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:23,19:0.452:42:10,10:13,9:48:84,0,50:49.158,7.4552e-05,53:0,34.77,37.77:13,10,10,9:8,15,11,8	0/1:19,19:0.5:38:9,8:10,11:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:13,6,10,9:9,10,13,6	0/1:15,27:0.643:42:7,13:8,14:42:85,0,39:50,0.00029019,42.453:0,34.77,37.78:11,4,23,4:5,10,15,12	A	missense_variant	MODERATE	SLC3A1	6519	Transcript	NM_000341.4	protein_coding	10-Oct		c.1854G>A	p.Met618Ile	1910	1854	618	M/I	atG/atA	rs698761&COSV53215689	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	tolerated(0.31)	benign(0)	NA	0.4609	0.6599	0.2617	0.5192	0.6836	0.3574	0.5978	0.6804	0.6922	0.6241	0.6645	0.5342	0.2722	0.7697	0.5563	0.6862	0.314	0.5823	0.6327	0.678	0.5629	0.6495	0.7697	gnomADg_AMI	benign&conflicting_interpretations_of_pathogenicity	0&1	1&1	NA	NA	NA	T	0.00476	-0.514041	T	0.372	-0.367341	0.4034	0.154&0.154&0.154	3	-31	-3	8	0	0	0	0	SLC3A1	likely_benign	hg38	0.1655	M618I	ENST00000260649.11	Q07837	336214	NA	Conflicting_classifications_of_pathogenicity	not_provided&Cystinuria	NC_000002.12:g.44320435G>A		single_nucleotide_variant	SLC3A1:6519&PREPL:9581	MedGen:C3661900&Human_Phenotype_Ontology:HP:0003131&MONDO:MONDO:0009067&MedGen:C0010691&OMIM:220100&Orphanet:214	Pathogenic(1)&Benign(5)	criteria_provided&_conflicting_classifications		SLC3A1	Cystinuria	Multiple and/or complex pattern	220100	Inherited disorders of metabolism	NBScreening	-11	Benign	PP2,BP4_Strong,BA1	rs698761	chr2_44320435_G_A	Female	0/1	Heterozygous
chr2	47029272	.	G	A	50	PASS	"FS=1.451;MQ=250;MQRankSum=4.652;QD=1.56;ReadPosRankSum=2.744;SOR=0.694;FractionInformativeReads=1;R2_5P_bias=15.545;DP=65;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|TTC7A|57217|Transcript|NM_020458.4|protein_coding|15/20||NM_020458.4:c.1690G>A|NP_065191.2:p.Asp564Asn|2008|1690|564|D/N|Gat/Aat|COSV99766112||1||SNV|EntrezGene||YES|||G|G|||deleterious(0)|probably_damaging(1)|||||||||||||||||||||||||||1|1||||T|0.40999|-0.0720547|T|0.40201|-0.341278|0.55201|0.245&0.245&0.245|48|-48|-10|26|0.00|0.00|0.02|0.00|TTC7A|likely_benign|hg38|0.1416|D564N|ENST00000319190.11|Q9ULT0|2105542||Uncertain_significance|Multiple_gastrointestinal_atresias|NC_000002.12:g.47029272G>A||single_nucleotide_variant|TTC7A:57217|MONDO:MONDO:0009465&MedGen:C0220744&Orphanet:2300||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,20:0.625:32:8,8:4,12:46:85,0,46:50,0.00010329,48.609:0,34.77,37.77:5,7,11,9:5,7,11,9	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,17:0.515:33:9,7:7,10:48:85,0,50:50,6.5492e-05,52.933:0,34.77,37.77:5,11,9,8:8,8,9,8	A	missense_variant	MODERATE	TTC7A	57217	Transcript	NM_020458.4	protein_coding	15/20		c.1690G>A	p.Asp564Asn	2008	1690	564	D/N	Gat/Aat	COSV99766112	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0)	probably_damaging(1)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA			1	1	NA	NA	NA	T	0.40999	-0.0720547	T	0.40201	-0.341278	0.55201	0.245&0.245&0.245	48	-48	-10	26	0	0	0.02	0	TTC7A	likely_benign	hg38	0.1416	D564N	ENST00000319190.11	Q9ULT0	2105542	NA	Uncertain_significance	Multiple_gastrointestinal_atresias	NC_000002.12:g.47029272G>A		single_nucleotide_variant	TTC7A:57217	MONDO:MONDO:0009465&MedGen:C0220744&Orphanet:2300		criteria_provided&_single_submitter		TTC7A	Gastrointestinal defects and immunodeficiency syndrome 1	AR	243150	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	2	Uncertain_significance	PM2		chr2_47029272_G_A	Female	0/1	Heterozygous
chr2	47414420	.	TA	T	101.89	PASS	"FS=0;MQ=249.16;QD=4.06;SOR=1.022;FractionInformativeReads=0.76;MQRankSum=0.964;ReadPosRankSum=0.385;R2_5P_bias=0;DP=69;AF=1;AN=6;AC=6;CSQ=-|splice_donor_region_variant&intron_variant|LOW|MSH2|4436|Transcript|NM_000251.3|protein_coding||5/15|NM_000251.3:c.942+29del|||||||rs11309117&COSV51881499&CS941511||1||deletion|EntrezGene||YES|||A|A|||||26||0.1865|0.121|0.1068|0.1333|0.1303|0.1148|0.1717|0.1988|0.1738|0.1344|0.5231|0.3781|0.4823|0.6217|0.604|0.605|0.5934|0.5714|0.5849|0.569|0.5434|0.6217|gnomADg_AMR||0&1&1|1&1&1||||||||||||-25|-50|-3|1|0.00|0.00|0.00|0.00|MSH2|||||||374958||Conflicting_classifications_of_pathogenicity|Lynch_syndrome_1&Hereditary_nonpolyposis_colorectal_neoplasms&not_specified&Breast_and/or_ovarian_cancer&Hereditary_cancer-predisposing_syndrome&not_provided&Mismatch_repair_cancer_syndrome_1|NC_000002.12:g.47414447del||Deletion|MSH2:4436|MONDO:MONDO:0007356&MedGen:C2936783&OMIM:120435&Orphanet:144&MeSH:D003123&MedGen:C0009405&MedGen:CN169374&MedGen:CN221562&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:C3661900&MONDO:MONDO:0010159&MedGen:C5399763&OMIM:276300&Orphanet:252202|Uncertain_significance(1)&Benign(6)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,19:1:19:0,6:0,13:51:108,54,0:101.39,51.388,3.1581e-05:0,4,7:0,0,11,8:0,0,10,9	1/1:0,19:1:19:0,8:0,11:52:109,55,0:101.89,51.895,2.7957e-05:0,4,7:0,0,17,2:0,0,10,9	1/1:1,17:0.944:18:1,8:0,9:32:89,35,0:82.069,32.069,0.0026979:0,4,7:1,0,15,2:1,0,8,9	-	splice_donor_region_variant&intron_variant	LOW	MSH2	4436	Transcript	NM_000251.3	protein_coding		15-May	c.942+29del							rs11309117&COSV51881499&CS941511	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			26	NA	0.1865	0.121	0.1068	0.1333	0.1303	0.1148	0.1717	0.1988	0.1738	0.1344	0.5231	0.3781	0.4823	0.6217	0.604	0.605	0.5934	0.5714	0.5849	0.569	0.5434	0.6217	gnomADg_AMR		0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-25	-50	-3	1	0	0	0	0	MSH2			NA				374958	NA	Conflicting_classifications_of_pathogenicity	Lynch_syndrome_1&Hereditary_nonpolyposis_colorectal_neoplasms&not_specified&Breast_and/or_ovarian_cancer&Hereditary_cancer-predisposing_syndrome&not_provided&Mismatch_repair_cancer_syndrome_1	NC_000002.12:g.47414447del		Deletion	MSH2:4436	MONDO:MONDO:0007356&MedGen:C2936783&OMIM:120435&Orphanet:144&MeSH:D003123&MedGen:C0009405&MedGen:CN169374&MedGen:CN221562&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:C3661900&MONDO:MONDO:0010159&MedGen:C5399763&OMIM:276300&Orphanet:252202	Uncertain_significance(1)&Benign(6)&Likely_benign(1)	criteria_provided&_conflicting_classifications		MSH2	Lynch syndrome 1	AD	120435	Tumor predisposition syndromes	NBScreening	-5	Likely_benign	BP6,BS2	rs11309117	chr2_47414420_TA_T	Female	01-Jan	Homozygous
chr2	47414420	.	TA	T	101.89	PASS	"FS=0;MQ=249.16;QD=4.06;SOR=1.022;FractionInformativeReads=0.76;MQRankSum=0.964;ReadPosRankSum=0.385;R2_5P_bias=0;DP=69;AF=1;AN=6;AC=6;CSQ=-|splice_donor_region_variant&intron_variant|LOW|MSH2|4436|Transcript|NM_000251.3|protein_coding||5/15|NM_000251.3:c.942+29del|||||||rs11309117&COSV51881499&CS941511||1||deletion|EntrezGene||YES|||A|A|||||26||0.1865|0.121|0.1068|0.1333|0.1303|0.1148|0.1717|0.1988|0.1738|0.1344|0.5231|0.3781|0.4823|0.6217|0.604|0.605|0.5934|0.5714|0.5849|0.569|0.5434|0.6217|gnomADg_AMR||0&1&1|1&1&1||||||||||||-25|-50|-3|1|0.00|0.00|0.00|0.00|MSH2|||||||374958||Conflicting_classifications_of_pathogenicity|Lynch_syndrome_1&Hereditary_nonpolyposis_colorectal_neoplasms&not_specified&Breast_and/or_ovarian_cancer&Hereditary_cancer-predisposing_syndrome&not_provided&Mismatch_repair_cancer_syndrome_1|NC_000002.12:g.47414447del||Deletion|MSH2:4436|MONDO:MONDO:0007356&MedGen:C2936783&OMIM:120435&Orphanet:144&MeSH:D003123&MedGen:C0009405&MedGen:CN169374&MedGen:CN221562&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:C3661900&MONDO:MONDO:0010159&MedGen:C5399763&OMIM:276300&Orphanet:252202|Uncertain_significance(1)&Benign(6)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,19:1:19:0,6:0,13:51:108,54,0:101.39,51.388,3.1581e-05:0,4,7:0,0,11,8:0,0,10,9	1/1:0,19:1:19:0,8:0,11:52:109,55,0:101.89,51.895,2.7957e-05:0,4,7:0,0,17,2:0,0,10,9	1/1:1,17:0.944:18:1,8:0,9:32:89,35,0:82.069,32.069,0.0026979:0,4,7:1,0,15,2:1,0,8,9	-	splice_donor_region_variant&intron_variant	LOW	MSH2	4436	Transcript	NM_000251.3	protein_coding		15-May	c.942+29del							rs11309117&COSV51881499&CS941511	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			26	NA	0.1865	0.121	0.1068	0.1333	0.1303	0.1148	0.1717	0.1988	0.1738	0.1344	0.5231	0.3781	0.4823	0.6217	0.604	0.605	0.5934	0.5714	0.5849	0.569	0.5434	0.6217	gnomADg_AMR		0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-25	-50	-3	1	0	0	0	0	MSH2			NA				374958	NA	Conflicting_classifications_of_pathogenicity	Lynch_syndrome_1&Hereditary_nonpolyposis_colorectal_neoplasms&not_specified&Breast_and/or_ovarian_cancer&Hereditary_cancer-predisposing_syndrome&not_provided&Mismatch_repair_cancer_syndrome_1	NC_000002.12:g.47414447del		Deletion	MSH2:4436	MONDO:MONDO:0007356&MedGen:C2936783&OMIM:120435&Orphanet:144&MeSH:D003123&MedGen:C0009405&MedGen:CN169374&MedGen:CN221562&MONDO:MONDO:0015356&MeSH:D009386&MedGen:C0027672&Orphanet:140162&MedGen:C3661900&MONDO:MONDO:0010159&MedGen:C5399763&OMIM:276300&Orphanet:252202	Uncertain_significance(1)&Benign(6)&Likely_benign(1)	criteria_provided&_conflicting_classifications		MSH2	Mismatch repair cancer syndrome 1	AR	276300	Tumor predisposition syndromes	NBScreening	-5	Likely_benign	BP6,BS2	rs11309117	chr2_47414420_TA_T	Female	01-Jan	Homozygous
chr2	69323678	.	AT	A	50	PASS	"FS=5.036;MQ=244.76;MQRankSum=3.047;QD=1.32;ReadPosRankSum=0.634;SOR=0.217;FractionInformativeReads=0.974;R2_5P_bias=2.625;DP=38;AF=0.5;AN=2;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|GFPT1|2673|Transcript|NM_001244710.2|protein_coding|20/20||NM_001244710.2:c.*2510del||4766|||||rs370178312||-1||deletion|EntrezGene||YES|||T|T|||||||0.25|||||||0.25|||0.6281|0.7869|0.6635|0.5519|0.6281|0.4548|0.5529|0.5978|0.5793|0.6001|0.6277|0.7869|gnomADg_AFR|uncertain_significance||1||||||||||||-1|-31|14|7|0.00|0.00|0.00|0.00|GFPT1|||||||336830||Uncertain_significance|not_provided&Congenital_Myasthenic_Syndrome&_Recessive|NC_000002.12:g.69323696del||Deletion|GFPT1:2673|MedGen:C3661900&MedGen:CN239337||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,22:0.595:37:9,8:6,14:47:56,0,47:50,8.5683e-05,50.11:0,6,9:11,4,12,10:9,6,12,10	-	3_prime_UTR_variant	MODIFIER	GFPT1	2673	Transcript	NM_001244710.2	protein_coding	20/20		c.*2510del		4766					rs370178312	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	0.25	NA	NA	NA	NA	NA	NA	0.25	NA	NA	0.6281	0.7869	0.6635	0.5519	0.6281	0.4548	0.5529	0.5978	0.5793	0.6001	0.6277	0.7869	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-1	-31	14	7	0	0	0	0	GFPT1			NA				336830	NA	Uncertain_significance	not_provided&Congenital_Myasthenic_Syndrome&_Recessive	NC_000002.12:g.69323696del		Deletion	GFPT1:2673	MedGen:C3661900&MedGen:CN239337		criteria_provided&_multiple_submitters&_no_conflicts		GFPT1	Congenital myasthenic syndrome 12	AR	610542	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs370178312	chr2_69323678_AT_A	Female	./.	Other
chr2	69323678	.	AT	A	50	PASS	"FS=5.036;MQ=244.76;MQRankSum=3.047;QD=1.32;ReadPosRankSum=0.634;SOR=0.217;FractionInformativeReads=0.974;R2_5P_bias=2.625;DP=38;AF=0.5;AN=2;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|GFPT1|2673|Transcript|NM_001244710.2|protein_coding|20/20||NM_001244710.2:c.*2510del||4766|||||rs370178312||-1||deletion|EntrezGene||YES|||T|T|||||||0.25|||||||0.25|||0.6281|0.7869|0.6635|0.5519|0.6281|0.4548|0.5529|0.5978|0.5793|0.6001|0.6277|0.7869|gnomADg_AFR|uncertain_significance||1||||||||||||-1|-31|14|7|0.00|0.00|0.00|0.00|GFPT1|||||||336830||Uncertain_significance|not_provided&Congenital_Myasthenic_Syndrome&_Recessive|NC_000002.12:g.69323696del||Deletion|GFPT1:2673|MedGen:C3661900&MedGen:CN239337||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,22:0.595:37:9,8:6,14:47:56,0,47:50,8.5683e-05,50.11:0,6,9:11,4,12,10:9,6,12,10	-	3_prime_UTR_variant	MODIFIER	GFPT1	2673	Transcript	NM_001244710.2	protein_coding	20/20		c.*2510del		4766					rs370178312	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	0.25	NA	NA	NA	NA	NA	NA	0.25	NA	NA	0.6281	0.7869	0.6635	0.5519	0.6281	0.4548	0.5529	0.5978	0.5793	0.6001	0.6277	0.7869	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-1	-31	14	7	0	0	0	0	GFPT1			NA				336830	NA	Uncertain_significance	not_provided&Congenital_Myasthenic_Syndrome&_Recessive	NC_000002.12:g.69323696del		Deletion	GFPT1:2673	MedGen:C3661900&MedGen:CN239337		criteria_provided&_multiple_submitters&_no_conflicts		GFPT1	Congenital myasthenic syndrome, limb-girdle	AR	603034	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs370178312	chr2_69323678_AT_A	Female	./.	Other
chr2	69326243	.	GA	G	50	PASS	"FS=1.394;MQ=250;MQRankSum=4.82;QD=1.39;ReadPosRankSum=0.284;SOR=0.898;FractionInformativeReads=0.944;R2_5P_bias=-1.247;DP=36;AF=0.5;AN=2;AC=1;CSQ=-|splice_polypyrimidine_tract_variant&intron_variant|LOW|GFPT1|2673|Transcript|NM_001244710.2|protein_coding||19/19|NM_001244710.2:c.2056-11del|||||||rs201268947||-1||deletion|EntrezGene||YES|||A|A|||||||0.4721|0.5446|0.4487|0.5008|0.297|0.4755|0.5037|0.4796|0.473|0.4329|0.6332|0.7813|0.681|0.5747|0.6455|0.3023|0.5629|0.6418|0.595|0.6144|0.5344|0.7813|gnomADg_AFR|uncertain_significance&benign||1||||||||||||-11|36|-23|-40|0.00|0.00|0.00|0.00|GFPT1|||||||336873||Conflicting_classifications_of_pathogenicity|Congenital_myasthenic_syndrome_12&not_provided&not_specified&Congenital_Myasthenic_Syndrome&_Recessive|NC_000002.12:g.69326256del||Deletion|GFPT1:2673|MONDO:MONDO:0012518&MedGen:C3552335&OMIM:610542&Orphanet:353327&Orphanet:590&MedGen:C3661900&MedGen:CN169374&MedGen:CN239337|Uncertain_significance(1)&Benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,21:0.618:34:9,9:4,12:46:60,0,46:50,9.9921e-05,48.863:0,10,13:7,6,9,12:5,8,11,10	-	splice_polypyrimidine_tract_variant&intron_variant	LOW	GFPT1	2673	Transcript	NM_001244710.2	protein_coding		19/19	c.2056-11del							rs201268947	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.4721	0.5446	0.4487	0.5008	0.297	0.4755	0.5037	0.4796	0.473	0.4329	0.6332	0.7813	0.681	0.5747	0.6455	0.3023	0.5629	0.6418	0.595	0.6144	0.5344	0.7813	gnomADg_AFR	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-11	36	-23	-40	0	0	0	0	GFPT1			NA				336873	NA	Conflicting_classifications_of_pathogenicity	Congenital_myasthenic_syndrome_12&not_provided&not_specified&Congenital_Myasthenic_Syndrome&_Recessive	NC_000002.12:g.69326256del		Deletion	GFPT1:2673	MONDO:MONDO:0012518&MedGen:C3552335&OMIM:610542&Orphanet:353327&Orphanet:590&MedGen:C3661900&MedGen:CN169374&MedGen:CN239337	Uncertain_significance(1)&Benign(4)	criteria_provided&_conflicting_classifications		GFPT1	Congenital myasthenic syndrome 12	AR	610542	Neuromuscular and musculoskelettal disorders	NBScreening	-9	Benign	BP6,BA1	rs201268947	chr2_69326243_GA_G	Female	./.	Other
chr2	69326243	.	GA	G	50	PASS	"FS=1.394;MQ=250;MQRankSum=4.82;QD=1.39;ReadPosRankSum=0.284;SOR=0.898;FractionInformativeReads=0.944;R2_5P_bias=-1.247;DP=36;AF=0.5;AN=2;AC=1;CSQ=-|splice_polypyrimidine_tract_variant&intron_variant|LOW|GFPT1|2673|Transcript|NM_001244710.2|protein_coding||19/19|NM_001244710.2:c.2056-11del|||||||rs201268947||-1||deletion|EntrezGene||YES|||A|A|||||||0.4721|0.5446|0.4487|0.5008|0.297|0.4755|0.5037|0.4796|0.473|0.4329|0.6332|0.7813|0.681|0.5747|0.6455|0.3023|0.5629|0.6418|0.595|0.6144|0.5344|0.7813|gnomADg_AFR|uncertain_significance&benign||1||||||||||||-11|36|-23|-40|0.00|0.00|0.00|0.00|GFPT1|||||||336873||Conflicting_classifications_of_pathogenicity|Congenital_myasthenic_syndrome_12&not_provided&not_specified&Congenital_Myasthenic_Syndrome&_Recessive|NC_000002.12:g.69326256del||Deletion|GFPT1:2673|MONDO:MONDO:0012518&MedGen:C3552335&OMIM:610542&Orphanet:353327&Orphanet:590&MedGen:C3661900&MedGen:CN169374&MedGen:CN239337|Uncertain_significance(1)&Benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,21:0.618:34:9,9:4,12:46:60,0,46:50,9.9921e-05,48.863:0,10,13:7,6,9,12:5,8,11,10	-	splice_polypyrimidine_tract_variant&intron_variant	LOW	GFPT1	2673	Transcript	NM_001244710.2	protein_coding		19/19	c.2056-11del							rs201268947	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.4721	0.5446	0.4487	0.5008	0.297	0.4755	0.5037	0.4796	0.473	0.4329	0.6332	0.7813	0.681	0.5747	0.6455	0.3023	0.5629	0.6418	0.595	0.6144	0.5344	0.7813	gnomADg_AFR	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-11	36	-23	-40	0	0	0	0	GFPT1			NA				336873	NA	Conflicting_classifications_of_pathogenicity	Congenital_myasthenic_syndrome_12&not_provided&not_specified&Congenital_Myasthenic_Syndrome&_Recessive	NC_000002.12:g.69326256del		Deletion	GFPT1:2673	MONDO:MONDO:0012518&MedGen:C3552335&OMIM:610542&Orphanet:353327&Orphanet:590&MedGen:C3661900&MedGen:CN169374&MedGen:CN239337	Uncertain_significance(1)&Benign(4)	criteria_provided&_conflicting_classifications		GFPT1	Congenital myasthenic syndrome, limb-girdle	AR	603034	Neuromuscular and musculoskelettal disorders	NBScreening	-9	Benign	BP6,BA1	rs201268947	chr2_69326243_GA_G	Female	./.	Other
chr2	71644058	.	C	T	49.96	PASS	"FS=1.56;MQ=250;MQRankSum=4.826;QD=1.47;ReadPosRankSum=1.512;SOR=1.179;FractionInformativeReads=1;R2_5P_bias=3.644;DP=105;AF=0.5;AN=6;AC=3;CSQ=T|synonymous_variant|LOW|DYSF|8291|Transcript|NM_001130987.2|protein_coding|42/56||NM_001130987.2:c.4621C>T|NP_001124459.1:p.Leu1541%3D|4765|4621|1541|L|Ctg/Ttg|rs7573406&COSV50435908||1||SNV|EntrezGene||YES|||C|C||||||0.0086|0.008239|0.007745|0.006873|0.009589|0|0.003536|0.03282|0.007882|0.01037|0.01701|0.008149|0.007991|0|0.008827|0.0072|0.0001928|0.00226|0.03401|0.009084|0.0123|0.0145|0.03401|gnomADg_MID|benign&uncertain_significance&conflicting_interpretations_of_pathogenicity&likely_benign|0&1|1&1||||||||||||-1|-47|5|33|0.00|0.00|0.00|0.00|DYSF|||||||94325||Conflicting_classifications_of_pathogenicity|not_specified&Limb-girdle_muscular_dystrophy&_recessive&Miyoshi_myopathy&Qualitative_or_quantitative_defects_of_dysferlin&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2B&Miyoshi_muscular_dystrophy_1|NC_000002.12:g.71644058C>T||single_nucleotide_variant|DYSF:8291|MedGen:CN169374&MedGen:CN239352&MONDO:MONDO:0009685&MedGen:C5553104&OMIM:PS254130&Orphanet:45448&MONDO:MONDO:0016145&MedGen:C2931687&Orphanet:207073&MONDO:MONDO:0009676&MedGen:C1850889&OMIM:253601&Orphanet:268&MONDO:MONDO:0024545&MedGen:C4551973&OMIM:254130&Orphanet:45448|Uncertain_significance(3)&Benign(6)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,14:0.424:33:13,8:6,6:47:83,0,50:48.582,8.2059e-05,53:0,34.77,37.77:6,13,3,11:8,11,9,5	0/1:17,16:0.485:33:5,12:12,4:48:85,0,50:49.96,6.5492e-05,53:0,34.77,37.77:5,12,5,11:13,4,5,11	0/1:23,16:0.41:39:13,7:10,9:46:82,0,50:46.879,0.00011079,53:0,34.77,37.77:5,18,3,13:11,12,8,8	T	synonymous_variant	LOW	DYSF	8291	Transcript	NM_001130987.2	protein_coding	42/56		c.4621C>T	p.Leu1541%3D	4765	4621	1541	L	Ctg/Ttg	rs7573406&COSV50435908	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0086	0.008239	0.007745	0.006873	0.009589	0	0.003536	0.03282	0.007882	0.01037	0.01701	0.008149	0.007991	0	0.008827	0.0072	0.0001928	0.00226	0.03401	0.009084	0.0123	0.0145	0.03401	gnomADg_MID	benign&uncertain_significance&conflicting_interpretations_of_pathogenicity&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-1	-47	5	33	0	0	0	0	DYSF			NA				94325	NA	Conflicting_classifications_of_pathogenicity	not_specified&Limb-girdle_muscular_dystrophy&_recessive&Miyoshi_myopathy&Qualitative_or_quantitative_defects_of_dysferlin&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2B&Miyoshi_muscular_dystrophy_1	NC_000002.12:g.71644058C>T		single_nucleotide_variant	DYSF:8291	MedGen:CN169374&MedGen:CN239352&MONDO:MONDO:0009685&MedGen:C5553104&OMIM:PS254130&Orphanet:45448&MONDO:MONDO:0016145&MedGen:C2931687&Orphanet:207073&MONDO:MONDO:0009676&MedGen:C1850889&OMIM:253601&Orphanet:268&MONDO:MONDO:0024545&MedGen:C4551973&OMIM:254130&Orphanet:45448	Uncertain_significance(3)&Benign(6)&Likely_benign(1)	criteria_provided&_conflicting_classifications		DYSF	Miyoshi muscular dystrophy 1	AR	254130	Neuromuscular and musculoskelettal disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BS1,BS2	rs7573406	chr2_71644058_C_T	Female	0/1	Heterozygous
chr2	71644058	.	C	T	49.96	PASS	"FS=1.56;MQ=250;MQRankSum=4.826;QD=1.47;ReadPosRankSum=1.512;SOR=1.179;FractionInformativeReads=1;R2_5P_bias=3.644;DP=105;AF=0.5;AN=6;AC=3;CSQ=T|synonymous_variant|LOW|DYSF|8291|Transcript|NM_001130987.2|protein_coding|42/56||NM_001130987.2:c.4621C>T|NP_001124459.1:p.Leu1541%3D|4765|4621|1541|L|Ctg/Ttg|rs7573406&COSV50435908||1||SNV|EntrezGene||YES|||C|C||||||0.0086|0.008239|0.007745|0.006873|0.009589|0|0.003536|0.03282|0.007882|0.01037|0.01701|0.008149|0.007991|0|0.008827|0.0072|0.0001928|0.00226|0.03401|0.009084|0.0123|0.0145|0.03401|gnomADg_MID|benign&uncertain_significance&conflicting_interpretations_of_pathogenicity&likely_benign|0&1|1&1||||||||||||-1|-47|5|33|0.00|0.00|0.00|0.00|DYSF|||||||94325||Conflicting_classifications_of_pathogenicity|not_specified&Limb-girdle_muscular_dystrophy&_recessive&Miyoshi_myopathy&Qualitative_or_quantitative_defects_of_dysferlin&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2B&Miyoshi_muscular_dystrophy_1|NC_000002.12:g.71644058C>T||single_nucleotide_variant|DYSF:8291|MedGen:CN169374&MedGen:CN239352&MONDO:MONDO:0009685&MedGen:C5553104&OMIM:PS254130&Orphanet:45448&MONDO:MONDO:0016145&MedGen:C2931687&Orphanet:207073&MONDO:MONDO:0009676&MedGen:C1850889&OMIM:253601&Orphanet:268&MONDO:MONDO:0024545&MedGen:C4551973&OMIM:254130&Orphanet:45448|Uncertain_significance(3)&Benign(6)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,14:0.424:33:13,8:6,6:47:83,0,50:48.582,8.2059e-05,53:0,34.77,37.77:6,13,3,11:8,11,9,5	0/1:17,16:0.485:33:5,12:12,4:48:85,0,50:49.96,6.5492e-05,53:0,34.77,37.77:5,12,5,11:13,4,5,11	0/1:23,16:0.41:39:13,7:10,9:46:82,0,50:46.879,0.00011079,53:0,34.77,37.77:5,18,3,13:11,12,8,8	T	synonymous_variant	LOW	DYSF	8291	Transcript	NM_001130987.2	protein_coding	42/56		c.4621C>T	p.Leu1541%3D	4765	4621	1541	L	Ctg/Ttg	rs7573406&COSV50435908	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0086	0.008239	0.007745	0.006873	0.009589	0	0.003536	0.03282	0.007882	0.01037	0.01701	0.008149	0.007991	0	0.008827	0.0072	0.0001928	0.00226	0.03401	0.009084	0.0123	0.0145	0.03401	gnomADg_MID	benign&uncertain_significance&conflicting_interpretations_of_pathogenicity&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-1	-47	5	33	0	0	0	0	DYSF			NA				94325	NA	Conflicting_classifications_of_pathogenicity	not_specified&Limb-girdle_muscular_dystrophy&_recessive&Miyoshi_myopathy&Qualitative_or_quantitative_defects_of_dysferlin&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2B&Miyoshi_muscular_dystrophy_1	NC_000002.12:g.71644058C>T		single_nucleotide_variant	DYSF:8291	MedGen:CN169374&MedGen:CN239352&MONDO:MONDO:0009685&MedGen:C5553104&OMIM:PS254130&Orphanet:45448&MONDO:MONDO:0016145&MedGen:C2931687&Orphanet:207073&MONDO:MONDO:0009676&MedGen:C1850889&OMIM:253601&Orphanet:268&MONDO:MONDO:0024545&MedGen:C4551973&OMIM:254130&Orphanet:45448	Uncertain_significance(3)&Benign(6)&Likely_benign(1)	criteria_provided&_conflicting_classifications		DYSF	Autosomal recessive limb-girdle muscular dystrophy type 2B	AR	253601	Neuromuscular and musculoskelettal disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BS1,BS2	rs7573406	chr2_71644058_C_T	Female	0/1	Heterozygous
chr2	73946743	.	A	G	50	PASS	"FS=5.294;MQ=250;MQRankSum=4.881;QD=1.47;ReadPosRankSum=3.517;SOR=0.188;FractionInformativeReads=1;R2_5P_bias=3.309;DP=34;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|DGUOK|1716|Transcript|NM_080916.3|protein_coding|3/7||NM_080916.3:c.280A>G|NP_550438.1:p.Asn94Asp|311|280|94|N/D|Aac/Gac|rs747937764||1||SNV|EntrezGene||YES|||A|A|||deleterious(0)|probably_damaging(0.997)|||2.121e-05|0|0|0.0004974|0|0|0.000174|1.259e-05|4.967e-05|0|1.973e-05|0|0|0|0.0002884|0|0|0|1.47e-05|0.0004785|0|0.0004974|gnomADe_ASJ|uncertain_significance||1||||D|0.93384|0.471319|D|0.93301|0.439241|0.96243|0.874&0.874|-24|-7|37|-3|0.00|0.00|0.00|0.00|DGUOK|likely_pathogenic|hg38|0.5783|N94D|ENST00000264093.9|Q16854|1378276||Uncertain_significance|not_provided|NC_000002.12:g.73946743A>G||single_nucleotide_variant|DGUOK:1716|MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,20:0.588:34:6,12:8,8:47:85,0,47:50,8.5425e-05,50.136:0,34.77,37.77:10,4,10,10:6,8,8,12	G	missense_variant	MODERATE	DGUOK	1716	Transcript	NM_080916.3	protein_coding	07-Mar		c.280A>G	p.Asn94Asp	311	280	94	N/D	Aac/Gac	rs747937764	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	deleterious(0)	probably_damaging(0.997)	NA	NA	2.121e-05	0	0	0.0004974	0	0	0.000174	1.259e-05	4.967e-05	0	1.973e-05	0	0	0	0.0002884	0	0	0	1.47e-05	0.0004785	0	0.0004974	gnomADe_ASJ	uncertain_significance		1	NA	NA	NA	D	0.93384	0.471319	D	0.93301	0.439241	0.96243	0.874&0.874	-24	-7	37	-3	0	0	0	0	DGUOK	likely_pathogenic	hg38	0.5783	N94D	ENST00000264093.9	Q16854	1378276	NA	Uncertain_significance	not_provided	NC_000002.12:g.73946743A>G		single_nucleotide_variant	DGUOK:1716	MedGen:C3661900		criteria_provided&_single_submitter		DGUOK	Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	AR	251880	Inherited disorders of metabolism	NBScreening	2	Uncertain_significance	PM2,PP3,BP4	rs747937764	chr2_73946743_A_G	Female	./.	Other
chr2	73946743	.	A	G	50	PASS	"FS=5.294;MQ=250;MQRankSum=4.881;QD=1.47;ReadPosRankSum=3.517;SOR=0.188;FractionInformativeReads=1;R2_5P_bias=3.309;DP=34;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|DGUOK|1716|Transcript|NM_080916.3|protein_coding|3/7||NM_080916.3:c.280A>G|NP_550438.1:p.Asn94Asp|311|280|94|N/D|Aac/Gac|rs747937764||1||SNV|EntrezGene||YES|||A|A|||deleterious(0)|probably_damaging(0.997)|||2.121e-05|0|0|0.0004974|0|0|0.000174|1.259e-05|4.967e-05|0|1.973e-05|0|0|0|0.0002884|0|0|0|1.47e-05|0.0004785|0|0.0004974|gnomADe_ASJ|uncertain_significance||1||||D|0.93384|0.471319|D|0.93301|0.439241|0.96243|0.874&0.874|-24|-7|37|-3|0.00|0.00|0.00|0.00|DGUOK|likely_pathogenic|hg38|0.5783|N94D|ENST00000264093.9|Q16854|1378276||Uncertain_significance|not_provided|NC_000002.12:g.73946743A>G||single_nucleotide_variant|DGUOK:1716|MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,20:0.588:34:6,12:8,8:47:85,0,47:50,8.5425e-05,50.136:0,34.77,37.77:10,4,10,10:6,8,8,12	G	missense_variant	MODERATE	DGUOK	1716	Transcript	NM_080916.3	protein_coding	07-Mar		c.280A>G	p.Asn94Asp	311	280	94	N/D	Aac/Gac	rs747937764	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	deleterious(0)	probably_damaging(0.997)	NA	NA	2.121e-05	0	0	0.0004974	0	0	0.000174	1.259e-05	4.967e-05	0	1.973e-05	0	0	0	0.0002884	0	0	0	1.47e-05	0.0004785	0	0.0004974	gnomADe_ASJ	uncertain_significance		1	NA	NA	NA	D	0.93384	0.471319	D	0.93301	0.439241	0.96243	0.874&0.874	-24	-7	37	-3	0	0	0	0	DGUOK	likely_pathogenic	hg38	0.5783	N94D	ENST00000264093.9	Q16854	1378276	NA	Uncertain_significance	not_provided	NC_000002.12:g.73946743A>G		single_nucleotide_variant	DGUOK:1716	MedGen:C3661900		criteria_provided&_single_submitter		DGUOK	Mitochondrial DNA depletion syndrome 15 (hepatocerebral type)	AR	617156	Inherited disorders of metabolism	NBScreening	2	Uncertain_significance	PM2,PP3,BP4	rs747937764	chr2_73946743_A_G	Female	./.	Other
chr2	127271427	.	C	T	50	PASS	"FS=4.561;MQ=250;MQRankSum=3.633;QD=2.5;ReadPosRankSum=2.327;SOR=1.981;FractionInformativeReads=0.95;R2_5P_bias=2.719;DP=44;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|ERCC3|2071|Transcript|NM_000122.2|protein_coding|12/15||NM_000122.2:c.1854G>A|NP_000113.1:p.Pro618%3D|1917|1854|618|P|ccG/ccA|rs765724086||-1||SNV|EntrezGene||YES|||C|C|||||||2.736e-05|0.0001792|0.0001342|0|0|0|0|2.248e-05|4.967e-05|0|3.947e-05|0.0001209|0|0|0|0|0|0|1.47e-05|0|0|0.0001792|gnomADe_AFR|likely_benign&uncertain_significance||1||||||||||||-22|22|27|-9|0.00|0.02|0.00|0.00|ERCC3|||||||1026430||Conflicting_classifications_of_pathogenicity|not_provided&Xeroderma_pigmentosum|NC_000002.12:g.127271427C>T||single_nucleotide_variant|ERCC3:2071|MedGen:C3661900&MONDO:MONDO:0019600&MedGen:C0043346&Orphanet:910|Uncertain_significance(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:9,10:0.526:19:5,5:4,5:48:85,0,50:50,6.5751e-05,52.886:0,34.77,37.77:5,4,8,2:3,6,5,5	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,10:0.417:24:5,5:9,5:47:83,0,50:48.376,8.4907e-05,53:0,34.77,37.77:8,6,5,5:7,7,6,4	T	synonymous_variant	LOW	ERCC3	2071	Transcript	NM_000122.2	protein_coding	15-Dec		c.1854G>A	p.Pro618%3D	1917	1854	618	P	ccG/ccA	rs765724086	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	2.736e-05	0.0001792	0.0001342	0	0	0	0	2.248e-05	4.967e-05	0	3.947e-05	0.0001209	0	0	0	0	0	0	1.47e-05	0	0	0.0001792	gnomADe_AFR	likely_benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-22	22	27	-9	0	0.02	0	0	ERCC3			NA				1026430	NA	Conflicting_classifications_of_pathogenicity	not_provided&Xeroderma_pigmentosum	NC_000002.12:g.127271427C>T		single_nucleotide_variant	ERCC3:2071	MedGen:C3661900&MONDO:MONDO:0019600&MedGen:C0043346&Orphanet:910	Uncertain_significance(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		ERCC3	Xeroderma pigmentosum group B	AR	610651	Skelettal, skin, and connective tissue disorders	NBScreening	-4	Likely_benign	BP4_Moderate,BP6,BP7	rs765724086	chr2_127271427_C_T	Female	0/1	Heterozygous
chr2	144387045	.	G	GTA	97.68	PASS	"FS=0;MQ=247.32;MQRankSum=2.737;QD=1.92;ReadPosRankSum=0.53;SOR=0.693;FractionInformativeReads=0.692;R2_5P_bias=-8.894;DP=78;AF=0.5;AN=6;AC=4;CSQ=TA|3_prime_UTR_variant|MODIFIER|ZEB2|9839|Transcript|NM_014795.4|protein_coding|10/10||NM_014795.4:c.*2404_*2405dup||6300-6301|||||rs143648355||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.6793|0.5549|0.7357|0.7539|0.6185|0.8729|0.7142|0.6213|0.7199|0.6578|0.7038|0.8729|gnomADg_EAS|||1|||||||||||||||||||||||||||331259||Uncertain_significance|Mowat-Wilson_syndrome&not_provided|NC_000002.12:g.144387046TA[10]||Microsatellite|ZEB2:9839|MONDO:MONDO:0009341&MedGen:C1856113&OMIM:235730&Orphanet:2152&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:9,9:0.5:18:5,7:4,2:48:59,0,50:50,6.5233e-05,53:0,9,12:6,3,6,3:4,5,6,3	1/1:0,17:1:17:0,8:0,9:48:110,51,0:97.681,47.681,7.4034e-05:0,9,12:0,0,9,8:0,0,8,9	0/1:11,12:0.522:23:5,7:6,5:48:59,0,50:50,6.5751e-05,52.906:0,9,12:6,5,5,7:6,5,10,2	TA	3_prime_UTR_variant	MODIFIER	ZEB2	9839	Transcript	NM_014795.4	protein_coding	10-Oct		c.*2404_*2405dup		6300-6301					rs143648355	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.6793	0.5549	0.7357	0.7539	0.6185	0.8729	0.7142	0.6213	0.7199	0.6578	0.7038	0.8729	gnomADg_EAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				331259	NA	Uncertain_significance	Mowat-Wilson_syndrome&not_provided	NC_000002.12:g.144387046TA[10]		Microsatellite	ZEB2:9839	MONDO:MONDO:0009341&MedGen:C1856113&OMIM:235730&Orphanet:2152&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		ZEB2	Mowat-Wilson syndrome	AD	235730	Complex genetic syndromes	NBScreening	-8	Benign	BA1	rs143648355	chr2_144387045_G_GTA	Female	0/1	Heterozygous
chr2	151546001	.	T	TAA	50	PASS	"FS=0;MQ=241;MQRankSum=2.75;QD=1.92;ReadPosRankSum=-0.028;SOR=0.914;FractionInformativeReads=1;R2_5P_bias=6.654;DP=54;AF=0.5;AN=4;AC=2;CSQ=AA|splice_region_variant&splice_polypyrimidine_tract_variant&intron_variant|LOW|NEB|4703|Transcript|NM_001164508.2|protein_coding||134/181|NM_001164508.2:c.20467-5_20467-4dup|||||||rs10687343&COSV51460554||-1||insertion|EntrezGene||YES|||||||||||0.2258|0.09533|0.2483|0.1663|0.2286|0.261|0.2082|0.237|0.2191|0.1566|0.2744|0.1258|0.1437|0.2926|0.2221|0.2815|0.3645|0.2993|0.3541|0.2795|0.2023|0.3645|gnomADg_FIN|uncertain_significance&benign&likely_benign|0&1|1&1|||||||||||||||||||||||||||331432||Conflicting_classifications_of_pathogenicity|not_specified&Nemaline_Myopathy&_Recessive|NC_000002.12:g.151546017_151546018dup||Duplication|NEB:4703|MedGen:CN169374&MedGen:CN239479|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:8,18:0.692:26:5,8:3,10:41:58,0,38:50,0.00035776,41.403:0,8,11.01:4,4,10,8:5,3,10,8	0/1:13,15:0.536:28:8,7:5,8:47:58,0,47:50,9.0084e-05,49.686:0,8,11.01:6,7,11,4:7,6,11,4	AA	splice_region_variant&splice_polypyrimidine_tract_variant&intron_variant	LOW	NEB	4703	Transcript	NM_001164508.2	protein_coding		134/181	c.20467-5_20467-4dup							rs10687343&COSV51460554	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.2258	0.09533	0.2483	0.1663	0.2286	0.261	0.2082	0.237	0.2191	0.1566	0.2744	0.1258	0.1437	0.2926	0.2221	0.2815	0.3645	0.2993	0.3541	0.2795	0.2023	0.3645	gnomADg_FIN	uncertain_significance&benign&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				331432	NA	Conflicting_classifications_of_pathogenicity	not_specified&Nemaline_Myopathy&_Recessive	NC_000002.12:g.151546017_151546018dup		Duplication	NEB:4703	MedGen:CN169374&MedGen:CN239479	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		NEB	Nemaline myopathy 2	AR	256030	Neuromuscular and musculoskelettal disorders	NBScreening	-9	Benign	BP6,BA1	rs10687343	chr2_151546001_T_TAA	Female	./.	Other
chr2	151579405	.	C	T	21.67	PASS	"FS=2.74;MQ=65.72;MQRankSum=-0.124;QD=1.03;ReadPosRankSum=2.106;SOR=1.845;FractionInformativeReads=1;R2_5P_bias=15.083;DP=40;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|NEB|4703|Transcript|NM_001164508.2|protein_coding|105/182||NM_001164508.2:c.16637G>A|NP_001157980.2:p.Arg5546His|16829|16637|5546|R/H|cGc/cAc|rs201111610||-1||SNV|EntrezGene||YES|||C|C||||unknown(0)|||0.001991|0.001619|0.002135|0.0002403|0.0016|0.003656|0.000496|0.002064|0.002322|0.0006782|0.01222|0.01266|0.001106|0.00757|0.001176|0.004544|0.00752|0.01379|0.01575|0.009014|0.004898|0.01575|gnomADg_NFE|likely_benign&benign&uncertain_significance||1||||T|0.08929|-0.297172|T|0.07957|-0.664644|0.15330|0.054&.&0.054&0.054&.&.|-23|48|46|-3|0.01|0.00|0.03|0.00|NEB|||||||257765||Conflicting_classifications_of_pathogenicity|not_provided&Peripheral_neuropathy&not_specified|NC_000002.12:g.151579405C>T||single_nucleotide_variant|NEB:4703|MedGen:C3661900&Human_Phenotype_Ontology:HP:0003157&Human_Phenotype_Ontology:HP:0003407&Human_Phenotype_Ontology:HP:0007088&Human_Phenotype_Ontology:HP:0007235&Human_Phenotype_Ontology:HP:0007355&Human_Phenotype_Ontology:HP:0009830&MONDO:MONDO:0005244&MedGen:C0031117&MedGen:CN169374|Uncertain_significance(1)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,5:0.238:21:4,3:12,2:22:56,0,45:21.666,0.029762,48.23:0,34.77,37.77:4,12,0,5:10,6,2,3	0/1:15,4:0.211:19:8,2:7,2:12:47,0,45:12.253,0.26658,48.467:0,34.77,37.77:6,9,0,4:9,6,2,2	T	missense_variant	MODERATE	NEB	4703	Transcript	NM_001164508.2	protein_coding	105/182		c.16637G>A	p.Arg5546His	16829	16637	5546	R/H	cGc/cAc	rs201111610	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA		unknown(0)	NA	NA	0.001991	0.001619	0.002135	0.0002403	0.0016	0.003656	0.000496	0.002064	0.002322	0.0006782	0.01222	0.01266	0.001106	0.00757	0.001176	0.004544	0.00752	0.01379	0.01575	0.009014	0.004898	0.01575	gnomADg_NFE	likely_benign&benign&uncertain_significance		1	NA	NA	NA	T	0.08929	-0.297172	T	0.07957	-0.664644	0.1533	0.054&.&0.054&0.054&.&.	-23	48	46	-3	0.01	0	0.03	0	NEB			NA				257765	NA	Conflicting_classifications_of_pathogenicity	not_provided&Peripheral_neuropathy&not_specified	NC_000002.12:g.151579405C>T		single_nucleotide_variant	NEB:4703	MedGen:C3661900&Human_Phenotype_Ontology:HP:0003157&Human_Phenotype_Ontology:HP:0003407&Human_Phenotype_Ontology:HP:0007088&Human_Phenotype_Ontology:HP:0007235&Human_Phenotype_Ontology:HP:0007355&Human_Phenotype_Ontology:HP:0009830&MONDO:MONDO:0005244&MedGen:C0031117&MedGen:CN169374	Uncertain_significance(1)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		NEB	Nemaline myopathy 2	AR	256030	Neuromuscular and musculoskelettal disorders	NBScreening	-5	Likely_benign	BP4_Strong,BP6	rs201111610	chr2_151579405_C_T	Female	./.	Other
chr2	165294010	.	TAA	T	135.73	PASS	"FS=0;MQ=247.34;QD=4.97;SOR=1.911;FractionInformativeReads=0.6;MQRankSum=0.743;ReadPosRankSum=1.239;R2_5P_bias=0;DP=76;AF=0.5;AN=6;AC=4;CSQ=-|intron_variant|MODIFIER|SCN2A|6326|Transcript|NM_001040142.2|protein_coding||1/26|NM_001040142.2:c.-51-1736_-51-1735del|||||||rs67417831||1||deletion|EntrezGene||YES|||AA|AA|||||26||0.1214|0.1799|0.05696|0.1796|0.1335|0.04762|0.1838|0.1189|0.1294|0.1104|0.157|0.2905|0.05556|0.1285|0.1641|0.1465|0.09797|0.2083|0.1087|0.1777|0.1002|0.2905|gnomADg_AFR|uncertain_significance&benign||1||||||||||||47|27|-23|-28|0.00|0.00|0.00|0.00|SCN2A|||||||331709||Conflicting_classifications_of_pathogenicity|not_provided&Early_Infantile_Epileptic_Encephalopathy&_Autosomal_Dominant&Seizures&_benign_familial_infantile&_3|NC_000002.12:g.165294037_165294038del||Deletion|SCN2A:6326&LOC120977013:120977013|MedGen:C3661900&MedGen:CN239232&MONDO:MONDO:0011904&MedGen:C1843140&OMIM:607745&Orphanet:140927&Orphanet:306|Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,9:0.6:15:0,8:0,1:49:132,78,53:124.22,74.218,51.726:0,4,7:0,0,11,4:0,0,8,7	1/1:1,20:0.952:21:0,11:1,9:53:110,56,0:103.47,53.471,1.9415e-05:0,4,7:0,1,15,5:1,0,14,6	1/0:0,11:0.611:18:0,5:0,6:49:144,90,52:135.73,85.732,51.068:0,4,7:0,0,10,8:0,0,12,6	-	intron_variant	MODIFIER	SCN2A	6326	Transcript	NM_001040142.2	protein_coding		26-Jan	c.-51-1736_-51-1735del							rs67417831	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	AA	AA	NA	NA			26	NA	0.1214	0.1799	0.05696	0.1796	0.1335	0.04762	0.1838	0.1189	0.1294	0.1104	0.157	0.2905	0.05556	0.1285	0.1641	0.1465	0.09797	0.2083	0.1087	0.1777	0.1002	0.2905	gnomADg_AFR	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		47	27	-23	-28	0	0	0	0	SCN2A			NA				331709	NA	Conflicting_classifications_of_pathogenicity	not_provided&Early_Infantile_Epileptic_Encephalopathy&_Autosomal_Dominant&Seizures&_benign_familial_infantile&_3	NC_000002.12:g.165294037_165294038del		Deletion	SCN2A:6326&LOC120977013:120977013	MedGen:C3661900&MedGen:CN239232&MONDO:MONDO:0011904&MedGen:C1843140&OMIM:607745&Orphanet:140927&Orphanet:306	Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		SCN2A	Developmental and epileptic encephalopathy, 11	AD	613721	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-9	Benign	BP6,BA1	rs67417831	chr2_165294010_TAA_T	Female	1/0	Heterozygous
chr2	169127533	.	T	TAA	112.52	PASS	"FS=0;MQ=244.81;MQRankSum=2.627;QD=1.67;ReadPosRankSum=1.248;SOR=0.409;FractionInformativeReads=0.733;R2_5P_bias=-7.956;DP=88;AF=0.5;AN=6;AC=4;CSQ=AA|3_prime_UTR_variant|MODIFIER|LRP2|4036|Transcript|NM_004525.3|protein_coding|79/79||NM_004525.3:c.*1128_*1129dup||15232-15233|||||rs3083240||-1||insertion|EntrezGene||YES|||||||||||0.06349|||||0.06557|||0||0.5938|0.3808|0.745|0.6443|0.6311|0.4184|0.5702|0.6064|0.6721|0.6291|0.6261|0.745|gnomADg_AMI|uncertain_significance||1|||||||||||||||||||||||||||332047||Uncertain_significance|not_provided&Donnai-Barrow_syndrome|NC_000002.12:g.169127554_169127555dup||Duplication|LRP2:4036|MedGen:C3661900&MONDO:MONDO:0009104&MedGen:C1857277&OMIM:222448&Orphanet:2143||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,11:0.5:22:6,6:5,5:47:55,0,47:50,8.6978e-05,50:0,5,8.01:8,3,7,4:9,2,6,5	1/1:0,22:1:22:0,5:0,17:63:120,66,0:112.52,62.521,2.3297e-06:0,4,7:0,0,12,10:0,0,11,11	0/1:12,11:0.478:23:3,5:9,6:47:55,0,47:49.797,8.9049e-05,50:0,5,8.01:6,6,7,4:7,5,9,2	AA	3_prime_UTR_variant	MODIFIER	LRP2	4036	Transcript	NM_004525.3	protein_coding	79/79		c.*1128_*1129dup		15232-15233					rs3083240	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.06349	NA	NA	NA	NA	0.06557	NA	NA	0	NA	0.5938	0.3808	0.745	0.6443	0.6311	0.4184	0.5702	0.6064	0.6721	0.6291	0.6261	0.745	gnomADg_AMI	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				332047	NA	Uncertain_significance	not_provided&Donnai-Barrow_syndrome	NC_000002.12:g.169127554_169127555dup		Duplication	LRP2:4036	MedGen:C3661900&MONDO:MONDO:0009104&MedGen:C1857277&OMIM:222448&Orphanet:2143		criteria_provided&_multiple_submitters&_no_conflicts		LRP2	Donnai-Barrow syndrome	AR	222448	Complex genetic syndromes	NBScreening	-8	Benign	BA1	rs3083240	chr2_169127533_T_TAA	Female	0/1	Heterozygous
chr2	169127752	.	A	ATT	296.54	PASS	"FS=0;MQ=250;MQRankSum=4.635;QD=1.56;ReadPosRankSum=0.27;SOR=0.636;FractionInformativeReads=0.938;R2_5P_bias=-25.373;DP=102;AF=0.5;AN=6;AC=2;CSQ=TT|3_prime_UTR_variant|MODIFIER|LRP2|4036|Transcript|NM_004525.3|protein_coding|79/79||NM_004525.3:c.*909_*910dup||15013-15014|||||rs11411235||-1||insertion|EntrezGene||YES|||||||||||0.03409|||||0.03468||0|0||0.01799|0.007074|0.06484|0.01379|0.009936|0.00159|0.03311|0.01773|0.02472|0.009286|0.01728|0.06484|gnomADg_AMI|uncertain_significance&benign||1|||||||||||||||||||||||||||332053||Uncertain_significance|Donnai-Barrow_syndrome|NC_000002.12:g.169127763_169127764dup||Duplication|LRP2:4036|MONDO:MONDO:0009104&MedGen:C1857277&OMIM:222448&Orphanet:2143||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:14,16:0.533:30:8,7:6,9:47:61,0,47:50,9.0602e-05,49.652:0,11,14.01:5,9,6,10:9,5,9,7	0/1:1,13:0.371:35:1,4:0,9:47:319,382,61:296.54,371.33,53:0,11,14:0,1,14,20:0,1,18,16	0/0:17,.:0.371:34:8,.:9,.:48:60,.,.:50,.,.:0,.,.:9,8,4,13:6,11,9,8	TT	3_prime_UTR_variant	MODIFIER	LRP2	4036	Transcript	NM_004525.3	protein_coding	79/79		c.*909_*910dup		15013-15014					rs11411235	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.03409	NA	NA	NA	NA	0.03468	NA	0	0	NA	0.01799	0.007074	0.06484	0.01379	0.009936	0.00159	0.03311	0.01773	0.02472	0.009286	0.01728	0.06484	gnomADg_AMI	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				332053	NA	Uncertain_significance	Donnai-Barrow_syndrome	NC_000002.12:g.169127763_169127764dup		Duplication	LRP2:4036	MONDO:MONDO:0009104&MedGen:C1857277&OMIM:222448&Orphanet:2143		criteria_provided&_single_submitter		LRP2	Donnai-Barrow syndrome	AR	222448	Complex genetic syndromes	NBScreening	-5	Likely_benign	BS1_Supporting,BS2	rs11411235	chr2_169127752_A_ATT	Female	0/1	Heterozygous
chr2	169289151	.	C	T	50	PASS	"FS=6.345;MQ=250;MQRankSum=5.255;QD=1.32;ReadPosRankSum=2.949;SOR=2.303;FractionInformativeReads=1;R2_5P_bias=-1.524;DP=67;AF=0.5;AN=4;AC=2;CSQ=T|splice_region_variant&splice_polypyrimidine_tract_variant&intron_variant|LOW|LRP2|4036|Transcript|NM_004525.3|protein_coding||8/78|NM_004525.3:c.923-6G>A|||||||rs144147038&COSV55570422||-1||SNV|EntrezGene||YES|||C|C||||||0.0118|0.009717|0.001613|0.007827|0.02867|2.52e-05|0.002192|0.05723|0.007567|0.01202|0.04014|0.0073|0.001517|0|0.007644|0.03112|0.0001931|0.003019|0.05442|0.00853|0.009943|0.03595|0.05723|gnomADe_MID|likely_benign&conflicting_interpretations_of_pathogenicity&benign/likely_benign|0&1|1&1|4.35149026089613E-5|0.008||||||||||-2|-6|-38|-5|0.00|0.00|0.00|0.00|LRP2|||||||129545||Conflicting_classifications_of_pathogenicity|Donnai-Barrow_syndrome&not_provided&not_specified|NC_000002.12:g.169289151C>T||single_nucleotide_variant|LRP2:4036|MONDO:MONDO:0009104&MedGen:C1857277&OMIM:222448&Orphanet:2143&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(1)&Benign(2)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,19:0.5:38:11,11:8,8:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:13,6,17,2:9,10,9,10	0/1:13,16:0.552:29:7,8:6,8:48:85,0,49:50,6.8339e-05,52.408:0,34.77,37.77:9,4,10,6:5,8,8,8	T	splice_region_variant&splice_polypyrimidine_tract_variant&intron_variant	LOW	LRP2	4036	Transcript	NM_004525.3	protein_coding		8/78	c.923-6G>A							rs144147038&COSV55570422	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0118	0.009717	0.001613	0.007827	0.02867	2.52e-05	0.002192	0.05723	0.007567	0.01202	0.04014	0.0073	0.001517	0	0.007644	0.03112	0.0001931	0.003019	0.05442	0.00853	0.009943	0.03595	0.05723	gnomADe_MID	likely_benign&conflicting_interpretations_of_pathogenicity&benign/likely_benign	0&1	1&1	4.35149026089613e-05	0.008	NA		NA	NA		NA	NA	NA		-2	-6	-38	-5	0	0	0	0	LRP2			NA				129545	NA	Conflicting_classifications_of_pathogenicity	Donnai-Barrow_syndrome&not_provided&not_specified	NC_000002.12:g.169289151C>T		single_nucleotide_variant	LRP2:4036	MONDO:MONDO:0009104&MedGen:C1857277&OMIM:222448&Orphanet:2143&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(1)&Benign(2)&Likely_benign(2)	criteria_provided&_conflicting_classifications		LRP2	Donnai-Barrow syndrome	AR	222448	Complex genetic syndromes	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs144147038	chr2_169289151_C_T	Female	./.	Other
chr2	178528964	.	G	A	50	PASS	"FS=1.623;MQ=250;MQRankSum=4.539;QD=1.72;ReadPosRankSum=2.653;SOR=1.387;FractionInformativeReads=1;R2_5P_bias=11.009;DP=53;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|360/363||NM_001267550.2:c.106787C>T|NP_001254479.2:p.Thr35596Ile|107012|106787|35596|T/I|aCa/aTa|rs55842557||-1||SNV|EntrezGene||YES|||G|G||||||0.0038|0.00795|0.0008363|0.001185|0.0008418|0|0.06591|0.001387|0.00671|0.008|0.0005333|0.01013|0.001179|0|0.004381|0.000288|0|0.07591|0|0.008819|0.008996|0.0006216|0.07591|gnomADg_FIN|uncertain_significance&benign&likely_benign||1||||T|0.00770|-0.477021|T|0.28249|-0.445011|0.23913|0.082&0.082&.&.&0.082&0.082&.|-8|45|2|-19|0.00|0.00|0.00|0.00|TTN|||||||47712||Conflicting_classifications_of_pathogenicity|Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiovascular_phenotype&Tibial_muscular_dystrophy&Early-onset_myopathy_with_fatal_cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&not_provided&Cardiomyopathy|NC_000002.12:g.178528964G>A||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN230736&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848|Uncertain_significance(1)&Benign(14)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:13,16:0.552:29:8,10:5,6:48:85,0,49:50,6.8857e-05,52.324:0,34.77,37.77:8,5,12,4:5,8,10,6	0/1:14,9:0.391:23:6,6:8,3:47:82,0,50:47.621,9.6815e-05,53:0,34.77,37.77:11,3,8,1:7,7,5,4	./.:.:.:.:.:.:.:.:.:.:.:.	A	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	360/363		c.106787C>T	p.Thr35596Ile	107012	106787	35596	T/I	aCa/aTa	rs55842557	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0038	0.00795	0.0008363	0.001185	0.0008418	0	0.06591	0.001387	0.00671	0.008	0.0005333	0.01013	0.001179	0	0.004381	0.000288	0	0.07591	0	0.008819	0.008996	0.0006216	0.07591	gnomADg_FIN	uncertain_significance&benign&likely_benign		1	NA	NA	NA	T	0.0077	-0.477021	T	0.28249	-0.445011	0.23913	0.082&0.082&.&.&0.082&0.082&.	-8	45	2	-19	0	0	0	0	TTN			NA				47712	NA	Conflicting_classifications_of_pathogenicity	Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiovascular_phenotype&Tibial_muscular_dystrophy&Early-onset_myopathy_with_fatal_cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&not_provided&Cardiomyopathy	NC_000002.12:g.178528964G>A		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN230736&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848	Uncertain_significance(1)&Benign(14)&Likely_benign(3)	criteria_provided&_conflicting_classifications		TTN	Dilated cardiomyopathy 1G	AD	604145	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs55842557	chr2_178528964_G_A	Female	0/1	Heterozygous
chr2	178528964	.	G	A	50	PASS	"FS=1.623;MQ=250;MQRankSum=4.539;QD=1.72;ReadPosRankSum=2.653;SOR=1.387;FractionInformativeReads=1;R2_5P_bias=11.009;DP=53;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|360/363||NM_001267550.2:c.106787C>T|NP_001254479.2:p.Thr35596Ile|107012|106787|35596|T/I|aCa/aTa|rs55842557||-1||SNV|EntrezGene||YES|||G|G||||||0.0038|0.00795|0.0008363|0.001185|0.0008418|0|0.06591|0.001387|0.00671|0.008|0.0005333|0.01013|0.001179|0|0.004381|0.000288|0|0.07591|0|0.008819|0.008996|0.0006216|0.07591|gnomADg_FIN|uncertain_significance&benign&likely_benign||1||||T|0.00770|-0.477021|T|0.28249|-0.445011|0.23913|0.082&0.082&.&.&0.082&0.082&.|-8|45|2|-19|0.00|0.00|0.00|0.00|TTN|||||||47712||Conflicting_classifications_of_pathogenicity|Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiovascular_phenotype&Tibial_muscular_dystrophy&Early-onset_myopathy_with_fatal_cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&not_provided&Cardiomyopathy|NC_000002.12:g.178528964G>A||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN230736&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848|Uncertain_significance(1)&Benign(14)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:13,16:0.552:29:8,10:5,6:48:85,0,49:50,6.8857e-05,52.324:0,34.77,37.77:8,5,12,4:5,8,10,6	0/1:14,9:0.391:23:6,6:8,3:47:82,0,50:47.621,9.6815e-05,53:0,34.77,37.77:11,3,8,1:7,7,5,4	./.:.:.:.:.:.:.:.:.:.:.:.	A	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	360/363		c.106787C>T	p.Thr35596Ile	107012	106787	35596	T/I	aCa/aTa	rs55842557	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0038	0.00795	0.0008363	0.001185	0.0008418	0	0.06591	0.001387	0.00671	0.008	0.0005333	0.01013	0.001179	0	0.004381	0.000288	0	0.07591	0	0.008819	0.008996	0.0006216	0.07591	gnomADg_FIN	uncertain_significance&benign&likely_benign		1	NA	NA	NA	T	0.0077	-0.477021	T	0.28249	-0.445011	0.23913	0.082&0.082&.&.&0.082&0.082&.	-8	45	2	-19	0	0	0	0	TTN			NA				47712	NA	Conflicting_classifications_of_pathogenicity	Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiovascular_phenotype&Tibial_muscular_dystrophy&Early-onset_myopathy_with_fatal_cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&not_provided&Cardiomyopathy	NC_000002.12:g.178528964G>A		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN230736&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848	Uncertain_significance(1)&Benign(14)&Likely_benign(3)	criteria_provided&_conflicting_classifications		TTN	Hypertrophic cardiomyopathy 9	AD	613765	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs55842557	chr2_178528964_G_A	Female	0/1	Heterozygous
chr2	178528964	.	G	A	50	PASS	"FS=1.623;MQ=250;MQRankSum=4.539;QD=1.72;ReadPosRankSum=2.653;SOR=1.387;FractionInformativeReads=1;R2_5P_bias=11.009;DP=53;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|360/363||NM_001267550.2:c.106787C>T|NP_001254479.2:p.Thr35596Ile|107012|106787|35596|T/I|aCa/aTa|rs55842557||-1||SNV|EntrezGene||YES|||G|G||||||0.0038|0.00795|0.0008363|0.001185|0.0008418|0|0.06591|0.001387|0.00671|0.008|0.0005333|0.01013|0.001179|0|0.004381|0.000288|0|0.07591|0|0.008819|0.008996|0.0006216|0.07591|gnomADg_FIN|uncertain_significance&benign&likely_benign||1||||T|0.00770|-0.477021|T|0.28249|-0.445011|0.23913|0.082&0.082&.&.&0.082&0.082&.|-8|45|2|-19|0.00|0.00|0.00|0.00|TTN|||||||47712||Conflicting_classifications_of_pathogenicity|Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiovascular_phenotype&Tibial_muscular_dystrophy&Early-onset_myopathy_with_fatal_cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&not_provided&Cardiomyopathy|NC_000002.12:g.178528964G>A||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN230736&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848|Uncertain_significance(1)&Benign(14)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:13,16:0.552:29:8,10:5,6:48:85,0,49:50,6.8857e-05,52.324:0,34.77,37.77:8,5,12,4:5,8,10,6	0/1:14,9:0.391:23:6,6:8,3:47:82,0,50:47.621,9.6815e-05,53:0,34.77,37.77:11,3,8,1:7,7,5,4	./.:.:.:.:.:.:.:.:.:.:.:.	A	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	360/363		c.106787C>T	p.Thr35596Ile	107012	106787	35596	T/I	aCa/aTa	rs55842557	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0038	0.00795	0.0008363	0.001185	0.0008418	0	0.06591	0.001387	0.00671	0.008	0.0005333	0.01013	0.001179	0	0.004381	0.000288	0	0.07591	0	0.008819	0.008996	0.0006216	0.07591	gnomADg_FIN	uncertain_significance&benign&likely_benign		1	NA	NA	NA	T	0.0077	-0.477021	T	0.28249	-0.445011	0.23913	0.082&0.082&.&.&0.082&0.082&.	-8	45	2	-19	0	0	0	0	TTN			NA				47712	NA	Conflicting_classifications_of_pathogenicity	Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiovascular_phenotype&Tibial_muscular_dystrophy&Early-onset_myopathy_with_fatal_cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&not_provided&Cardiomyopathy	NC_000002.12:g.178528964G>A		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN230736&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MedGen:C3661900&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848	Uncertain_significance(1)&Benign(14)&Likely_benign(3)	criteria_provided&_conflicting_classifications		TTN	Centronuclear myopathy	AR	NA	Neuromuscular and musculoskelettal disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs55842557	chr2_178528964_G_A	Female	0/1	Heterozygous
chr2	178531846	.	T	G	49.56	PASS	"FS=3.035;MQ=250;MQRankSum=5.31;QD=1.27;ReadPosRankSum=2.747;SOR=1.27;FractionInformativeReads=1;R2_5P_bias=-5.306;DP=75;AF=0.5;AN=4;AC=2;CSQ=G|synonymous_variant|LOW|TTN|7273|Transcript|NM_001267550.2|protein_coding|358/363||NM_001267550.2:c.104769A>C|NP_001254479.2:p.Thr34923%3D|104994|104769|34923|T|acA/acC|rs56375087||-1||SNV|EntrezGene||YES|||T|T||||||0.0038|0.008001|0.0008364|0.001185|0.0008419|0|0.06619|0.001387|0.006763|0.008017|0.0005333|0.01016|0.001179|0|0.004381|0.000288|0|0.07617|0|0.008823|0.008979|0.0006224|0.07617|gnomADg_FIN|benign&likely_benign&uncertain_significance||1||||||||||||-34|39|40|-11|0.00|0.00|0.00|0.00|TTN|||||||47677||Conflicting_classifications_of_pathogenicity|not_specified&Tibial_muscular_dystrophy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Dilated_cardiomyopathy_1G&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_provided|NC_000002.12:g.178531846T>G||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:C3661900|Uncertain_significance(1)&Benign(13)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:21,18:0.462:39:10,9:11,9:48:84,0,50:49.56,6.9893e-05,53:0,34.77,37.77:14,7,14,4:13,8,9,9	0/1:25,11:0.306:36:14,8:11,3:38:73,0,50:37.841,0.00073574,53.001:0,34.77,37.77:13,12,5,6:12,13,6,5	./.:.:.:.:.:.:.:.:.:.:.:.	G	synonymous_variant	LOW	TTN	7273	Transcript	NM_001267550.2	protein_coding	358/363		c.104769A>C	p.Thr34923%3D	104994	104769	34923	T	acA/acC	rs56375087	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.0038	0.008001	0.0008364	0.001185	0.0008419	0	0.06619	0.001387	0.006763	0.008017	0.0005333	0.01016	0.001179	0	0.004381	0.000288	0	0.07617	0	0.008823	0.008979	0.0006224	0.07617	gnomADg_FIN	benign&likely_benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-34	39	40	-11	0	0	0	0	TTN			NA				47677	NA	Conflicting_classifications_of_pathogenicity	not_specified&Tibial_muscular_dystrophy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Dilated_cardiomyopathy_1G&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_provided	NC_000002.12:g.178531846T>G		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:C3661900	Uncertain_significance(1)&Benign(13)&Likely_benign(3)	criteria_provided&_conflicting_classifications		TTN	Dilated cardiomyopathy 1G	AD	604145	Cardiac and vascular disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BS1,BS2	rs56375087	chr2_178531846_T_G	Female	0/1	Heterozygous
chr2	178531846	.	T	G	49.56	PASS	"FS=3.035;MQ=250;MQRankSum=5.31;QD=1.27;ReadPosRankSum=2.747;SOR=1.27;FractionInformativeReads=1;R2_5P_bias=-5.306;DP=75;AF=0.5;AN=4;AC=2;CSQ=G|synonymous_variant|LOW|TTN|7273|Transcript|NM_001267550.2|protein_coding|358/363||NM_001267550.2:c.104769A>C|NP_001254479.2:p.Thr34923%3D|104994|104769|34923|T|acA/acC|rs56375087||-1||SNV|EntrezGene||YES|||T|T||||||0.0038|0.008001|0.0008364|0.001185|0.0008419|0|0.06619|0.001387|0.006763|0.008017|0.0005333|0.01016|0.001179|0|0.004381|0.000288|0|0.07617|0|0.008823|0.008979|0.0006224|0.07617|gnomADg_FIN|benign&likely_benign&uncertain_significance||1||||||||||||-34|39|40|-11|0.00|0.00|0.00|0.00|TTN|||||||47677||Conflicting_classifications_of_pathogenicity|not_specified&Tibial_muscular_dystrophy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Dilated_cardiomyopathy_1G&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_provided|NC_000002.12:g.178531846T>G||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:C3661900|Uncertain_significance(1)&Benign(13)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:21,18:0.462:39:10,9:11,9:48:84,0,50:49.56,6.9893e-05,53:0,34.77,37.77:14,7,14,4:13,8,9,9	0/1:25,11:0.306:36:14,8:11,3:38:73,0,50:37.841,0.00073574,53.001:0,34.77,37.77:13,12,5,6:12,13,6,5	./.:.:.:.:.:.:.:.:.:.:.:.	G	synonymous_variant	LOW	TTN	7273	Transcript	NM_001267550.2	protein_coding	358/363		c.104769A>C	p.Thr34923%3D	104994	104769	34923	T	acA/acC	rs56375087	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.0038	0.008001	0.0008364	0.001185	0.0008419	0	0.06619	0.001387	0.006763	0.008017	0.0005333	0.01016	0.001179	0	0.004381	0.000288	0	0.07617	0	0.008823	0.008979	0.0006224	0.07617	gnomADg_FIN	benign&likely_benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-34	39	40	-11	0	0	0	0	TTN			NA				47677	NA	Conflicting_classifications_of_pathogenicity	not_specified&Tibial_muscular_dystrophy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Dilated_cardiomyopathy_1G&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_provided	NC_000002.12:g.178531846T>G		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:C3661900	Uncertain_significance(1)&Benign(13)&Likely_benign(3)	criteria_provided&_conflicting_classifications		TTN	Hypertrophic cardiomyopathy 9	AD	613765	Cardiac and vascular disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BS1,BS2	rs56375087	chr2_178531846_T_G	Female	0/1	Heterozygous
chr2	178531846	.	T	G	49.56	PASS	"FS=3.035;MQ=250;MQRankSum=5.31;QD=1.27;ReadPosRankSum=2.747;SOR=1.27;FractionInformativeReads=1;R2_5P_bias=-5.306;DP=75;AF=0.5;AN=4;AC=2;CSQ=G|synonymous_variant|LOW|TTN|7273|Transcript|NM_001267550.2|protein_coding|358/363||NM_001267550.2:c.104769A>C|NP_001254479.2:p.Thr34923%3D|104994|104769|34923|T|acA/acC|rs56375087||-1||SNV|EntrezGene||YES|||T|T||||||0.0038|0.008001|0.0008364|0.001185|0.0008419|0|0.06619|0.001387|0.006763|0.008017|0.0005333|0.01016|0.001179|0|0.004381|0.000288|0|0.07617|0|0.008823|0.008979|0.0006224|0.07617|gnomADg_FIN|benign&likely_benign&uncertain_significance||1||||||||||||-34|39|40|-11|0.00|0.00|0.00|0.00|TTN|||||||47677||Conflicting_classifications_of_pathogenicity|not_specified&Tibial_muscular_dystrophy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Dilated_cardiomyopathy_1G&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_provided|NC_000002.12:g.178531846T>G||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:C3661900|Uncertain_significance(1)&Benign(13)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:21,18:0.462:39:10,9:11,9:48:84,0,50:49.56,6.9893e-05,53:0,34.77,37.77:14,7,14,4:13,8,9,9	0/1:25,11:0.306:36:14,8:11,3:38:73,0,50:37.841,0.00073574,53.001:0,34.77,37.77:13,12,5,6:12,13,6,5	./.:.:.:.:.:.:.:.:.:.:.:.	G	synonymous_variant	LOW	TTN	7273	Transcript	NM_001267550.2	protein_coding	358/363		c.104769A>C	p.Thr34923%3D	104994	104769	34923	T	acA/acC	rs56375087	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.0038	0.008001	0.0008364	0.001185	0.0008419	0	0.06619	0.001387	0.006763	0.008017	0.0005333	0.01016	0.001179	0	0.004381	0.000288	0	0.07617	0	0.008823	0.008979	0.0006224	0.07617	gnomADg_FIN	benign&likely_benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-34	39	40	-11	0	0	0	0	TTN			NA				47677	NA	Conflicting_classifications_of_pathogenicity	not_specified&Tibial_muscular_dystrophy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Dilated_cardiomyopathy_1G&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_provided	NC_000002.12:g.178531846T>G		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:C3661900	Uncertain_significance(1)&Benign(13)&Likely_benign(3)	criteria_provided&_conflicting_classifications		TTN	Centronuclear myopathy	AR	NA	Neuromuscular and musculoskelettal disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BS1,BS2	rs56375087	chr2_178531846_T_G	Female	0/1	Heterozygous
chr2	178549450	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=5.75;QD=1.05;ReadPosRankSum=1.562;SOR=0.56;FractionInformativeReads=1;R2_5P_bias=9.686;DP=79;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|339/363||NM_001267550.2:c.92176C>T|NP_001254479.2:p.Pro30726Ser|92401|92176|30726|P/S|Cca/Tca|rs72648247||-1||SNV|EntrezGene||YES|||G|G||||||0.0020|0.002736|0.0004521|0.000948|0.004431|0|0.001241|0.006799|0.002826|0.002083|0.005242|0.001983|0.0003851|0|0.0007194|0.002594|0|0.00179|0.01361|0.003102|0.00189|0.005804|0.01361|gnomADg_MID|benign/likely_benign&uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_pathogenic&likely_benign||1||||T|0.07964|-0.30756|T|0.53482|-0.21223|0.79583|0.520&0.520&.&.&0.520&0.520&.|-4|23|-4|-21|0.00|0.00|0.00|0.00|TTN|||||||47520||Conflicting_classifications_of_pathogenicity|Cardiomyopathy&Tibial_muscular_dystrophy&Dilated_cardiomyopathy_1G&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Tip-toe_gait&Supraventricular_tachycardia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Cardiovascular_phenotype&TTN-related_disorder&Dilated_Cardiomyopathy&_Dominant&Limb-girdle_muscular_dystrophy&_recessive&Hypertrophic_cardiomyopathy&not_provided&Early-onset_myopathy_with_fatal_cardiomyopathy&TTN-related_myopathy|NC_000002.12:g.178549450G>A||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MedGen:CN230736&.&MedGen:CN239310&MedGen:CN239352&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&MedGen:C3661900&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0100175&MedGen:CN294812|Uncertain_significance(8)&Benign(5)&Likely_benign(9)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:26,20:0.435:46:15,8:11,12:47:83,0,50:48.269,8.646e-05,53:0,34.77,37.77:14,12,10,10:13,13,10,10	0/1:9,24:0.727:33:2,14:7,10:38:85,0,35:50.001,0.00070027,38.204:0,34.77,37.77:7,2,13,11:2,7,7,17	A	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	339/363		c.92176C>T	p.Pro30726Ser	92401	92176	30726	P/S	Cca/Tca	rs72648247	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.002	0.002736	0.0004521	0.000948	0.004431	0	0.001241	0.006799	0.002826	0.002083	0.005242	0.001983	0.0003851	0	0.0007194	0.002594	0	0.00179	0.01361	0.003102	0.00189	0.005804	0.01361	gnomADg_MID	benign/likely_benign&uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_pathogenic&likely_benign		1	NA	NA	NA	T	0.07964	-0.30756	T	0.53482	-0.21223	0.79583	0.520&0.520&.&.&0.520&0.520&.	-4	23	-4	-21	0	0	0	0	TTN			NA				47520	NA	Conflicting_classifications_of_pathogenicity	Cardiomyopathy&Tibial_muscular_dystrophy&Dilated_cardiomyopathy_1G&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Tip-toe_gait&Supraventricular_tachycardia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Cardiovascular_phenotype&TTN-related_disorder&Dilated_Cardiomyopathy&_Dominant&Limb-girdle_muscular_dystrophy&_recessive&Hypertrophic_cardiomyopathy&not_provided&Early-onset_myopathy_with_fatal_cardiomyopathy&TTN-related_myopathy	NC_000002.12:g.178549450G>A		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MedGen:CN230736&.&MedGen:CN239310&MedGen:CN239352&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&MedGen:C3661900&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0100175&MedGen:CN294812	Uncertain_significance(8)&Benign(5)&Likely_benign(9)	criteria_provided&_conflicting_classifications		TTN	Dilated cardiomyopathy 1G	AD	604145	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72648247	chr2_178549450_G_A	Female	./.	Other
chr2	178549450	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=5.75;QD=1.05;ReadPosRankSum=1.562;SOR=0.56;FractionInformativeReads=1;R2_5P_bias=9.686;DP=79;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|339/363||NM_001267550.2:c.92176C>T|NP_001254479.2:p.Pro30726Ser|92401|92176|30726|P/S|Cca/Tca|rs72648247||-1||SNV|EntrezGene||YES|||G|G||||||0.0020|0.002736|0.0004521|0.000948|0.004431|0|0.001241|0.006799|0.002826|0.002083|0.005242|0.001983|0.0003851|0|0.0007194|0.002594|0|0.00179|0.01361|0.003102|0.00189|0.005804|0.01361|gnomADg_MID|benign/likely_benign&uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_pathogenic&likely_benign||1||||T|0.07964|-0.30756|T|0.53482|-0.21223|0.79583|0.520&0.520&.&.&0.520&0.520&.|-4|23|-4|-21|0.00|0.00|0.00|0.00|TTN|||||||47520||Conflicting_classifications_of_pathogenicity|Cardiomyopathy&Tibial_muscular_dystrophy&Dilated_cardiomyopathy_1G&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Tip-toe_gait&Supraventricular_tachycardia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Cardiovascular_phenotype&TTN-related_disorder&Dilated_Cardiomyopathy&_Dominant&Limb-girdle_muscular_dystrophy&_recessive&Hypertrophic_cardiomyopathy&not_provided&Early-onset_myopathy_with_fatal_cardiomyopathy&TTN-related_myopathy|NC_000002.12:g.178549450G>A||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MedGen:CN230736&.&MedGen:CN239310&MedGen:CN239352&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&MedGen:C3661900&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0100175&MedGen:CN294812|Uncertain_significance(8)&Benign(5)&Likely_benign(9)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:26,20:0.435:46:15,8:11,12:47:83,0,50:48.269,8.646e-05,53:0,34.77,37.77:14,12,10,10:13,13,10,10	0/1:9,24:0.727:33:2,14:7,10:38:85,0,35:50.001,0.00070027,38.204:0,34.77,37.77:7,2,13,11:2,7,7,17	A	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	339/363		c.92176C>T	p.Pro30726Ser	92401	92176	30726	P/S	Cca/Tca	rs72648247	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.002	0.002736	0.0004521	0.000948	0.004431	0	0.001241	0.006799	0.002826	0.002083	0.005242	0.001983	0.0003851	0	0.0007194	0.002594	0	0.00179	0.01361	0.003102	0.00189	0.005804	0.01361	gnomADg_MID	benign/likely_benign&uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_pathogenic&likely_benign		1	NA	NA	NA	T	0.07964	-0.30756	T	0.53482	-0.21223	0.79583	0.520&0.520&.&.&0.520&0.520&.	-4	23	-4	-21	0	0	0	0	TTN			NA				47520	NA	Conflicting_classifications_of_pathogenicity	Cardiomyopathy&Tibial_muscular_dystrophy&Dilated_cardiomyopathy_1G&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Tip-toe_gait&Supraventricular_tachycardia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Cardiovascular_phenotype&TTN-related_disorder&Dilated_Cardiomyopathy&_Dominant&Limb-girdle_muscular_dystrophy&_recessive&Hypertrophic_cardiomyopathy&not_provided&Early-onset_myopathy_with_fatal_cardiomyopathy&TTN-related_myopathy	NC_000002.12:g.178549450G>A		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MedGen:CN230736&.&MedGen:CN239310&MedGen:CN239352&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&MedGen:C3661900&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0100175&MedGen:CN294812	Uncertain_significance(8)&Benign(5)&Likely_benign(9)	criteria_provided&_conflicting_classifications		TTN	Hypertrophic cardiomyopathy 9	AD	613765	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72648247	chr2_178549450_G_A	Female	./.	Other
chr2	178549450	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=5.75;QD=1.05;ReadPosRankSum=1.562;SOR=0.56;FractionInformativeReads=1;R2_5P_bias=9.686;DP=79;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|339/363||NM_001267550.2:c.92176C>T|NP_001254479.2:p.Pro30726Ser|92401|92176|30726|P/S|Cca/Tca|rs72648247||-1||SNV|EntrezGene||YES|||G|G||||||0.0020|0.002736|0.0004521|0.000948|0.004431|0|0.001241|0.006799|0.002826|0.002083|0.005242|0.001983|0.0003851|0|0.0007194|0.002594|0|0.00179|0.01361|0.003102|0.00189|0.005804|0.01361|gnomADg_MID|benign/likely_benign&uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_pathogenic&likely_benign||1||||T|0.07964|-0.30756|T|0.53482|-0.21223|0.79583|0.520&0.520&.&.&0.520&0.520&.|-4|23|-4|-21|0.00|0.00|0.00|0.00|TTN|||||||47520||Conflicting_classifications_of_pathogenicity|Cardiomyopathy&Tibial_muscular_dystrophy&Dilated_cardiomyopathy_1G&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Tip-toe_gait&Supraventricular_tachycardia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Cardiovascular_phenotype&TTN-related_disorder&Dilated_Cardiomyopathy&_Dominant&Limb-girdle_muscular_dystrophy&_recessive&Hypertrophic_cardiomyopathy&not_provided&Early-onset_myopathy_with_fatal_cardiomyopathy&TTN-related_myopathy|NC_000002.12:g.178549450G>A||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MedGen:CN230736&.&MedGen:CN239310&MedGen:CN239352&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&MedGen:C3661900&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0100175&MedGen:CN294812|Uncertain_significance(8)&Benign(5)&Likely_benign(9)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:26,20:0.435:46:15,8:11,12:47:83,0,50:48.269,8.646e-05,53:0,34.77,37.77:14,12,10,10:13,13,10,10	0/1:9,24:0.727:33:2,14:7,10:38:85,0,35:50.001,0.00070027,38.204:0,34.77,37.77:7,2,13,11:2,7,7,17	A	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	339/363		c.92176C>T	p.Pro30726Ser	92401	92176	30726	P/S	Cca/Tca	rs72648247	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.002	0.002736	0.0004521	0.000948	0.004431	0	0.001241	0.006799	0.002826	0.002083	0.005242	0.001983	0.0003851	0	0.0007194	0.002594	0	0.00179	0.01361	0.003102	0.00189	0.005804	0.01361	gnomADg_MID	benign/likely_benign&uncertain_significance&conflicting_interpretations_of_pathogenicity&benign&likely_pathogenic&likely_benign		1	NA	NA	NA	T	0.07964	-0.30756	T	0.53482	-0.21223	0.79583	0.520&0.520&.&.&0.520&0.520&.	-4	23	-4	-21	0	0	0	0	TTN			NA				47520	NA	Conflicting_classifications_of_pathogenicity	Cardiomyopathy&Tibial_muscular_dystrophy&Dilated_cardiomyopathy_1G&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Tip-toe_gait&Supraventricular_tachycardia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Cardiovascular_phenotype&TTN-related_disorder&Dilated_Cardiomyopathy&_Dominant&Limb-girdle_muscular_dystrophy&_recessive&Hypertrophic_cardiomyopathy&not_provided&Early-onset_myopathy_with_fatal_cardiomyopathy&TTN-related_myopathy	NC_000002.12:g.178549450G>A		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MedGen:CN230736&.&MedGen:CN239310&MedGen:CN239352&Human_Phenotype_Ontology:HP:0001639&MONDO:MONDO:0005045&MeSH:D002312&MedGen:C0007194&Orphanet:217569&MedGen:C3661900&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0100175&MedGen:CN294812	Uncertain_significance(8)&Benign(5)&Likely_benign(9)	criteria_provided&_conflicting_classifications		TTN	Centronuclear myopathy	AR	NA	Neuromuscular and musculoskelettal disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72648247	chr2_178549450_G_A	Female	./.	Other
chr2	178563069	.	C	T	50	PASS	"FS=6.467;MQ=250;MQRankSum=4.539;QD=1.7;ReadPosRankSum=0.592;SOR=0.101;FractionInformativeReads=1;R2_5P_bias=-6.614;DP=65;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|326/363||NM_001267550.2:c.83063G>A|NP_001254479.2:p.Arg27688His|83288|83063|27688|R/H|cGt/cAt|rs185002960&COSV60316013||-1||SNV|EntrezGene||YES|||C|C||||||0.0014|0.00184|0.0003586|0.0002236|0.0001914|0.0004283|0.02943|0|0.0008671|0.00169|9.275e-05|0.003049|0.0003129|0|6.558e-05|0.0002882|0|0.03235|0|0.00147|0.002367|0.0002075|0.03235|gnomADg_FIN|conflicting_interpretations_of_pathogenicity&uncertain_significance&benign|0&1|1&1||||T|0.06206|-0.328752|T|0.50195|-0.246162|0.72252|0.411&0.411&.&.&0.411&0.411&.|14|-39|-1|14|0.00|0.00|0.00|0.00|TTN|||||||191875||Conflicting_classifications_of_pathogenicity|Tibial_muscular_dystrophy&TTN-related_disorder&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&not_provided|NC_000002.12:g.178563069C>T||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&.&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MedGen:C3661900|Uncertain_significance(4)&Benign(11)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,13:0.448:29:8,8:8,5:48:84,0,50:49.325,7.2481e-05,53:0,34.77,37.77:13,3,7,6:5,11,8,5	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,19:0.559:34:6,11:9,8:48:85,0,49:50,7.0928e-05,51.978:0,34.77,37.77:7,8,6,13:12,3,10,9	T	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	326/363		c.83063G>A	p.Arg27688His	83288	83063	27688	R/H	cGt/cAt	rs185002960&COSV60316013	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0014	0.00184	0.0003586	0.0002236	0.0001914	0.0004283	0.02943	0	0.0008671	0.00169	9.275e-05	0.003049	0.0003129	0	6.558e-05	0.0002882	0	0.03235	0	0.00147	0.002367	0.0002075	0.03235	gnomADg_FIN	conflicting_interpretations_of_pathogenicity&uncertain_significance&benign	0&1	1&1	NA	NA	NA	T	0.06206	-0.328752	T	0.50195	-0.246162	0.72252	0.411&0.411&.&.&0.411&0.411&.	14	-39	-1	14	0	0	0	0	TTN			NA				191875	NA	Conflicting_classifications_of_pathogenicity	Tibial_muscular_dystrophy&TTN-related_disorder&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&not_provided	NC_000002.12:g.178563069C>T		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&.&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MedGen:C3661900	Uncertain_significance(4)&Benign(11)&Likely_benign(1)	criteria_provided&_conflicting_classifications		TTN	Dilated cardiomyopathy 1G	AD	604145	Cardiac and vascular disorders	NBScreening	-9	Benign	BP4_Strong,BP6,BS2	rs185002960	chr2_178563069_C_T	Female	0/1	Heterozygous
chr2	178563069	.	C	T	50	PASS	"FS=6.467;MQ=250;MQRankSum=4.539;QD=1.7;ReadPosRankSum=0.592;SOR=0.101;FractionInformativeReads=1;R2_5P_bias=-6.614;DP=65;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|326/363||NM_001267550.2:c.83063G>A|NP_001254479.2:p.Arg27688His|83288|83063|27688|R/H|cGt/cAt|rs185002960&COSV60316013||-1||SNV|EntrezGene||YES|||C|C||||||0.0014|0.00184|0.0003586|0.0002236|0.0001914|0.0004283|0.02943|0|0.0008671|0.00169|9.275e-05|0.003049|0.0003129|0|6.558e-05|0.0002882|0|0.03235|0|0.00147|0.002367|0.0002075|0.03235|gnomADg_FIN|conflicting_interpretations_of_pathogenicity&uncertain_significance&benign|0&1|1&1||||T|0.06206|-0.328752|T|0.50195|-0.246162|0.72252|0.411&0.411&.&.&0.411&0.411&.|14|-39|-1|14|0.00|0.00|0.00|0.00|TTN|||||||191875||Conflicting_classifications_of_pathogenicity|Tibial_muscular_dystrophy&TTN-related_disorder&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&not_provided|NC_000002.12:g.178563069C>T||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&.&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MedGen:C3661900|Uncertain_significance(4)&Benign(11)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,13:0.448:29:8,8:8,5:48:84,0,50:49.325,7.2481e-05,53:0,34.77,37.77:13,3,7,6:5,11,8,5	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,19:0.559:34:6,11:9,8:48:85,0,49:50,7.0928e-05,51.978:0,34.77,37.77:7,8,6,13:12,3,10,9	T	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	326/363		c.83063G>A	p.Arg27688His	83288	83063	27688	R/H	cGt/cAt	rs185002960&COSV60316013	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0014	0.00184	0.0003586	0.0002236	0.0001914	0.0004283	0.02943	0	0.0008671	0.00169	9.275e-05	0.003049	0.0003129	0	6.558e-05	0.0002882	0	0.03235	0	0.00147	0.002367	0.0002075	0.03235	gnomADg_FIN	conflicting_interpretations_of_pathogenicity&uncertain_significance&benign	0&1	1&1	NA	NA	NA	T	0.06206	-0.328752	T	0.50195	-0.246162	0.72252	0.411&0.411&.&.&0.411&0.411&.	14	-39	-1	14	0	0	0	0	TTN			NA				191875	NA	Conflicting_classifications_of_pathogenicity	Tibial_muscular_dystrophy&TTN-related_disorder&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&not_provided	NC_000002.12:g.178563069C>T		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&.&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MedGen:C3661900	Uncertain_significance(4)&Benign(11)&Likely_benign(1)	criteria_provided&_conflicting_classifications		TTN	Hypertrophic cardiomyopathy 9	AD	613765	Cardiac and vascular disorders	NBScreening	-9	Benign	BP4_Strong,BP6,BS2	rs185002960	chr2_178563069_C_T	Female	0/1	Heterozygous
chr2	178563069	.	C	T	50	PASS	"FS=6.467;MQ=250;MQRankSum=4.539;QD=1.7;ReadPosRankSum=0.592;SOR=0.101;FractionInformativeReads=1;R2_5P_bias=-6.614;DP=65;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|326/363||NM_001267550.2:c.83063G>A|NP_001254479.2:p.Arg27688His|83288|83063|27688|R/H|cGt/cAt|rs185002960&COSV60316013||-1||SNV|EntrezGene||YES|||C|C||||||0.0014|0.00184|0.0003586|0.0002236|0.0001914|0.0004283|0.02943|0|0.0008671|0.00169|9.275e-05|0.003049|0.0003129|0|6.558e-05|0.0002882|0|0.03235|0|0.00147|0.002367|0.0002075|0.03235|gnomADg_FIN|conflicting_interpretations_of_pathogenicity&uncertain_significance&benign|0&1|1&1||||T|0.06206|-0.328752|T|0.50195|-0.246162|0.72252|0.411&0.411&.&.&0.411&0.411&.|14|-39|-1|14|0.00|0.00|0.00|0.00|TTN|||||||191875||Conflicting_classifications_of_pathogenicity|Tibial_muscular_dystrophy&TTN-related_disorder&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&not_provided|NC_000002.12:g.178563069C>T||single_nucleotide_variant|TTN:7273&TTN-AS1:100506866|MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&.&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MedGen:C3661900|Uncertain_significance(4)&Benign(11)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,13:0.448:29:8,8:8,5:48:84,0,50:49.325,7.2481e-05,53:0,34.77,37.77:13,3,7,6:5,11,8,5	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,19:0.559:34:6,11:9,8:48:85,0,49:50,7.0928e-05,51.978:0,34.77,37.77:7,8,6,13:12,3,10,9	T	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	326/363		c.83063G>A	p.Arg27688His	83288	83063	27688	R/H	cGt/cAt	rs185002960&COSV60316013	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0014	0.00184	0.0003586	0.0002236	0.0001914	0.0004283	0.02943	0	0.0008671	0.00169	9.275e-05	0.003049	0.0003129	0	6.558e-05	0.0002882	0	0.03235	0	0.00147	0.002367	0.0002075	0.03235	gnomADg_FIN	conflicting_interpretations_of_pathogenicity&uncertain_significance&benign	0&1	1&1	NA	NA	NA	T	0.06206	-0.328752	T	0.50195	-0.246162	0.72252	0.411&0.411&.&.&0.411&0.411&.	14	-39	-1	14	0	0	0	0	TTN			NA				191875	NA	Conflicting_classifications_of_pathogenicity	Tibial_muscular_dystrophy&TTN-related_disorder&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&not_specified&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&not_provided	NC_000002.12:g.178563069C>T		single_nucleotide_variant	TTN:7273&TTN-AS1:100506866	MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&.&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&MedGen:CN169374&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MedGen:C3661900	Uncertain_significance(4)&Benign(11)&Likely_benign(1)	criteria_provided&_conflicting_classifications		TTN	Centronuclear myopathy	AR	NA	Neuromuscular and musculoskelettal disorders	NBScreening	-9	Benign	BP4_Strong,BP6,BS2	rs185002960	chr2_178563069_C_T	Female	0/1	Heterozygous
chr2	178734746	.	C	G	50	PASS	"FS=0;MQ=250;MQRankSum=4.546;QD=1.43;ReadPosRankSum=2.83;SOR=0.586;FractionInformativeReads=1;R2_5P_bias=-5.49;DP=69;AF=0.5;AN=4;AC=2;CSQ=G|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|51/363||NM_001267550.2:c.15178G>C|NP_001254479.2:p.Val5060Leu|15403|15178|5060|V/L|Gtc/Ctc|rs72648929&COSV59921618||-1||SNV|EntrezGene||YES|||C|C||||||0.0034|0.003265|0.0005081|0.0006934|0.009723|0.000126|0.001311|0.009896|0.003074|0.003198|0.008433|0.002351|0.0004329|0|0.0005889|0.00951|0.0003862|0.001884|0|0.003353|0.002365|0.00891|0.0123|SAS|benign&likely_benign&likely_pathogenic&uncertain_significance|0&1|1&1||||T|0.02097|-0.406531|T|0.39005|-0.351743|0.53931|0.236&.&.&.|-39|41|49|-39|0.00|0.00|0.00|0.04|TTN|||||||46599||Conflicting_classifications_of_pathogenicity|not_provided&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Tip-toe_gait&Supraventricular_tachycardia&Tibial_muscular_dystrophy&Cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&not_specified&TTN-related_myopathy|NC_000002.12:g.178734746C>G||single_nucleotide_variant|TTN:7273|MedGen:C3661900&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MedGen:CN169374&MONDO:MONDO:0100175&MedGen:CN294812|Uncertain_significance(1)&Benign(11)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:10,25:0.714:35:7,15:3,10:39:85,0,36:50.001,0.00060862,38.856:0,34.77,37.77:4,6,11,14:5,5,11,14	0/1:14,20:0.588:34:8,15:6,5:47:85,0,48:50,7.973e-05,50.769:0,34.77,37.77:7,7,3,17:7,7,6,14	G	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	51/363		c.15178G>C	p.Val5060Leu	15403	15178	5060	V/L	Gtc/Ctc	rs72648929&COSV59921618	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0034	0.003265	0.0005081	0.0006934	0.009723	0.000126	0.001311	0.009896	0.003074	0.003198	0.008433	0.002351	0.0004329	0	0.0005889	0.00951	0.0003862	0.001884	0	0.003353	0.002365	0.00891	0.0123	SAS	benign&likely_benign&likely_pathogenic&uncertain_significance	0&1	1&1	NA	NA	NA	T	0.02097	-0.406531	T	0.39005	-0.351743	0.53931	0.236&.&.&.	-39	41	49	-39	0	0	0	0.04	TTN			NA				46599	NA	Conflicting_classifications_of_pathogenicity	not_provided&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Tip-toe_gait&Supraventricular_tachycardia&Tibial_muscular_dystrophy&Cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&not_specified&TTN-related_myopathy	NC_000002.12:g.178734746C>G		single_nucleotide_variant	TTN:7273	MedGen:C3661900&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MedGen:CN169374&MONDO:MONDO:0100175&MedGen:CN294812	Uncertain_significance(1)&Benign(11)&Likely_benign(5)	criteria_provided&_conflicting_classifications		TTN	Dilated cardiomyopathy 1G	AD	604145	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72648929	chr2_178734746_C_G	Female	./.	Other
chr2	178734746	.	C	G	50	PASS	"FS=0;MQ=250;MQRankSum=4.546;QD=1.43;ReadPosRankSum=2.83;SOR=0.586;FractionInformativeReads=1;R2_5P_bias=-5.49;DP=69;AF=0.5;AN=4;AC=2;CSQ=G|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|51/363||NM_001267550.2:c.15178G>C|NP_001254479.2:p.Val5060Leu|15403|15178|5060|V/L|Gtc/Ctc|rs72648929&COSV59921618||-1||SNV|EntrezGene||YES|||C|C||||||0.0034|0.003265|0.0005081|0.0006934|0.009723|0.000126|0.001311|0.009896|0.003074|0.003198|0.008433|0.002351|0.0004329|0|0.0005889|0.00951|0.0003862|0.001884|0|0.003353|0.002365|0.00891|0.0123|SAS|benign&likely_benign&likely_pathogenic&uncertain_significance|0&1|1&1||||T|0.02097|-0.406531|T|0.39005|-0.351743|0.53931|0.236&.&.&.|-39|41|49|-39|0.00|0.00|0.00|0.04|TTN|||||||46599||Conflicting_classifications_of_pathogenicity|not_provided&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Tip-toe_gait&Supraventricular_tachycardia&Tibial_muscular_dystrophy&Cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&not_specified&TTN-related_myopathy|NC_000002.12:g.178734746C>G||single_nucleotide_variant|TTN:7273|MedGen:C3661900&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MedGen:CN169374&MONDO:MONDO:0100175&MedGen:CN294812|Uncertain_significance(1)&Benign(11)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:10,25:0.714:35:7,15:3,10:39:85,0,36:50.001,0.00060862,38.856:0,34.77,37.77:4,6,11,14:5,5,11,14	0/1:14,20:0.588:34:8,15:6,5:47:85,0,48:50,7.973e-05,50.769:0,34.77,37.77:7,7,3,17:7,7,6,14	G	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	51/363		c.15178G>C	p.Val5060Leu	15403	15178	5060	V/L	Gtc/Ctc	rs72648929&COSV59921618	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0034	0.003265	0.0005081	0.0006934	0.009723	0.000126	0.001311	0.009896	0.003074	0.003198	0.008433	0.002351	0.0004329	0	0.0005889	0.00951	0.0003862	0.001884	0	0.003353	0.002365	0.00891	0.0123	SAS	benign&likely_benign&likely_pathogenic&uncertain_significance	0&1	1&1	NA	NA	NA	T	0.02097	-0.406531	T	0.39005	-0.351743	0.53931	0.236&.&.&.	-39	41	49	-39	0	0	0	0.04	TTN			NA				46599	NA	Conflicting_classifications_of_pathogenicity	not_provided&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Tip-toe_gait&Supraventricular_tachycardia&Tibial_muscular_dystrophy&Cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&not_specified&TTN-related_myopathy	NC_000002.12:g.178734746C>G		single_nucleotide_variant	TTN:7273	MedGen:C3661900&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MedGen:CN169374&MONDO:MONDO:0100175&MedGen:CN294812	Uncertain_significance(1)&Benign(11)&Likely_benign(5)	criteria_provided&_conflicting_classifications		TTN	Hypertrophic cardiomyopathy 9	AD	613765	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72648929	chr2_178734746_C_G	Female	./.	Other
chr2	178734746	.	C	G	50	PASS	"FS=0;MQ=250;MQRankSum=4.546;QD=1.43;ReadPosRankSum=2.83;SOR=0.586;FractionInformativeReads=1;R2_5P_bias=-5.49;DP=69;AF=0.5;AN=4;AC=2;CSQ=G|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|51/363||NM_001267550.2:c.15178G>C|NP_001254479.2:p.Val5060Leu|15403|15178|5060|V/L|Gtc/Ctc|rs72648929&COSV59921618||-1||SNV|EntrezGene||YES|||C|C||||||0.0034|0.003265|0.0005081|0.0006934|0.009723|0.000126|0.001311|0.009896|0.003074|0.003198|0.008433|0.002351|0.0004329|0|0.0005889|0.00951|0.0003862|0.001884|0|0.003353|0.002365|0.00891|0.0123|SAS|benign&likely_benign&likely_pathogenic&uncertain_significance|0&1|1&1||||T|0.02097|-0.406531|T|0.39005|-0.351743|0.53931|0.236&.&.&.|-39|41|49|-39|0.00|0.00|0.00|0.04|TTN|||||||46599||Conflicting_classifications_of_pathogenicity|not_provided&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Tip-toe_gait&Supraventricular_tachycardia&Tibial_muscular_dystrophy&Cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&not_specified&TTN-related_myopathy|NC_000002.12:g.178734746C>G||single_nucleotide_variant|TTN:7273|MedGen:C3661900&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MedGen:CN169374&MONDO:MONDO:0100175&MedGen:CN294812|Uncertain_significance(1)&Benign(11)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:10,25:0.714:35:7,15:3,10:39:85,0,36:50.001,0.00060862,38.856:0,34.77,37.77:4,6,11,14:5,5,11,14	0/1:14,20:0.588:34:8,15:6,5:47:85,0,48:50,7.973e-05,50.769:0,34.77,37.77:7,7,3,17:7,7,6,14	G	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	51/363		c.15178G>C	p.Val5060Leu	15403	15178	5060	V/L	Gtc/Ctc	rs72648929&COSV59921618	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0034	0.003265	0.0005081	0.0006934	0.009723	0.000126	0.001311	0.009896	0.003074	0.003198	0.008433	0.002351	0.0004329	0	0.0005889	0.00951	0.0003862	0.001884	0	0.003353	0.002365	0.00891	0.0123	SAS	benign&likely_benign&likely_pathogenic&uncertain_significance	0&1	1&1	NA	NA	NA	T	0.02097	-0.406531	T	0.39005	-0.351743	0.53931	0.236&.&.&.	-39	41	49	-39	0	0	0	0.04	TTN			NA				46599	NA	Conflicting_classifications_of_pathogenicity	not_provided&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Tip-toe_gait&Supraventricular_tachycardia&Tibial_muscular_dystrophy&Cardiomyopathy&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Early-onset_myopathy_with_fatal_cardiomyopathy&Cardiovascular_phenotype&not_specified&TTN-related_myopathy	NC_000002.12:g.178734746C>G		single_nucleotide_variant	TTN:7273	MedGen:C3661900&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0002394&Human_Phenotype_Ontology:HP:0030051&Human_Phenotype_Ontology:HP:0040083&MedGen:C0427144&Human_Phenotype_Ontology:HP:0004755&MedGen:C0039240&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MedGen:CN230736&MedGen:CN169374&MONDO:MONDO:0100175&MedGen:CN294812	Uncertain_significance(1)&Benign(11)&Likely_benign(5)	criteria_provided&_conflicting_classifications		TTN	Centronuclear myopathy	AR	NA	Neuromuscular and musculoskelettal disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72648929	chr2_178734746_C_G	Female	./.	Other
chr2	178768898	.	C	T	50	PASS	"FS=3.166;MQ=250;MQRankSum=4.863;QD=1.5;ReadPosRankSum=0.741;SOR=1.473;FractionInformativeReads=1;R2_5P_bias=5.36;DP=61;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|38/363||NM_001267550.2:c.8938G>A|NP_001254479.2:p.Ala2980Thr|9163|8938|2980|A/T|Gct/Act|rs72647885&COSV100630370||-1||SNV|EntrezGene||YES|||C|C||||||0.0016|0.0001758|0.004002|0.000425|0.0002679|0|0|0.0003469|4.766e-05|0.0004968|0.0001391|0.001262|0.003954|0|0.001178|0.0002884|0|0|0.003401|7.352e-05|0.001422|0|0.0045|AFR|likely_benign&benign&benign/likely_benign&uncertain_significance|0&1|1&1||||T|0.23900|-0.178894|D|0.68431|-0.0290666|0.75822|0.461&0.461&.&.&0.461&0.461&.&0.461|-30|35|-40|-29|0.00|0.00|0.00|0.00|TTN|ambiguous|hg38|0.4699|A2980T|ENST00000615779.5|Q8WZ42|47578||Conflicting_classifications_of_pathogenicity|Early-onset_myopathy_with_fatal_cardiomyopathy&Dilated_cardiomyopathy_1G&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Tibial_muscular_dystrophy&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&TTN-related_disorder&not_specified&not_provided|NC_000002.12:g.178768898C>T||single_nucleotide_variant|TTN:7273|MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&.&MedGen:CN169374&MedGen:C3661900|Uncertain_significance(3)&Benign(4)&Likely_benign(9)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,15:0.455:33:9,8:9,7:48:84,0,50:49.409,7.1446e-05,53:0,34.77,37.77:9,9,10,5:8,10,7,8	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,17:0.607:28:8,6:3,11:47:85,0,47:50,8.3612e-05,50.342:0,34.77,37.77:6,5,8,9:7,4,7,10	T	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	38/363		c.8938G>A	p.Ala2980Thr	9163	8938	2980	A/T	Gct/Act	rs72647885&COSV100630370	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0016	0.0001758	0.004002	0.000425	0.0002679	0	0	0.0003469	4.766e-05	0.0004968	0.0001391	0.001262	0.003954	0	0.001178	0.0002884	0	0	0.003401	7.352e-05	0.001422	0	0.0045	AFR	likely_benign&benign&benign/likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA	T	0.239	-0.178894	D	0.68431	-0.0290666	0.75822	0.461&0.461&.&.&0.461&0.461&.&0.461	-30	35	-40	-29	0	0	0	0	TTN	ambiguous	hg38	0.4699	A2980T	ENST00000615779.5	Q8WZ42	47578	NA	Conflicting_classifications_of_pathogenicity	Early-onset_myopathy_with_fatal_cardiomyopathy&Dilated_cardiomyopathy_1G&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Tibial_muscular_dystrophy&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&TTN-related_disorder&not_specified&not_provided	NC_000002.12:g.178768898C>T		single_nucleotide_variant	TTN:7273	MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&.&MedGen:CN169374&MedGen:C3661900	Uncertain_significance(3)&Benign(4)&Likely_benign(9)	criteria_provided&_conflicting_classifications		TTN	Dilated cardiomyopathy 1G	AD	604145	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72647885	chr2_178768898_C_T	Female	0/1	Heterozygous
chr2	178768898	.	C	T	50	PASS	"FS=3.166;MQ=250;MQRankSum=4.863;QD=1.5;ReadPosRankSum=0.741;SOR=1.473;FractionInformativeReads=1;R2_5P_bias=5.36;DP=61;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|38/363||NM_001267550.2:c.8938G>A|NP_001254479.2:p.Ala2980Thr|9163|8938|2980|A/T|Gct/Act|rs72647885&COSV100630370||-1||SNV|EntrezGene||YES|||C|C||||||0.0016|0.0001758|0.004002|0.000425|0.0002679|0|0|0.0003469|4.766e-05|0.0004968|0.0001391|0.001262|0.003954|0|0.001178|0.0002884|0|0|0.003401|7.352e-05|0.001422|0|0.0045|AFR|likely_benign&benign&benign/likely_benign&uncertain_significance|0&1|1&1||||T|0.23900|-0.178894|D|0.68431|-0.0290666|0.75822|0.461&0.461&.&.&0.461&0.461&.&0.461|-30|35|-40|-29|0.00|0.00|0.00|0.00|TTN|ambiguous|hg38|0.4699|A2980T|ENST00000615779.5|Q8WZ42|47578||Conflicting_classifications_of_pathogenicity|Early-onset_myopathy_with_fatal_cardiomyopathy&Dilated_cardiomyopathy_1G&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Tibial_muscular_dystrophy&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&TTN-related_disorder&not_specified&not_provided|NC_000002.12:g.178768898C>T||single_nucleotide_variant|TTN:7273|MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&.&MedGen:CN169374&MedGen:C3661900|Uncertain_significance(3)&Benign(4)&Likely_benign(9)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,15:0.455:33:9,8:9,7:48:84,0,50:49.409,7.1446e-05,53:0,34.77,37.77:9,9,10,5:8,10,7,8	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,17:0.607:28:8,6:3,11:47:85,0,47:50,8.3612e-05,50.342:0,34.77,37.77:6,5,8,9:7,4,7,10	T	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	38/363		c.8938G>A	p.Ala2980Thr	9163	8938	2980	A/T	Gct/Act	rs72647885&COSV100630370	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0016	0.0001758	0.004002	0.000425	0.0002679	0	0	0.0003469	4.766e-05	0.0004968	0.0001391	0.001262	0.003954	0	0.001178	0.0002884	0	0	0.003401	7.352e-05	0.001422	0	0.0045	AFR	likely_benign&benign&benign/likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA	T	0.239	-0.178894	D	0.68431	-0.0290666	0.75822	0.461&0.461&.&.&0.461&0.461&.&0.461	-30	35	-40	-29	0	0	0	0	TTN	ambiguous	hg38	0.4699	A2980T	ENST00000615779.5	Q8WZ42	47578	NA	Conflicting_classifications_of_pathogenicity	Early-onset_myopathy_with_fatal_cardiomyopathy&Dilated_cardiomyopathy_1G&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Tibial_muscular_dystrophy&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&TTN-related_disorder&not_specified&not_provided	NC_000002.12:g.178768898C>T		single_nucleotide_variant	TTN:7273	MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&.&MedGen:CN169374&MedGen:C3661900	Uncertain_significance(3)&Benign(4)&Likely_benign(9)	criteria_provided&_conflicting_classifications		TTN	Hypertrophic cardiomyopathy 9	AD	613765	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72647885	chr2_178768898_C_T	Female	0/1	Heterozygous
chr2	178768898	.	C	T	50	PASS	"FS=3.166;MQ=250;MQRankSum=4.863;QD=1.5;ReadPosRankSum=0.741;SOR=1.473;FractionInformativeReads=1;R2_5P_bias=5.36;DP=61;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|38/363||NM_001267550.2:c.8938G>A|NP_001254479.2:p.Ala2980Thr|9163|8938|2980|A/T|Gct/Act|rs72647885&COSV100630370||-1||SNV|EntrezGene||YES|||C|C||||||0.0016|0.0001758|0.004002|0.000425|0.0002679|0|0|0.0003469|4.766e-05|0.0004968|0.0001391|0.001262|0.003954|0|0.001178|0.0002884|0|0|0.003401|7.352e-05|0.001422|0|0.0045|AFR|likely_benign&benign&benign/likely_benign&uncertain_significance|0&1|1&1||||T|0.23900|-0.178894|D|0.68431|-0.0290666|0.75822|0.461&0.461&.&.&0.461&0.461&.&0.461|-30|35|-40|-29|0.00|0.00|0.00|0.00|TTN|ambiguous|hg38|0.4699|A2980T|ENST00000615779.5|Q8WZ42|47578||Conflicting_classifications_of_pathogenicity|Early-onset_myopathy_with_fatal_cardiomyopathy&Dilated_cardiomyopathy_1G&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Tibial_muscular_dystrophy&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&TTN-related_disorder&not_specified&not_provided|NC_000002.12:g.178768898C>T||single_nucleotide_variant|TTN:7273|MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&.&MedGen:CN169374&MedGen:C3661900|Uncertain_significance(3)&Benign(4)&Likely_benign(9)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,15:0.455:33:9,8:9,7:48:84,0,50:49.409,7.1446e-05,53:0,34.77,37.77:9,9,10,5:8,10,7,8	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,17:0.607:28:8,6:3,11:47:85,0,47:50,8.3612e-05,50.342:0,34.77,37.77:6,5,8,9:7,4,7,10	T	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	38/363		c.8938G>A	p.Ala2980Thr	9163	8938	2980	A/T	Gct/Act	rs72647885&COSV100630370	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0016	0.0001758	0.004002	0.000425	0.0002679	0	0	0.0003469	4.766e-05	0.0004968	0.0001391	0.001262	0.003954	0	0.001178	0.0002884	0	0	0.003401	7.352e-05	0.001422	0	0.0045	AFR	likely_benign&benign&benign/likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA	T	0.239	-0.178894	D	0.68431	-0.0290666	0.75822	0.461&0.461&.&.&0.461&0.461&.&0.461	-30	35	-40	-29	0	0	0	0	TTN	ambiguous	hg38	0.4699	A2980T	ENST00000615779.5	Q8WZ42	47578	NA	Conflicting_classifications_of_pathogenicity	Early-onset_myopathy_with_fatal_cardiomyopathy&Dilated_cardiomyopathy_1G&Cardiovascular_phenotype&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&Cardiomyopathy&Tibial_muscular_dystrophy&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&TTN-related_disorder&not_specified&not_provided	NC_000002.12:g.178768898C>T		single_nucleotide_variant	TTN:7273	MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MedGen:CN230736&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&.&MedGen:CN169374&MedGen:C3661900	Uncertain_significance(3)&Benign(4)&Likely_benign(9)	criteria_provided&_conflicting_classifications		TTN	Centronuclear myopathy	AR	NA	Neuromuscular and musculoskelettal disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs72647885	chr2_178768898_C_T	Female	0/1	Heterozygous
chr2	178779048	.	C	T	49.03	PASS	"FS=3.296;MQ=250;MQRankSum=5.038;QD=1.33;ReadPosRankSum=1.316;SOR=1.387;FractionInformativeReads=1;R2_5P_bias=-2.229;DP=72;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|24/363||NM_001267550.2:c.4034G>A|NP_001254479.2:p.Gly1345Asp|4259|4034|1345|G/D|gGc/gAc|rs36021856&CM1516206||-1||SNV|EntrezGene||YES|||C|C||||||0.0038|0.008091|0.0008963|0.001476|0.0008418|0|0.06578|0.00104|0.006878|0.008147|0.0005797|0.01018|0.001203|0|0.004379|0.0002882|0|0.07592|0|0.008937|0.008515|0.0006219|0.07592|gnomADg_FIN|benign&uncertain_significance&likely_benign|0&1|1&1||||T|0.28414|-0.149351|D|0.71996|0.0256652|0.88205|0.679&0.679&.&.&0.679&0.679&.&0.679|-36|3|-8|-14|0.01|0.00|0.00|0.00|TTN|likely_pathogenic|hg38|0.9539|G1345D|ENST00000615779.5|Q8WZ42|47018||Conflicting_classifications_of_pathogenicity|not_provided&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&Tibial_muscular_dystrophy&Cardiovascular_phenotype&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiomyopathy&Early-onset_myopathy_with_fatal_cardiomyopathy|NC_000002.12:g.178779048C>T||single_nucleotide_variant|TTN:7273&LOC101927055:101927055|MedGen:C3661900&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MedGen:CN230736&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377|Uncertain_significance(1)&Benign(14)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:21,15:0.417:36:7,7:14,8:47:83,0,50:47.821,9.3449e-05,53:0,34.77,37.77:14,7,12,3:10,11,6,9	0/1:20,16:0.444:36:10,4:10,12:48:84,0,50:49.033,7.6105e-05,53:0,34.77,37.77:11,9,7,9:11,9,13,3	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	24/363		c.4034G>A	p.Gly1345Asp	4259	4034	1345	G/D	gGc/gAc	rs36021856&CM1516206	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0038	0.008091	0.0008963	0.001476	0.0008418	0	0.06578	0.00104	0.006878	0.008147	0.0005797	0.01018	0.001203	0	0.004379	0.0002882	0	0.07592	0	0.008937	0.008515	0.0006219	0.07592	gnomADg_FIN	benign&uncertain_significance&likely_benign	0&1	1&1	NA	NA	NA	T	0.28414	-0.149351	D	0.71996	0.0256652	0.88205	0.679&0.679&.&.&0.679&0.679&.&0.679	-36	3	-8	-14	0.01	0	0	0	TTN	likely_pathogenic	hg38	0.9539	G1345D	ENST00000615779.5	Q8WZ42	47018	NA	Conflicting_classifications_of_pathogenicity	not_provided&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&Tibial_muscular_dystrophy&Cardiovascular_phenotype&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiomyopathy&Early-onset_myopathy_with_fatal_cardiomyopathy	NC_000002.12:g.178779048C>T		single_nucleotide_variant	TTN:7273&LOC101927055:101927055	MedGen:C3661900&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MedGen:CN230736&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377	Uncertain_significance(1)&Benign(14)&Likely_benign(3)	criteria_provided&_conflicting_classifications		TTN	Dilated cardiomyopathy 1G	AD	604145	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs36021856	chr2_178779048_C_T	Female	0/1	Heterozygous
chr2	178779048	.	C	T	49.03	PASS	"FS=3.296;MQ=250;MQRankSum=5.038;QD=1.33;ReadPosRankSum=1.316;SOR=1.387;FractionInformativeReads=1;R2_5P_bias=-2.229;DP=72;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|24/363||NM_001267550.2:c.4034G>A|NP_001254479.2:p.Gly1345Asp|4259|4034|1345|G/D|gGc/gAc|rs36021856&CM1516206||-1||SNV|EntrezGene||YES|||C|C||||||0.0038|0.008091|0.0008963|0.001476|0.0008418|0|0.06578|0.00104|0.006878|0.008147|0.0005797|0.01018|0.001203|0|0.004379|0.0002882|0|0.07592|0|0.008937|0.008515|0.0006219|0.07592|gnomADg_FIN|benign&uncertain_significance&likely_benign|0&1|1&1||||T|0.28414|-0.149351|D|0.71996|0.0256652|0.88205|0.679&0.679&.&.&0.679&0.679&.&0.679|-36|3|-8|-14|0.01|0.00|0.00|0.00|TTN|likely_pathogenic|hg38|0.9539|G1345D|ENST00000615779.5|Q8WZ42|47018||Conflicting_classifications_of_pathogenicity|not_provided&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&Tibial_muscular_dystrophy&Cardiovascular_phenotype&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiomyopathy&Early-onset_myopathy_with_fatal_cardiomyopathy|NC_000002.12:g.178779048C>T||single_nucleotide_variant|TTN:7273&LOC101927055:101927055|MedGen:C3661900&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MedGen:CN230736&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377|Uncertain_significance(1)&Benign(14)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:21,15:0.417:36:7,7:14,8:47:83,0,50:47.821,9.3449e-05,53:0,34.77,37.77:14,7,12,3:10,11,6,9	0/1:20,16:0.444:36:10,4:10,12:48:84,0,50:49.033,7.6105e-05,53:0,34.77,37.77:11,9,7,9:11,9,13,3	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	24/363		c.4034G>A	p.Gly1345Asp	4259	4034	1345	G/D	gGc/gAc	rs36021856&CM1516206	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0038	0.008091	0.0008963	0.001476	0.0008418	0	0.06578	0.00104	0.006878	0.008147	0.0005797	0.01018	0.001203	0	0.004379	0.0002882	0	0.07592	0	0.008937	0.008515	0.0006219	0.07592	gnomADg_FIN	benign&uncertain_significance&likely_benign	0&1	1&1	NA	NA	NA	T	0.28414	-0.149351	D	0.71996	0.0256652	0.88205	0.679&0.679&.&.&0.679&0.679&.&0.679	-36	3	-8	-14	0.01	0	0	0	TTN	likely_pathogenic	hg38	0.9539	G1345D	ENST00000615779.5	Q8WZ42	47018	NA	Conflicting_classifications_of_pathogenicity	not_provided&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&Tibial_muscular_dystrophy&Cardiovascular_phenotype&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiomyopathy&Early-onset_myopathy_with_fatal_cardiomyopathy	NC_000002.12:g.178779048C>T		single_nucleotide_variant	TTN:7273&LOC101927055:101927055	MedGen:C3661900&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MedGen:CN230736&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377	Uncertain_significance(1)&Benign(14)&Likely_benign(3)	criteria_provided&_conflicting_classifications		TTN	Hypertrophic cardiomyopathy 9	AD	613765	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs36021856	chr2_178779048_C_T	Female	0/1	Heterozygous
chr2	178779048	.	C	T	49.03	PASS	"FS=3.296;MQ=250;MQRankSum=5.038;QD=1.33;ReadPosRankSum=1.316;SOR=1.387;FractionInformativeReads=1;R2_5P_bias=-2.229;DP=72;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|TTN|7273|Transcript|NM_001267550.2|protein_coding|24/363||NM_001267550.2:c.4034G>A|NP_001254479.2:p.Gly1345Asp|4259|4034|1345|G/D|gGc/gAc|rs36021856&CM1516206||-1||SNV|EntrezGene||YES|||C|C||||||0.0038|0.008091|0.0008963|0.001476|0.0008418|0|0.06578|0.00104|0.006878|0.008147|0.0005797|0.01018|0.001203|0|0.004379|0.0002882|0|0.07592|0|0.008937|0.008515|0.0006219|0.07592|gnomADg_FIN|benign&uncertain_significance&likely_benign|0&1|1&1||||T|0.28414|-0.149351|D|0.71996|0.0256652|0.88205|0.679&0.679&.&.&0.679&0.679&.&0.679|-36|3|-8|-14|0.01|0.00|0.00|0.00|TTN|likely_pathogenic|hg38|0.9539|G1345D|ENST00000615779.5|Q8WZ42|47018||Conflicting_classifications_of_pathogenicity|not_provided&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&Tibial_muscular_dystrophy&Cardiovascular_phenotype&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiomyopathy&Early-onset_myopathy_with_fatal_cardiomyopathy|NC_000002.12:g.178779048C>T||single_nucleotide_variant|TTN:7273&LOC101927055:101927055|MedGen:C3661900&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MedGen:CN230736&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377|Uncertain_significance(1)&Benign(14)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:21,15:0.417:36:7,7:14,8:47:83,0,50:47.821,9.3449e-05,53:0,34.77,37.77:14,7,12,3:10,11,6,9	0/1:20,16:0.444:36:10,4:10,12:48:84,0,50:49.033,7.6105e-05,53:0,34.77,37.77:11,9,7,9:11,9,13,3	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	TTN	7273	Transcript	NM_001267550.2	protein_coding	24/363		c.4034G>A	p.Gly1345Asp	4259	4034	1345	G/D	gGc/gAc	rs36021856&CM1516206	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0038	0.008091	0.0008963	0.001476	0.0008418	0	0.06578	0.00104	0.006878	0.008147	0.0005797	0.01018	0.001203	0	0.004379	0.0002882	0	0.07592	0	0.008937	0.008515	0.0006219	0.07592	gnomADg_FIN	benign&uncertain_significance&likely_benign	0&1	1&1	NA	NA	NA	T	0.28414	-0.149351	D	0.71996	0.0256652	0.88205	0.679&0.679&.&.&0.679&0.679&.&0.679	-36	3	-8	-14	0.01	0	0	0	TTN	likely_pathogenic	hg38	0.9539	G1345D	ENST00000615779.5	Q8WZ42	47018	NA	Conflicting_classifications_of_pathogenicity	not_provided&Myopathy&_myofibrillar&_9&_with_early_respiratory_failure&not_specified&Tibial_muscular_dystrophy&Cardiovascular_phenotype&Dilated_cardiomyopathy_1G&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2J&Cardiomyopathy&Early-onset_myopathy_with_fatal_cardiomyopathy	NC_000002.12:g.178779048C>T		single_nucleotide_variant	TTN:7273&LOC101927055:101927055	MedGen:C3661900&MONDO:MONDO:0011362&MedGen:C1863599&OMIM:603689&Orphanet:178464&Orphanet:34521&MedGen:CN169374&MONDO:MONDO:0010870&MedGen:C1838244&OMIM:600334&Orphanet:609&MedGen:CN230736&MONDO:MONDO:0011400&MedGen:C1858763&OMIM:604145&Orphanet:154&MONDO:MONDO:0012127&MedGen:C1837342&OMIM:608807&Orphanet:140922&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&MONDO:MONDO:0012714&MedGen:C2673677&OMIM:611705&Orphanet:289377	Uncertain_significance(1)&Benign(14)&Likely_benign(3)	criteria_provided&_conflicting_classifications		TTN	Centronuclear myopathy	AR	NA	Neuromuscular and musculoskelettal disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs36021856	chr2_178779048_C_T	Female	0/1	Heterozygous
chr2	188994708	.	CT	C	49.94	PASS	"FS=3.155;MQ=250;MQRankSum=4.635;QD=1.55;ReadPosRankSum=0.769;SOR=1.329;FractionInformativeReads=0.938;R2_5P_bias=16.397;DP=69;AF=0.5;AN=4;AC=2;CSQ=-|splice_polypyrimidine_tract_variant&intron_variant|LOW|COL3A1|1281|Transcript|NM_000090.4|protein_coding||19/50|NM_000090.4:c.1348-4del|||||||rs758567906||1||deletion|EntrezGene||YES|||T|T|||||11||0.194|0.105|0.1481|0.2419|0.1384|0.1439|0.2237|0.209|0.1879|0.09859|0.1109|0.05523|0.223|0.1183|0.1937|0.07151|0.08768|0.1857|0.1459|0.1425|0.05585|0.2419|gnomADe_ASJ|uncertain_significance&benign&likely_benign||1||||||||||||34|21|-49|33|0.00|0.00|0.00|0.00|COL3A1|||||||199694||Conflicting_classifications_of_pathogenicity|Ehlers-Danlos_syndrome&_type_4&not_provided&Familial_thoracic_aortic_aneurysm_and_aortic_dissection|NC_000002.12:g.188994720del||Deletion|COL3A1:1281|MONDO:MONDO:0017314&MedGen:C0268338&OMIM:130050&Orphanet:286&MedGen:C3661900&MONDO:MONDO:0019625&MedGen:C4707243&OMIM:PS607086&Orphanet:91387|Uncertain_significance(1)&Benign(3)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,14:0.467:30:5,8:11,6:48:60,0,50:49.708,6.8081e-05,53:0,10,13:8,8,5,9:5,11,5,9	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,18:0.486:37:12,9:7,9:48:60,0,50:49.936,6.5751e-05,53:0,10,13:11,8,9,9:10,9,10,8	-	splice_polypyrimidine_tract_variant&intron_variant	LOW	COL3A1	1281	Transcript	NM_000090.4	protein_coding		19/50	c.1348-4del							rs758567906	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			11	NA	0.194	0.105	0.1481	0.2419	0.1384	0.1439	0.2237	0.209	0.1879	0.09859	0.1109	0.05523	0.223	0.1183	0.1937	0.07151	0.08768	0.1857	0.1459	0.1425	0.05585	0.2419	gnomADe_ASJ	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		34	21	-49	33	0	0	0	0	COL3A1			NA				199694	NA	Conflicting_classifications_of_pathogenicity	Ehlers-Danlos_syndrome&_type_4&not_provided&Familial_thoracic_aortic_aneurysm_and_aortic_dissection	NC_000002.12:g.188994720del		Deletion	COL3A1:1281	MONDO:MONDO:0017314&MedGen:C0268338&OMIM:130050&Orphanet:286&MedGen:C3661900&MONDO:MONDO:0019625&MedGen:C4707243&OMIM:PS607086&Orphanet:91387	Uncertain_significance(1)&Benign(3)&Likely_benign(1)	criteria_provided&_conflicting_classifications		COL3A1	Ehlers-Danlos syndrome, type 4	AD	130050	Skelettal, skin, and connective tissue disorders	NBScreening	-9	Benign	BP6,BA1	rs758567906	chr2_188994708_CT_C	Female	0/1	Heterozygous
chr2	218339877	.	A	G	50	PASS	"FS=1.51;MQ=248.14;MQRankSum=4.392;QD=1.85;ReadPosRankSum=3.858;SOR=0.883;FractionInformativeReads=1;R2_5P_bias=-4.959;DP=27;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|PNKD|25953|Transcript|NM_015488.5|protein_coding|3/10||NM_015488.5:c.331A>G|NP_056303.3:p.Thr111Ala|348|331|111|T/A|Acc/Gcc|rs202190131&COSV51230896||1||SNV|EntrezGene||YES|||A|A|||tolerated(0.54)|benign(0)||0.0002|0.000178|0|2.672e-05|0|0.005435|0|0.0004263|2.586e-05|0.0001549|0.0001293|0.0001201|0|0|0|0|0.002569|0|0|4.475e-05|0.0004826|0.0002129|0.005435|gnomADe_EAS|conflicting_interpretations_of_pathogenicity&likely_benign|0&1|1&1||||T|0.44481|-0.0497828|T|0.43737|-0.309286|0.58883|0.273&0.273&0.273|-42|-45|21|27|0.00|0.00|0.00|0.00|PNKD|likely_benign|hg38|0.067|T111A|ENST00000273077.9|Q8N490|334313||Conflicting_classifications_of_pathogenicity|not_provided&Paroxysmal_nonkinesigenic_dyskinesia_1&Paroxysmal_nonkinesigenic_dyskinesia|NC_000002.12:g.218339877A>G||single_nucleotide_variant|PNKD:25953&CATIP-AS2:103689911|MedGen:C3661900&MONDO:MONDO:0700089&MedGen:C4551506&OMIM:118800&Orphanet:98810&MONDO:MONDO:0700088&MedGen:C1869117&Orphanet:98810|Uncertain_significance(1)&Benign(1)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,14:0.519:27:7,10:6,4:48:85,0,50:50,6.5492e-05,52.919:0,34.77,37.77:7,6,6,8:5,8,8,6	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	PNKD	25953	Transcript	NM_015488.5	protein_coding	10-Mar		c.331A>G	p.Thr111Ala	348	331	111	T/A	Acc/Gcc	rs202190131&COSV51230896	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	tolerated(0.54)	benign(0)	NA	2,00E-04	0.000178	0	2.672e-05	0	0.005435	0	0.0004263	2.586e-05	0.0001549	0.0001293	0.0001201	0	0	0	0	0.002569	0	0	4.475e-05	0.0004826	0.0002129	0.005435	gnomADe_EAS	conflicting_interpretations_of_pathogenicity&likely_benign	0&1	1&1	NA	NA	NA	T	0.44481	-0.0497828	T	0.43737	-0.309286	0.58883	0.273&0.273&0.273	-42	-45	21	27	0	0	0	0	PNKD	likely_benign	hg38	0.067	T111A	ENST00000273077.9	Q8N490	334313	NA	Conflicting_classifications_of_pathogenicity	not_provided&Paroxysmal_nonkinesigenic_dyskinesia_1&Paroxysmal_nonkinesigenic_dyskinesia	NC_000002.12:g.218339877A>G		single_nucleotide_variant	PNKD:25953&CATIP-AS2:103689911	MedGen:C3661900&MONDO:MONDO:0700089&MedGen:C4551506&OMIM:118800&Orphanet:98810&MONDO:MONDO:0700088&MedGen:C1869117&Orphanet:98810	Uncertain_significance(1)&Benign(1)&Likely_benign(2)	criteria_provided&_conflicting_classifications		PNKD	Paroxysmal nonkinesigenic dyskinesia 1	AD	118800	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-9	Benign	BP4_Strong,BP6,BS2	rs202190131	chr2_218339877_A_G	Female	./.	Other
chr2	218882255	.	C	T	50	PASS	"FS=12.525;MQ=249.67;MQRankSum=3.435;QD=2.08;ReadPosRankSum=2.281;SOR=1.881;FractionInformativeReads=1;R2_5P_bias=6.398;DP=58;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|WNT10A|80326|Transcript|NM_025216.3|protein_coding|2/4||NM_025216.3:c.208C>T|NP_079492.2:p.Arg70Trp|352|208|70|R/W|Cgg/Tgg|rs146460077&CM138360&COSV51462814||1||SNV|EntrezGene||YES|||C|C|||deleterious(0)|probably_damaging(0.952)||0.0028|0.001387|0.0001493|0.001073|0|2.519e-05|0.001367|0.004161|0.001138|0.001507|0.00604|0.00111|0.0002406|0|0.000588|0|0|0.0008481|0.003401|0.001411|0.002372|0.008081|0.0133|SAS|benign&conflicting_interpretations_of_pathogenicity&uncertain_significance&likely_benign|0&1&1|1&1&1||||T|0.29199|-0.144364|D|0.71763|0.0220503|0.89514|0.707|46|-11|-29|11|0.08|0.03|0.00|0.01|WNT10A|likely_benign|hg38|0.286|R70W|ENST00000258411.8|Q9GZT5|334394||Conflicting_classifications_of_pathogenicity|SchC6pf-Schulz-Passarge_syndrome&Tooth_agenesis&_selective&_4&Odonto-onycho-dermal_dysplasia&WNT10A-related_disorder&not_provided|NC_000002.12:g.218882255C>T||single_nucleotide_variant|WNT10A:80326|MONDO:MONDO:0009145&MedGen:C1857069&OMIM:224750&Orphanet:50944&MONDO:MONDO:0007881&MedGen:C1835492&OMIM:150400&Orphanet:99798&MONDO:MONDO:0009773&MedGen:C0796093&OMIM:257980&Orphanet:2721&.&MedGen:C3661900|Uncertain_significance(1)&Benign(1)&Likely_benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,12:0.5:24:4,6:8,6:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:8,4,3,9:6,6,7,5	0/1:21,13:0.382:34:11,5:10,8:45:81,0,50:45.876,0.00013409,53:0,34.77,37.77:9,12,8,5:11,10,8,5	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	WNT10A	80326	Transcript	NM_025216.3	protein_coding	04-Feb		c.208C>T	p.Arg70Trp	352	208	70	R/W	Cgg/Tgg	rs146460077&CM138360&COSV51462814	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious(0)	probably_damaging(0.952)	NA	0.0028	0.001387	0.0001493	0.001073	0	2.519e-05	0.001367	0.004161	0.001138	0.001507	0.00604	0.00111	0.0002406	0	0.000588	0	0	0.0008481	0.003401	0.001411	0.002372	0.008081	0.0133	SAS	benign&conflicting_interpretations_of_pathogenicity&uncertain_significance&likely_benign	0&1&1	1&1&1	NA	NA	NA	T	0.29199	-0.144364	D	0.71763	0.0220503	0.89514	0.707	46	-11	-29	11	0.08	0.03	0	0.01	WNT10A	likely_benign	hg38	0.286	R70W	ENST00000258411.8	Q9GZT5	334394	NA	Conflicting_classifications_of_pathogenicity	SchC6pf-Schulz-Passarge_syndrome&Tooth_agenesis&_selective&_4&Odonto-onycho-dermal_dysplasia&WNT10A-related_disorder&not_provided	NC_000002.12:g.218882255C>T		single_nucleotide_variant	WNT10A:80326	MONDO:MONDO:0009145&MedGen:C1857069&OMIM:224750&Orphanet:50944&MONDO:MONDO:0007881&MedGen:C1835492&OMIM:150400&Orphanet:99798&MONDO:MONDO:0009773&MedGen:C0796093&OMIM:257980&Orphanet:2721&.&MedGen:C3661900	Uncertain_significance(1)&Benign(1)&Likely_benign(5)	criteria_provided&_conflicting_classifications		WNT10A	Ectodermal dysplasia	AR	617364	Skelettal, skin, and connective tissue disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs146460077	chr2_218882255_C_T	Female	0/1	Heterozygous
chr2	219571283	.	T	G	154.86	PASS	"FS=6.043;MQ=250;MQRankSum=2.976;QD=1;ReadPosRankSum=1.087;SOR=2.833;FractionInformativeReads=1;R2_5P_bias=11.97;DP=39;AF=1;AN=4;AC=3;CSQ=G|5_prime_UTR_variant|MODIFIER|OBSL1|23363|Transcript|NM_015311.3|protein_coding|1/21||NM_015311.3:c.-51A>C||257|||||rs796511004||-1||SNV|EntrezGene||YES|||T|T|||||||0.02164|0.009106|0.0191|0.03392|0.009|0.03392|0.02225|0.02197|0.02133|0.02471|0.1918|0.105|0.09122|0.1778|0.2853|0.1154|0.2214|0.2197|0.238|0.2298|0.2918|0.2918|gnomADg_SAS|uncertain_significance||1||||||||||||-35|-2|-35|-2|0.00|0.00|0.00|0.00|OBSL1|||||||334545||Uncertain_significance|not_provided&3M_syndrome_2|NC_000002.12:g.219571283T>G||single_nucleotide_variant|OBSL1:23363|MedGen:C3661900&MONDO:MONDO:0013039&MedGen:C2752041&OMIM:612921&Orphanet:2616||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	0|1:16,4:0.2:20:9,2:7,2:20:55,0,47:19.924,0.044464,50.044:0,34.77,37.78:9,7,4,0:12,4,2,2:219571274	1/1:0,19:1:19:0,13:0,6:113:193,116,0:154.86,113.37,0:0,34.77,37.78:0,0,19,0:0,0,13,6:.	./.:.:.:.:.:.:.:.:.:.:.:.:.	G	5_prime_UTR_variant	MODIFIER	OBSL1	23363	Transcript	NM_015311.3	protein_coding	21-Jan		c.-51A>C		257					rs796511004	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	0.02164	0.009106	0.0191	0.03392	0.009	0.03392	0.02225	0.02197	0.02133	0.02471	0.1918	0.105	0.09122	0.1778	0.2853	0.1154	0.2214	0.2197	0.238	0.2298	0.2918	0.2918	gnomADg_SAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-35	-2	-35	-2	0	0	0	0	OBSL1			NA				334545	NA	Uncertain_significance	not_provided&3M_syndrome_2	NC_000002.12:g.219571283T>G		single_nucleotide_variant	OBSL1:23363	MedGen:C3661900&MONDO:MONDO:0013039&MedGen:C2752041&OMIM:612921&Orphanet:2616		criteria_provided&_multiple_submitters&_no_conflicts		OBSL1	3-M syndrome 2	AR	612921	Complex genetic syndromes	NBScreening	-4	Likely_benign	BP4_Strong	rs796511004	chr2_219571283_T_G	Female	0|1	Heterozygous
chr2	222201817	.	C	CA	135.87	PASS	"FS=6.094;MQ=248.25;MQRankSum=3.857;QD=1.72;ReadPosRankSum=0.188;SOR=1.203;FractionInformativeReads=0.966;R2_5P_bias=-7.827;DP=98;AF=1;AN=6;AC=4;CSQ=A|intron_variant|MODIFIER|PAX3|5077|Transcript|NM_181458.4|protein_coding||8/8|NM_181458.4:c.1420+126dup|||||||rs368725878||-1||insertion|EntrezGene||YES|||||||||||0.2754|0.228|0.1885|0.2779|0.2631|0.2428|0.2626|0.2818|0.275|0.2734|0.2393|0.2002|0.1987|0.2236|0.2809|0.3104|0.2498|0.3211|0.2518|0.2275|0.312|0.3211|gnomADg_MID|uncertain_significance&benign&likely_benign||1||||||||||||-11|22|26|22|0.00|0.00|0.00|0.01|PAX3|||||||334553||Conflicting_classifications_of_pathogenicity|Craniofacial-deafness-hand_syndrome&Waardenburg_syndrome&not_provided|NC_000002.12:g.222201832dup||Duplication|PAX3:5077|MONDO:MONDO:0007395&MedGen:C1852510&OMIM:122880&Orphanet:1529&MONDO:MONDO:0018094&MedGen:C3266898&OMIM:PS193500&Orphanet:3440&MedGen:C3661900|Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,17:0.607:28:5,6:6,11:47:58,0,47:50,8.5425e-05,50.146:0,8,11:7,4,6,11:5,6,11,6	0/1:18,15:0.455:33:10,8:8,7:48:57,0,50:49.429,7.1187e-05,53:0,8,11:7,11,7,8:11,7,4,11	1/1:1,35:0.972:36:0,19:1,16:86:147,89,0:135.87,85.867,0:0,8,11:0,1,19,16:1,0,21,14	A	intron_variant	MODIFIER	PAX3	5077	Transcript	NM_181458.4	protein_coding		08-Aug	c.1420+126dup							rs368725878	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.2754	0.228	0.1885	0.2779	0.2631	0.2428	0.2626	0.2818	0.275	0.2734	0.2393	0.2002	0.1987	0.2236	0.2809	0.3104	0.2498	0.3211	0.2518	0.2275	0.312	0.3211	gnomADg_MID	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-11	22	26	22	0	0	0	0.01	PAX3			NA				334553	NA	Conflicting_classifications_of_pathogenicity	Craniofacial-deafness-hand_syndrome&Waardenburg_syndrome&not_provided	NC_000002.12:g.222201832dup		Duplication	PAX3:5077	MONDO:MONDO:0007395&MedGen:C1852510&OMIM:122880&Orphanet:1529&MONDO:MONDO:0018094&MedGen:C3266898&OMIM:PS193500&Orphanet:3440&MedGen:C3661900	Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		PAX3	Waardenburg syndrome type 1	AD	193500	Complex genetic syndromes	NBScreening	-9	Benign	BP6,BA1	rs368725878	chr2_222201817_C_CA	Female	0/1	Heterozygous
chr2	222201817	.	C	CA	135.87	PASS	"FS=6.094;MQ=248.25;MQRankSum=3.857;QD=1.72;ReadPosRankSum=0.188;SOR=1.203;FractionInformativeReads=0.966;R2_5P_bias=-7.827;DP=98;AF=1;AN=6;AC=4;CSQ=A|intron_variant|MODIFIER|PAX3|5077|Transcript|NM_181458.4|protein_coding||8/8|NM_181458.4:c.1420+126dup|||||||rs368725878||-1||insertion|EntrezGene||YES|||||||||||0.2754|0.228|0.1885|0.2779|0.2631|0.2428|0.2626|0.2818|0.275|0.2734|0.2393|0.2002|0.1987|0.2236|0.2809|0.3104|0.2498|0.3211|0.2518|0.2275|0.312|0.3211|gnomADg_MID|uncertain_significance&benign&likely_benign||1||||||||||||-11|22|26|22|0.00|0.00|0.00|0.01|PAX3|||||||334553||Conflicting_classifications_of_pathogenicity|Craniofacial-deafness-hand_syndrome&Waardenburg_syndrome&not_provided|NC_000002.12:g.222201832dup||Duplication|PAX3:5077|MONDO:MONDO:0007395&MedGen:C1852510&OMIM:122880&Orphanet:1529&MONDO:MONDO:0018094&MedGen:C3266898&OMIM:PS193500&Orphanet:3440&MedGen:C3661900|Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,17:0.607:28:5,6:6,11:47:58,0,47:50,8.5425e-05,50.146:0,8,11:7,4,6,11:5,6,11,6	0/1:18,15:0.455:33:10,8:8,7:48:57,0,50:49.429,7.1187e-05,53:0,8,11:7,11,7,8:11,7,4,11	1/1:1,35:0.972:36:0,19:1,16:86:147,89,0:135.87,85.867,0:0,8,11:0,1,19,16:1,0,21,14	A	intron_variant	MODIFIER	PAX3	5077	Transcript	NM_181458.4	protein_coding		08-Aug	c.1420+126dup							rs368725878	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.2754	0.228	0.1885	0.2779	0.2631	0.2428	0.2626	0.2818	0.275	0.2734	0.2393	0.2002	0.1987	0.2236	0.2809	0.3104	0.2498	0.3211	0.2518	0.2275	0.312	0.3211	gnomADg_MID	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-11	22	26	22	0	0	0	0.01	PAX3			NA				334553	NA	Conflicting_classifications_of_pathogenicity	Craniofacial-deafness-hand_syndrome&Waardenburg_syndrome&not_provided	NC_000002.12:g.222201832dup		Duplication	PAX3:5077	MONDO:MONDO:0007395&MedGen:C1852510&OMIM:122880&Orphanet:1529&MONDO:MONDO:0018094&MedGen:C3266898&OMIM:PS193500&Orphanet:3440&MedGen:C3661900	Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		PAX3	Waardenburg syndrome type 3	Multiple and/or complex pattern	148820	Complex genetic syndromes	NBScreening	-9	Benign	BP6,BA1	rs368725878	chr2_222201817_C_CA	Female	0/1	Heterozygous
chr2	227032024	.	G	A	50	PASS	"FS=3.512;MQ=250;MQRankSum=4.468;QD=1.77;ReadPosRankSum=4.468;SOR=0.472;FractionInformativeReads=1;R2_5P_bias=3.888;DP=62;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|COL4A4|1286|Transcript|NM_000092.5|protein_coding|40/48||NM_000092.5:c.3738C>T|NP_000083.3:p.Ala1246%3D|4038|3738|1246|A|gcC/gcT|rs2149978554||-1||SNV|EntrezGene||YES|||G|G||||||||||||||||||||||||||||||uncertain_significance||1||||||||||||22|29|5|18|0.01|0.00|0.00|0.00|COL4A4|||||||1195978||Uncertain_significance|Autosomal_recessive_Alport_syndrome|NC_000002.12:g.227032024G>A||single_nucleotide_variant|COL4A4:1286|MONDO:MONDO:0008762&MedGen:C4746745&OMIM:203780&Orphanet:63&Orphanet:88919||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,13:0.464:28:10,10:5,3:48:84,0,50:49.623,6.9116e-05,53:0,34.77,37.77:10,5,6,7:11,4,7,6	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,17:0.515:33:11,9:5,8:48:85,0,50:50,6.5751e-05,52.907:0,34.77,37.77:11,5,11,6:8,8,9,8	A	synonymous_variant	LOW	COL4A4	1286	Transcript	NM_000092.5	protein_coding	40/48		c.3738C>T	p.Ala1246%3D	4038	3738	1246	A	gcC/gcT	rs2149978554	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		22	29	5	18	0.01	0	0	0	COL4A4			NA				1195978	NA	Uncertain_significance	Autosomal_recessive_Alport_syndrome	NC_000002.12:g.227032024G>A		single_nucleotide_variant	COL4A4:1286	MONDO:MONDO:0008762&MedGen:C4746745&OMIM:203780&Orphanet:63&Orphanet:88919		criteria_provided&_single_submitter		COL4A4	Autosomal recessive Alport syndrome	AR	203780	Renal disorders	NBScreening	-3	Likely_benign	PM2,BP4_Strong,BP7	rs2149978554	chr2_227032024_G_A	Female	0/1	Heterozygous
chr2	227032024	.	G	A	50	PASS	"FS=3.512;MQ=250;MQRankSum=4.468;QD=1.77;ReadPosRankSum=4.468;SOR=0.472;FractionInformativeReads=1;R2_5P_bias=3.888;DP=62;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|COL4A4|1286|Transcript|NM_000092.5|protein_coding|40/48||NM_000092.5:c.3738C>T|NP_000083.3:p.Ala1246%3D|4038|3738|1246|A|gcC/gcT|rs2149978554||-1||SNV|EntrezGene||YES|||G|G||||||||||||||||||||||||||||||uncertain_significance||1||||||||||||22|29|5|18|0.01|0.00|0.00|0.00|COL4A4|||||||1195978||Uncertain_significance|Autosomal_recessive_Alport_syndrome|NC_000002.12:g.227032024G>A||single_nucleotide_variant|COL4A4:1286|MONDO:MONDO:0008762&MedGen:C4746745&OMIM:203780&Orphanet:63&Orphanet:88919||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,13:0.464:28:10,10:5,3:48:84,0,50:49.623,6.9116e-05,53:0,34.77,37.77:10,5,6,7:11,4,7,6	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,17:0.515:33:11,9:5,8:48:85,0,50:50,6.5751e-05,52.907:0,34.77,37.77:11,5,11,6:8,8,9,8	A	synonymous_variant	LOW	COL4A4	1286	Transcript	NM_000092.5	protein_coding	40/48		c.3738C>T	p.Ala1246%3D	4038	3738	1246	A	gcC/gcT	rs2149978554	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		22	29	5	18	0.01	0	0	0	COL4A4			NA				1195978	NA	Uncertain_significance	Autosomal_recessive_Alport_syndrome	NC_000002.12:g.227032024G>A		single_nucleotide_variant	COL4A4:1286	MONDO:MONDO:0008762&MedGen:C4746745&OMIM:203780&Orphanet:63&Orphanet:88919		criteria_provided&_single_submitter		COL4A4	Alport syndrome 3B, autosomal recessive	AR	620536	Renal disorders	NBScreening	-3	Likely_benign	PM2,BP4_Strong,BP7	rs2149978554	chr2_227032024_G_A	Female	0/1	Heterozygous
chr2	227312926	.	TA	T	247.64	PASS	"FS=3.581;MQ=248.77;MQRankSum=4.007;QD=1.39;ReadPosRankSum=-0.022;SOR=1.739;FractionInformativeReads=0.806;R2_5P_bias=18.484;DP=101;AF=0.5;AN=6;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|COL4A3|1285|Transcript|NM_000091.5|protein_coding|52/52||NM_000091.5:c.*1070del||6173|||||rs11297279||1||deletion|EntrezGene||YES|||A|A|||||13||0.4767|||||0.4767|||||0.458|0.3501|0.5944|0.5256|0.4373|0.5176|0.509|0.4441|0.5007|0.4804|0.3671|0.5944|gnomADg_AMI|uncertain_significance||1||||||||||||-25|-46|-3|-47|0.00|0.00|0.00|0.00|COL4A3|||||||334805||Uncertain_significance|not_provided&Alport_syndrome|NC_000002.12:g.227312940del||Deletion|COL4A3:1285&MFF-DT:654841|MedGen:C3661900&MONDO:MONDO:0018965&MedGen:C1567741&OMIM:PS301050&Orphanet:63||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:12,.:.:29:3,.:9,.:48:59,.,.:50,.,.:0,.,.:6,6,5,12:7,5,11,6	0/1:13,14:0.519:27:9,8:4,6:46:60,0,45:50,0.00011261,47.975:0,10,13.01:4,9,8,6:8,5,6,8	1/0:0,21:0.677:31:0,13:0,8:44:266,207,50:247.64,197.64,44.308:0,9,12:0,0,14,17:0,0,18,13	-	3_prime_UTR_variant	MODIFIER	COL4A3	1285	Transcript	NM_000091.5	protein_coding	52/52		c.*1070del		6173					rs11297279	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			13	NA	0.4767	NA	NA	NA	NA	0.4767	NA	NA	NA	NA	0.458	0.3501	0.5944	0.5256	0.4373	0.5176	0.509	0.4441	0.5007	0.4804	0.3671	0.5944	gnomADg_AMI	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-25	-46	-3	-47	0	0	0	0	COL4A3			NA				334805	NA	Uncertain_significance	not_provided&Alport_syndrome	NC_000002.12:g.227312940del		Deletion	COL4A3:1285&MFF-DT:654841	MedGen:C3661900&MONDO:MONDO:0018965&MedGen:C1567741&OMIM:PS301050&Orphanet:63		criteria_provided&_multiple_submitters&_no_conflicts		COL4A3	Autosomal recessive Alport syndrome	AR	203780	Renal disorders	NBScreening	-8	Benign	BA1	rs11297279	chr2_227312926_TA_T	Female	0/0	Other
chr2	227312926	.	TA	T	247.64	PASS	"FS=3.581;MQ=248.77;MQRankSum=4.007;QD=1.39;ReadPosRankSum=-0.022;SOR=1.739;FractionInformativeReads=0.806;R2_5P_bias=18.484;DP=101;AF=0.5;AN=6;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|COL4A3|1285|Transcript|NM_000091.5|protein_coding|52/52||NM_000091.5:c.*1070del||6173|||||rs11297279||1||deletion|EntrezGene||YES|||A|A|||||13||0.4767|||||0.4767|||||0.458|0.3501|0.5944|0.5256|0.4373|0.5176|0.509|0.4441|0.5007|0.4804|0.3671|0.5944|gnomADg_AMI|uncertain_significance||1||||||||||||-25|-46|-3|-47|0.00|0.00|0.00|0.00|COL4A3|||||||334805||Uncertain_significance|not_provided&Alport_syndrome|NC_000002.12:g.227312940del||Deletion|COL4A3:1285&MFF-DT:654841|MedGen:C3661900&MONDO:MONDO:0018965&MedGen:C1567741&OMIM:PS301050&Orphanet:63||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:12,.:.:29:3,.:9,.:48:59,.,.:50,.,.:0,.,.:6,6,5,12:7,5,11,6	0/1:13,14:0.519:27:9,8:4,6:46:60,0,45:50,0.00011261,47.975:0,10,13.01:4,9,8,6:8,5,6,8	1/0:0,21:0.677:31:0,13:0,8:44:266,207,50:247.64,197.64,44.308:0,9,12:0,0,14,17:0,0,18,13	-	3_prime_UTR_variant	MODIFIER	COL4A3	1285	Transcript	NM_000091.5	protein_coding	52/52		c.*1070del		6173					rs11297279	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			13	NA	0.4767	NA	NA	NA	NA	0.4767	NA	NA	NA	NA	0.458	0.3501	0.5944	0.5256	0.4373	0.5176	0.509	0.4441	0.5007	0.4804	0.3671	0.5944	gnomADg_AMI	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-25	-46	-3	-47	0	0	0	0	COL4A3			NA				334805	NA	Uncertain_significance	not_provided&Alport_syndrome	NC_000002.12:g.227312940del		Deletion	COL4A3:1285&MFF-DT:654841	MedGen:C3661900&MONDO:MONDO:0018965&MedGen:C1567741&OMIM:PS301050&Orphanet:63		criteria_provided&_multiple_submitters&_no_conflicts		COL4A3	Alport syndrome 2, autosomal recessive	AR	203780	Renal disorders	NBScreening	-8	Benign	BA1	rs11297279	chr2_227312926_TA_T	Female	0/0	Other
chr2	230210491	.	G	A	50	PASS	"FS=6.869;MQ=250;MQRankSum=5.282;QD=1.28;ReadPosRankSum=2.28;SOR=1.196;FractionInformativeReads=1;R2_5P_bias=14.11;DP=73;AF=0.5;AN=4;AC=2;CSQ=A|intron_variant|MODIFIER|SP110|3431|Transcript|NM_080424.4|protein_coding||6/18|NM_080424.4:c.752-483C>T|||||||rs2114592&CS066652||-1||SNV|EntrezGene||YES|||G|G||||||0.1805|||||||||||0.1261|0.1695|0.08114|0.08254|0.1852|0.1819|0.06276|0.1905|0.1022|0.1246|0.2701|0.3057|SAS|uncertain_significance|0&1|1&1||||||||||||-40|-23|39|-24|0.00|0.00|0.00|0.00|SP110|||||||5540||Uncertain_significance|Mycobacterium_tuberculosis&_susceptibility_to|NC_000002.12:g.230210491G>A||single_nucleotide_variant|SP110:3431&SP140:11262|MedGen:C1834752&OMIM:607948||no_assertion_criteria_provided|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,22:0.564:39:13,10:4,12:48:85,0,49:50,7.274e-05,51.706:0,34.77,37.77:10,7,8,14:6,11,14,8	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,18:0.529:34:6,8:10,10:48:85,0,50:50,6.6527e-05,52.746:0,34.77,37.77:4,12,8,10:6,10,10,8	A	intron_variant	MODIFIER	SP110	3431	Transcript	NM_080424.4	protein_coding		18-Jun	c.752-483C>T							rs2114592&CS066652	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.1805	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.1261	0.1695	0.08114	0.08254	0.1852	0.1819	0.06276	0.1905	0.1022	0.1246	0.2701	0.3057	SAS	uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-40	-23	39	-24	0	0	0	0	SP110			NA				5540	NA	Uncertain_significance	Mycobacterium_tuberculosis&_susceptibility_to	NC_000002.12:g.230210491G>A		single_nucleotide_variant	SP110:3431&SP140:11262	MedGen:C1834752&OMIM:607948		no_assertion_criteria_provided		SP110	Hepatic venoocclusive disease with immunodeficiency	AR	235550	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-12	Benign	BP4_Strong,BA1	rs2114592	chr2_230210491_G_A	Female	0/1	Heterozygous
chr3	10152060	.	CA	C	114	PASS	"FS=0;MQ=238.97;QD=4.38;SOR=1.179;FractionInformativeReads=0.885;MQRankSum=0.537;ReadPosRankSum=1.61;R2_5P_bias=-13.297;DP=66;AF=1;AN=6;AC=5;CSQ=-|3_prime_UTR_variant|MODIFIER|VHL|7428|Transcript|NM_000551.4|protein_coding|3/3||NM_000551.4:c.*2117del||2808|||||rs757106274||1||deletion|EntrezGene||YES|||A|A|||||21||0.3243|0.1136|0.3333|0.3788|0.35|0.5|0.3333|0.3203|0.2946|0.4286|0.6516|0.3512|0.8111|0.7252|0.8587|0.8044|0.7658|0.7808|0.7866|0.672|0.6543|0.8587|gnomADg_ASJ|uncertain_significance||1||||||||||||8|10|8|7|0.00|0.00|0.00|0.00|VHL|||||||342463||Uncertain_significance|Von_Hippel-Lindau_syndrome|NC_000003.12:g.10152082del||Deletion|VHL:7428&LOC107303340:107303340|MONDO:MONDO:0008667&MedGen:C0019562&OMIM:193300&Orphanet:892||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,23:1:23:0,6:0,17:64:121,67,0:114,64.001,1.812e-06:0,4,7:0,0,14,9:0,0,15,8	0/1:10,7:0.412:17:5,1:5,6:47:54,0,47:49.13,9.6556e-05,50:0,5,8.01:8,2,3,4:3,7,3,4	1/1:3,19:0.864:22:1,9:2,10:44:102,47,0:93.55,43.55,0.00019182:0,5,8.01:0,3,12,7:2,1,12,7	-	3_prime_UTR_variant	MODIFIER	VHL	7428	Transcript	NM_000551.4	protein_coding	03-Mar		c.*2117del		2808					rs757106274	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			21	NA	0.3243	0.1136	0.3333	0.3788	0.35	0.5	0.3333	0.3203	0.2946	0.4286	0.6516	0.3512	0.8111	0.7252	0.8587	0.8044	0.7658	0.7808	0.7866	0.672	0.6543	0.8587	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		8	10	8	7	0	0	0	0	VHL			NA				342463	NA	Uncertain_significance	Von_Hippel-Lindau_syndrome	NC_000003.12:g.10152082del		Deletion	VHL:7428&LOC107303340:107303340	MONDO:MONDO:0008667&MedGen:C0019562&OMIM:193300&Orphanet:892		criteria_provided&_single_submitter		VHL	Von Hippel-Lindau syndrome	AD	193300	Tumor predisposition syndromes	NBScreening	-8	Benign	BA1	rs757106274	chr3_10152060_CA_C	Female	01-Jan	Homozygous
chr3	10152481	.	CTTTTTT	C	171.7	PASS	"FS=2.769;MQ=225.2;MQRankSum=1.031;QD=3.88;ReadPosRankSum=-0.424;SOR=0.223;FractionInformativeReads=0.667;R2_5P_bias=0;DP=65;AF=0.5;AN=6;AC=4;CSQ=-|3_prime_UTR_variant|MODIFIER|VHL|7428|Transcript|NM_000551.4|protein_coding|3/3||NM_000551.4:c.*2540_*2545del||3229-3234|||||rs71052299||1||deletion|EntrezGene||YES|||TTTTTT|TTTTTT|||||23||||||||||||0.353|0.2036|0.3852|0.397|0.4282|0.4311|0.2385|0.4028|0.4057|0.3763|0.3155|0.4311|gnomADg_EAS|uncertain_significance||1|||||||||||||||||||||||||||342471||Uncertain_significance|Von_Hippel-Lindau_syndrome|NC_000003.12:g.10152505_10152510del||Deletion|VHL:7428&LOC107303340:107303340|MONDO:MONDO:0008667&MedGen:C0019562&OMIM:193300&Orphanet:892||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:4,12:0.75:16:1,5:3,7:43:101,46,0:93.118,43.118,0.00021175:0,5,8.01:0,4,3,9:3,1,8,4	0/1:3,9:0.75:12:2,4:1,5:45:54,0,43:50,0.00014341,46.374:0,4,7:2,1,3,6:3,0,6,3	0/1:2,9:0.5:18:0,5:2,4:50:180,126,54:171.7,121.75,53:0,4,7:2,0,5,11:0,2,9,7	-	3_prime_UTR_variant	MODIFIER	VHL	7428	Transcript	NM_000551.4	protein_coding	03-Mar		c.*2540_*2545del		3229-3234					rs71052299	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TTTTTT	TTTTTT	NA	NA			23	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.353	0.2036	0.3852	0.397	0.4282	0.4311	0.2385	0.4028	0.4057	0.3763	0.3155	0.4311	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				342471	NA	Uncertain_significance	Von_Hippel-Lindau_syndrome	NC_000003.12:g.10152505_10152510del		Deletion	VHL:7428&LOC107303340:107303340	MONDO:MONDO:0008667&MedGen:C0019562&OMIM:193300&Orphanet:892		criteria_provided&_single_submitter		VHL	Von Hippel-Lindau syndrome	AD	193300	Tumor predisposition syndromes	NBScreening	0	Uncertain_significance		rs71052299	chr3_10152481_CTTTTTT_C	Female	01-Jan	Homozygous
chr3	15521729	.	T	TTG	84.77	PASS	"FS=0;MQ=246.24;MQRankSum=0.791;QD=3.03;ReadPosRankSum=0.791;SOR=0.693;FractionInformativeReads=0.478;R2_5P_bias=0;DP=86;AF=1;AN=6;AC=6;CSQ=TG|upstream_gene_variant|MODIFIER|COLQ|8292|Transcript|NM_005677.4|protein_coding||||||||||rs746566925|23|-1||insertion|EntrezGene||YES|||||||||||0.1825|0.3061|0.2555|0.1878|0.2355|0.1166|0.2281|0.1758|0.1937|0.1911|0.2696|0.3754|0.167|0.3074|0.2298|0.2766|0.1317|0.2705|0.2249|0.2744|0.2276|0.3754|gnomADg_AFR|||1|||||||||||||||||||||||||||343893||Conflicting_classifications_of_pathogenicity|Congenital_Myasthenic_Syndrome&_Recessive&not_provided|NC_000003.12:g.15521730TG[9]||Microsatellite|COLQ:8292|MedGen:CN239337&MedGen:C3661900|Uncertain_significance(3)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:1,10:0.909:11:0,4:1,6:20:84,23,0:69.632,19.632,0.047531:0,11,14:0,1,3,7:1,0,7,3	1/1:0,5:1:5:0,2:0,3:35:101,38,0:84.772,34.772,0.0014478:0,13,16.01:0,0,3,2:0,0,4,1	1/1:0,9:1:9:0,3:0,6:35:100,38,0:84.772,34.772,0.0014478:0,12,15.01:0,0,2,7:0,0,8,1	TG	upstream_gene_variant	MODIFIER	COLQ	8292	Transcript	NM_005677.4	protein_coding										rs746566925	23	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.1825	0.3061	0.2555	0.1878	0.2355	0.1166	0.2281	0.1758	0.1937	0.1911	0.2696	0.3754	0.167	0.3074	0.2298	0.2766	0.1317	0.2705	0.2249	0.2744	0.2276	0.3754	gnomADg_AFR			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				343893	NA	Conflicting_classifications_of_pathogenicity	Congenital_Myasthenic_Syndrome&_Recessive&not_provided	NC_000003.12:g.15521730TG[9]		Microsatellite	COLQ:8292	MedGen:CN239337&MedGen:C3661900	Uncertain_significance(3)&Benign(1)	criteria_provided&_conflicting_classifications		COLQ	Congenital myasthenic syndrome 5	AR	603034	Neuromuscular and musculoskelettal disorders	NBScreening	-9	Benign	BP6,BA1	rs746566925	chr3_15521729_T_TTG	Female	01-Jan	Homozygous
chr3	49126004	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=5.534;QD=1.19;ReadPosRankSum=3.471;SOR=0.533;FractionInformativeReads=1;R2_5P_bias=17.488;DP=42;AF=0.5;AN=2;AC=1;CSQ=A|synonymous_variant|LOW|LAMB2|3913|Transcript|NM_002292.4|protein_coding|17/32||NM_002292.4:c.2307C>T|NP_002283.3:p.Leu769%3D|2490|2307|769|L|ctC/ctT|rs147076626||-1||SNV|EntrezGene||YES|||G|G||||||0.0022|0.003606|0.0005376|0.001789|0.00241|0|0.0002059|0.008498|0.003835|0.002848|0.007118|0.002488|0.0009143|0|0.003202|0.00173|0|0.0001883|0.006803|0.003704|0.002841|0.004975|0.008498|gnomADe_MID|likely_benign&benign&uncertain_significance||1||||||||||||-6|17|18|-37|0.00|0.00|0.00|0.00|LAMB2|||||||258603||Conflicting_classifications_of_pathogenicity|not_provided&Pierson_syndrome&LAMB2-related_disorder&Focal_segmental_glomerulosclerosis&LAMB2-related_infantile-onset_nephrotic_syndrome|NC_000003.12:g.49126004G>A||single_nucleotide_variant|LAMB2:3913|MedGen:C3661900&MONDO:MONDO:0012184&MedGen:C1836876&OMIM:609049&Orphanet:2670&.&Human_Phenotype_Ontology:HP:0000097&Human_Phenotype_Ontology:HP:0004747&MONDO:MONDO:0100313&MedGen:C0017668&MONDO:MONDO:0013621&MedGen:C3280113&OMIM:614199&Orphanet:306507|Uncertain_significance(1)&Benign(1)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:21,21:0.5:42:9,11:12,10:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:12,9,11,10:8,13,9,12	A	synonymous_variant	LOW	LAMB2	3913	Transcript	NM_002292.4	protein_coding	17/32		c.2307C>T	p.Leu769%3D	2490	2307	769	L	ctC/ctT	rs147076626	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0022	0.003606	0.0005376	0.001789	0.00241	0	0.0002059	0.008498	0.003835	0.002848	0.007118	0.002488	0.0009143	0	0.003202	0.00173	0	0.0001883	0.006803	0.003704	0.002841	0.004975	0.008498	gnomADe_MID	likely_benign&benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-6	17	18	-37	0	0	0	0	LAMB2			NA				258603	NA	Conflicting_classifications_of_pathogenicity	not_provided&Pierson_syndrome&LAMB2-related_disorder&Focal_segmental_glomerulosclerosis&LAMB2-related_infantile-onset_nephrotic_syndrome	NC_000003.12:g.49126004G>A		single_nucleotide_variant	LAMB2:3913	MedGen:C3661900&MONDO:MONDO:0012184&MedGen:C1836876&OMIM:609049&Orphanet:2670&.&Human_Phenotype_Ontology:HP:0000097&Human_Phenotype_Ontology:HP:0004747&MONDO:MONDO:0100313&MedGen:C0017668&MONDO:MONDO:0013621&MedGen:C3280113&OMIM:614199&Orphanet:306507	Uncertain_significance(1)&Benign(1)&Likely_benign(3)	criteria_provided&_conflicting_classifications		LAMB2	Pierson syndrome	AR	609049	Renal disorders	NBScreening	-12	Benign	BP4_Moderate,BP6,BP7,BS1,BS2	rs147076626	chr3_49126004_G_A	Female	./.	Other
chr3	124745368	.	ATT	A	191.43	PASS	"FS=0;MQ=248.79;QD=3.92;SOR=0.76;FractionInformativeReads=0.853;MQRankSum=5.31;ReadPosRankSum=0.803;R2_5P_bias=3.629;DP=106;AF=0.5;AN=6;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|UMPS|7372|Transcript|NM_000373.4|protein_coding|6/6||NM_000373.4:c.*1298_*1299del||2748-2749|||||rs11330991||1||deletion|EntrezGene||YES|||TT|TT|||||13||0.1989|0.1569|0.3008|0.1277|0.2085|0.1933|0.192|0.1847|0.177|0.2136|0.1771|0.1506|0.1816|0.2588|0.08309|0.1824|0.2073|0.1028|0.1731|0.1715|0.2118|0.3008|gnomADe_AMR|uncertain_significance&benign||1||||||||||||-12|22|-50|18|0.00|0.00|0.00|0.00|UMPS|||||||342955||Uncertain_significance|Oroticaciduria|NC_000003.12:g.124745382_124745383del||Deletion|UMPS:7372|Human_Phenotype_Ontology:HP:0003218&MedGen:C0268128&Orphanet:30||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:0,.:.:29:0,.:0,.:83:144,.,.:133.4,.,.:0,.,.:0,0,15,14:0,0,12,17	0/0:21,.:.:39:11,.:10,.:48:57,.,.:49.487,.,.:0,.,.:15,6,12,6:11,10,8,10	0/1:0,7:0.292:24:0,2:0,5:43:207,318,58:191.43,310.09,53:0,8,11:0,0,14,10:0,0,10,14	-	3_prime_UTR_variant	MODIFIER	UMPS	7372	Transcript	NM_000373.4	protein_coding	06-Jun		c.*1298_*1299del		2748-2749					rs11330991	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TT	TT	NA	NA			13	NA	0.1989	0.1569	0.3008	0.1277	0.2085	0.1933	0.192	0.1847	0.177	0.2136	0.1771	0.1506	0.1816	0.2588	0.08309	0.1824	0.2073	0.1028	0.1731	0.1715	0.2118	0.3008	gnomADe_AMR	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-12	22	-50	18	0	0	0	0	UMPS			NA				342955	NA	Uncertain_significance	Oroticaciduria	NC_000003.12:g.124745382_124745383del		Deletion	UMPS:7372	Human_Phenotype_Ontology:HP:0003218&MedGen:C0268128&Orphanet:30		criteria_provided&_single_submitter		UMPS	Orotic aciduria	AR	258900	"Haematological disorders;Skelettal, skin, and connective tissue disorders;Inherited disorders of metabolism"	NBScreening	-8	Benign	BA1	rs11330991	chr3_124745368_ATT_A	Female	0/0	Other
chr3	132680734	.	C	T	50	PASS	"FS=1.348;MQ=250;MQRankSum=5.11;QD=1.39;ReadPosRankSum=1.503;SOR=1.197;FractionInformativeReads=1;R2_5P_bias=17.233;DP=71;AF=0.5;AN=4;AC=2;CSQ=T|3_prime_UTR_variant|MODIFIER|NPHP3|27031|Transcript|NM_153240.5|protein_coding|27/27||NM_153240.5:c.*1176G>A||5223|||||rs183658380||-1||SNV|EntrezGene||YES|||C|C||||||0.0014|||||||||||0.0006381|0.001231|0.001096|0.0007859|0|0|0|0|0.0004119|0.0004739|0.0008295|0.0043|AMR|uncertain_significance&likely_benign||1|||||||||||||||||||||||||||343353||Conflicting_classifications_of_pathogenicity|NPHP3-related_Meckel-like_syndrome&Nephronophthisis_3&Renal-hepatic-pancreatic_dysplasia_1|NC_000003.12:g.132680734C>T||single_nucleotide_variant|NPHP3:27031&NPHP3-ACAD11:100532724|MONDO:MONDO:0009966&MedGen:C2673885&OMIM:267010&Orphanet:3032&MONDO:MONDO:0011456&MedGen:C1858392&OMIM:604387&Orphanet:655&MONDO:MONDO:0008833&MedGen:C3715199&OMIM:208540|Uncertain_significance(1)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,18:0.5:36:14,5:4,13:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:10,8,12,6:8,10,5,13	0/1:18,16:0.471:34:8,7:10,9:48:85,0,50:49.745,6.7822e-05,53:0,34.77,37.77:11,7,12,4:9,9,3,13	./.:.:.:.:.:.:.:.:.:.:.:.	T	3_prime_UTR_variant	MODIFIER	NPHP3	27031	Transcript	NM_153240.5	protein_coding	27/27		c.*1176G>A		5223					rs183658380	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0014	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0006381	0.001231	0.001096	0.0007859	0	0	0	0	0.0004119	0.0004739	0.0008295	0.0043	AMR	uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				343353	NA	Conflicting_classifications_of_pathogenicity	NPHP3-related_Meckel-like_syndrome&Nephronophthisis_3&Renal-hepatic-pancreatic_dysplasia_1	NC_000003.12:g.132680734C>T		single_nucleotide_variant	NPHP3:27031&NPHP3-ACAD11:100532724	MONDO:MONDO:0009966&MedGen:C2673885&OMIM:267010&Orphanet:3032&MONDO:MONDO:0011456&MedGen:C1858392&OMIM:604387&Orphanet:655&MONDO:MONDO:0008833&MedGen:C3715199&OMIM:208540	Uncertain_significance(1)&Likely_benign(2)	criteria_provided&_conflicting_classifications		NPHP3	Nephronophthisis 3	AR	604387	Renal disorders	NBScreening	-9	Benign	BP4_Strong,BP6,BS1	rs183658380	chr3_132680734_C_T	Female	0/1	Heterozygous
chr3	132680984	.	G	A	50	PASS	"FS=5.127;MQ=250;MQRankSum=5.248;QD=1.32;ReadPosRankSum=2.149;SOR=1.751;FractionInformativeReads=1;R2_5P_bias=-6.531;DP=82;AF=0.5;AN=4;AC=2;CSQ=A|3_prime_UTR_variant|MODIFIER|NPHP3|27031|Transcript|NM_153240.5|protein_coding|27/27||NM_153240.5:c.*926C>T||4973|||||rs570076170||-1||SNV|EntrezGene||YES|||G|G||||||0.0014|0|||||||0|||0.0006304|0.001203|0.001096|0.0007844|0|0|0|0|0.0004117|0.0004744|0.0008292|0.0043|AMR|likely_benign&uncertain_significance||1|||||||||||||||||||||||||||902586||Conflicting_classifications_of_pathogenicity|Renal-hepatic-pancreatic_dysplasia_1&NPHP3-related_Meckel-like_syndrome&Nephronophthisis_3|NC_000003.12:g.132680984G>A||single_nucleotide_variant|NPHP3:27031&NPHP3-ACAD11:100532724|MONDO:MONDO:0008833&MedGen:C3715199&OMIM:208540&MONDO:MONDO:0009966&MedGen:C2673885&OMIM:267010&Orphanet:3032&MONDO:MONDO:0011456&MedGen:C1858392&OMIM:604387&Orphanet:655|Uncertain_significance(1)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,20:0.526:38:7,9:11,11:48:85,0,50:50,6.6269e-05,52.815:0,34.77,37.77:10,8,15,5:9,9,12,8	0/1:24,20:0.455:44:15,6:9,14:48:84,0,50:49.279,7.2999e-05,53:0,34.77,37.77:10,14,11,9:11,13,9,11	./.:.:.:.:.:.:.:.:.:.:.:.	A	3_prime_UTR_variant	MODIFIER	NPHP3	27031	Transcript	NM_153240.5	protein_coding	27/27		c.*926C>T		4973					rs570076170	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0014	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.0006304	0.001203	0.001096	0.0007844	0	0	0	0	0.0004117	0.0004744	0.0008292	0.0043	AMR	likely_benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				902586	NA	Conflicting_classifications_of_pathogenicity	Renal-hepatic-pancreatic_dysplasia_1&NPHP3-related_Meckel-like_syndrome&Nephronophthisis_3	NC_000003.12:g.132680984G>A		single_nucleotide_variant	NPHP3:27031&NPHP3-ACAD11:100532724	MONDO:MONDO:0008833&MedGen:C3715199&OMIM:208540&MONDO:MONDO:0009966&MedGen:C2673885&OMIM:267010&Orphanet:3032&MONDO:MONDO:0011456&MedGen:C1858392&OMIM:604387&Orphanet:655	Uncertain_significance(1)&Likely_benign(2)	criteria_provided&_conflicting_classifications		NPHP3	Nephronophthisis 3	AR	604387	Renal disorders	NBScreening	-9	Benign	BP4_Strong,BP6,BS1	rs570076170	chr3_132680984_G_A	Female	0/1	Heterozygous
chr3	149141200	.	C	CTTTTT	140.24	PASS	"FS=0;MQ=242.35;QD=4.38;SOR=1.044;FractionInformativeReads=0.969;MQRankSum=3.792;ReadPosRankSum=0.405;R2_5P_bias=8.582;DP=106;AF=0.5;AN=6;AC=4;CSQ=TTTTT|intron_variant|MODIFIER|HPS3|84343|Transcript|NM_032383.5|protein_coding||3/16|NM_032383.5:c.884+21_884+25dup|||||||rs10693502||1||insertion|EntrezGene||YES|||||||||13||0.126|0.01614|0.05438|0.06605|0.1337|0.1271|0.04926|0.1336|0.1139|0.1355|0.162|0.0392|0.1806|0.1516|0.1322|0.2658|0.2489|0.1204|0.216|0.1362|0.2525|0.2658|gnomADg_EAS|uncertain_significance&benign&likely_benign||1|||||||||||||||||||||||||||343698||Conflicting_classifications_of_pathogenicity|Hermansky-Pudlak_syndrome&not_provided|NC_000003.12:g.149141209_149141213dup||Duplication|HPS3:84343|MONDO:MONDO:0019312&MedGen:C0079504&OMIM:PS203300&Orphanet:79430&MedGen:C3661900|Uncertain_significance(1)&Benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,31:1:31:0,16:0,15:90:153,93,0:140.24,90.239,0:0,10,13:0,0,18,13:0,0,13,18	0/1:23,11:0.324:34:11,4:12,7:40:51,0,50:40.522,0.00040695,53:0,10,13:10,13,8,3:10,13,5,6	0/1:18,18:0.5:36:9,12:9,6:48:60,0,50:50,6.5233e-05,53:0,10,13:10,8,13,5:9,9,15,3	TTTTT	intron_variant	MODIFIER	HPS3	84343	Transcript	NM_032383.5	protein_coding		16-Mar	c.884+21_884+25dup							rs10693502	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			13	NA	0.126	0.01614	0.05438	0.06605	0.1337	0.1271	0.04926	0.1336	0.1139	0.1355	0.162	0.0392	0.1806	0.1516	0.1322	0.2658	0.2489	0.1204	0.216	0.1362	0.2525	0.2658	gnomADg_EAS	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				343698	NA	Conflicting_classifications_of_pathogenicity	Hermansky-Pudlak_syndrome&not_provided	NC_000003.12:g.149141209_149141213dup		Duplication	HPS3:84343	MONDO:MONDO:0019312&MedGen:C0079504&OMIM:PS203300&Orphanet:79430&MedGen:C3661900	Uncertain_significance(1)&Benign(2)	criteria_provided&_conflicting_classifications		HPS3	Hermansky-Pudlak syndrome 3	AR	614072	Eye disorders	NBScreening	-9	Benign	BP6,BA1	rs10693502	chr3_149141200_C_CTTTTT	Female	01-Jan	Homozygous
chr3	149172318	.	T	TCACA	50	PASS	"FS=1.935;MQ=248.75;MQRankSum=2.554;QD=1.28;ReadPosRankSum=-0.708;SOR=0.32;FractionInformativeReads=0.59;R2_5P_bias=-1.813;DP=77;AF=0.5;AN=4;AC=2;CSQ=CACA|3_prime_UTR_variant|MODIFIER|HPS3|84343|Transcript|NM_032383.5|protein_coding|17/17||NM_032383.5:c.*131_*134dup||3197-3198|||||rs113015797&COSV52829011||1||insertion|EntrezGene||YES|||||||||38||0.1024|0.05719|0.07457|0.05099|0.1572|0.1543|0.03859|0.09716|0.09863|0.1216|0.1386|0.08042|0.1479|0.1238|0.08169|0.2299|0.2501|0.06643|0.1548|0.1201|0.1704|0.2501|gnomADg_FIN||0&1|1&1|||||||||||||||||||||||||||343719||Conflicting_classifications_of_pathogenicity|not_provided&Hermansky-Pudlak_syndrome|NC_000003.12:g.149172319CA[21]||Microsatellite|CP:1356&HPS3:84343|MedGen:C3661900&MONDO:MONDO:0019312&MedGen:C0079504&OMIM:PS203300&Orphanet:79430|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,11:0.478:23:7,6:5,5:48:52,0,50:49.885,6.6269e-05,53:0,2,5:2,10,3,8:7,5,8,3	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:7,10:0.588:17:2,5:5,5:48:52,0,49:50,7.0669e-05,52.042:0,2,5:4,3,1,9:3,4,6,4	CACA	3_prime_UTR_variant	MODIFIER	HPS3	84343	Transcript	NM_032383.5	protein_coding	17/17		c.*131_*134dup		3197-3198					rs113015797&COSV52829011	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			38	NA	0.1024	0.05719	0.07457	0.05099	0.1572	0.1543	0.03859	0.09716	0.09863	0.1216	0.1386	0.08042	0.1479	0.1238	0.08169	0.2299	0.2501	0.06643	0.1548	0.1201	0.1704	0.2501	gnomADg_FIN		0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				343719	NA	Conflicting_classifications_of_pathogenicity	not_provided&Hermansky-Pudlak_syndrome	NC_000003.12:g.149172319CA[21]		Microsatellite	CP:1356&HPS3:84343	MedGen:C3661900&MONDO:MONDO:0019312&MedGen:C0079504&OMIM:PS203300&Orphanet:79430	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		HPS3	Hermansky-Pudlak syndrome 3	AR	614072	Eye disorders	NBScreening	-9	Benign	BP6,BA1	rs113015797	chr3_149172318_T_TCACA	Female	0/1	Heterozygous
chr3	165019591	.	T	C	50	PASS	"FS=7.319;MQ=250;MQRankSum=4.951;QD=1.47;ReadPosRankSum=0.121;SOR=0.556;FractionInformativeReads=1;R2_5P_bias=0.949;DP=34;AF=0.5;AN=2;AC=1;CSQ=C|intron_variant|MODIFIER|SI|6476|Transcript|NM_001041.4|protein_coding||28/47|NM_001041.4:c.3423+11A>G|||||||rs770815174||-1||SNV|EntrezGene||YES|||T|T|||||||2.055e-06|0|0|0|0|0|0|2.702e-06|0|0||||||||||||2.702e-06|gnomADe_NFE|uncertain_significance&likely_benign||1||||||||||||6|11|-31|7|0.00|0.00|0.00|0.10|SI|||||||344029||Conflicting_classifications_of_pathogenicity|not_provided&Sucrase-isomaltase_deficiency|NC_000003.12:g.165019591T>C||single_nucleotide_variant|SI:6476|MedGen:C3661900&MONDO:MONDO:0009114&MedGen:C1283620&OMIM:222900&Orphanet:35122|Uncertain_significance(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,18:0.529:34:13,9:3,9:48:85,0,50:50,6.6527e-05,52.745:0,34.77,37.77:11,5,8,10:8,8,13,5	./.:.:.:.:.:.:.:.:.:.:.:.	C	intron_variant	MODIFIER	SI	6476	Transcript	NM_001041.4	protein_coding		28/47	c.3423+11A>G							rs770815174	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	2.055e-06	0	0	0	0	0	0	2.702e-06	0	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2.702e-06	gnomADe_NFE	uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		6	11	-31	7	0	0	0	0.1	SI			NA				344029	NA	Conflicting_classifications_of_pathogenicity	not_provided&Sucrase-isomaltase_deficiency	NC_000003.12:g.165019591T>C		single_nucleotide_variant	SI:6476	MedGen:C3661900&MONDO:MONDO:0009114&MedGen:C1283620&OMIM:222900&Orphanet:35122	Uncertain_significance(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		SI	Sucrase-isomaltase deficiency	AR	222900	Inherited disorders of metabolism	NBScreening	-3	Likely_benign	PM2,BP4_Strong,BP6	rs770815174	chr3_165019591_T_C	Female	./.	Other
chr3	165773492	.	C	T	50	PASS	"FS=8.021;MQ=248.86;MQRankSum=6.086;QD=0.98;ReadPosRankSum=2.906;SOR=0.18;FractionInformativeReads=1;R2_5P_bias=-10.224;DP=103;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|BCHE|590|Transcript|NM_000055.4|protein_coding|4/4||NM_000055.4:c.1699G>A|NP_000046.1:p.Ala567Thr|1817|1699|567|A/T|Gca/Aca|rs1803274&CM920127&COSV52256958||-1||SNV|EntrezGene||YES|||C|C|||deleterious(0.04)|benign(0.012)||0.1585|0.1952|0.1919|0.1175|0.1779|0.1388|0.1691|0.23|0.2027|0.1945|0.1868|0.1828|0.1886|0.2121|0.1383|0.1763|0.1173|0.1653|0.2007|0.1978|0.1835|0.1677|0.23|gnomADe_MID|benign&pathogenic|0&1&1|1&1&1||||T|0.00877|-0.467858|T|0.44619|-0.301002|0.36778|0.136&0.136|-4|14|-4|-1|0.00|0.01|0.00|0.00|BCHE|likely_benign|hg38|0.0848|A567T|ENST00000264381.8|P06276|13220||Conflicting_classifications_of_pathogenicity|not_specified&Deficiency_of_butyrylcholinesterase&Butyrylcholinesterase_activity&not_provided|NC_000003.12:g.165773492C>T||single_nucleotide_variant|BCHE:590|MedGen:CN169374&MONDO:MONDO:0015270&MedGen:C1283400&OMIM:617936&Orphanet:132&.&MedGen:C3661900|Pathogenic(1)&Benign(3)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:23,28:0.549:51:11,17:12,11:48:85,0,49:50,7.0152e-05,52.088:0,34.77,37.77:17,6,15,13:11,12,12,16	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:30,20:0.4:50:15,9:15,11:45:81,0,50:45.776,0.00013668,53:0,34.77,37.77:20,10,12,8:15,15,11,9	T	missense_variant	MODERATE	BCHE	590	Transcript	NM_000055.4	protein_coding	04-Apr		c.1699G>A	p.Ala567Thr	1817	1699	567	A/T	Gca/Aca	rs1803274&CM920127&COSV52256958	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious(0.04)	benign(0.012)	NA	0.1585	0.1952	0.1919	0.1175	0.1779	0.1388	0.1691	0.23	0.2027	0.1945	0.1868	0.1828	0.1886	0.2121	0.1383	0.1763	0.1173	0.1653	0.2007	0.1978	0.1835	0.1677	0.23	gnomADe_MID	benign&pathogenic	0&1&1	1&1&1	NA	NA	NA	T	0.00877	-0.467858	T	0.44619	-0.301002	0.36778	0.136&0.136	-4	14	-4	-1	0	0.01	0	0	BCHE	likely_benign	hg38	0.0848	A567T	ENST00000264381.8	P06276	13220	NA	Conflicting_classifications_of_pathogenicity	not_specified&Deficiency_of_butyrylcholinesterase&Butyrylcholinesterase_activity&not_provided	NC_000003.12:g.165773492C>T		single_nucleotide_variant	BCHE:590	MedGen:CN169374&MONDO:MONDO:0015270&MedGen:C1283400&OMIM:617936&Orphanet:132&.&MedGen:C3661900	Pathogenic(1)&Benign(3)&Likely_benign(1)	criteria_provided&_conflicting_classifications		BCHE	Increased sensitivity to choline ester anesthesia	AR	NA	Complex genetic syndromes	NBScreening	-12	Benign	BP4_Strong,BA1	rs1803274	chr3_165773492_C_T	Female	0/1	Heterozygous
chr3	165830185	.	C	G	50	PASS	"FS=2.966;MQ=250;MQRankSum=5.033;QD=1.43;ReadPosRankSum=3.053;SOR=0.704;FractionInformativeReads=1;R2_5P_bias=-9.731;DP=67;AF=0.5;AN=4;AC=2;CSQ=G|missense_variant|MODERATE|BCHE|590|Transcript|NM_000055.4|protein_coding|2/4||NM_000055.4:c.849G>C|NP_000046.1:p.Glu283Asp|967|849|283|E/D|gaG/gaC|rs16849700&CM080102&COSV52263259||-1||SNV|EntrezGene||YES|||C|C|||tolerated(0.3)|benign(0)||0.0228|0.01457|0.06318|0.008638|0.01106|7.558e-05|0.002471|0.04353|0.0133|0.01727|0.02659|0.02275|0.05564|0|0.009494|0.01326|0.0001932|0.0016|0.01701|0.01145|0.02318|0.02299|0.06318|gnomADe_AFR|conflicting_interpretations_of_pathogenicity&benign/likely_benign|0&1&1|1&1&1||||T|0.00107|-0.621603|T|0.10997|-0.622409|0.20116|0.069|3|-1|41|3|0.00|0.00|0.00|0.00|BCHE|likely_benign|hg38|0.0736|E283D|ENST00000264381.8|P06276|254777||Conflicting_classifications_of_pathogenicity|not_specified&Deficiency_of_butyrylcholinesterase|NC_000003.12:g.165830185C>G||single_nucleotide_variant|BCHE:590|MedGen:CN169374&MONDO:MONDO:0015270&MedGen:C1283400&OMIM:617936&Orphanet:132|Uncertain_significance(1)&Benign(2)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,18:0.514:35:7,10:10,8:48:85,0,50:50,6.5492e-05,52.962:0,34.77,37.77:10,7,8,10:12,5,6,12	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,15:0.484:31:10,6:6,9:48:85,0,50:49.956,6.5492e-05,53:0,34.77,37.77:4,12,9,6:8,8,6,9	G	missense_variant	MODERATE	BCHE	590	Transcript	NM_000055.4	protein_coding	04-Feb		c.849G>C	p.Glu283Asp	967	849	283	E/D	gaG/gaC	rs16849700&CM080102&COSV52263259	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	tolerated(0.3)	benign(0)	NA	0.0228	0.01457	0.06318	0.008638	0.01106	7.558e-05	0.002471	0.04353	0.0133	0.01727	0.02659	0.02275	0.05564	0	0.009494	0.01326	0.0001932	0.0016	0.01701	0.01145	0.02318	0.02299	0.06318	gnomADe_AFR	conflicting_interpretations_of_pathogenicity&benign/likely_benign	0&1&1	1&1&1	NA	NA	NA	T	0.00107	-0.621603	T	0.10997	-0.622409	0.20116	0.069	3	-1	41	3	0	0	0	0	BCHE	likely_benign	hg38	0.0736	E283D	ENST00000264381.8	P06276	254777	NA	Conflicting_classifications_of_pathogenicity	not_specified&Deficiency_of_butyrylcholinesterase	NC_000003.12:g.165830185C>G		single_nucleotide_variant	BCHE:590	MedGen:CN169374&MONDO:MONDO:0015270&MedGen:C1283400&OMIM:617936&Orphanet:132	Uncertain_significance(1)&Benign(2)&Likely_benign(1)	criteria_provided&_conflicting_classifications		BCHE	Increased sensitivity to choline ester anesthesia	AR	NA	Complex genetic syndromes	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs16849700	chr3_165830185_C_G	Female	0/1	Heterozygous
chr4	5812008	.	C	G	23.4	PASS	"FS=7.174;MQ=144.81;MQRankSum=-1.911;QD=0.81;ReadPosRankSum=2.88;SOR=1.472;FractionInformativeReads=1;R2_5P_bias=11.742;DP=29;AF=0.5;AN=2;AC=1;CSQ=G|3_prime_UTR_variant|MODIFIER|EVC|2121|Transcript|NM_153717.3|protein_coding|21/21||NM_153717.3:c.*971C>G||4130|||||rs13121258||1||SNV|EntrezGene||YES|||C|C|||||||0.001187|0|0.01852|0|0|0.002959|0|0.001077|0|0.001085|0.00156|0.002556|0.002137|0.001023|0|0.004029|0.00409|0.01087|0.0008959|0|0.0003882|0.01852|gnomADe_AMR|uncertain_significance||1||||||||||||33|3|37|3|0.00|0.00|0.00|0.00|EVC|||||||905379||Uncertain_significance|Ellis-van_Creveld_syndrome|NC_000004.12:g.5812008C>G||single_nucleotide_variant|EVC:2121|MONDO:MONDO:0009162&MedGen:C0013903&OMIM:225500&Orphanet:289||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:22,7:0.241:29:12,3:10,4:23:58,0,50:23.401,0.019914,53.02:0,34.77,37.77:14,8,2,5:14,8,4,3	G	3_prime_UTR_variant	MODIFIER	EVC	2121	Transcript	NM_153717.3	protein_coding	21/21		c.*971C>G		4130					rs13121258	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0.001187	0	0.01852	0	0	0.002959	0	0.001077	0	0.001085	0.00156	0.002556	0.002137	0.001023	0	0.004029	0.00409	0.01087	0.0008959	0	0.0003882	0.01852	gnomADe_AMR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		33	3	37	3	0	0	0	0	EVC			NA				905379	NA	Uncertain_significance	Ellis-van_Creveld_syndrome	NC_000004.12:g.5812008C>G		single_nucleotide_variant	EVC:2121	MONDO:MONDO:0009162&MedGen:C0013903&OMIM:225500&Orphanet:289		criteria_provided&_single_submitter		EVC	Ellis-van Creveld syndrome	AR	225500	Complex genetic syndromes	NBScreening	-4	Likely_benign	BP4_Strong	rs13121258	chr4_5812008_C_G	Female	./.	Other
chr4	5812149	.	T	C	43.24	PASS	"FS=0;MQ=69.14;MQRankSum=-0.488;QD=2.16;ReadPosRankSum=0.054;SOR=0.693;FractionInformativeReads=0.8;R2_5P_bias=14.088;DP=20;AF=0.5;AN=2;AC=1;CSQ=C|3_prime_UTR_variant|MODIFIER|EVC|2121|Transcript|NM_153717.3|protein_coding|21/21||NM_153717.3:c.*1112T>C||4271|||||rs28460555||1||SNV|EntrezGene||YES|||T|T|||||||0.1433|0|0.1667|0.2222|0|0.1463|0.0625|0.1364|0.1333|0.1964|0.2116|0.1506|0.3943|0.1556|0.2265|0.01225|0.3694|0.1522|0.2286|0.1821|0.2829|0.3943|gnomADg_AMI|uncertain_significance||1||||||||||||46|8|46|-2|0.00|0.00|0.00|0.00|EVC|||||||905895||Uncertain_significance|not_provided&Ellis-van_Creveld_syndrome|NC_000004.12:g.5812149T>C||single_nucleotide_variant|EVC:2121|MedGen:C3661900&MONDO:MONDO:0009162&MedGen:C0013903&OMIM:225500&Orphanet:289||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:10,6:0.375:16:3,4:7,2:42:78,0,47:43.235,0.00024903,50.05:0,34.77,37.77:5,5,3,3:6,4,3,3	./.:.:.:.:.:.:.:.:.:.:.:.	C	3_prime_UTR_variant	MODIFIER	EVC	2121	Transcript	NM_153717.3	protein_coding	21/21		c.*1112T>C		4271					rs28460555	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	0.1433	0	0.1667	0.2222	0	0.1463	0.0625	0.1364	0.1333	0.1964	0.2116	0.1506	0.3943	0.1556	0.2265	0.01225	0.3694	0.1522	0.2286	0.1821	0.2829	0.3943	gnomADg_AMI	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		46	8	46	-2	0	0	0	0	EVC			NA				905895	NA	Uncertain_significance	not_provided&Ellis-van_Creveld_syndrome	NC_000004.12:g.5812149T>C		single_nucleotide_variant	EVC:2121	MedGen:C3661900&MONDO:MONDO:0009162&MedGen:C0013903&OMIM:225500&Orphanet:289		criteria_provided&_multiple_submitters&_no_conflicts		EVC	Ellis-van Creveld syndrome	AR	225500	Complex genetic syndromes	NBScreening	-12	Benign	BP4_Strong,BA1	rs28460555	chr4_5812149_T_C	Female	./.	Other
chr4	5812160	.	A	G	42.36	PASS	"FS=0;MQ=71.19;MQRankSum=-0.326;QD=1.84;ReadPosRankSum=-0.109;SOR=0.569;FractionInformativeReads=0.913;R2_5P_bias=14.903;DP=23;AF=0.5;AN=2;AC=1;CSQ=G|3_prime_UTR_variant|MODIFIER|EVC|2121|Transcript|NM_153717.3|protein_coding|21/21||NM_153717.3:c.*1123A>G||4282|||||rs112378896||1||SNV|EntrezGene||YES|||A|A|||||||0.003156|0|0|0|0|0|0|0.003717|0|0.003846|0.01439|0.04497|0.008834|0.007518|0.001995|0.0009671|0.006456|0.01087|0.003886|0.01024|0.003873|0.04497|gnomADg_AFR|uncertain_significance||1||||||||||||-3|23|-3|9|0.00|0.00|0.00|0.00|EVC|||||||905896||Uncertain_significance|not_provided&Ellis-van_Creveld_syndrome|NC_000004.12:g.5812160A>G||single_nucleotide_variant|EVC:2121|MedGen:C3661900&MONDO:MONDO:0009162&MedGen:C0013903&OMIM:225500&Orphanet:289||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,8:0.381:21:5,4:8,4:42:77,0,47:42.358,0.00029537,50.05:0,34.77,37.77:7,6,4,4:9,4,4,4	./.:.:.:.:.:.:.:.:.:.:.:.	G	3_prime_UTR_variant	MODIFIER	EVC	2121	Transcript	NM_153717.3	protein_coding	21/21		c.*1123A>G		4282					rs112378896	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.003156	0	0	0	0	0	0	0.003717	0	0.003846	0.01439	0.04497	0.008834	0.007518	0.001995	0.0009671	0.006456	0.01087	0.003886	0.01024	0.003873	0.04497	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-3	23	-3	9	0	0	0	0	EVC			NA				905896	NA	Uncertain_significance	not_provided&Ellis-van_Creveld_syndrome	NC_000004.12:g.5812160A>G		single_nucleotide_variant	EVC:2121	MedGen:C3661900&MONDO:MONDO:0009162&MedGen:C0013903&OMIM:225500&Orphanet:289		criteria_provided&_multiple_submitters&_no_conflicts		EVC	Ellis-van Creveld syndrome	AR	225500	Complex genetic syndromes	NBScreening	-4	Likely_benign	BP4_Strong	rs112378896	chr4_5812160_A_G	Female	./.	Other
chr4	5812294	.	G	T	16.28	PASS	"FS=2.447;MQ=101.41;MQRankSum=-1.893;QD=1.02;ReadPosRankSum=1.763;SOR=1.555;FractionInformativeReads=0.938;R2_5P_bias=5.44;DP=16;AF=0.5;AN=2;AC=1;CSQ=T|3_prime_UTR_variant|MODIFIER|EVC|2121|Transcript|NM_153717.3|protein_coding|21/21||NM_153717.3:c.*1257G>T||4416|||||rs1013315409||1||SNV|EntrezGene||YES|||G|G|||||||0.006045|0|0|0.02439|0.009434|0.008523|0|0.006256|0.006993|0.002304|0.002648|0.003836|0.003759|0.001967|0.0008078|0.002686|0.006048|0.03125|0.00183|0.0007353|0.002841|0.03125|gnomADg_MID|uncertain_significance||1||||||||||||-21|36|-2|0|0.00|0.00|0.00|0.00|EVC|||||||907970||Uncertain_significance|Ellis-van_Creveld_syndrome|NC_000004.12:g.5812294G>T||single_nucleotide_variant|EVC:2121|MONDO:MONDO:0009162&MedGen:C0013903&OMIM:225500&Orphanet:289||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,4:0.267:15:4,1:7,3:16:51,0,46:16.278,0.10362,48.86:0,34.77,37.78:5,6,3,1:8,3,2,2	./.:.:.:.:.:.:.:.:.:.:.:.	T	3_prime_UTR_variant	MODIFIER	EVC	2121	Transcript	NM_153717.3	protein_coding	21/21		c.*1257G>T		4416					rs1013315409	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	0.006045	0	0	0.02439	0.009434	0.008523	0	0.006256	0.006993	0.002304	0.002648	0.003836	0.003759	0.001967	0.0008078	0.002686	0.006048	0.03125	0.00183	0.0007353	0.002841	0.03125	gnomADg_MID	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-21	36	-2	0	0	0	0	0	EVC			NA				907970	NA	Uncertain_significance	Ellis-van_Creveld_syndrome	NC_000004.12:g.5812294G>T		single_nucleotide_variant	EVC:2121	MONDO:MONDO:0009162&MedGen:C0013903&OMIM:225500&Orphanet:289		criteria_provided&_single_submitter		EVC	Ellis-van Creveld syndrome	AR	225500	Complex genetic syndromes	NBScreening	-4	Likely_benign	BP4_Strong	rs1013315409	chr4_5812294_G_T	Female	./.	Other
chr4	5812549	.	T	C	16.37	DRAGENSnpHardQUAL	"FS=0;MQ=187.58;MQRankSum=-1.423;QD=0.56;ReadPosRankSum=-2.435;SOR=0.399;FractionInformativeReads=1;R2_5P_bias=35.938;DP=53;AF=0.5;AN=4;AC=2;CSQ=C|3_prime_UTR_variant|MODIFIER|EVC|2121|Transcript|NM_153717.3|protein_coding|21/21||NM_153717.3:c.*1512T>C||4671|||||rs576620294&COSV53836134||1||SNV|EntrezGene||YES|||T|T||||||0.0014|0.05419|0.04412|0|0.02273|0|0.07522|0.08333|0.05131|0.08416|0.06566|0.02388|0.02634|0.03497|0.01842|0.02692|0.03596|0.01262|0.04688|0.02415|0.0201|0.02442|0.08416|gnomADe_REMAINING|uncertain_significance|0&1|1&1||||||||||||-18|12|-38|20|0.00|0.00|0.00|0.00|EVC|||||||349251||Uncertain_significance|Ellis-van_Creveld_syndrome|NC_000004.12:g.5812549T>C||single_nucleotide_variant|EVC:2121|MONDO:MONDO:0009162&MedGen:C0013903&OMIM:225500&Orphanet:289||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:25,4:0.138:29:11,4:14,0:16:51,0,50:16.374,0.10128,53.101:0,34.77,37.77:19,6,3,1:15,10,3,1	0/1:17,4:0.19:21:10,2:7,2:9:43,0,50:8.508,0.66006,53.66:0,34.77,37.77:11,6,2,2:10,7,2,2	./.:.:.:.:.:.:.:.:.:.:.:.	C	3_prime_UTR_variant	MODIFIER	EVC	2121	Transcript	NM_153717.3	protein_coding	21/21		c.*1512T>C		4671					rs576620294&COSV53836134	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.0014	0.05419	0.04412	0	0.02273	0	0.07522	0.08333	0.05131	0.08416	0.06566	0.02388	0.02634	0.03497	0.01842	0.02692	0.03596	0.01262	0.04688	0.02415	0.0201	0.02442	0.08416	gnomADe_REMAINING	uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-18	12	-38	20	0	0	0	0	EVC			NA				349251	NA	Uncertain_significance	Ellis-van_Creveld_syndrome	NC_000004.12:g.5812549T>C		single_nucleotide_variant	EVC:2121	MONDO:MONDO:0009162&MedGen:C0013903&OMIM:225500&Orphanet:289		criteria_provided&_single_submitter		EVC	Ellis-van Creveld syndrome	AR	225500	Complex genetic syndromes	NBScreening	-4	Likely_benign	BP4_Strong	rs576620294	chr4_5812549_T_C	Female	0/1	Heterozygous
chr4	6300980	.	C	T	49.76	PASS	"FS=5.002;MQ=250;MQRankSum=5.102;QD=1.38;ReadPosRankSum=2.915;SOR=0.819;FractionInformativeReads=1;R2_5P_bias=13.107;DP=58;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|WFS1|7466|Transcript|NM_006005.3|protein_coding|8/8||NM_006005.3:c.1185C>T|NP_005996.2:p.Val395%3D|1355|1185|395|V|gtC/gtT|rs1801206&CM021362&COSV56987540||1||SNV|EntrezGene||YES|||C|C||||||0.6416|0.6051|0.4555|0.726|0.6765|0.9578|0.5715|0.5902|0.589|0.6193|0.6353|0.5756|0.4596|0.389|0.6659|0.6603|0.9332|0.5667|0.6156|0.5925|0.6087|0.6444|0.9578|gnomADe_EAS|benign&uncertain_significance|0&1&1|1&1&1||||||||||||-3|-8|-3|34|0.00|0.00|0.00|0.00|WFS1|||||||45431||Conflicting_classifications_of_pathogenicity|not_specified&Autosomal_dominant_nonsyndromic_hearing_loss_6&not_provided&WFS1-Related_Spectrum_Disorders&Wolfram_syndrome_1|NC_000004.12:g.6300980C>T||single_nucleotide_variant|WFS1:7466|MedGen:CN169374&MONDO:MONDO:0010963&MedGen:C1833021&OMIM:600965&Orphanet:90635&MedGen:C3661900&MedGen:CN239410&MONDO:MONDO:0009101&MedGen:C4551693&OMIM:222300&Orphanet:3463|Uncertain_significance(1)&Benign(9)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,17:0.472:36:8,8:11,9:48:85,0,50:49.759,6.7563e-05,53:0,34.77,37.77:12,7,7,10:9,10,10,7	0/1:13,9:0.409:22:4,5:9,4:47:83,0,50:48.412,8.4389e-05,53:0,34.77,37.77:10,3,7,2:7,6,3,6	./.:.:.:.:.:.:.:.:.:.:.:.	T	synonymous_variant	LOW	WFS1	7466	Transcript	NM_006005.3	protein_coding	08-Aug		c.1185C>T	p.Val395%3D	1355	1185	395	V	gtC/gtT	rs1801206&CM021362&COSV56987540	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.6416	0.6051	0.4555	0.726	0.6765	0.9578	0.5715	0.5902	0.589	0.6193	0.6353	0.5756	0.4596	0.389	0.6659	0.6603	0.9332	0.5667	0.6156	0.5925	0.6087	0.6444	0.9578	gnomADe_EAS	benign&uncertain_significance	0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-3	-8	-3	34	0	0	0	0	WFS1			NA				45431	NA	Conflicting_classifications_of_pathogenicity	not_specified&Autosomal_dominant_nonsyndromic_hearing_loss_6&not_provided&WFS1-Related_Spectrum_Disorders&Wolfram_syndrome_1	NC_000004.12:g.6300980C>T		single_nucleotide_variant	WFS1:7466	MedGen:CN169374&MONDO:MONDO:0010963&MedGen:C1833021&OMIM:600965&Orphanet:90635&MedGen:C3661900&MedGen:CN239410&MONDO:MONDO:0009101&MedGen:C4551693&OMIM:222300&Orphanet:3463	Uncertain_significance(1)&Benign(9)	criteria_provided&_conflicting_classifications		WFS1	Wolfram syndrome 1	AR	222300	"Endocrine disorders;Hearing disorders"	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1801206	chr4_6300980_C_T	Female	0/1	Heterozygous
chr4	6300980	.	C	T	49.76	PASS	"FS=5.002;MQ=250;MQRankSum=5.102;QD=1.38;ReadPosRankSum=2.915;SOR=0.819;FractionInformativeReads=1;R2_5P_bias=13.107;DP=58;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|WFS1|7466|Transcript|NM_006005.3|protein_coding|8/8||NM_006005.3:c.1185C>T|NP_005996.2:p.Val395%3D|1355|1185|395|V|gtC/gtT|rs1801206&CM021362&COSV56987540||1||SNV|EntrezGene||YES|||C|C||||||0.6416|0.6051|0.4555|0.726|0.6765|0.9578|0.5715|0.5902|0.589|0.6193|0.6353|0.5756|0.4596|0.389|0.6659|0.6603|0.9332|0.5667|0.6156|0.5925|0.6087|0.6444|0.9578|gnomADe_EAS|benign&uncertain_significance|0&1&1|1&1&1||||||||||||-3|-8|-3|34|0.00|0.00|0.00|0.00|WFS1|||||||45431||Conflicting_classifications_of_pathogenicity|not_specified&Autosomal_dominant_nonsyndromic_hearing_loss_6&not_provided&WFS1-Related_Spectrum_Disorders&Wolfram_syndrome_1|NC_000004.12:g.6300980C>T||single_nucleotide_variant|WFS1:7466|MedGen:CN169374&MONDO:MONDO:0010963&MedGen:C1833021&OMIM:600965&Orphanet:90635&MedGen:C3661900&MedGen:CN239410&MONDO:MONDO:0009101&MedGen:C4551693&OMIM:222300&Orphanet:3463|Uncertain_significance(1)&Benign(9)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,17:0.472:36:8,8:11,9:48:85,0,50:49.759,6.7563e-05,53:0,34.77,37.77:12,7,7,10:9,10,10,7	0/1:13,9:0.409:22:4,5:9,4:47:83,0,50:48.412,8.4389e-05,53:0,34.77,37.77:10,3,7,2:7,6,3,6	./.:.:.:.:.:.:.:.:.:.:.:.	T	synonymous_variant	LOW	WFS1	7466	Transcript	NM_006005.3	protein_coding	08-Aug		c.1185C>T	p.Val395%3D	1355	1185	395	V	gtC/gtT	rs1801206&CM021362&COSV56987540	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.6416	0.6051	0.4555	0.726	0.6765	0.9578	0.5715	0.5902	0.589	0.6193	0.6353	0.5756	0.4596	0.389	0.6659	0.6603	0.9332	0.5667	0.6156	0.5925	0.6087	0.6444	0.9578	gnomADe_EAS	benign&uncertain_significance	0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-3	-8	-3	34	0	0	0	0	WFS1			NA				45431	NA	Conflicting_classifications_of_pathogenicity	not_specified&Autosomal_dominant_nonsyndromic_hearing_loss_6&not_provided&WFS1-Related_Spectrum_Disorders&Wolfram_syndrome_1	NC_000004.12:g.6300980C>T		single_nucleotide_variant	WFS1:7466	MedGen:CN169374&MONDO:MONDO:0010963&MedGen:C1833021&OMIM:600965&Orphanet:90635&MedGen:C3661900&MedGen:CN239410&MONDO:MONDO:0009101&MedGen:C4551693&OMIM:222300&Orphanet:3463	Uncertain_significance(1)&Benign(9)	criteria_provided&_conflicting_classifications		WFS1	Autosomal dominant nonsyndromic hearing loss 6	AD	600965	"Hearing disorders;Endocrine disorders"	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1801206	chr4_6300980_C_T	Female	0/1	Heterozygous
chr4	6301295	.	C	T	50	PASS	"FS=11.649;MQ=249.93;MQRankSum=5.023;QD=1.1;ReadPosRankSum=3.057;SOR=1.93;FractionInformativeReads=1;R2_5P_bias=5.491;DP=84;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|WFS1|7466|Transcript|NM_006005.3|protein_coding|8/8||NM_006005.3:c.1500C>T|NP_005996.2:p.Asn500%3D|1670|1500|500|N|aaC/aaT|rs1801214||1||SNV|EntrezGene||YES|||C|C||||||0.7294|0.6232|0.6757|0.7449|0.696|0.9621|0.5729|0.6281|0.5982|0.6483|0.6951|0.6443|0.6704|0.3904|0.7014|0.6817|0.9402|0.5669|0.6531|0.6019|0.6596|0.703|0.9621|gnomADe_EAS|uncertain_significance&benign||1||||||||||||0|-41|0|24|0.00|0.00|0.00|0.00|WFS1|||||||45437||Conflicting_classifications_of_pathogenicity|not_provided&not_specified&Autosomal_dominant_nonsyndromic_hearing_loss_6&Type_2_diabetes_mellitus&WFS1-Related_Spectrum_Disorders|NC_000004.12:g.6301295C>T||single_nucleotide_variant|WFS1:7466|MedGen:C3661900&MedGen:CN169374&MONDO:MONDO:0010963&MedGen:C1833021&OMIM:600965&Orphanet:90635&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:CN239410|Uncertain_significance(1)&Benign(8)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:25,19:0.432:44:9,8:16,11:47:83,0,50:48.214,8.7237e-05,53:0,34.77,37.77:11,14,14,5:13,12,7,12	0/1:17,23:0.575:40:11,12:6,11:48:85,0,48:50,7.5847e-05,51.272:0,34.77,37.77:12,5,13,10:10,7,14,9	./.:.:.:.:.:.:.:.:.:.:.:.	T	synonymous_variant	LOW	WFS1	7466	Transcript	NM_006005.3	protein_coding	08-Aug		c.1500C>T	p.Asn500%3D	1670	1500	500	N	aaC/aaT	rs1801214	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.7294	0.6232	0.6757	0.7449	0.696	0.9621	0.5729	0.6281	0.5982	0.6483	0.6951	0.6443	0.6704	0.3904	0.7014	0.6817	0.9402	0.5669	0.6531	0.6019	0.6596	0.703	0.9621	gnomADe_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		0	-41	0	24	0	0	0	0	WFS1			NA				45437	NA	Conflicting_classifications_of_pathogenicity	not_provided&not_specified&Autosomal_dominant_nonsyndromic_hearing_loss_6&Type_2_diabetes_mellitus&WFS1-Related_Spectrum_Disorders	NC_000004.12:g.6301295C>T		single_nucleotide_variant	WFS1:7466	MedGen:C3661900&MedGen:CN169374&MONDO:MONDO:0010963&MedGen:C1833021&OMIM:600965&Orphanet:90635&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:CN239410	Uncertain_significance(1)&Benign(8)	criteria_provided&_conflicting_classifications		WFS1	Wolfram syndrome 1	AR	222300	"Endocrine disorders;Hearing disorders"	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1801214	chr4_6301295_C_T	Female	0/1	Heterozygous
chr4	6301295	.	C	T	50	PASS	"FS=11.649;MQ=249.93;MQRankSum=5.023;QD=1.1;ReadPosRankSum=3.057;SOR=1.93;FractionInformativeReads=1;R2_5P_bias=5.491;DP=84;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|WFS1|7466|Transcript|NM_006005.3|protein_coding|8/8||NM_006005.3:c.1500C>T|NP_005996.2:p.Asn500%3D|1670|1500|500|N|aaC/aaT|rs1801214||1||SNV|EntrezGene||YES|||C|C||||||0.7294|0.6232|0.6757|0.7449|0.696|0.9621|0.5729|0.6281|0.5982|0.6483|0.6951|0.6443|0.6704|0.3904|0.7014|0.6817|0.9402|0.5669|0.6531|0.6019|0.6596|0.703|0.9621|gnomADe_EAS|uncertain_significance&benign||1||||||||||||0|-41|0|24|0.00|0.00|0.00|0.00|WFS1|||||||45437||Conflicting_classifications_of_pathogenicity|not_provided&not_specified&Autosomal_dominant_nonsyndromic_hearing_loss_6&Type_2_diabetes_mellitus&WFS1-Related_Spectrum_Disorders|NC_000004.12:g.6301295C>T||single_nucleotide_variant|WFS1:7466|MedGen:C3661900&MedGen:CN169374&MONDO:MONDO:0010963&MedGen:C1833021&OMIM:600965&Orphanet:90635&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:CN239410|Uncertain_significance(1)&Benign(8)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:25,19:0.432:44:9,8:16,11:47:83,0,50:48.214,8.7237e-05,53:0,34.77,37.77:11,14,14,5:13,12,7,12	0/1:17,23:0.575:40:11,12:6,11:48:85,0,48:50,7.5847e-05,51.272:0,34.77,37.77:12,5,13,10:10,7,14,9	./.:.:.:.:.:.:.:.:.:.:.:.	T	synonymous_variant	LOW	WFS1	7466	Transcript	NM_006005.3	protein_coding	08-Aug		c.1500C>T	p.Asn500%3D	1670	1500	500	N	aaC/aaT	rs1801214	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.7294	0.6232	0.6757	0.7449	0.696	0.9621	0.5729	0.6281	0.5982	0.6483	0.6951	0.6443	0.6704	0.3904	0.7014	0.6817	0.9402	0.5669	0.6531	0.6019	0.6596	0.703	0.9621	gnomADe_EAS	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		0	-41	0	24	0	0	0	0	WFS1			NA				45437	NA	Conflicting_classifications_of_pathogenicity	not_provided&not_specified&Autosomal_dominant_nonsyndromic_hearing_loss_6&Type_2_diabetes_mellitus&WFS1-Related_Spectrum_Disorders	NC_000004.12:g.6301295C>T		single_nucleotide_variant	WFS1:7466	MedGen:C3661900&MedGen:CN169374&MONDO:MONDO:0010963&MedGen:C1833021&OMIM:600965&Orphanet:90635&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:CN239410	Uncertain_significance(1)&Benign(8)	criteria_provided&_conflicting_classifications		WFS1	Autosomal dominant nonsyndromic hearing loss 6	AD	600965	"Hearing disorders;Endocrine disorders"	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1801214	chr4_6301295_C_T	Female	0/1	Heterozygous
chr4	15480812	.	C	T	50	PASS	"FS=2.92;MQ=250;MQRankSum=5.189;QD=1.26;ReadPosRankSum=2.735;SOR=0.33;FractionInformativeReads=1;R2_5P_bias=19.423;DP=73;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|CC2D2A|57545|Transcript|NM_001378615.1|protein_coding|4/37||NM_001378615.1:c.232C>T|NP_001365544.1:p.Arg78Trp|426|232|78|R/W|Cgg/Tgg|rs769077754||1||SNV|EntrezGene||YES|||C|C|||deleterious_low_confidence(0)|possibly_damaging(0.738)|||7.532e-06|0|0|3.834e-05|2.521e-05|1.874e-05|0|5.399e-06|0|2.325e-05||||||||||||3.834e-05|gnomADe_ASJ|uncertain_significance||1||||T|0.44171|-0.0518213|T|0.59849|-0.143086|0.19503|0.067&0.067&0.067&0.067&0.067|15|-48|-12|15|0.00|0.00|0.00|0.01|CC2D2A|likely_benign|hg38|0.1222|R78W|ENST00000503292.5|Q9P2K1|2150847||Uncertain_significance|Meckel-Gruber_syndrome&Familial_aplasia_of_the_vermis&Meckel_syndrome&_type_6&Retinitis_pigmentosa_93&Joubert_syndrome_9&COACH_syndrome_2|NC_000004.12:g.15480812C>T||single_nucleotide_variant|CC2D2A:57545|MONDO:MONDO:0018921&MedGen:C0265215&OMIM:PS249000&Orphanet:564&MONDO:MONDO:0018772&MedGen:C0431399&OMIM:PS213300&Orphanet:475&MONDO:MONDO:0012848&MedGen:C2676790&OMIM:612284&Orphanet:564&MONDO:MONDO:0030797&MedGen:C5676970&OMIM:619845&MONDO:MONDO:0012849&MedGen:C2676788&OMIM:612285&Orphanet:2318&MONDO:MONDO:0030859&MedGen:C5436837&OMIM:619111||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:22,16:0.421:38:13,7:9,9:47:83,0,50:47.774,9.4226e-05,53:0,34.77,37.77:7,15,7,9:10,12,8,8	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:12,23:0.657:35:6,10:6,13:44:85,0,42:50,0.00016982,45.358:0,34.77,37.77:3,9,9,14:7,5,10,13	T	missense_variant	MODERATE	CC2D2A	57545	Transcript	NM_001378615.1	protein_coding	4/37		c.232C>T	p.Arg78Trp	426	232	78	R/W	Cgg/Tgg	rs769077754	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious_low_confidence(0)	possibly_damaging(0.738)	NA	NA	7.532e-06	0	0	3.834e-05	2.521e-05	1.874e-05	0	5.399e-06	0	2.325e-05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	3.834e-05	gnomADe_ASJ	uncertain_significance		1	NA	NA	NA	T	0.44171	-0.0518213	T	0.59849	-0.143086	0.19503	0.067&0.067&0.067&0.067&0.067	15	-48	-12	15	0	0	0	0.01	CC2D2A	likely_benign	hg38	0.1222	R78W	ENST00000503292.5	Q9P2K1	2150847	NA	Uncertain_significance	Meckel-Gruber_syndrome&Familial_aplasia_of_the_vermis&Meckel_syndrome&_type_6&Retinitis_pigmentosa_93&Joubert_syndrome_9&COACH_syndrome_2	NC_000004.12:g.15480812C>T		single_nucleotide_variant	CC2D2A:57545	MONDO:MONDO:0018921&MedGen:C0265215&OMIM:PS249000&Orphanet:564&MONDO:MONDO:0018772&MedGen:C0431399&OMIM:PS213300&Orphanet:475&MONDO:MONDO:0012848&MedGen:C2676790&OMIM:612284&Orphanet:564&MONDO:MONDO:0030797&MedGen:C5676970&OMIM:619845&MONDO:MONDO:0012849&MedGen:C2676788&OMIM:612285&Orphanet:2318&MONDO:MONDO:0030859&MedGen:C5436837&OMIM:619111		criteria_provided&_multiple_submitters&_no_conflicts		CC2D2A	Joubert syndrome 9	AR	612285	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	0	Uncertain_significance	PM2,BP4_Moderate	rs769077754	chr4_15480812_C_T	Female	0/1	Heterozygous
chr4	88008343	.	C	T	47.27	PASS	"FS=0;MQ=250;MQRankSum=2.637;QD=3.94;ReadPosRankSum=0;SOR=0.223;FractionInformativeReads=1;R2_5P_bias=7.525;DP=12;AF=0.5;AN=2;AC=1;CSQ=T|intron_variant|MODIFIER|PKD2|5311|Transcript|NM_000297.4|protein_coding||1/14|NM_000297.4:c.595+15C>T|||||||rs559555727||1||SNV|EntrezGene||YES|||C|C||||||0.0022|0.0002344|0|2.966e-05|0|0.007808|0|0|2.059e-05|0.0003348|0.0001434|0.0003812|0|0|0|0|0.01055|0|0|0|0.001422|0.000207|0.0109|EAS|benign&uncertain_significance&likely_benign||1||||||||||||7|-7|12|-15|0.00|0.00|0.00|0.00|PKD2|||||||440151||Conflicting_classifications_of_pathogenicity|not_provided&Polycystic_kidney_disease_2&not_specified&Autosomal_dominant_polycystic_kidney_disease&Polycystic_kidney_disease|NC_000004.12:g.88008343C>T||single_nucleotide_variant|PKD2:5311|MedGen:C3661900&MONDO:MONDO:0013131&MedGen:C2751306&OMIM:613095&MedGen:CN169374&MONDO:MONDO:0004691&MedGen:C0085413&Orphanet:730&Human_Phenotype_Ontology:HP:0000113&Human_Phenotype_Ontology:HP:0004716&Human_Phenotype_Ontology:HP:0004739&Human_Phenotype_Ontology:HP:0004740&Human_Phenotype_Ontology:HP:0008645&Human_Phenotype_Ontology:HP:0008673&Human_Phenotype_Ontology:HP:0008699&MONDO:MONDO:0020642&MeSH:D007690&MedGen:C0022680&OMIM:PS173900|Uncertain_significance(1)&Benign(2)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:8,4:0.333:12:5,3:3,1:46:82,0,50:47.269,0.00010329,53:0,34.77,37.77:7,1,3,1:4,4,2,2	T	intron_variant	MODIFIER	PKD2	5311	Transcript	NM_000297.4	protein_coding		14-Jan	c.595+15C>T							rs559555727	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0022	0.0002344	0	2.966e-05	0	0.007808	0	0	2.059e-05	0.0003348	0.0001434	0.0003812	0	0	0	0	0.01055	0	0	0	0.001422	0.000207	0.0109	EAS	benign&uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		7	-7	12	-15	0	0	0	0	PKD2			NA				440151	NA	Conflicting_classifications_of_pathogenicity	not_provided&Polycystic_kidney_disease_2&not_specified&Autosomal_dominant_polycystic_kidney_disease&Polycystic_kidney_disease	NC_000004.12:g.88008343C>T		single_nucleotide_variant	PKD2:5311	MedGen:C3661900&MONDO:MONDO:0013131&MedGen:C2751306&OMIM:613095&MedGen:CN169374&MONDO:MONDO:0004691&MedGen:C0085413&Orphanet:730&Human_Phenotype_Ontology:HP:0000113&Human_Phenotype_Ontology:HP:0004716&Human_Phenotype_Ontology:HP:0004739&Human_Phenotype_Ontology:HP:0004740&Human_Phenotype_Ontology:HP:0008645&Human_Phenotype_Ontology:HP:0008673&Human_Phenotype_Ontology:HP:0008699&MONDO:MONDO:0020642&MeSH:D007690&MedGen:C0022680&OMIM:PS173900	Uncertain_significance(1)&Benign(2)&Likely_benign(1)	criteria_provided&_conflicting_classifications		PKD2	Polycystic kidney disease 2	AD	613095	Renal disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs559555727	chr4_88008343_C_T	Female	./.	Other
chr4	122742008	.	T	C	50	PASS	"FS=0;MQ=250;MQRankSum=4.646;QD=1.61;ReadPosRankSum=2.862;SOR=0.96;FractionInformativeReads=0.968;R2_5P_bias=-3.211;DP=79;AF=0.5;AN=4;AC=2;CSQ=C|missense_variant|MODERATE|BBS12|166379|Transcript|NM_152618.3|protein_coding|2/2||NM_152618.3:c.116T>C|NP_689831.2:p.Ile39Thr|307|116|39|I/T|aTt/aCt|rs138036823&CM1010465||1||SNV|EntrezGene||YES|||T|T|||deleterious(0)|benign(0.388)||0.0022|0.007455|0.001047|0.005261|0.0147|0|0.002266|0.0118|0.008293|0.007057|0.00471|0.005679|0.001179|0.002198|0.01144|0.01527|0.0001928|0.0009413|0.0102|0.007938|0.006149|0.003939|0.01527|gnomADg_ASJ|benign&likely_benign&benign/likely_benign&conflicting_interpretations_of_pathogenicity|0&1|1&1||||T|0.58885|0.054235|D|0.88794|0.31309|0.87479|0.664&0.664&0.664|-39|6|43|5|0.00|0.00|0.00|0.00|BBS12|ambiguous|hg38|0.4075|I39T|ENST00000314218.8|Q6ZW61|96504||Conflicting_classifications_of_pathogenicity|Bardet-Biedl_syndrome&not_provided&Bardet-Biedl_syndrome_1&not_specified&Bardet-Biedl_syndrome_12|NC_000004.12:g.122742008T>C||single_nucleotide_variant|BBS12:166379|MONDO:MONDO:0015229&MedGen:C0752166&OMIM:PS209900&Orphanet:110&MedGen:C3661900&MONDO:MONDO:0008854&MedGen:C2936862&OMIM:209900&MedGen:CN169374&MONDO:MONDO:0014440&MedGen:C1859570&OMIM:615989&Orphanet:110|Uncertain_significance(2)&Benign(5)&Likely_benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,15:0.5:30:8,8:7,7:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:7,8,6,9:6,9,5,10	0/1:27,20:0.426:47:12,7:15,13:46:82,0,50:47.54,9.8368e-05,53:0,34.77,37.77:8,19,10,10:11,16,7,13	./.:.:.:.:.:.:.:.:.:.:.:.	C	missense_variant	MODERATE	BBS12	166379	Transcript	NM_152618.3	protein_coding	02-Feb		c.116T>C	p.Ile39Thr	307	116	39	I/T	aTt/aCt	rs138036823&CM1010465	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	deleterious(0)	benign(0.388)	NA	0.0022	0.007455	0.001047	0.005261	0.0147	0	0.002266	0.0118	0.008293	0.007057	0.00471	0.005679	0.001179	0.002198	0.01144	0.01527	0.0001928	0.0009413	0.0102	0.007938	0.006149	0.003939	0.01527	gnomADg_ASJ	benign&likely_benign&benign/likely_benign&conflicting_interpretations_of_pathogenicity	0&1	1&1	NA	NA	NA	T	0.58885	0.054235	D	0.88794	0.31309	0.87479	0.664&0.664&0.664	-39	6	43	5	0	0	0	0	BBS12	ambiguous	hg38	0.4075	I39T	ENST00000314218.8	Q6ZW61	96504	NA	Conflicting_classifications_of_pathogenicity	Bardet-Biedl_syndrome&not_provided&Bardet-Biedl_syndrome_1&not_specified&Bardet-Biedl_syndrome_12	NC_000004.12:g.122742008T>C		single_nucleotide_variant	BBS12:166379	MONDO:MONDO:0015229&MedGen:C0752166&OMIM:PS209900&Orphanet:110&MedGen:C3661900&MONDO:MONDO:0008854&MedGen:C2936862&OMIM:209900&MedGen:CN169374&MONDO:MONDO:0014440&MedGen:C1859570&OMIM:615989&Orphanet:110	Uncertain_significance(2)&Benign(5)&Likely_benign(4)	criteria_provided&_conflicting_classifications		BBS12	Bardet-Biedl syndrome 12	AR	615989	Complex genetic syndromes	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs138036823	chr4_122742008_T_C	Female	0/1	Heterozygous
chr4	150867800	.	C	T	50	PASS	"FS=1.365;MQ=250;MQRankSum=4.951;QD=1.47;ReadPosRankSum=1.087;SOR=1.179;FractionInformativeReads=1;R2_5P_bias=-0.701;DP=76;AF=0.5;AN=4;AC=2;CSQ=T|synonymous_variant|LOW|LRBA|987|Transcript|NM_001364905.1|protein_coding|22/57||NM_001364905.1:c.2637G>A|NP_001351834.1:p.Lys879%3D|2939|2637|879|K|aaG/aaA|rs138956153&COSV63956552&COSV63958553||-1||SNV|EntrezGene||YES|||C|C||||||0.0016|0.001942|0.000478|0.003131|0.001148|2.522e-05|0.0008053|0.001908|0.001978|0.002435|0.002911|0.001677|0.0002169|0.03414|0.004785|0.002308|0|0.0007584|0|0.001633|0.003318|0.00166|0.03414|gnomADg_AMI|conflicting_interpretations_of_pathogenicity&benign&uncertain_significance&likely_benign|0&1&1|1&1&1||||||||||||-8|-1|-8|-30|0.07|0.18|0.00|0.02|LRBA|||||||594578||Conflicting_classifications_of_pathogenicity|not_specified&Combined_immunodeficiency_due_to_LRBA_deficiency&not_provided&LRBA-related_disorder|NC_000004.12:g.150867800C>T||single_nucleotide_variant|LRBA:987|MedGen:CN169374&MONDO:MONDO:0013863&MedGen:C3553512&OMIM:614700&Orphanet:445018&MedGen:C3661900&.|Uncertain_significance(2)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,18:0.529:34:8,11:8,7:48:85,0,50:50,6.7045e-05,52.636:0,34.77,37.77:8,8,7,11:8,8,8,10	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:22,20:0.476:42:9,8:13,12:48:85,0,50:49.83,6.6786e-05,53:0,34.77,37.77:13,9,13,7:10,12,9,11	T	synonymous_variant	LOW	LRBA	987	Transcript	NM_001364905.1	protein_coding	22/57		c.2637G>A	p.Lys879%3D	2939	2637	879	K	aaG/aaA	rs138956153&COSV63956552&COSV63958553	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0016	0.001942	0.000478	0.003131	0.001148	2.522e-05	0.0008053	0.001908	0.001978	0.002435	0.002911	0.001677	0.0002169	0.03414	0.004785	0.002308	0	0.0007584	0	0.001633	0.003318	0.00166	0.03414	gnomADg_AMI	conflicting_interpretations_of_pathogenicity&benign&uncertain_significance&likely_benign	0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-8	-1	-8	-30	0.07	0.18	0	0.02	LRBA			NA				594578	NA	Conflicting_classifications_of_pathogenicity	not_specified&Combined_immunodeficiency_due_to_LRBA_deficiency&not_provided&LRBA-related_disorder	NC_000004.12:g.150867800C>T		single_nucleotide_variant	LRBA:987	MedGen:CN169374&MONDO:MONDO:0013863&MedGen:C3553512&OMIM:614700&Orphanet:445018&MedGen:C3661900&.	Uncertain_significance(2)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		LRBA	Immunodeficiency, common variable, 8, with autoimmunity	AR	614700	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-12	Benign	BP4_Moderate,BP6,BP7,BS1,BS2	rs138956153	chr4_150867800_C_T	Female	0/1	Heterozygous
chr4	154586438	.	T	C	46.7	PASS	"FS=1.515;MQ=248.36;MQRankSum=4.377;QD=1.42;ReadPosRankSum=2.882;SOR=0.392;FractionInformativeReads=1;R2_5P_bias=11.276;DP=54;AF=0.5;AN=4;AC=2;CSQ=C|missense_variant|MODERATE|FGA|2243|Transcript|NM_021871.4|protein_coding|5/5||NM_021871.4:c.991A>G|NP_068657.1:p.Thr331Ala|1046|991|331|T/A|Act/Gct|rs6050&CM994632&COSV57394233||-1||SNV|EntrezGene||YES|||T|T|||tolerated(0.73)|benign(0.071)||0.3271|0.266|0.3629|0.2417|0.1859|0.4674|0.3153|0.2183|0.2525|0.2547|0.3265|0.2938|0.3634|0.2572|0.2478|0.1818|0.4451|0.3124|0.2041|0.2543|0.2578|0.3042|0.4674|gnomADe_EAS|benign&risk_factor&conflicting_interpretations_of_pathogenicity|0&1&1|1&1&1||||T|0.00043|-0.68717|T|0.11501|-0.616028|0.26621|0.092&0.092|-38|3|1|3|0.00|0.00|0.00|0.00|FGA|likely_benign|hg38|0.0703|T331A|ENST00000651975.1|P02671|16420||Conflicting_classifications_of_pathogenicity|Congenital_afibrinogenemia&not_provided&Familial_visceral_amyloidosis&_Ostertag_type&Venous_thromboembolism&_susceptibility_to&not_specified|NC_000004.12:g.154586438T>C||single_nucleotide_variant|FGA:2243|MONDO:MONDO:0008737&MedGen:C2584774&OMIM:202400&Orphanet:335&Orphanet:98880&MedGen:C3661900&MONDO:MONDO:0007099&MedGen:C0268389&OMIM:105200&Orphanet:85450&MedGen:C1858965&MedGen:CN169374|Uncertain_significance(1)&Benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:20,10:0.333:30:11,5:9,5:42:77,0,50:42.628,0.00025887,53:0,34.77,37.77:12,8,5,5:11,9,8,2	0/1:15,9:0.375:24:11,4:4,5:46:81,0,50:46.704,0.00011442,53:0,34.77,37.77:10,5,6,3:12,3,5,4	./.:.:.:.:.:.:.:.:.:.:.:.	C	missense_variant	MODERATE	FGA	2243	Transcript	NM_021871.4	protein_coding	05-May		c.991A>G	p.Thr331Ala	1046	991	331	T/A	Act/Gct	rs6050&CM994632&COSV57394233	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	tolerated(0.73)	benign(0.071)	NA	0.3271	0.266	0.3629	0.2417	0.1859	0.4674	0.3153	0.2183	0.2525	0.2547	0.3265	0.2938	0.3634	0.2572	0.2478	0.1818	0.4451	0.3124	0.2041	0.2543	0.2578	0.3042	0.4674	gnomADe_EAS	benign&risk_factor&conflicting_interpretations_of_pathogenicity	0&1&1	1&1&1	NA	NA	NA	T	0.00043	-0.68717	T	0.11501	-0.616028	0.26621	0.092&0.092	-38	3	1	3	0	0	0	0	FGA	likely_benign	hg38	0.0703	T331A	ENST00000651975.1	P02671	16420	NA	Conflicting_classifications_of_pathogenicity	Congenital_afibrinogenemia&not_provided&Familial_visceral_amyloidosis&_Ostertag_type&Venous_thromboembolism&_susceptibility_to&not_specified	NC_000004.12:g.154586438T>C		single_nucleotide_variant	FGA:2243	MONDO:MONDO:0008737&MedGen:C2584774&OMIM:202400&Orphanet:335&Orphanet:98880&MedGen:C3661900&MONDO:MONDO:0007099&MedGen:C0268389&OMIM:105200&Orphanet:85450&MedGen:C1858965&MedGen:CN169374	Uncertain_significance(1)&Benign(4)	criteria_provided&_conflicting_classifications		FGA	Congenital afibrinogenemia	AR	202400	Haematological disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs6050	chr4_154586438_T_C	Female	0/1	Heterozygous
chr4	154606073	.	T	C	47.39	PASS	"FS=0;MQ=250;MQRankSum=3.73;QD=2.15;ReadPosRankSum=1.05;SOR=0.693;FractionInformativeReads=0.955;R2_5P_bias=2.694;DP=22;AF=0.5;AN=2;AC=1;CSQ=C|intron_variant|MODIFIER|FGG|2266|Transcript|NM_021870.3|protein_coding||8/8|NM_021870.3:c.1129+632A>G|||||||rs2066862&CS930811||-1||SNV|EntrezGene||YES|||T|T||||||0.0026|||||||||||0.005327|0.001588|0.005482|0.003464|0.009222|0.0001937|0.002074|0.006803|0.008911|0.008049|0.001451|0.0099|EUR|other&uncertain_significance&pathogenic&benign|0&1|1&1||||||||||||-1|-26|1|-5|0.00|0.00|0.00|0.00|FGG|||||||16371||Conflicting_classifications_of_pathogenicity|FIBRINOGEN_PARIS_1&Congenital_afibrinogenemia&not_specified&FGG-related_disorder&not_provided|NC_000004.12:g.154606073T>C||single_nucleotide_variant|FGG:2266|.&MONDO:MONDO:0008737&MedGen:C2584774&OMIM:202400&Orphanet:335&Orphanet:98880&MedGen:CN169374&.&MedGen:C3661900|Pathogenic(1)&Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,8:0.381:21:10,4:3,4:46:82,0,50:47.388,0.00010096,53:0,34.77,37.77:5,8,3,5:6,7,3,5	./.:.:.:.:.:.:.:.:.:.:.:.	C	intron_variant	MODIFIER	FGG	2266	Transcript	NM_021870.3	protein_coding		08-Aug	c.1129+632A>G							rs2066862&CS930811	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	0.0026	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.005327	0.001588	0.005482	0.003464	0.009222	0.0001937	0.002074	0.006803	0.008911	0.008049	0.001451	0.0099	EUR	other&uncertain_significance&pathogenic&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-1	-26	1	-5	0	0	0	0	FGG			NA				16371	NA	Conflicting_classifications_of_pathogenicity	FIBRINOGEN_PARIS_1&Congenital_afibrinogenemia&not_specified&FGG-related_disorder&not_provided	NC_000004.12:g.154606073T>C		single_nucleotide_variant	FGG:2266	.&MONDO:MONDO:0008737&MedGen:C2584774&OMIM:202400&Orphanet:335&Orphanet:98880&MedGen:CN169374&.&MedGen:C3661900	Pathogenic(1)&Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		FGG	Congenital afibrinogenemia	AR	202400	Haematological disorders	NBScreening	-9	Benign	BP4_Strong,BS1_Supporting,BS2	rs2066862	chr4_154606073_T_C	Female	./.	Other
chr4	157170596	.	GAAC	G	134.29	PASS	"FS=0;MQ=250;QD=4.63;SOR=1.071;FractionInformativeReads=1;MQRankSum=4.863;ReadPosRankSum=0.235;R2_5P_bias=4.193;DP=114;AF=0.5;AN=6;AC=4;CSQ=-|inframe_deletion|MODERATE|GLRB|2743|Transcript|NM_000824.5|protein_coding|10/10||NM_000824.5:c.1368_1370del|NP_000815.1:p.Asn456del|1540-1542|1363-1365|455|N/-|AAC/-|rs373895476||1||deletion|EntrezGene||YES|||AAC|CAA|||||5|0.0006|0.0004065|0.0001494|0.0003359|0|0.0001008|1.872e-05|0|0.0004903|0.0002484|0.0001044|0.0002695|0|0|6.55e-05|0|0|9.427e-05|0|0.0005742|0|0|0.003|EUR|||1||||||||||||-32|46|-34|-40|0.00|0.00|0.00|0.00|GLRB|||||||347928||Conflicting_classifications_of_pathogenicity|Hyperekplexia&Hyperekplexia_2|NC_000004.12:g.157170599CAA[1]||Microsatellite|GLRB:2743|MONDO:MONDO:0017658&MedGen:C0234166&Orphanet:306773&MONDO:MONDO:0013828&MedGen:C3553291&OMIM:614619&Orphanet:3197|Uncertain_significance(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,29:1:29:0,17:0,12:84:166,87,0:134.29,84.295,0:0,29,32:0,0,17,12:0,0,15,14	0/1:18,15:0.455:33:12,7:6,8:48:78,0,50:49.422,7.1446e-05,53:0,29,32:5,13,7,8:7,11,9,6	0/1:21,24:0.533:45:10,11:11,13:48:79,0,50:50,6.7563e-05,52.555:0,29,32:12,9,12,12:11,10,13,11	-	inframe_deletion	MODERATE	GLRB	2743	Transcript	NM_000824.5	protein_coding	10-Oct		c.1368_1370del	p.Asn456del	1540-1542	1363-1365	455	N/-	AAC/-	rs373895476	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	AAC	CAA	NA	NA			5	6,00E-04	0.0004065	0.0001494	0.0003359	0	0.0001008	1.872e-05	0	0.0004903	0.0002484	0.0001044	0.0002695	0	0	6.55e-05	0	0	9.427e-05	0	0.0005742	0	0	0.003	EUR			1	NA	NA	NA		NA	NA		NA	NA	NA		-32	46	-34	-40	0	0	0	0	GLRB			NA				347928	NA	Conflicting_classifications_of_pathogenicity	Hyperekplexia&Hyperekplexia_2	NC_000004.12:g.157170599CAA[1]		Microsatellite	GLRB:2743	MONDO:MONDO:0017658&MedGen:C0234166&Orphanet:306773&MONDO:MONDO:0013828&MedGen:C3553291&OMIM:614619&Orphanet:3197	Uncertain_significance(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		GLRB	Hyperekplexia 2	AR	614619	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-4	Likely_benign	PM4_Supporting,BP6,BS1	rs373895476	chr4_157170596_GAAC_G	Female	01-Jan	Homozygous
chr5	13841918	.	C	CA	50	PASS	"FS=3.565;MQ=246.24;MQRankSum=3.285;QD=1.43;ReadPosRankSum=0.988;SOR=1.765;FractionInformativeReads=0.8;R2_5P_bias=13.839;DP=35;AF=0.5;AN=2;AC=1;CSQ=A|splice_polypyrimidine_tract_variant&intron_variant|LOW|DNAH5|1767|Transcript|NM_001369.3|protein_coding||32/78|NM_001369.3:c.5272-15dup|||||||rs35337694||-1||insertion|EntrezGene||YES|||||||||||0.1467|0.09898|0.126|0.1291|0.08856|0.1692|0.1496|0.151|0.1442|0.1664|0.4865|0.355|0.4672|0.5155|0.5243|0.2115|0.4794|0.52|0.5594|0.5043|0.5548|0.5594|gnomADg_NFE|uncertain_significance&benign&likely_benign||1||||||||||||-49|-15|-16|-36|0.01|0.00|0.00|0.00|DNAH5|||||||351094||Conflicting_classifications_of_pathogenicity|Primary_ciliary_dyskinesia&not_provided|NC_000005.10:g.13841937dup||Duplication|DNAH5:1767|Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:C3661900|Uncertain_significance(1)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,14:0.5:28:6,5:8,9:48:55,0,50:50,6.5233e-05,53:0,5,8:7,7,10,4:9,5,7,7	A	splice_polypyrimidine_tract_variant&intron_variant	LOW	DNAH5	1767	Transcript	NM_001369.3	protein_coding		32/78	c.5272-15dup							rs35337694	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.1467	0.09898	0.126	0.1291	0.08856	0.1692	0.1496	0.151	0.1442	0.1664	0.4865	0.355	0.4672	0.5155	0.5243	0.2115	0.4794	0.52	0.5594	0.5043	0.5548	0.5594	gnomADg_NFE	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-49	-15	-16	-36	0.01	0	0	0	DNAH5			NA				351094	NA	Conflicting_classifications_of_pathogenicity	Primary_ciliary_dyskinesia&not_provided	NC_000005.10:g.13841937dup		Duplication	DNAH5:1767	Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:C3661900	Uncertain_significance(1)&Likely_benign(2)	criteria_provided&_conflicting_classifications		DNAH5	Primary ciliary dyskinesia 3	AR	608644	Respiratory system disorders	NBScreening	-9	Benign	BP6,BA1	rs35337694	chr5_13841918_C_CA	Female	./.	Other
chr5	13886135	.	CAAA	C	269.63	PASS	"FS=5.746;MQ=245.61;MQRankSum=2.444;QD=4.68;ReadPosRankSum=2.008;SOR=0.1;FractionInformativeReads=0.96;R2_5P_bias=0;DP=87;AF=0.5;AN=6;AC=1;CSQ=-|splice_region_variant&splice_polypyrimidine_tract_variant&intron_variant|LOW|DNAH5|1767|Transcript|NM_001369.3|protein_coding||17/78|NM_001369.3:c.2578-9_2578-7del|||||||rs71600031||-1||deletion|EntrezGene||YES|||AAA|AAA|||||||0.2197|0.1733|0.2636|0.229|0.06643|0.2132|0.2468|0.2261|0.2174|0.2025|0.2129|0.1491|0.2864|0.2821|0.282|0.06198|0.2497|0.2924|0.2356|0.2207|0.2146|0.2924|gnomADg_MID|uncertain_significance&benign&likely_benign||1||||||||||||-7|-48|-7|44|0.10|0.00|0.00|0.00|DNAH5|||||||351200||Conflicting_classifications_of_pathogenicity|Primary_ciliary_dyskinesia&not_provided&not_specified|NC_000005.10:g.13886152_13886154del||Deletion|DNAH5:1767|Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:C3661900&MedGen:CN169374|Uncertain_significance(1)&Benign(3)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:3,.:.:24:0,.:3,.:67:127,.,.:116.98,.,.:0,.,.:0,3,9,12:3,0,6,15	0/0:0,.:.:26:0,.:0,.:75:134,.,.:125.1,.,.:0,.,.:0,0,5,21:0,0,13,13	0/1:0,12:0.444:27:0,7:0,5:49:280,280,55:269.63,275.42,53:0,5,8:0,0,6,21:0,0,14,13	-	splice_region_variant&splice_polypyrimidine_tract_variant&intron_variant	LOW	DNAH5	1767	Transcript	NM_001369.3	protein_coding		17/78	c.2578-9_2578-7del							rs71600031	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	AAA	AAA	NA	NA			NA	NA	0.2197	0.1733	0.2636	0.229	0.06643	0.2132	0.2468	0.2261	0.2174	0.2025	0.2129	0.1491	0.2864	0.2821	0.282	0.06198	0.2497	0.2924	0.2356	0.2207	0.2146	0.2924	gnomADg_MID	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-7	-48	-7	44	0.1	0	0	0	DNAH5			NA				351200	NA	Conflicting_classifications_of_pathogenicity	Primary_ciliary_dyskinesia&not_provided&not_specified	NC_000005.10:g.13886152_13886154del		Deletion	DNAH5:1767	Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:C3661900&MedGen:CN169374	Uncertain_significance(1)&Benign(3)&Likely_benign(1)	criteria_provided&_conflicting_classifications		DNAH5	Primary ciliary dyskinesia 3	AR	608644	Respiratory system disorders	NBScreening	-9	Benign	BP6,BA1	rs71600031	chr5_13886135_CAAA_C	Female	0/0	Other
chr5	38482647	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=4.318;QD=1.78;ReadPosRankSum=3.183;SOR=0.495;FractionInformativeReads=1;R2_5P_bias=0.257;DP=88;AF=0.5;AN=6;AC=3;CSQ=A|missense_variant|MODERATE|LIFR|3977|Transcript|NM_001127671.2|protein_coding|19/20||NM_001127671.2:c.2612C>T|NP_001121143.1:p.Pro871Leu|2944|2612|871|P/L|cCt/cTt|||-1||SNV|EntrezGene||YES|||G|G|||deleterious(0)|probably_damaging(0.998)||||||||||||||||||||||||||||||||D|0.70454|0.162746|D|0.70076|-0.00400376|0.83747|0.592&0.592|-18|20|-49|-23|0.01|0.00|0.00|0.00|LIFR|likely_pathogenic|hg38|0.9506|P871L|ENST00000263409.8|P42702||||||||||||"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,11:0.407:27:9,4:7,7:47:83,0,50:47.979,9.0861e-05,53:0,34.77,37.77:5,11,4,7:6,10,7,4	0/1:13,16:0.552:29:10,9:3,7:48:85,0,49:50,6.9375e-05,52.224:0,34.77,37.77:9,4,11,5:8,5,8,8	0/1:18,14:0.438:32:8,9:10,5:48:84,0,50:49.009,7.6364e-05,53:0,34.77,37.77:8,10,3,11:8,10,8,6	A	missense_variant	MODERATE	LIFR	3977	Transcript	NM_001127671.2	protein_coding	19/20		c.2612C>T	p.Pro871Leu	2944	2612	871	P/L	cCt/cTt		NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0)	probably_damaging(0.998)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA					NA	NA	NA	D	0.70454	0.162746	D	0.70076	-0.00400376	0.83747	0.592&0.592	-18	20	-49	-23	0.01	0	0	0	LIFR	likely_pathogenic	hg38	0.9506	P871L	ENST00000263409.8	P42702	NA	NA	NA										LIFR	Stuve-Wiedemann syndrome 2	AR	619751	Skelettal, skin, and connective tissue disorders	NBScreening	4	Uncertain_significance	PM2,PP3_Moderate		chr5_38482647_G_A	Female	0/1	Heterozygous
chr5	38528849	.	GAC	G	50	PASS	"FS=1.984;MQ=249.4;MQRankSum=3.592;QD=1.92;ReadPosRankSum=-1.115;SOR=0.223;FractionInformativeReads=0.731;R2_5P_bias=-1.128;DP=113;AF=0.5;AN=6;AC=3;CSQ=-|splice_polypyrimidine_tract_variant&intron_variant|LOW|LIFR|3977|Transcript|NM_001127671.2|protein_coding||2/19|NM_001127671.2:c.143-11_143-10del|||||||rs10637374||-1||deletion|EntrezGene||YES|||AC|AC|||||||0.2992|0.1605|0.2828|0.4123|0.2437|0.3501|0.3471|0.2931|0.3145|0.3421|0.3263|0.1328|0.3872|0.3252|0.5692|0.3125|0.3579|0.4286|0.4208|0.3804|0.4408|0.5692|gnomADg_ASJ|||1||||||||||||-10|-30|-28|-10|0.00|0.00|0.00|0.00|LIFR|||||||353634||Conflicting_classifications_of_pathogenicity|Stve-Wiedemann_syndrome_1&Stuve-Wiedemann_syndrome&not_provided|NC_000005.10:g.38528851CA[13]||Microsatellite|LIFR:3977|MONDO:MONDO:0800043&MedGen:C5676888&OMIM:601559&Orphanet:3206&MONDO:MONDO:0031280&MedGen:C0796176&OMIM:PS601559&Orphanet:3206&MedGen:C3661900|Uncertain_significance(1)&Benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	0/1:8,11:0.579:19:3,7:5,4:46:54,0,46:50,0.0001038,48.564:0,4,7.01:2,6,5,6:5,3,7,4:.	0|1:16,16:0.5:32:5,9:11,7:47:55,0,47:50,8.6978e-05,50:0,5,8.01:7,9,13,3:8,8,10,6:38528849	0/1:12,21:0.636:33:3,10:9,11:42:54,0,40:50,0.0002524,43.178:0,4,7.01:9,3,14,7:2,10,11,10:.	-	splice_polypyrimidine_tract_variant&intron_variant	LOW	LIFR	3977	Transcript	NM_001127671.2	protein_coding		19-Feb	c.143-11_143-10del							rs10637374	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	AC	AC	NA	NA			NA	NA	0.2992	0.1605	0.2828	0.4123	0.2437	0.3501	0.3471	0.2931	0.3145	0.3421	0.3263	0.1328	0.3872	0.3252	0.5692	0.3125	0.3579	0.4286	0.4208	0.3804	0.4408	0.5692	gnomADg_ASJ			1	NA	NA	NA		NA	NA		NA	NA	NA		-10	-30	-28	-10	0	0	0	0	LIFR			NA				353634	NA	Conflicting_classifications_of_pathogenicity	Stve-Wiedemann_syndrome_1&Stuve-Wiedemann_syndrome&not_provided	NC_000005.10:g.38528851CA[13]		Microsatellite	LIFR:3977	MONDO:MONDO:0800043&MedGen:C5676888&OMIM:601559&Orphanet:3206&MONDO:MONDO:0031280&MedGen:C0796176&OMIM:PS601559&Orphanet:3206&MedGen:C3661900	Uncertain_significance(1)&Benign(3)	criteria_provided&_conflicting_classifications		LIFR	Stuve-Wiedemann syndrome 2	AR	619751	Skelettal, skin, and connective tissue disorders	NBScreening	-9	Benign	BP6,BA1	rs10637374	chr5_38528849_GAC_G	Female	0/1	Heterozygous
chr5	41730773	.	A	G	50	PASS	"FS=0;MQ=250;MQRankSum=5.39;QD=1.25;ReadPosRankSum=2.302;SOR=0.685;FractionInformativeReads=1;R2_5P_bias=-11.328;DP=60;AF=0.5;AN=4;AC=2;CSQ=G|3_prime_UTR_variant|MODIFIER|OXCT1|5019|Transcript|NM_000436.4|protein_coding|17/17||NM_000436.4:c.*956T>C||2586|||||rs17847289||-1||SNV|EntrezGene||YES|||A|A|||||||||||||||||0.0001444|0|0|0.000588|0|0.001349|0|0|7.35e-05|0|0.0002071|0.001349|gnomADg_EAS|uncertain_significance||1||||||||||||43|-14|37|2|0.00|0.00|0.00|0.00|OXCT1|||||||904967||Uncertain_significance|Succinyl-CoA_acetoacetate_transferase_deficiency|NC_000005.10:g.41730773A>G||single_nucleotide_variant|OXCT1:5019|MONDO:MONDO:0009492&MedGen:C0342792&OMIM:245050&Orphanet:832||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:19,21:0.525:40:7,13:12,8:48:85,0,50:50,6.5233e-05,52.992:0,34.77,37.77:10,9,11,10:8,11,11,10	0/1:11,9:0.45:20:4,8:7,1:48:84,0,50:49.566,6.9634e-05,53:0,34.77,37.77:8,3,2,7:3,8,3,6	./.:.:.:.:.:.:.:.:.:.:.:.	G	3_prime_UTR_variant	MODIFIER	OXCT1	5019	Transcript	NM_000436.4	protein_coding	17/17		c.*956T>C		2586					rs17847289	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.0001444	0	0	0.000588	0	0.001349	0	0	7.35e-05	0	0.0002071	0.001349	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		43	-14	37	2	0	0	0	0	OXCT1			NA				904967	NA	Uncertain_significance	Succinyl-CoA_acetoacetate_transferase_deficiency	NC_000005.10:g.41730773A>G		single_nucleotide_variant	OXCT1:5019	MONDO:MONDO:0009492&MedGen:C0342792&OMIM:245050&Orphanet:832		criteria_provided&_single_submitter		OXCT1	Succinyl-CoA acetoacetate transferase deficiency	AR	245050	Inherited disorders of metabolism	NBScreening	-5	Likely_benign	BP4_Strong,BS1_Supporting	rs17847289	chr5_41730773_A_G	Female	0/1	Heterozygous
chr5	53093481	.	G	GGTATGTTTAGC	50	PASS	"FS=0;MQ=248.58;MQRankSum=3.293;QD=2.17;ReadPosRankSum=0.031;SOR=0.593;FractionInformativeReads=1;R2_5P_bias=-1.201;DP=89;AF=0.5;AN=6;AC=3;CSQ=GTATGTTTAGC|3_prime_UTR_variant|MODIFIER|ITGA2|3673|Transcript|NM_002203.4|protein_coding|30/30||NM_002203.4:c.*2883_*2893dup||6545-6546|||||rs6149022||1||insertion|EntrezGene||YES|||||||||11||0|||||||0|||0.7435|0.7907|0.7048|0.7597|0.7387|0.4338|0.7362|0.7397|0.737|0.7493|0.732|0.7907|gnomADg_AFR|uncertain_significance||1|||||||||||||||||||||||||||353836||Uncertain_significance|Platelet-type_bleeding_disorder_9&not_provided|NC_000005.10:g.53093482_53093492dup||Duplication|ITGA2:3673|MONDO:MONDO:0013622&MedGen:C3280114&OMIM:614200&Orphanet:73271&Orphanet:98886&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,11:0.478:23:6,4:6,7:48:79,0,50:49.906,6.601e-05,53:0,29,32:9,3,8,3:7,5,7,4	0/1:10,14:0.583:24:5,7:5,7:48:79,0,49:50,7.3776e-05,51.546:0,29,32:8,2,6,8:5,5,7,7	0/1:20,19:0.487:39:10,11:10,8:48:79,0,50:49.939,6.5751e-05,53:0,29,32:14,6,11,8:10,10,11,8	GTATGTTTAGC	3_prime_UTR_variant	MODIFIER	ITGA2	3673	Transcript	NM_002203.4	protein_coding	30/30		c.*2883_*2893dup		6545-6546					rs6149022	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			11	NA	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.7435	0.7907	0.7048	0.7597	0.7387	0.4338	0.7362	0.7397	0.737	0.7493	0.732	0.7907	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				353836	NA	Uncertain_significance	Platelet-type_bleeding_disorder_9&not_provided	NC_000005.10:g.53093482_53093492dup		Duplication	ITGA2:3673	MONDO:MONDO:0013622&MedGen:C3280114&OMIM:614200&Orphanet:73271&Orphanet:98886&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		ITGA2	Platelet-type bleeding disorder 9	AD	614200	Haematological disorders	NBScreening	-8	Benign	BA1	rs6149022	chr5_53093481_G_GGTATGTTTAGC	Female	0/1	Heterozygous
chr5	53094196	.	A	AATTATATAAACAACTTTGTAGGACT	50	PASS	"FS=5.159;MQ=248.28;MQRankSum=4.721;QD=1.19;ReadPosRankSum=1.387;SOR=0.204;FractionInformativeReads=0.976;R2_5P_bias=-10.183;DP=134;AF=0.5;AN=6;AC=3;CSQ=ATTATATAAACAACTTTGTAGGACT|3_prime_UTR_variant|MODIFIER|ITGA2|3673|Transcript|NM_002203.4|protein_coding|30/30||NM_002203.4:c.*3599_*3600insTATATAAACAACTTTGTAGGACTAT||7260-7261|||||rs57674800||1||insertion|EntrezGene||YES|||||||||2||0.5|||||0.55|||0||0.3519|0.2858|0.4077|0.4107|0.3429|0.3135|0.4006|0.3333|0.3743|0.3576|0.3471|0.55|gnomADe_FIN|||1|||||||||||||||||||||||||||353855||Uncertain_significance|Platelet-type_bleeding_disorder_9&not_provided|NC_000005.10:g.53094198_53094199insTATATAAACAACTTTGTAGGACTAT||Insertion|ITGA2:3673|MONDO:MONDO:0013622&MedGen:C3280114&OMIM:614200&Orphanet:73271&Orphanet:98886&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:13,28:0.683:41:5,13:8,15:40:79,0,38:50,0.00039426,40.927:0,29,32:10,3,16,12:6,7,11,17	0/1:29,26:0.473:55:15,8:14,18:48:79,0,50:49.626,6.9116e-05,53:0,29,32:13,16,13,13:17,12,15,11	0/1:12,24:0.667:36:4,9:8,15:43:79,0,41:50,0.00021046,44.147:0,29,32:10,2,17,7:4,8,8,16	ATTATATAAACAACTTTGTAGGACT	3_prime_UTR_variant	MODIFIER	ITGA2	3673	Transcript	NM_002203.4	protein_coding	30/30		c.*3599_*3600insTATATAAACAACTTTGTAGGACTAT		7260-7261					rs57674800	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			2	NA	0.5	NA	NA	NA	NA	0.55	NA	NA	0	NA	0.3519	0.2858	0.4077	0.4107	0.3429	0.3135	0.4006	0.3333	0.3743	0.3576	0.3471	0.55	gnomADe_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				353855	NA	Uncertain_significance	Platelet-type_bleeding_disorder_9&not_provided	NC_000005.10:g.53094198_53094199insTATATAAACAACTTTGTAGGACTAT		Insertion	ITGA2:3673	MONDO:MONDO:0013622&MedGen:C3280114&OMIM:614200&Orphanet:73271&Orphanet:98886&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		ITGA2	Platelet-type bleeding disorder 9	AD	614200	Haematological disorders	NBScreening	-8	Benign	BA1	rs57674800	chr5_53094196_A_AATTATATAAACAACTTTGTAGGACT	Female	0/1	Heterozygous
chr5	126543235	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=4.724;QD=1.52;ReadPosRankSum=-1.799;SOR=0.582;FractionInformativeReads=0.939;R2_5P_bias=-27.809;DP=70;AF=0.5;AN=4;AC=2;CSQ=A|3_prime_UTR_variant|MODIFIER|ALDH7A1|501|Transcript|NM_001182.5|protein_coding|18/18||NM_001182.5:c.*1730C>T||3371|||||rs185960737&COSV69259915||-1||SNV|EntrezGene||YES|||G|G||||||0.0036|||||||||||0.003683|0.000919|0|0.002655|0.003185|0|0.001401|0.0137|0.005345|0.006876|0.01467|0.01467|gnomADg_SAS|uncertain_significance&benign|0&1|1&1||||||||||||-42|35|27|48|0.00|0.00|0.00|0.00|ALDH7A1|||||||350548||Conflicting_classifications_of_pathogenicity|Pyridoxine-dependent_epilepsy&not_provided|NC_000005.10:g.126543235G>A||single_nucleotide_variant|ALDH7A1:501|MONDO:MONDO:0009945&MedGen:C1849508&OMIM:266100&Orphanet:3006&MedGen:C3661900|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,16:0.516:31:4,5:11,11:47:85,0,47:50,8.6978e-05,50:0,34.77,37.78:7,8,8,8:8,7,9,7	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,21:0.583:36:6,6:9,15:47:85,0,48:50,8.0765e-05,50.649:0,34.77,37.77:11,4,12,9:6,9,9,12	A	3_prime_UTR_variant	MODIFIER	ALDH7A1	501	Transcript	NM_001182.5	protein_coding	18/18		c.*1730C>T		3371					rs185960737&COSV69259915	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0036	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.003683	0.000919	0	0.002655	0.003185	0	0.001401	0.0137	0.005345	0.006876	0.01467	0.01467	gnomADg_SAS	uncertain_significance&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-42	35	27	48	0	0	0	0	ALDH7A1			NA				350548	NA	Conflicting_classifications_of_pathogenicity	Pyridoxine-dependent_epilepsy&not_provided	NC_000005.10:g.126543235G>A		single_nucleotide_variant	ALDH7A1:501	MONDO:MONDO:0009945&MedGen:C1849508&OMIM:266100&Orphanet:3006&MedGen:C3661900	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		ALDH7A1	Pyridoxine-dependent epilepsy	AR	266100	Inherited disorders of metabolism	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs185960737	chr5_126543235_G_A	Female	0/1	Heterozygous
chr5	126543964	.	C	CT	254.97	PASS	"FS=0;MQ=246.11;QD=9.11;SOR=0.997;FractionInformativeReads=1;MQRankSum=3.729;ReadPosRankSum=-0.283;R2_5P_bias=-11.227;DP=88;AF=0.5;AN=6;AC=2;CSQ=T|3_prime_UTR_variant|MODIFIER|ALDH7A1|501|Transcript|NM_001182.5|protein_coding|18/18||NM_001182.5:c.*1000dup||2641-2642|||||rs60217601||-1||insertion|EntrezGene||YES|||||||||||0.125|||||||0.1667|0||0.1578|0.1158|0.1211|0.1516|0.1195|0.3034|0.1241|0.1604|0.1773|0.1571|0.1441|0.3034|gnomADg_EAS|uncertain_significance||1||||||||||||-45|-2|12|36|0.00|0.00|0.00|0.00|ALDH7A1|||||||350565||Uncertain_significance|Pyridoxine-dependent_epilepsy&not_provided|NC_000005.10:g.126543984dup||Duplication|ALDH7A1:501&LOC112997555:112997555|MONDO:MONDO:0009945&MedGen:C1849508&OMIM:266100&Orphanet:3006&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,15:0.536:28:0,10:0,5:47:265,212,52:254.97,206.91,49.693:0,5,8.01:0,0,16,12:0,0,17,11	0/0:12,.:0.464:26:9,.:3,.:47:55,.,.:50,.,.:0,.,.:9,3,9,5:8,4,11,3	0/1:0,15:0.455:33:0,6:0,9:47:263,303,52:253.33,297.5,50:0,5,8.01:0,0,23,10:0,0,13,20	T	3_prime_UTR_variant	MODIFIER	ALDH7A1	501	Transcript	NM_001182.5	protein_coding	18/18		c.*1000dup		2641-2642					rs60217601	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.125	NA	NA	NA	NA	NA	NA	0.1667	0	NA	0.1578	0.1158	0.1211	0.1516	0.1195	0.3034	0.1241	0.1604	0.1773	0.1571	0.1441	0.3034	gnomADg_EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-45	-2	12	36	0	0	0	0	ALDH7A1			NA				350565	NA	Uncertain_significance	Pyridoxine-dependent_epilepsy&not_provided	NC_000005.10:g.126543984dup		Duplication	ALDH7A1:501&LOC112997555:112997555	MONDO:MONDO:0009945&MedGen:C1849508&OMIM:266100&Orphanet:3006&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		ALDH7A1	Pyridoxine-dependent epilepsy	AR	266100	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs60217601	chr5_126543964_C_CT	Female	1/0	Heterozygous
chr5	126543964	.	C	CTT	254.97	PASS	"FS=0;MQ=246.11;QD=9.11;SOR=0.997;FractionInformativeReads=1;MQRankSum=3.729;ReadPosRankSum=-0.283;R2_5P_bias=-11.227;DP=88;AF=0.5;AN=6;AC=3;CSQ=TT|3_prime_UTR_variant|MODIFIER|ALDH7A1|501|Transcript|NM_001182.5|protein_coding|18/18||NM_001182.5:c.*999_*1000dup||2641-2642|||||rs60217601||-1||insertion|EntrezGene||YES|||||||||||0|||||||0|0||0.2834|0.1222|0.3561|0.2165|0.3408|0.09371|0.3352|0.2736|0.3851|0.2818|0.3747|0.3851|gnomADg_NFE|uncertain_significance||1|||||||||||||||||||||||||||350566||Uncertain_significance|Pyridoxine-dependent_epilepsy|NC_000005.10:g.126543983_126543984dup||Duplication|ALDH7A1:501&LOC112997555:112997555|MONDO:MONDO:0009945&MedGen:C1849508&OMIM:266100&Orphanet:3006||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:0,13:0.464:28:0,7:0,6:47:265,210,52:254.97,204.97,50:0,5,8.01:0,0,16,12:0,0,17,11	0/1:12,14:0.538:26:9,6:3,8:47:55,0,47:50,9.0861e-05,49.613:0,5,8.01:9,3,9,5:8,4,11,3	1/0:0,18:0.545:33:0,9:0,9:47:263,208,51:253.33,203.33,49.325:0,5,8.01:0,0,23,10:0,0,13,20	TT	3_prime_UTR_variant	MODIFIER	ALDH7A1	501	Transcript	NM_001182.5	protein_coding	18/18		c.*999_*1000dup		2641-2642					rs60217601	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0	NA	NA	NA	NA	NA	NA	0	0	NA	0.2834	0.1222	0.3561	0.2165	0.3408	0.09371	0.3352	0.2736	0.3851	0.2818	0.3747	0.3851	gnomADg_NFE	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				350566	NA	Uncertain_significance	Pyridoxine-dependent_epilepsy	NC_000005.10:g.126543983_126543984dup		Duplication	ALDH7A1:501&LOC112997555:112997555	MONDO:MONDO:0009945&MedGen:C1849508&OMIM:266100&Orphanet:3006		criteria_provided&_single_submitter		ALDH7A1	Pyridoxine-dependent epilepsy	AR	266100	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs60217601	chr5_126543964_C_CTT	Female	0/1	Heterozygous
chr5	134612641	.	TAAAAAAAAAAAAAA	T	50	PASS	"FS=0;MQ=227.69;MQRankSum=0.318;QD=2.08;ReadPosRankSum=0.212;SOR=0.458;FractionInformativeReads=0.667;R2_5P_bias=23.048;DP=71;AF=0.5;AN=6;AC=3;CSQ=-|intron_variant|MODIFIER|SAR1B|51128|Transcript|NM_016103.4|protein_coding||4/6|NM_016103.4:c.244+36_244+49del|||||||rs34365859||-1||deletion|EntrezGene||YES|||AAAAAAAAAAAAAA|AAAAAAAAAAAAAA|||||||0.04167|0.01537|0.05554|0.06584|0.0287|0.06602|0.05482|0.04147|0.04566|0.03235|0.2296|0.09239|0.3988|0.286|0.3592|0.05591|0.2285|0.3594|0.2831|0.2222|0.1465|0.3988|gnomADg_AMI||||||||||||||||||||||||||||||2091500||Uncertain_significance|not_provided|NC_000005.10:g.134612668_134612681del||Deletion|SAR1B:51128|MedGen:C3661900||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:7,9:0.562:16:5,6:2,3:48:54,0,49:50,6.9116e-05,52.286:0,4,7:6,1,7,2:4,3,6,3	0/1:6,8:0.571:14:1,5:5,3:48:54,0,49:50,7.3258e-05,51.646:0,4,7:6,0,8,0:1,5,5,3	0/1:13,7:0.35:20:6,4:7,3:43:49,0,44:44.883,0.00022884,46.949:0,4,7:13,0,5,2:6,7,4,3	-	intron_variant	MODIFIER	SAR1B	51128	Transcript	NM_016103.4	protein_coding		06-Apr	c.244+36_244+49del							rs34365859	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	AAAAAAAAAAAAAA	AAAAAAAAAAAAAA	NA	NA			NA	NA	0.04167	0.01537	0.05554	0.06584	0.0287	0.06602	0.05482	0.04147	0.04566	0.03235	0.2296	0.09239	0.3988	0.286	0.3592	0.05591	0.2285	0.3594	0.2831	0.2222	0.1465	0.3988	gnomADg_AMI				NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				2091500	NA	Uncertain_significance	not_provided	NC_000005.10:g.134612668_134612681del		Deletion	SAR1B:51128	MedGen:C3661900		criteria_provided&_single_submitter		SAR1B	Chylomicron retention disease	AR	246700	Inherited disorders of metabolism	NBScreening	0	Uncertain_significance		rs34365859	chr5_134612641_TAAAAAAAAAAAAAA_T	Female	0/1	Heterozygous
chr5	137618889	.	ATT	A	167.39	PASS	"FS=0;MQ=248.25;QD=4.09;SOR=0.693;FractionInformativeReads=0.974;DP=116;AF=1;AN=6;AC=6;CSQ=-|3_prime_UTR_variant|MODIFIER|KLHL3|26249|Transcript|NM_017415.3|protein_coding|15/15||NM_017415.3:c.*3207_*3208del||5414-5415|||||rs369833337||-1||deletion|EntrezGene||YES|||TT|TT|||||||||||||||||0.6349|0.5542|0.6629|0.652|0.7264|0.4862|0.7096|0.6619|0.6705|0.6491|0.7082|0.7264|gnomADg_ASJ|uncertain_significance||1||||||||||||-14|38|30|-4|0.00|0.00|0.00|0.00|KLHL3|||||||350935||Uncertain_significance|not_provided&Autosomal_dominant_pseudohypoaldosteronism_type_1|NC_000005.10:g.137618893_137618894del||Deletion|KLHL3:26249|MedGen:C3661900&MONDO:MONDO:0008329&MedGen:C1449842&OMIM:177735&Orphanet:171871&Orphanet:756||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	1|1:0,38:1:38:0,19:0,19:110:193,113,0:159.58,109.58,0:0,30,33.01:0,0,19,19:0,0,16,22:137618889	1|1:0,40:1:40:0,21:0,19:117:200,120,0:167.39,117.39,0:0,30,33.01:0,0,25,15:0,0,24,16:137618889	1|1:0,34:1:34:0,14:0,20:97:179,100,0:147.42,97.424,0:0,29,32:0,0,22,12:0,0,14,20:137618889	-	3_prime_UTR_variant	MODIFIER	KLHL3	26249	Transcript	NM_017415.3	protein_coding	15/15		c.*3207_*3208del		5414-5415					rs369833337	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	TT	TT	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.6349	0.5542	0.6629	0.652	0.7264	0.4862	0.7096	0.6619	0.6705	0.6491	0.7082	0.7264	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-14	38	30	-4	0	0	0	0	KLHL3			NA				350935	NA	Uncertain_significance	not_provided&Autosomal_dominant_pseudohypoaldosteronism_type_1	NC_000005.10:g.137618893_137618894del		Deletion	KLHL3:26249	MedGen:C3661900&MONDO:MONDO:0008329&MedGen:C1449842&OMIM:177735&Orphanet:171871&Orphanet:756		criteria_provided&_multiple_submitters&_no_conflicts		KLHL3	Pseudohypoaldosteronism, type IID	Multiple and/or complex pattern	614495	Endocrine disorders	NBScreening	-8	Benign	BA1	rs369833337	chr5_137618889_ATT_A	Female	1|1	Homozygous
chr5	137621777	.	TAC	T	115.63	PASS	"FS=0;MQ=248.14;QD=3.87;SOR=1.179;FractionInformativeReads=0.692;DP=100;AF=1;AN=6;AC=6;CSQ=-|3_prime_UTR_variant|MODIFIER|KLHL3|26249|Transcript|NM_017415.3|protein_coding|15/15||NM_017415.3:c.*319_*320del||2526-2527|||||rs3839339||-1||deletion|EntrezGene||YES|||AC|AC|||||||0.5955|0.5778|0.5607|0.5865|0.4989|0.6331|0.5928|0.6139|0.5961|0.513|0.8291|0.8015|0.9372|0.7848|0.813|0.567|0.8739|0.8571|0.8789|0.8235|0.678|0.9372|gnomADg_AMI|||1||||||||||||16|44|10|6|0.00|0.00|0.00|0.00|KLHL3|||||||350976||Conflicting_classifications_of_pathogenicity|Autosomal_dominant_pseudohypoaldosteronism_type_1&not_provided|NC_000005.10:g.137621778AC[12]||Microsatellite|KLHL3:26249|MONDO:MONDO:0008329&MedGen:C1449842&OMIM:177735&Orphanet:171871&Orphanet:756&MedGen:C3661900|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,18:1:18:0,8:0,10:51:108,54,0:100.68,50.684,3.7017e-05:0,4,7:0,0,7,11:0,0,9,9	1/1:0,23:1:23:0,14:0,9:66:123,69,0:115.63,65.633,1.2943e-06:0,4,7:0,0,6,17:0,0,7,16	1/1:0,22:1:22:0,9:0,13:63:120,66,0:112.69,62.686,2.3297e-06:0,4,7:0,0,8,14:0,0,13,9	-	3_prime_UTR_variant	MODIFIER	KLHL3	26249	Transcript	NM_017415.3	protein_coding	15/15		c.*319_*320del		2526-2527					rs3839339	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	AC	AC	NA	NA			NA	NA	0.5955	0.5778	0.5607	0.5865	0.4989	0.6331	0.5928	0.6139	0.5961	0.513	0.8291	0.8015	0.9372	0.7848	0.813	0.567	0.8739	0.8571	0.8789	0.8235	0.678	0.9372	gnomADg_AMI			1	NA	NA	NA		NA	NA		NA	NA	NA		16	44	10	6	0	0	0	0	KLHL3			NA				350976	NA	Conflicting_classifications_of_pathogenicity	Autosomal_dominant_pseudohypoaldosteronism_type_1&not_provided	NC_000005.10:g.137621778AC[12]		Microsatellite	KLHL3:26249	MONDO:MONDO:0008329&MedGen:C1449842&OMIM:177735&Orphanet:171871&Orphanet:756&MedGen:C3661900	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		KLHL3	Pseudohypoaldosteronism, type IID	Multiple and/or complex pattern	614495	Endocrine disorders	NBScreening	-9	Benign	BP6,BA1	rs3839339	chr5_137621777_TAC_T	Female	01-Jan	Homozygous
chr5	148987809	.	CTGTG	C	296.59	PASS	"FS=0;MQ=245.41;QD=7.06;SOR=1.721;FractionInformativeReads=0.606;DP=116;AF=0.5;AN=6;AC=1;CSQ=-|3_prime_UTR_variant|MODIFIER|SH3TC2|79628|Transcript|NM_024577.4|protein_coding|17/17||NM_024577.4:c.*16898_*16901del||20805-20808|||||rs71957589||-1||deletion|EntrezGene||YES|||TGTG|TGTG|||||||||||||||||0.1565|0.1343|0.1516|0.1469|0.1527|0.07021|0.1475|0.1387|0.1785|0.1765|0.1503|0.1785|gnomADg_NFE|||1|||||||||||||||||||||||||||351630||Uncertain_significance|Charcot-Marie-Tooth_disease_type_4&Mononeuropathy_of_the_Median_Nerve|NC_000005.10:g.148987811GT[21]||Microsatellite|SH3TC2:79628|MONDO:MONDO:0018995&MedGen:C4082197&Orphanet:64749&MedGen:C3150597||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:0,.:.:20:0,.:0,.:50:237,.,.:232.85,.,.:0,.,.:0,0,6,14:0,0,14,6	0/0:0,.:0.45:16:0,.:0,.:49:172,.,.:167.59,.,.:0,.,.:0,0,6,10:0,0,8,8	1/0:0,15:0.577:26:0,7:0,8:50:301,249,51:296.59,246.59,52.48:0,2,5:0,0,15,11:0,0,17,9	-	3_prime_UTR_variant	MODIFIER	SH3TC2	79628	Transcript	NM_024577.4	protein_coding	17/17		c.*16898_*16901del		20805-20808					rs71957589	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	TGTG	TGTG	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.1565	0.1343	0.1516	0.1469	0.1527	0.07021	0.1475	0.1387	0.1785	0.1765	0.1503	0.1785	gnomADg_NFE			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				351630	NA	Uncertain_significance	Charcot-Marie-Tooth_disease_type_4&Mononeuropathy_of_the_Median_Nerve	NC_000005.10:g.148987811GT[21]		Microsatellite	SH3TC2:79628	MONDO:MONDO:0018995&MedGen:C4082197&Orphanet:64749&MedGen:C3150597		criteria_provided&_single_submitter		SH3TC2	Charcot-Marie-Tooth disease type 4C	AR	601596	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs71957589	chr5_148987809_CTGTG_C	Female	0/0	Other
chr5	148992269	.	T	C	50	PASS	"FS=3.581;MQ=248.42;MQRankSum=4.427;QD=1.6;ReadPosRankSum=2.674;SOR=0.501;FractionInformativeReads=1;R2_5P_bias=0.817;DP=110;AF=0.5;AN=6;AC=3;CSQ=C|3_prime_UTR_variant|MODIFIER|SH3TC2|79628|Transcript|NM_024577.4|protein_coding|17/17||NM_024577.4:c.*12442A>G||16349|||||rs56848629||-1||SNV|EntrezGene||YES|||T|T|||||||||||||||||0.222|0.2959|0.2297|0.1563|0.249|0.02696|0.1904|0.2177|0.2087|0.2327|0.2356|0.2959|gnomADg_AFR|uncertain_significance||1|||||||||||||||||||||||||||906301||Uncertain_significance|Charcot-Marie-Tooth_disease_type_4C&Susceptibility_to_mononeuropathy_of_the_median_nerve&_mild|NC_000005.10:g.148992269T>C||single_nucleotide_variant|SH3TC2:79628|MONDO:MONDO:0011113&MedGen:C1866636&OMIM:601596&Orphanet:99949&MONDO:MONDO:0013237&MedGen:C3150596&OMIM:613353||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,11:0.379:29:8,8:10,3:46:81,0,50:46.467,0.00011959,53:0,34.77,37.77:12,6,5,6:10,8,6,5	0/1:17,20:0.541:37:13,17:4,3:48:85,0,49:50,6.8081e-05,52.471:0,34.77,37.77:11,6,11,9:11,6,12,8	0/1:17,27:0.614:44:8,12:9,15:46:85,0,45:50,0.00011183,48.023:0,34.77,37.77:12,5,13,14:9,8,12,15	C	3_prime_UTR_variant	MODIFIER	SH3TC2	79628	Transcript	NM_024577.4	protein_coding	17/17		c.*12442A>G		16349					rs56848629	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.222	0.2959	0.2297	0.1563	0.249	0.02696	0.1904	0.2177	0.2087	0.2327	0.2356	0.2959	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				906301	NA	Uncertain_significance	Charcot-Marie-Tooth_disease_type_4C&Susceptibility_to_mononeuropathy_of_the_median_nerve&_mild	NC_000005.10:g.148992269T>C		single_nucleotide_variant	SH3TC2:79628	MONDO:MONDO:0011113&MedGen:C1866636&OMIM:601596&Orphanet:99949&MONDO:MONDO:0013237&MedGen:C3150596&OMIM:613353		criteria_provided&_single_submitter		SH3TC2	Charcot-Marie-Tooth disease type 4C	AR	601596	Neuromuscular and musculoskelettal disorders	NBScreening	-12	Benign	BP4_Strong,BA1	rs56848629	chr5_148992269_T_C	Female	0/1	Heterozygous
chr5	148994697	.	A	AGGAT	132.9	PASS	"FS=0;MQ=245.74;QD=4.24;SOR=1.708;FractionInformativeReads=0.852;MQRankSum=4.188;ReadPosRankSum=0.684;R2_5P_bias=18.896;DP=102;AF=0.5;AN=6;AC=5;CSQ=GGAT|3_prime_UTR_variant|MODIFIER|SH3TC2|79628|Transcript|NM_024577.4|protein_coding|17/17||NM_024577.4:c.*10010_*10013dup||13920-13921|||||rs201323132||-1||insertion|EntrezGene||YES|||||||||||||||||||||0.1744|0.3095|0.1306|0.2637|0.1832|0.1526|0.05568|0.191|0.09596|0.1811|0.1562|0.3095|gnomADg_AFR|||1|||||||||||||||||||||||||||351728||Uncertain_significance|Charcot-Marie-Tooth_disease_type_4&Mononeuropathy_of_the_Median_Nerve|NC_000005.10:g.148994699GATG[11]||Microsatellite|SH3TC2:79628|MONDO:MONDO:0018995&MedGen:C4082197&Orphanet:64749&MedGen:C3150597||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,23:1:23:0,16:0,7:64:120,67,0:114.47,64.473,1.5532e-06:0,3,6:0,0,7,16:0,0,8,15	1/1:0,29:1:29:0,19:0,10:83:139,86,0:132.9,82.904,0:0,3,6:0,0,8,21:0,0,12,17	0/1:11,14:0.56:25:5,9:6,5:48:52,0,49:50,6.9116e-05,52.289:0,2,5:4,7,5,9:8,3,4,10	GGAT	3_prime_UTR_variant	MODIFIER	SH3TC2	79628	Transcript	NM_024577.4	protein_coding	17/17		c.*10010_*10013dup		13920-13921					rs201323132	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.1744	0.3095	0.1306	0.2637	0.1832	0.1526	0.05568	0.191	0.09596	0.1811	0.1562	0.3095	gnomADg_AFR			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				351728	NA	Uncertain_significance	Charcot-Marie-Tooth_disease_type_4&Mononeuropathy_of_the_Median_Nerve	NC_000005.10:g.148994699GATG[11]		Microsatellite	SH3TC2:79628	MONDO:MONDO:0018995&MedGen:C4082197&Orphanet:64749&MedGen:C3150597		criteria_provided&_single_submitter		SH3TC2	Charcot-Marie-Tooth disease type 4C	AR	601596	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs201323132	chr5_148994697_A_AGGAT	Female	01-Jan	Homozygous
chr5	148996600	.	T	G	50	PASS	"FS=1.133;MQ=250;MQRankSum=5.907;QD=1.04;ReadPosRankSum=1.997;SOR=0.997;FractionInformativeReads=1;R2_5P_bias=-3.629;DP=104;AF=0.5;AN=6;AC=3;CSQ=G|3_prime_UTR_variant|MODIFIER|SH3TC2|79628|Transcript|NM_024577.4|protein_coding|17/17||NM_024577.4:c.*8111A>C||12018|||||rs17109205||-1||SNV|EntrezGene||YES|||T|T|||||||||||||||||0.2384|0.353|0.2313|0.1628|0.2487|0.02667|0.1902|0.2211|0.2089|0.2412|0.2364|0.353|gnomADg_AFR|uncertain_significance&benign||1|||||||||||||||||||||||||||351761||Conflicting_classifications_of_pathogenicity|Susceptibility_to_mononeuropathy_of_the_median_nerve&_mild&Charcot-Marie-Tooth_disease_type_4C&not_provided|NC_000005.10:g.148996600T>G||single_nucleotide_variant|SH3TC2:79628|MONDO:MONDO:0013237&MedGen:C3150596&OMIM:613353&MONDO:MONDO:0011113&MedGen:C1866636&OMIM:601596&Orphanet:99949&MedGen:C3661900|Uncertain_significance(2)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:22,26:0.542:48:14,10:8,16:48:85,0,49:50,6.9116e-05,52.275:0,34.77,37.77:10,12,10,16:8,14,12,14	0/1:17,14:0.452:31:6,4:11,10:48:84,0,50:49.184,7.4034e-05,53:0,34.77,37.77:8,9,9,5:9,8,5,9	0/1:12,13:0.52:25:8,5:4,8:48:85,0,50:50,6.5751e-05,52.913:0,34.77,37.77:6,6,6,7:4,8,8,5	G	3_prime_UTR_variant	MODIFIER	SH3TC2	79628	Transcript	NM_024577.4	protein_coding	17/17		c.*8111A>C		12018					rs17109205	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.2384	0.353	0.2313	0.1628	0.2487	0.02667	0.1902	0.2211	0.2089	0.2412	0.2364	0.353	gnomADg_AFR	uncertain_significance&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				351761	NA	Conflicting_classifications_of_pathogenicity	Susceptibility_to_mononeuropathy_of_the_median_nerve&_mild&Charcot-Marie-Tooth_disease_type_4C&not_provided	NC_000005.10:g.148996600T>G		single_nucleotide_variant	SH3TC2:79628	MONDO:MONDO:0013237&MedGen:C3150596&OMIM:613353&MONDO:MONDO:0011113&MedGen:C1866636&OMIM:601596&Orphanet:99949&MedGen:C3661900	Uncertain_significance(2)&Benign(1)	criteria_provided&_conflicting_classifications		SH3TC2	Charcot-Marie-Tooth disease type 4C	AR	601596	Neuromuscular and musculoskelettal disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs17109205	chr5_148996600_T_G	Female	0/1	Heterozygous
chr5	155870343	.	G	A	50	PASS	"FS=6.369;MQ=249.07;MQRankSum=5.228;QD=1.06;ReadPosRankSum=1.115;SOR=0.768;FractionInformativeReads=0.957;R2_5P_bias=-8.365;DP=47;AF=0.5;AN=2;AC=1;CSQ=A|splice_acceptor_variant|HIGH|SGCD|6444|Transcript|XM_047417518.1|protein_coding||1/11|XM_047417518.1:c.-344-1G>A|||||||rs148165058||1||SNV|EntrezGene|||||G|G||||||0.0024|0|||||||0|||0.003447|0.0004572|0|0.001177|0.003744|0.0003857|0.008391|0.003401|0.004836|0.00473|0.009125|0.009125|gnomADg_SAS|||||||||||||||||||||||||||||||||||||||||"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,26:0.578:45:6,16:13,10:47:85,0,48:50,8.1024e-05,50.627:0,34.77,37.77:7,12,15,11:16,3,15,11	A	splice_acceptor_variant	HIGH	SGCD	6444	Transcript	XM_047417518.1	protein_coding		11-Jan	c.-344-1G>A							rs148165058	NA	1	NA	SNV	EntrezGene	NA		NA	NA	G	G	NA	NA			NA	0.0024	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.003447	0.0004572	0	0.001177	0.003744	0.0003857	0.008391	0.003401	0.004836	0.00473	0.009125	0.009125	gnomADg_SAS				NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				NA	NA	NA										SGCD	Autosomal recessive limb-girdle muscular dystrophy type 2F	AR	601287	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BP4_Strong,BS1	rs148165058	chr5_155870343_G_A	Female	./.	Other
chr5	155870343	.	G	A	50	PASS	"FS=6.369;MQ=249.07;MQRankSum=5.228;QD=1.06;ReadPosRankSum=1.115;SOR=0.768;FractionInformativeReads=0.957;R2_5P_bias=-8.365;DP=47;AF=0.5;AN=2;AC=1;CSQ=A|splice_acceptor_variant|HIGH|SGCD|6444|Transcript|XM_047417518.1|protein_coding||1/11|XM_047417518.1:c.-344-1G>A|||||||rs148165058||1||SNV|EntrezGene|||||G|G||||||0.0024|0|||||||0|||0.003447|0.0004572|0|0.001177|0.003744|0.0003857|0.008391|0.003401|0.004836|0.00473|0.009125|0.009125|gnomADg_SAS|||||||||||||||||||||||||||||||||||||||||"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,26:0.578:45:6,16:13,10:47:85,0,48:50,8.1024e-05,50.627:0,34.77,37.77:7,12,15,11:16,3,15,11	A	splice_acceptor_variant	HIGH	SGCD	6444	Transcript	XM_047417518.1	protein_coding		11-Jan	c.-344-1G>A							rs148165058	NA	1	NA	SNV	EntrezGene	NA		NA	NA	G	G	NA	NA			NA	0.0024	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.003447	0.0004572	0	0.001177	0.003744	0.0003857	0.008391	0.003401	0.004836	0.00473	0.009125	0.009125	gnomADg_SAS				NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				NA	NA	NA										SGCD	Dilated cardiomyopathy 1L	AD	606685	Cardiac and vascular disorders	NBScreening	-8	Benign	BP4_Strong,BS1	rs148165058	chr5_155870343_G_A	Female	./.	Other
chr5	156766034	.	TA	T	50	PASS	"FS=3.106;MQ=250;MQRankSum=4.947;QD=1.32;ReadPosRankSum=-1.288;SOR=1.202;FractionInformativeReads=0.974;R2_5P_bias=-1.727;DP=70;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|SGCD|6444|Transcript|NM_000337.6|protein_coding|9/9||NM_000337.6:c.*6660del||7630|||||rs57240389||1||deletion|EntrezGene||YES|||A|A|||||15||||||||||||0.1103|0.1594|0.1377|0.08388|0.1162|0.007576|0.1062|0.1102|0.09577|0.096|0.09326|0.1594|gnomADg_AFR|uncertain_significance||1|||||||||||||||||||||||||||352426||Uncertain_significance|Dilated_Cardiomyopathy&_Dominant&Limb-girdle_muscular_dystrophy&_recessive&not_provided&Qualitative_or_quantitative_defects_of_delta-sarcoglycan|NC_000005.10:g.156766050del||Deletion|SGCD:6444|MedGen:CN239310&MedGen:CN239352&MedGen:C3661900&MONDO:MONDO:0016144&MedGen:C5680806&Orphanet:207070||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:13,24:0.649:37:5,12:8,12:44:57,0,43:50,0.00015558,45.884:0,7,10:6,7,15,9:6,7,17,7	0/1:20,10:0.333:30:10,5:10,5:42:50,0,50:42.587,0.0002612,53:0,7,10:14,6,4,6:10,10,5,5	./.:.:.:.:.:.:.:.:.:.:.:.	-	3_prime_UTR_variant	MODIFIER	SGCD	6444	Transcript	NM_000337.6	protein_coding	09-Sep		c.*6660del		7630					rs57240389	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			15	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.1103	0.1594	0.1377	0.08388	0.1162	0.007576	0.1062	0.1102	0.09577	0.096	0.09326	0.1594	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				352426	NA	Uncertain_significance	Dilated_Cardiomyopathy&_Dominant&Limb-girdle_muscular_dystrophy&_recessive&not_provided&Qualitative_or_quantitative_defects_of_delta-sarcoglycan	NC_000005.10:g.156766050del		Deletion	SGCD:6444	MedGen:CN239310&MedGen:CN239352&MedGen:C3661900&MONDO:MONDO:0016144&MedGen:C5680806&Orphanet:207070		criteria_provided&_multiple_submitters&_no_conflicts		SGCD	Autosomal recessive limb-girdle muscular dystrophy type 2F	AR	601287	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs57240389	chr5_156766034_TA_T	Female	0/1	Heterozygous
chr5	156766034	.	TA	T	50	PASS	"FS=3.106;MQ=250;MQRankSum=4.947;QD=1.32;ReadPosRankSum=-1.288;SOR=1.202;FractionInformativeReads=0.974;R2_5P_bias=-1.727;DP=70;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|SGCD|6444|Transcript|NM_000337.6|protein_coding|9/9||NM_000337.6:c.*6660del||7630|||||rs57240389||1||deletion|EntrezGene||YES|||A|A|||||15||||||||||||0.1103|0.1594|0.1377|0.08388|0.1162|0.007576|0.1062|0.1102|0.09577|0.096|0.09326|0.1594|gnomADg_AFR|uncertain_significance||1|||||||||||||||||||||||||||352426||Uncertain_significance|Dilated_Cardiomyopathy&_Dominant&Limb-girdle_muscular_dystrophy&_recessive&not_provided&Qualitative_or_quantitative_defects_of_delta-sarcoglycan|NC_000005.10:g.156766050del||Deletion|SGCD:6444|MedGen:CN239310&MedGen:CN239352&MedGen:C3661900&MONDO:MONDO:0016144&MedGen:C5680806&Orphanet:207070||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:13,24:0.649:37:5,12:8,12:44:57,0,43:50,0.00015558,45.884:0,7,10:6,7,15,9:6,7,17,7	0/1:20,10:0.333:30:10,5:10,5:42:50,0,50:42.587,0.0002612,53:0,7,10:14,6,4,6:10,10,5,5	./.:.:.:.:.:.:.:.:.:.:.:.	-	3_prime_UTR_variant	MODIFIER	SGCD	6444	Transcript	NM_000337.6	protein_coding	09-Sep		c.*6660del		7630					rs57240389	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			15	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.1103	0.1594	0.1377	0.08388	0.1162	0.007576	0.1062	0.1102	0.09577	0.096	0.09326	0.1594	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				352426	NA	Uncertain_significance	Dilated_Cardiomyopathy&_Dominant&Limb-girdle_muscular_dystrophy&_recessive&not_provided&Qualitative_or_quantitative_defects_of_delta-sarcoglycan	NC_000005.10:g.156766050del		Deletion	SGCD:6444	MedGen:CN239310&MedGen:CN239352&MedGen:C3661900&MONDO:MONDO:0016144&MedGen:C5680806&Orphanet:207070		criteria_provided&_multiple_submitters&_no_conflicts		SGCD	Dilated cardiomyopathy 1L	AD	606685	Cardiac and vascular disorders	NBScreening	-8	Benign	BA1	rs57240389	chr5_156766034_TA_T	Female	0/1	Heterozygous
chr5	156767484	.	G	GA	50	PASS	"FS=1.527;MQ=247.82;MQRankSum=3.837;QD=1.61;ReadPosRankSum=-0.988;SOR=0.307;FractionInformativeReads=0.903;R2_5P_bias=-9.09;DP=61;AF=0.5;AN=4;AC=2;CSQ=A|3_prime_UTR_variant|MODIFIER|SGCD|6444|Transcript|NM_000337.6|protein_coding|9/9||NM_000337.6:c.*8114dup||9079-9080|||||rs397736317||1||insertion|EntrezGene||YES|||||||||20||||||||||||0.1851|0.2859|0.1379|0.1427|0.2169|0.2067|0.09345|0.3261|0.1257|0.1859|0.2244|0.3261|gnomADg_MID|uncertain_significance||1|||||||||||||||||||||||||||352450||Uncertain_significance|Dilated_Cardiomyopathy&_Dominant&Qualitative_or_quantitative_defects_of_delta-sarcoglycan&not_provided&Limb-girdle_muscular_dystrophy&_recessive|NC_000005.10:g.156767504dup||Duplication|SGCD:6444|MedGen:CN239310&MONDO:MONDO:0016144&MedGen:C5680806&Orphanet:207070&MedGen:C3661900&MedGen:CN239352||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:14,14:0.5:28:7,7:7,7:47:55,0,47:49.909,8.7754e-05,50:0,5,8.01:9,5,7,7:4,10,8,6	0/1:11,14:0.56:25:7,8:4,6:48:54,0,49:50,6.9893e-05,52.145:0,4,7:6,5,9,5:4,7,9,5	./.:.:.:.:.:.:.:.:.:.:.:.	A	3_prime_UTR_variant	MODIFIER	SGCD	6444	Transcript	NM_000337.6	protein_coding	09-Sep		c.*8114dup		9079-9080					rs397736317	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.1851	0.2859	0.1379	0.1427	0.2169	0.2067	0.09345	0.3261	0.1257	0.1859	0.2244	0.3261	gnomADg_MID	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				352450	NA	Uncertain_significance	Dilated_Cardiomyopathy&_Dominant&Qualitative_or_quantitative_defects_of_delta-sarcoglycan&not_provided&Limb-girdle_muscular_dystrophy&_recessive	NC_000005.10:g.156767504dup		Duplication	SGCD:6444	MedGen:CN239310&MONDO:MONDO:0016144&MedGen:C5680806&Orphanet:207070&MedGen:C3661900&MedGen:CN239352		criteria_provided&_multiple_submitters&_no_conflicts		SGCD	Autosomal recessive limb-girdle muscular dystrophy type 2F	AR	601287	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs397736317	chr5_156767484_G_GA	Female	0/1	Heterozygous
chr5	156767484	.	G	GA	50	PASS	"FS=1.527;MQ=247.82;MQRankSum=3.837;QD=1.61;ReadPosRankSum=-0.988;SOR=0.307;FractionInformativeReads=0.903;R2_5P_bias=-9.09;DP=61;AF=0.5;AN=4;AC=2;CSQ=A|3_prime_UTR_variant|MODIFIER|SGCD|6444|Transcript|NM_000337.6|protein_coding|9/9||NM_000337.6:c.*8114dup||9079-9080|||||rs397736317||1||insertion|EntrezGene||YES|||||||||20||||||||||||0.1851|0.2859|0.1379|0.1427|0.2169|0.2067|0.09345|0.3261|0.1257|0.1859|0.2244|0.3261|gnomADg_MID|uncertain_significance||1|||||||||||||||||||||||||||352450||Uncertain_significance|Dilated_Cardiomyopathy&_Dominant&Qualitative_or_quantitative_defects_of_delta-sarcoglycan&not_provided&Limb-girdle_muscular_dystrophy&_recessive|NC_000005.10:g.156767504dup||Duplication|SGCD:6444|MedGen:CN239310&MONDO:MONDO:0016144&MedGen:C5680806&Orphanet:207070&MedGen:C3661900&MedGen:CN239352||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:14,14:0.5:28:7,7:7,7:47:55,0,47:49.909,8.7754e-05,50:0,5,8.01:9,5,7,7:4,10,8,6	0/1:11,14:0.56:25:7,8:4,6:48:54,0,49:50,6.9893e-05,52.145:0,4,7:6,5,9,5:4,7,9,5	./.:.:.:.:.:.:.:.:.:.:.:.	A	3_prime_UTR_variant	MODIFIER	SGCD	6444	Transcript	NM_000337.6	protein_coding	09-Sep		c.*8114dup		9079-9080					rs397736317	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.1851	0.2859	0.1379	0.1427	0.2169	0.2067	0.09345	0.3261	0.1257	0.1859	0.2244	0.3261	gnomADg_MID	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				352450	NA	Uncertain_significance	Dilated_Cardiomyopathy&_Dominant&Qualitative_or_quantitative_defects_of_delta-sarcoglycan&not_provided&Limb-girdle_muscular_dystrophy&_recessive	NC_000005.10:g.156767504dup		Duplication	SGCD:6444	MedGen:CN239310&MONDO:MONDO:0016144&MedGen:C5680806&Orphanet:207070&MedGen:C3661900&MedGen:CN239352		criteria_provided&_multiple_submitters&_no_conflicts		SGCD	Dilated cardiomyopathy 1L	AD	606685	Cardiac and vascular disorders	NBScreening	-8	Benign	BA1	rs397736317	chr5_156767484_G_GA	Female	0/1	Heterozygous
chr6	6174633	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=4.881;QD=1.47;ReadPosRankSum=3.517;SOR=0.56;FractionInformativeReads=1;R2_5P_bias=-15.052;DP=72;AF=0.5;AN=4;AC=2;CSQ=A|missense_variant|MODERATE|F13A1|2162|Transcript|NM_000129.4|protein_coding|12/15||NM_000129.4:c.1694C>T|NP_000120.2:p.Pro565Leu|1788|1694|565|P/L|cCg/cTg|rs5982&CM995295&COSV53555780||-1||SNV|EntrezGene||YES|||G|G|||tolerated(0.17)|benign(0.003)||0.2404|0.2156|0.1539|0.1013|0.221|0.3015|0.2031|0.2525|0.21|0.2248|0.3279|0.1958|0.1586|0.2029|0.1354|0.219|0.3065|0.2133|0.2687|0.2087|0.1957|0.3479|0.3773|SAS|conflicting_interpretations_of_pathogenicity&benign|0&1&1|1&1&1||||T|0.00057|-0.666851|T|0.13941|-0.586841|0.22490|0.077|-5|39|-24|-48|0.00|0.00|0.00|0.00|F13A1|likely_benign|hg38|0.0749|P565L|ENST00000264870.7|P00488|255183||Conflicting_classifications_of_pathogenicity|not_specified&Factor_XIII&_A_subunit&_deficiency_of&not_provided|NC_000006.12:g.6174633G>A||single_nucleotide_variant|F13A1:2162|MedGen:CN169374&Human_Phenotype_Ontology:HP:0040233&MONDO:MONDO:0013187&MedGen:C2750514&OMIM:613225&Orphanet:331&MedGen:C3661900|Uncertain_significance(1)&Benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:14,20:0.588:34:10,13:4,7:47:85,0,47:50,8.3871e-05,50.323:0,34.77,37.77:5,9,8,12:5,9,11,9	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:21,17:0.447:38:7,7:14,10:48:84,0,50:48.982,7.6623e-05,53:0,34.77,37.77:8,13,8,9:12,9,8,9	A	missense_variant	MODERATE	F13A1	2162	Transcript	NM_000129.4	protein_coding	15-Dec		c.1694C>T	p.Pro565Leu	1788	1694	565	P/L	cCg/cTg	rs5982&CM995295&COSV53555780	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	tolerated(0.17)	benign(0.003)	NA	0.2404	0.2156	0.1539	0.1013	0.221	0.3015	0.2031	0.2525	0.21	0.2248	0.3279	0.1958	0.1586	0.2029	0.1354	0.219	0.3065	0.2133	0.2687	0.2087	0.1957	0.3479	0.3773	SAS	conflicting_interpretations_of_pathogenicity&benign	0&1&1	1&1&1	NA	NA	NA	T	0.00057	-0.666851	T	0.13941	-0.586841	0.2249	0.077	-5	39	-24	-48	0	0	0	0	F13A1	likely_benign	hg38	0.0749	P565L	ENST00000264870.7	P00488	255183	NA	Conflicting_classifications_of_pathogenicity	not_specified&Factor_XIII&_A_subunit&_deficiency_of&not_provided	NC_000006.12:g.6174633G>A		single_nucleotide_variant	F13A1:2162	MedGen:CN169374&Human_Phenotype_Ontology:HP:0040233&MONDO:MONDO:0013187&MedGen:C2750514&OMIM:613225&Orphanet:331&MedGen:C3661900	Uncertain_significance(1)&Benign(4)	criteria_provided&_conflicting_classifications		F13A1	Factor XIII, A subunit, deficiency of	AR	613225	Haematological disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs5982	chr6_6174633_G_A	Female	0/1	Heterozygous
chr6	7585734	.	G	C	143.31	PASS	"FS=0;MQ=250;QD=4.82;SOR=0.846;FractionInformativeReads=1;DP=90;AF=1;AN=6;AC=6;CSQ=C|synonymous_variant|LOW|DSP|1832|Transcript|NM_004415.4|protein_coding|24/24||NM_004415.4:c.8472G>C|NP_004406.2:p.Gly2824%3D|8717|8472|2824|G|ggG/ggC|rs2744380&COSV60939587||1||SNV|EntrezGene||YES|||G|G||||||0.7095|0.7026|0.6292|0.7523|0.7458|0.8141|0.6463|0.7567|0.6983|0.7106|0.7218|0.6908|0.6384|0.6941|0.7554|0.7524|0.7964|0.6493|0.7993|0.7001|0.7079|0.7252|0.8141|gnomADe_EAS|benign|0&1|1&1||||||||||||-38|-2|47|-1|0.00|0.00|0.00|0.00|DSP|||||||44967||Conflicting_classifications_of_pathogenicity|not_provided&Arrhythmogenic_cardiomyopathy_with_wooly_hair_and_keratoderma&Arrhythmogenic_right_ventricular_dysplasia_8&Cardiomyopathy&DSP-related_disorder&Keratosis_palmoplantaris_striata_2&Lethal_acantholytic_epidermolysis_bullosa&Woolly_hair-skin_fragility_syndrome&Cardiomyopathy&_dilated&_with_wooly_hair&_keratoderma&_and_tooth_agenesis&not_specified&Cardiovascular_phenotype|NC_000006.12:g.7585734G>C||single_nucleotide_variant|DSP:1832|MedGen:C3661900&MONDO:MONDO:0011581&MedGen:C1854063&OMIM:605676&Orphanet:65282&MONDO:MONDO:0011831&MedGen:C1843896&OMIM:607450&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&.&MONDO:MONDO:0013034&MedGen:C1852127&OMIM:612908&MONDO:MONDO:0012323&MedGen:C1864826&OMIM:609638&Orphanet:158687&MONDO:MONDO:0957307&MedGen:C1843292&OMIM:620415&Orphanet:293165&MONDO:MONDO:0014355&MedGen:C4014393&OMIM:615821&Orphanet:476096&Orphanet:65282&MedGen:CN169374&MedGen:CN230736|Uncertain_significance(1)&Benign(18)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,26:1:26:0,11:0,15:75:163,78,0:125.26,75.26,0:0,34.77,37.77:0,0,14,12:0,0,13,13	1/1:0,32:1:32:0,15:0,17:93:181,96,0:142.86,92.859,0:0,34.77,37.77:0,0,15,17:0,0,18,14	1/1:0,32:1:32:0,9:0,23:93:181,96,0:143.31,93.307,0:0,34.77,37.77:0,0,17,15:0,0,18,14	C	synonymous_variant	LOW	DSP	1832	Transcript	NM_004415.4	protein_coding	24/24		c.8472G>C	p.Gly2824%3D	8717	8472	2824	G	ggG/ggC	rs2744380&COSV60939587	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.7095	0.7026	0.6292	0.7523	0.7458	0.8141	0.6463	0.7567	0.6983	0.7106	0.7218	0.6908	0.6384	0.6941	0.7554	0.7524	0.7964	0.6493	0.7993	0.7001	0.7079	0.7252	0.8141	gnomADe_EAS	benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-38	-2	47	-1	0	0	0	0	DSP			NA				44967	NA	Conflicting_classifications_of_pathogenicity	not_provided&Arrhythmogenic_cardiomyopathy_with_wooly_hair_and_keratoderma&Arrhythmogenic_right_ventricular_dysplasia_8&Cardiomyopathy&DSP-related_disorder&Keratosis_palmoplantaris_striata_2&Lethal_acantholytic_epidermolysis_bullosa&Woolly_hair-skin_fragility_syndrome&Cardiomyopathy&_dilated&_with_wooly_hair&_keratoderma&_and_tooth_agenesis&not_specified&Cardiovascular_phenotype	NC_000006.12:g.7585734G>C		single_nucleotide_variant	DSP:1832	MedGen:C3661900&MONDO:MONDO:0011581&MedGen:C1854063&OMIM:605676&Orphanet:65282&MONDO:MONDO:0011831&MedGen:C1843896&OMIM:607450&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&.&MONDO:MONDO:0013034&MedGen:C1852127&OMIM:612908&MONDO:MONDO:0012323&MedGen:C1864826&OMIM:609638&Orphanet:158687&MONDO:MONDO:0957307&MedGen:C1843292&OMIM:620415&Orphanet:293165&MONDO:MONDO:0014355&MedGen:C4014393&OMIM:615821&Orphanet:476096&Orphanet:65282&MedGen:CN169374&MedGen:CN230736	Uncertain_significance(1)&Benign(18)	criteria_provided&_conflicting_classifications		DSP	Lethal acantholytic epidermolysis bullosa	AD	609638	"Cardiac and vascular disorders;Skelettal, skin, and connective tissue disorders"	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs2744380	chr6_7585734_G_C	Female	01-Jan	Homozygous
chr6	7585734	.	G	C	143.31	PASS	"FS=0;MQ=250;QD=4.82;SOR=0.846;FractionInformativeReads=1;DP=90;AF=1;AN=6;AC=6;CSQ=C|synonymous_variant|LOW|DSP|1832|Transcript|NM_004415.4|protein_coding|24/24||NM_004415.4:c.8472G>C|NP_004406.2:p.Gly2824%3D|8717|8472|2824|G|ggG/ggC|rs2744380&COSV60939587||1||SNV|EntrezGene||YES|||G|G||||||0.7095|0.7026|0.6292|0.7523|0.7458|0.8141|0.6463|0.7567|0.6983|0.7106|0.7218|0.6908|0.6384|0.6941|0.7554|0.7524|0.7964|0.6493|0.7993|0.7001|0.7079|0.7252|0.8141|gnomADe_EAS|benign|0&1|1&1||||||||||||-38|-2|47|-1|0.00|0.00|0.00|0.00|DSP|||||||44967||Conflicting_classifications_of_pathogenicity|not_provided&Arrhythmogenic_cardiomyopathy_with_wooly_hair_and_keratoderma&Arrhythmogenic_right_ventricular_dysplasia_8&Cardiomyopathy&DSP-related_disorder&Keratosis_palmoplantaris_striata_2&Lethal_acantholytic_epidermolysis_bullosa&Woolly_hair-skin_fragility_syndrome&Cardiomyopathy&_dilated&_with_wooly_hair&_keratoderma&_and_tooth_agenesis&not_specified&Cardiovascular_phenotype|NC_000006.12:g.7585734G>C||single_nucleotide_variant|DSP:1832|MedGen:C3661900&MONDO:MONDO:0011581&MedGen:C1854063&OMIM:605676&Orphanet:65282&MONDO:MONDO:0011831&MedGen:C1843896&OMIM:607450&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&.&MONDO:MONDO:0013034&MedGen:C1852127&OMIM:612908&MONDO:MONDO:0012323&MedGen:C1864826&OMIM:609638&Orphanet:158687&MONDO:MONDO:0957307&MedGen:C1843292&OMIM:620415&Orphanet:293165&MONDO:MONDO:0014355&MedGen:C4014393&OMIM:615821&Orphanet:476096&Orphanet:65282&MedGen:CN169374&MedGen:CN230736|Uncertain_significance(1)&Benign(18)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,26:1:26:0,11:0,15:75:163,78,0:125.26,75.26,0:0,34.77,37.77:0,0,14,12:0,0,13,13	1/1:0,32:1:32:0,15:0,17:93:181,96,0:142.86,92.859,0:0,34.77,37.77:0,0,15,17:0,0,18,14	1/1:0,32:1:32:0,9:0,23:93:181,96,0:143.31,93.307,0:0,34.77,37.77:0,0,17,15:0,0,18,14	C	synonymous_variant	LOW	DSP	1832	Transcript	NM_004415.4	protein_coding	24/24		c.8472G>C	p.Gly2824%3D	8717	8472	2824	G	ggG/ggC	rs2744380&COSV60939587	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.7095	0.7026	0.6292	0.7523	0.7458	0.8141	0.6463	0.7567	0.6983	0.7106	0.7218	0.6908	0.6384	0.6941	0.7554	0.7524	0.7964	0.6493	0.7993	0.7001	0.7079	0.7252	0.8141	gnomADe_EAS	benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-38	-2	47	-1	0	0	0	0	DSP			NA				44967	NA	Conflicting_classifications_of_pathogenicity	not_provided&Arrhythmogenic_cardiomyopathy_with_wooly_hair_and_keratoderma&Arrhythmogenic_right_ventricular_dysplasia_8&Cardiomyopathy&DSP-related_disorder&Keratosis_palmoplantaris_striata_2&Lethal_acantholytic_epidermolysis_bullosa&Woolly_hair-skin_fragility_syndrome&Cardiomyopathy&_dilated&_with_wooly_hair&_keratoderma&_and_tooth_agenesis&not_specified&Cardiovascular_phenotype	NC_000006.12:g.7585734G>C		single_nucleotide_variant	DSP:1832	MedGen:C3661900&MONDO:MONDO:0011581&MedGen:C1854063&OMIM:605676&Orphanet:65282&MONDO:MONDO:0011831&MedGen:C1843896&OMIM:607450&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&.&MONDO:MONDO:0013034&MedGen:C1852127&OMIM:612908&MONDO:MONDO:0012323&MedGen:C1864826&OMIM:609638&Orphanet:158687&MONDO:MONDO:0957307&MedGen:C1843292&OMIM:620415&Orphanet:293165&MONDO:MONDO:0014355&MedGen:C4014393&OMIM:615821&Orphanet:476096&Orphanet:65282&MedGen:CN169374&MedGen:CN230736	Uncertain_significance(1)&Benign(18)	criteria_provided&_conflicting_classifications		DSP	Arrhythmogenic right ventricular dysplasia 8	AD	607450	"Cardiac and vascular disorders;Neuromuscular and musculoskelettal disorders"	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs2744380	chr6_7585734_G_C	Female	01-Jan	Homozygous
chr6	7585734	.	G	C	143.31	PASS	"FS=0;MQ=250;QD=4.82;SOR=0.846;FractionInformativeReads=1;DP=90;AF=1;AN=6;AC=6;CSQ=C|synonymous_variant|LOW|DSP|1832|Transcript|NM_004415.4|protein_coding|24/24||NM_004415.4:c.8472G>C|NP_004406.2:p.Gly2824%3D|8717|8472|2824|G|ggG/ggC|rs2744380&COSV60939587||1||SNV|EntrezGene||YES|||G|G||||||0.7095|0.7026|0.6292|0.7523|0.7458|0.8141|0.6463|0.7567|0.6983|0.7106|0.7218|0.6908|0.6384|0.6941|0.7554|0.7524|0.7964|0.6493|0.7993|0.7001|0.7079|0.7252|0.8141|gnomADe_EAS|benign|0&1|1&1||||||||||||-38|-2|47|-1|0.00|0.00|0.00|0.00|DSP|||||||44967||Conflicting_classifications_of_pathogenicity|not_provided&Arrhythmogenic_cardiomyopathy_with_wooly_hair_and_keratoderma&Arrhythmogenic_right_ventricular_dysplasia_8&Cardiomyopathy&DSP-related_disorder&Keratosis_palmoplantaris_striata_2&Lethal_acantholytic_epidermolysis_bullosa&Woolly_hair-skin_fragility_syndrome&Cardiomyopathy&_dilated&_with_wooly_hair&_keratoderma&_and_tooth_agenesis&not_specified&Cardiovascular_phenotype|NC_000006.12:g.7585734G>C||single_nucleotide_variant|DSP:1832|MedGen:C3661900&MONDO:MONDO:0011581&MedGen:C1854063&OMIM:605676&Orphanet:65282&MONDO:MONDO:0011831&MedGen:C1843896&OMIM:607450&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&.&MONDO:MONDO:0013034&MedGen:C1852127&OMIM:612908&MONDO:MONDO:0012323&MedGen:C1864826&OMIM:609638&Orphanet:158687&MONDO:MONDO:0957307&MedGen:C1843292&OMIM:620415&Orphanet:293165&MONDO:MONDO:0014355&MedGen:C4014393&OMIM:615821&Orphanet:476096&Orphanet:65282&MedGen:CN169374&MedGen:CN230736|Uncertain_significance(1)&Benign(18)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,26:1:26:0,11:0,15:75:163,78,0:125.26,75.26,0:0,34.77,37.77:0,0,14,12:0,0,13,13	1/1:0,32:1:32:0,15:0,17:93:181,96,0:142.86,92.859,0:0,34.77,37.77:0,0,15,17:0,0,18,14	1/1:0,32:1:32:0,9:0,23:93:181,96,0:143.31,93.307,0:0,34.77,37.77:0,0,17,15:0,0,18,14	C	synonymous_variant	LOW	DSP	1832	Transcript	NM_004415.4	protein_coding	24/24		c.8472G>C	p.Gly2824%3D	8717	8472	2824	G	ggG/ggC	rs2744380&COSV60939587	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.7095	0.7026	0.6292	0.7523	0.7458	0.8141	0.6463	0.7567	0.6983	0.7106	0.7218	0.6908	0.6384	0.6941	0.7554	0.7524	0.7964	0.6493	0.7993	0.7001	0.7079	0.7252	0.8141	gnomADe_EAS	benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-38	-2	47	-1	0	0	0	0	DSP			NA				44967	NA	Conflicting_classifications_of_pathogenicity	not_provided&Arrhythmogenic_cardiomyopathy_with_wooly_hair_and_keratoderma&Arrhythmogenic_right_ventricular_dysplasia_8&Cardiomyopathy&DSP-related_disorder&Keratosis_palmoplantaris_striata_2&Lethal_acantholytic_epidermolysis_bullosa&Woolly_hair-skin_fragility_syndrome&Cardiomyopathy&_dilated&_with_wooly_hair&_keratoderma&_and_tooth_agenesis&not_specified&Cardiovascular_phenotype	NC_000006.12:g.7585734G>C		single_nucleotide_variant	DSP:1832	MedGen:C3661900&MONDO:MONDO:0011581&MedGen:C1854063&OMIM:605676&Orphanet:65282&MONDO:MONDO:0011831&MedGen:C1843896&OMIM:607450&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&.&MONDO:MONDO:0013034&MedGen:C1852127&OMIM:612908&MONDO:MONDO:0012323&MedGen:C1864826&OMIM:609638&Orphanet:158687&MONDO:MONDO:0957307&MedGen:C1843292&OMIM:620415&Orphanet:293165&MONDO:MONDO:0014355&MedGen:C4014393&OMIM:615821&Orphanet:476096&Orphanet:65282&MedGen:CN169374&MedGen:CN230736	Uncertain_significance(1)&Benign(18)	criteria_provided&_conflicting_classifications		DSP	Cardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesis	AD	615821	Cardiac and vascular disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs2744380	chr6_7585734_G_C	Female	01-Jan	Homozygous
chr6	7585734	.	G	C	143.31	PASS	"FS=0;MQ=250;QD=4.82;SOR=0.846;FractionInformativeReads=1;DP=90;AF=1;AN=6;AC=6;CSQ=C|synonymous_variant|LOW|DSP|1832|Transcript|NM_004415.4|protein_coding|24/24||NM_004415.4:c.8472G>C|NP_004406.2:p.Gly2824%3D|8717|8472|2824|G|ggG/ggC|rs2744380&COSV60939587||1||SNV|EntrezGene||YES|||G|G||||||0.7095|0.7026|0.6292|0.7523|0.7458|0.8141|0.6463|0.7567|0.6983|0.7106|0.7218|0.6908|0.6384|0.6941|0.7554|0.7524|0.7964|0.6493|0.7993|0.7001|0.7079|0.7252|0.8141|gnomADe_EAS|benign|0&1|1&1||||||||||||-38|-2|47|-1|0.00|0.00|0.00|0.00|DSP|||||||44967||Conflicting_classifications_of_pathogenicity|not_provided&Arrhythmogenic_cardiomyopathy_with_wooly_hair_and_keratoderma&Arrhythmogenic_right_ventricular_dysplasia_8&Cardiomyopathy&DSP-related_disorder&Keratosis_palmoplantaris_striata_2&Lethal_acantholytic_epidermolysis_bullosa&Woolly_hair-skin_fragility_syndrome&Cardiomyopathy&_dilated&_with_wooly_hair&_keratoderma&_and_tooth_agenesis&not_specified&Cardiovascular_phenotype|NC_000006.12:g.7585734G>C||single_nucleotide_variant|DSP:1832|MedGen:C3661900&MONDO:MONDO:0011581&MedGen:C1854063&OMIM:605676&Orphanet:65282&MONDO:MONDO:0011831&MedGen:C1843896&OMIM:607450&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&.&MONDO:MONDO:0013034&MedGen:C1852127&OMIM:612908&MONDO:MONDO:0012323&MedGen:C1864826&OMIM:609638&Orphanet:158687&MONDO:MONDO:0957307&MedGen:C1843292&OMIM:620415&Orphanet:293165&MONDO:MONDO:0014355&MedGen:C4014393&OMIM:615821&Orphanet:476096&Orphanet:65282&MedGen:CN169374&MedGen:CN230736|Uncertain_significance(1)&Benign(18)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,26:1:26:0,11:0,15:75:163,78,0:125.26,75.26,0:0,34.77,37.77:0,0,14,12:0,0,13,13	1/1:0,32:1:32:0,15:0,17:93:181,96,0:142.86,92.859,0:0,34.77,37.77:0,0,15,17:0,0,18,14	1/1:0,32:1:32:0,9:0,23:93:181,96,0:143.31,93.307,0:0,34.77,37.77:0,0,17,15:0,0,18,14	C	synonymous_variant	LOW	DSP	1832	Transcript	NM_004415.4	protein_coding	24/24		c.8472G>C	p.Gly2824%3D	8717	8472	2824	G	ggG/ggC	rs2744380&COSV60939587	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.7095	0.7026	0.6292	0.7523	0.7458	0.8141	0.6463	0.7567	0.6983	0.7106	0.7218	0.6908	0.6384	0.6941	0.7554	0.7524	0.7964	0.6493	0.7993	0.7001	0.7079	0.7252	0.8141	gnomADe_EAS	benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-38	-2	47	-1	0	0	0	0	DSP			NA				44967	NA	Conflicting_classifications_of_pathogenicity	not_provided&Arrhythmogenic_cardiomyopathy_with_wooly_hair_and_keratoderma&Arrhythmogenic_right_ventricular_dysplasia_8&Cardiomyopathy&DSP-related_disorder&Keratosis_palmoplantaris_striata_2&Lethal_acantholytic_epidermolysis_bullosa&Woolly_hair-skin_fragility_syndrome&Cardiomyopathy&_dilated&_with_wooly_hair&_keratoderma&_and_tooth_agenesis&not_specified&Cardiovascular_phenotype	NC_000006.12:g.7585734G>C		single_nucleotide_variant	DSP:1832	MedGen:C3661900&MONDO:MONDO:0011581&MedGen:C1854063&OMIM:605676&Orphanet:65282&MONDO:MONDO:0011831&MedGen:C1843896&OMIM:607450&Human_Phenotype_Ontology:HP:0001638&MONDO:MONDO:0004994&MedGen:C0878544&Orphanet:167848&.&MONDO:MONDO:0013034&MedGen:C1852127&OMIM:612908&MONDO:MONDO:0012323&MedGen:C1864826&OMIM:609638&Orphanet:158687&MONDO:MONDO:0957307&MedGen:C1843292&OMIM:620415&Orphanet:293165&MONDO:MONDO:0014355&MedGen:C4014393&OMIM:615821&Orphanet:476096&Orphanet:65282&MedGen:CN169374&MedGen:CN230736	Uncertain_significance(1)&Benign(18)	criteria_provided&_conflicting_classifications		DSP	Arrhythmogenic cardiomyopathy with wooly hair and keratoderma	AR	605676	Cardiac and vascular disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs2744380	chr6_7585734_G_C	Female	01-Jan	Homozygous
chr6	26092952	.	T	C	50	PASS	"FS=5.783;MQ=250;MQRankSum=6.01;QD=1;ReadPosRankSum=2.023;SOR=0.51;FractionInformativeReads=1;R2_5P_bias=-3.751;DP=50;AF=0.5;AN=2;AC=1;CSQ=C|missense_variant|MODERATE|HFE|3077|Transcript|NM_000410.4|protein_coding|4/6||NM_000410.4:c.884T>C|NP_000401.1:p.Val295Ala|896|884|295|V/A|gTg/gCg|rs143175221&HM030028||1||SNV|EntrezGene||YES|||T|T|||tolerated(1)|benign(0.001)||0.0016|0.0003975|2.987e-05|0.0009167|3.826e-05|0.001889|0|0.0007065|0.0002725|0.000414|0.001519|0.0006041|7.216e-05|0|0.002747|0|0.004247|0|0|0.0002793|0.0009461|0.0008282|0.004247|gnomADg_EAS|likely_benign&conflicting_interpretations_of_pathogenicity&uncertain_significance|0&1|1&1||||T|0.10378|-0.282758|T|0.56746|-0.177572|0.53644|0.234&0.234&0.234&0.234&0.234&0.234&0.234&0.234&0.234&0.234&0.234|8|-35|8|-35|0.00|0.00|0.02|0.07|HFE|likely_benign|hg38|0.1383|V295A|ENST00000357618.9|Q30201|461195||Conflicting_classifications_of_pathogenicity|not_provided&Hereditary_hemochromatosis&Hemochromatosis_type_1&HFE-related_disorder|NC_000006.12:g.26092952T>C||single_nucleotide_variant|HFE:3077|MedGen:C3661900&MONDO:MONDO:0006507&MedGen:C0392514&OMIM:PS235200&MONDO:MONDO:0021001&MedGen:C3469186&OMIM:235200&Orphanet:139498&Orphanet:465508&.|Uncertain_significance(3)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:22,28:0.56:50:10,19:12,9:48:85,0,48:50,7.507e-05,51.385:0,34.77,37.77:8,14,15,13:14,8,14,14	C	missense_variant	MODERATE	HFE	3077	Transcript	NM_000410.4	protein_coding	06-Apr		c.884T>C	p.Val295Ala	896	884	295	V/A	gTg/gCg	rs143175221&HM030028	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	tolerated(1)	benign(0.001)	NA	0.0016	0.0003975	2.987e-05	0.0009167	3.826e-05	0.001889	0	0.0007065	0.0002725	0.000414	0.001519	0.0006041	7.216e-05	0	0.002747	0	0.004247	0	0	0.0002793	0.0009461	0.0008282	0.004247	gnomADg_EAS	likely_benign&conflicting_interpretations_of_pathogenicity&uncertain_significance	0&1	1&1	NA	NA	NA	T	0.10378	-0.282758	T	0.56746	-0.177572	0.53644	0.234&0.234&0.234&0.234&0.234&0.234&0.234&0.234&0.234&0.234&0.234	8	-35	8	-35	0	0	0.02	0.07	HFE	likely_benign	hg38	0.1383	V295A	ENST00000357618.9	Q30201	461195	NA	Conflicting_classifications_of_pathogenicity	not_provided&Hereditary_hemochromatosis&Hemochromatosis_type_1&HFE-related_disorder	NC_000006.12:g.26092952T>C		single_nucleotide_variant	HFE:3077	MedGen:C3661900&MONDO:MONDO:0006507&MedGen:C0392514&OMIM:PS235200&MONDO:MONDO:0021001&MedGen:C3469186&OMIM:235200&Orphanet:139498&Orphanet:465508&.	Uncertain_significance(3)&Likely_benign(3)	criteria_provided&_conflicting_classifications		HFE	Hemochromatosis type 1	AR	235200	Inherited disorders of metabolism	NBScreening	-9	Benign	BP4_Strong,BP6,BS1	rs143175221	chr6_26092952_T_C	Female	./.	Other
chr6	35823388	.	TAC	T	49.86	PASS	"FS=0;MQ=221.33;MQRankSum=-0.794;QD=1.92;ReadPosRankSum=-0.794;SOR=0.818;FractionInformativeReads=0.75;R2_5P_bias=17.093;DP=36;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|LHFPL5|222662|Transcript|NM_182548.4|protein_coding|4/4||NM_182548.4:c.*459_*460del||1403-1404|||||rs67626900||1||deletion|EntrezGene||YES|||AC|AC|||||35||0.201|0.1667|0.6667|0.5|0.4|0||0.1667|0.25|0.5|0.2887|0.2635|0.2696|0.3699|0.3397|0.4486|0.2771|0.2273|0.2706|0.2954|0.2556|0.6667|gnomADe_AMR|||1||||||||||||22|44|-37|27|0.00|0.00|0.00|0.00|LHFPL5|||||||356504||Uncertain_significance|Hearing_loss&_autosomal_recessive|NC_000006.12:g.35823390CA[17]||Microsatellite|LHFPL5:222662|MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,3:0.2:15:7,0:5,3:38:41,0,47:38.386,0.00067335,50.001:0,3,6.01:7,5,2,1:6,6,1,2	0/1:6,6:0.5:12:4,2:2,4:47:53,0,47:49.856,8.8272e-05,50:0,3,6.01:3,3,3,3:5,1,3,3	./.:.:.:.:.:.:.:.:.:.:.:.	-	3_prime_UTR_variant	MODIFIER	LHFPL5	222662	Transcript	NM_182548.4	protein_coding	04-Apr		c.*459_*460del		1403-1404					rs67626900	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	AC	AC	NA	NA			35	NA	0.201	0.1667	0.6667	0.5	0.4	0	NA	0.1667	0.25	0.5	0.2887	0.2635	0.2696	0.3699	0.3397	0.4486	0.2771	0.2273	0.2706	0.2954	0.2556	0.6667	gnomADe_AMR			1	NA	NA	NA		NA	NA		NA	NA	NA		22	44	-37	27	0	0	0	0	LHFPL5			NA				356504	NA	Uncertain_significance	Hearing_loss&_autosomal_recessive	NC_000006.12:g.35823390CA[17]		Microsatellite	LHFPL5:222662	MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636		criteria_provided&_single_submitter		LHFPL5	Autosomal recessive nonsyndromic hearing loss 67	AR	610265	Hearing disorders	NBScreening	-8	Benign	BA1	rs67626900	chr6_35823388_TAC_T	Female	0/1	Heterozygous
chr6	35823440	.	CAT	C	50	PASS	"FS=4.398;MQ=207.32;MQRankSum=0.386;QD=1.79;ReadPosRankSum=0.643;SOR=0.157;FractionInformativeReads=0.964;R2_5P_bias=-19.239;DP=79;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|LHFPL5|222662|Transcript|NM_182548.4|protein_coding|4/4||NM_182548.4:c.*483_*484del||1455-1456|||||rs879430131||1||deletion|EntrezGene||YES|||AT|AT|||||7||0.01397|0|0.07692|0|0|0|0|0.01175|0|0.1|0.3074|0.3095|0.2454|0.2857|0.3592|0.1516|0.3185|0.3307|0.31|0.3042|0.4426|0.4426|gnomADg_SAS|||1||||||||||||-32|-16|31|29|0.00|0.00|0.00|0.00|LHFPL5|||||||356516||Uncertain_significance|Hearing_loss&_autosomal_recessive&not_provided|NC_000006.12:g.35823442TA[3]||Microsatellite|LHFPL5:222662|MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	0|1:9,18:0.667:27:2,12:7,6:46:80,0,45:50,0.00011494,47.829:0,30,33.01:8,1,12,6:3,6,10,8:35823440	0|1:11,13:0.542:24:5,7:6,6:47:79,0,46:50,9.2414e-05,49.487:0,29,32.01:9,2,7,6:5,6,11,2:35823440	0|1:12,8:0.4:20:7,3:5,5:47:79,0,47:49.922,8.7754e-05,50:0,29,32.01:9,3,4,4:6,6,5,3:35823440	-	3_prime_UTR_variant	MODIFIER	LHFPL5	222662	Transcript	NM_182548.4	protein_coding	04-Apr		c.*483_*484del		1455-1456					rs879430131	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	AT	AT	NA	NA			7	NA	0.01397	0	0.07692	0	0	0	0	0.01175	0	0.1	0.3074	0.3095	0.2454	0.2857	0.3592	0.1516	0.3185	0.3307	0.31	0.3042	0.4426	0.4426	gnomADg_SAS			1	NA	NA	NA		NA	NA		NA	NA	NA		-32	-16	31	29	0	0	0	0	LHFPL5			NA				356516	NA	Uncertain_significance	Hearing_loss&_autosomal_recessive&not_provided	NC_000006.12:g.35823442TA[3]		Microsatellite	LHFPL5:222662	MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		LHFPL5	Autosomal recessive nonsyndromic hearing loss 67	AR	610265	Hearing disorders	NBScreening	-8	Benign	BA1	rs879430131	chr6_35823440_CAT_C	Female	0|1	Heterozygous
chr6	35823448	.	T	TAC	49.49	PASS	"FS=6.69;MQ=208.69;MQRankSum=1.303;QD=1.65;ReadPosRankSum=-1.584;SOR=3.215;FractionInformativeReads=0.724;R2_5P_bias=9.679;DP=56;AF=0.5;AN=4;AC=2;CSQ=AC|3_prime_UTR_variant|MODIFIER|LHFPL5|222662|Transcript|NM_182548.4|protein_coding|4/4||NM_182548.4:c.*512_*513dup||1462-1463|||||rs70975109||1||insertion|EntrezGene||YES|||||||||30||0.02094|0|0|0|0|0||0.02516|0|0|0.1114|0.03913|0.1021|0.1295|0.1722|0.06969|0.09396|0.1524|0.1507|0.1514|0.1008|0.1722|gnomADg_ASJ|||1|||||||||||||||||||||||||||356522||Uncertain_significance|Hearing_loss&_autosomal_recessive&not_provided|NC_000006.12:g.35823449AC[16]||Microsatellite|LHFPL5:222662|MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,10:0.476:21:6,3:5,7:46:52,0,47:47.829,0.00011494,50:0,4,7.01:8,3,10,0:5,6,3,7	0/1:10,13:0.565:23:7,5:3,8:47:53,0,47:49.487,9.2414e-05,50:0,4,7.01:7,3,11,2:8,2,5,8	./.:.:.:.:.:.:.:.:.:.:.:.	AC	3_prime_UTR_variant	MODIFIER	LHFPL5	222662	Transcript	NM_182548.4	protein_coding	04-Apr		c.*512_*513dup		1462-1463					rs70975109	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			30	NA	0.02094	0	0	0	0	0	NA	0.02516	0	0	0.1114	0.03913	0.1021	0.1295	0.1722	0.06969	0.09396	0.1524	0.1507	0.1514	0.1008	0.1722	gnomADg_ASJ			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				356522	NA	Uncertain_significance	Hearing_loss&_autosomal_recessive&not_provided	NC_000006.12:g.35823449AC[16]		Microsatellite	LHFPL5:222662	MONDO:MONDO:0019588&MedGen:C1846647&OMIM:607197&OMIM:PS220290&Orphanet:90635&Orphanet:90636&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		LHFPL5	Autosomal recessive nonsyndromic hearing loss 67	AR	610265	Hearing disorders	NBScreening	-8	Benign	BA1	rs70975109	chr6_35823448_T_TAC	Female	0/1	Heterozygous
chr6	42963889	.	GTTTA	G	50	PASS	"FS=0;MQ=250;MQRankSum=4.096;QD=1.65;ReadPosRankSum=-0.916;SOR=0.714;FractionInformativeReads=0.963;R2_5P_bias=-10.122;DP=73;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|PEX6|5190|Transcript|NM_000287.4|protein_coding|17/17||NM_000287.4:c.*442_*445del||3416-3419|||||rs144286892||-1||deletion|EntrezGene||YES|||TTTA|TTTA||||||0.6474|0.5727|0.9184|0.5473|0.5051|0.3599|0.5005|0.6168|0.5761|0.5928|0.645|0.6587|0.9162|0.6826|0.583|0.5087|0.3234|0.5061|0.581|0.5796|0.6463|0.6385|0.9788|AFR|uncertain_significance&benign&pathogenic||1||||||||||||-15|50|-15|-23|0.06|0.00|0.00|0.00|PEX6|||||||356786||Conflicting_classifications_of_pathogenicity|Peroxisome_biogenesis_disorder_1A_(Zellweger)&not_provided&not_specified&PEX6_POLYMORPHISM|NC_000006.12:g.42963891TTAT[1]|2627659:Pathogenic|Microsatellite|PEX6:5190&GNMT:27232|MONDO:MONDO:0008953&MedGen:C4721541&OMIM:214100&MedGen:C3661900&MedGen:CN169374&.|Uncertain_significance(1)&Benign(4)|criteria_provided&_conflicting_classifications|Peroxisome_biogenesis_disorder_4B"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,9:0.346:26:9,4:8,5:44:74,0,50:44.581,0.00017292,53:0,29,32:6,11,3,6:8,9,4,5	0/1:11,6:0.353:17:3,2:8,4:46:76,0,50:46.8,0.00011261,53:0,29,32:3,8,1,5:7,4,3,3	0/1:11,12:0.522:23:7,6:4,6:48:79,0,50:50,6.5751e-05,52.898:0,29,32:5,6,3,9:3,8,7,5	-	3_prime_UTR_variant	MODIFIER	PEX6	5190	Transcript	NM_000287.4	protein_coding	17/17		c.*442_*445del		3416-3419					rs144286892	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	TTTA	TTTA	NA	NA			NA	0.6474	0.5727	0.9184	0.5473	0.5051	0.3599	0.5005	0.6168	0.5761	0.5928	0.645	0.6587	0.9162	0.6826	0.583	0.5087	0.3234	0.5061	0.581	0.5796	0.6463	0.6385	0.9788	AFR	uncertain_significance&benign&pathogenic		1	NA	NA	NA		NA	NA		NA	NA	NA		-15	50	-15	-23	0.06	0	0	0	PEX6			NA				356786	NA	Conflicting_classifications_of_pathogenicity	Peroxisome_biogenesis_disorder_1A_(Zellweger)&not_provided&not_specified&PEX6_POLYMORPHISM	NC_000006.12:g.42963891TTAT[1]	2627659:Pathogenic	Microsatellite	PEX6:5190&GNMT:27232	MONDO:MONDO:0008953&MedGen:C4721541&OMIM:214100&MedGen:C3661900&MedGen:CN169374&.	Uncertain_significance(1)&Benign(4)	criteria_provided&_conflicting_classifications	Peroxisome_biogenesis_disorder_4B	PEX6	Peroxisome biogenesis disorder 4A (Zellweger)	AR	614862	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs144286892	chr6_42963889_GTTTA_G	Female	0/1	Heterozygous
chr6	42963889	.	GTTTA	G	50	PASS	"FS=0;MQ=250;MQRankSum=4.096;QD=1.65;ReadPosRankSum=-0.916;SOR=0.714;FractionInformativeReads=0.963;R2_5P_bias=-10.122;DP=73;AF=0.5;AN=6;AC=3;CSQ=-|3_prime_UTR_variant|MODIFIER|PEX6|5190|Transcript|NM_000287.4|protein_coding|17/17||NM_000287.4:c.*442_*445del||3416-3419|||||rs144286892||-1||deletion|EntrezGene||YES|||TTTA|TTTA||||||0.6474|0.5727|0.9184|0.5473|0.5051|0.3599|0.5005|0.6168|0.5761|0.5928|0.645|0.6587|0.9162|0.6826|0.583|0.5087|0.3234|0.5061|0.581|0.5796|0.6463|0.6385|0.9788|AFR|uncertain_significance&benign&pathogenic||1||||||||||||-15|50|-15|-23|0.06|0.00|0.00|0.00|PEX6|||||||356786||Conflicting_classifications_of_pathogenicity|Peroxisome_biogenesis_disorder_1A_(Zellweger)&not_provided&not_specified&PEX6_POLYMORPHISM|NC_000006.12:g.42963891TTAT[1]|2627659:Pathogenic|Microsatellite|PEX6:5190&GNMT:27232|MONDO:MONDO:0008953&MedGen:C4721541&OMIM:214100&MedGen:C3661900&MedGen:CN169374&.|Uncertain_significance(1)&Benign(4)|criteria_provided&_conflicting_classifications|Peroxisome_biogenesis_disorder_4B"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,9:0.346:26:9,4:8,5:44:74,0,50:44.581,0.00017292,53:0,29,32:6,11,3,6:8,9,4,5	0/1:11,6:0.353:17:3,2:8,4:46:76,0,50:46.8,0.00011261,53:0,29,32:3,8,1,5:7,4,3,3	0/1:11,12:0.522:23:7,6:4,6:48:79,0,50:50,6.5751e-05,52.898:0,29,32:5,6,3,9:3,8,7,5	-	3_prime_UTR_variant	MODIFIER	PEX6	5190	Transcript	NM_000287.4	protein_coding	17/17		c.*442_*445del		3416-3419					rs144286892	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	TTTA	TTTA	NA	NA			NA	0.6474	0.5727	0.9184	0.5473	0.5051	0.3599	0.5005	0.6168	0.5761	0.5928	0.645	0.6587	0.9162	0.6826	0.583	0.5087	0.3234	0.5061	0.581	0.5796	0.6463	0.6385	0.9788	AFR	uncertain_significance&benign&pathogenic		1	NA	NA	NA		NA	NA		NA	NA	NA		-15	50	-15	-23	0.06	0	0	0	PEX6			NA				356786	NA	Conflicting_classifications_of_pathogenicity	Peroxisome_biogenesis_disorder_1A_(Zellweger)&not_provided&not_specified&PEX6_POLYMORPHISM	NC_000006.12:g.42963891TTAT[1]	2627659:Pathogenic	Microsatellite	PEX6:5190&GNMT:27232	MONDO:MONDO:0008953&MedGen:C4721541&OMIM:214100&MedGen:C3661900&MedGen:CN169374&.	Uncertain_significance(1)&Benign(4)	criteria_provided&_conflicting_classifications	Peroxisome_biogenesis_disorder_4B	PEX6	Heimler syndrome 2	AR	616617	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs144286892	chr6_42963889_GTTTA_G	Female	0/1	Heterozygous
chr6	43037713	.	G	A	50	PASS	"FS=3.556;MQ=246.68;MQRankSum=4.433;QD=1.79;ReadPosRankSum=0.812;SOR=1.609;FractionInformativeReads=1;R2_5P_bias=4.171;DP=102;AF=0.5;AN=6;AC=3;CSQ=A|missense_variant|MODERATE|CUL7|9820|Transcript|NM_014780.5|protein_coding|26/26||NM_014780.5:c.5072C>T|NP_055595.2:p.Thr1691Ile|5310|5072|1691|T/I|aCc/aTc|rs140092102||-1||SNV|EntrezGene||YES|||G|G|||deleterious(0.02)|possibly_damaging(0.899)|||0.0001378|0|5.502e-05|0|0|4.004e-05|0|0.0001624|0.0001542|6.258e-05|9.857e-05|2.413e-05|0|0|0|0|9.413e-05|0|0.0001764|0|0.0002069|0.0002069|gnomADg_SAS|uncertain_significance||1||||T|0.34428|-0.112052|T|0.59205|-0.150422|0.74935|0.448&0.448|40|-44|-21|28|0.00|0.00|0.00|0.00|CUL7|likely_benign|hg38|0.2022|T1691I|ENST00000265348.7|Q14999|356814||Uncertain_significance|3M_syndrome_1&not_provided|NC_000006.12:g.43037713G>A||single_nucleotide_variant|CUL7:9820|MONDO:MONDO:0010117&MedGen:C2678312&OMIM:273750&Orphanet:2616&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:12,16:0.571:28:7,9:5,7:48:85,0,49:50,7.2481e-05,51.756:0,34.77,37.77:6,6,5,11:5,7,4,12	0/1:17,23:0.575:40:10,7:7,16:47:85,0,48:50,7.7659e-05,51.04:0,34.77,37.77:3,14,7,16:8,9,17,6	0/1:17,17:0.5:34:7,10:10,7:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:5,12,6,11:9,8,5,12	A	missense_variant	MODERATE	CUL7	9820	Transcript	NM_014780.5	protein_coding	26/26		c.5072C>T	p.Thr1691Ile	5310	5072	1691	T/I	aCc/aTc	rs140092102	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0.02)	possibly_damaging(0.899)	NA	NA	0.0001378	0	5.502e-05	0	0	4.004e-05	0	0.0001624	0.0001542	6.258e-05	9.857e-05	2.413e-05	0	0	0	0	9.413e-05	0	0.0001764	0	0.0002069	0.0002069	gnomADg_SAS	uncertain_significance		1	NA	NA	NA	T	0.34428	-0.112052	T	0.59205	-0.150422	0.74935	0.448&0.448	40	-44	-21	28	0	0	0	0	CUL7	likely_benign	hg38	0.2022	T1691I	ENST00000265348.7	Q14999	356814	NA	Uncertain_significance	3M_syndrome_1&not_provided	NC_000006.12:g.43037713G>A		single_nucleotide_variant	CUL7:9820	MONDO:MONDO:0010117&MedGen:C2678312&OMIM:273750&Orphanet:2616&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		CUL7	3-M syndrome 1	AR	273750	Complex genetic syndromes	NBScreening	0	Uncertain_significance		rs140092102	chr6_43037713_G_A	Female	0/1	Heterozygous
chr6	52493365	.	C	CATAT	205.42	PASS	"FS=0;MQ=246.7;MQRankSum=3.788;QD=1.67;ReadPosRankSum=0.307;SOR=0.976;FractionInformativeReads=0.733;R2_5P_bias=3.216;DP=82;AF=0.5;AN=6;AC=3;CSQ=ATAT|3_prime_UTR_variant|MODIFIER|EFHC1|114327|Transcript|NM_018100.4|protein_coding|11/11||NM_018100.4:c.*1041_*1044dup||3016-3017|||||rs59794069||1||insertion|EntrezGene||YES|||||||||20|0.2416|0.03554|0.01619|0.02276|0.07354|0.06506|0.01267|0.03457|0.03452|0.03162|0.04036|0.2123|0.2652|0.1268|0.1615|0.2298|0.5383|0.1238|0.2865|0.1701|0.1839|0.2895|0.5383|gnomADg_EAS|||1|||||||||||||||||||||||||||357501||Conflicting_classifications_of_pathogenicity|Juvenile_myoclonic_epilepsy|NC_000006.12:g.52493366AT[12]||Microsatellite|EFHC1:114327|MONDO:MONDO:0009696&MedGen:C0270853&OMIM:PS254770&Orphanet:307|Uncertain_significance(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:8,14:0.636:22:3,6:5,8:47:57,0,46:50,9.6297e-05,49.139:0,7,10:4,4,6,8:3,5,8,6	1/0:0,11:0.733:15:0,8:0,3:43:219,162,48:205.42,155.42,43.791:0,7,10:0,0,4,11:0,0,5,10	0/1:12,13:0.52:25:9,8:3,5:47:58,0,47:50,8.7754e-05,49.923:0,8,11.01:3,9,7,6:4,8,8,5	ATAT	3_prime_UTR_variant	MODIFIER	EFHC1	114327	Transcript	NM_018100.4	protein_coding	11-Nov		c.*1041_*1044dup		3016-3017					rs59794069	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			20	0.2416	0.03554	0.01619	0.02276	0.07354	0.06506	0.01267	0.03457	0.03452	0.03162	0.04036	0.2123	0.2652	0.1268	0.1615	0.2298	0.5383	0.1238	0.2865	0.1701	0.1839	0.2895	0.5383	gnomADg_EAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				357501	NA	Conflicting_classifications_of_pathogenicity	Juvenile_myoclonic_epilepsy	NC_000006.12:g.52493366AT[12]		Microsatellite	EFHC1:114327	MONDO:MONDO:0009696&MedGen:C0270853&OMIM:PS254770&Orphanet:307	Uncertain_significance(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		EFHC1	Myoclonic epilepsy	AD	612437	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-9	Benign	BP6,BA1	rs59794069	chr6_52493365_C_CATAT	Female	0/1	Heterozygous
chr6	131884939	.	C	T	50	PASS	"FS=3.471;MQ=250;MQRankSum=4.476;QD=1.67;ReadPosRankSum=1.291;SOR=0.774;FractionInformativeReads=1;R2_5P_bias=19.572;DP=68;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|ENPP1|5167|Transcript|NM_006208.3|protein_coding|23/25||NM_006208.3:c.2320C>T|NP_006199.2:p.Arg774Cys|2336|2320|774|R/C|Cgc/Tgc|rs28933977&CM031974||1||SNV|EntrezGene||YES|||C|C|||deleterious(0.01)|possibly_damaging(0.803)||0.0188|0.03445|0.0046|0.0119|0.01343|0.0002268|0.09708|0.02479|0.0347|0.0319|0.04021|0.02823|0.00556|0.09868|0.01466|0.01067|0.0005789|0.09252|0.02041|0.03662|0.03078|0.03548|0.09868|gnomADg_AMI|benign/likely_benign&uncertain_significance&likely_benign&benign|0&1|1&1||||T|0.02904|-0.384824|T|0.46103|-0.28682|0.56959|0.258&.|-4|-8|-2|28|0.00|0.01|0.00|0.00|ENPP1|likely_benign|hg38|0.1058|R774C|ENST00000647893.1|P22413|13586||Conflicting_classifications_of_pathogenicity|not_provided&Type_2_diabetes_mellitus&Arterial_calcification&_generalized&_of_infancy&_1&Hypophosphatemic_rickets&_autosomal_recessive&_2&not_specified|NC_000006.12:g.131884939C>T||single_nucleotide_variant|ENPP1:5167|MedGen:C3661900&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MONDO:MONDO:0008817&MedGen:C4551985&OMIM:208000&Orphanet:51608&MONDO:MONDO:0013219&MedGen:C2750078&OMIM:613312&Orphanet:289176&MedGen:CN169374|Uncertain_significance(1)&Benign(3)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:11,19:0.633:30:5,5:6,14:46:85,0,46:50,0.00010225,48.684:0,34.77,37.77:4,7,11,8:4,7,9,10	0/1:17,21:0.553:38:12,13:5,8:48:85,0,49:50,6.9375e-05,52.25:0,34.77,37.77:9,8,12,9:8,9,10,11	T	missense_variant	MODERATE	ENPP1	5167	Transcript	NM_006208.3	protein_coding	23/25		c.2320C>T	p.Arg774Cys	2336	2320	774	R/C	Cgc/Tgc	rs28933977&CM031974	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious(0.01)	possibly_damaging(0.803)	NA	0.0188	0.03445	0.0046	0.0119	0.01343	0.0002268	0.09708	0.02479	0.0347	0.0319	0.04021	0.02823	0.00556	0.09868	0.01466	0.01067	0.0005789	0.09252	0.02041	0.03662	0.03078	0.03548	0.09868	gnomADg_AMI	benign/likely_benign&uncertain_significance&likely_benign&benign	0&1	1&1	NA	NA	NA	T	0.02904	-0.384824	T	0.46103	-0.28682	0.56959	0.258&.	-4	-8	-2	28	0	0.01	0	0	ENPP1	likely_benign	hg38	0.1058	R774C	ENST00000647893.1	P22413	13586	NA	Conflicting_classifications_of_pathogenicity	not_provided&Type_2_diabetes_mellitus&Arterial_calcification&_generalized&_of_infancy&_1&Hypophosphatemic_rickets&_autosomal_recessive&_2&not_specified	NC_000006.12:g.131884939C>T		single_nucleotide_variant	ENPP1:5167	MedGen:C3661900&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MONDO:MONDO:0008817&MedGen:C4551985&OMIM:208000&Orphanet:51608&MONDO:MONDO:0013219&MedGen:C2750078&OMIM:613312&Orphanet:289176&MedGen:CN169374	Uncertain_significance(1)&Benign(3)&Likely_benign(3)	criteria_provided&_conflicting_classifications		ENPP1	Arterial calcification, generalized, of infancy, 1	AR	208000	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs28933977	chr6_131884939_C_T	Female	./.	Other
chr6	131893949	.	CT	C	69.25	PASS	"FS=0;MQ=216.09;MQRankSum=-1.393;QD=3.15;ReadPosRankSum=0.348;SOR=4.608;FractionInformativeReads=0.455;R2_5P_bias=0;DP=22;AF=1;AN=2;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|ENPP1|5167|Transcript|NM_006208.3|protein_coding|25/25||NM_006208.3:c.*3468del||6233|||||rs564304453||1||deletion|EntrezGene||YES|||T|T|||||29||0|||||||0|||0.1187|0.04358|0.1107|0.08023|0.1396|0.0622|0.01087|0.01471|0.1684|0.1062|0.05835|0.1684|gnomADg_NFE|uncertain_significance||1||||||||||||33|49|3|33|0.00|0.00|0.00|0.00|ENPP1|||||||355416||Uncertain_significance|Arterial_calcification&_generalized&_of_infancy&_1&Hypophosphatemic_Rickets&_Recessive|NC_000006.12:g.131893979del||Deletion|ENPP1:5167|MONDO:MONDO:0008817&MedGen:C4551985&OMIM:208000&Orphanet:51608&MedGen:CN239452||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:1,9:0.9:10:0,3:1,6:19:77,22,0:69.251,19.251,0.051912:0,5,8.01:1,0,0,9:0,1,6,3	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	-	3_prime_UTR_variant	MODIFIER	ENPP1	5167	Transcript	NM_006208.3	protein_coding	25/25		c.*3468del		6233					rs564304453	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			29	NA	0	NA	NA	NA	NA	NA	NA	0	NA	NA	0.1187	0.04358	0.1107	0.08023	0.1396	0.0622	0.01087	0.01471	0.1684	0.1062	0.05835	0.1684	gnomADg_NFE	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		33	49	3	33	0	0	0	0	ENPP1			NA				355416	NA	Uncertain_significance	Arterial_calcification&_generalized&_of_infancy&_1&Hypophosphatemic_Rickets&_Recessive	NC_000006.12:g.131893979del		Deletion	ENPP1:5167	MONDO:MONDO:0008817&MedGen:C4551985&OMIM:208000&Orphanet:51608&MedGen:CN239452		criteria_provided&_single_submitter		ENPP1	Arterial calcification, generalized, of infancy, 1	AR	208000	Cardiac and vascular disorders	NBScreening	0	Uncertain_significance		rs564304453	chr6_131893949_CT_C	Female	01-Jan	Homozygous
chr6	144188708	.	T	TA	50	PASS	"FS=0;MQ=241.61;MQRankSum=1.078;QD=1.72;ReadPosRankSum=0.539;SOR=0.619;FractionInformativeReads=0.897;R2_5P_bias=12.676;DP=29;AF=0.5;AN=2;AC=1;CSQ=A|3_prime_UTR_variant|MODIFIER|STX11|8676|Transcript|NM_003764.4|protein_coding|2/2||NM_003764.4:c.*1221dup||2273-2274|||||rs397725572||1||insertion|EntrezGene||YES|||||||||4|0.5583|||||||||||0.5018|0.8102|0.378|0.3393|0.4099|0.6088|0.3293|0.4388|0.3902|0.4736|0.395|0.8918|AFR|uncertain_significance||1|||||||||||||||||||||||||||355616||Conflicting_classifications_of_pathogenicity|Familial_hemophagocytic_lymphohistiocytosis|NC_000006.12:g.144188712dup||Duplication|STX11:8676|MONDO:MONDO:0015541&MedGen:C0272199&OMIM:PS267700&Orphanet:158038&Orphanet:540|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:9,17:0.654:26:6,10:3,7:46:79,0,45:50,0.00011908,47.585:0,29,32:5,4,9,8:4,5,6,11	./.:.:.:.:.:.:.:.:.:.:.:.	A	3_prime_UTR_variant	MODIFIER	STX11	8676	Transcript	NM_003764.4	protein_coding	02-Feb		c.*1221dup		2273-2274					rs397725572	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			4	0.5583	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.5018	0.8102	0.378	0.3393	0.4099	0.6088	0.3293	0.4388	0.3902	0.4736	0.395	0.8918	AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				355616	NA	Conflicting_classifications_of_pathogenicity	Familial_hemophagocytic_lymphohistiocytosis	NC_000006.12:g.144188712dup		Duplication	STX11:8676	MONDO:MONDO:0015541&MedGen:C0272199&OMIM:PS267700&Orphanet:158038&Orphanet:540	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		STX11	Familial hemophagocytic lymphohistiocytosis 4	AR	603552	Autoimmune, inflammatory, and immunogenetic disorders	NBScreening	-9	Benign	BP6,BA1	rs397725572	chr6_144188708_T_TA	Female	./.	Other
chr7	16089315	.	C	T	49.91	PASS	"FS=3.976;MQ=144.12;MQRankSum=-1.631;QD=2.17;ReadPosRankSum=-0.154;SOR=0.197;FractionInformativeReads=1;R2_5P_bias=19.935;DP=23;AF=0.5;AN=2;AC=1;CSQ=T|3_prime_UTR_variant|MODIFIER|CRPPA|729920|Transcript|NM_001101426.4|protein_coding|10/10||NM_001101426.4:c.*2380G>A||3952|||||rs28444529||-1||SNV|EntrezGene||YES|||C|C||||||0.3325|0.3627|0.08515|0.254|0.1386|0.31|0.3894|0.2635|0.3677|0.3359|0.4915|0.3346|0.1319|0.262|0.3351|0.2456|0.306|0.4585|0.364|0.4154|0.3268|0.5614|0.5951|SAS|uncertain_significance||1|||||||||||||||||||||||||||359521||Uncertain_significance|Congenital_Muscular_Dystrophy&_alpha-dystroglycan_related&not_provided|NC_000007.14:g.16089315C>T||single_nucleotide_variant|CRPPA:729920|MedGen:CN239202&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	./.:.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.:.	0|1:12,11:0.478:23:6,8:6,3:48:85,0,50:49.906,6.601e-05,53:0,34.77,37.77:3,9,5,6:5,7,4,7:16089315	T	3_prime_UTR_variant	MODIFIER	CRPPA	729920	Transcript	NM_001101426.4	protein_coding	10-Oct		c.*2380G>A		3952					rs28444529	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.3325	0.3627	0.08515	0.254	0.1386	0.31	0.3894	0.2635	0.3677	0.3359	0.4915	0.3346	0.1319	0.262	0.3351	0.2456	0.306	0.4585	0.364	0.4154	0.3268	0.5614	0.5951	SAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				359521	NA	Uncertain_significance	Congenital_Muscular_Dystrophy&_alpha-dystroglycan_related&not_provided	NC_000007.14:g.16089315C>T		single_nucleotide_variant	CRPPA:729920	MedGen:CN239202&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		CRPPA	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	AR	614643	Neuromuscular and musculoskelettal disorders	NBScreening	-10	Benign	BP4_Moderate,BA1	rs28444529	chr7_16089315_C_T	Female	./.	Other
chr7	16090549	.	C	CA	269.5	PASS	"FS=1.918;MQ=218.63;MQRankSum=-3.37;QD=2;ReadPosRankSum=0.409;SOR=1.371;FractionInformativeReads=0.92;R2_5P_bias=-15.296;DP=83;AF=0.5;AN=6;AC=1;CSQ=A|3_prime_UTR_variant|MODIFIER|CRPPA|729920|Transcript|NM_001101426.4|protein_coding|10/10||NM_001101426.4:c.*1145dup||2717-2718|||||rs56034283||-1||insertion|EntrezGene||YES|||||||||||0.25|||||||0.25|||0.344|0.2802|0.2287|0.3247|0.2589|0.316|0.4107|0.3113|0.3731|0.3154|0.4814|0.4814|gnomADg_SAS|uncertain_significance||1|||||||||||||||||||||||||||359562||Uncertain_significance|Congenital_Muscular_Dystrophy&_alpha-dystroglycan_related|NC_000007.14:g.16090573dup||Duplication|CRPPA:729920|MedGen:CN239202||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:9,.:.:23:6,.:3,.:46:55,.,.:50,.,.:0,.,.:6,3,11,3:9,0,6,8	0/0:14,.:.:25:5,.:9,.:47:54,.,.:49.181,.,.:0,.,.:4,10,6,5:7,7,7,4	0/1:0,16:0.5:32:0,8:0,8:47:280,250,52:269.5,245.19,50:0,5,8.01:0,0,20,12:0,0,16,16	A	3_prime_UTR_variant	MODIFIER	CRPPA	729920	Transcript	NM_001101426.4	protein_coding	10-Oct		c.*1145dup		2717-2718					rs56034283	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.25	NA	NA	NA	NA	NA	NA	0.25	NA	NA	0.344	0.2802	0.2287	0.3247	0.2589	0.316	0.4107	0.3113	0.3731	0.3154	0.4814	0.4814	gnomADg_SAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				359562	NA	Uncertain_significance	Congenital_Muscular_Dystrophy&_alpha-dystroglycan_related	NC_000007.14:g.16090573dup		Duplication	CRPPA:729920	MedGen:CN239202		criteria_provided&_single_submitter		CRPPA	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	AR	614643	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs56034283	chr7_16090549_C_CA	Female	0/0	Other
chr7	16278234	.	T	TA	50	PASS	"FS=8.217;MQ=250;MQRankSum=4.933;QD=1.39;ReadPosRankSum=-2.172;SOR=2.179;FractionInformativeReads=0.972;R2_5P_bias=-14.096;DP=71;AF=0.5;AN=4;AC=2;CSQ=A|splice_polypyrimidine_tract_variant&intron_variant|LOW|CRPPA|729920|Transcript|NM_001101426.4|protein_coding||5/9|NM_001101426.4:c.836-9dup|||||||rs3839757||-1||insertion|EntrezGene||YES|||||||||||0.04123|0.158|0.04019|0.1747|0.03159|0.02544|0.08909|0.0345|0.05781|0.04409|0.0699|0.1606|0.03222|0.04418|0.1694|0.01922|0.01923|0.05517|0.02898|0.07328|0.03898|0.1747|gnomADe_ASJ|uncertain_significance&benign&likely_benign||1|||||||||||||||||||||||||||198120||Conflicting_classifications_of_pathogenicity|not_provided&Congenital_Muscular_Dystrophy&_alpha-dystroglycan_related&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2U&Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies)&_type_A&_7&not_specified|NC_000007.14:g.16278245dup||Duplication|CRPPA:729920|MedGen:C3661900&MedGen:CN239202&MONDO:MONDO:0014474&MedGen:C5190987&OMIM:616052&Orphanet:352479&MONDO:MONDO:0013835&MedGen:C3553330&OMIM:614643&Orphanet:899&MedGen:CN169374|Uncertain_significance(1)&Benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:14,21:0.6:35:8,9:6,12:47:62,0,47:50,8.7754e-05,49.921:0,12,15:6,8,4,17:6,8,12,9	0/1:17,17:0.5:34:10,10:7,7:48:62,0,50:50,6.5233e-05,53:0,12,15:4,13,6,11:9,8,7,10	./.:.:.:.:.:.:.:.:.:.:.:.	A	splice_polypyrimidine_tract_variant&intron_variant	LOW	CRPPA	729920	Transcript	NM_001101426.4	protein_coding		09-May	c.836-9dup							rs3839757	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.04123	0.158	0.04019	0.1747	0.03159	0.02544	0.08909	0.0345	0.05781	0.04409	0.0699	0.1606	0.03222	0.04418	0.1694	0.01922	0.01923	0.05517	0.02898	0.07328	0.03898	0.1747	gnomADe_ASJ	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				198120	NA	Conflicting_classifications_of_pathogenicity	not_provided&Congenital_Muscular_Dystrophy&_alpha-dystroglycan_related&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2U&Muscular_dystrophy-dystroglycanopathy_(congenital_with_brain_and_eye_anomalies)&_type_A&_7&not_specified	NC_000007.14:g.16278245dup		Duplication	CRPPA:729920	MedGen:C3661900&MedGen:CN239202&MONDO:MONDO:0014474&MedGen:C5190987&OMIM:616052&Orphanet:352479&MONDO:MONDO:0013835&MedGen:C3553330&OMIM:614643&Orphanet:899&MedGen:CN169374	Uncertain_significance(1)&Benign(3)	criteria_provided&_conflicting_classifications		CRPPA	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	AR	614643	Neuromuscular and musculoskelettal disorders	NBScreening	-9	Benign	BP6,BA1	rs3839757	chr7_16278234_T_TA	Female	0/1	Heterozygous
chr7	21724986	.	G	GCCAGGTCATCCTGTGGACTTGGGCATCACTGGT	156.64	PASS	"FS=0;MQ=244.95;QD=4.29;SOR=1.352;FractionInformativeReads=0.971;DP=118;AF=1;AN=6;AC=6;CSQ=CCAGGTCATCCTGTGGACTTGGGCATCACTGGT|intron_variant|MODIFIER|DNAH11|8701|Transcript|NM_001277115.2|protein_coding||44/81|NM_001277115.2:c.7267-808_7267-807insCTTGGGCATCACTGGTCCAGGTCATCCTGTGGA|||||||rs71026814||1||insertion|EntrezGene||YES|||||||||17||||||||||||0.5995|0.6258|0.5567|0.6397|0.4861|0.5631|0.576|0.5479|0.5808|0.5794|0.7032|0.7032|gnomADg_SAS||||||||||||||||||||||||||||||3352649||Uncertain_significance|DNAH11-related_disorder|NC_000007.14:g.21725003_21725004insCTTGGGCATCACTGGTCCAGGTCATCCTGTGGA||Insertion|DNAH11:8701|.||no_assertion_criteria_provided|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,33:1:33:0,12:0,21:96:178,99,0:146.01,96.015,0:0,29,32:0,0,21,12:0,0,14,19	1/1:0,36:1:36:0,14:0,22:103:185,106,0:152.74,102.74,0:0,29,32:0,0,23,13:0,0,19,17	1/1:0,37:1:37:0,27:0,10:107:189,110,0:156.64,106.64,0:0,29,32:0,0,25,12:0,0,21,16	CCAGGTCATCCTGTGGACTTGGGCATCACTGGT	intron_variant	MODIFIER	DNAH11	8701	Transcript	NM_001277115.2	protein_coding		44/81	c.7267-808_7267-807insCTTGGGCATCACTGGTCCAGGTCATCCTGTGGA							rs71026814	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			17	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.5995	0.6258	0.5567	0.6397	0.4861	0.5631	0.576	0.5479	0.5808	0.5794	0.7032	0.7032	gnomADg_SAS				NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				3352649	NA	Uncertain_significance	DNAH11-related_disorder	NC_000007.14:g.21725003_21725004insCTTGGGCATCACTGGTCCAGGTCATCCTGTGGA		Insertion	DNAH11:8701	.		no_assertion_criteria_provided		DNAH11	Primary ciliary dyskinesia 7	AR	611884	Respiratory system disorders	NBScreening	-8	Benign	BA1	rs71026814	chr7_21724986_G_GCCAGGTCATCCTGTGGACTTGGGCATCACTGGT	Female	01-Jan	Homozygous
chr7	33129656	.	G	A	48.41	PASS	"FS=4.2;MQ=246.95;MQRankSum=1.269;QD=2.2;ReadPosRankSum=2.538;SOR=1.863;FractionInformativeReads=1;R2_5P_bias=15.698;DP=22;AF=0.5;AN=2;AC=1;CSQ=A|5_prime_UTR_variant|MODIFIER|BBS9|27241|Transcript|NM_198428.3|protein_coding|1/23||NM_198428.3:c.-397G>A||93|||||rs561901329||1||SNV|EntrezGene||YES|||G|G|||||||0|0|0|0|0|0|0|0|0|0|0.0006961|9.626e-05|0|0.0007847|0.01009|0|0.0003768|0|0.0007351|0.0004739|0|0.01009|gnomADg_ASJ|uncertain_significance||1||||||||||||37|34|-49|23|0.00|0.00|0.00|0.02|BBS9|||||||360052||Uncertain_significance|not_provided&Bardet-Biedl_syndrome_9|NC_000007.14:g.33129656G>A||single_nucleotide_variant|BBS9:27241|MedGen:C3661900&MONDO:MONDO:0014437&MedGen:C1859567&OMIM:615986&Orphanet:110||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:13,9:0.409:22:6,5:7,4:47:83,0,50:48.41,8.4389e-05,53:0,34.77,37.77:6,7,2,7:5,8,4,5	A	5_prime_UTR_variant	MODIFIER	BBS9	27241	Transcript	NM_198428.3	protein_coding	23-Jan		c.-397G>A		93					rs561901329	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	0	0	0	0	0	0	0	0	0	0	0.0006961	9.626e-05	0	0.0007847	0.01009	0	0.0003768	0	0.0007351	0.0004739	0	0.01009	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		37	34	-49	23	0	0	0	0.02	BBS9			NA				360052	NA	Uncertain_significance	not_provided&Bardet-Biedl_syndrome_9	NC_000007.14:g.33129656G>A		single_nucleotide_variant	BBS9:27241	MedGen:C3661900&MONDO:MONDO:0014437&MedGen:C1859567&OMIM:615986&Orphanet:110		criteria_provided&_multiple_submitters&_no_conflicts		BBS9	Bardet-Biedl syndrome 9	AR	615986	Complex genetic syndromes	NBScreening	-4	Likely_benign	BP4_Strong	rs561901329	chr7_33129656_G_A	Female	./.	Other
chr7	44145485	.	G	A	50	PASS	"FS=5.225;MQ=249.61;MQRankSum=4.625;QD=1.35;ReadPosRankSum=2.892;SOR=1.733;FractionInformativeReads=1;R2_5P_bias=-6.753;DP=37;AF=0.5;AN=2;AC=1;CSQ=A|intron_variant|MODIFIER|GCK|2645|Transcript|NM_000162.5|protein_coding||9/9|NM_000162.5:c.1253+12C>T|||||||rs768491249||-1||SNV|EntrezGene||YES|||G|G|||||||6.947e-06|0|0|0|2.574e-05|0|0|9.09e-07|0|9.498e-05|1.314e-05|0|0|0|0|0|0|0|0|0.0004776|0.000207|0.0004776|gnomADg_REMAINING|benign&uncertain_significance&likely_benign||1||||||||||||12|22|-13|12|0.00|0.00|0.00|0.00|GCK|||||||911565||Conflicting_classifications_of_pathogenicity|Hyperinsulinism_due_to_glucokinase_deficiency&Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Transient_Neonatal_Diabetes&_Recessive&Maturity-onset_diabetes_of_the_young_type_2|NC_000007.14:g.44145485G>A||single_nucleotide_variant|GCK:2645|MONDO:MONDO:0011236&MedGen:C1865290&OMIM:602485&Orphanet:79299&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN239376&MONDO:MONDO:0007453&MedGen:C0342277&OMIM:125851&Orphanet:552|Uncertain_significance(3)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,22:0.595:37:4,11:11,11:47:85,0,47:50,8.4389e-05,50.25:0,34.77,37.77:7,8,6,16:8,7,15,7	A	intron_variant	MODIFIER	GCK	2645	Transcript	NM_000162.5	protein_coding		09-Sep	c.1253+12C>T							rs768491249	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	6.947e-06	0	0	0	2.574e-05	0	0	9.09e-07	0	9.498e-05	1.314e-05	0	0	0	0	0	0	0	0	0.0004776	0.000207	0.0004776	gnomADg_REMAINING	benign&uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		12	22	-13	12	0	0	0	0	GCK			NA				911565	NA	Conflicting_classifications_of_pathogenicity	Hyperinsulinism_due_to_glucokinase_deficiency&Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Transient_Neonatal_Diabetes&_Recessive&Maturity-onset_diabetes_of_the_young_type_2	NC_000007.14:g.44145485G>A		single_nucleotide_variant	GCK:2645	MONDO:MONDO:0011236&MedGen:C1865290&OMIM:602485&Orphanet:79299&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN239376&MONDO:MONDO:0007453&MedGen:C0342277&OMIM:125851&Orphanet:552	Uncertain_significance(3)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		GCK	Permanent neonatal diabetes mellitus 1	AR	606176	Endocrine disorders	NBScreening	-5	Likely_benign	BP4_Strong,BP6	rs768491249	chr7_44145485_G_A	Female	./.	Other
chr7	44145485	.	G	A	50	PASS	"FS=5.225;MQ=249.61;MQRankSum=4.625;QD=1.35;ReadPosRankSum=2.892;SOR=1.733;FractionInformativeReads=1;R2_5P_bias=-6.753;DP=37;AF=0.5;AN=2;AC=1;CSQ=A|intron_variant|MODIFIER|GCK|2645|Transcript|NM_000162.5|protein_coding||9/9|NM_000162.5:c.1253+12C>T|||||||rs768491249||-1||SNV|EntrezGene||YES|||G|G|||||||6.947e-06|0|0|0|2.574e-05|0|0|9.09e-07|0|9.498e-05|1.314e-05|0|0|0|0|0|0|0|0|0.0004776|0.000207|0.0004776|gnomADg_REMAINING|benign&uncertain_significance&likely_benign||1||||||||||||12|22|-13|12|0.00|0.00|0.00|0.00|GCK|||||||911565||Conflicting_classifications_of_pathogenicity|Hyperinsulinism_due_to_glucokinase_deficiency&Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Transient_Neonatal_Diabetes&_Recessive&Maturity-onset_diabetes_of_the_young_type_2|NC_000007.14:g.44145485G>A||single_nucleotide_variant|GCK:2645|MONDO:MONDO:0011236&MedGen:C1865290&OMIM:602485&Orphanet:79299&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN239376&MONDO:MONDO:0007453&MedGen:C0342277&OMIM:125851&Orphanet:552|Uncertain_significance(3)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,22:0.595:37:4,11:11,11:47:85,0,47:50,8.4389e-05,50.25:0,34.77,37.77:7,8,6,16:8,7,15,7	A	intron_variant	MODIFIER	GCK	2645	Transcript	NM_000162.5	protein_coding		09-Sep	c.1253+12C>T							rs768491249	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	6.947e-06	0	0	0	2.574e-05	0	0	9.09e-07	0	9.498e-05	1.314e-05	0	0	0	0	0	0	0	0	0.0004776	0.000207	0.0004776	gnomADg_REMAINING	benign&uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		12	22	-13	12	0	0	0	0	GCK			NA				911565	NA	Conflicting_classifications_of_pathogenicity	Hyperinsulinism_due_to_glucokinase_deficiency&Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Transient_Neonatal_Diabetes&_Recessive&Maturity-onset_diabetes_of_the_young_type_2	NC_000007.14:g.44145485G>A		single_nucleotide_variant	GCK:2645	MONDO:MONDO:0011236&MedGen:C1865290&OMIM:602485&Orphanet:79299&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN239376&MONDO:MONDO:0007453&MedGen:C0342277&OMIM:125851&Orphanet:552	Uncertain_significance(3)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		GCK	Maturity-onset diabetes of the young type 2	AD	125851	Endocrine disorders	NBScreening	-5	Likely_benign	BP4_Strong,BP6	rs768491249	chr7_44145485_G_A	Female	./.	Other
chr7	44145485	.	G	A	50	PASS	"FS=5.225;MQ=249.61;MQRankSum=4.625;QD=1.35;ReadPosRankSum=2.892;SOR=1.733;FractionInformativeReads=1;R2_5P_bias=-6.753;DP=37;AF=0.5;AN=2;AC=1;CSQ=A|intron_variant|MODIFIER|GCK|2645|Transcript|NM_000162.5|protein_coding||9/9|NM_000162.5:c.1253+12C>T|||||||rs768491249||-1||SNV|EntrezGene||YES|||G|G|||||||6.947e-06|0|0|0|2.574e-05|0|0|9.09e-07|0|9.498e-05|1.314e-05|0|0|0|0|0|0|0|0|0.0004776|0.000207|0.0004776|gnomADg_REMAINING|benign&uncertain_significance&likely_benign||1||||||||||||12|22|-13|12|0.00|0.00|0.00|0.00|GCK|||||||911565||Conflicting_classifications_of_pathogenicity|Hyperinsulinism_due_to_glucokinase_deficiency&Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Transient_Neonatal_Diabetes&_Recessive&Maturity-onset_diabetes_of_the_young_type_2|NC_000007.14:g.44145485G>A||single_nucleotide_variant|GCK:2645|MONDO:MONDO:0011236&MedGen:C1865290&OMIM:602485&Orphanet:79299&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN239376&MONDO:MONDO:0007453&MedGen:C0342277&OMIM:125851&Orphanet:552|Uncertain_significance(3)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,22:0.595:37:4,11:11,11:47:85,0,47:50,8.4389e-05,50.25:0,34.77,37.77:7,8,6,16:8,7,15,7	A	intron_variant	MODIFIER	GCK	2645	Transcript	NM_000162.5	protein_coding		09-Sep	c.1253+12C>T							rs768491249	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	6.947e-06	0	0	0	2.574e-05	0	0	9.09e-07	0	9.498e-05	1.314e-05	0	0	0	0	0	0	0	0	0.0004776	0.000207	0.0004776	gnomADg_REMAINING	benign&uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		12	22	-13	12	0	0	0	0	GCK			NA				911565	NA	Conflicting_classifications_of_pathogenicity	Hyperinsulinism_due_to_glucokinase_deficiency&Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Transient_Neonatal_Diabetes&_Recessive&Maturity-onset_diabetes_of_the_young_type_2	NC_000007.14:g.44145485G>A		single_nucleotide_variant	GCK:2645	MONDO:MONDO:0011236&MedGen:C1865290&OMIM:602485&Orphanet:79299&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN239376&MONDO:MONDO:0007453&MedGen:C0342277&OMIM:125851&Orphanet:552	Uncertain_significance(3)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		GCK	Hyperinsulinism due to glucokinase deficiency	AD	602485	Endocrine disorders	NBScreening	-5	Likely_benign	BP4_Strong,BP6	rs768491249	chr7_44145485_G_A	Female	./.	Other
chr7	44145485	.	G	A	50	PASS	"FS=5.225;MQ=249.61;MQRankSum=4.625;QD=1.35;ReadPosRankSum=2.892;SOR=1.733;FractionInformativeReads=1;R2_5P_bias=-6.753;DP=37;AF=0.5;AN=2;AC=1;CSQ=A|intron_variant|MODIFIER|GCK|2645|Transcript|NM_000162.5|protein_coding||9/9|NM_000162.5:c.1253+12C>T|||||||rs768491249||-1||SNV|EntrezGene||YES|||G|G|||||||6.947e-06|0|0|0|2.574e-05|0|0|9.09e-07|0|9.498e-05|1.314e-05|0|0|0|0|0|0|0|0|0.0004776|0.000207|0.0004776|gnomADg_REMAINING|benign&uncertain_significance&likely_benign||1||||||||||||12|22|-13|12|0.00|0.00|0.00|0.00|GCK|||||||911565||Conflicting_classifications_of_pathogenicity|Hyperinsulinism_due_to_glucokinase_deficiency&Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Transient_Neonatal_Diabetes&_Recessive&Maturity-onset_diabetes_of_the_young_type_2|NC_000007.14:g.44145485G>A||single_nucleotide_variant|GCK:2645|MONDO:MONDO:0011236&MedGen:C1865290&OMIM:602485&Orphanet:79299&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN239376&MONDO:MONDO:0007453&MedGen:C0342277&OMIM:125851&Orphanet:552|Uncertain_significance(3)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:15,22:0.595:37:4,11:11,11:47:85,0,47:50,8.4389e-05,50.25:0,34.77,37.77:7,8,6,16:8,7,15,7	A	intron_variant	MODIFIER	GCK	2645	Transcript	NM_000162.5	protein_coding		09-Sep	c.1253+12C>T							rs768491249	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	6.947e-06	0	0	0	2.574e-05	0	0	9.09e-07	0	9.498e-05	1.314e-05	0	0	0	0	0	0	0	0	0.0004776	0.000207	0.0004776	gnomADg_REMAINING	benign&uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		12	22	-13	12	0	0	0	0	GCK			NA				911565	NA	Conflicting_classifications_of_pathogenicity	Hyperinsulinism_due_to_glucokinase_deficiency&Maturity_onset_diabetes_mellitus_in_young&Permanent_neonatal_diabetes_mellitus&Transient_Neonatal_Diabetes&_Recessive&Maturity-onset_diabetes_of_the_young_type_2	NC_000007.14:g.44145485G>A		single_nucleotide_variant	GCK:2645	MONDO:MONDO:0011236&MedGen:C1865290&OMIM:602485&Orphanet:79299&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&MONDO:MONDO:0100164&MedGen:C1833104&OMIM:PS606176&Orphanet:99885&MedGen:CN239376&MONDO:MONDO:0007453&MedGen:C0342277&OMIM:125851&Orphanet:552	Uncertain_significance(3)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		GCK	Hyperinsulinemic hypoglycemia, familial, 8	AD	620211	Endocrine disorders	NBScreening	-5	Likely_benign	BP4_Strong,BP6	rs768491249	chr7_44145485_G_A	Female	./.	Other
chr7	75986234	.	G	A	50	PASS	"FS=1.393;MQ=250;MQRankSum=4.652;QD=1.56;ReadPosRankSum=1.771;SOR=0.446;FractionInformativeReads=1;R2_5P_bias=-3.854;DP=32;AF=0.5;AN=2;AC=1;CSQ=A|missense_variant|MODERATE|POR|5447|Transcript|NM_001395413.1|protein_coding|15/16||NM_001395413.1:c.1882G>A|NP_001382342.1:p.Val628Ile|1920|1882|628|V/I|Gtc/Atc|rs145782750&CM057355||1||SNV|EntrezGene||YES|||G|G|||tolerated(0.54)|benign(0.001)||0.0024|0.001428|0.0002091|0.002215|0.0007652|2.519e-05|0.0007656|0.005201|0.001268|0.00174|0.004336|0.001208|0.0005051|0|0.001764|0.001153|0|0.0002827|0.006803|0.0015|0.002367|0.004153|0.0072|SAS|uncertain_significance&conflicting_interpretations_of_pathogenicity|0&1|1&1||||T|0.24125|-0.177389|D|0.68494|-0.0281043|0.72176|0.410&0.410&0.410|-47|11|3|11|0.00|0.00|0.05|0.01|POR|||||||284175||Conflicting_classifications_of_pathogenicity|not_provided&Congenital_adrenal_hyperplasia_due_to_cytochrome_P450_oxidoreductase_deficiency&Antley-Bixler_syndrome_with_genital_anomalies_and_disordered_steroidogenesis&POR-related_disorder|NC_000007.14:g.75986234G>A||single_nucleotide_variant|POR:5447|MedGen:C3661900&MONDO:MONDO:0013310&MedGen:C1860042&OMIM:613571&Orphanet:95699&MONDO:MONDO:0008726&MedGen:C3150099&OMIM:201750&Orphanet:63269&.|Uncertain_significance(3)&Benign(1)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:12,20:0.625:32:6,10:6,10:46:85,0,46:50,9.8368e-05,48.97:0,34.77,37.77:5,7,10,10:5,7,8,12	./.:.:.:.:.:.:.:.:.:.:.:.	A	missense_variant	MODERATE	POR	5447	Transcript	NM_001395413.1	protein_coding	15/16		c.1882G>A	p.Val628Ile	1920	1882	628	V/I	Gtc/Atc	rs145782750&CM057355	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	tolerated(0.54)	benign(0.001)	NA	0.0024	0.001428	0.0002091	0.002215	0.0007652	2.519e-05	0.0007656	0.005201	0.001268	0.00174	0.004336	0.001208	0.0005051	0	0.001764	0.001153	0	0.0002827	0.006803	0.0015	0.002367	0.004153	0.0072	SAS	uncertain_significance&conflicting_interpretations_of_pathogenicity	0&1	1&1	NA	NA	NA	T	0.24125	-0.177389	D	0.68494	-0.0281043	0.72176	0.410&0.410&0.410	-47	11	3	11	0	0	0.05	0.01	POR			NA				284175	NA	Conflicting_classifications_of_pathogenicity	not_provided&Congenital_adrenal_hyperplasia_due_to_cytochrome_P450_oxidoreductase_deficiency&Antley-Bixler_syndrome_with_genital_anomalies_and_disordered_steroidogenesis&POR-related_disorder	NC_000007.14:g.75986234G>A		single_nucleotide_variant	POR:5447	MedGen:C3661900&MONDO:MONDO:0013310&MedGen:C1860042&OMIM:613571&Orphanet:95699&MONDO:MONDO:0008726&MedGen:C3150099&OMIM:201750&Orphanet:63269&.	Uncertain_significance(3)&Benign(1)&Likely_benign(3)	criteria_provided&_conflicting_classifications		POR	Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	AR	201750	Endocrine disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs145782750	chr7_75986234_G_A	Female	./.	Other
chr7	92499847	.	CA	C	157.71	PASS	"FS=0;MQ=250;MQRankSum=1.655;QD=3.43;ReadPosRankSum=-1.116;SOR=0.631;FractionInformativeReads=0.978;R2_5P_bias=0;DP=133;AF=0.5;AN=6;AC=4;CSQ=-|splice_polypyrimidine_tract_variant&intron_variant|LOW|PEX1|5189|Transcript|NM_000466.3|protein_coding||15/23|NM_000466.3:c.2584-10del|||||||rs5885806||-1||deletion|EntrezGene||YES|||A|A|||||||0.5851|0.51|0.5557|0.5589|0.5474|0.5831|0.6467|0.5926|0.5761|0.568|0.7451|0.6243|0.819|0.7682|0.7791|0.6893|0.7818|0.7778|0.7999|0.7537|0.8506|0.8506|gnomADg_SAS|uncertain_significance&benign&likely_benign||1||||||||||||-17|2|-17|-36|0.01|0.00|0.00|0.00|PEX1|||||||360922||Conflicting_classifications_of_pathogenicity|Peroxisome_biogenesis_disorder_1A_(Zellweger)&Heimler_syndrome_1&not_specified&Peroxisome_biogenesis_disorder&Peroxisome_biogenesis_disorder_1B&not_provided&Zellweger_spectrum_disorders|NC_000007.14:g.92499859del||Deletion|PEX1:5189|MONDO:MONDO:0008953&MedGen:C4721541&OMIM:214100&MedGen:C4551980&OMIM:234580&Orphanet:3220&MedGen:CN169374&MONDO:MONDO:0019234&MedGen:C1832200&OMIM:PS214100&Orphanet:79189&MONDO:MONDO:0011101&MedGen:C0282527&OMIM:601539&Orphanet:44&MedGen:C3661900&MONDO:MONDO:0019609&MedGen:C0043459&Orphanet:912|Uncertain_significance(1)&Benign(6)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:1,44:0.978:45:1,24:0,20:108:171,111,0:157.71,107.71,0:0,10,13:1,0,29,15:1,0,21,23	0/1:25,14:0.359:39:12,5:13,9:42:55,0,47:43.173,0.00025265,50:0,12,15.01:19,6,7,7:12,13,6,8	0/1:20,24:0.545:44:8,10:12,14:47:61,0,47:50,8.9308e-05,49.753:0,11,14.01:8,12,14,10:8,12,10,14	-	splice_polypyrimidine_tract_variant&intron_variant	LOW	PEX1	5189	Transcript	NM_000466.3	protein_coding		15/23	c.2584-10del							rs5885806	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.5851	0.51	0.5557	0.5589	0.5474	0.5831	0.6467	0.5926	0.5761	0.568	0.7451	0.6243	0.819	0.7682	0.7791	0.6893	0.7818	0.7778	0.7999	0.7537	0.8506	0.8506	gnomADg_SAS	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-17	2	-17	-36	0.01	0	0	0	PEX1			NA				360922	NA	Conflicting_classifications_of_pathogenicity	Peroxisome_biogenesis_disorder_1A_(Zellweger)&Heimler_syndrome_1&not_specified&Peroxisome_biogenesis_disorder&Peroxisome_biogenesis_disorder_1B&not_provided&Zellweger_spectrum_disorders	NC_000007.14:g.92499859del		Deletion	PEX1:5189	MONDO:MONDO:0008953&MedGen:C4721541&OMIM:214100&MedGen:C4551980&OMIM:234580&Orphanet:3220&MedGen:CN169374&MONDO:MONDO:0019234&MedGen:C1832200&OMIM:PS214100&Orphanet:79189&MONDO:MONDO:0011101&MedGen:C0282527&OMIM:601539&Orphanet:44&MedGen:C3661900&MONDO:MONDO:0019609&MedGen:C0043459&Orphanet:912	Uncertain_significance(1)&Benign(6)&Likely_benign(2)	criteria_provided&_conflicting_classifications		PEX1	Peroxisome biogenesis disorder 1A (Zellweger)	AR	214100	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs5885806	chr7_92499847_CA_C	Female	01-Jan	Homozygous
chr7	92499847	.	CA	C	157.71	PASS	"FS=0;MQ=250;MQRankSum=1.655;QD=3.43;ReadPosRankSum=-1.116;SOR=0.631;FractionInformativeReads=0.978;R2_5P_bias=0;DP=133;AF=0.5;AN=6;AC=4;CSQ=-|splice_polypyrimidine_tract_variant&intron_variant|LOW|PEX1|5189|Transcript|NM_000466.3|protein_coding||15/23|NM_000466.3:c.2584-10del|||||||rs5885806||-1||deletion|EntrezGene||YES|||A|A|||||||0.5851|0.51|0.5557|0.5589|0.5474|0.5831|0.6467|0.5926|0.5761|0.568|0.7451|0.6243|0.819|0.7682|0.7791|0.6893|0.7818|0.7778|0.7999|0.7537|0.8506|0.8506|gnomADg_SAS|uncertain_significance&benign&likely_benign||1||||||||||||-17|2|-17|-36|0.01|0.00|0.00|0.00|PEX1|||||||360922||Conflicting_classifications_of_pathogenicity|Peroxisome_biogenesis_disorder_1A_(Zellweger)&Heimler_syndrome_1&not_specified&Peroxisome_biogenesis_disorder&Peroxisome_biogenesis_disorder_1B&not_provided&Zellweger_spectrum_disorders|NC_000007.14:g.92499859del||Deletion|PEX1:5189|MONDO:MONDO:0008953&MedGen:C4721541&OMIM:214100&MedGen:C4551980&OMIM:234580&Orphanet:3220&MedGen:CN169374&MONDO:MONDO:0019234&MedGen:C1832200&OMIM:PS214100&Orphanet:79189&MONDO:MONDO:0011101&MedGen:C0282527&OMIM:601539&Orphanet:44&MedGen:C3661900&MONDO:MONDO:0019609&MedGen:C0043459&Orphanet:912|Uncertain_significance(1)&Benign(6)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:1,44:0.978:45:1,24:0,20:108:171,111,0:157.71,107.71,0:0,10,13:1,0,29,15:1,0,21,23	0/1:25,14:0.359:39:12,5:13,9:42:55,0,47:43.173,0.00025265,50:0,12,15.01:19,6,7,7:12,13,6,8	0/1:20,24:0.545:44:8,10:12,14:47:61,0,47:50,8.9308e-05,49.753:0,11,14.01:8,12,14,10:8,12,10,14	-	splice_polypyrimidine_tract_variant&intron_variant	LOW	PEX1	5189	Transcript	NM_000466.3	protein_coding		15/23	c.2584-10del							rs5885806	NA	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.5851	0.51	0.5557	0.5589	0.5474	0.5831	0.6467	0.5926	0.5761	0.568	0.7451	0.6243	0.819	0.7682	0.7791	0.6893	0.7818	0.7778	0.7999	0.7537	0.8506	0.8506	gnomADg_SAS	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-17	2	-17	-36	0.01	0	0	0	PEX1			NA				360922	NA	Conflicting_classifications_of_pathogenicity	Peroxisome_biogenesis_disorder_1A_(Zellweger)&Heimler_syndrome_1&not_specified&Peroxisome_biogenesis_disorder&Peroxisome_biogenesis_disorder_1B&not_provided&Zellweger_spectrum_disorders	NC_000007.14:g.92499859del		Deletion	PEX1:5189	MONDO:MONDO:0008953&MedGen:C4721541&OMIM:214100&MedGen:C4551980&OMIM:234580&Orphanet:3220&MedGen:CN169374&MONDO:MONDO:0019234&MedGen:C1832200&OMIM:PS214100&Orphanet:79189&MONDO:MONDO:0011101&MedGen:C0282527&OMIM:601539&Orphanet:44&MedGen:C3661900&MONDO:MONDO:0019609&MedGen:C0043459&Orphanet:912	Uncertain_significance(1)&Benign(6)&Likely_benign(2)	criteria_provided&_conflicting_classifications		PEX1	Heimler syndrome 1	AR	234580	Inherited disorders of metabolism	NBScreening	-9	Benign	BP6,BA1	rs5885806	chr7_92499847_CA_C	Female	01-Jan	Homozygous
chr7	107701928	.	G	A	50	PASS	"FS=3.22;MQ=250;MQRankSum=4.925;QD=1.47;ReadPosRankSum=3.018;SOR=0.269;FractionInformativeReads=1;R2_5P_bias=15.838;DP=66;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|SLC26A4|5172|Transcript|NM_000441.2|protein_coding|17/21||NM_000441.2:c.1905G>A|NP_000432.1:p.Glu635%3D|1936|1905|635|E|gaG/gaA|rs541538556&CM1211143||1||SNV|EntrezGene||YES|||G|G||||||0.0002|2.328e-05|0|0|0|0.0008065|0|0|0|3.314e-05|0|8.536e-05|0|0|0|0|0.002506|0|0|0|0|0|0.002506|gnomADg_EAS|conflicting_interpretations_of_pathogenicity&likely_benign&uncertain_significance|0&1|1&1||||||||||||-8|-47|6|36|0.00|0.00|0.00|0.00|SLC26A4|||||||551205||Conflicting_classifications_of_pathogenicity|not_provided&Pendred_syndrome&not_specified&Autosomal_recessive_nonsyndromic_hearing_loss_4&Inborn_genetic_diseases|NC_000007.14:g.107701928G>A||single_nucleotide_variant|SLC26A4:5172|MedGen:C3661900&MONDO:MONDO:0010134&MedGen:C0271829&OMIM:274600&Orphanet:705&MedGen:CN169374&MONDO:MONDO:0010933&MedGen:C3538946&OMIM:600791&Orphanet:90636&MeSH:D030342&MedGen:C0950123|Uncertain_significance(4)&Likely_benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,19:0.559:34:6,7:9,12:48:85,0,49:50,6.9893e-05,52.164:0,34.77,37.77:4,11,8,11:9,6,12,7	0/1:20,12:0.375:32:12,7:8,5:45:81,0,50:45.787,0.00013642,53:0,34.77,37.77:9,11,4,8:9,11,5,7	./.:.:.:.:.:.:.:.:.:.:.:.	A	synonymous_variant	LOW	SLC26A4	5172	Transcript	NM_000441.2	protein_coding	17/21		c.1905G>A	p.Glu635%3D	1936	1905	635	E	gaG/gaA	rs541538556&CM1211143	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	2,00E-04	2.328e-05	0	0	0	0.0008065	0	0	0	3.314e-05	0	8.536e-05	0	0	0	0	0.002506	0	0	0	0	0	0.002506	gnomADg_EAS	conflicting_interpretations_of_pathogenicity&likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-8	-47	6	36	0	0	0	0	SLC26A4			NA				551205	NA	Conflicting_classifications_of_pathogenicity	not_provided&Pendred_syndrome&not_specified&Autosomal_recessive_nonsyndromic_hearing_loss_4&Inborn_genetic_diseases	NC_000007.14:g.107701928G>A		single_nucleotide_variant	SLC26A4:5172	MedGen:C3661900&MONDO:MONDO:0010134&MedGen:C0271829&OMIM:274600&Orphanet:705&MedGen:CN169374&MONDO:MONDO:0010933&MedGen:C3538946&OMIM:600791&Orphanet:90636&MeSH:D030342&MedGen:C0950123	Uncertain_significance(4)&Likely_benign(4)	criteria_provided&_conflicting_classifications		SLC26A4	Pendred syndrome	AR	274600	Hearing disorders	NBScreening	-4	Likely_benign	BP4_Moderate,BP6,BP7	rs541538556	chr7_107701928_G_A	Female	0/1	Heterozygous
chr7	107701928	.	G	A	50	PASS	"FS=3.22;MQ=250;MQRankSum=4.925;QD=1.47;ReadPosRankSum=3.018;SOR=0.269;FractionInformativeReads=1;R2_5P_bias=15.838;DP=66;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|SLC26A4|5172|Transcript|NM_000441.2|protein_coding|17/21||NM_000441.2:c.1905G>A|NP_000432.1:p.Glu635%3D|1936|1905|635|E|gaG/gaA|rs541538556&CM1211143||1||SNV|EntrezGene||YES|||G|G||||||0.0002|2.328e-05|0|0|0|0.0008065|0|0|0|3.314e-05|0|8.536e-05|0|0|0|0|0.002506|0|0|0|0|0|0.002506|gnomADg_EAS|conflicting_interpretations_of_pathogenicity&likely_benign&uncertain_significance|0&1|1&1||||||||||||-8|-47|6|36|0.00|0.00|0.00|0.00|SLC26A4|||||||551205||Conflicting_classifications_of_pathogenicity|not_provided&Pendred_syndrome&not_specified&Autosomal_recessive_nonsyndromic_hearing_loss_4&Inborn_genetic_diseases|NC_000007.14:g.107701928G>A||single_nucleotide_variant|SLC26A4:5172|MedGen:C3661900&MONDO:MONDO:0010134&MedGen:C0271829&OMIM:274600&Orphanet:705&MedGen:CN169374&MONDO:MONDO:0010933&MedGen:C3538946&OMIM:600791&Orphanet:90636&MeSH:D030342&MedGen:C0950123|Uncertain_significance(4)&Likely_benign(4)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,19:0.559:34:6,7:9,12:48:85,0,49:50,6.9893e-05,52.164:0,34.77,37.77:4,11,8,11:9,6,12,7	0/1:20,12:0.375:32:12,7:8,5:45:81,0,50:45.787,0.00013642,53:0,34.77,37.77:9,11,4,8:9,11,5,7	./.:.:.:.:.:.:.:.:.:.:.:.	A	synonymous_variant	LOW	SLC26A4	5172	Transcript	NM_000441.2	protein_coding	17/21		c.1905G>A	p.Glu635%3D	1936	1905	635	E	gaG/gaA	rs541538556&CM1211143	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	2,00E-04	2.328e-05	0	0	0	0.0008065	0	0	0	3.314e-05	0	8.536e-05	0	0	0	0	0.002506	0	0	0	0	0	0.002506	gnomADg_EAS	conflicting_interpretations_of_pathogenicity&likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-8	-47	6	36	0	0	0	0	SLC26A4			NA				551205	NA	Conflicting_classifications_of_pathogenicity	not_provided&Pendred_syndrome&not_specified&Autosomal_recessive_nonsyndromic_hearing_loss_4&Inborn_genetic_diseases	NC_000007.14:g.107701928G>A		single_nucleotide_variant	SLC26A4:5172	MedGen:C3661900&MONDO:MONDO:0010134&MedGen:C0271829&OMIM:274600&Orphanet:705&MedGen:CN169374&MONDO:MONDO:0010933&MedGen:C3538946&OMIM:600791&Orphanet:90636&MeSH:D030342&MedGen:C0950123	Uncertain_significance(4)&Likely_benign(4)	criteria_provided&_conflicting_classifications		SLC26A4	Autosomal recessive nonsyndromic hearing loss 4	AR	600791	Hearing disorders	NBScreening	-4	Likely_benign	BP4_Moderate,BP6,BP7	rs541538556	chr7_107701928_G_A	Female	0/1	Heterozygous
chr7	117594996	.	A	T	50	PASS	"FS=5.501;MQ=250;MQRankSum=4.881;QD=1.52;ReadPosRankSum=2.936;SOR=0.168;FractionInformativeReads=1;R2_5P_bias=-8.082;DP=33;AF=0.5;AN=2;AC=1;CSQ=T|missense_variant|MODERATE|CFTR|1080|Transcript|NM_000492.4|protein_coding|15/27||NM_000492.4:c.2557A>T|NP_000483.3:p.Ile853Phe|2627|2557|853|I/F|Att/Ttt|rs780187979&CM044595||1||SNV|EntrezGene||YES|||A|A|||tolerated_low_confidence(0.07)|benign(0.003)|||6.846e-06|0|0|0|0.0001518|0|0|2.7e-06|1.657e-05|0|1.315e-05|0|0|0|0|0.0001925|0|0|1.471e-05|0|0|0.0001925|gnomADg_EAS|uncertain_significance|0&1|1&1||||D|0.71620|0.175405|D|0.71253|0.0141807|0.79886|0.525&.&0.525&.|15|0|5|37|0.00|0.00|0.00|0.00|CFTR|likely_benign|hg38|0.0738|I853F|ENST00000003084.10|P13569|556101||Uncertain_significance|not_specified&CFTR-related_disorder&Hereditary_pancreatitis&Cystic_fibrosis|NC_000007.14:g.117594996A>T||single_nucleotide_variant|CFTR:1080|MedGen:CN169374&MedGen:C5924204&MONDO:MONDO:0008185&MedGen:C0238339&OMIM:167800&Orphanet:676&MONDO:MONDO:0009061&MedGen:C0010674&OMIM:219700&Orphanet:586||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,17:0.515:33:11,10:5,7:48:85,0,50:50,6.5492e-05,52.934:0,34.77,37.77:4,12,8,9:7,9,7,10	T	missense_variant	MODERATE	CFTR	1080	Transcript	NM_000492.4	protein_coding	15/27		c.2557A>T	p.Ile853Phe	2627	2557	853	I/F	Att/Ttt	rs780187979&CM044595	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	tolerated_low_confidence(0.07)	benign(0.003)	NA	NA	6.846e-06	0	0	0	0.0001518	0	0	2.7e-06	1.657e-05	0	1.315e-05	0	0	0	0	0.0001925	0	0	1.471e-05	0	0	0.0001925	gnomADg_EAS	uncertain_significance	0&1	1&1	NA	NA	NA	D	0.7162	0.175405	D	0.71253	0.0141807	0.79886	0.525&.&0.525&.	15	0	5	37	0	0	0	0	CFTR	likely_benign	hg38	0.0738	I853F	ENST00000003084.10	P13569	556101	NA	Uncertain_significance	not_specified&CFTR-related_disorder&Hereditary_pancreatitis&Cystic_fibrosis	NC_000007.14:g.117594996A>T		single_nucleotide_variant	CFTR:1080	MedGen:CN169374&MedGen:C5924204&MONDO:MONDO:0008185&MedGen:C0238339&OMIM:167800&Orphanet:676&MONDO:MONDO:0009061&MedGen:C0010674&OMIM:219700&Orphanet:586		criteria_provided&_multiple_submitters&_no_conflicts		CFTR	Cystic fibrosis	AR	219700	Respiratory system disorders	NBScreening	3	Uncertain_significance	PM5,PP2	rs780187979	chr7_117594996_A_T	Female	./.	Other
chr7	117602811	.	C	G	50	PASS	"FS=1.377;MQ=250;MQRankSum=4.881;QD=1.52;ReadPosRankSum=1.567;SOR=1.058;FractionInformativeReads=1;R2_5P_bias=2.905;DP=33;AF=0.5;AN=2;AC=1;CSQ=G|splice_polypyrimidine_tract_variant&intron_variant|LOW|CFTR|1080|Transcript|NM_000492.4|protein_coding||15/26|NM_000492.4:c.2620-15C>G|||||||rs139379077&CS004690||1||SNV|EntrezGene||YES|||C|C||||||0.0014|0.001894|0.0009267|0.002974|0.02175|2.52e-05|0|0.03313|0.0013|0.004373|0.001554|0.002167|0.0002165|0|0.004838|0.02477|0|0|0.02381|0.00197|0.007096|0.001038|0.03313|gnomADe_MID|likely_benign&benign/likely_benign&conflicting_interpretations_of_pathogenicity&uncertain_significance|0&1|1&1||||||||||||-6|15|15|48|0.00|0.00|0.00|0.00|CFTR|||||||35844||Conflicting_classifications_of_pathogenicity|CFTR-related_disorder&not_specified&Hereditary_pancreatitis&not_provided&Cystic_fibrosis|NC_000007.14:g.117602811C>G||single_nucleotide_variant|CFTR:1080|MedGen:C5924204&MedGen:CN169374&MONDO:MONDO:0008185&MedGen:C0238339&OMIM:167800&Orphanet:676&MedGen:C3661900&MONDO:MONDO:0009061&MedGen:C0010674&OMIM:219700&Orphanet:586|Uncertain_significance(3)&Benign(6)&Likely_benign(6)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,17:0.515:33:8,11:8,6:48:85,0,50:50,6.5751e-05,52.907:0,34.77,37.77:7,9,6,11:9,7,12,5	./.:.:.:.:.:.:.:.:.:.:.:.	G	splice_polypyrimidine_tract_variant&intron_variant	LOW	CFTR	1080	Transcript	NM_000492.4	protein_coding		15/26	c.2620-15C>G							rs139379077&CS004690	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.0014	0.001894	0.0009267	0.002974	0.02175	2.52e-05	0	0.03313	0.0013	0.004373	0.001554	0.002167	0.0002165	0	0.004838	0.02477	0	0	0.02381	0.00197	0.007096	0.001038	0.03313	gnomADe_MID	likely_benign&benign/likely_benign&conflicting_interpretations_of_pathogenicity&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-6	15	15	48	0	0	0	0	CFTR			NA				35844	NA	Conflicting_classifications_of_pathogenicity	CFTR-related_disorder&not_specified&Hereditary_pancreatitis&not_provided&Cystic_fibrosis	NC_000007.14:g.117602811C>G		single_nucleotide_variant	CFTR:1080	MedGen:C5924204&MedGen:CN169374&MONDO:MONDO:0008185&MedGen:C0238339&OMIM:167800&Orphanet:676&MedGen:C3661900&MONDO:MONDO:0009061&MedGen:C0010674&OMIM:219700&Orphanet:586	Uncertain_significance(3)&Benign(6)&Likely_benign(6)	criteria_provided&_conflicting_classifications		CFTR	Cystic fibrosis	AR	219700	Respiratory system disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BS1,BS2	rs139379077	chr7_117602811_C_G	Female	./.	Other
chr7	127611134	.	T	G	179.44	PASS	"FS=0;MQ=250;QD=4.73;SOR=1.101;FractionInformativeReads=1;DP=114;AF=1;AN=6;AC=6;CSQ=G|missense_variant|MODERATE|PAX4|5078|Transcript|NM_001366110.1|protein_coding|12/12||NM_001366110.1:c.986A>C|NP_001353039.1:p.His329Pro|1392|986|329|H/P|cAc/cCc|rs712701&CM051949&COSV58387831||-1||SNV|EntrezGene||YES|||T|T|||tolerated_low_confidence(0.45)|benign(0)||0.6705|0.7674|0.7074|0.7284|0.8786|0.3413|0.731|0.8259|0.7867|0.767|0.7429|0.7435|0.7148|0.7971|0.7502|0.8839|0.3684|0.72|0.8605|0.7833|0.7431|0.7408|0.8839|gnomADg_ASJ|benign&conflicting_interpretations_of_pathogenicity|0&1&1|1&1&1||||T|0.00218|-0.571133|T|0.27768|-0.44935|0.41658|0.161&.&0.161|-10|-16|-10|-4|0.00|0.00|0.00|0.00|PAX4|||||||129878||Conflicting_classifications_of_pathogenicity|Maturity_onset_diabetes_mellitus_in_young&Type_2_diabetes_mellitus&not_specified&not_provided|NC_000007.14:g.127611134T>G||single_nucleotide_variant|PAX4:5078|Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:CN169374&MedGen:C3661900|Uncertain_significance(1)&Benign(6)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,27:1:27:0,15:0,12:78:166,81,0:127.8,77.799,0:0,34.77,37.77:0,0,16,11:0,0,10,17	1/1:0,44:1:44:0,20:0,24:129:217,132,0:179.44,129.44,0:0,34.77,37.77:0,0,31,13:0,0,29,15	1/1:0,42:1:42:0,20:0,22:123:211,126,0:172.82,122.82,0:0,34.77,37.78:0,0,29,13:0,0,19,23	G	missense_variant	MODERATE	PAX4	5078	Transcript	NM_001366110.1	protein_coding	12-Dec		c.986A>C	p.His329Pro	1392	986	329	H/P	cAc/cCc	rs712701&CM051949&COSV58387831	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	tolerated_low_confidence(0.45)	benign(0)	NA	0.6705	0.7674	0.7074	0.7284	0.8786	0.3413	0.731	0.8259	0.7867	0.767	0.7429	0.7435	0.7148	0.7971	0.7502	0.8839	0.3684	0.72	0.8605	0.7833	0.7431	0.7408	0.8839	gnomADg_ASJ	benign&conflicting_interpretations_of_pathogenicity	0&1&1	1&1&1	NA	NA	NA	T	0.00218	-0.571133	T	0.27768	-0.44935	0.41658	0.161&.&0.161	-10	-16	-10	-4	0	0	0	0	PAX4			NA				129878	NA	Conflicting_classifications_of_pathogenicity	Maturity_onset_diabetes_mellitus_in_young&Type_2_diabetes_mellitus&not_specified&not_provided	NC_000007.14:g.127611134T>G		single_nucleotide_variant	PAX4:5078	Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552&Human_Phenotype_Ontology:HP:0005965&Human_Phenotype_Ontology:HP:0005978&Human_Phenotype_Ontology:HP:0100652&MONDO:MONDO:0005148&MeSH:D003924&MedGen:C0011860&OMIM:125853&MedGen:CN169374&MedGen:C3661900	Uncertain_significance(1)&Benign(6)	criteria_provided&_conflicting_classifications		PAX4	Maturity-onset diabetes of the young type 9	AD	612225	"Endocrine disorders;Inherited disorders of metabolism"	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs712701	chr7_127611134_T_G	Female	01-Jan	Homozygous
chr7	128257567	.	T	TA	391.7	PASS	"FS=0;MQ=245.65;QD=9.55;SOR=0.798;FractionInformativeReads=0.927;MQRankSum=1.936;ReadPosRankSum=0.904;R2_5P_bias=0;DP=106;AF=0.5;AN=6;AC=3;CSQ=A|3_prime_UTR_variant|MODIFIER|LEP|3952|Transcript|NM_000230.3|protein_coding|3/3||NM_000230.3:c.*2822dup||3365-3366|||||rs56247456||1||insertion|EntrezGene||YES|||||||||18||0.5|||||||0.5|||0.06521|0.1801|0.1025|0.0378|0.02205|0.009951|0.02957|0.05769|0.01615|0.05132|0.04249|0.5|gnomADe_NFE|uncertain_significance&likely_benign||1||||||||||||5|19|17|4|0.00|0.00|0.00|0.00|LEP|||||||358854||Uncertain_significance|Monogenic_Non-Syndromic_Obesity&Obesity_due_to_congenital_leptin_deficiency|NC_000007.14:g.128257585dup||Duplication|LEP:3952|MedGen:CN239457&MONDO:MONDO:0013991&MedGen:C3554224&OMIM:614962&Orphanet:66628||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,20:0.526:38:0,10:0,10:50:404,443,56:391.7,436.49,52.775:0,6,9:0,0,18,20:0,0,29,9	1/0:2,16:0.552:29:0,5:2,11:48:286,230,53:274.38,224.38,49.721:0,6,9:1,1,21,6:1,1,12,15	1/0:0,15:0.5:30:0,9:0,6:50:315,369,56:302.92,362.9,53:0,6,9:0,0,20,10:0,0,14,16	A	3_prime_UTR_variant	MODIFIER	LEP	3952	Transcript	NM_000230.3	protein_coding	03-Mar		c.*2822dup		3365-3366					rs56247456	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			18	NA	0.5	NA	NA	NA	NA	NA	NA	0.5	NA	NA	0.06521	0.1801	0.1025	0.0378	0.02205	0.009951	0.02957	0.05769	0.01615	0.05132	0.04249	0.5	gnomADe_NFE	uncertain_significance&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		5	19	17	4	0	0	0	0	LEP			NA				358854	NA	Uncertain_significance	Monogenic_Non-Syndromic_Obesity&Obesity_due_to_congenital_leptin_deficiency	NC_000007.14:g.128257585dup		Duplication	LEP:3952	MedGen:CN239457&MONDO:MONDO:0013991&MedGen:C3554224&OMIM:614962&Orphanet:66628		criteria_provided&_single_submitter		LEP	Obesity due to congenital leptin deficiency	AR	614962	Complex genetic syndromes	NBScreening	-8	Benign	BA1	rs56247456	chr7_128257567_T_TA	Female	1/0	Heterozygous
chr7	140734797	.	G	GA	181.27	PASS	"FS=0;MQ=245.78;QD=3.99;SOR=1.819;FractionInformativeReads=0.919;MQRankSum=1.171;ReadPosRankSum=0.702;R2_5P_bias=0;DP=126;AF=1;AN=6;AC=6;CSQ=A|intron_variant|MODIFIER|BRAF|673|Transcript|NM_004333.6|protein_coding||17/17|NM_004333.6:c.2128-28dup|||||||rs60814637||-1||insertion|EntrezGene||YES|||||||||||0.8401|0.6242|0.8409|0.8259|0.8332|0.8231|0.8187|0.8519|0.8244|0.7675|0.8154|0.677|0.7105|0.8832|0.8663|0.882|0.8731|0.8107|0.8558|0.8501|0.856|0.8832|gnomADg_AMR|benign&uncertain_significance||1||||||||||||-28|-13|12|-28|0.01|0.00|0.00|0.00|BRAF|||||||359047||Conflicting_classifications_of_pathogenicity|Noonan_syndrome_with_multiple_lentigines&Noonan_syndrome&not_specified&Cardio-facio-cutaneous_syndrome|NC_000007.14:g.140734806dup||Duplication|BRAF:673|MONDO:MONDO:0007893&MedGen:C0175704&OMIM:PS151100&Orphanet:500&MONDO:MONDO:0018997&MeSH:D009634&MedGen:C0028326&OMIM:PS163950&Orphanet:648&MedGen:CN169374&MONDO:MONDO:0015280&MedGen:C1275081&OMIM:PS115150&Orphanet:1340|Uncertain_significance(3)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,34:1:34:0,22:0,12:98:168,101,0:147.81,97.813,0:0,17,20:0,0,24,10:0,0,24,10	1/1:1,36:0.973:37:1,16:0,20:82:152,85,0:132.12,82.115,0:0,17,20:0,1,26,10:0,1,18,18	1/1:0,45:1:45:0,19:0,26:131:202,134,0:181.27,131.27,0:0,18,21.01:0,0,31,14:0,0,25,20	A	intron_variant	MODIFIER	BRAF	673	Transcript	NM_004333.6	protein_coding		17/17	c.2128-28dup							rs60814637	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.8401	0.6242	0.8409	0.8259	0.8332	0.8231	0.8187	0.8519	0.8244	0.7675	0.8154	0.677	0.7105	0.8832	0.8663	0.882	0.8731	0.8107	0.8558	0.8501	0.856	0.8832	gnomADg_AMR	benign&uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-28	-13	12	-28	0.01	0	0	0	BRAF			NA				359047	NA	Conflicting_classifications_of_pathogenicity	Noonan_syndrome_with_multiple_lentigines&Noonan_syndrome&not_specified&Cardio-facio-cutaneous_syndrome	NC_000007.14:g.140734806dup		Duplication	BRAF:673	MONDO:MONDO:0007893&MedGen:C0175704&OMIM:PS151100&Orphanet:500&MONDO:MONDO:0018997&MeSH:D009634&MedGen:C0028326&OMIM:PS163950&Orphanet:648&MedGen:CN169374&MONDO:MONDO:0015280&MedGen:C1275081&OMIM:PS115150&Orphanet:1340	Uncertain_significance(3)&Benign(1)	criteria_provided&_conflicting_classifications		BRAF	Cardiofaciocutaneous syndrome 1	AD	115150	Complex genetic syndromes	NBScreening	-9	Benign	BP6,BA1	rs60814637	chr7_140734797_G_GA	Female	01-Jan	Homozygous
chr7	150951830	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=4.664;QD=1.55;ReadPosRankSum=2.662;SOR=0.77;FractionInformativeReads=1;R2_5P_bias=-0.381;DP=67;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|KCNH2|3757|Transcript|NM_000238.4|protein_coding|7/15||NM_000238.4:c.1563C>T|NP_000229.1:p.Ile521%3D|1971|1563|521|I|atC/atT|rs143011005&COSV51167521||-1||SNV|EntrezGene||YES|||G|G||||||0.0016|0.000866|0.0001213|0.00165|0.0092|2.553e-05|4.014e-05|0.005221|0.0006612|0.002013|0.000849|0.0009978|0.000457|0|0.00209|0.008651|0|9.414e-05|0.003401|0.0008966|0.00237|0.0006209|0.0092|gnomADe_ASJ|benign&conflicting_interpretations_of_pathogenicity&likely_benign|0&1|1&1||||||||||||-13|5|-13|-33|0.00|0.00|0.00|0.00|KCNH2|||||||70633||Conflicting_classifications_of_pathogenicity|Cardiac_arrhythmia&not_provided&Long_QT_syndrome&Cardiovascular_phenotype&Long_QT_syndrome_2&not_specified|NC_000007.14:g.150951830G>A||single_nucleotide_variant|KCNH2:3757|EFO:EFO_0004269&Human_Phenotype_Ontology:HP:0001656&Human_Phenotype_Ontology:HP:0001661&Human_Phenotype_Ontology:HP:0001665&Human_Phenotype_Ontology:HP:0001666&Human_Phenotype_Ontology:HP:0001687&Human_Phenotype_Ontology:HP:0001721&Human_Phenotype_Ontology:HP:0004351&Human_Phenotype_Ontology:HP:0005158&Human_Phenotype_Ontology:HP:0011675&MONDO:MONDO:0007263&MedGen:C0003811&MedGen:C3661900&MONDO:MONDO:0002442&MeSH:D008133&MedGen:C0023976&MedGen:CN230736&MONDO:MONDO:0013367&MedGen:C3150943&OMIM:613688&Orphanet:101016&Orphanet:768&MedGen:CN169374|Uncertain_significance(1)&Benign(8)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,13:0.419:31:8,9:10,4:47:83,0,50:48.073,8.9308e-05,53:0,34.77,37.77:12,6,9,4:10,8,7,6	0/1:18,18:0.5:36:9,6:9,12:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:10,8,6,12:11,7,10,8	./.:.:.:.:.:.:.:.:.:.:.:.	A	synonymous_variant	LOW	KCNH2	3757	Transcript	NM_000238.4	protein_coding	15-Jul		c.1563C>T	p.Ile521%3D	1971	1563	521	I	atC/atT	rs143011005&COSV51167521	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0016	0.000866	0.0001213	0.00165	0.0092	2.553e-05	4.014e-05	0.005221	0.0006612	0.002013	0.000849	0.0009978	0.000457	0	0.00209	0.008651	0	9.414e-05	0.003401	0.0008966	0.00237	0.0006209	0.0092	gnomADe_ASJ	benign&conflicting_interpretations_of_pathogenicity&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-13	5	-13	-33	0	0	0	0	KCNH2			NA				70633	NA	Conflicting_classifications_of_pathogenicity	Cardiac_arrhythmia&not_provided&Long_QT_syndrome&Cardiovascular_phenotype&Long_QT_syndrome_2&not_specified	NC_000007.14:g.150951830G>A		single_nucleotide_variant	KCNH2:3757	EFO:EFO_0004269&Human_Phenotype_Ontology:HP:0001656&Human_Phenotype_Ontology:HP:0001661&Human_Phenotype_Ontology:HP:0001665&Human_Phenotype_Ontology:HP:0001666&Human_Phenotype_Ontology:HP:0001687&Human_Phenotype_Ontology:HP:0001721&Human_Phenotype_Ontology:HP:0004351&Human_Phenotype_Ontology:HP:0005158&Human_Phenotype_Ontology:HP:0011675&MONDO:MONDO:0007263&MedGen:C0003811&MedGen:C3661900&MONDO:MONDO:0002442&MeSH:D008133&MedGen:C0023976&MedGen:CN230736&MONDO:MONDO:0013367&MedGen:C3150943&OMIM:613688&Orphanet:101016&Orphanet:768&MedGen:CN169374	Uncertain_significance(1)&Benign(8)&Likely_benign(2)	criteria_provided&_conflicting_classifications		KCNH2	Long QT syndrome 2	AD	613688	Cardiac and vascular disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BS1,BS2	rs143011005	chr7_150951830_G_A	Female	0/1	Heterozygous
chr7	151556160	.	G	GA	49.94	PASS	"FS=0;MQ=248.18;MQRankSum=4.439;QD=1.35;ReadPosRankSum=-0.38;SOR=1.022;FractionInformativeReads=0.946;R2_5P_bias=-4.179;DP=37;AF=0.5;AN=2;AC=1;CSQ=A|3_prime_UTR_variant|MODIFIER|PRKAG2|51422|Transcript|NM_016203.4|protein_coding|16/16||NM_016203.4:c.*1040dup||3245-3246|||||rs56898021||-1||insertion|EntrezGene||YES|||||||||||0.4615|||||0.4615|||||0.5378|0.2676|0.46|0.5328|0.671|0.5933|0.6873|0.5787|0.6562|0.5556|0.6415|0.6873|gnomADg_FIN|uncertain_significance||1||||||||||||-4|32|-4|-41|0.01|0.00|0.00|0.00|PRKAG2|||||||359322||Uncertain_significance|Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&not_provided&Lethal_congenital_glycogen_storage_disease_of_heart&Wolff-Parkinson-White_pattern|NC_000007.14:g.151556171dup||Duplication|PRKAG2:51422|MedGen:CN239247&MedGen:C3661900&MONDO:MONDO:0009867&MedGen:C1849813&OMIM:261740&Orphanet:439854&Human_Phenotype_Ontology:HP:0001716&MONDO:MONDO:0008685&MedGen:C0043202&OMIM:194200&Orphanet:907||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:18,17:0.486:35:4,9:14,8:48:62,0,50:49.94,6.5751e-05,53:0,12,15:3,15,2,15:11,7,8,9	A	3_prime_UTR_variant	MODIFIER	PRKAG2	51422	Transcript	NM_016203.4	protein_coding	16/16		c.*1040dup		3245-3246					rs56898021	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.4615	NA	NA	NA	NA	0.4615	NA	NA	NA	NA	0.5378	0.2676	0.46	0.5328	0.671	0.5933	0.6873	0.5787	0.6562	0.5556	0.6415	0.6873	gnomADg_FIN	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-4	32	-4	-41	0.01	0	0	0	PRKAG2			NA				359322	NA	Uncertain_significance	Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&not_provided&Lethal_congenital_glycogen_storage_disease_of_heart&Wolff-Parkinson-White_pattern	NC_000007.14:g.151556171dup		Duplication	PRKAG2:51422	MedGen:CN239247&MedGen:C3661900&MONDO:MONDO:0009867&MedGen:C1849813&OMIM:261740&Orphanet:439854&Human_Phenotype_Ontology:HP:0001716&MONDO:MONDO:0008685&MedGen:C0043202&OMIM:194200&Orphanet:907		criteria_provided&_multiple_submitters&_no_conflicts		PRKAG2	Hypertrophic cardiomyopathy 6	AD	600858	"Cardiac and vascular disorders;Inherited disorders of metabolism"	NBScreening	-8	Benign	BA1	rs56898021	chr7_151556160_G_GA	Female	./.	Other
chr7	151556160	.	G	GA	49.94	PASS	"FS=0;MQ=248.18;MQRankSum=4.439;QD=1.35;ReadPosRankSum=-0.38;SOR=1.022;FractionInformativeReads=0.946;R2_5P_bias=-4.179;DP=37;AF=0.5;AN=2;AC=1;CSQ=A|3_prime_UTR_variant|MODIFIER|PRKAG2|51422|Transcript|NM_016203.4|protein_coding|16/16||NM_016203.4:c.*1040dup||3245-3246|||||rs56898021||-1||insertion|EntrezGene||YES|||||||||||0.4615|||||0.4615|||||0.5378|0.2676|0.46|0.5328|0.671|0.5933|0.6873|0.5787|0.6562|0.5556|0.6415|0.6873|gnomADg_FIN|uncertain_significance||1||||||||||||-4|32|-4|-41|0.01|0.00|0.00|0.00|PRKAG2|||||||359322||Uncertain_significance|Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&not_provided&Lethal_congenital_glycogen_storage_disease_of_heart&Wolff-Parkinson-White_pattern|NC_000007.14:g.151556171dup||Duplication|PRKAG2:51422|MedGen:CN239247&MedGen:C3661900&MONDO:MONDO:0009867&MedGen:C1849813&OMIM:261740&Orphanet:439854&Human_Phenotype_Ontology:HP:0001716&MONDO:MONDO:0008685&MedGen:C0043202&OMIM:194200&Orphanet:907||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:18,17:0.486:35:4,9:14,8:48:62,0,50:49.94,6.5751e-05,53:0,12,15:3,15,2,15:11,7,8,9	A	3_prime_UTR_variant	MODIFIER	PRKAG2	51422	Transcript	NM_016203.4	protein_coding	16/16		c.*1040dup		3245-3246					rs56898021	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.4615	NA	NA	NA	NA	0.4615	NA	NA	NA	NA	0.5378	0.2676	0.46	0.5328	0.671	0.5933	0.6873	0.5787	0.6562	0.5556	0.6415	0.6873	gnomADg_FIN	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-4	32	-4	-41	0.01	0	0	0	PRKAG2			NA				359322	NA	Uncertain_significance	Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&not_provided&Lethal_congenital_glycogen_storage_disease_of_heart&Wolff-Parkinson-White_pattern	NC_000007.14:g.151556171dup		Duplication	PRKAG2:51422	MedGen:CN239247&MedGen:C3661900&MONDO:MONDO:0009867&MedGen:C1849813&OMIM:261740&Orphanet:439854&Human_Phenotype_Ontology:HP:0001716&MONDO:MONDO:0008685&MedGen:C0043202&OMIM:194200&Orphanet:907		criteria_provided&_multiple_submitters&_no_conflicts		PRKAG2	Wolff-Parkinson-White pattern	AD	194200	Cardiac and vascular disorders	NBScreening	-8	Benign	BA1	rs56898021	chr7_151556160_G_GA	Female	./.	Other
chr7	151556160	.	G	GA	49.94	PASS	"FS=0;MQ=248.18;MQRankSum=4.439;QD=1.35;ReadPosRankSum=-0.38;SOR=1.022;FractionInformativeReads=0.946;R2_5P_bias=-4.179;DP=37;AF=0.5;AN=2;AC=1;CSQ=A|3_prime_UTR_variant|MODIFIER|PRKAG2|51422|Transcript|NM_016203.4|protein_coding|16/16||NM_016203.4:c.*1040dup||3245-3246|||||rs56898021||-1||insertion|EntrezGene||YES|||||||||||0.4615|||||0.4615|||||0.5378|0.2676|0.46|0.5328|0.671|0.5933|0.6873|0.5787|0.6562|0.5556|0.6415|0.6873|gnomADg_FIN|uncertain_significance||1||||||||||||-4|32|-4|-41|0.01|0.00|0.00|0.00|PRKAG2|||||||359322||Uncertain_significance|Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&not_provided&Lethal_congenital_glycogen_storage_disease_of_heart&Wolff-Parkinson-White_pattern|NC_000007.14:g.151556171dup||Duplication|PRKAG2:51422|MedGen:CN239247&MedGen:C3661900&MONDO:MONDO:0009867&MedGen:C1849813&OMIM:261740&Orphanet:439854&Human_Phenotype_Ontology:HP:0001716&MONDO:MONDO:0008685&MedGen:C0043202&OMIM:194200&Orphanet:907||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:18,17:0.486:35:4,9:14,8:48:62,0,50:49.94,6.5751e-05,53:0,12,15:3,15,2,15:11,7,8,9	A	3_prime_UTR_variant	MODIFIER	PRKAG2	51422	Transcript	NM_016203.4	protein_coding	16/16		c.*1040dup		3245-3246					rs56898021	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.4615	NA	NA	NA	NA	0.4615	NA	NA	NA	NA	0.5378	0.2676	0.46	0.5328	0.671	0.5933	0.6873	0.5787	0.6562	0.5556	0.6415	0.6873	gnomADg_FIN	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-4	32	-4	-41	0.01	0	0	0	PRKAG2			NA				359322	NA	Uncertain_significance	Familial_Hypertrophic_Cardiomyopathy_with_Wolff-Parkinson-White_Syndrome&not_provided&Lethal_congenital_glycogen_storage_disease_of_heart&Wolff-Parkinson-White_pattern	NC_000007.14:g.151556171dup		Duplication	PRKAG2:51422	MedGen:CN239247&MedGen:C3661900&MONDO:MONDO:0009867&MedGen:C1849813&OMIM:261740&Orphanet:439854&Human_Phenotype_Ontology:HP:0001716&MONDO:MONDO:0008685&MedGen:C0043202&OMIM:194200&Orphanet:907		criteria_provided&_multiple_submitters&_no_conflicts		PRKAG2	Lethal congenital glycogen storage disease of heart	AD	261740	"Cardiac and vascular disorders;Inherited disorders of metabolism"	NBScreening	-8	Benign	BA1	rs56898021	chr7_151556160_G_GA	Female	./.	Other
chr8	11757066	.	A	G	50	PASS	"FS=0;MQ=250;MQRankSum=5.166;QD=1.34;ReadPosRankSum=3.063;SOR=0.619;FractionInformativeReads=1;R2_5P_bias=9.563;DP=123;AF=0.5;AN=6;AC=3;CSQ=G|missense_variant|MODERATE|GATA4|2626|Transcript|NM_001308093.3|protein_coding|6/7||NM_001308093.3:c.1132A>G|NP_001295022.1:p.Ser378Gly|1692|1132|378|S/G|Agc/Ggc|rs3729856&CM164458&COSV58732556||1||SNV|EntrezGene||YES|||A|A|||tolerated(0.39)|benign(0.011)||0.0429|0.1117|0.01978|0.04589|0.1768|0.0002267|0.1454|0.1376|0.1224|0.1075|0.0564|0.08854|0.02102|0.0956|0.05278|0.1842|0.00135|0.1405|0.1054|0.1342|0.08743|0.04867|0.1842|gnomADg_ASJ|benign&uncertain_significance|0&1&1|1&1&1||||T|0.01859|-0.414397|T|0.52182|-0.225751|0.61040|0.291&0.291&0.291&0.291&.|5|2|17|10|0.00|0.00|0.00|0.00|GATA4|||||||44334||Conflicting_classifications_of_pathogenicity|Neonatal_insulin-dependent_diabetes_mellitus&Cardiovascular_phenotype&not_provided&not_specified&Atrioventricular_septal_defect_4|NC_000008.11:g.11757066A>G||single_nucleotide_variant|GATA4:2626|Human_Phenotype_Ontology:HP:0000857&MedGen:C3278636&MedGen:CN230736&MedGen:C3661900&MedGen:CN169374&MONDO:MONDO:0013747&MedGen:C3280781&OMIM:614430|Uncertain_significance(1)&Benign(6)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:20,17:0.459:37:11,6:9,11:48:84,0,50:49.47,7.0928e-05,53:0,34.77,37.77:9,11,8,9:8,12,7,10	0/1:17,21:0.553:38:3,12:14,9:48:85,0,49:50,7.041e-05,52.084:0,34.77,37.77:8,9,7,14:8,9,12,9	0/1:28,20:0.417:48:14,10:14,10:45:82,0,47:47.173,0.00012658,50:0,34.77,37.78:12,16,8,12:14,14,10,10	G	missense_variant	MODERATE	GATA4	2626	Transcript	NM_001308093.3	protein_coding	07-Jun		c.1132A>G	p.Ser378Gly	1692	1132	378	S/G	Agc/Ggc	rs3729856&CM164458&COSV58732556	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	tolerated(0.39)	benign(0.011)	NA	0.0429	0.1117	0.01978	0.04589	0.1768	0.0002267	0.1454	0.1376	0.1224	0.1075	0.0564	0.08854	0.02102	0.0956	0.05278	0.1842	0.00135	0.1405	0.1054	0.1342	0.08743	0.04867	0.1842	gnomADg_ASJ	benign&uncertain_significance	0&1&1	1&1&1	NA	NA	NA	T	0.01859	-0.414397	T	0.52182	-0.225751	0.6104	0.291&0.291&0.291&0.291&.	5	2	17	10	0	0	0	0	GATA4			NA				44334	NA	Conflicting_classifications_of_pathogenicity	Neonatal_insulin-dependent_diabetes_mellitus&Cardiovascular_phenotype&not_provided&not_specified&Atrioventricular_septal_defect_4	NC_000008.11:g.11757066A>G		single_nucleotide_variant	GATA4:2626	Human_Phenotype_Ontology:HP:0000857&MedGen:C3278636&MedGen:CN230736&MedGen:C3661900&MedGen:CN169374&MONDO:MONDO:0013747&MedGen:C3280781&OMIM:614430	Uncertain_significance(1)&Benign(6)	criteria_provided&_conflicting_classifications		GATA4	Congenital heart defects and ectodermal dysplasia	AD	617364	Cardiac and vascular disorders	NBScreening	-13	Benign	BP4_Strong,BP6,BA1	rs3729856	chr8_11757066_A_G	Female	0/1	Heterozygous
chr8	11758829	.	A	C	154.43	PASS	"FS=0;MQ=250;MQRankSum=5.39;QD=1.24;ReadPosRankSum=2.952;SOR=0.551;FractionInformativeReads=1;R2_5P_bias=28.001;DP=76;AF=1;AN=4;AC=3;CSQ=C|3_prime_UTR_variant|MODIFIER|GATA4|2626|Transcript|NM_001308093.3|protein_coding|7/7||NM_001308093.3:c.*354A>C||2246|||||rs867858||1||SNV|EntrezGene||YES|||A|A||||||0.3614|0.3373|0.2409|0.3176|0.3294|0.5432|0.3161|0.3599|0.3156|0.3299|0.3862|0.2997|0.2245|0.3256|0.3134|0.337|0.5594|0.3033|0.3776|0.313|0.3205|0.3845|0.5804|EAS|uncertain_significance||1||||||||||||-18|-11|-43|-12|0.01|0.00|0.00|0.00|GATA4|||||||139593||Uncertain_significance|not_provided|NC_000008.11:g.11758829A>C||single_nucleotide_variant|GATA4:2626|MedGen:C3661900||no_assertion_criteria_provided|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:21,19:0.475:40:9,9:12,10:48:85,0,50:49.736,6.7822e-05,53:0,34.77,37.77:13,8,11,8:9,12,9,10	1/1:0,36:1:36:0,17:0,19:104:192,107,0:154.43,104.43,0:0,34.77,37.77:0,0,14,22:0,0,17,19	./.:.:.:.:.:.:.:.:.:.:.:.	C	3_prime_UTR_variant	MODIFIER	GATA4	2626	Transcript	NM_001308093.3	protein_coding	07-Jul		c.*354A>C		2246					rs867858	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.3614	0.3373	0.2409	0.3176	0.3294	0.5432	0.3161	0.3599	0.3156	0.3299	0.3862	0.2997	0.2245	0.3256	0.3134	0.337	0.5594	0.3033	0.3776	0.313	0.3205	0.3845	0.5804	EAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-18	-11	-43	-12	0.01	0	0	0	GATA4			NA				139593	NA	Uncertain_significance	not_provided	NC_000008.11:g.11758829A>C		single_nucleotide_variant	GATA4:2626	MedGen:C3661900		no_assertion_criteria_provided		GATA4	Congenital heart defects and ectodermal dysplasia	AD	617364	Cardiac and vascular disorders	NBScreening	-12	Benign	BP4_Strong,BA1	rs867858	chr8_11758829_A_C	Female	0/1	Heterozygous
chr8	11758901	.	C	T	158.37	PASS	"FS=6.937;MQ=250;MQRankSum=5.335;QD=1.25;ReadPosRankSum=4.022;SOR=0.327;FractionInformativeReads=1;R2_5P_bias=-4.593;DP=78;AF=1;AN=4;AC=3;CSQ=T|3_prime_UTR_variant|MODIFIER|GATA4|2626|Transcript|NM_001308093.3|protein_coding|7/7||NM_001308093.3:c.*426C>T||2318|||||rs1062219||1||SNV|EntrezGene||YES|||C|C||||||0.2272|0.3658|0.1707|0.2443|0.5405|0.02146|0.296|0.4422|0.4327|0.3806|0.296|0.3293|0.1731|0.3802|0.2858|0.5761|0.02104|0.2897|0.4252|0.4512|0.3812|0.2918|0.5761|gnomADg_ASJ|uncertain_significance||1||||||||||||5|-7|-2|-12|0.00|0.00|0.00|0.00|GATA4|||||||139594||Uncertain_significance|not_provided|NC_000008.11:g.11758901C>T||single_nucleotide_variant|GATA4:2626|MedGen:C3661900||no_assertion_criteria_provided|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,23:0.575:40:10,10:7,13:47:85,0,48:50,7.7659e-05,51.038:0,34.77,37.77:12,5,11,12:9,8,10,13	./.:.:.:.:.:.:.:.:.:.:.:.	1/1:0,37:1:37:0,22:0,15:108:196,111,0:158.37,108.37,0:0,34.77,37.77:0,0,14,23:0,0,15,22	T	3_prime_UTR_variant	MODIFIER	GATA4	2626	Transcript	NM_001308093.3	protein_coding	07-Jul		c.*426C>T		2318					rs1062219	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.2272	0.3658	0.1707	0.2443	0.5405	0.02146	0.296	0.4422	0.4327	0.3806	0.296	0.3293	0.1731	0.3802	0.2858	0.5761	0.02104	0.2897	0.4252	0.4512	0.3812	0.2918	0.5761	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		5	-7	-2	-12	0	0	0	0	GATA4			NA				139594	NA	Uncertain_significance	not_provided	NC_000008.11:g.11758901C>T		single_nucleotide_variant	GATA4:2626	MedGen:C3661900		no_assertion_criteria_provided		GATA4	Congenital heart defects and ectodermal dysplasia	AD	617364	Cardiac and vascular disorders	NBScreening	-12	Benign	BP4_Strong,BA1	rs1062219	chr8_11758901_C_T	Female	0/1	Heterozygous
chr8	27803549	.	T	TAC	147.2	PASS	"FS=0;MQ=250;QD=3.23;SOR=0.88;FractionInformativeReads=0.733;MQRankSum=1.648;ReadPosRankSum=-0.803;R2_5P_bias=0;DP=143;AF=1;AN=6;AC=6;CSQ=AC|3_prime_UTR_variant|MODIFIER|ESCO2|157570|Transcript|NM_001017420.3|protein_coding|11/11||NM_001017420.3:c.*128_*129dup||1987-1988|||||rs56062620||1||insertion|EntrezGene||YES|||||||||18||0.4041|0.3718|0.4614|0.3295|0.4982|0.3682|0.3292|0.406|0.3981|0.3697|0.4399|0.4337|0.5066|0.5022|0.2907|0.6505|0.3778|0.3655|0.4312|0.4163|0.4347|0.6505|gnomADg_EAS|||1|||||||||||||||||||||||||||362750||Conflicting_classifications_of_pathogenicity|not_provided&Roberts-SC_phocomelia_syndrome|NC_000008.11:g.27803550AC[10]||Microsatellite|ESCO2:157570|MedGen:C3661900&MONDO:MONDO:0100253&MedGen:C0392475&OMIM:268300&Orphanet:3103|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,33:1:33:0,11:0,22:95:157,98,0:145.39,95.386,0:0,9,12:0,0,15,18:0,0,17,16	1/1:0,31:1:31:0,15:0,16:89:151,92,0:139.23,89.232,0:0,9,12:0,0,13,18:0,0,17,14	1/1:1,40:0.976:41:1,15:0,25:97:159,100,0:147.2,97.197,0:0,9,12:1,0,15,25:1,0,24,16	AC	3_prime_UTR_variant	MODIFIER	ESCO2	157570	Transcript	NM_001017420.3	protein_coding	11-Nov		c.*128_*129dup		1987-1988					rs56062620	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			18	NA	0.4041	0.3718	0.4614	0.3295	0.4982	0.3682	0.3292	0.406	0.3981	0.3697	0.4399	0.4337	0.5066	0.5022	0.2907	0.6505	0.3778	0.3655	0.4312	0.4163	0.4347	0.6505	gnomADg_EAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				362750	NA	Conflicting_classifications_of_pathogenicity	not_provided&Roberts-SC_phocomelia_syndrome	NC_000008.11:g.27803550AC[10]		Microsatellite	ESCO2:157570	MedGen:C3661900&MONDO:MONDO:0100253&MedGen:C0392475&OMIM:268300&Orphanet:3103	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		ESCO2	Roberts-SC phocomelia syndrome	AR	268300	Complex genetic syndromes	NBScreening	-9	Benign	BP6,BA1	rs56062620	chr8_27803549_T_TAC	Female	01-Jan	Homozygous
chr8	38411237	.	T	C	50	PASS	"FS=5.993;MQ=250;MQRankSum=5.99;QD=1.02;ReadPosRankSum=3.01;SOR=0.365;FractionInformativeReads=1;R2_5P_bias=7.962;DP=91;AF=0.5;AN=4;AC=2;CSQ=C|3_prime_UTR_variant|MODIFIER|FGFR1|2260|Transcript|NM_023110.3|protein_coding|18/18||NM_023110.3:c.*2391A>G||5603|||||rs185729862||-1||SNV|EntrezGene||YES|||T|T||||||0.0002|0.000785|0|0|0.009396|0|0|0.00641|0.0001497|0.0006582|0|0.0002691|2.405e-05|0|0.0003268|0.006916|0|0|0.003401|0.000147|0|0|0.009396|gnomADe_ASJ|uncertain_significance||1||||||||||||-10|-4|1|9|0.00|0.00|0.00|0.00|FGFR1|||||||362856||Uncertain_significance|not_provided&Craniosynostosis_syndrome&Osteoglophonic_dysplasia&Trigonocephaly_1&Hypogonadotropic_hypogonadism_2_with_or_without_anosmia|NC_000008.11:g.38411237T>C||single_nucleotide_variant|FGFR1:2260&LOC102723716:102723716|MedGen:C3661900&Human_Phenotype_Ontology:HP:0001363&Human_Phenotype_Ontology:HP:0001365&Human_Phenotype_Ontology:HP:0004494&Human_Phenotype_Ontology:HP:0005448&Human_Phenotype_Ontology:HP:0005457&Human_Phenotype_Ontology:HP:0005467&Human_Phenotype_Ontology:HP:0008492&MONDO:MONDO:0015469&MeSH:D003398&MedGen:C0010278&OMIM:PS123100&Orphanet:1531&MONDO:MONDO:0008150&MedGen:C0432283&OMIM:166250&Orphanet:2645&MONDO:MONDO:0008603&MedGen:C0432122&OMIM:190440&Orphanet:3366&MONDO:MONDO:0007844&MedGen:C1563720&OMIM:147950&Orphanet:478||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:24,25:0.51:49:11,11:13,14:48:85,0,50:50,6.5492e-05,52.955:0,34.77,37.77:8,16,13,12:13,11,15,10	0/1:22,20:0.476:42:13,14:9,6:48:85,0,50:49.749,6.7822e-05,53:0,34.77,37.77:8,14,9,11:9,13,11,9	./.:.:.:.:.:.:.:.:.:.:.:.	C	3_prime_UTR_variant	MODIFIER	FGFR1	2260	Transcript	NM_023110.3	protein_coding	18/18		c.*2391A>G		5603					rs185729862	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA			NA	2,00E-04	0.000785	0	0	0.009396	0	0	0.00641	0.0001497	0.0006582	0	0.0002691	2.405e-05	0	0.0003268	0.006916	0	0	0.003401	0.000147	0	0	0.009396	gnomADe_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-10	-4	1	9	0	0	0	0	FGFR1			NA				362856	NA	Uncertain_significance	not_provided&Craniosynostosis_syndrome&Osteoglophonic_dysplasia&Trigonocephaly_1&Hypogonadotropic_hypogonadism_2_with_or_without_anosmia	NC_000008.11:g.38411237T>C		single_nucleotide_variant	FGFR1:2260&LOC102723716:102723716	MedGen:C3661900&Human_Phenotype_Ontology:HP:0001363&Human_Phenotype_Ontology:HP:0001365&Human_Phenotype_Ontology:HP:0004494&Human_Phenotype_Ontology:HP:0005448&Human_Phenotype_Ontology:HP:0005457&Human_Phenotype_Ontology:HP:0005467&Human_Phenotype_Ontology:HP:0008492&MONDO:MONDO:0015469&MeSH:D003398&MedGen:C0010278&OMIM:PS123100&Orphanet:1531&MONDO:MONDO:0008150&MedGen:C0432283&OMIM:166250&Orphanet:2645&MONDO:MONDO:0008603&MedGen:C0432122&OMIM:190440&Orphanet:3366&MONDO:MONDO:0007844&MedGen:C1563720&OMIM:147950&Orphanet:478		criteria_provided&_multiple_submitters&_no_conflicts		FGFR1	Kallmann syndrome with spastic paraplegia	AD	308750	Complex genetic syndromes	NBScreening	-5	Likely_benign	BP4_Strong,BS1_Supporting	rs185729862	chr8_38411237_T_C	Female	0/1	Heterozygous
chr8	43201910	.	G	A	49.93	PASS	"FS=1.412;MQ=250;MQRankSum=4.724;QD=1.61;ReadPosRankSum=1.719;SOR=1.112;FractionInformativeReads=1;R2_5P_bias=10.585;DP=65;AF=0.5;AN=4;AC=2;CSQ=A|3_prime_UTR_variant|MODIFIER|HGSNAT|138050|Transcript|NM_152419.3|protein_coding|18/18||NM_152419.3:c.*2341G>A||4282|||||rs143662681||1||SNV|EntrezGene||YES|||G|G||||||0.0026|0|0||||0||0|||0.003781|0.0006736|0.001096|0.002875|0.01443|0.0001929|0.007248|0.003401|0.004733|0.007102|0.00766|0.01443|gnomADg_ASJ|uncertain_significance||1||||||||||||47|-5|1|-48|0.00|0.00|0.00|0.00|HGSNAT|||||||363182||Uncertain_significance|Mucopolysaccharidosis&_MPS-III-C|NC_000008.11:g.43201910G>A||single_nucleotide_variant|HGSNAT:138050|MONDO:MONDO:0009657&MedGen:C0086649&OMIM:252930&Orphanet:581&Orphanet:79271||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,15:0.484:31:10,7:6,8:48:85,0,50:49.93,6.601e-05,53:0,34.77,37.77:8,8,6,9:10,6,6,9	0/1:20,14:0.412:34:15,9:5,5:46:82,0,50:47.506,9.8886e-05,53:0,34.77,37.77:6,14,7,7:7,13,8,6	./.:.:.:.:.:.:.:.:.:.:.:.	A	3_prime_UTR_variant	MODIFIER	HGSNAT	138050	Transcript	NM_152419.3	protein_coding	18/18		c.*2341G>A		4282					rs143662681	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0026	0	0	NA	NA	NA	0	NA	0	NA	NA	0.003781	0.0006736	0.001096	0.002875	0.01443	0.0001929	0.007248	0.003401	0.004733	0.007102	0.00766	0.01443	gnomADg_ASJ	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		47	-5	1	-48	0	0	0	0	HGSNAT			NA				363182	NA	Uncertain_significance	Mucopolysaccharidosis&_MPS-III-C	NC_000008.11:g.43201910G>A		single_nucleotide_variant	HGSNAT:138050	MONDO:MONDO:0009657&MedGen:C0086649&OMIM:252930&Orphanet:581&Orphanet:79271		criteria_provided&_single_submitter		HGSNAT	Mucopolysaccharidosis, MPS-III-C	AR	252930	Inherited disorders of metabolism	NBScreening	-9	Benign	BP4_Strong,BS1_Supporting,BS2	rs143662681	chr8_43201910_G_A	Female	0/1	Heterozygous
chr8	60678764	.	C	CGCG	207.23	PASS	"FS=0;MQ=245.66;MQRankSum=2.039;QD=2.4;ReadPosRankSum=0.793;SOR=0.836;FractionInformativeReads=0.842;R2_5P_bias=4.095;DP=35;AF=0.5;AN=4;AC=2;CSQ=GCG|5_prime_UTR_variant|MODIFIER|CHD7|55636|Transcript|NM_017780.4|protein_coding|1/38||NM_017780.4:c.-469_-467dup||25-26|||||rs886063023||1||insertion|EntrezGene||YES|||||||||26||0.4934|0.5|0.75||0|0||0.3511|0.5|0.5625|0.6504|0.6548|0.6235|0.6691|0.6445|0.6931|0.7328|0.5269|0.6292|0.6485|0.6917|0.75|gnomADe_AMR|||1|||||||||||||||||||||||||||363419||Uncertain_significance|CHARGE_syndrome&not_provided&Hypogonadism_with_anosmia|NC_000008.11:g.60678767GGC[9]||Microsatellite|CHD7:55636|MONDO:MONDO:0008965&MedGen:C0265354&OMIM:214800&Orphanet:138&MedGen:C3661900&MONDO:MONDO:0018800&MedGen:C0162809&Orphanet:478||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,5:0.312:16:4,3:7,2:45:56,0,50:45.608,0.00014108,53:0,10,13:6,5,3,2:3,8,3,2	./.:.,.:.:.:.,.:.,.:.:.:.:.:.:.	0/1:0,7:0.5:14:0,3:0,4:50:225,173,59:207.23,164.15,53:0,9,12:0,0,8,6:0,0,7,7	GCG	5_prime_UTR_variant	MODIFIER	CHD7	55636	Transcript	NM_017780.4	protein_coding	1/38		c.-469_-467dup		25-26					rs886063023	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			26	NA	0.4934	0.5	0.75	NA	0	0	NA	0.3511	0.5	0.5625	0.6504	0.6548	0.6235	0.6691	0.6445	0.6931	0.7328	0.5269	0.6292	0.6485	0.6917	0.75	gnomADe_AMR			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				363419	NA	Uncertain_significance	CHARGE_syndrome&not_provided&Hypogonadism_with_anosmia	NC_000008.11:g.60678767GGC[9]		Microsatellite	CHD7:55636	MONDO:MONDO:0008965&MedGen:C0265354&OMIM:214800&Orphanet:138&MedGen:C3661900&MONDO:MONDO:0018800&MedGen:C0162809&Orphanet:478		criteria_provided&_multiple_submitters&_no_conflicts		CHD7	CHARGE syndrome	AD	214800	Complex genetic syndromes	NBScreening	-8	Benign	BA1	rs886063023	chr8_60678764_C_CGCG	Female	0/1	Heterozygous
chr8	60678764	.	C	CGCGGCG	207.23	PASS	"FS=0;MQ=245.66;MQRankSum=2.039;QD=2.4;ReadPosRankSum=0.793;SOR=0.836;FractionInformativeReads=0.842;R2_5P_bias=4.095;DP=35;AF=0.5;AN=4;AC=1;CSQ=GCGGCG|5_prime_UTR_variant|MODIFIER|CHD7|55636|Transcript|NM_017780.4|protein_coding|1/38||NM_017780.4:c.-472_-467dup||25-26|||||rs886063023||1||insertion|EntrezGene||YES|||||||||26||0.06863|0|0||0|0||0.03608|0.1667|0.085|0.09211|0.1418|0.04009|0.05492|0.06745|0.1969|0.04644|0.1|0.06991|0.07452|0.111|0.1969|gnomADg_EAS|||1|||||||||||||||||||||||||||363418||Uncertain_significance|CHARGE_syndrome&not_provided&Hypogonadism_with_anosmia|NC_000008.11:g.60678767GGC[10]||Microsatellite|CHD7:55636|MONDO:MONDO:0008965&MedGen:C0265354&OMIM:214800&Orphanet:138&MedGen:C3661900&MONDO:MONDO:0018800&MedGen:C0162809&Orphanet:478||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:11,.:.:16:4,.:7,.:45:56,.,.:45.608,.,.:0,.,.:6,5,3,2:3,8,3,2	./.:.,.:.:.:.,.:.,.:.:.:.:.:.:.	1/0:0,7:0.5:14:0,2:0,5:50:225,166,59:207.23,157.23,53:0,9,12:0,0,8,6:0,0,7,7	GCGGCG	5_prime_UTR_variant	MODIFIER	CHD7	55636	Transcript	NM_017780.4	protein_coding	1/38		c.-472_-467dup		25-26					rs886063023	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			26	NA	0.06863	0	0	NA	0	0	NA	0.03608	0.1667	0.085	0.09211	0.1418	0.04009	0.05492	0.06745	0.1969	0.04644	0.1	0.06991	0.07452	0.111	0.1969	gnomADg_EAS			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				363418	NA	Uncertain_significance	CHARGE_syndrome&not_provided&Hypogonadism_with_anosmia	NC_000008.11:g.60678767GGC[10]		Microsatellite	CHD7:55636	MONDO:MONDO:0008965&MedGen:C0265354&OMIM:214800&Orphanet:138&MedGen:C3661900&MONDO:MONDO:0018800&MedGen:C0162809&Orphanet:478		criteria_provided&_multiple_submitters&_no_conflicts		CHD7	CHARGE syndrome	AD	214800	Complex genetic syndromes	NBScreening	-8	Benign	BA1	rs886063023	chr8_60678764_C_CGCGGCG	Female	0/0	Other
chr8	60777762	.	A	G	135.92	PASS	"FS=3.22;MQ=250;MQRankSum=4.767;QD=1.48;ReadPosRankSum=2.488;SOR=0.741;FractionInformativeReads=0.97;R2_5P_bias=12.811;DP=64;AF=1;AN=4;AC=3;CSQ=G|intron_variant|MODIFIER|CHD7|55636|Transcript|NM_017780.4|protein_coding||2/37|NM_017780.4:c.1666-3238A>G|||||||rs4738824&CS072148||1||SNV|EntrezGene||YES|||A|A||||||0.8606|||||||||||0.8023|0.8081|0.7303|0.8146|0.7641|0.9427|0.8324|0.7653|0.7761|0.7812|0.9174|0.9444|EAS|uncertain_significance|0&1|1&1||||||||||||-3|14|14|-36|0.00|0.00|0.00|0.00|CHD7|||||||2030||Uncertain_significance|Scoliosis&_isolated&_susceptibility_to&_3|NC_000008.11:g.60777762A>G||single_nucleotide_variant|CHD7:55636|MONDO:MONDO:0012115&MedGen:C1837461&OMIM:608765||no_assertion_criteria_provided|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:18,14:0.438:32:11,11:7,3:47:84,0,50:48.791,7.9212e-05,53:0,34.77,37.77:11,7,6,8:10,8,7,7	./.:.:.:.:.:.:.:.:.:.:.:.	1/1:0,30:1:30:0,19:0,11:86:174,89,0:135.92,85.919,0:0,34.77,37.77:0,0,13,17:0,0,16,14	G	intron_variant	MODIFIER	CHD7	55636	Transcript	NM_017780.4	protein_coding		2/37	c.1666-3238A>G							rs4738824&CS072148	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.8606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0.8023	0.8081	0.7303	0.8146	0.7641	0.9427	0.8324	0.7653	0.7761	0.7812	0.9174	0.9444	EAS	uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-3	14	14	-36	0	0	0	0	CHD7			NA				2030	NA	Uncertain_significance	Scoliosis&_isolated&_susceptibility_to&_3	NC_000008.11:g.60777762A>G		single_nucleotide_variant	CHD7:55636	MONDO:MONDO:0012115&MedGen:C1837461&OMIM:608765		no_assertion_criteria_provided		CHD7	CHARGE syndrome	AD	214800	Complex genetic syndromes	NBScreening	-12	Benign	BP4_Strong,BA1	rs4738824	chr8_60777762_A_G	Female	0/1	Heterozygous
chr8	71362155	.	CTT	C	157.33	PASS	"FS=0;MQ=237.73;QD=5.62;SOR=1.127;FractionInformativeReads=0.714;MQRankSum=3.107;ReadPosRankSum=0.252;R2_5P_bias=0;DP=77;AF=1;AN=6;AC=3;CSQ=-|upstream_gene_variant|MODIFIER|EYA1|2138|Transcript|NM_000503.6|protein_coding||||||||||rs35320129|87|-1||deletion|EntrezGene||YES|||TT|TT|||||||0.0681|0.1651|0.04964|0.04808|0.03301|0.05785|0.04964|0.06695|0.06675|0.04947|0.07952|0.1457|0.05045|0.06349|0.05493|0.01128|0.1033|0.1129|0.05668|0.09347|0.04086|0.1651|gnomADe_AFR|uncertain_significance||1|||||||||||||||||||||||||||363681||Uncertain_significance|Branchiootorenal_Spectrum_Disorders&Otofaciocervical_syndrome_1|NC_000008.11:g.71362179_71362180del||Deletion|EYA1:2138|MedGen:CN043574&MONDO:MONDO:0024532&MedGen:C3714941&OMIM:166780||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,10:0.5:20:0,4:0,6:45:167,112,49:157.33,107.33,46.907:0,5,8.01:0,0,8,12:0,0,13,7	1/1:6,22:0.786:28:5,13:1,9:9:67,12,0:59.161,9.1612,0.56162:0,5,8.01:6,0,7,15:5,1,12,10	0/0:0,.:.:15:0,.:0,.:36:137,.,.:126.66,.,.:0,.,.:0,0,5,10:0,0,6,9	-	upstream_gene_variant	MODIFIER	EYA1	2138	Transcript	NM_000503.6	protein_coding										rs35320129	87	-1	NA	deletion	EntrezGene	NA	YES	NA	NA	TT	TT	NA	NA			NA	NA	0.0681	0.1651	0.04964	0.04808	0.03301	0.05785	0.04964	0.06695	0.06675	0.04947	0.07952	0.1457	0.05045	0.06349	0.05493	0.01128	0.1033	0.1129	0.05668	0.09347	0.04086	0.1651	gnomADe_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				363681	NA	Uncertain_significance	Branchiootorenal_Spectrum_Disorders&Otofaciocervical_syndrome_1	NC_000008.11:g.71362179_71362180del		Deletion	EYA1:2138	MedGen:CN043574&MONDO:MONDO:0024532&MedGen:C3714941&OMIM:166780		criteria_provided&_single_submitter		EYA1	Branchiootorenal syndrome 1	AD	113650	Complex genetic syndromes	NBScreening	0	Uncertain_significance		rs35320129	chr8_71362155_CTT_C	Female	1/0	Heterozygous
chr8	74367098	.	C	CAA	336.3	PASS	"FS=0;MQ=250;QD=6.04;SOR=0.919;FractionInformativeReads=0.959;DP=122;AF=0.5;AN=6;AC=2;CSQ=AA|downstream_gene_variant|MODIFIER|GDAP1|54332|Transcript|NM_018972.4|protein_coding||||||||||rs71563287|222|1||insertion|EntrezGene||YES|||||||||||0.3928|0.5|0.4286|0.3667|0.4054|0.3704||0.3877|0.3986|0.3896|0.6353|0.7199|0.5594|0.6682|0.5589|0.7006|0.5877|0.556|0.5886|0.6435|0.574|0.7199|gnomADg_AFR|uncertain_significance||1|||||||||||||||||||||||||||363766||Uncertain_significance|Charcot-Marie-Tooth&_Intermediate&Charcot-Marie-Tooth_with_Vocal_Cord_Paresis|NC_000008.11:g.74367112_74367113dup||Duplication|GDAP1:54332|MedGen:CN239334&MedGen:CN239254||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,34:0.723:47:0,19:0,15:31:314,255,37:295.99,245.99,30.719:0,9,12.01:0,0,21,26:0,0,29,18	1/0:0,16:0.485:33:0,7:0,9:50:352,309,58:336.3,300.86,53:0,8,11:0,0,14,19:0,0,16,17	0/0:0,.:0.485:37:0,.:0,.:108:170,.,.:158.22,.,.:0,.,.:0,0,15,22:0,0,21,16	AA	downstream_gene_variant	MODIFIER	GDAP1	54332	Transcript	NM_018972.4	protein_coding										rs71563287	222	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.3928	0.5	0.4286	0.3667	0.4054	0.3704	NA	0.3877	0.3986	0.3896	0.6353	0.7199	0.5594	0.6682	0.5589	0.7006	0.5877	0.556	0.5886	0.6435	0.574	0.7199	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				363766	NA	Uncertain_significance	Charcot-Marie-Tooth&_Intermediate&Charcot-Marie-Tooth_with_Vocal_Cord_Paresis	NC_000008.11:g.74367112_74367113dup		Duplication	GDAP1:54332	MedGen:CN239334&MedGen:CN239254		criteria_provided&_single_submitter		GDAP1	Charcot-Marie-Tooth disease type 4A	AR	214400	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs71563287	chr8_74367098_C_CAA	Female	1/0	Heterozygous
chr8	74367098	.	C	CAA	336.3	PASS	"FS=0;MQ=250;QD=6.04;SOR=0.919;FractionInformativeReads=0.959;DP=122;AF=0.5;AN=6;AC=2;CSQ=AA|downstream_gene_variant|MODIFIER|GDAP1|54332|Transcript|NM_018972.4|protein_coding||||||||||rs71563287|222|1||insertion|EntrezGene||YES|||||||||||0.3928|0.5|0.4286|0.3667|0.4054|0.3704||0.3877|0.3986|0.3896|0.6353|0.7199|0.5594|0.6682|0.5589|0.7006|0.5877|0.556|0.5886|0.6435|0.574|0.7199|gnomADg_AFR|uncertain_significance||1|||||||||||||||||||||||||||363766||Uncertain_significance|Charcot-Marie-Tooth&_Intermediate&Charcot-Marie-Tooth_with_Vocal_Cord_Paresis|NC_000008.11:g.74367112_74367113dup||Duplication|GDAP1:54332|MedGen:CN239334&MedGen:CN239254||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,34:0.723:47:0,19:0,15:31:314,255,37:295.99,245.99,30.719:0,9,12.01:0,0,21,26:0,0,29,18	1/0:0,16:0.485:33:0,7:0,9:50:352,309,58:336.3,300.86,53:0,8,11:0,0,14,19:0,0,16,17	0/0:0,.:0.485:37:0,.:0,.:108:170,.,.:158.22,.,.:0,.,.:0,0,15,22:0,0,21,16	AA	downstream_gene_variant	MODIFIER	GDAP1	54332	Transcript	NM_018972.4	protein_coding										rs71563287	222	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.3928	0.5	0.4286	0.3667	0.4054	0.3704	NA	0.3877	0.3986	0.3896	0.6353	0.7199	0.5594	0.6682	0.5589	0.7006	0.5877	0.556	0.5886	0.6435	0.574	0.7199	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				363766	NA	Uncertain_significance	Charcot-Marie-Tooth&_Intermediate&Charcot-Marie-Tooth_with_Vocal_Cord_Paresis	NC_000008.11:g.74367112_74367113dup		Duplication	GDAP1:54332	MedGen:CN239334&MedGen:CN239254		criteria_provided&_single_submitter		GDAP1	Charcot-Marie-Tooth disease axonal type 2K	AR	607831	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs71563287	chr8_74367098_C_CAA	Female	1/0	Heterozygous
chr8	74367098	.	C	CAA	336.3	PASS	"FS=0;MQ=250;QD=6.04;SOR=0.919;FractionInformativeReads=0.959;DP=122;AF=0.5;AN=6;AC=2;CSQ=AA|downstream_gene_variant|MODIFIER|GDAP1|54332|Transcript|NM_018972.4|protein_coding||||||||||rs71563287|222|1||insertion|EntrezGene||YES|||||||||||0.3928|0.5|0.4286|0.3667|0.4054|0.3704||0.3877|0.3986|0.3896|0.6353|0.7199|0.5594|0.6682|0.5589|0.7006|0.5877|0.556|0.5886|0.6435|0.574|0.7199|gnomADg_AFR|uncertain_significance||1|||||||||||||||||||||||||||363766||Uncertain_significance|Charcot-Marie-Tooth&_Intermediate&Charcot-Marie-Tooth_with_Vocal_Cord_Paresis|NC_000008.11:g.74367112_74367113dup||Duplication|GDAP1:54332|MedGen:CN239334&MedGen:CN239254||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/0:0,34:0.723:47:0,19:0,15:31:314,255,37:295.99,245.99,30.719:0,9,12.01:0,0,21,26:0,0,29,18	1/0:0,16:0.485:33:0,7:0,9:50:352,309,58:336.3,300.86,53:0,8,11:0,0,14,19:0,0,16,17	0/0:0,.:0.485:37:0,.:0,.:108:170,.,.:158.22,.,.:0,.,.:0,0,15,22:0,0,21,16	AA	downstream_gene_variant	MODIFIER	GDAP1	54332	Transcript	NM_018972.4	protein_coding										rs71563287	222	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.3928	0.5	0.4286	0.3667	0.4054	0.3704	NA	0.3877	0.3986	0.3896	0.6353	0.7199	0.5594	0.6682	0.5589	0.7006	0.5877	0.556	0.5886	0.6435	0.574	0.7199	gnomADg_AFR	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				363766	NA	Uncertain_significance	Charcot-Marie-Tooth&_Intermediate&Charcot-Marie-Tooth_with_Vocal_Cord_Paresis	NC_000008.11:g.74367112_74367113dup		Duplication	GDAP1:54332	MedGen:CN239334&MedGen:CN239254		criteria_provided&_single_submitter		GDAP1	Charcot-Marie-Tooth disease recessive intermediate A	AR	608340	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs71563287	chr8_74367098_C_CAA	Female	1/0	Heterozygous
chr8	118933262	.	C	T	50	PASS	"FS=5.738;MQ=250;MQRankSum=6.177;QD=0.94;ReadPosRankSum=1.272;SOR=0.787;FractionInformativeReads=0.981;R2_5P_bias=-11.065;DP=53;AF=0.5;AN=2;AC=1;CSQ=T|synonymous_variant|LOW|TNFRSF11B|4982|Transcript|NM_002546.4|protein_coding|2/5||NM_002546.4:c.69G>A|NP_002537.3:p.Thr23%3D|133|69|23|T|acG/acA|rs146450643||-1||SNV|EntrezGene||YES|||C|C|||||||0.0001355|0.0005974|0.0004025|0|0|0|0.002254|0.0001088|0.0003808|3.478e-05|0.0001051|7.218e-05|0|0.0001961|0|0|0|0.003401|0.0001029|0.0004735|0.000207|0.003401|gnomADg_MID|likely_benign&conflicting_interpretations_of_pathogenicity||1||||||||||||-46|38|-11|1|0.00|0.00|0.00|0.00|TNFRSF11B|||||||289070||Conflicting_classifications_of_pathogenicity|not_provided&TNFRSF11B-related_disorder|NC_000008.11:g.118933262C>T||single_nucleotide_variant|TNFRSF11B:4982|MedGen:C3661900&.|Uncertain_significance(1)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:26,26:0.5:52:14,14:12,12:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:10,16,15,11:12,14,13,13	T	synonymous_variant	LOW	TNFRSF11B	4982	Transcript	NM_002546.4	protein_coding	05-Feb		c.69G>A	p.Thr23%3D	133	69	23	T	acG/acA	rs146450643	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0.0001355	0.0005974	0.0004025	0	0	0	0.002254	0.0001088	0.0003808	3.478e-05	0.0001051	7.218e-05	0	0.0001961	0	0	0	0.003401	0.0001029	0.0004735	0.000207	0.003401	gnomADg_MID	likely_benign&conflicting_interpretations_of_pathogenicity		1	NA	NA	NA		NA	NA		NA	NA	NA		-46	38	-11	1	0	0	0	0	TNFRSF11B			NA				289070	NA	Conflicting_classifications_of_pathogenicity	not_provided&TNFRSF11B-related_disorder	NC_000008.11:g.118933262C>T		single_nucleotide_variant	TNFRSF11B:4982	MedGen:C3661900&.	Uncertain_significance(1)&Likely_benign(2)	criteria_provided&_conflicting_classifications		TNFRSF11B	Extramammary Paget disease	AR	167300	Skelettal, skin, and connective tissue disorders	NBScreening	-10	Benign	BP4_Strong,BP6,BP7,BS1	rs146450643	chr8_118933262_C_T	Female	./.	Other
chr8	132898178	.	G	T	50	PASS	"FS=9.037;MQ=250;MQRankSum=4.433;QD=1.74;ReadPosRankSum=1.741;SOR=1.25;FractionInformativeReads=1;R2_5P_bias=4.777;DP=55;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|TG|7038|Transcript|NM_003235.5|protein_coding|13/48||NM_003235.5:c.3149G>T|NP_003226.4:p.Trp1050Leu|3192|3149|1050|W/L|tGg/tTg|rs142124591&CM1615617||1||SNV|EntrezGene||YES|||G|G|||deleterious(0.01)|probably_damaging(0.998)||0.0006|0.0001234|0|0.0009393|0.0003483|0|0.0001324|0.003044|7.23e-05|0.0003833|3.584e-05|0.0001379|2.406e-05|0|0.0005227|0|0|0|0.0102|0.0001323|0|0|0.0102|gnomADg_MID|uncertain_significance|0&1|1&1||||T|0.52407|0.00547762|D|0.82264|0.184651|0.96096|0.870|9|-9|-9|0|0.00|0.06|0.00|0.00|TG|likely_pathogenic|hg38|0.7001|W1050L|ENST00000220616.9|P01266|981843||Uncertain_significance|not_specified&not_provided&Hereditary_breast_ovarian_cancer_syndrome&Iodotyrosyl_coupling_defect&Autoimmune_thyroid_disease&_susceptibility_to&_3|NC_000008.11:g.132898178G>T||single_nucleotide_variant|TG:7038|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0003582&MeSH:D061325&MedGen:C0677776&Orphanet:145&MONDO:MONDO:0010135&MedGen:C0342194&OMIM:274700&Orphanet:95716&MONDO:MONDO:0011982&MedGen:C1842444&OMIM:608175||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:16,12:0.429:28:6,8:10,4:47:83,0,50:48.611,8.1542e-05,53:0,34.77,37.77:5,11,8,4:11,5,6,6	0/1:13,14:0.519:27:8,7:5,7:48:85,0,50:50,6.5233e-05,53.014:0,34.77,37.77:6,7,10,4:7,6,5,9	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	TG	7038	Transcript	NM_003235.5	protein_coding	13/48		c.3149G>T	p.Trp1050Leu	3192	3149	1050	W/L	tGg/tTg	rs142124591&CM1615617	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious(0.01)	probably_damaging(0.998)	NA	6,00E-04	0.0001234	0	0.0009393	0.0003483	0	0.0001324	0.003044	7.23e-05	0.0003833	3.584e-05	0.0001379	2.406e-05	0	0.0005227	0	0	0	0.0102	0.0001323	0	0	0.0102	gnomADg_MID	uncertain_significance	0&1	1&1	NA	NA	NA	T	0.52407	0.00547762	D	0.82264	0.184651	0.96096	0.870	9	-9	-9	0	0	0.06	0	0	TG	likely_pathogenic	hg38	0.7001	W1050L	ENST00000220616.9	P01266	981843	NA	Uncertain_significance	not_specified&not_provided&Hereditary_breast_ovarian_cancer_syndrome&Iodotyrosyl_coupling_defect&Autoimmune_thyroid_disease&_susceptibility_to&_3	NC_000008.11:g.132898178G>T		single_nucleotide_variant	TG:7038	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0003582&MeSH:D061325&MedGen:C0677776&Orphanet:145&MONDO:MONDO:0010135&MedGen:C0342194&OMIM:274700&Orphanet:95716&MONDO:MONDO:0011982&MedGen:C1842444&OMIM:608175		criteria_provided&_multiple_submitters&_no_conflicts		TG	Iodotyrosyl coupling defect	AR	274700	Endocrine disorders	NBScreening	0	Uncertain_significance		rs142124591	chr8_132898178_G_T	Female	0/1	Heterozygous
chr8	143919093	.	G	A	202.52	PASS	"FS=0;MQ=249.28;QD=3.89;SOR=1.244;FractionInformativeReads=1;MQRankSum=5.239;ReadPosRankSum=3.041;R2_5P_bias=-8.667;DP=129;AF=0.5;AN=6;AC=4;CSQ=A|synonymous_variant|LOW|PLEC|5339|Transcript|NM_201384.3|protein_coding|32/32||NM_201384.3:c.10728C>T|NP_958786.1:p.Gly3576%3D|10864|10728|3576|G|ggC/ggT|rs372840016&COSV59617247||-1||SNV|EntrezGene||YES|||G|G||||||0.0002|0.0002885|5.974e-05|2.236e-05|0|0.004761|0|0.0001734|0.0001682|0.0001822|0.0003478|0.0001248|7.216e-05|0|0|0|0.0005792|0|0|0.000147|0|0.0006219|0.004761|gnomADe_EAS|uncertain_significance&likely_benign|0&1|1&1||||||||||||-9|14|2|-39|0.00|0.00|0.00|0.00|PLEC|||||||283034||Conflicting_classifications_of_pathogenicity|not_specified&not_provided&Epidermolysis_bullosa_simplex&_Ogna_type&Epidermolysis_bullosa_simplex_5C&_with_pyloric_atresia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2Q&Epidermolysis_bullosa_simplex_with_nail_dystrophy&Epidermolysis_bullosa_simplex_5B&_with_muscular_dystrophy|NC_000008.11:g.143919093G>A||single_nucleotide_variant|PLEC:5339|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0007555&MedGen:C0432317&OMIM:131950&Orphanet:79401&MONDO:MONDO:0012807&MedGen:C2677349&OMIM:612138&Orphanet:158684&MONDO:MONDO:0013390&MedGen:C3150989&OMIM:613723&Orphanet:254361&MONDO:MONDO:0014661&MedGen:C4225309&OMIM:616487&MONDO:MONDO:0009181&MedGen:C2931072&OMIM:226670&Orphanet:257|Uncertain_significance(1)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,52:1:52:0,24:0,28:153:240,156,0:202.52,152.52,0:0,34.77,37.78:0,0,20,32:0,0,26,26	0/1:16,23:0.59:39:8,11:8,12:47:85,0,48:50,8.18e-05,50.528:0,34.77,37.77:8,8,8,15:8,8,12,11	0/1:13,24:0.649:37:8,7:5,17:45:85,0,43:50,0.00015092,46.062:0,34.77,37.77:4,9,12,12:5,8,13,11	A	synonymous_variant	LOW	PLEC	5339	Transcript	NM_201384.3	protein_coding	32/32		c.10728C>T	p.Gly3576%3D	10864	10728	3576	G	ggC/ggT	rs372840016&COSV59617247	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	2,00E-04	0.0002885	5.974e-05	2.236e-05	0	0.004761	0	0.0001734	0.0001682	0.0001822	0.0003478	0.0001248	7.216e-05	0	0	0	0.0005792	0	0	0.000147	0	0.0006219	0.004761	gnomADe_EAS	uncertain_significance&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-9	14	2	-39	0	0	0	0	PLEC			NA				283034	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided&Epidermolysis_bullosa_simplex&_Ogna_type&Epidermolysis_bullosa_simplex_5C&_with_pyloric_atresia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2Q&Epidermolysis_bullosa_simplex_with_nail_dystrophy&Epidermolysis_bullosa_simplex_5B&_with_muscular_dystrophy	NC_000008.11:g.143919093G>A		single_nucleotide_variant	PLEC:5339	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0007555&MedGen:C0432317&OMIM:131950&Orphanet:79401&MONDO:MONDO:0012807&MedGen:C2677349&OMIM:612138&Orphanet:158684&MONDO:MONDO:0013390&MedGen:C3150989&OMIM:613723&Orphanet:254361&MONDO:MONDO:0014661&MedGen:C4225309&OMIM:616487&MONDO:MONDO:0009181&MedGen:C2931072&OMIM:226670&Orphanet:257	Uncertain_significance(1)&Likely_benign(3)	criteria_provided&_conflicting_classifications		PLEC	Epidermolysis bullosa simplex, Ogna type	AR	131950	"Skelettal, skin, and connective tissue disorders;Neuromuscular and musculoskelettal disorders"	NBScreening	-10	Benign	BP4_Strong,BP6,BP7,BS1	rs372840016	chr8_143919093_G_A	Female	01-Jan	Homozygous
chr8	143919093	.	G	A	202.52	PASS	"FS=0;MQ=249.28;QD=3.89;SOR=1.244;FractionInformativeReads=1;MQRankSum=5.239;ReadPosRankSum=3.041;R2_5P_bias=-8.667;DP=129;AF=0.5;AN=6;AC=4;CSQ=A|synonymous_variant|LOW|PLEC|5339|Transcript|NM_201384.3|protein_coding|32/32||NM_201384.3:c.10728C>T|NP_958786.1:p.Gly3576%3D|10864|10728|3576|G|ggC/ggT|rs372840016&COSV59617247||-1||SNV|EntrezGene||YES|||G|G||||||0.0002|0.0002885|5.974e-05|2.236e-05|0|0.004761|0|0.0001734|0.0001682|0.0001822|0.0003478|0.0001248|7.216e-05|0|0|0|0.0005792|0|0|0.000147|0|0.0006219|0.004761|gnomADe_EAS|uncertain_significance&likely_benign|0&1|1&1||||||||||||-9|14|2|-39|0.00|0.00|0.00|0.00|PLEC|||||||283034||Conflicting_classifications_of_pathogenicity|not_specified&not_provided&Epidermolysis_bullosa_simplex&_Ogna_type&Epidermolysis_bullosa_simplex_5C&_with_pyloric_atresia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2Q&Epidermolysis_bullosa_simplex_with_nail_dystrophy&Epidermolysis_bullosa_simplex_5B&_with_muscular_dystrophy|NC_000008.11:g.143919093G>A||single_nucleotide_variant|PLEC:5339|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0007555&MedGen:C0432317&OMIM:131950&Orphanet:79401&MONDO:MONDO:0012807&MedGen:C2677349&OMIM:612138&Orphanet:158684&MONDO:MONDO:0013390&MedGen:C3150989&OMIM:613723&Orphanet:254361&MONDO:MONDO:0014661&MedGen:C4225309&OMIM:616487&MONDO:MONDO:0009181&MedGen:C2931072&OMIM:226670&Orphanet:257|Uncertain_significance(1)&Likely_benign(3)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,52:1:52:0,24:0,28:153:240,156,0:202.52,152.52,0:0,34.77,37.78:0,0,20,32:0,0,26,26	0/1:16,23:0.59:39:8,11:8,12:47:85,0,48:50,8.18e-05,50.528:0,34.77,37.77:8,8,8,15:8,8,12,11	0/1:13,24:0.649:37:8,7:5,17:45:85,0,43:50,0.00015092,46.062:0,34.77,37.77:4,9,12,12:5,8,13,11	A	synonymous_variant	LOW	PLEC	5339	Transcript	NM_201384.3	protein_coding	32/32		c.10728C>T	p.Gly3576%3D	10864	10728	3576	G	ggC/ggT	rs372840016&COSV59617247	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	2,00E-04	0.0002885	5.974e-05	2.236e-05	0	0.004761	0	0.0001734	0.0001682	0.0001822	0.0003478	0.0001248	7.216e-05	0	0	0	0.0005792	0	0	0.000147	0	0.0006219	0.004761	gnomADe_EAS	uncertain_significance&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		-9	14	2	-39	0	0	0	0	PLEC			NA				283034	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided&Epidermolysis_bullosa_simplex&_Ogna_type&Epidermolysis_bullosa_simplex_5C&_with_pyloric_atresia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2Q&Epidermolysis_bullosa_simplex_with_nail_dystrophy&Epidermolysis_bullosa_simplex_5B&_with_muscular_dystrophy	NC_000008.11:g.143919093G>A		single_nucleotide_variant	PLEC:5339	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0007555&MedGen:C0432317&OMIM:131950&Orphanet:79401&MONDO:MONDO:0012807&MedGen:C2677349&OMIM:612138&Orphanet:158684&MONDO:MONDO:0013390&MedGen:C3150989&OMIM:613723&Orphanet:254361&MONDO:MONDO:0014661&MedGen:C4225309&OMIM:616487&MONDO:MONDO:0009181&MedGen:C2931072&OMIM:226670&Orphanet:257	Uncertain_significance(1)&Likely_benign(3)	criteria_provided&_conflicting_classifications		PLEC	Autosomal recessive limb-girdle muscular dystrophy type 2Q	AR	613723	"Skelettal, skin, and connective tissue disorders;Neuromuscular and musculoskelettal disorders"	NBScreening	-10	Benign	BP4_Strong,BP6,BP7,BS1	rs372840016	chr8_143919093_G_A	Female	01-Jan	Homozygous
chr8	143934047	.	G	A	156.96	PASS	"FS=0;MQ=250;QD=4.24;SOR=0.984;FractionInformativeReads=1;MQRankSum=4.951;ReadPosRankSum=3.709;R2_5P_bias=10.414;DP=109;AF=0.5;AN=6;AC=4;CSQ=A|missense_variant|MODERATE|PLEC|5339|Transcript|NM_201384.3|protein_coding|12/32||NM_201384.3:c.1214C>T|NP_958786.1:p.Ala405Val|1350|1214|405|A/V|gCg/gTg|rs377430087||-1||SNV|EntrezGene||YES|||G|G|||deleterious_low_confidence(0)|unknown(0)|||5.482e-06|5.986e-05|2.24e-05|0|0|0|0|4.499e-06|0|0|3.285e-05|4.826e-05|0|6.542e-05|0|0|0|0|2.94e-05|0|0|6.542e-05|gnomADg_AMR|uncertain_significance||1||||T|0.52948|0.00944158|T|0.60000|-0.141349|0.76685|0.474&0.474&0.474&0.474&0.474&0.474&0.474&0.474&.&0.474&0.474|28|44|2|-45|0.00|0.00|0.05|0.01|PLEC|||||||194175||Uncertain_significance|Epidermolysis_bullosa_simplex_with_nail_dystrophy&Epidermolysis_bullosa_simplex_5B&_with_muscular_dystrophy&Epidermolysis_bullosa_simplex&_Ogna_type&Epidermolysis_bullosa_simplex_5C&_with_pyloric_atresia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2Q&not_provided&Inborn_genetic_diseases|NC_000008.11:g.143934047G>A||single_nucleotide_variant|PLEC:5339|MONDO:MONDO:0014661&MedGen:C4225309&OMIM:616487&MONDO:MONDO:0009181&MedGen:C2931072&OMIM:226670&Orphanet:257&MONDO:MONDO:0007555&MedGen:C0432317&OMIM:131950&Orphanet:79401&MONDO:MONDO:0012807&MedGen:C2677349&OMIM:612138&Orphanet:158684&MONDO:MONDO:0013390&MedGen:C3150989&OMIM:613723&Orphanet:254361&MedGen:C3661900&MeSH:D030342&MedGen:C0950123||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,37:1:37:0,20:0,17:107:195,110,0:156.96,106.96,0:0,34.77,37.78:0,0,16,21:0,0,17,20	0/1:18,16:0.471:34:8,8:10,8:48:85,0,50:49.787,6.7304e-05,53:0,34.77,37.77:12,6,10,6:8,10,6,10	0/1:16,21:0.568:37:7,11:9,10:46:85,0,45:50,0.00010639,48.395:0,34.77,37.78:4,12,9,12:9,7,9,12	A	missense_variant	MODERATE	PLEC	5339	Transcript	NM_201384.3	protein_coding	12/32		c.1214C>T	p.Ala405Val	1350	1214	405	A/V	gCg/gTg	rs377430087	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious_low_confidence(0)	unknown(0)	NA	NA	5.482e-06	5.986e-05	2.24e-05	0	0	0	0	4.499e-06	0	0	3.285e-05	4.826e-05	0	6.542e-05	0	0	0	0	2.94e-05	0	0	6.542e-05	gnomADg_AMR	uncertain_significance		1	NA	NA	NA	T	0.52948	0.00944158	T	0.6	-0.141349	0.76685	0.474&0.474&0.474&0.474&0.474&0.474&0.474&0.474&.&0.474&0.474	28	44	2	-45	0	0	0.05	0.01	PLEC			NA				194175	NA	Uncertain_significance	Epidermolysis_bullosa_simplex_with_nail_dystrophy&Epidermolysis_bullosa_simplex_5B&_with_muscular_dystrophy&Epidermolysis_bullosa_simplex&_Ogna_type&Epidermolysis_bullosa_simplex_5C&_with_pyloric_atresia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2Q&not_provided&Inborn_genetic_diseases	NC_000008.11:g.143934047G>A		single_nucleotide_variant	PLEC:5339	MONDO:MONDO:0014661&MedGen:C4225309&OMIM:616487&MONDO:MONDO:0009181&MedGen:C2931072&OMIM:226670&Orphanet:257&MONDO:MONDO:0007555&MedGen:C0432317&OMIM:131950&Orphanet:79401&MONDO:MONDO:0012807&MedGen:C2677349&OMIM:612138&Orphanet:158684&MONDO:MONDO:0013390&MedGen:C3150989&OMIM:613723&Orphanet:254361&MedGen:C3661900&MeSH:D030342&MedGen:C0950123		criteria_provided&_multiple_submitters&_no_conflicts		PLEC	Epidermolysis bullosa simplex, Ogna type	AR	131950	"Skelettal, skin, and connective tissue disorders;Neuromuscular and musculoskelettal disorders"	NBScreening	0	Uncertain_significance		rs377430087	chr8_143934047_G_A	Female	01-Jan	Homozygous
chr8	143934047	.	G	A	156.96	PASS	"FS=0;MQ=250;QD=4.24;SOR=0.984;FractionInformativeReads=1;MQRankSum=4.951;ReadPosRankSum=3.709;R2_5P_bias=10.414;DP=109;AF=0.5;AN=6;AC=4;CSQ=A|missense_variant|MODERATE|PLEC|5339|Transcript|NM_201384.3|protein_coding|12/32||NM_201384.3:c.1214C>T|NP_958786.1:p.Ala405Val|1350|1214|405|A/V|gCg/gTg|rs377430087||-1||SNV|EntrezGene||YES|||G|G|||deleterious_low_confidence(0)|unknown(0)|||5.482e-06|5.986e-05|2.24e-05|0|0|0|0|4.499e-06|0|0|3.285e-05|4.826e-05|0|6.542e-05|0|0|0|0|2.94e-05|0|0|6.542e-05|gnomADg_AMR|uncertain_significance||1||||T|0.52948|0.00944158|T|0.60000|-0.141349|0.76685|0.474&0.474&0.474&0.474&0.474&0.474&0.474&0.474&.&0.474&0.474|28|44|2|-45|0.00|0.00|0.05|0.01|PLEC|||||||194175||Uncertain_significance|Epidermolysis_bullosa_simplex_with_nail_dystrophy&Epidermolysis_bullosa_simplex_5B&_with_muscular_dystrophy&Epidermolysis_bullosa_simplex&_Ogna_type&Epidermolysis_bullosa_simplex_5C&_with_pyloric_atresia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2Q&not_provided&Inborn_genetic_diseases|NC_000008.11:g.143934047G>A||single_nucleotide_variant|PLEC:5339|MONDO:MONDO:0014661&MedGen:C4225309&OMIM:616487&MONDO:MONDO:0009181&MedGen:C2931072&OMIM:226670&Orphanet:257&MONDO:MONDO:0007555&MedGen:C0432317&OMIM:131950&Orphanet:79401&MONDO:MONDO:0012807&MedGen:C2677349&OMIM:612138&Orphanet:158684&MONDO:MONDO:0013390&MedGen:C3150989&OMIM:613723&Orphanet:254361&MedGen:C3661900&MeSH:D030342&MedGen:C0950123||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,37:1:37:0,20:0,17:107:195,110,0:156.96,106.96,0:0,34.77,37.78:0,0,16,21:0,0,17,20	0/1:18,16:0.471:34:8,8:10,8:48:85,0,50:49.787,6.7304e-05,53:0,34.77,37.77:12,6,10,6:8,10,6,10	0/1:16,21:0.568:37:7,11:9,10:46:85,0,45:50,0.00010639,48.395:0,34.77,37.78:4,12,9,12:9,7,9,12	A	missense_variant	MODERATE	PLEC	5339	Transcript	NM_201384.3	protein_coding	12/32		c.1214C>T	p.Ala405Val	1350	1214	405	A/V	gCg/gTg	rs377430087	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious_low_confidence(0)	unknown(0)	NA	NA	5.482e-06	5.986e-05	2.24e-05	0	0	0	0	4.499e-06	0	0	3.285e-05	4.826e-05	0	6.542e-05	0	0	0	0	2.94e-05	0	0	6.542e-05	gnomADg_AMR	uncertain_significance		1	NA	NA	NA	T	0.52948	0.00944158	T	0.6	-0.141349	0.76685	0.474&0.474&0.474&0.474&0.474&0.474&0.474&0.474&.&0.474&0.474	28	44	2	-45	0	0	0.05	0.01	PLEC			NA				194175	NA	Uncertain_significance	Epidermolysis_bullosa_simplex_with_nail_dystrophy&Epidermolysis_bullosa_simplex_5B&_with_muscular_dystrophy&Epidermolysis_bullosa_simplex&_Ogna_type&Epidermolysis_bullosa_simplex_5C&_with_pyloric_atresia&Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2Q&not_provided&Inborn_genetic_diseases	NC_000008.11:g.143934047G>A		single_nucleotide_variant	PLEC:5339	MONDO:MONDO:0014661&MedGen:C4225309&OMIM:616487&MONDO:MONDO:0009181&MedGen:C2931072&OMIM:226670&Orphanet:257&MONDO:MONDO:0007555&MedGen:C0432317&OMIM:131950&Orphanet:79401&MONDO:MONDO:0012807&MedGen:C2677349&OMIM:612138&Orphanet:158684&MONDO:MONDO:0013390&MedGen:C3150989&OMIM:613723&Orphanet:254361&MedGen:C3661900&MeSH:D030342&MedGen:C0950123		criteria_provided&_multiple_submitters&_no_conflicts		PLEC	Autosomal recessive limb-girdle muscular dystrophy type 2Q	AR	613723	"Skelettal, skin, and connective tissue disorders;Neuromuscular and musculoskelettal disorders"	NBScreening	0	Uncertain_significance		rs377430087	chr8_143934047_G_A	Female	01-Jan	Homozygous
chr9	34648170	.	A	G	50	PASS	"FS=0;MQ=250;MQRankSum=4.933;QD=1.43;ReadPosRankSum=3.115;SOR=0.542;FractionInformativeReads=1;R2_5P_bias=-0.028;DP=35;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant&splice_region_variant|MODERATE|GALT|2592|Transcript|NM_000155.4|protein_coding|6/11||NM_000155.4:c.563A>G|NP_000146.2:p.Gln188Arg|593|563|188|Q/R|cAg/cGg|rs75391579&CM152743&CM910169||1||SNV|EntrezGene||YES|||A|A|||deleterious(0.01)|probably_damaging(0.998)||0.0006|0.002611|0.0005078|0.0007826|3.826e-05|0|0.0001498|0.0001737|0.0032|0.002417|0.0005913|0.001871|0.0008179|0.005482|0.001242|0|0|9.413e-05|0|0.003249|0.002365|0|0.005482|gnomADg_AMI|conflicting_interpretations_of_pathogenicity&pathogenic|0&1&1|1&1&1|0.995766831452802|0.964||D|0.77924|0.24278|D|0.96280|0.57417|0.99762|0.975&0.975&0.975|7|2|-40|1|0.00|0.02|0.11|0.30|GALT|likely_pathogenic|hg38|0.9664|Q188R|ENST00000378842.7|P07902|3614||Conflicting_classifications_of_pathogenicity|Inborn_genetic_diseases&GALT-related_disorder&not_provided&Deficiency_of_UDPglucose-hexose-1-phosphate_uridylyltransferase&Galactosemia|NC_000009.12:g.34648170A>G||single_nucleotide_variant|GALT:2592|MeSH:D030342&MedGen:C0950123&.&MedGen:C3661900&MONDO:MONDO:0009258&MedGen:C0268151&OMIM:230400&Orphanet:352&Orphanet:79239&Human_Phenotype_Ontology:HP:0004919&MONDO:MONDO:0018116&MedGen:C0016952&OMIM:PS230400&Orphanet:352|Pathogenic(31)&Uncertain_significance(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:14,21:0.6:35:10,15:4,6:47:85,0,47:50,8.5942e-05,50.086:0,34.77,37.77:8,6,11,10:6,8,13,8	G	missense_variant&splice_region_variant	MODERATE	GALT	2592	Transcript	NM_000155.4	protein_coding	11-Jun		c.563A>G	p.Gln188Arg	593	563	188	Q/R	cAg/cGg	rs75391579&CM152743&CM910169	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA	deleterious(0.01)	probably_damaging(0.998)	NA	6,00E-04	0.002611	0.0005078	0.0007826	3.826e-05	0	0.0001498	0.0001737	0.0032	0.002417	0.0005913	0.001871	0.0008179	0.005482	0.001242	0	0	9.413e-05	0	0.003249	0.002365	0	0.005482	gnomADg_AMI	conflicting_interpretations_of_pathogenicity&pathogenic	0&1&1	1&1&1	0.995766831452802	0.964	NA	D	0.77924	0.24278	D	0.9628	0.57417	0.99762	0.975&0.975&0.975	7	2	-40	1	0	0.02	0.11	0.3	GALT	likely_pathogenic	hg38	0.9664	Q188R	ENST00000378842.7	P07902	3614	NA	Conflicting_classifications_of_pathogenicity	Inborn_genetic_diseases&GALT-related_disorder&not_provided&Deficiency_of_UDPglucose-hexose-1-phosphate_uridylyltransferase&Galactosemia	NC_000009.12:g.34648170A>G		single_nucleotide_variant	GALT:2592	MeSH:D030342&MedGen:C0950123&.&MedGen:C3661900&MONDO:MONDO:0009258&MedGen:C0268151&OMIM:230400&Orphanet:352&Orphanet:79239&Human_Phenotype_Ontology:HP:0004919&MONDO:MONDO:0018116&MedGen:C0016952&OMIM:PS230400&Orphanet:352	Pathogenic(31)&Uncertain_significance(1)	criteria_provided&_conflicting_classifications		GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	AR	230400	Inherited disorders of metabolism	NBScreening	4	Uncertain_significance	PM1,PP2,PP3,PP5,BS2_Supporting	rs75391579	chr9_34648170_A_G	Female	./.	Other
chr9	34650282	.	C	CA	340.98	PASS	"FS=0;MQ=236.11;QD=3.8;SOR=1.942;FractionInformativeReads=0.829;DP=86;AF=0.5;AN=6;AC=2;CSQ=A|intron_variant|MODIFIER|GALT|2592|Transcript|NM_000155.4|protein_coding||10/10|NM_000155.4:c.1060-71dup|||||||rs56121779||1||insertion|EntrezGene||YES|||||||||16|0.5581|0.3245|0.2687|0.3617|0.3065|0.3355|0.2874|0.3133|0.328|0.3162|0.3216|0.4724|0.42|0.5441|0.5806|0.4239|0.5251|0.5706|0.5319|0.4639|0.494|0.5696|0.663|EUR|||1||||||||||||-16|-28|50|-28|0.00|0.00|0.00|0.00|GALT|||||||1339767||Uncertain_significance|not_specified&not_provided|NC_000009.12:g.34650298dup||Duplication|GALT:2592|MedGen:CN169374&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/0:0,.:.:29:0,.:0,.:83:144,.,.:133,.,.:0,.,.:0,0,21,8:0,0,18,11	1/0:0,10:0.625:16:0,4:0,6:49:248,251,55:234.17,244.09,50.722:0,7,10:0,0,8,8:0,0,11,5	1/0:0,15:0.577:26:0,5:0,10:49:355,461,56:340.98,450,51.582:0,7,10:0,0,15,11:0,0,12,14	A	intron_variant	MODIFIER	GALT	2592	Transcript	NM_000155.4	protein_coding		10-Oct	c.1060-71dup							rs56121779	NA	1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			16	0.5581	0.3245	0.2687	0.3617	0.3065	0.3355	0.2874	0.3133	0.328	0.3162	0.3216	0.4724	0.42	0.5441	0.5806	0.4239	0.5251	0.5706	0.5319	0.4639	0.494	0.5696	0.663	EUR			1	NA	NA	NA		NA	NA		NA	NA	NA		-16	-28	50	-28	0	0	0	0	GALT			NA				1339767	NA	Uncertain_significance	not_specified&not_provided	NC_000009.12:g.34650298dup		Duplication	GALT:2592	MedGen:CN169374&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		GALT	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	AR	230400	Inherited disorders of metabolism	NBScreening	-8	Benign	BA1	rs56121779	chr9_34650282_C_CA	Female	0/0	Other
chr9	36216640	.	G	GATTATT	127.88	PASS	"FS=0;MQ=245.68;QD=4.74;SOR=0.922;FractionInformativeReads=1;MQRankSum=3.004;ReadPosRankSum=0.46;R2_5P_bias=3.933;DP=80;AF=0.5;AN=6;AC=5;CSQ=ATTATT|3_prime_UTR_variant|MODIFIER|GNE|10020|Transcript|NM_005476.7|protein_coding|12/12||NM_005476.7:c.*719_*724dup||3063-3064|||||rs113316798||-1||insertion|EntrezGene||YES|||||||||||0|||0||||0|||0.2555|0.3025|0.1509|0.2044|0.2951|0.2723|0.1654|0.2598|0.2475|0.2719|0.2579|0.3025|gnomADg_AFR|||1|||||||||||||||||||||||||||366826||Uncertain_significance|GNE_myopathy&Sialuria&Inclusion_Body_Myopathy&_Recessive&not_provided|NC_000009.12:g.36216641ATT[13]||Microsatellite|GNE:10020|MONDO:MONDO:0011603&MedGen:C1853926&OMIM:605820&Orphanet:602&MONDO:MONDO:0010028&MedGen:C0342853&OMIM:269921&Orphanet:3166&MedGen:CN239230&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,27:1:27:0,14:0,13:78:136,81,0:127.88,77.883,0:0,5,8.01:0,0,12,15:0,0,11,16	1/1:0,20:1:20:0,11:0,9:57:113,60,0:106.91,56.908,8.8012e-06:0,3,6:0,0,9,11:0,0,10,10	0/1:13,16:0.552:29:9,11:4,5:47:54,0,46:50,9.3449e-05,49.389:0,4,7.01:6,7,6,10:4,9,9,7	ATTATT	3_prime_UTR_variant	MODIFIER	GNE	10020	Transcript	NM_005476.7	protein_coding	12-Dec		c.*719_*724dup		3063-3064					rs113316798	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0	NA	NA	0	NA	NA	NA	0	NA	NA	0.2555	0.3025	0.1509	0.2044	0.2951	0.2723	0.1654	0.2598	0.2475	0.2719	0.2579	0.3025	gnomADg_AFR			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				366826	NA	Uncertain_significance	GNE_myopathy&Sialuria&Inclusion_Body_Myopathy&_Recessive&not_provided	NC_000009.12:g.36216641ATT[13]		Microsatellite	GNE:10020	MONDO:MONDO:0011603&MedGen:C1853926&OMIM:605820&Orphanet:602&MONDO:MONDO:0010028&MedGen:C0342853&OMIM:269921&Orphanet:3166&MedGen:CN239230&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		GNE	Inclusion body myositis	AR	147421	Neuromuscular and musculoskelettal disorders	NBScreening	-8	Benign	BA1	rs113316798	chr9_36216640_G_GATTATT	Female	01-Jan	Homozygous
chr9	77220298	.	C	T	50	PASS	"FS=2.835;MQ=250;MQRankSum=5.226;QD=1.32;ReadPosRankSum=3.112;SOR=0.34;FractionInformativeReads=1;R2_5P_bias=-2.946;DP=79;AF=0.5;AN=4;AC=2;CSQ=T|missense_variant|MODERATE|VPS13A|23230|Transcript|NM_033305.3|protein_coding|12/72||NM_033305.3:c.904C>T|NP_150648.2:p.Leu302Phe|1075|904|302|L/F|Ctt/Ttt|rs541051874||1||SNV|EntrezGene||YES|||C|C|||deleterious_low_confidence(0)|probably_damaging(0.998)||0.0002|2.123e-05|0|0|0|0|0|0|9e-06|3.318e-05|0.0002209|2.635e-05|0|0|0|0|0|0|0|0|0|0.0008319|0.001|SAS|uncertain_significance||1||||T|0.27819|-0.153159|T|0.49404|-0.254179|0.60456|0.286&0.286&0.286&0.286&.&.&.|41|-21|-21|-13|0.01|0.05|0.00|0.00|VPS13A|likely_benign|hg38|0.2678|L302F|ENST00000360280.8|Q96RL7|548478||Uncertain_significance|Chorea-acanthocytosis&Inborn_genetic_diseases|NC_000009.12:g.77220298C>T||single_nucleotide_variant|VPS13A:23230|MONDO:MONDO:0008695&MedGen:C0393576&OMIM:200150&Orphanet:2388&MeSH:D030342&MedGen:C0950123||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,21:0.553:38:7,8:10,13:48:85,0,49:50,7.041e-05,52.084:0,34.77,37.77:6,11,10,11:10,7,11,10	0/1:23,18:0.439:41:13,10:10,8:47:83,0,50:48.673,8.0765e-05,53:0,34.77,37.77:16,7,9,9:12,11,7,11	./.:.:.:.:.:.:.:.:.:.:.:.	T	missense_variant	MODERATE	VPS13A	23230	Transcript	NM_033305.3	protein_coding	12/72		c.904C>T	p.Leu302Phe	1075	904	302	L/F	Ctt/Ttt	rs541051874	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA	deleterious_low_confidence(0)	probably_damaging(0.998)	NA	2,00E-04	2.123e-05	0	0	0	0	0	0	9,00E-06	3.318e-05	0.0002209	2.635e-05	0	0	0	0	0	0	0	0	0	0.0008319	0.001	SAS	uncertain_significance		1	NA	NA	NA	T	0.27819	-0.153159	T	0.49404	-0.254179	0.60456	0.286&0.286&0.286&0.286&.&.&.	41	-21	-21	-13	0.01	0.05	0	0	VPS13A	likely_benign	hg38	0.2678	L302F	ENST00000360280.8	Q96RL7	548478	NA	Uncertain_significance	Chorea-acanthocytosis&Inborn_genetic_diseases	NC_000009.12:g.77220298C>T		single_nucleotide_variant	VPS13A:23230	MONDO:MONDO:0008695&MedGen:C0393576&OMIM:200150&Orphanet:2388&MeSH:D030342&MedGen:C0950123		criteria_provided&_multiple_submitters&_no_conflicts		VPS13A	Choreoacanthocytosis	AR	200150	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-2	Likely_benign	BP4_Moderate	rs541051874	chr9_77220298_C_T	Female	0/1	Heterozygous
chr9	94603492	.	G	A	50	PASS	"FS=0;MQ=248.98;MQRankSum=3.039;QD=2.5;ReadPosRankSum=0.836;SOR=0.665;FractionInformativeReads=1;R2_5P_bias=14.084;DP=54;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|FBP1|2203|Transcript|NM_000507.4|protein_coding|7/7||NM_000507.4:c.906C>T|NP_000498.2:p.Ala302%3D|1114|906|302|A|gcC/gcT|rs28369776||-1||SNV|EntrezGene||YES|||G|G||||||0.0022|0.0007251|0.0002688|0.0001789|0.003214|0|0|0.002081|0.0001043|0.0007617|0.009101|0.0005781|0.0001685|0|0.0001962|0.003456|0.0001933|0|0|0.0001323|0.00189|0.01081|0.01081|gnomADg_SAS|likely_benign&conflicting_interpretations_of_pathogenicity||1||||||||||||-23|32|49|-2|0.03|0.00|0.00|0.00|FBP1|||||||377876||Conflicting_classifications_of_pathogenicity|FBP1-related_disorder&Fructose-biphosphatase_deficiency&not_provided|NC_000009.12:g.94603492G>A||single_nucleotide_variant|FBP1:2203|.&MONDO:MONDO:0009251&MedGen:C0016756&OMIM:229700&Orphanet:348&MedGen:C3661900|Uncertain_significance(1)&Benign(1)&Likely_benign(2)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:9,11:0.55:20:5,4:4,7:48:85,0,50:50,6.7045e-05,52.645:0,34.77,37.77:5,4,6,5:5,4,9,2	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:17,17:0.5:34:5,8:12,9:48:85,0,50:50,6.5233e-05,53:0,34.77,37.77:7,10,9,8:9,8,8,9	A	synonymous_variant	LOW	FBP1	2203	Transcript	NM_000507.4	protein_coding	07-Jul		c.906C>T	p.Ala302%3D	1114	906	302	A	gcC/gcT	rs28369776	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	0.0022	0.0007251	0.0002688	0.0001789	0.003214	0	0	0.002081	0.0001043	0.0007617	0.009101	0.0005781	0.0001685	0	0.0001962	0.003456	0.0001933	0	0	0.0001323	0.00189	0.01081	0.01081	gnomADg_SAS	likely_benign&conflicting_interpretations_of_pathogenicity		1	NA	NA	NA		NA	NA		NA	NA	NA		-23	32	49	-2	0.03	0	0	0	FBP1			NA				377876	NA	Conflicting_classifications_of_pathogenicity	FBP1-related_disorder&Fructose-biphosphatase_deficiency&not_provided	NC_000009.12:g.94603492G>A		single_nucleotide_variant	FBP1:2203	.&MONDO:MONDO:0009251&MedGen:C0016756&OMIM:229700&Orphanet:348&MedGen:C3661900	Uncertain_significance(1)&Benign(1)&Likely_benign(2)	criteria_provided&_conflicting_classifications		FBP1	Fructose-biphosphatase deficiency	AR	229700	Inherited disorders of metabolism	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BS1,BS2	rs28369776	chr9_94603492_G_A	Female	0/1	Heterozygous
chr9	100301139	.	TCA	T	110.76	PASS	"FS=0;MQ=249.02;MQRankSum=1.977;QD=1.84;ReadPosRankSum=1;SOR=0.754;FractionInformativeReads=0.444;R2_5P_bias=10.5;DP=59;AF=0.5;AN=4;AC=2;CSQ=-|3_prime_UTR_variant|MODIFIER|INVS|27130|Transcript|NM_014425.5|protein_coding|17/17||NM_014425.5:c.*504_*505del||3862-3863|||||rs10527613||1||deletion|EntrezGene||YES|||CA|CA|||||38||0.005956|0|0.009566|0|0|0.0008977|0|0.008408|0.005948|0.00145|0.145|0.07317|0.07488|0.1533|0.118|0.1801|0.1981|0.1208|0.1688|0.1489|0.1342|0.1981|gnomADg_FIN|||1|||||||||||||||||||||||||||364243||Uncertain_significance|Nephronophthisis|NC_000009.12:g.100301140CA[19]||Microsatellite|INVS:27130|Human_Phenotype_Ontology:HP:0000090&Human_Phenotype_Ontology:HP:0004748&MONDO:MONDO:0019005&MedGen:C0687120&OMIM:PS256100&Orphanet:655||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:5,7:0.583:12:4,6:1,1:47:53,0,47:49.745,8.9566e-05,50:0,3,6.01:3,2,3,4:2,3,4,3	1/0:0,4:0.286:14:0,3:0,1:45:115,155,52:110.76,153.31,53:0,2,5:0,0,6,8:0,0,4,10	./.:.,.:0.286:.:.,.:.,.:.:.:.:.:.:.	-	3_prime_UTR_variant	MODIFIER	INVS	27130	Transcript	NM_014425.5	protein_coding	17/17		c.*504_*505del		3862-3863					rs10527613	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	CA	CA	NA	NA			38	NA	0.005956	0	0.009566	0	0	0.0008977	0	0.008408	0.005948	0.00145	0.145	0.07317	0.07488	0.1533	0.118	0.1801	0.1981	0.1208	0.1688	0.1489	0.1342	0.1981	gnomADg_FIN			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				364243	NA	Uncertain_significance	Nephronophthisis	NC_000009.12:g.100301140CA[19]		Microsatellite	INVS:27130	Human_Phenotype_Ontology:HP:0000090&Human_Phenotype_Ontology:HP:0004748&MONDO:MONDO:0019005&MedGen:C0687120&OMIM:PS256100&Orphanet:655		criteria_provided&_single_submitter		INVS	Nephronophthisis 2	AR	604387	Renal disorders	NBScreening	-8	Benign	BA1	rs10527613	chr9_100301139_TCA_T	Female	0/1	Heterozygous
chr9	101421520	.	G	C	50	PASS	"FS=0;MQ=249.91;MQRankSum=4.485;QD=1.13;ReadPosRankSum=4.485;SOR=0.641;FractionInformativeReads=0.971;R2_5P_bias=15.212;DP=82;AF=0.5;AN=4;AC=2;CSQ=C|3_prime_UTR_variant|MODIFIER|ALDOB|229|Transcript|NM_000035.4|protein_coding|9/9||NM_000035.4:c.*289C>G||1460|||||rs886063290||-1||SNV|EntrezGene||YES|||G|G|||||||2.323e-05|0|0|0|0.0001221|0|0|0|0|0.0001146|6.567e-06|0|0|0|0|0|0|0|0|0|0.0002071|0.0002071|gnomADg_SAS|uncertain_significance||1||||||||||||0|-14|1|-41|0.00|0.00|0.00|0.00|ALDOB|||||||364300||Uncertain_significance|Hereditary_fructosuria|NC_000009.12:g.101421520G>C||single_nucleotide_variant|ALDOB:229|Human_Phenotype_Ontology:HP:0005973&MONDO:MONDO:0009249&MedGen:C0016751&OMIM:229600&Orphanet:469||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:23,10:0.303:33:12,4:11,6:38:73,0,50:38.567,0.00062597,53.001:0,34.77,37.77:18,5,8,2:11,12,4,6	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:16,32:0.667:48:13,16:3,16:41:85,0,38:50,0.00037096,41.227:0,34.77,37.77:11,5,26,6:8,8,18,14	C	3_prime_UTR_variant	MODIFIER	ALDOB	229	Transcript	NM_000035.4	protein_coding	09-Sep		c.*289C>G		1460					rs886063290	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	2.323e-05	0	0	0	0.0001221	0	0	0	0	0.0001146	6.567e-06	0	0	0	0	0	0	0	0	0	0.0002071	0.0002071	gnomADg_SAS	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		0	-14	1	-41	0	0	0	0	ALDOB			NA				364300	NA	Uncertain_significance	Hereditary_fructosuria	NC_000009.12:g.101421520G>C		single_nucleotide_variant	ALDOB:229	Human_Phenotype_Ontology:HP:0005973&MONDO:MONDO:0009249&MedGen:C0016751&OMIM:229600&Orphanet:469		criteria_provided&_single_submitter		ALDOB	Hereditary fructosuria	AR	229600	Inherited disorders of metabolism	NBScreening	-2	Likely_benign	PM2,BP4_Strong	rs886063290	chr9_101421520_G_C	Female	0/1	Heterozygous
chr9	108874950	.	A	C	49.04	PASS	"FS=3.77;MQ=247.44;MQRankSum=6.449;QD=0.85;ReadPosRankSum=2.812;SOR=1.353;FractionInformativeReads=0.983;R2_5P_bias=5.547;DP=58;AF=0.5;AN=2;AC=1;CSQ=C|synonymous_variant|LOW|ELP1|8518|Transcript|NM_003640.5|protein_coding|36/37||NM_003640.5:c.3876T>G|NP_003631.2:p.Thr1292%3D|4192|3876|1292|T|acT/acG|rs61749202||-1||SNV|EntrezGene||YES|||A|A||||||0.0076|0.01545|0.00332|0.01328|0.05084|0|0.004071|0.04979|0.01588|0.01779|0.01518|0.01281|0.003583|0.001096|0.02327|0.04839|0|0.002822|0.03401|0.0168|0.01512|0.01305|0.05084|gnomADe_ASJ|conflicting_interpretations_of_pathogenicity&benign||1|||||||||||||||||||||||||||364551||Conflicting_classifications_of_pathogenicity|Familial_dysautonomia&not_provided&ELP1-related_disorder|NC_000009.12:g.108874950A>C||single_nucleotide_variant|ELP1:8518|MONDO:MONDO:0009131&MedGen:C0013364&OMIM:223900&Orphanet:1764&MedGen:C3661900&.|Uncertain_significance(1)&Benign(5)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:31,26:0.456:57:10,12:21,14:48:84,0,50:49.036,7.5847e-05,53:0,34.77,37.77:16,15,17,9:13,18,15,11	C	synonymous_variant	LOW	ELP1	8518	Transcript	NM_003640.5	protein_coding	36/37		c.3876T>G	p.Thr1292%3D	4192	3876	1292	T	acT/acG	rs61749202	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	0.0076	0.01545	0.00332	0.01328	0.05084	0	0.004071	0.04979	0.01588	0.01779	0.01518	0.01281	0.003583	0.001096	0.02327	0.04839	0	0.002822	0.03401	0.0168	0.01512	0.01305	0.05084	gnomADe_ASJ	conflicting_interpretations_of_pathogenicity&benign		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				364551	NA	Conflicting_classifications_of_pathogenicity	Familial_dysautonomia&not_provided&ELP1-related_disorder	NC_000009.12:g.108874950A>C		single_nucleotide_variant	ELP1:8518	MONDO:MONDO:0009131&MedGen:C0013364&OMIM:223900&Orphanet:1764&MedGen:C3661900&.	Uncertain_significance(1)&Benign(5)	criteria_provided&_conflicting_classifications		ELP1	Familial dysautonomia	AR	223900	Neurodevelopmental, neurodegenerative, and neurogenetic disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BS1,BS2	rs61749202	chr9_108874950_A_C	Female	./.	Other
chr9	126697837	.	CTGTTT	C	157.98	PASS	"FS=0;MQ=220.54;MQRankSum=-0.182;QD=3.51;ReadPosRankSum=-0.243;SOR=0.598;FractionInformativeReads=0.919;R2_5P_bias=0;DP=114;AF=1;AN=6;AC=6;CSQ=-|3_prime_UTR_variant|MODIFIER|LMX1B|4010|Transcript|NM_001174147.2|protein_coding|8/8||NM_001174147.2:c.*1437_*1441del||3118-3122|||||rs59836255||1||deletion|EntrezGene||YES|||TGTTT|TGTTT|||||50||0.227|0.2222|0.2143|0.3333|0.1618|0.2143|0.5|0.2313|0.2073|0.25|0.3599|0.2874|0.519|0.356|0.4901|0.2607|0.3347|0.5483|0.3973|0.407|0.4512|0.5483|gnomADg_MID|||1|||||||||||||||||||||||||||364923||Uncertain_significance|Nail-patella_syndrome|NC_000009.12:g.126697838TGTTT[10]||Microsatellite|LMX1B:4010|MONDO:MONDO:0008061&MedGen:C0027341&OMIM:161200&Orphanet:2614||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:3,31:0.912:34:0,18:3,13:80:136,83,0:129.71,79.71,0:0,3,6.01:2,1,18,13:1,2,15,16	1/1:0,22:1:22:0,15:0,7:63:118,66,0:113.23,63.227,2.0709e-06:0,2,5:0,0,12,10:0,0,13,9	1/1:0,37:1:37:0,20:0,17:108:163,111,0:157.98,107.98,0:0,2,5:0,0,20,17:0,0,13,24	-	3_prime_UTR_variant	MODIFIER	LMX1B	4010	Transcript	NM_001174147.2	protein_coding	08-Aug		c.*1437_*1441del		3118-3122					rs59836255	NA	1	NA	deletion	EntrezGene	NA	YES	NA	NA	TGTTT	TGTTT	NA	NA			50	NA	0.227	0.2222	0.2143	0.3333	0.1618	0.2143	0.5	0.2313	0.2073	0.25	0.3599	0.2874	0.519	0.356	0.4901	0.2607	0.3347	0.5483	0.3973	0.407	0.4512	0.5483	gnomADg_MID			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				364923	NA	Uncertain_significance	Nail-patella_syndrome	NC_000009.12:g.126697838TGTTT[10]		Microsatellite	LMX1B:4010	MONDO:MONDO:0008061&MedGen:C0027341&OMIM:161200&Orphanet:2614		criteria_provided&_single_submitter		LMX1B	Nail-patella syndrome	AD	161200	Complex genetic syndromes	NBScreening	-8	Benign	BA1	rs59836255	chr9_126697837_CTGTTT_C	Female	01-Jan	Homozygous
chr9	133071462	.	T	G	42.5	PASS	"FS=2.632;MQ=36.46;MQRankSum=-0.387;QD=3.86;ReadPosRankSum=0.717;SOR=1.981;FractionInformativeReads=1;R2_5P_bias=-0.858;DP=11;AF=0.5;AN=2;AC=1;CSQ=G|missense_variant|MODERATE|CEL|1056|Transcript|NM_001807.6|protein_coding|11/11||NM_001807.6:c.1960T>G|NP_001798.3:p.Ser654Ala|1982|1960|654|S/A|Tcc/Gcc|rs587780308&COSV100672945||1||SNV|EntrezGene||YES|||T|T|||tolerated_low_confidence(0.23)|benign(0.026)||||||||||||||||||||||||||uncertain_significance|0&1|1&1||||T|0.28951|-0.145922|T|0.27985|-0.447383|0.10176|0.039|27|-6|27|-6|0.00|0.00|0.00|0.00|CEL|||||||128687||Uncertain_significance|not_provided&Maturity-onset_diabetes_of_the_young_type_8|NC_000009.12:g.133071462T>G||single_nucleotide_variant|CEL:1056|MedGen:C3661900&MONDO:MONDO:0012348&MedGen:C1853297&OMIM:609812&Orphanet:552||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:6,5:0.455:11:3,4:3,1:34:77,0,31:42.502,0.001845,34.335:0,34.77,37.78:3,3,4,1:4,2,3,2	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	G	missense_variant	MODERATE	CEL	1056	Transcript	NM_001807.6	protein_coding	11-Nov		c.1960T>G	p.Ser654Ala	1982	1960	654	S/A	Tcc/Gcc	rs587780308&COSV100672945	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	T	T	NA	NA	tolerated_low_confidence(0.23)	benign(0.026)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		uncertain_significance	0&1	1&1	NA	NA	NA	T	0.28951	-0.145922	T	0.27985	-0.447383	0.10176	0.039	27	-6	27	-6	0	0	0	0	CEL			NA				128687	NA	Uncertain_significance	not_provided&Maturity-onset_diabetes_of_the_young_type_8	NC_000009.12:g.133071462T>G		single_nucleotide_variant	CEL:1056	MedGen:C3661900&MONDO:MONDO:0012348&MedGen:C1853297&OMIM:609812&Orphanet:552		criteria_provided&_multiple_submitters&_no_conflicts		CEL	Maturity-onset diabetes of the young type 8	AD	609812	Endocrine disorders	NBScreening	-5	Likely_benign	BP4_Strong,BP6	rs587780308	chr9_133071462_T_G	Female	0/1	Heterozygous
chr9	133071468	.	G	C	42.5	PASS	"FS=2.632;MQ=34.98;MQRankSum=-0.583;QD=3.54;ReadPosRankSum=0.869;SOR=2.303;FractionInformativeReads=1;R2_5P_bias=1.961;DP=12;AF=0.5;AN=2;AC=1;CSQ=C|missense_variant|MODERATE|CEL|1056|Transcript|NM_001807.6|protein_coding|11/11||NM_001807.6:c.1966G>C|NP_001798.3:p.Ala656Pro|1988|1966|656|A/P|Gcc/Ccc|rs587780309&COSV104658896&COSV104658904||1||SNV|EntrezGene||YES|||G|G|||deleterious_low_confidence(0.01)|probably_damaging(0.981)|||0.004153|0.0008347|0.001277|0.006959|0.0003493|0.005329|0.007143|0.002921|0.003967|0.01651|0.001738|0.0001956|0.005556|0.001228|0.009483|0|0.001807|0|0.002468|0.001548|0.004932|0.01651|gnomADe_SAS|uncertain_significance|0&1&1|1&1&1||||T|0.02412|-0.397278|T|0.37114|-0.368066|0.42761|0.167|-45|10|-12|21|0.00|0.00|0.00|0.00|CEL|||||||128688||Uncertain_significance|not_provided&Maturity_onset_diabetes_mellitus_in_young|NC_000009.12:g.133071468G>C||single_nucleotide_variant|CEL:1056|MedGen:C3661900&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:6,6:0.5:12:3,5:3,1:34:77,0,31:42.502,0.001845,34.335:0,34.77,37.78:3,3,5,1:4,2,4,2	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	C	missense_variant	MODERATE	CEL	1056	Transcript	NM_001807.6	protein_coding	11-Nov		c.1966G>C	p.Ala656Pro	1988	1966	656	A/P	Gcc/Ccc	rs587780309&COSV104658896&COSV104658904	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA	deleterious_low_confidence(0.01)	probably_damaging(0.981)	NA	NA	0.004153	0.0008347	0.001277	0.006959	0.0003493	0.005329	0.007143	0.002921	0.003967	0.01651	0.001738	0.0001956	0.005556	0.001228	0.009483	0	0.001807	0	0.002468	0.001548	0.004932	0.01651	gnomADe_SAS	uncertain_significance	0&1&1	1&1&1	NA	NA	NA	T	0.02412	-0.397278	T	0.37114	-0.368066	0.42761	0.167	-45	10	-12	21	0	0	0	0	CEL			NA				128688	NA	Uncertain_significance	not_provided&Maturity_onset_diabetes_mellitus_in_young	NC_000009.12:g.133071468G>C		single_nucleotide_variant	CEL:1056	MedGen:C3661900&Human_Phenotype_Ontology:HP:0004904&MONDO:MONDO:0018911&MedGen:C0342276&OMIM:606391&Orphanet:552		criteria_provided&_multiple_submitters&_no_conflicts		CEL	Maturity-onset diabetes of the young type 8	AD	609812	Endocrine disorders	NBScreening	-9	Benign	BP4_Strong,BS1_Supporting,BS2	rs587780309	chr9_133071468_G_C	Female	0/1	Heterozygous
chr9	133555922	.	C	T	127.8	PASS	"FS=0;MQ=250;QD=4.73;SOR=0.765;FractionInformativeReads=1;MQRankSum=4.983;ReadPosRankSum=3.083;R2_5P_bias=23.289;DP=101;AF=0.5;AN=6;AC=4;CSQ=T|synonymous_variant|LOW|ADAMTSL2|9719|Transcript|NM_014694.4|protein_coding|11/19||NM_014694.4:c.1641C>T|NP_055509.2:p.His547%3D|2005|1641|547|H|caC/caT|rs7868941&COSV63203106||1||SNV|EntrezGene||YES|||C|C|||||||0.1558|0.1409|0.1034|0.1845|0.0004786|0.2171|0.2226|0.1673|0.1555|0.0618|0.1564|0.1426|0.2357|0.1371|0.1958|0.0009649|0.2236|0.2041|0.1741|0.1776|0.05035|0.2357|gnomADg_AMI|uncertain_significance&benign&likely_benign|0&1|1&1||||||||||||4|-36|-42|8|0.00|0.00|0.00|0.00|ADAMTSL2|||||||365599||Conflicting_classifications_of_pathogenicity|not_specified&not_provided&Geleophysic_dysplasia_1|NC_000009.12:g.133555922C>T||single_nucleotide_variant|ADAMTSL2:9719|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623|Uncertain_significance(1)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,27:1:27:0,11:0,16:78:166,81,0:127.8,77.797,0:0,34.77,37.77:0,0,14,13:0,0,12,15	0/1:20,15:0.429:35:8,5:12,10:47:83,0,50:48.443,8.3871e-05,53:0,34.77,37.77:8,12,7,8:12,8,7,8	0/1:21,18:0.462:39:8,7:13,11:48:84,0,50:49.354,7.2222e-05,53:0,34.77,37.77:7,14,9,9:8,13,6,12	T	synonymous_variant	LOW	ADAMTSL2	9719	Transcript	NM_014694.4	protein_coding	19-Nov		c.1641C>T	p.His547%3D	2005	1641	547	H	caC/caT	rs7868941&COSV63203106	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0.1558	0.1409	0.1034	0.1845	0.0004786	0.2171	0.2226	0.1673	0.1555	0.0618	0.1564	0.1426	0.2357	0.1371	0.1958	0.0009649	0.2236	0.2041	0.1741	0.1776	0.05035	0.2357	gnomADg_AMI	uncertain_significance&benign&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		4	-36	-42	8	0	0	0	0	ADAMTSL2			NA				365599	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided&Geleophysic_dysplasia_1	NC_000009.12:g.133555922C>T		single_nucleotide_variant	ADAMTSL2:9719	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623	Uncertain_significance(1)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		ADAMTSL2	Geleophysic dysplasia 1	AR	231050	Skelettal, skin, and connective tissue disorders	NBScreening	-12	Benign	BP4_Moderate,BP6,BP7,BA1	rs7868941	chr9_133555922_C_T	Female	01-Jan	Homozygous
chr9	133568420	.	C	T	178.97	PASS	"FS=0;MQ=250;QD=4.07;SOR=0.784;FractionInformativeReads=1;MQRankSum=4.603;ReadPosRankSum=2.129;R2_5P_bias=9.152;DP=122;AF=0.5;AN=6;AC=4;CSQ=T|synonymous_variant|LOW|ADAMTSL2|9719|Transcript|NM_014694.4|protein_coding|14/19||NM_014694.4:c.2022C>T|NP_055509.2:p.Pro674%3D|2386|2022|674|P|ccC/ccT|rs534165083&COSV63204352||1||SNV|EntrezGene||YES|||C|C|||||||0.1392|0.08472|0.08214|0.1171|0.01152|0.203|0.151|0.1524|0.1308|0.051|0.1254|0.08638|0.04386|0.1089|0.1227|0.003863|0.2088|0.1293|0.1561|0.138|0.04099|0.2088|gnomADg_FIN|uncertain_significance&conflicting_interpretations_of_pathogenicity&benign|0&1|1&1||||||||||||13|-45|-2|50|0.00|0.01|0.00|0.00|ADAMTSL2|||||||518395||Conflicting_classifications_of_pathogenicity|not_specified&not_provided&Geleophysic_dysplasia_1|NC_000009.12:g.133568420C>T||single_nucleotide_variant|ADAMTSL2:9719|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623|Uncertain_significance(2)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,44:1:44:0,26:0,18:129:217,132,0:178.97,128.97,0:0,34.77,37.77:0,0,23,21:0,0,21,23	0/1:19,12:0.387:31:8,7:11,5:46:81,0,50:46.702,0.00011468,53:0,34.77,37.77:6,13,4,8:5,14,5,7	0/1:24,23:0.489:47:14,11:10,12:48:85,0,50:49.935,6.5751e-05,53:0,34.77,37.77:11,13,12,11:9,15,12,11	T	synonymous_variant	LOW	ADAMTSL2	9719	Transcript	NM_014694.4	protein_coding	14/19		c.2022C>T	p.Pro674%3D	2386	2022	674	P	ccC/ccT	rs534165083&COSV63204352	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0.1392	0.08472	0.08214	0.1171	0.01152	0.203	0.151	0.1524	0.1308	0.051	0.1254	0.08638	0.04386	0.1089	0.1227	0.003863	0.2088	0.1293	0.1561	0.138	0.04099	0.2088	gnomADg_FIN	uncertain_significance&conflicting_interpretations_of_pathogenicity&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		13	-45	-2	50	0	0.01	0	0	ADAMTSL2			NA				518395	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided&Geleophysic_dysplasia_1	NC_000009.12:g.133568420C>T		single_nucleotide_variant	ADAMTSL2:9719	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623	Uncertain_significance(2)&Likely_benign(1)	criteria_provided&_conflicting_classifications		ADAMTSL2	Geleophysic dysplasia 1	AR	231050	Skelettal, skin, and connective tissue disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs534165083	chr9_133568420_C_T	Female	01-Jan	Homozygous
chr9	133568656	.	G	A	50	PASS	"FS=0;MQ=250;MQRankSum=4.767;QD=1.53;ReadPosRankSum=0.057;SOR=0.745;FractionInformativeReads=1;R2_5P_bias=9.041;DP=74;AF=0.5;AN=4;AC=2;CSQ=A|synonymous_variant|LOW|ADAMTSL2|9719|Transcript|NM_014694.4|protein_coding|15/19||NM_014694.4:c.2142G>A|NP_055509.2:p.Ser714%3D|2506|2142|714|S|tcG/tcA|rs11542920&COSV63203136||1||SNV|EntrezGene||YES|||G|G|||||||0.03737|0.0228|0.02197|0.06009|0.08158|0.02354|0.105|0.03079|0.03986|0.1108|0.03273|0.02461|0.02303|0.02752|0.05677|0.06226|0.02072|0.07483|0.03202|0.03217|0.1063|0.1108|gnomADe_SAS|likely_benign&uncertain_significance|0&1|1&1||||||||||||2|4|2|36|0.27|0.02|0.00|0.00|ADAMTSL2|||||||365603||Conflicting_classifications_of_pathogenicity|not_provided&Geleophysic_dysplasia_1|NC_000009.12:g.133568656G>A||single_nucleotide_variant|ADAMTSL2:9719|MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623|Uncertain_significance(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:18,14:0.438:32:13,5:5,9:48:84,0,50:49.011,7.6364e-05,53:0,34.77,37.77:8,10,6,8:11,7,7,7	0/1:19,22:0.537:41:7,12:12,10:48:85,0,50:50,6.7304e-05,52.582:0,34.77,37.77:8,11,7,15:10,9,9,13	A	synonymous_variant	LOW	ADAMTSL2	9719	Transcript	NM_014694.4	protein_coding	15/19		c.2142G>A	p.Ser714%3D	2506	2142	714	S	tcG/tcA	rs11542920&COSV63203136	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	0.03737	0.0228	0.02197	0.06009	0.08158	0.02354	0.105	0.03079	0.03986	0.1108	0.03273	0.02461	0.02303	0.02752	0.05677	0.06226	0.02072	0.07483	0.03202	0.03217	0.1063	0.1108	gnomADe_SAS	likely_benign&uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		2	4	2	36	0.27	0.02	0	0	ADAMTSL2			NA				365603	NA	Conflicting_classifications_of_pathogenicity	not_provided&Geleophysic_dysplasia_1	NC_000009.12:g.133568656G>A		single_nucleotide_variant	ADAMTSL2:9719	MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623	Uncertain_significance(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		ADAMTSL2	Geleophysic dysplasia 1	AR	231050	Skelettal, skin, and connective tissue disorders	NBScreening	-9	Benign	BP6,BA1	rs11542920	chr9_133568656_G_A	Female	./.	Other
chr9	133569476	.	A	G	190.87	PASS	"FS=0;MQ=247.86;QD=4.21;SOR=0.85;FractionInformativeReads=1;DP=126;AF=1;AN=6;AC=6;CSQ=G|synonymous_variant|LOW|ADAMTSL2|9719|Transcript|NM_014694.4|protein_coding|16/19||NM_014694.4:c.2313A>G|NP_055509.2:p.Val771%3D|2677|2313|771|V|gtA/gtG|rs1064975&COSV63204110&COSV63206113||1||SNV|EntrezGene||YES|||A|A|||||||0.5605|0.7681|0.4251|0.5568|0.1084|0.5472|0.6215|0.5858|0.548|0.4461|0.6001|0.7598|0.3695|0.5075|0.5591|0.09012|0.5535|0.6301|0.5883|0.5572|0.4239|0.7681|gnomADe_AFR|uncertain_significance&likely_benign&benign|0&1&1|1&1&1||||||||||||-33|2|0|-3|0.00|0.00|0.00|0.01|ADAMTSL2|||||||518396||Conflicting_classifications_of_pathogenicity|not_specified&not_provided&Geleophysic_dysplasia_1|NC_000009.12:g.133569476A>G||single_nucleotide_variant|ADAMTSL2:9719|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623|Uncertain_significance(1)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	1/1:0,39:1:39:0,17:0,22:114:202,117,0:164.38,114.38,0:0,34.77,37.77:0,0,21,18:0,0,13,26:.	1|1:0,39:1:39:0,15:0,24:114:202,117,0:163.91,113.91,0:0,34.77,37.77:0,0,21,18:0,0,15,24:133569476	1/1:0,48:1:48:0,20:0,28:141:229,144,0:190.87,140.87,0:0,34.77,37.78:0,0,28,20:0,0,24,24:.	G	synonymous_variant	LOW	ADAMTSL2	9719	Transcript	NM_014694.4	protein_coding	16/19		c.2313A>G	p.Val771%3D	2677	2313	771	V	gtA/gtG	rs1064975&COSV63204110&COSV63206113	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	A	A	NA	NA			NA	NA	0.5605	0.7681	0.4251	0.5568	0.1084	0.5472	0.6215	0.5858	0.548	0.4461	0.6001	0.7598	0.3695	0.5075	0.5591	0.09012	0.5535	0.6301	0.5883	0.5572	0.4239	0.7681	gnomADe_AFR	uncertain_significance&likely_benign&benign	0&1&1	1&1&1	NA	NA	NA		NA	NA		NA	NA	NA		-33	2	0	-3	0	0	0	0.01	ADAMTSL2			NA				518396	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided&Geleophysic_dysplasia_1	NC_000009.12:g.133569476A>G		single_nucleotide_variant	ADAMTSL2:9719	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623	Uncertain_significance(1)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		ADAMTSL2	Geleophysic dysplasia 1	AR	231050	Skelettal, skin, and connective tissue disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs1064975	chr9_133569476_A_G	Female	01-Jan	Homozygous
chr9	133569488	.	C	G	47.84	PASS	"FS=3.111;MQ=249.29;MQRankSum=4.778;QD=1.22;ReadPosRankSum=3.006;SOR=1.325;FractionInformativeReads=1;R2_5P_bias=16.626;DP=83;AF=0.5;AN=4;AC=2;CSQ=G|synonymous_variant|LOW|ADAMTSL2|9719|Transcript|NM_014694.4|protein_coding|16/19||NM_014694.4:c.2325C>G|NP_055509.2:p.Ser775%3D|2689|2325|775|S|tcC/tcG|rs2301606&COSV63203143||1||SNV|EntrezGene||YES|||C|C|||||||0.03752|0.02285|0.02185|0.05991|0.0821|0.02354|0.1056|0.03099|0.0403|0.1106|0.03288|0.02463|0.02303|0.02757|0.05674|0.06344|0.02071|0.07192|0.03227|0.03214|0.1062|0.1106|gnomADe_SAS|uncertain_significance&likely_benign|0&1|1&1||||||||||||4|-15|40|-15|0.00|0.00|0.00|0.00|ADAMTSL2|||||||365604||Conflicting_classifications_of_pathogenicity|not_provided&Geleophysic_dysplasia_1|NC_000009.12:g.133569488C>G||single_nucleotide_variant|ADAMTSL2:9719|MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623|Uncertain_significance(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB:PS	./.:.:.:.:.:.:.:.:.:.:.:.:.	0|1:23,12:0.343:35:9,6:14,6:42:77,0,50:42.578,0.00026172,53:0,34.77,37.77:12,11,8,4:10,13,2,10:133569476	0/1:27,20:0.426:47:12,7:15,13:47:83,0,50:47.844,9.319e-05,53:0,34.77,37.77:14,13,14,6:15,12,9,11:.	G	synonymous_variant	LOW	ADAMTSL2	9719	Transcript	NM_014694.4	protein_coding	16/19		c.2325C>G	p.Ser775%3D	2689	2325	775	S	tcC/tcG	rs2301606&COSV63203143	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	NA	0.03752	0.02285	0.02185	0.05991	0.0821	0.02354	0.1056	0.03099	0.0403	0.1106	0.03288	0.02463	0.02303	0.02757	0.05674	0.06344	0.02071	0.07192	0.03227	0.03214	0.1062	0.1106	gnomADe_SAS	uncertain_significance&likely_benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		4	-15	40	-15	0	0	0	0	ADAMTSL2			NA				365604	NA	Conflicting_classifications_of_pathogenicity	not_provided&Geleophysic_dysplasia_1	NC_000009.12:g.133569488C>G		single_nucleotide_variant	ADAMTSL2:9719	MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623	Uncertain_significance(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		ADAMTSL2	Geleophysic dysplasia 1	AR	231050	Skelettal, skin, and connective tissue disorders	NBScreening	-14	Benign	BP4_Strong,BP6,BP7,BA1	rs2301606	chr9_133569488_C_G	Female	./.	Other
chr9	133573863	.	G	A	132.44	PASS	"FS=0;MQ=250;QD=4.57;SOR=0.906;FractionInformativeReads=1;MQRankSum=4.188;ReadPosRankSum=0.356;R2_5P_bias=-4.928;DP=90;AF=0.5;AN=6;AC=4;CSQ=A|synonymous_variant|LOW|ADAMTSL2|9719|Transcript|NM_014694.4|protein_coding|18/19||NM_014694.4:c.2613G>A|NP_055509.2:p.Val871%3D|2977|2613|871|V|gtG/gtA|rs62637566&COSV63203125||1||SNV|EntrezGene||YES|||G|G|||||||0.1354|0.08823|0.08099|0.1175|0.01156|0.1984|0.155|0.1477|0.1287|0.05001|0.1243|0.09102|0.05702|0.1072|0.1238|0.003858|0.203|0.1327|0.152|0.1329|0.04004|0.203|gnomADg_FIN|uncertain_significance&likely_benign&benign|0&1|1&1||||||||||||2|9|-3|8|0.00|0.00|0.00|0.00|ADAMTSL2|||||||365611||Conflicting_classifications_of_pathogenicity|not_specified&not_provided&Geleophysic_dysplasia_1|NC_000009.12:g.133573863G>A||single_nucleotide_variant|ADAMTSL2:9719|MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623|Uncertain_significance(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	1/1:0,29:1:29:0,12:0,17:82:170,85,0:132.44,82.435,0:0,34.77,37.77:0,0,16,13:0,0,11,18	0/1:14,11:0.44:25:6,3:8,8:48:84,0,50:49.31,7.274e-05,53:0,34.77,37.77:5,9,6,5:9,5,8,3	0/1:16,20:0.556:36:8,9:8,11:48:85,0,49:50,7.0669e-05,52.034:0,34.77,37.77:8,8,8,12:12,4,9,11	A	synonymous_variant	LOW	ADAMTSL2	9719	Transcript	NM_014694.4	protein_coding	18/19		c.2613G>A	p.Val871%3D	2977	2613	871	V	gtG/gtA	rs62637566&COSV63203125	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	0.1354	0.08823	0.08099	0.1175	0.01156	0.1984	0.155	0.1477	0.1287	0.05001	0.1243	0.09102	0.05702	0.1072	0.1238	0.003858	0.203	0.1327	0.152	0.1329	0.04004	0.203	gnomADg_FIN	uncertain_significance&likely_benign&benign	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		2	9	-3	8	0	0	0	0	ADAMTSL2			NA				365611	NA	Conflicting_classifications_of_pathogenicity	not_specified&not_provided&Geleophysic_dysplasia_1	NC_000009.12:g.133573863G>A		single_nucleotide_variant	ADAMTSL2:9719	MedGen:CN169374&MedGen:C3661900&MONDO:MONDO:0009269&MedGen:C3278147&OMIM:231050&Orphanet:2623	Uncertain_significance(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		ADAMTSL2	Geleophysic dysplasia 1	AR	231050	Skelettal, skin, and connective tissue disorders	NBScreening	-12	Benign	BP4_Moderate,BP6,BP7,BA1	rs62637566	chr9_133573863_G_A	Female	01-Jan	Homozygous
chrX	13713450	.	C	CAAAAAAA	50	PASS	"FS=1.475;MQ=230.99;MQRankSum=1.775;QD=1.35;ReadPosRankSum=-1.284;SOR=0.412;FractionInformativeReads=0.865;R2_5P_bias=-5.3;DP=75;AF=0.5;AN=4;AC=2;CSQ=AAAAAAA|3_prime_UTR_variant|MODIFIER|TRAPPC2|6399|Transcript|NM_001011658.4|protein_coding|6/6||NM_001011658.4:c.*950_*956dup||1636-1637|||||rs57103709||-1||insertion|EntrezGene||YES|||||||||||0.05263||0|||||0.05882|0||0.3277|0.3745|0.304|0.2279|0.3117|0.3341|0.2252|0.2436|0.3321|0.3267|0.2282|0.3745|gnomADg_AFR|||1|||||||||||||||||||||||||||367977||Uncertain_significance|Spondyloepiphyseal_dysplasia_congenita&not_provided|NC_000023.11:g.13713451_13713457dup||Duplication|TRAPPC2:6399|MONDO:MONDO:0008471&MedGen:C2745959&OMIM:183900&Orphanet:94068&MedGen:C3661900||criteria_provided&_multiple_submitters&_no_conflicts|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:15,17:0.531:32:7,9:8,8:46:77,0,45:50,0.00011494,47.836:0,27,30.01:11,4,11,6:7,8,9,8	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:22,15:0.405:37:11,5:11,10:46:74,0,47:47.853,0.00011468,50:0,26,29.01:16,6,10,5:13,9,4,11	AAAAAAA	3_prime_UTR_variant	MODIFIER	TRAPPC2	6399	Transcript	NM_001011658.4	protein_coding	06-Jun		c.*950_*956dup		1636-1637					rs57103709	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.05263	NA	0	NA	NA	NA	NA	0.05882	0	NA	0.3277	0.3745	0.304	0.2279	0.3117	0.3341	0.2252	0.2436	0.3321	0.3267	0.2282	0.3745	gnomADg_AFR			1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				367977	NA	Uncertain_significance	Spondyloepiphyseal_dysplasia_congenita&not_provided	NC_000023.11:g.13713451_13713457dup		Duplication	TRAPPC2:6399	MONDO:MONDO:0008471&MedGen:C2745959&OMIM:183900&Orphanet:94068&MedGen:C3661900		criteria_provided&_multiple_submitters&_no_conflicts		TRAPPC2	Spondyloepiphyseal dysplasia tarda, X-linked	XLR	313400	Skelettal, skin, and connective tissue disorders	NBScreening	-8	Benign	BA1	rs57103709	chrX_13713450_C_CAAAAAAA	Female	0/1	Heterozygous
chrX	13714143	.	G	GA	44.04	PASS	"FS=4.043;MQ=241.76;MQRankSum=-0.437;QD=1.59;ReadPosRankSum=-1.544;SOR=0.193;FractionInformativeReads=0.926;R2_5P_bias=15.736;DP=61;AF=0.5;AN=4;AC=2;CSQ=A|3_prime_UTR_variant|MODIFIER|TRAPPC2|6399|Transcript|NM_001011658.4|protein_coding|6/6||NM_001011658.4:c.*263dup||943-944|||||rs1057515794||-1||insertion|EntrezGene||YES|||||||||||0.1857|0.1126|0.1641|0.1706|0.1728|0.2074|0.2222|0.1956|0.1725|0.1135|0.3836|0.2632|0.4933|0.2946|0.4589|0.3186|0.2908|0.3647|0.4633|0.4034|0.3073|0.4933|gnomADg_AMI|uncertain_significance&benign&likely_benign||1||||||||||||-41|-10|-10|-12|0.00|0.00|0.00|0.00|TRAPPC2|||||||367993||Conflicting_classifications_of_pathogenicity|Spondyloepiphyseal_dysplasia_congenita&not_provided|NC_000023.11:g.13714163dup||Duplication|TRAPPC2:6399|MONDO:MONDO:0008471&MedGen:C2745959&OMIM:183900&Orphanet:94068&MedGen:C3661900|Uncertain_significance(1)&Benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:17,8:0.32:25:8,1:9,7:43:47,0,50:43.048,0.00023712,53:0,4,7:12,5,4,4:9,8,3,5	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:19,10:0.345:29:12,5:7,5:44:48,0,50:44.042,0.00019311,53:0,4,7:16,3,6,4:13,6,7,3	A	3_prime_UTR_variant	MODIFIER	TRAPPC2	6399	Transcript	NM_001011658.4	protein_coding	06-Jun		c.*263dup		943-944					rs1057515794	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.1857	0.1126	0.1641	0.1706	0.1728	0.2074	0.2222	0.1956	0.1725	0.1135	0.3836	0.2632	0.4933	0.2946	0.4589	0.3186	0.2908	0.3647	0.4633	0.4034	0.3073	0.4933	gnomADg_AMI	uncertain_significance&benign&likely_benign		1	NA	NA	NA		NA	NA		NA	NA	NA		-41	-10	-10	-12	0	0	0	0	TRAPPC2			NA				367993	NA	Conflicting_classifications_of_pathogenicity	Spondyloepiphyseal_dysplasia_congenita&not_provided	NC_000023.11:g.13714163dup		Duplication	TRAPPC2:6399	MONDO:MONDO:0008471&MedGen:C2745959&OMIM:183900&Orphanet:94068&MedGen:C3661900	Uncertain_significance(1)&Benign(1)	criteria_provided&_conflicting_classifications		TRAPPC2	Spondyloepiphyseal dysplasia tarda, X-linked	XLR	313400	Skelettal, skin, and connective tissue disorders	NBScreening	-9	Benign	BP6,BA1	rs1057515794	chrX_13714143_G_GA	Female	0/1	Heterozygous
chrX	19360950	.	G	A	49.77	PASS	"FS=1.189;MQ=250;MQRankSum=5.39;QD=1.24;ReadPosRankSum=1.3;SOR=0.914;FractionInformativeReads=1;R2_5P_bias=-3.62;DP=40;AF=0.5;AN=2;AC=1;CSQ=A|3_prime_UTR_variant|MODIFIER|PDHA1|5160|Transcript|NM_000284.4|protein_coding|11/11||NM_000284.4:c.*1297G>A||2581|||||rs778678656||1||SNV|EntrezGene||YES|||G|G|||||||0.0009358|0.0001768|0.0004727|0|0|0.002323|0|0.001122|0.0005915|0|0.001069|6.411e-05|0.03061|0.0005591|0|0|0.002226|0|0.00146|0|0|0.03061|gnomADg_AMI|uncertain_significance||1||||||||||||-8|0|0|41|0.00|0.00|0.00|0.00|PDHA1|||||||914974||Uncertain_significance|Pyruvate_dehydrogenase_E1-alpha_deficiency|NC_000023.11:g.19360950G>A||single_nucleotide_variant|PDHA1:5160&MAP3K15:389840|MONDO:MONDO:0010717&MedGen:C1839413&OMIM:312170&Orphanet:79243||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	./.:.:.:.:.:.:.:.:.:.:.:.	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:21,19:0.475:40:12,7:9,12:47:85,0,47:49.773,8.9308e-05,50:0,34.77,37.78:10,11,8,11:11,10,12,7	A	3_prime_UTR_variant	MODIFIER	PDHA1	5160	Transcript	NM_000284.4	protein_coding	11-Nov		c.*1297G>A		2581					rs778678656	NA	1	NA	SNV	EntrezGene	NA	YES	NA	NA	G	G	NA	NA			NA	NA	0.0009358	0.0001768	0.0004727	0	0	0.002323	0	0.001122	0.0005915	0	0.001069	6.411e-05	0.03061	0.0005591	0	0	0.002226	0	0.00146	0	0	0.03061	gnomADg_AMI	uncertain_significance		1	NA	NA	NA		NA	NA		NA	NA	NA		-8	0	0	41	0	0	0	0	PDHA1			NA				914974	NA	Uncertain_significance	Pyruvate_dehydrogenase_E1-alpha_deficiency	NC_000023.11:g.19360950G>A		single_nucleotide_variant	PDHA1:5160&MAP3K15:389840	MONDO:MONDO:0010717&MedGen:C1839413&OMIM:312170&Orphanet:79243		criteria_provided&_single_submitter		PDHA1	Pyruvate dehydrogenase E1-alpha deficiency	XLD	312170	Inherited disorders of metabolism	NBScreening	-9	Benign	BP4_Strong,BS1_Supporting,BS2	rs778678656	chrX_19360950_G_A	Female	./.	Other
chrX	38286059	.	C	CTCCCCTTCTCCTTCCTCCCCT	55.78	PASS	"FS=0;MQ=118;QD=18.59;SOR=2.833;FractionInformativeReads=1;DP=3;AF=1;AN=1;AC=1;CSQ=TCCCCTTCTCCTTCCTCCCCT|inframe_insertion|MODERATE|RPGR|6103|Transcript|NM_001034853.2|protein_coding|15/15||NM_001034853.2:c.2919_2939dup|NP_001030025.1:p.Gly977_Glu983dup|3081-3082|2939-2940|980|E/EGEEGEGE|gag/gaAGGGGAGGAAGGAGAAGGGGAg|rs772859148||-1||insertion|EntrezGene||YES|||||||||||0.02245|0.07478|0.1088|0.0162|0.07662|0.0628|0.01386|0.007434|0.02672|0.09988|0.005699|0.0115|0|0.01136|0.004024|0.005822|0.00941|0|0.002174|0.004342|0.00813|0.1088|gnomADe_AMR|benign&likely_benign&likely_pathogenic||1|||||||||||||||||||||||||||1575633||Conflicting_classifications_of_pathogenicity|Retinitis_pigmentosa_3&Primary_ciliary_dyskinesia&not_provided|NC_000023.11:g.38286077_38286097dup||Duplication|RPGR:6103|MONDO:MONDO:0010227&MedGen:C1845667&OMIM:300029&Orphanet:791&Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:C3661900|Likely_pathogenic(1)&Benign(1)&Likely_benign(1)|criteria_provided&_conflicting_classifications|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	.:.:.:.:.:.:.:.:.:.:.:.	1:0,3:1:3:0,0:0,3:56:85,0:55.781,1.139e-05:0,29:0,0,0,3:0,0,3,0	.:.:.:.:.:.:.:.:.:.:.:.	TCCCCTTCTCCTTCCTCCCCT	inframe_insertion	MODERATE	RPGR	6103	Transcript	NM_001034853.2	protein_coding	15/15		c.2919_2939dup	p.Gly977_Glu983dup	3081-3082	2939-2940	980	E/EGEEGEGE	gag/gaAGGGGAGGAAGGAGAAGGGGAg	rs772859148	NA	-1	NA	insertion	EntrezGene	NA	YES	NA	NA			NA	NA			NA	NA	0.02245	0.07478	0.1088	0.0162	0.07662	0.0628	0.01386	0.007434	0.02672	0.09988	0.005699	0.0115	0	0.01136	0.004024	0.005822	0.00941	0	0.002174	0.004342	0.00813	0.1088	gnomADe_AMR	benign&likely_benign&likely_pathogenic		1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				1575633	NA	Conflicting_classifications_of_pathogenicity	Retinitis_pigmentosa_3&Primary_ciliary_dyskinesia&not_provided	NC_000023.11:g.38286077_38286097dup		Duplication	RPGR:6103	MONDO:MONDO:0010227&MedGen:C1845667&OMIM:300029&Orphanet:791&Human_Phenotype_Ontology:HP:0012265&MONDO:MONDO:0016575&MedGen:C0008780&OMIM:PS244400&Orphanet:244&MedGen:C3661900	Likely_pathogenic(1)&Benign(1)&Likely_benign(1)	criteria_provided&_conflicting_classifications		RPGR	Retinitis pigmentosa	XLR	268000	Eye disorders	NBScreening	-14	Benign	PM4,BP6_Very_Strong,BA1	rs772859148	chrX_38286059_C_CTCCCCTTCTCCTTCCTCCCCT	Female	.	Other
chrX	154531643	.	C	T	50	PASS	"FS=3.976;MQ=241.24;MQRankSum=2;QD=2.17;ReadPosRankSum=2;SOR=0.18;FractionInformativeReads=1;R2_5P_bias=-0.063;DP=45;AF=0.5;AN=4;AC=2;CSQ=T|3_prime_UTR_variant|MODIFIER|G6PD|2539|Transcript|NM_001360016.2|protein_coding|13/13||NM_001360016.2:c.*357G>A||1971|||||rs1050757&CR133485||-1||SNV|EntrezGene||YES|||C|C||||||0.5846|0.7596|0.09001|0.7306|0.7058|0.855|0.8981|0.5365|0.8453|0.7333|0.576|0.6412|0.15|0.8772|0.7275|0.7686|0.8698|0.9186|0.6991|0.862|0.6582|0.5241|0.9186|gnomADg_FIN|uncertain_significance|0&1|1&1|||||||||||||||||||||||||||1722702||Uncertain_significance|Anemia&_nonspherocytic_hemolytic&_due_to_G6PD_deficiency|NC_000023.11:g.154531643C>T||single_nucleotide_variant|G6PD:2539|MONDO:MONDO:0010480&MedGen:C2720289&OMIM:300908&Orphanet:466026||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,12:0.522:23:5,5:6,7:47:85,0,47:50,8.7754e-05,49.906:0,34.77,37.78:3,8,6,6:3,8,7,5	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:10,12:0.545:22:6,3:4,9:48:85,0,50:50,6.7304e-05,52.603:0,34.77,37.77:1,9,5,7:3,7,4,8	T	3_prime_UTR_variant	MODIFIER	G6PD	2539	Transcript	NM_001360016.2	protein_coding	13/13		c.*357G>A		1971					rs1050757&CR133485	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.5846	0.7596	0.09001	0.7306	0.7058	0.855	0.8981	0.5365	0.8453	0.7333	0.576	0.6412	0.15	0.8772	0.7275	0.7686	0.8698	0.9186	0.6991	0.862	0.6582	0.5241	0.9186	gnomADg_FIN	uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				1722702	NA	Uncertain_significance	Anemia&_nonspherocytic_hemolytic&_due_to_G6PD_deficiency	NC_000023.11:g.154531643C>T		single_nucleotide_variant	G6PD:2539	MONDO:MONDO:0010480&MedGen:C2720289&OMIM:300908&Orphanet:466026		criteria_provided&_single_submitter		G6PD	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	XLD	300908	"Haematological disorders;Inherited disorders of metabolism"	NBScreening	-12	Benign	BP4_Strong,BA1	rs1050757	chrX_154531643_C_T	Female	0/1	Heterozygous
chrX	154531643	.	C	T	50	PASS	"FS=3.976;MQ=241.24;MQRankSum=2;QD=2.17;ReadPosRankSum=2;SOR=0.18;FractionInformativeReads=1;R2_5P_bias=-0.063;DP=45;AF=0.5;AN=4;AC=2;CSQ=T|3_prime_UTR_variant|MODIFIER|G6PD|2539|Transcript|NM_001360016.2|protein_coding|13/13||NM_001360016.2:c.*357G>A||1971|||||rs1050757&CR133485||-1||SNV|EntrezGene||YES|||C|C||||||0.5846|0.7596|0.09001|0.7306|0.7058|0.855|0.8981|0.5365|0.8453|0.7333|0.576|0.6412|0.15|0.8772|0.7275|0.7686|0.8698|0.9186|0.6991|0.862|0.6582|0.5241|0.9186|gnomADg_FIN|uncertain_significance|0&1|1&1|||||||||||||||||||||||||||1722702||Uncertain_significance|Anemia&_nonspherocytic_hemolytic&_due_to_G6PD_deficiency|NC_000023.11:g.154531643C>T||single_nucleotide_variant|G6PD:2539|MONDO:MONDO:0010480&MedGen:C2720289&OMIM:300908&Orphanet:466026||criteria_provided&_single_submitter|"	GT:AD:AF:DP:F1R2:F2R1:GQ:PL:GP:PRI:SB:MB	0/1:11,12:0.522:23:5,5:6,7:47:85,0,47:50,8.7754e-05,49.906:0,34.77,37.78:3,8,6,6:3,8,7,5	./.:.:.:.:.:.:.:.:.:.:.:.	0/1:10,12:0.545:22:6,3:4,9:48:85,0,50:50,6.7304e-05,52.603:0,34.77,37.77:1,9,5,7:3,7,4,8	T	3_prime_UTR_variant	MODIFIER	G6PD	2539	Transcript	NM_001360016.2	protein_coding	13/13		c.*357G>A		1971					rs1050757&CR133485	NA	-1	NA	SNV	EntrezGene	NA	YES	NA	NA	C	C	NA	NA			NA	0.5846	0.7596	0.09001	0.7306	0.7058	0.855	0.8981	0.5365	0.8453	0.7333	0.576	0.6412	0.15	0.8772	0.7275	0.7686	0.8698	0.9186	0.6991	0.862	0.6582	0.5241	0.9186	gnomADg_FIN	uncertain_significance	0&1	1&1	NA	NA	NA		NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA				NA				1722702	NA	Uncertain_significance	Anemia&_nonspherocytic_hemolytic&_due_to_G6PD_deficiency	NC_000023.11:g.154531643C>T		single_nucleotide_variant	G6PD:2539	MONDO:MONDO:0010480&MedGen:C2720289&OMIM:300908&Orphanet:466026		criteria_provided&_single_submitter		G6PD	Glucose-6-phosphate dehydrogenase deficiency	XLR	232220	"Haematological disorders;Inherited disorders of metabolism"	NBScreening	-12	Benign	BP4_Strong,BA1	rs1050757	chrX_154531643_C_T	Female	0/1	Heterozygous